archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,PID INTEGRIN4 PATHWAY,5.6999e-08,1.4589,1.3862,1,1
1,INTERCELLULAR JUNCTION ASSEMBLY,6.93e-08,1.1892,1.0936,1,1
1,REACTOME SMOOTH MUSCLE CONTRACTION,2.8496e-08,1.1892,1.3187,1,1
1,BIOCARTA PLATELETAPP PATHWAY,2.1702e-06,1.1877,0.98736,1,1
1,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,6.8936e-07,1.1664,1.0976,1,1
1,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,5.508e-06,1.1564,1.0611,1,1
1,PID INTEGRIN5 PATHWAY,2.3654e-06,1.0719,0.96848,1,1
1,BIOCARTA IL4 PATHWAY,1.8084e-07,1.0425,1.0236,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON SULFUR GROUP OF DONORS,4.6826e-08,1.0254,1.0213,1,1
1,CYTOPLASM ORGANIZATION AND BIOGENESIS,4.9191e-08,1.0111,0.923,1,1
1,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,6.6003e-08,0.97894,1.0229,1,1
1,SA MMP CYTOKINE CONNECTION,1.2862e-06,0.92128,0.92703,1,1
1,PID INTEGRIN1 PATHWAY,5.6999e-08,0.91345,1.0017,1,1
1,INTERCELLULAR JUNCTION ASSEMBLY AND MAINTENANCE,1.8084e-07,0.90925,0.86749,1,1
1,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,1.1964e-05,0.90812,0.9845,1,1
1,POSITIVE REGULATION OF ANGIOGENESIS,3.17e-07,0.90145,0.78638,1,1
1,PID INTEGRIN3 PATHWAY,5.0194e-07,0.88711,0.88476,1,1
1,KEGG ALLOGRAFT REJECTION,1.1493e-05,0.88557,0.75361,1,1
1,BIOCARTA VITCB PATHWAY,7.547e-05,0.88459,0.674,1,1
1,REACTOME IL 6 SIGNALING,6.5149e-05,0.87687,0.75241,1,1
1,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,1.1788e-07,0.8426,0.75541,1,1
1,BIOCARTA AMI PATHWAY,3.7145e-05,0.83775,0.61897,1,1
1,BIOCARTA FIBRINOLYSIS PATHWAY,1.4674e-06,0.8342,0.83257,1,1
1,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,4.6826e-08,0.8287,0.89107,1,1
1,REACTOME METABOLISM OF PORPHYRINS,6.5896e-07,0.82321,0.81342,1,1
1,PID A6B1 A6B4 INTEGRIN PATHWAY,5.2533e-07,0.8216,0.70286,1,1
1,PID UPA UPAR PATHWAY,5.1671e-08,0.80786,0.99585,1,1
1,POSITIVE REGULATION OF CELL CYCLE,1.7806e-05,0.79532,0.61425,1,1
1,BIOCARTA SODD PATHWAY,2.0784e-06,0.78442,0.90777,1,1
1,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,4.7955e-07,0.78193,0.7139,1,1
1,COLLAGEN,6.4994e-06,0.77495,0.87419,1,1
1,KEGG ECM RECEPTOR INTERACTION,4.6826e-08,0.77305,0.83156,1,1
1,REACTOME COLLAGEN FORMATION,1.6729e-06,0.76633,0.7354,1,1
1,POSITIVE REGULATION OF PHOSPHORYLATION,9.2696e-08,0.75502,0.78639,1,1
1,REACTOME SIGNALING BY HIPPO,9.3916e-06,0.74033,0.71474,1,1
1,REACTOME INTERFERON ALPHA BETA SIGNALING,5.4121e-05,0.73772,0.80672,1,1
1,BIOCARTA TOB1 PATHWAY,9.7801e-06,0.73421,0.63622,1,1
1,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,2.6322e-07,0.7276,0.75047,1,1
1,REACTOME ER PHAGOSOME PATHWAY,1.6729e-06,0.72723,0.63561,1,1
1,KEGG AUTOIMMUNE THYROID DISEASE,2.4346e-05,0.72535,0.58475,1,1
1,PID SYNDECAN 1 PATHWAY,3.4772e-07,0.72206,0.82676,1,1
1,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,3.8131e-07,0.72159,0.68339,1,1
1,REACTOME MUSCLE CONTRACTION,6.2859e-08,0.72116,0.76099,1,1
1,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,2.6322e-07,0.71954,0.69676,1,1
1,BIOCARTA RELA PATHWAY,1.3605e-07,0.71128,0.63692,1,1
1,PID ERBB NETWORK PATHWAY,3.1904e-06,0.71026,0.6649,1,1
1,PID SYNDECAN 4 PATHWAY,1.6729e-06,0.70708,0.75806,1,1
1,KEGG OTHER GLYCAN DEGRADATION,1.104e-05,0.69845,0.63779,1,1
1,REGULATION OF CELL MIGRATION,1.1237e-07,0.69518,0.72719,1,1
1,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,2.0033e-05,0.69414,0.62615,1,1
1,SARCOMERE,1.906e-06,0.6892,0.65634,1,1
1,PID INTEGRIN CS PATHWAY,1.6452e-07,0.68519,0.79337,1,1
1,REACTOME HYALURONAN METABOLISM,4.5813e-07,0.68492,0.63152,1,1
1,KEGG GLYCOSAMINOGLYCAN DEGRADATION,3.4728e-06,0.68206,0.53168,1,1
1,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,4.4712e-06,0.68198,0.67869,1,1
1,BIOCARTA PML PATHWAY,5.4977e-07,0.68109,0.63563,1,1
1,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.3287e-06,0.67727,0.65996,1,1
1,KEGG GRAFT VERSUS HOST DISEASE,1.5201e-05,0.67474,0.68451,1,1
1,BIOCARTA CASPASE PATHWAY,3.1888e-05,0.67456,0.6168,1,1
1,EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX,0.00074557,0.66074,0.46093,1,1
1,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,5.4977e-07,0.6604,0.59174,1,1
1,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,6.0198e-07,0.65841,0.6668,1,1
1,BIOCARTA EXTRINSIC PATHWAY,6.0504e-05,0.65484,0.57998,1,1
1,BIOCARTA TH1TH2 PATHWAY,8.3127e-06,0.65327,0.59658,1,1
1,BIOCARTA IL10 PATHWAY,3.6228e-06,0.65147,0.69598,1,1
1,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,3.6414e-07,0.64746,0.64575,1,1
1,REACTOME CALNEXIN CALRETICULIN CYCLE,6.2367e-06,0.64491,0.56078,1,1
1,BIOCARTA INTRINSIC PATHWAY,0.00021909,0.64288,0.52985,1,1
1,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,3.17e-07,0.63887,0.65013,1,1
1,BIOCARTA DEATH PATHWAY,1.3441e-06,0.63697,0.59497,1,1
1,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,1.7806e-05,0.63541,0.54423,1,1
1,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,4.6623e-06,0.62909,0.52421,1,1
1,EXTRACELLULAR MATRIX PART,5.0194e-07,0.6215,0.66929,1,1
1,PID NFKAPPABCANONICALPATHWAY,2.6902e-06,0.62119,0.55847,1,1
1,BIOCARTA CARDIACEGF PATHWAY,7.8282e-05,0.61927,0.58626,1,1
1,PID FRA PATHWAY,9.2696e-08,0.61697,0.82533,1,1
1,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,3.3202e-07,0.61295,0.62817,1,1
1,I KAPPAB KINASE NF KAPPAB CASCADE,5.2533e-07,0.61158,0.59793,1,1
1,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,9.8628e-07,0.61091,0.52824,1,1
1,LIPID HOMEOSTASIS,2.9301e-06,0.60831,0.61759,1,1
1,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,2.8077e-06,0.60604,0.55157,1,1
1,PID AVB3 INTEGRIN PATHWAY,6.2859e-08,0.60579,0.68987,1,1
1,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,4.8612e-06,0.59925,0.54876,1,1
1,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,1.9873e-07,0.59725,0.49886,1,1
1,BIOCARTA TID PATHWAY,1.3441e-06,0.59295,0.51767,1,1
1,BASEMENT MEMBRANE,7.5427e-07,0.59262,0.58553,1,1
1,BIOCARTA CD40 PATHWAY,8.2505e-07,0.59119,0.66559,1,1
1,REGULATION OF INTRACELLULAR TRANSPORT,2.0833e-05,0.59053,0.47347,1,1
1,BIOCARTA INFLAM PATHWAY,3.17e-07,0.57915,0.75754,1,1
1,PID AP1 PATHWAY,1.8521e-05,0.57889,0.51982,1,1
1,PROTEASE INHIBITOR ACTIVITY,0.00010462,0.57813,0.46179,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,9.389e-05,0.57631,0.41377,1,1
1,BIOCARTA NFKB PATHWAY,1.4674e-06,0.57552,0.5593,1,1
1,ENDOPLASMIC RETICULUM LUMEN,1.6729e-06,0.57439,0.65182,1,1
1,LIPID TRANSPORT,4.1112e-06,0.57267,0.46772,1,1
1,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,1.9904e-06,0.57117,0.4832,1,1
1,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,9.4334e-07,0.56866,0.58429,1,1
1,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.011326,0.56857,0.35751,1,1
1,EPITHELIAL TO MESENCHYMAL TRANSITION,4.4878e-05,0.56821,0.71685,1,1
1,PID AVB3 OPN PATHWAY,0.00047456,0.56697,0.47523,1,1
1,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.0045306,0.56647,0.43662,1,1
1,BASAL LAMINA,1.7118e-05,0.56618,0.55314,1,1
1,REACTOME PEPTIDE CHAIN ELONGATION,0.02166,0.56532,0.35635,1,1
1,BIOCARTA CLASSIC PATHWAY,8.3127e-06,0.56396,0.60231,1,1
1,PID TNFPATHWAY,2.2879e-07,0.56132,0.54034,1,1
1,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.7955e-07,0.56091,0.60879,1,1
1,KEGG RIBOSOME,0.02166,0.56021,0.34323,1,1
1,POSITIVE REGULATION OF DNA METABOLIC PROCESS,4.6623e-06,0.55833,0.5462,1,1
1,REGULATION OF PROTEIN MODIFICATION PROCESS,1.2366e-07,0.55769,0.5893,1,1
1,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,6.8936e-07,0.55689,0.53686,1,1
1,PROTEASOME COMPLEX,1.9263e-05,0.55579,0.45819,1,1
1,BIOCARTA CBL PATHWAY,4.0073e-05,0.55545,0.516,1,1
1,EXTRACELLULAR MATRIX,9.2696e-08,0.55503,0.67883,1,1
1,PROTEINACEOUS EXTRACELLULAR MATRIX,9.7275e-08,0.55419,0.68169,1,1
1,PID TOLL ENDOGENOUS PATHWAY,0.0049174,0.55364,0.40185,1,1
1,REACTOME REGULATION OF COMPLEMENT CASCADE,2.1663e-05,0.55319,0.65332,1,1
1,PID MYC REPRESSPATHWAY,1.1237e-07,0.5513,0.515,1,1
1,BIOCARTA IL22BP PATHWAY,0.00044439,0.54586,0.47456,1,1
1,REACTOME ACYL CHAIN REMODELLING OF PI,5.2139e-05,0.54572,0.4369,1,1
1,BIOCARTA RHO PATHWAY,4.3763e-07,0.54535,0.50634,1,1
1,REGULATION OF CELL SHAPE,6.4994e-06,0.54027,0.48371,1,1
1,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,5.2837e-06,0.53966,0.46207,1,1
1,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.0179e-06,0.53902,0.64866,1,1
1,KEGG ASTHMA,0.00072223,0.53895,0.34652,1,1
1,OXIDOREDUCTASE ACTIVITY GO 0016706,0.011612,0.53531,0.42632,1,1
1,BIOCARTA P53HYPOXIA PATHWAY,0.00059588,0.53324,0.40442,1,1
1,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,1.4044e-06,0.53223,0.54445,1,1
1,PID CASPASE PATHWAY,0.00030804,0.5321,0.41188,1,1
1,PID SYNDECAN 2 PATHWAY,1.3441e-06,0.53025,0.56494,1,1
1,REACTOME HS GAG DEGRADATION,0.00055855,0.53019,0.48185,1,1
1,FOCAL ADHESION,0.00095906,0.52776,0.48592,1,1
1,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,2.9301e-06,0.52775,0.48959,1,1
1,KEGG VIRAL MYOCARDITIS,8.628e-07,0.5267,0.5332,1,1
1,STRUCTURAL CONSTITUENT OF RIBOSOME,0.027188,0.52658,0.32664,1,1
1,KEGG PROTEASOME,7.3528e-06,0.52528,0.48275,1,1
1,BIOCARTA NTHI PATHWAY,4.6623e-06,0.52485,0.4963,1,1
1,FATTY ACID BETA OXIDATION,4.8612e-06,0.52414,0.62851,1,1
1,PID TRAIL PATHWAY,1.0779e-06,0.52298,0.48767,1,1
1,MYELOID LEUKOCYTE DIFFERENTIATION,0.016734,0.52273,0.41108,1,1
1,KEGG ANTIGEN PROCESSING AND PRESENTATION,4.1617e-05,0.52182,0.49426,1,1
1,BIOCARTA COMP PATHWAY,1.3441e-06,0.52102,0.55175,1,1
1,CONTRACTILE FIBER PART,1.8958e-07,0.51809,0.54159,1,1
1,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.01282,0.51712,0.34724,1,1
1,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,3.7791e-06,0.51501,0.45549,1,1
1,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,3.1491e-08,0.51429,0.57909,1,1
1,REGULATION OF CELL MORPHOGENESIS,5.2837e-06,0.5117,0.47292,1,1
1,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.0689e-05,0.51118,0.45838,1,1
1,REACTOME STRIATED MUSCLE CONTRACTION,2.4692e-06,0.51101,0.47165,1,1
1,PID TGFBRPATHWAY,1.4268e-07,0.51078,0.49484,1,1
1,PID IL27PATHWAY,6.0198e-07,0.5106,0.58819,1,1
1,PID PDGFRAPATHWAY,6.5149e-05,0.51007,0.41516,1,1
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,3.9418e-06,0.5075,0.50046,1,1
1,BIOCARTA RANKL PATHWAY,0.00010092,0.50528,0.56831,1,1
1,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.0079323,0.5049,0.32564,1,1
1,PID INTEGRIN A9B1 PATHWAY,5.0683e-06,0.50452,0.64634,1,1
1,KEGG BLADDER CANCER,3.0689e-05,0.50424,0.39214,1,1
1,KEGG FOCAL ADHESION,2.2167e-08,0.50401,0.60004,1,1
1,CELL MATRIX JUNCTION,6.7596e-05,0.50333,0.50932,1,1
1,KEGG LYSOSOME,5.2837e-06,0.5029,0.42886,1,1
1,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,5.9841e-06,0.50263,0.54748,1,1
1,REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS,0.0094949,0.50249,0.33745,1,1
1,PID ECADHERIN STABILIZATION PATHWAY,1.0779e-06,0.50105,0.48463,1,1
1,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,8.0176e-08,0.50105,0.53819,1,1
1,ST TUMOR NECROSIS FACTOR PATHWAY,7.889e-07,0.4989,0.59424,1,1
1,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,3.4772e-07,0.49663,0.57696,1,1
1,STEROL BINDING,2.4346e-05,0.49657,0.53083,1,1
1,JAK STAT CASCADE,2.1663e-05,0.49636,0.48902,1,1
1,BIOCARTA CELL2CELL PATHWAY,2.2524e-05,0.49588,0.49596,1,1
1,PID HIF2PATHWAY,0.00031859,0.49549,0.43639,1,1
1,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,9.0179e-06,0.49544,0.47542,1,1
1,SA CASPASE CASCADE,1.1267e-06,0.49415,0.50526,1,1
1,REGULATION OF VIRAL REPRODUCTION,0.0010206,0.49324,0.36438,1,1
1,BIOCARTA UCALPAIN PATHWAY,6.8936e-07,0.4931,0.62365,1,1
1,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,3.4728e-06,0.49233,0.46018,1,1
1,PID DELTANP63PATHWAY,4.3218e-05,0.49086,0.5439,1,1
1,REACTOME GAP JUNCTION DEGRADATION,8.3127e-06,0.49056,0.47496,1,1
1,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,4.1112e-06,0.49001,0.47849,1,1
1,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,7.5427e-07,0.48606,0.46776,1,1
1,BIOCARTA TEL PATHWAY,2.3418e-05,0.48591,0.5177,1,1
1,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,3.0576e-06,0.48475,0.64018,1,1
1,REACTOME INTERFERON SIGNALING,1.5201e-05,0.48399,0.46132,1,1
1,BIOCARTA PROTEASOME PATHWAY,2.0033e-05,0.48229,0.38588,1,1
1,REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,9.0221e-07,0.48146,0.5205,1,1
1,COLLAGEN BINDING,0.016734,0.47876,0.52859,1,1
1,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.00026003,0.47833,0.36716,1,1
1,KEGG SMALL CELL LUNG CANCER,4.3763e-07,0.47473,0.441,1,1
1,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,1.3441e-06,0.47362,0.4265,1,1
1,KEGG SULFUR METABOLISM,0.00030804,0.4736,0.38077,1,1
1,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,9.8628e-07,0.4728,0.4715,1,1
1,PID ILK PATHWAY,4.3763e-07,0.47253,0.55056,1,1
1,BIOCARTA SPRY PATHWAY,0.00027832,0.47173,0.42104,1,1
1,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.023741,0.47168,0.30053,1,1
1,LIPID RAFT,4.6597e-05,0.4695,0.45273,1,1
1,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,4.5813e-07,0.46937,0.50355,1,1
1,PID FAK PATHWAY,1.5691e-07,0.46806,0.50334,1,1
1,BIOCARTA FAS PATHWAY,4.1112e-06,0.46806,0.46044,1,1
1,LYSOSOMAL TRANSPORT,2.8891e-07,0.46737,0.52095,1,1
1,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.014841,0.46701,0.29822,1,1
1,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,1.1964e-05,0.46697,0.35858,1,1
1,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,5.753e-07,0.46493,0.41456,1,1
1,INTEGRIN COMPLEX,9.3916e-06,0.46424,0.63126,1,1
1,REACTOME HDL MEDIATED LIPID TRANSPORT,3.5759e-05,0.46381,0.45326,1,1
1,REACTOME TRANSLATION,0.0059384,0.46357,0.3049,1,1
1,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,1.2962e-05,0.46309,0.5017,1,1
1,PROTEIN TARGETING TO MITOCHONDRION,0.00029782,0.46271,0.38384,1,1
1,BIOCARTA LAIR PATHWAY,4.1112e-06,0.46075,0.61309,1,1
1,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,1.7806e-05,0.46051,0.39019,1,1
1,PEPTIDYL TYROSINE MODIFICATION,3.3202e-07,0.46014,0.52433,1,1
1,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,4.3218e-05,0.45996,0.50154,1,1
1,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00057693,0.45958,0.40017,1,1
1,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.00030804,0.45902,0.38858,1,1
1,PEPTIDYL TYROSINE PHOSPHORYLATION,6.2985e-07,0.45719,0.51566,1,1
1,KEGG COMPLEMENT AND COAGULATION CASCADES,2.1702e-06,0.45468,0.50685,1,1
1,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,7.6603e-06,0.45446,0.44134,1,1
1,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,2.4692e-06,0.45365,0.4679,1,1
1,COFACTOR METABOLIC PROCESS,0.00013917,0.45188,0.31938,1,1
1,REACTOME KERATAN SULFATE DEGRADATION,1.9263e-05,0.45163,0.61141,1,1
1,REGULATION OF MUSCLE CONTRACTION,4.6597e-05,0.45087,0.46599,1,1
1,PID TAP63PATHWAY,3.7145e-05,0.45086,0.47328,1,1
1,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,1.1237e-07,0.45073,0.45449,1,1
1,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.00021909,0.44995,0.31874,1,1
1,PROTEIN IMPORT INTO NUCLEUS,2.6902e-06,0.44791,0.38046,1,1
1,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.00037661,0.44695,0.33841,1,1
1,SULFUR COMPOUND BIOSYNTHETIC PROCESS,1.4963e-07,0.44598,0.58957,1,1
1,REACTOME SIGNALING BY WNT,2.3654e-06,0.4444,0.38398,1,1
1,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,1.0311e-06,0.44284,0.41251,1,1
1,HEPARIN BINDING,6.5149e-05,0.44263,0.36378,1,1
1,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,1.1493e-05,0.44221,0.36573,1,1
1,AMINE BIOSYNTHETIC PROCESS,0.00047456,0.44124,0.37461,1,1
1,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,6.4994e-06,0.44109,0.39319,1,1
1,BIOCARTA CTL PATHWAY,4.6597e-05,0.44108,0.48952,1,1
1,FATTY ACID OXIDATION,2.3418e-05,0.44102,0.44418,1,1
1,REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES,6.7596e-05,0.43939,0.45615,1,1
1,PID INTEGRIN A4B1 PATHWAY,0.00040247,0.43882,0.36492,1,1
1,REGULATION OF PHOSPHORYLATION,7.6603e-06,0.43878,0.41082,1,1
1,HEME METABOLIC PROCESS,7.2754e-05,0.43875,0.45048,1,1
1,BIOCARTA GCR PATHWAY,7.013e-05,0.43837,0.40843,1,1
1,REACTOME P75NTR SIGNALS VIA NFKB,4.4878e-05,0.43806,0.46106,1,1
1,INTRINSIC TO GOLGI MEMBRANE,1.4039e-05,0.4362,0.37274,1,1
1,BASOLATERAL PLASMA MEMBRANE,0.0001165,0.43576,0.3529,1,1
1,BIOCARTA EIF PATHWAY,0.0028141,0.43467,0.27381,1,1
1,BIOCARTA HIVNEF PATHWAY,4.1112e-06,0.43424,0.42243,1,1
1,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,1.5201e-05,0.43371,0.46901,1,1
1,INTERLEUKIN BINDING,4.2876e-06,0.43364,0.52297,1,1
1,CELLULAR DEFENSE RESPONSE,7.013e-05,0.43185,0.42508,1,1
1,INTERLEUKIN RECEPTOR ACTIVITY,2.0833e-05,0.43166,0.58364,1,1
1,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.014486,0.43153,0.28484,1,1
1,REGULATION OF DNA REPLICATION,0.00032948,0.43095,0.37543,1,1
1,BIOCARTA GSK3 PATHWAY,1.5816e-05,0.42993,0.39163,1,1
1,REACTOME CS DS DEGRADATION,0.00016595,0.42948,0.67709,1,1
1,BIOCARTA IL1R PATHWAY,0.00052342,0.42899,0.41908,1,1
1,CELL SUBSTRATE ADHERENS JUNCTION,0.00021909,0.42756,0.47671,1,1
1,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,9.3916e-06,0.42716,0.37486,1,1
1,NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00022676,0.427,0.39444,1,1
1,RAS GTPASE ACTIVATOR ACTIVITY,0.00018427,0.42621,0.36099,1,1
1,REACTOME LIPOPROTEIN METABOLISM,1.0604e-05,0.42504,0.40069,1,1
1,VIRAL REPRODUCTIVE PROCESS,3.8131e-07,0.42501,0.42815,1,1
1,BIOCARTA TNFR2 PATHWAY,1.8521e-05,0.42406,0.4926,1,1
1,SPHINGOID METABOLIC PROCESS,1.9904e-06,0.42381,0.40639,1,1
1,PID IL6 7PATHWAY,4.0073e-05,0.42319,0.42754,1,1
1,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,4.2876e-06,0.42309,0.4024,1,1
1,RUFFLE,0.00063551,0.42193,0.40898,1,1
1,REGULATION OF CELL GROWTH,3.4728e-06,0.42085,0.41752,1,1
1,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.023741,0.41884,0.45028,1,1
1,CYTOKINE BINDING,9.3916e-06,0.41876,0.36508,1,1
1,KEGG RENIN ANGIOTENSIN SYSTEM,0.00042998,0.41853,0.40971,1,1
1,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,1.2308e-06,0.41821,0.50423,1,1
1,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,2.7343e-05,0.41688,0.32319,1,1
1,ST GAQ PATHWAY,6.7728e-06,0.41681,0.40413,1,1
1,VIRAL GENOME REPLICATION,1.4674e-06,0.41664,0.41358,1,1
1,PID LYMPHANGIOGENESIS PATHWAY,1.0604e-05,0.41525,0.5233,1,1
1,KEGG HEMATOPOIETIC CELL LINEAGE,1.1267e-06,0.41501,0.50594,1,1
1,PROTEIN TYROSINE KINASE ACTIVITY,2.5308e-05,0.41336,0.34054,1,1
1,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,2.1663e-05,0.41294,0.43801,1,1
1,PID ARF 3PATHWAY,9.8628e-07,0.41232,0.39599,1,1
1,STEROID BINDING,0.00023468,0.41231,0.38231,1,1
1,PID P53DOWNSTREAMPATHWAY,0.0022332,0.41197,0.30148,1,1
1,BIOCARTA ARAP PATHWAY,1.7474e-06,0.41061,0.41553,1,1
1,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.0001547,0.41033,0.46487,1,1
1,PID IL23PATHWAY,0.0047853,0.41032,0.37512,1,1
1,PROTEOGLYCAN METABOLIC PROCESS,0.00011241,0.40995,0.36058,1,1
1,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.00021909,0.40965,0.36297,1,1
1,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,1.2962e-05,0.40945,0.35142,1,1
1,REACTOME REGULATION OF APOPTOSIS,2.6902e-06,0.40934,0.37844,1,1
1,REACTOME SHC1 EVENTS IN EGFR SIGNALING,3.8583e-05,0.4092,0.37455,1,1
1,AGING,0.00011241,0.40869,0.40071,1,1
1,PID HIVNEFPATHWAY,6.7596e-05,0.40866,0.38388,1,1
1,COFACTOR BIOSYNTHETIC PROCESS,7.8282e-05,0.40744,0.3818,1,1
1,KEGG APOPTOSIS,2.0784e-06,0.40637,0.38631,1,1
1,STEROID HORMONE RECEPTOR ACTIVITY,2.9532e-05,0.40593,0.33401,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,4.3218e-05,0.40554,0.45946,1,1
1,RESPONSE TO OXIDATIVE STRESS,4.8612e-06,0.40438,0.34552,1,1
1,NUCLEAR IMPORT,8.3127e-06,0.40343,0.34734,1,1
1,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,1.4039e-05,0.40341,0.36542,1,1
1,REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS,0.0031536,0.40248,0.37207,1,1
1,MEMBRANE COAT,5.0683e-06,0.4017,0.34018,1,1
1,COATED MEMBRANE,5.0683e-06,0.4017,0.34018,1,1
1,KEGG VALINE LEUCINE AND ISOLEUCINE BIOSYNTHESIS,0.011326,0.40047,0.3713,1,1
1,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,6.2786e-05,0.40005,0.29597,1,1
1,REACTOME METABOLISM OF MRNA,0.00013917,0.39997,0.31121,1,1
1,TRANSITION METAL ION TRANSPORT,4.2876e-06,0.39848,0.39099,1,1
1,INTERFERON GAMMA PRODUCTION,4.6597e-05,0.39787,0.37456,1,1
1,BIOCARTA EGFR SMRTE PATHWAY,0.0031536,0.39612,0.42962,1,1
1,RESPONSE TO DRUG,0.00065623,0.39538,0.33284,1,1
1,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,9.3916e-06,0.39525,0.36966,1,1
1,AMINOPEPTIDASE ACTIVITY,5.7413e-06,0.39322,0.43891,1,1
1,REACTOME INFLUENZA LIFE CYCLE,0.0079323,0.39313,0.27396,1,1
1,PID TCPTP PATHWAY,1.0311e-06,0.392,0.43213,1,1
1,RHO GTPASE ACTIVATOR ACTIVITY,9.389e-05,0.39196,0.38422,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.0013872,0.39182,0.46715,1,1
1,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,7.9801e-06,0.39062,0.37079,1,1
1,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.0081404,0.38997,0.31125,1,1
1,REACTOME COMPLEMENT CASCADE,3.7791e-06,0.38988,0.4859,1,1
1,BIOCARTA SALMONELLA PATHWAY,1.6015e-06,0.38958,0.42404,1,1
1,ER GOLGI INTERMEDIATE COMPARTMENT,7.547e-05,0.38922,0.45653,1,1
1,REACTOME GAP JUNCTION ASSEMBLY,0.00052342,0.3886,0.32859,1,1
1,TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.508e-06,0.38845,0.40732,1,1
1,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,9.0179e-06,0.38753,0.4336,1,1
1,REACTOME INTERFERON GAMMA SIGNALING,0.0032441,0.3852,0.42254,1,1
1,ANTI APOPTOSIS,2.5122e-07,0.38464,0.39228,1,1
1,PID WNT SIGNALING PATHWAY,0.00016595,0.38422,0.41077,1,1
1,LYSOSOME ORGANIZATION AND BIOGENESIS,0.001228,0.38253,0.33417,1,1
1,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,2.3418e-05,0.3824,0.32406,1,1
1,BIOCARTA CDC42RAC PATHWAY,4.8612e-06,0.38207,0.42119,1,1
1,REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL,0.0028141,0.38112,0.39947,1,1
1,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,2.8418e-05,0.38109,0.30518,1,1
1,PID ARF6 PATHWAY,2.7578e-07,0.38016,0.46743,1,1
1,KEGG GALACTOSE METABOLISM,0.00032948,0.37913,0.28035,1,1
1,PID RAS PATHWAY,3.1904e-06,0.37487,0.4389,1,1
1,PID GLYPICAN 1PATHWAY,9.7801e-06,0.37168,0.39289,1,1
1,PID AURORA B PATHWAY,9.7346e-05,0.37153,0.37583,1,1
1,BIOCARTA CERAMIDE PATHWAY,0.0013054,0.37112,0.29126,1,1
1,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,1.5331e-06,0.37086,0.37358,1,1
1,GROWTH FACTOR ACTIVITY,7.0571e-06,0.36884,0.40084,1,1
1,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,1.1493e-05,0.36594,0.36984,1,1
1,PROTEIN IMPORT,6.0198e-07,0.36524,0.32147,1,1
1,SIGNAL SEQUENCE BINDING,0.00011241,0.36418,0.2903,1,1
1,BIOCARTA WNT PATHWAY,0.00019079,0.36219,0.32209,1,1
1,BIOCARTA EPONFKB PATHWAY,0.018836,0.36127,0.28338,1,1
1,BIOCARTA IL6 PATHWAY,0.00019753,0.36097,0.43226,1,1
1,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,9.7801e-06,0.36061,0.41925,1,1
1,DRUG BINDING,2.8418e-05,0.36056,0.35259,1,1
1,BIOCARTA MCALPAIN PATHWAY,5.0683e-06,0.3602,0.47889,1,1
1,MYOBLAST DIFFERENTIATION,0.012508,0.36002,0.35832,1,1
1,VESICLE COAT,2.0833e-05,0.35944,0.31887,1,1
1,COENZYME METABOLIC PROCESS,0.0021062,0.35894,0.25632,1,1
1,NEGATIVE REGULATION OF APOPTOSIS,1.4044e-06,0.35838,0.34677,1,1
1,KEGG THYROID CANCER,3.8583e-05,0.35824,0.33959,1,1
1,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.00049035,0.35796,0.40231,1,1
1,KEGG SELENOAMINO ACID METABOLISM,7.013e-05,0.35781,0.29227,1,1
1,GOLGI MEMBRANE,7.2111e-07,0.35778,0.34351,1,1
1,PID IL12 STAT4PATHWAY,6.5149e-05,0.3573,0.33934,1,1
1,REGULATION OF ANGIOGENESIS,1.349e-05,0.35708,0.3821,1,1
1,INFLAMMATORY RESPONSE,0.00013917,0.35703,0.35301,1,1
1,BIOCARTA TGFB PATHWAY,0.014486,0.35652,0.3331,1,1
1,BIOCARTA TNFR1 PATHWAY,0.00017796,0.35539,0.30564,1,1
1,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.00090094,0.3551,0.27754,1,1
1,PID RXR VDR PATHWAY,2.5774e-06,0.35428,0.39199,1,1
1,TRANSLATION,0.00032948,0.35375,0.2802,1,1
1,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,2.7578e-07,0.3533,0.42057,1,1
1,COATED VESICLE MEMBRANE,2.2524e-05,0.35309,0.32057,1,1
1,REACTOME ORC1 REMOVAL FROM CHROMATIN,3.7145e-05,0.35304,0.28932,1,1
1,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,2.2879e-07,0.35251,0.41703,1,1
1,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,7.3528e-06,0.35229,0.3546,1,1
1,REACTOME NUCLEAR SIGNALING BY ERBB4,3.8131e-07,0.35084,0.34141,1,1
1,KEGG PRIMARY IMMUNODEFICIENCY,0.00012074,0.35054,0.28488,1,1
1,REACTOME GLYCOSAMINOGLYCAN METABOLISM,1.2454e-05,0.35029,0.36316,1,1
1,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,1.7474e-06,0.35007,0.34963,1,1
1,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,5.0683e-06,0.34932,0.38413,1,1
1,PID SHP2 PATHWAY,3.7145e-05,0.34909,0.33493,1,1
1,REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN,0.029068,0.34836,0.34278,1,1
1,REACTOME METABOLISM OF RNA,9.7346e-05,0.34817,0.28393,1,1
1,REACTOME COMMON PATHWAY,0.001872,0.34805,0.25792,1,1
1,REACTOME PYRIMIDINE METABOLISM,0.00012964,0.34786,0.46492,1,1
1,BIOCARTA ALK PATHWAY,4.0073e-05,0.34776,0.36516,1,1
1,SKELETAL DEVELOPMENT,2.0033e-05,0.34762,0.37713,1,1
1,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.00013917,0.34752,0.32804,1,1
1,MITOCHONDRIAL MATRIX,0.0014299,0.34717,0.24499,1,1
1,MITOCHONDRIAL LUMEN,0.0014299,0.34717,0.24499,1,1
1,HETEROCYCLE METABOLIC PROCESS,1.4609e-05,0.34697,0.3682,1,1
1,ENDOSOME TRANSPORT,7.547e-05,0.346,0.31463,1,1
1,REACTOME REGULATION OF MITOTIC CELL CYCLE,2.5308e-05,0.34329,0.31545,1,1
1,BIOCARTA KERATINOCYTE PATHWAY,0.024846,0.34321,0.24057,1,1
1,SULFUR METABOLIC PROCESS,1.2454e-05,0.34284,0.34491,1,1
1,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00016595,0.34258,0.29272,1,1
1,VACUOLE ORGANIZATION AND BIOGENESIS,0.0013872,0.34191,0.30096,1,1
1,PID INTEGRIN2 PATHWAY,6.2367e-06,0.34154,0.50485,1,1
1,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00042998,0.34042,0.32523,1,1
1,BIOCARTA TFF PATHWAY,3.6228e-06,0.33815,0.39581,1,1
1,PID ALK1PATHWAY,9.389e-05,0.3379,0.38648,1,1
1,REACTOME M G1 TRANSITION,0.00057693,0.3367,0.22954,1,1
1,REGULATION OF MITOTIC CELL CYCLE,2.0829e-07,0.33642,0.39544,1,1
1,REGULATION OF SIGNAL TRANSDUCTION,1.2862e-06,0.33625,0.34345,1,1
1,POSITIVE REGULATION OF TRANSLATION,2.0784e-06,0.33579,0.41581,1,1
1,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,6.7596e-05,0.33533,0.39915,1,1
1,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,5.7413e-06,0.33279,0.35632,1,1
1,RESPONSE TO WOUNDING,1.0604e-05,0.33204,0.35157,1,1
1,RECEPTOR COMPLEX,0.00019753,0.33178,0.31581,1,1
1,PID FOXM1PATHWAY,1.2454e-05,0.33123,0.35241,1,1
1,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,3.0576e-06,0.33105,0.30406,1,1
1,CORNIFIED ENVELOPE,0.011326,0.33089,0.29528,1,1
1,POSITIVE REGULATION OF CELL ADHESION,0.0013872,0.33082,0.56428,1,1
1,GROWTH,1.4674e-06,0.32988,0.32773,1,1
1,BIOCARTA INTEGRIN PATHWAY,4.5813e-07,0.32957,0.48432,1,1
1,VIRAL REPRODUCTION,1.1493e-05,0.32952,0.30885,1,1
1,BIOCARTA RARRXR PATHWAY,0.00017796,0.32916,0.26036,1,1
1,TRNA PROCESSING,0.0006154,0.32909,0.32791,1,1
1,BIOCARTA EIF4 PATHWAY,2.6307e-05,0.32828,0.31335,1,1
1,BIOCARTA RANMS PATHWAY,0.0025083,0.32793,0.29241,1,1
1,NEGATIVE REGULATION OF TRANSPORT,0.00017186,0.32752,0.29726,1,1
1,BIOCARTA HER2 PATHWAY,9.0551e-05,0.32698,0.26462,1,1
1,VASCULATURE DEVELOPMENT,1.349e-05,0.32683,0.34605,1,1
1,KEGG JAK STAT SIGNALING PATHWAY,1.5201e-05,0.32648,0.30898,1,1
1,TRANSLATION REGULATOR ACTIVITY,0.0013872,0.32576,0.23782,1,1
1,INTERACTION WITH HOST,7.2754e-05,0.32558,0.34528,1,1
1,MANNOSYLTRANSFERASE ACTIVITY,0.0087944,0.32547,0.22146,1,1
1,BIOCARTA EGF PATHWAY,0.0020453,0.32522,0.27519,1,1
1,CYTOKINESIS,0.00055855,0.32473,0.31138,1,1
1,CELL DIVISION,0.00057693,0.32459,0.34596,1,1
1,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,2.1831e-07,0.32288,0.32828,1,1
1,REACTOME EGFR DOWNREGULATION,2.6902e-06,0.32239,0.366,1,1
1,REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,0.00079435,0.32201,0.38757,1,1
1,POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.4878e-05,0.32196,0.25985,1,1
1,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,3.9418e-06,0.32092,0.3657,1,1
1,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.024846,0.3204,0.23956,1,1
1,PID ANGIOPOIETINRECEPTOR PATHWAY,2.3418e-05,0.31991,0.33932,1,1
1,BIOCARTA MTOR PATHWAY,3.4421e-05,0.31851,0.27577,1,1
1,CONTRACTILE FIBER,1.4044e-06,0.31827,0.38148,1,1
1,MYOFIBRIL,6.7728e-06,0.31786,0.45486,1,1
1,REACTOME KERATAN SULFATE KERATIN METABOLISM,3.7145e-05,0.31697,0.34823,1,1
1,KEGG BASAL CELL CARCINOMA,0.0057817,0.31674,0.20971,1,1
1,KEGG FATTY ACID METABOLISM,0.0049174,0.31584,0.25238,1,1
1,REGULATION OF ENDOCYTOSIS,0.00010462,0.31579,0.30756,1,1
1,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,4.8379e-05,0.31542,0.29934,1,1
1,STRIATED MUSCLE DEVELOPMENT,0.0032441,0.31539,0.24148,1,1
1,METALLOENDOPEPTIDASE ACTIVITY,0.0012662,0.3152,0.30469,1,1
1,BIOCARTA AKAP95 PATHWAY,0.007729,0.31505,0.23717,1,1
1,MUSCLE DEVELOPMENT,1.7118e-05,0.31485,0.29975,1,1
1,VIRAL INFECTIOUS CYCLE,7.547e-05,0.31476,0.28148,1,1
1,REACTOME SIGNALING BY BMP,0.014486,0.31432,0.25968,1,1
1,BIOCARTA AGR PATHWAY,0.004408,0.31405,0.22512,1,1
1,N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00079435,0.31319,0.24571,1,1
1,PID TELOMERASEPATHWAY,2.1663e-05,0.31297,0.27901,1,1
1,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.00045924,0.31213,0.27139,1,1
1,KEGG P53 SIGNALING PATHWAY,0.0018173,0.31177,0.26125,1,1
1,AMINO SUGAR METABOLIC PROCESS,2.6307e-05,0.31168,0.30725,1,1
1,ADHERENS JUNCTION,0.019739,0.31159,0.25966,1,1
1,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.00090094,0.31053,0.23993,1,1
1,PID VEGFR1 2 PATHWAY,8.6584e-06,0.31044,0.30102,1,1
1,KEGG ADHERENS JUNCTION,5.6174e-05,0.3103,0.2561,1,1
1,STRUCTURAL MOLECULE ACTIVITY,1.0604e-05,0.30966,0.32145,1,1
1,REGULATION OF ACTIN FILAMENT LENGTH,0.0032441,0.30912,0.32673,1,1
1,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,9.3916e-06,0.30854,0.31799,1,1
1,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.9532e-05,0.30832,0.27357,1,1
1,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.0069616,0.30799,0.28724,1,1
1,NEGATIVE REGULATION OF DNA REPLICATION,0.023205,0.30757,0.26794,1,1
1,PID AR PATHWAY,9.0179e-06,0.30753,0.27808,1,1
1,BIOCARTA LONGEVITY PATHWAY,0.00055855,0.30657,0.25643,1,1
1,BIOCARTA VEGF PATHWAY,4.8379e-05,0.30626,0.27409,1,1
1,PID CD40 PATHWAY,0.00084609,0.30605,0.3552,1,1
1,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.00054072,0.30539,0.28748,1,1
1,KEGG REGULATION OF ACTIN CYTOSKELETON,5.6999e-08,0.30507,0.32605,1,1
1,REGULATION OF CELLULAR COMPONENT SIZE,0.0025817,0.30503,0.32045,1,1
1,BIOCARTA AKAP13 PATHWAY,0.0017123,0.30444,0.28164,1,1
1,POSITIVE REGULATION OF CELL PROLIFERATION,1.1237e-07,0.30432,0.41585,1,1
1,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00014935,0.30431,0.24174,1,1
1,REACTOME PPARA ACTIVATES GENE EXPRESSION,1.4039e-05,0.30398,0.27476,1,1
1,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,8.1192e-05,0.30306,0.27062,1,1
1,GLUCOSAMINE METABOLIC PROCESS,4.1802e-07,0.30293,0.33754,1,1
1,UNFOLDED PROTEIN BINDING,9.0551e-05,0.30283,0.25851,1,1
1,PID MYC PATHWAY,0.00069957,0.30262,0.22864,1,1
1,PID NECTIN PATHWAY,0.0025083,0.30204,0.29698,1,1
1,BIOCARTA ERK PATHWAY,1.1267e-06,0.3016,0.36182,1,1
1,NEGATIVE REGULATION OF CELL ADHESION,0.0011199,0.30137,0.3504,1,1
1,KEGG PANCREATIC CANCER,6.2367e-06,0.30082,0.3026,1,1
1,TRANSLATIONAL INITIATION,0.0018173,0.30081,0.20856,1,1
1,BIOCARTA ACTINY PATHWAY,3.4421e-05,0.30049,0.28339,1,1
1,PID CERAMIDE PATHWAY,3.8583e-05,0.30039,0.26191,1,1
1,PROTEIN FOLDING,5.0683e-06,0.29976,0.32384,1,1
1,REACTOME SULFUR AMINO ACID METABOLISM,3.1888e-05,0.29971,0.34415,1,1
1,KEGG PATHWAYS IN CANCER,1.104e-05,0.29813,0.25428,1,1
1,BIOCARTA STRESS PATHWAY,0.0059384,0.29797,0.24219,1,1
1,TRNA METABOLIC PROCESS,0.0021689,0.29793,0.26781,1,1
1,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.001986,0.29781,0.26447,1,1
1,PID P73PATHWAY,2.0833e-05,0.2978,0.3046,1,1
1,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.7474e-06,0.29777,0.30179,1,1
1,REGULATION OF CELL ADHESION,0.0014299,0.29737,0.34469,1,1
1,TRANSLATION INITIATION FACTOR ACTIVITY,0.00081984,0.297,0.2994,1,1
1,REGULATION OF DNA METABOLIC PROCESS,0.00017186,0.29677,0.27971,1,1
1,PID IL1PATHWAY,0.00052342,0.29654,0.30557,1,1
1,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,9.3916e-06,0.29625,0.24968,1,1
1,KEGG DILATED CARDIOMYOPATHY,2.3418e-05,0.29565,0.29563,1,1
1,BIOCARTA VDR PATHWAY,0.00050664,0.29557,0.28413,1,1
1,PROTEOLYSIS,1.1964e-05,0.29481,0.23924,1,1
1,NEGATIVE REGULATION OF GROWTH,2.0033e-05,0.29354,0.26996,1,1
1,PROTEIN MATURATION,0.00084609,0.29336,0.29285,1,1
1,PID MYC ACTIVPATHWAY,0.0017123,0.29329,0.24854,1,1
1,REACTOME SPHINGOLIPID METABOLISM,0.0010206,0.29327,0.20197,1,1
1,CELLULAR BIOSYNTHETIC PROCESS,5.4121e-05,0.29194,0.24653,1,1
1,POSITIVE REGULATION OF CELLULAR PROCESS,1.5331e-06,0.29067,0.25633,1,1
1,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.1617e-05,0.29038,0.21211,1,1
1,REACTOME REGULATED PROTEOLYSIS OF P75NTR,0.001662,0.29038,0.25263,1,1
1,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.00041602,0.29034,0.30899,1,1
1,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.00028792,0.29012,0.25303,1,1
1,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.041967,0.2895,0.15713,1,1
1,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.0079323,0.2892,0.20076,1,1
1,NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.007729,0.28774,0.2745,1,1
1,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.0038387,0.28711,0.22515,1,1
1,REACTOME INNATE IMMUNE SYSTEM,0.00019079,0.28696,0.24277,1,1
1,PID PTP1BPATHWAY,0.00034072,0.28695,0.27912,1,1
1,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,2.6902e-06,0.28664,0.3815,1,1
1,RHO PROTEIN SIGNAL TRANSDUCTION,3.6228e-06,0.28636,0.28573,1,1
1,ST INTERLEUKIN 4 PATHWAY,0.00026003,0.2863,0.3306,1,1
1,CYTOKINE ACTIVITY,4.8379e-05,0.28592,0.33101,1,1
1,BIOCARTA P38MAPK PATHWAY,5.0683e-06,0.2859,0.32118,1,1
1,REACTOME IMMUNE SYSTEM,5.2837e-06,0.28523,0.24799,1,1
1,NEGATIVE REGULATION OF CELL MIGRATION,0.00031859,0.28482,0.42499,1,1
1,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,6.0504e-05,0.28443,0.25019,1,1
1,REACTOME GAP JUNCTION TRAFFICKING,5.9841e-06,0.28435,0.27037,1,1
1,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.00095906,0.2837,0.20262,1,1
1,REGULATION OF GROWTH,1.5816e-05,0.28361,0.28177,1,1
1,PID SMAD2 3NUCLEARPATHWAY,0.00098941,0.28346,0.24196,1,1
1,KEGG TGF BETA SIGNALING PATHWAY,0.00012512,0.28274,0.25677,1,1
1,CELL PROJECTION BIOGENESIS,0.001662,0.28245,0.20222,1,1
1,ANGIOGENESIS,0.00017186,0.28225,0.30974,1,1
1,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,4.7955e-07,0.2819,0.31868,1,1
1,PEPTIDYL AMINO ACID MODIFICATION,8.628e-07,0.28145,0.28853,1,1
1,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0062634,0.2812,0.22508,1,1
1,ELECTRON TRANSPORT GO 0006118,0.00017186,0.28113,0.2566,1,1
1,REACTOME HOST INTERACTIONS OF HIV FACTORS,3.3132e-05,0.28078,0.23354,1,1
1,REACTOME UNFOLDED PROTEIN RESPONSE,2.0833e-05,0.28047,0.2711,1,1
1,ST STAT3 PATHWAY,0.00049035,0.27983,0.36434,1,1
1,REACTOME APOPTOSIS,5.2139e-05,0.2797,0.22673,1,1
1,REGULATION OF PROTEIN METABOLIC PROCESS,8.628e-07,0.27969,0.29505,1,1
1,N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.2505e-07,0.2791,0.30107,1,1
1,STEROID HORMONE RECEPTOR BINDING,0.00057693,0.2777,0.29398,1,1
1,KEGG PYRUVATE METABOLISM,0.0040578,0.27761,0.22877,1,1
1,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.0020453,0.27756,0.20924,1,1
1,BLOOD COAGULATION,2.9532e-05,0.27698,0.33817,1,1
1,KEGG RETINOL METABOLISM,0.0007696,0.27675,0.21964,1,1
1,RAS PROTEIN SIGNAL TRANSDUCTION,2.3975e-07,0.27638,0.30294,1,1
1,CALCIUM MEDIATED SIGNALING,8.1192e-05,0.27595,0.36126,1,1
1,BIOCARTA HSP27 PATHWAY,0.00042998,0.27571,0.31762,1,1
1,PID RETINOIC ACID PATHWAY,0.00019753,0.27553,0.25033,1,1
1,PROTEIN TARGETING,3.4772e-07,0.27532,0.26446,1,1
1,PID IFNGPATHWAY,0.0027346,0.27527,0.23478,1,1
1,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.0042883,0.27421,0.20813,1,1
1,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060989,0.27361,0.20199,1,1
1,BIOCARTA CHEMICAL PATHWAY,0.00059588,0.27304,0.24742,1,1
1,GOLGI VESICLE TRANSPORT,0.00055855,0.27218,0.22832,1,1
1,REACTOME NOD1 2 SIGNALING PATHWAY,0.0016129,0.27177,0.35153,1,1
1,REACTOME BASIGIN INTERACTIONS,0.0011199,0.27152,0.41534,1,1
1,REACTOME PROTEIN FOLDING,1.4039e-05,0.27043,0.25248,1,1
1,DEFENSE RESPONSE,0.00055855,0.27042,0.25955,1,1
1,KEGG PROSTATE CANCER,1.9263e-05,0.27035,0.27207,1,1
1,REGULATION OF MITOSIS,4.0073e-05,0.27014,0.24053,1,1
1,REACTOME METABOLISM OF PROTEINS,0.00055855,0.27006,0.19339,1,1
1,EPIDERMIS DEVELOPMENT,0.00026903,0.26922,0.37268,1,1
1,BIOCARTA G1 PATHWAY,0.0083534,0.26903,0.24586,1,1
1,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,5.8301e-05,0.26839,0.25102,1,1
1,REACTOME XENOBIOTICS,0.036948,0.26825,0.13991,1,1
1,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.001872,0.26798,0.34192,1,1
1,POSITIVE REGULATION OF BIOLOGICAL PROCESS,1.9904e-06,0.26768,0.24545,1,1
1,BIOCARTA NKT PATHWAY,0.010773,0.26753,0.24917,1,1
1,REGULATION OF APOPTOSIS,4.1112e-06,0.2674,0.25183,1,1
1,REGULATION OF PROGRAMMED CELL DEATH,4.6623e-06,0.26721,0.2534,1,1
1,REACTOME INTRINSIC PATHWAY,0.0018173,0.26705,0.22023,1,1
1,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,2.2658e-06,0.26615,0.20977,1,1
1,NUCLEAR TRANSPORT,5.6174e-05,0.26551,0.23068,1,1
1,REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.26428,0.22104,1,1
1,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.010773,0.264,0.2594,1,1
1,REACTOME S PHASE,0.00063551,0.26398,0.1975,1,1
1,BIOCARTA CYTOKINE PATHWAY,0.00052342,0.2632,0.36174,1,1
1,INTEGRIN BINDING,0.00049035,0.26296,0.30643,1,1
1,NUCLEOCYTOPLASMIC TRANSPORT,5.8301e-05,0.26239,0.23409,1,1
1,PID PS1PATHWAY,1.5201e-05,0.26238,0.26488,1,1
1,ZINC ION BINDING,1.6455e-05,0.26203,0.21259,1,1
1,B CELL ACTIVATION,0.014138,0.26156,0.21521,1,1
1,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.1112e-06,0.25996,0.36306,1,1
1,BIOCARTA EDG1 PATHWAY,3.3132e-05,0.25984,0.29283,1,1
1,PROTEIN KINASE CASCADE,1.9263e-05,0.25889,0.25639,1,1
1,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.0062634,0.2586,0.2048,1,1
1,RESPONSE TO HEAT,0.0054795,0.25843,0.19701,1,1
1,KEGG LEISHMANIA INFECTION,0.00024286,0.25821,0.28422,1,1
1,BIOCARTA EIF2 PATHWAY,0.0041716,0.2573,0.23309,1,1
1,PID S1P S1P1 PATHWAY,0.00069957,0.25713,0.3636,1,1
1,METALLOPEPTIDASE ACTIVITY,6.5149e-05,0.25614,0.32468,1,1
1,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.00016023,0.25577,0.30011,1,1
1,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00084609,0.25561,0.20335,1,1
1,ST B CELL ANTIGEN RECEPTOR,2.5774e-06,0.25453,0.26421,1,1
1,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.00012964,0.25452,0.261,1,1
1,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00029782,0.25403,0.2253,1,1
1,SECONDARY METABOLIC PROCESS,0.00063551,0.25365,0.23454,1,1
1,ACID AMINO ACID LIGASE ACTIVITY,6.4994e-06,0.25354,0.2204,1,1
1,KEGG CIRCADIAN RHYTHM MAMMAL,0.010506,0.25219,0.28223,1,1
1,EXTRACELLULAR REGION PART,0.00012964,0.25185,0.28504,1,1
1,PROTEIN COMPLEX BINDING,0.00034072,0.25139,0.19913,1,1
1,OXIDOREDUCTASE ACTIVITY,0.00014935,0.25061,0.21501,1,1
1,CHAPERONE BINDING,0.00098941,0.25049,0.23726,1,1
1,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,2.3418e-05,0.25046,0.24811,1,1
1,REACTOME IL 7 SIGNALING,0.0023671,0.25021,0.27696,1,1
1,RIBOSOMAL SUBUNIT,0.025414,0.24994,0.18978,1,1
1,MITOTIC CELL CYCLE CHECKPOINT,5.0226e-05,0.24988,0.27134,1,1
1,REACTOME SHC MEDIATED CASCADE,0.00032948,0.24966,0.22546,1,1
1,REACTOME METABOLISM OF NUCLEOTIDES,0.00038934,0.24965,0.28868,1,1
1,MITOCHONDRIAL PART,0.0045306,0.24961,0.18364,1,1
1,COAGULATION,7.013e-05,0.24953,0.31485,1,1
1,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.0094949,0.24934,0.2061,1,1
1,PID WNT CANONICAL PATHWAY,4.3218e-05,0.24884,0.23038,1,1
1,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.020205,0.24882,0.22273,1,1
1,REGULATION OF TRANSLATION,8.3127e-06,0.2485,0.257,1,1
1,CYTOPLASMIC VESICLE MEMBRANE,0.00045924,0.24821,0.17932,1,1
1,CYTOPLASMIC VESICLE PART,0.00045924,0.24821,0.17932,1,1
1,BIOCARTA HIF PATHWAY,0.00040247,0.24762,0.37114,1,1
1,CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.021165,0.2475,0.29833,1,1
1,NEGATIVE REGULATION OF CELL CYCLE,7.3528e-06,0.24701,0.27536,1,1
1,KEGG ENDOCYTOSIS,2.1702e-06,0.24672,0.23697,1,1
1,PID ERBB4 PATHWAY,1.4044e-06,0.24565,0.2988,1,1
1,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,3.1904e-06,0.24477,0.20798,1,1
1,KEGG HOMOLOGOUS RECOMBINATION,0.0021062,0.24438,0.19527,1,1
1,APOPTOSIS GO,4.8612e-06,0.24435,0.22841,1,1
1,DOUBLE STRANDED RNA BINDING,0.0054795,0.24398,0.17527,1,1
1,PID AMB2 NEUTROPHILS PATHWAY,0.00030804,0.24391,0.30399,1,1
1,PID IL12 2PATHWAY,0.00016023,0.24349,0.27967,1,1
1,BIOCARTA THELPER PATHWAY,0.033166,0.24325,0.28907,1,1
1,PROGRAMMED CELL DEATH,4.6623e-06,0.24301,0.22971,1,1
1,MEMBRANE FUSION,0.00030804,0.24207,0.23404,1,1
1,REACTOME ADAPTIVE IMMUNE SYSTEM,1.4044e-06,0.24152,0.21442,1,1
1,PID ECADHERIN KERATINOCYTE PATHWAY,0.020205,0.24056,0.2416,1,1
1,CELL MATRIX ADHESION,0.00044439,0.2405,0.28083,1,1
1,REGULATION OF DNA BINDING,1.5691e-07,0.24037,0.27511,1,1
1,REACTOME ENOS ACTIVATION AND REGULATION,0.017549,0.23954,0.16224,1,1
1,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00018427,0.23939,0.26228,1,1
1,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,3.3132e-05,0.2388,0.25153,1,1
1,TRANSITION METAL ION BINDING,1.5331e-06,0.23879,0.2391,1,1
1,MITOCHONDRIAL MEMBRANE,0.014841,0.23875,0.13711,1,1
1,CELL PROLIFERATION GO 0008283,2.2658e-06,0.23872,0.22243,1,1
1,ENDOSOME,4.6597e-05,0.23765,0.20968,1,1
1,PID ARF6 TRAFFICKINGPATHWAY,5.0683e-06,0.23763,0.33145,1,1
1,BIOCARTA TALL1 PATHWAY,0.00072223,0.23761,0.18159,1,1
1,BIOCARTA BCELLSURVIVAL PATHWAY,0.00038934,0.23749,0.32443,1,1
1,REACTOME MITOTIC M M G1 PHASES,0.00065623,0.23731,0.18348,1,1
1,PID ERBB1 DOWNSTREAM PATHWAY,0.00019753,0.23692,0.19678,1,1
1,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.0041716,0.23666,0.23959,1,1
1,CELL SURFACE,7.013e-05,0.2361,0.2352,1,1
1,ST ERK1 ERK2 MAPK PATHWAY,2.6307e-05,0.23589,0.25884,1,1
1,WNT SIGNALING,2.9532e-05,0.23584,0.20772,1,1
1,REACTOME SYNTHESIS OF DNA,0.0011199,0.23556,0.18081,1,1
1,VACUOLAR TRANSPORT,0.00044439,0.23541,0.24942,1,1
1,REACTOME TRNA AMINOACYLATION,0.012508,0.23435,0.21114,1,1
1,REGULATION OF BINDING,1.9873e-07,0.2341,0.25937,1,1
1,RESPONSE TO HORMONE STIMULUS,0.00040247,0.23381,0.22371,1,1
1,REACTOME IL1 SIGNALING,0.00020448,0.23324,0.2751,1,1
1,ELECTRON CARRIER ACTIVITY,0.0015653,0.233,0.15818,1,1
1,PID SMAD2 3PATHWAY,0.023741,0.23295,0.17126,1,1
1,REACTOME SIGNALING BY PDGF,9.7346e-05,0.23239,0.21449,1,1
1,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00028792,0.23232,0.2716,1,1
1,GOLGI STACK,0.0067808,0.23174,0.20155,1,1
1,CELL SUBSTRATE ADHESION,0.00050664,0.2313,0.27021,1,1
1,INTRACELLULAR PROTEIN TRANSPORT,1.5331e-06,0.2313,0.22112,1,1
1,BIOCARTA IGF1MTOR PATHWAY,0.00084609,0.23081,0.20084,1,1
1,VACUOLE,0.0012662,0.23076,0.19138,1,1
1,KEGG ONE CARBON POOL BY FOLATE,0.011612,0.23035,0.17257,1,1
1,KEGG DORSO VENTRAL AXIS FORMATION,0.0017123,0.22947,0.25055,1,1
1,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.00036427,0.22919,0.17076,1,1
1,REACTOME G1 S TRANSITION,0.00026003,0.22911,0.19987,1,1
1,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0034322,0.22891,0.26602,1,1
1,KEGG DRUG METABOLISM OTHER ENZYMES,0.00025131,0.22865,0.25829,1,1
1,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.001228,0.22777,0.16918,1,1
1,RESPONSE TO EXTERNAL STIMULUS,0.00023468,0.22776,0.23427,1,1
1,REGULATION OF DEVELOPMENTAL PROCESS,1.2454e-05,0.22752,0.21225,1,1
1,RECEPTOR MEDIATED ENDOCYTOSIS,2.4346e-05,0.22732,0.21142,1,1
1,STRUCTURAL CONSTITUENT OF MUSCLE,9.7346e-05,0.22726,0.28639,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.009256,0.22707,0.19867,1,1
1,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.0081404,0.22696,0.14664,1,1
1,NEGATIVE REGULATION OF DNA BINDING,0.010506,0.22656,0.21624,1,1
1,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,1.4609e-05,0.22595,0.19957,1,1
1,PID IL4 2PATHWAY,0.0060989,0.22528,0.22672,1,1
1,ESTABLISHMENT OF PROTEIN LOCALIZATION,3.0576e-06,0.22441,0.18999,1,1
1,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,4.3218e-05,0.22361,0.20562,1,1
1,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.7791e-06,0.22358,0.2122,1,1
1,CELLULAR PROTEIN COMPLEX ASSEMBLY,1.5331e-06,0.22267,0.2355,1,1
1,ATP DEPENDENT DNA HELICASE ACTIVITY,0.0056288,0.2224,0.22756,1,1
1,UBIQUITIN PROTEIN LIGASE ACTIVITY,3.9418e-06,0.22201,0.20609,1,1
1,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.0040578,0.2217,0.18297,1,1
1,REGULATION OF CELL PROLIFERATION,3.7791e-06,0.22104,0.23794,1,1
1,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,6.4994e-06,0.22064,0.19874,1,1
1,ORGANELLAR RIBOSOME,0.011904,0.22059,0.21729,1,1
1,MITOCHONDRIAL RIBOSOME,0.011904,0.22059,0.21729,1,1
1,KEGG ASCORBATE AND ALDARATE METABOLISM,0.034637,0.22039,0.18073,1,1
1,BIOCARTA ECM PATHWAY,0.00038934,0.22038,0.34639,1,1
1,NEGATIVE REGULATION OF BINDING,0.00081984,0.21937,0.24686,1,1
1,REACTOME REGULATION OF IFNG SIGNALING,0.026586,0.21932,0.22062,1,1
1,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,3.17e-07,0.21932,0.22988,1,1
1,ATP DEPENDENT HELICASE ACTIVITY,0.012203,0.21882,0.17216,1,1
1,REACTOME DIABETES PATHWAYS,0.027803,0.21857,0.13629,1,1
1,NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.019283,0.21815,0.26064,1,1
1,PID NCADHERINPATHWAY,0.017549,0.21779,0.18245,1,1
1,BIOCARTA SARS PATHWAY,0.0075304,0.21764,0.40721,1,1
1,BIOCARTA GRANULOCYTES PATHWAY,0.00052342,0.21735,0.47344,1,1
1,PROTEIN COMPLEX ASSEMBLY,3.9418e-06,0.21716,0.20405,1,1
1,ST INTEGRIN SIGNALING PATHWAY,0.00072223,0.21702,0.22837,1,1
1,PID NFAT TFPATHWAY,2.9532e-05,0.21698,0.31322,1,1
1,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0022992,0.21678,0.27464,1,1
1,SMAD BINDING,0.0053338,0.21642,0.17836,1,1
1,NEGATIVE REGULATION OF CELLULAR PROCESS,1.104e-05,0.21641,0.19297,1,1
1,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,4.6623e-06,0.21573,0.20174,1,1
1,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.00042998,0.21539,0.16898,1,1
1,KEGG PEROXISOME,0.0060989,0.21529,0.15431,1,1
1,PIGMENT BIOSYNTHETIC PROCESS,0.001191,0.21466,0.24283,1,1
1,RESPONSE TO STRESS,7.547e-05,0.21446,0.1795,1,1
1,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.026586,0.21419,0.21673,1,1
1,PROTEIN TRANSPORT,2.3654e-06,0.21391,0.20403,1,1
1,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.0029794,0.21382,0.22573,1,1
1,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,1.1493e-05,0.21371,0.26433,1,1
1,PID PDGFRBPATHWAY,8.4205e-05,0.21351,0.21997,1,1
1,REACTOME CIRCADIAN CLOCK,5.6174e-05,0.21339,0.26091,1,1
1,MITOCHONDRIAL OUTER MEMBRANE,0.0032441,0.21321,0.14429,1,1
1,ST P38 MAPK PATHWAY,0.0039469,0.2129,0.15913,1,1
1,ST FAS SIGNALING PATHWAY,1.8521e-05,0.21287,0.22244,1,1
1,POSITIVE REGULATION OF METABOLIC PROCESS,4.3763e-07,0.2119,0.22256,1,1
1,MAINTENANCE OF PROTEIN LOCALIZATION,0.0015653,0.21186,0.2463,1,1
1,BIOCARTA MET PATHWAY,0.00026903,0.21165,0.27457,1,1
1,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.0019282,0.21159,0.24911,1,1
1,VESICLE MEMBRANE,0.00049035,0.21156,0.17939,1,1
1,REACTOME METABOLISM OF CARBOHYDRATES,1.2308e-06,0.21148,0.24006,1,1
1,REACTOME MEMBRANE TRAFFICKING,0.00014935,0.21135,0.18665,1,1
1,REACTOME DOWNSTREAM TCR SIGNALING,0.010773,0.21113,0.13893,1,1
1,REGULATION OF CELL CYCLE,2.2524e-05,0.21105,0.18346,1,1
1,PROTEIN SECRETION,0.024288,0.21099,0.18811,1,1
1,ENDOPLASMIC RETICULUM,1.8521e-05,0.21095,0.21203,1,1
1,BIOCARTA RACCYCD PATHWAY,0.00092958,0.2109,0.242,1,1
1,POSITIVE REGULATION OF JNK ACTIVITY,0.0085714,0.21078,0.17387,1,1
1,NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,0.21075,0.23471,1,1
1,BIOCARTA PTDINS PATHWAY,0.00074557,0.21048,0.21139,1,1
1,ECTODERM DEVELOPMENT,0.0016129,0.20977,0.30399,1,1
1,EXTRACELLULAR REGION,0.00030804,0.2091,0.23328,1,1
1,SEQUENCE SPECIFIC DNA BINDING,0.00079435,0.20901,0.18734,1,1
1,IMMUNE RESPONSE,0.0010528,0.20898,0.21578,1,1
1,PID VEGFR1 PATHWAY,0.014841,0.20893,0.1751,1,1
1,REACTOME CELL CYCLE CHECKPOINTS,0.00026903,0.20861,0.18759,1,1
1,KEGG CYSTEINE AND METHIONINE METABOLISM,0.00052342,0.20854,0.20553,1,1
1,WOUND HEALING,1.5201e-05,0.20843,0.33457,1,1
1,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.0023671,0.20835,0.1589,1,1
1,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0053338,0.20787,0.15703,1,1
1,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.041093,0.20779,0.14668,1,1
1,PID RHOA PATHWAY,1.5201e-05,0.20762,0.25769,1,1
1,ORGAN MORPHOGENESIS,0.00029782,0.20761,0.20444,1,1
1,DOUBLE STRAND BREAK REPAIR,0.0021062,0.20722,0.23175,1,1
1,PATTERN BINDING,0.026586,0.20678,0.15384,1,1
1,ST MYOCYTE AD PATHWAY,0.0010859,0.20541,0.25849,1,1
1,MITOCHONDRIAL ENVELOPE,0.011326,0.205,0.14923,1,1
1,GROWTH FACTOR BINDING,2.9532e-05,0.20494,0.25871,1,1
1,KEGG TIGHT JUNCTION,0.015953,0.20414,0.11464,1,1
1,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.00025131,0.20307,0.18518,1,1
1,SPINDLE POLE,0.0046564,0.20154,0.23809,1,1
1,RESPONSE TO OTHER ORGANISM,0.019283,0.20128,0.11491,1,1
1,ST GA13 PATHWAY,5.7413e-06,0.20045,0.26389,1,1
1,REGULATION OF JNK ACTIVITY,0.0071468,0.20034,0.1744,1,1
1,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.0067808,0.19987,0.15803,1,1
1,REGULATION OF T CELL PROLIFERATION,0.00038934,0.19917,0.2839,1,1
1,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR BINDING,0.00044439,0.19883,0.29989,1,1
1,MITOCHONDRIAL TRANSPORT,0.0031536,0.19857,0.18125,1,1
1,CYTOKINE PRODUCTION,0.0050528,0.19781,0.21741,1,1
1,REACTOME MITOTIC G1 G1 S PHASES,0.00023468,0.19765,0.17445,1,1
1,NITROGEN COMPOUND METABOLIC PROCESS,0.00012964,0.197,0.17872,1,1
1,PID TCRRASPATHWAY,0.0029794,0.19686,0.2683,1,1
1,ORGANELLE MEMBRANE,9.0179e-06,0.19587,0.16415,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.00041602,0.19585,0.21298,1,1
1,LIGASE ACTIVITY,0.00040247,0.1955,0.15228,1,1
1,REACTOME SIGNALING BY ERBB4,1.0311e-06,0.19536,0.19174,1,1
1,REACTOME TCR SIGNALING,0.014138,0.19512,0.11181,1,1
1,TISSUE DEVELOPMENT,0.0059384,0.19467,0.24369,1,1
1,ACTIVATION OF JNK ACTIVITY,0.014138,0.19464,0.1557,1,1
1,PEROXISOMAL MEMBRANE,0.011612,0.19424,0.14795,1,1
1,MICROBODY MEMBRANE,0.011612,0.19424,0.14795,1,1
1,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.011047,0.19419,0.15096,1,1
1,DEACETYLASE ACTIVITY,0.0085714,0.19397,0.17938,1,1
1,DNA POLYMERASE ACTIVITY,0.0036303,0.19381,0.18852,1,1
1,PROTEIN UBIQUITINATION,0.019283,0.19353,0.1165,1,1
1,REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE,0.036164,0.19315,0.155,1,1
1,CELL CYCLE ARREST GO 0007050,0.00012964,0.19297,0.22315,1,1
1,ANATOMICAL STRUCTURE FORMATION,0.00047456,0.1926,0.25553,1,1
1,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.00063551,0.19203,0.18596,1,1
1,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.00014935,0.19162,0.1894,1,1
1,REACTOME HEMOSTASIS,3.8583e-05,0.19099,0.17992,1,1
1,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.0066042,0.19086,0.26187,1,1
1,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,1.6455e-05,0.19077,0.21217,1,1
1,PROTEIN LOCALIZATION,4.1112e-06,0.19068,0.16918,1,1
1,REACTOME TOLL RECEPTOR CASCADES,0.00084609,0.19064,0.16943,1,1
1,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.00057693,0.19041,0.2274,1,1
1,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.031059,0.19009,0.15205,1,1
1,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.00072223,0.18992,0.16671,1,1
1,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.0029794,0.1895,0.17604,1,1
1,METHYLTRANSFERASE ACTIVITY,0.018398,0.18948,0.1258,1,1
1,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0040578,0.1893,0.1318,1,1
1,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.014841,0.18908,0.14922,1,1
1,LYTIC VACUOLE,0.0010859,0.18902,0.18474,1,1
1,LYSOSOME,0.0010859,0.18902,0.18474,1,1
1,HEMOSTASIS,0.00031859,0.1889,0.26846,1,1
1,PHAGOCYTOSIS,0.0014299,0.18837,0.24044,1,1
1,BIOCARTA MAPK PATHWAY,2.0833e-05,0.18794,0.19758,1,1
1,GOLGI APPARATUS,5.2837e-06,0.18685,0.16909,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,9.7346e-05,0.18675,0.19863,1,1
1,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.014841,0.18656,0.13052,1,1
1,KEGG COLORECTAL CANCER,0.0028957,0.18573,0.15214,1,1
1,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0054795,0.18561,0.1771,1,1
1,HOMEOSTASIS OF NUMBER OF CELLS,0.0011549,0.1856,0.24073,1,1
1,BIOCARTA PPARA PATHWAY,0.0017123,0.18555,0.16168,1,1
1,PID INSULIN PATHWAY,0.00050664,0.18479,0.19379,1,1
1,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.0020453,0.18474,0.16335,1,1
1,GLYCOSAMINOGLYCAN BINDING,0.035393,0.18437,0.17106,1,1
1,KEGG N GLYCAN BIOSYNTHESIS,0.0057817,0.18429,0.1367,1,1
1,NUCLEOLUS,0.014841,0.18427,0.12214,1,1
1,PID ECADHERIN NASCENTAJ PATHWAY,0.031748,0.18359,0.15298,1,1
1,PID CIRCADIANPATHWAY,0.0053338,0.1834,0.21667,1,1
1,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.015953,0.18307,0.12395,1,1
1,INTRACELLULAR TRANSPORT,2.6307e-05,0.18295,0.16957,1,1
1,REGULATION OF GTPASE ACTIVITY,0.035393,0.18242,0.21179,1,1
1,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00047456,0.18201,0.18461,1,1
1,REACTOME MTORC1 MEDIATED SIGNALLING,0.03939,0.18168,0.18841,1,1
1,KEGG NON SMALL CELL LUNG CANCER,6.7596e-05,0.18146,0.17493,1,1
1,MYOSIN COMPLEX,0.0013872,0.1809,0.23164,1,1
1,REACTOME DNA REPLICATION,0.0016129,0.18061,0.14485,1,1
1,ENDONUCLEASE ACTIVITY,0.0041716,0.18028,0.12941,1,1
1,DNA DIRECTED DNA POLYMERASE ACTIVITY,0.0059384,0.18014,0.16297,1,1
1,POSITIVE REGULATION OF RNA METABOLIC PROCESS,2.6307e-05,0.17979,0.20447,1,1
1,PID S1P META PATHWAY,0.0094949,0.17972,0.20989,1,1
1,BIOCARTA HCMV PATHWAY,0.0099891,0.1797,0.17368,1,1
1,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.0045306,0.17946,0.21541,1,1
1,REACTOME SIGNALING BY RHO GTPASES,0.0066042,0.17929,0.131,1,1
1,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.045624,0.17917,0.10521,1,1
1,ACTIVATION OF MAPK ACTIVITY,0.00059588,0.17913,0.14915,1,1
1,ORGANELLE OUTER MEMBRANE,0.0017641,0.1788,0.12315,1,1
1,GOLGI APPARATUS PART,6.2786e-05,0.17874,0.16999,1,1
1,AMINO ACID METABOLIC PROCESS,0.0025083,0.17772,0.14324,1,1
1,IMMUNE SYSTEM PROCESS,0.010773,0.17771,0.15108,1,1
1,PROTEIN HETERODIMERIZATION ACTIVITY,0.001228,0.17762,0.14689,1,1
1,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.014138,0.1776,0.14091,1,1
1,PROTEIN DIMERIZATION ACTIVITY,0.00026903,0.17758,0.13382,1,1
1,BIOCARTA AKT PATHWAY,0.0020453,0.17738,0.19475,1,1
1,KEGG ENDOMETRIAL CANCER,0.00040247,0.17717,0.19367,1,1
1,PID CD8TCRPATHWAY,0.013798,0.17713,0.11721,1,1
1,PID TXA2PATHWAY,0.0060989,0.17707,0.14558,1,1
1,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.0053338,0.17706,0.18747,1,1
1,MITOSIS,0.00079435,0.17699,0.16599,1,1
1,REACTOME HIV INFECTION,0.00026903,0.17589,0.16915,1,1
1,REACTOME METABOLISM OF NON CODING RNA,0.024846,0.17404,0.13447,1,1
1,POSITIVE REGULATION OF TRANSCRIPTION,1.0184e-05,0.17396,0.19507,1,1
1,BIOCARTA MEF2D PATHWAY,0.0014738,0.17367,0.23155,1,1
1,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,8.6584e-06,0.17351,0.18317,1,1
1,PORE COMPLEX,0.00087311,0.17249,0.20024,1,1
1,BIOCARTA PDGF PATHWAY,0.00087311,0.1724,0.2367,1,1
1,REACTOME ACTIVATED TLR4 SIGNALLING,0.010506,0.17236,0.14291,1,1
1,MULTI ORGANISM PROCESS,0.037747,0.17222,0.087976,1,1
1,RNA HELICASE ACTIVITY,0.044685,0.17196,0.14937,1,1
1,RNA BINDING,0.0015653,0.17186,0.16248,1,1
1,KINETOCHORE,0.019739,0.1715,0.15313,1,1
1,CIRCADIAN RHYTHM,0.015574,0.17117,0.13327,1,1
1,LIPID TRANSPORTER ACTIVITY,0.020205,0.17105,0.21682,1,1
1,ST G ALPHA I PATHWAY,0.041093,0.1709,0.14305,1,1
1,MACROMOLECULE LOCALIZATION,1.6455e-05,0.17021,0.14618,1,1
1,BIOCARTA GATA3 PATHWAY,0.024846,0.17018,0.14967,1,1
1,ENDONUCLEASE ACTIVITY GO 0016893,0.047551,0.16935,0.066057,1,1
1,REACTOME SIGNALING BY ILS,0.00036427,0.16861,0.2329,1,1
1,PID PLK1 PATHWAY,0.0025817,0.16842,0.20765,1,1
1,KEGG NON HOMOLOGOUS END JOINING,0.0014738,0.16838,0.2121,1,1
1,PROTEIN AMINO ACID ADP RIBOSYLATION,0.00025131,0.16835,0.21235,1,1
1,LEADING EDGE,0.0071468,0.16765,0.21207,1,1
1,RESPONSE TO BIOTIC STIMULUS,0.00092958,0.16722,0.16622,1,1
1,ENVELOPE,0.0038387,0.16714,0.1184,1,1
1,ORGANELLE ENVELOPE,0.0038387,0.16714,0.1184,1,1
1,PID HDAC CLASSI PATHWAY,7.547e-05,0.16636,0.15589,1,1
1,PID HIF1 TFPATHWAY,0.03939,0.16615,0.27053,1,1
1,KEGG BASE EXCISION REPAIR,0.015574,0.16551,0.11354,1,1
1,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.00035231,0.16544,0.15632,1,1
1,KEGG RENAL CELL CARCINOMA,0.041093,0.16426,0.10266,1,1
1,SPINDLE,0.0064317,0.16407,0.20126,1,1
1,M PHASE OF MITOTIC CELL CYCLE,0.0013457,0.16406,0.15943,1,1
1,ACTIN BINDING,0.025994,0.16287,0.11811,1,1
1,PID FCER1PATHWAY,0.0057817,0.1624,0.15536,1,1
1,PROTEIN METABOLIC PROCESS,1.1267e-06,0.16211,0.15753,1,1
1,PROTEIN RNA COMPLEX ASSEMBLY,0.030383,0.16173,0.11255,1,1
1,RIBONUCLEASE ACTIVITY,0.0060989,0.16108,0.14809,1,1
1,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.00021909,0.16094,0.16742,1,1
1,PID INSULIN GLUCOSE PATHWAY,0.0097392,0.16041,0.14661,1,1
1,PEPTIDASE ACTIVITY,0.0013872,0.16033,0.13716,1,1
1,ENZYME INHIBITOR ACTIVITY,0.046579,0.16019,0.12854,1,1
1,REACTOME GLUCOSE METABOLISM,0.018836,0.16003,0.12546,1,1
1,REGULATION OF BODY FLUID LEVELS,0.0019282,0.15945,0.23132,1,1
1,BIOCARTA CARM1 PATHWAY,0.013465,0.15943,0.20414,1,1
1,CELLULAR PROTEIN CATABOLIC PROCESS,0.00026003,0.15926,0.18113,1,1
1,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00034072,0.15902,0.14485,1,1
1,REACTOME DOUBLE STRAND BREAK REPAIR,0.036948,0.159,0.15439,1,1
1,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.004408,0.15868,0.10666,1,1
1,REGULATION OF MAP KINASE ACTIVITY,0.0034322,0.15853,0.15477,1,1
1,PID BETACATENIN NUC PATHWAY,0.017969,0.15851,0.15503,1,1
1,SPHINGOLIPID METABOLIC PROCESS,0.036164,0.15784,0.11156,1,1
1,POLYSACCHARIDE BINDING,0.044685,0.15738,0.15219,1,1
1,HORMONE RECEPTOR BINDING,0.0079323,0.15664,0.17886,1,1
1,ONE CARBON COMPOUND METABOLIC PROCESS,0.035393,0.15622,0.1082,1,1
1,PID EPHA2 FWDPATHWAY,0.004408,0.15584,0.21606,1,1
1,RECEPTOR BINDING,0.0037331,0.15479,0.12052,1,1
1,DNA REPLICATION,0.019283,0.15399,0.10031,1,1
1,NUCLEAR PORE,0.0027346,0.15379,0.19377,1,1
1,REGULATION OF DEFENSE RESPONSE,0.023205,0.15352,0.14289,1,1
1,KEGG PYRIMIDINE METABOLISM,6.5149e-05,0.15307,0.19532,1,1
1,PID IGF1 PATHWAY,0.0045306,0.15244,0.13961,1,1
1,PID CD8TCRDOWNSTREAMPATHWAY,0.00021909,0.15237,0.22194,1,1
1,REACTOME NUCLEOTIDE EXCISION REPAIR,0.019283,0.15212,0.11438,1,1
1,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.00079435,0.15198,0.15594,1,1
1,CELLULAR PROTEIN METABOLIC PROCESS,2.2658e-06,0.15197,0.14751,1,1
1,CELL DEVELOPMENT,9.7346e-05,0.15177,0.13802,1,1
1,MACROMOLECULE BIOSYNTHETIC PROCESS,0.00092958,0.15116,0.14307,1,1
1,CELLULAR MACROMOLECULE CATABOLIC PROCESS,8.4205e-05,0.15101,0.16331,1,1
1,PID P75NTRPATHWAY,0.0040578,0.15047,0.15013,1,1
1,CELLULAR MACROMOLECULE METABOLIC PROCESS,2.6902e-06,0.15015,0.14347,1,1
1,UBIQUITIN CYCLE,0.0073363,0.14994,0.13734,1,1
1,PID RB 1PATHWAY,0.0051916,0.14989,0.14407,1,1
1,CHROMOSOMEPERICENTRIC REGION,0.031748,0.14966,0.13003,1,1
1,CELL CYCLE GO 0007049,0.001191,0.14918,0.11983,1,1
1,PID DNAPK PATHWAY,0.00014418,0.14893,0.20213,1,1
1,REACTOME MITOTIC PROMETAPHASE,0.022165,0.14875,0.11978,1,1
1,REACTOME SYNTHESIS OF PA,0.042857,0.14835,0.13987,1,1
1,REGULATION OF CELLULAR METABOLIC PROCESS,0.00010092,0.14808,0.12777,1,1
1,REACTOME CELL CYCLE MITOTIC,0.0027346,0.14806,0.11833,1,1
1,MACROMOLECULAR COMPLEX ASSEMBLY,4.3218e-05,0.14764,0.13984,1,1
1,PID IL2 PI3KPATHWAY,0.034637,0.1469,0.12988,1,1
1,PID TCR PATHWAY,0.017137,0.14626,0.10166,1,1
1,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0017641,0.14618,0.16504,1,1
1,DNA HELICASE ACTIVITY,0.0056288,0.14546,0.16692,1,1
1,REGULATION OF METABOLIC PROCESS,0.00010845,0.14533,0.12653,1,1
1,ENDOPEPTIDASE ACTIVITY,0.0012662,0.14529,0.15313,1,1
1,BIOCARTA PTEN PATHWAY,0.00092958,0.1452,0.27605,1,1
1,EXTRACELLULAR SPACE,0.029068,0.14519,0.14961,1,1
1,MITOCHONDRION,0.0039469,0.14493,0.13268,1,1
1,ST T CELL SIGNAL TRANSDUCTION,0.0017641,0.14491,0.14594,1,1
1,LIPID BINDING,0.0067808,0.14488,0.13244,1,1
1,DNA DEPENDENT DNA REPLICATION,0.036164,0.14433,0.10582,1,1
1,INTRACELLULAR SIGNALING CASCADE,0.00059588,0.14363,0.13103,1,1
1,SULFOTRANSFERASE ACTIVITY,0.0083534,0.14316,0.187,1,1
1,PID MTOR 4PATHWAY,0.00014935,0.1427,0.14777,1,1
1,REACTOME METABOLISM OF POLYAMINES,0.010245,0.14252,0.20097,1,1
1,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.011612,0.14186,0.15234,1,1
1,NUCLEAR HORMONE RECEPTOR BINDING,0.015203,0.14173,0.15981,1,1
1,REACTOME FRS2 MEDIATED CASCADE,0.0097392,0.14098,0.13534,1,1
1,REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY,0.046579,0.14085,0.13995,1,1
1,NEGATIVE REGULATION OF TRANSCRIPTION,0.026586,0.1404,0.091344,1,1
1,KEGG HUNTINGTONS DISEASE,0.0045306,0.14006,0.090454,1,1
1,EMBRYO IMPLANTATION,0.033166,0.14003,0.15724,1,1
1,RESPONSE TO CHEMICAL STIMULUS,0.022165,0.13989,0.11388,1,1
1,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.00026003,0.13931,0.18629,1,1
1,KEGG GLIOMA,0.0011199,0.13876,0.13671,1,1
1,GTPASE BINDING,0.02843,0.13862,0.10106,1,1
1,KINASE BINDING,0.0071468,0.13805,0.10096,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.0039469,0.13804,0.2006,1,1
1,REACTOME GLOBAL GENOMIC NER GG NER,0.0059384,0.13798,0.14738,1,1
1,REACTOME G1 PHASE,0.0085714,0.13772,0.1351,1,1
1,PROTEIN KINASE ACTIVITY,0.0017641,0.13658,0.11963,1,1
1,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.00095906,0.1353,0.11803,1,1
1,CYTOPLASMIC PART,1.7806e-05,0.13496,0.1306,1,1
1,ENZYME BINDING,0.0014738,0.13491,0.090601,1,1
1,RHYTHMIC PROCESS,0.010245,0.1347,0.10915,1,1
1,ENZYME ACTIVATOR ACTIVITY,0.0013054,0.13442,0.14212,1,1
1,KEGG CELL CYCLE,0.033894,0.13423,0.096678,1,1
1,NF KAPPAB BINDING,0.019283,0.13411,0.15275,1,1
1,KEGG NUCLEOTIDE EXCISION REPAIR,0.0097392,0.13347,0.12491,1,1
1,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.0034322,0.13209,0.12169,1,1
1,REGULATION OF MOLECULAR FUNCTION,6.5149e-05,0.13091,0.13264,1,1
1,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.036948,0.13022,0.16734,1,1
1,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.0033369,0.13003,0.12476,1,1
1,PROTEIN AMINO ACID PHOSPHORYLATION,0.00022676,0.13001,0.13035,1,1
1,CELLULAR COMPONENT ASSEMBLY,0.00012074,0.12972,0.12734,1,1
1,BIOSYNTHETIC PROCESS,0.00095906,0.12943,0.13393,1,1
1,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.02166,0.12892,0.10145,1,1
1,RNA CATABOLIC PROCESS,0.033166,0.12874,0.11935,1,1
1,RESPONSE TO BACTERIUM,0.0021689,0.12874,0.097785,1,1
1,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.015203,0.12872,0.10831,1,1
1,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.00074557,0.12814,0.14807,1,1
1,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.00041602,0.12799,0.10807,1,1
1,CATION BINDING,4.1617e-05,0.12645,0.16261,1,1
1,REGULATION OF HYDROLASE ACTIVITY,0.00054072,0.12633,0.15267,1,1
1,ST ADRENERGIC,0.017969,0.1262,0.16911,1,1
1,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.00019079,0.12535,0.22184,1,1
1,RIBONUCLEOPROTEIN COMPLEX,0.020205,0.12488,0.098443,1,1
1,REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE,0.0041716,0.12461,0.16406,1,1
1,PID FGF PATHWAY,0.02166,0.1237,0.13077,1,1
1,M PHASE,0.02268,0.12364,0.1091,1,1
1,IDENTICAL PROTEIN BINDING,0.0069616,0.12323,0.098631,1,1
1,GTPASE ACTIVITY,0.018836,0.12259,0.11202,1,1
1,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.038561,0.12179,0.094874,1,1
1,CYTOSOL,9.0551e-05,0.12148,0.14886,1,1
1,NUCLEOTIDE EXCISION REPAIR,0.015953,0.12132,0.15028,1,1
1,ST GA12 PATHWAY,0.027188,0.12091,0.11064,1,1
1,SOLUBLE FRACTION,0.00353,0.12042,0.14267,1,1
1,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.001662,0.11979,0.10764,1,1
1,PHOSPHORYLATION,0.00021909,0.1195,0.12431,1,1
1,CYTOPLASM,3.8583e-05,0.11925,0.11673,1,1
1,RESPONSE TO UV,0.044685,0.11919,0.088596,1,1
1,PROTEIN CATABOLIC PROCESS,0.00021167,0.11917,0.15462,1,1
1,REGULATION OF GENE EXPRESSION,0.0010859,0.11879,0.1058,1,1
1,POSITIVE REGULATION OF CASPASE ACTIVITY,0.0045306,0.11875,0.17779,1,1
1,DNA DIRECTED RNA POLYMERASE COMPLEX,0.013139,0.11841,0.10826,1,1
1,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.013139,0.11841,0.10826,1,1
1,RNA POLYMERASE COMPLEX,0.013139,0.11841,0.10826,1,1
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.00035231,0.1177,0.092111,1,1
1,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.0022992,0.11746,0.1368,1,1
1,REGULATION OF TRANSFERASE ACTIVITY,0.00014935,0.11681,0.14141,1,1
1,BIOCARTA VIP PATHWAY,0.011326,0.11672,0.17548,1,1
1,SMALL GTPASE BINDING,0.033166,0.11671,0.090183,1,1
1,TRANSCRIPTION REPRESSOR ACTIVITY,0.0047853,0.11657,0.11663,1,1
1,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.045624,0.11525,0.13732,1,1
1,ACTIN FILAMENT BASED PROCESS,0.027188,0.1151,0.096349,1,1
1,REGULATION OF KINASE ACTIVITY,7.2754e-05,0.11468,0.1448,1,1
1,MITOTIC CELL CYCLE,0.00353,0.11456,0.12904,1,1
1,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.0085714,0.11396,0.12074,1,1
1,BIOCARTA LECTIN PATHWAY,0.0025817,0.11376,0.24009,1,1
1,REGULATION OF LYMPHOCYTE ACTIVATION,0.010773,0.11355,0.20902,1,1
1,REACTOME DNA REPAIR,0.036164,0.11339,0.079963,1,1
1,REPRODUCTIVE PROCESS,0.029719,0.11262,0.08758,1,1
1,ORGANELLE LUMEN,0.00353,0.11219,0.092308,1,1
1,MEMBRANE ENCLOSED LUMEN,0.00353,0.11219,0.092308,1,1
1,TRANSCRIPTION FACTOR TFIID COMPLEX,0.013139,0.11215,0.12109,1,1
1,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.0056288,0.11074,0.12788,1,1
1,BIOCARTA RAS PATHWAY,0.021165,0.11004,0.10995,1,1
1,DNA METABOLIC PROCESS,0.014138,0.10845,0.089089,1,1
1,KINASE ACTIVITY,0.0034322,0.10824,0.093293,1,1
1,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.0051916,0.10772,0.13948,1,1
1,REGULATION OF PROTEIN KINASE ACTIVITY,0.00012074,0.10743,0.14368,1,1
1,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.023205,0.10683,0.079002,1,1
1,BIOPOLYMER METABOLIC PROCESS,0.00072223,0.10609,0.08211,1,1
1,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.036948,0.10541,0.24432,1,1
1,BIOPOLYMER MODIFICATION,0.0022332,0.10519,0.086948,1,1
1,RNA METABOLIC PROCESS,0.0026572,0.10504,0.09053,1,1
1,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.0033369,0.10496,0.10794,1,1
1,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.0087944,0.10439,0.08995,1,1
1,PID CXCR4 PATHWAY,0.018398,0.10323,0.10656,1,1
1,REACTOME MRNA CAPPING,0.0099891,0.10293,0.12454,1,1
1,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.011612,0.10172,0.071154,1,1
1,REACTOME SPRY REGULATION OF FGF SIGNALING,0.0025083,0.10117,0.14803,1,1
1,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0023671,0.10115,0.095099,1,1
1,RESPONSE TO RADIATION,0.019283,0.10097,0.069434,1,1
1,SIGNAL TRANSDUCTION,0.013798,0.10073,0.087488,1,1
1,POST TRANSLATIONAL PROTEIN MODIFICATION,0.0013457,0.098816,0.098725,1,1
1,GTP BINDING,0.0071468,0.097823,0.14457,1,1
1,INTRACELLULAR ORGANELLE PART,0.00098941,0.097804,0.084222,1,1
1,REGULATION OF RNA METABOLIC PROCESS,0.013465,0.095558,0.085342,1,1
1,REGULATION OF TRANSCRIPTION,0.0025817,0.095065,0.097148,1,1
1,ORGANELLE PART,0.0010859,0.094643,0.084181,1,1
1,ION BINDING,0.00031859,0.094344,0.11819,1,1
1,KEGG VIBRIO CHOLERAE INFECTION,0.041093,0.093613,0.091499,1,1
1,REGULATION OF BIOLOGICAL QUALITY,0.037747,0.093589,0.079796,1,1
1,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.0085714,0.093118,0.089608,1,1
1,CELLULAR LOCALIZATION,0.0071468,0.092437,0.069559,1,1
1,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.0011549,0.092329,0.12302,1,1
1,TRANSCRIPTION,0.0025817,0.091685,0.091098,1,1
1,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.012508,0.091644,0.083571,1,1
1,NEGATIVE REGULATION OF METABOLIC PROCESS,0.011612,0.091129,0.084264,1,1
1,PROTEIN MODIFICATION PROCESS,0.0045306,0.090591,0.08199,1,1
1,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.019283,0.090556,0.07258,1,1
1,MACROMOLECULE CATABOLIC PROCESS,7.547e-05,0.089364,0.12136,1,1
1,REGULATION OF CATALYTIC ACTIVITY,0.00092958,0.087454,0.10527,1,1
1,NON MEMBRANE BOUND ORGANELLE,0.036164,0.087302,0.061469,1,1
1,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.036164,0.087302,0.061469,1,1
1,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.014138,0.085721,0.10055,1,1
1,RNA BIOSYNTHETIC PROCESS,0.0064317,0.084363,0.08341,1,1
1,TRANSCRIPTION DNA DEPENDENT,0.0062634,0.084003,0.08388,1,1
1,KEGG MAPK SIGNALING PATHWAY,0.014841,0.082956,0.098315,1,1
1,ENZYME REGULATOR ACTIVITY,0.017137,0.082388,0.093537,1,1
1,POSITIVE REGULATION OF BINDING,0.009256,0.08227,0.13333,1,1
1,NUCLEUS,0.0022992,0.082181,0.067283,1,1
1,POSITIVE REGULATION OF DNA BINDING,0.021165,0.080879,0.1174,1,1
1,BIOPOLYMER CATABOLIC PROCESS,0.00074557,0.08038,0.1086,1,1
1,MACROMOLECULAR COMPLEX,0.0041716,0.076263,0.071012,1,1
1,TRANSCRIPTION COREPRESSOR ACTIVITY,0.031748,0.071828,0.099965,1,1
1,MEMBRANE,0.045624,0.068962,0.050361,1,1
1,GUANYL NUCLEOTIDE BINDING,0.015574,0.068399,0.13971,1,1
1,PURINE NUCLEOTIDE BINDING,0.027188,0.068074,0.067931,1,1
1,PROTEIN COMPLEX,0.0071468,0.062374,0.066329,1,1
1,NUCLEOTIDE BINDING,0.034637,0.058946,0.063171,1,1
1,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.0062634,0.31922,0.27045,1,0
1,BIOCARTA DC PATHWAY,0.00030804,0.31515,0.38743,1,0
1,BIOCARTA ARF PATHWAY,0.001986,0.31063,0.31033,1,0
1,BIOCARTA CTCF PATHWAY,0.0001547,0.29142,0.34055,1,0
1,GLIOGENESIS,0.010506,0.27534,0.22993,1,0
1,PIGMENT METABOLIC PROCESS,0.001662,0.27302,0.25593,1,0
1,OLIGOSACCHARYL TRANSFERASE COMPLEX,0.0062634,0.27041,0.18859,1,0
1,ACTIN FILAMENT POLYMERIZATION,0.00074557,0.25965,0.28294,1,0
1,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.00026903,0.2595,0.26969,1,0
1,PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.042857,0.25787,0.20843,1,0
1,BONE REMODELING,0.0067808,0.25246,0.30305,1,0
1,CASPASE REGULATOR ACTIVITY,0.0022332,0.25036,0.32191,1,0
1,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.00032948,0.24994,0.20825,1,0
1,EARLY ENDOSOME,0.0018173,0.24745,0.26236,1,0
1,DEVELOPMENTAL GROWTH,0.011904,0.24736,0.27529,1,0
1,REACTOME METAL ION SLC TRANSPORTERS,0.00050664,0.24354,0.22425,1,0
1,REACTOME HS GAG BIOSYNTHESIS,0.030383,0.23893,0.21306,1,0
1,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.014841,0.23546,0.23634,1,0
1,CYTOKINE BIOSYNTHETIC PROCESS,0.0001165,0.2312,0.29634,1,0
1,ENDOPLASMIC RETICULUM PART,0.00044439,0.23084,0.20644,1,0
1,NUCLEOLAR PART,0.0064317,0.2251,0.23962,1,0
1,ISOPRENOID METABOLIC PROCESS,0.023741,0.22139,0.19661,1,0
1,CYTOKINE METABOLIC PROCESS,0.00040247,0.2204,0.28376,1,0
1,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.009256,0.21832,0.20192,1,0
1,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.0010859,0.21414,0.23443,1,0
1,OXIDOREDUCTASE ACTIVITY GO 0016616,0.0081404,0.2139,0.15561,1,0
1,FATTY ACID METABOLIC PROCESS,0.001191,0.21374,0.21584,1,0
1,REACTOME PEROXISOMAL LIPID METABOLISM,0.004408,0.20933,0.2519,1,0
1,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.010245,0.209,0.23919,1,0
1,TRANS GOLGI NETWORK TRANSPORT VESICLE,0.0033369,0.20613,0.25613,1,0
1,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00028792,0.20549,0.26053,1,0
1,COENZYME BIOSYNTHETIC PROCESS,0.045624,0.20119,0.24872,1,0
1,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0046564,0.19916,0.1459,1,0
1,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.00012964,0.19448,0.18326,1,0
1,GLYCOPROTEIN CATABOLIC PROCESS,0.0097392,0.19282,0.2069,1,0
1,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.0090226,0.19158,0.15295,1,0
1,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.016339,0.18964,0.13971,1,0
1,OXYGEN BINDING,0.010773,0.18748,0.16882,1,0
1,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.045624,0.18685,0.13542,1,0
1,MICROBODY,0.017137,0.1851,0.14426,1,0
1,PEROXISOME,0.017137,0.1851,0.14426,1,0
1,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015203,0.18021,0.14982,1,0
1,ENDOCYTIC VESICLE,0.016734,0.1801,0.18883,1,0
1,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.0069616,0.17964,0.16469,1,0
1,INTRINSIC TO ORGANELLE MEMBRANE,0.0037331,0.17277,0.13791,1,0
1,ENDOMEMBRANE SYSTEM,0.00011241,0.17089,0.14778,1,0
1,KEGG PROPANOATE METABOLISM,0.041093,0.1696,0.17509,1,0
1,REACTOME PURINE METABOLISM,0.01282,0.16646,0.21449,1,0
1,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.00098941,0.16632,0.19106,1,0
1,CARBOXYLIC ACID METABOLIC PROCESS,0.0017123,0.16571,0.13922,1,0
1,AMINO ACID CATABOLIC PROCESS,0.027188,0.16325,0.1332,1,0
1,ORGANIC ACID METABOLIC PROCESS,0.0013457,0.16089,0.14339,1,0
1,ANION TRANSPORT,0.00074557,0.1606,0.24041,1,0
1,REACTOME BIOLOGICAL OXIDATIONS,0.0023671,0.15729,0.17034,1,0
1,GTPASE ACTIVATOR ACTIVITY,0.02068,0.1559,0.14251,1,0
1,REGULATION OF RAS GTPASE ACTIVITY,0.042857,0.15444,0.12465,1,0
1,MEMBRANE FRACTION,0.00034072,0.15353,0.1429,1,0
1,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03245,0.1535,0.099762,1,0
1,LIPID METABOLIC PROCESS,0.00054072,0.15063,0.11739,1,0
1,ENDOPLASMIC RETICULUM MEMBRANE,0.0059384,0.1479,0.13652,1,0
1,KEGG DRUG METABOLISM CYTOCHROME P450,0.02166,0.14766,0.18749,1,0
1,PHOSPHOINOSITIDE METABOLIC PROCESS,0.0041716,0.14642,0.12931,1,0
1,METALLOEXOPEPTIDASE ACTIVITY,0.010773,0.14566,0.21427,1,0
1,LIPOPROTEIN METABOLIC PROCESS,0.011326,0.1456,0.12207,1,0
1,INTEGRAL TO ORGANELLE MEMBRANE,0.0038387,0.14481,0.13338,1,0
1,CELLULAR LIPID CATABOLIC PROCESS,0.004408,0.1432,0.18056,1,0
1,CARBOHYDRATE BINDING,0.0090226,0.14198,0.14156,1,0
1,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.0067808,0.14093,0.10552,1,0
1,REACTOME IRON UPTAKE AND TRANSPORT,0.00353,0.13932,0.15258,1,0
1,ANTIGEN BINDING,0.020205,0.13643,0.10559,1,0
1,KEGG SPHINGOLIPID METABOLISM,0.03245,0.13466,0.10981,1,0
1,AROMATIC COMPOUND METABOLIC PROCESS,0.010506,0.13444,0.12015,1,0
1,LIPID CATABOLIC PROCESS,0.0042883,0.13229,0.168,1,0
1,CELL FRACTION,0.00042998,0.13124,0.13222,1,0
1,OVULATION CYCLE,0.0056288,0.13033,0.15894,1,0
1,KEGG ABC TRANSPORTERS,0.040234,0.12818,0.11359,1,0
1,DEFENSE RESPONSE TO BACTERIUM,0.0060989,0.1268,0.092092,1,0
1,LATE ENDOSOME,0.010773,0.12554,0.16912,1,0
1,CELLULAR LIPID METABOLIC PROCESS,0.0099891,0.12317,0.076507,1,0
1,ISOMERASE ACTIVITY,0.02268,0.12255,0.1152,1,0
1,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.0025083,0.11817,0.13285,1,0
1,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.029719,0.11801,0.087741,1,0
1,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.020205,0.11785,0.12464,1,0
1,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.0049174,0.11398,0.10087,1,0
1,REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS,0.033894,0.11297,0.14031,1,0
1,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.024288,0.11201,0.14751,1,0
1,CERAMIDE METABOLIC PROCESS,0.016339,0.11169,0.15324,1,0
1,NEGATIVE REGULATION OF CELL PROLIFERATION,0.035393,0.11112,0.1025,1,0
1,BIOCARTA MAL PATHWAY,0.0047853,0.10893,0.15168,1,0
1,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.03939,0.10808,0.089081,1,0
1,REGULATION OF CATABOLIC PROCESS,0.015203,0.10282,0.11106,1,0
1,NUCLEAR MEMBRANE PART,0.011047,0.10121,0.12811,1,0
1,VITAMIN METABOLIC PROCESS,0.011612,0.10095,0.19334,1,0
1,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.013798,0.098003,0.094108,1,0
1,RAS GTPASE BINDING,0.0083534,0.095919,0.11734,1,0
1,REACTOME PHOSPHORYLATION OF THE APC C,0.043763,0.091648,0.11589,1,0
1,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.029068,0.088766,0.13782,1,0
1,PROTEIN N TERMINUS BINDING,0.023741,0.076021,0.092499,1,0
1,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.03939,0.05454,0.11379,1,0
1,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.027188,-0.078573,-0.086436,1,0
1,NEUROGENESIS,0.024288,-0.090286,-0.19885,1,0
1,GLYCOPROTEIN METABOLIC PROCESS,0.011904,-0.091768,-0.13614,1,0
1,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.016734,-0.095644,-0.088076,1,0
1,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.02843,-0.10115,-0.18577,1,0
1,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.020205,-0.11096,-0.12057,1,0
1,NUCLEAR CHROMOSOME PART,0.036948,-0.11477,-0.11938,1,0
1,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.015203,-0.11853,-0.12038,1,0
1,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.038561,-0.11935,-0.15363,1,0
1,SEXUAL REPRODUCTION,0.0014299,-0.12125,-0.14728,1,0
1,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.0016129,-0.13404,-0.13158,1,0
1,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.010245,-0.13435,-0.10514,1,0
1,CAMP MEDIATED SIGNALING,0.017137,-0.13917,-0.12699,1,0
1,KEGG OLFACTORY TRANSDUCTION,0.00034072,-0.13948,-0.12425,1,0
1,KEGG FC EPSILON RI SIGNALING PATHWAY,0.013139,-0.14161,-0.13622,1,0
1,ION TRANSPORT,0.0017123,-0.14217,-0.15168,1,0
1,GENERATION OF NEURONS,0.0079323,-0.14855,-0.26389,1,0
1,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0028141,-0.14901,-0.13392,1,0
1,KEGG RIBOFLAVIN METABOLISM,0.019283,-0.15055,-0.19066,1,0
1,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.0085714,-0.1511,-0.13953,1,0
1,G PROTEIN COUPLED RECEPTOR ACTIVITY,2.5308e-05,-0.15279,-0.15902,1,0
1,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.014841,-0.15281,-0.13237,1,0
1,TUBULIN BINDING,0.0047853,-0.15449,-0.16668,1,0
1,CHROMATIN,0.0046564,-0.1548,-0.16874,1,0
1,REACTOME RNA POL III CHAIN ELONGATION,0.027803,-0.15561,-0.12,1,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.0071468,-0.15671,-0.14686,1,0
1,REACTOME CTLA4 INHIBITORY SIGNALING,0.034637,-0.15672,-0.16713,1,0
1,MRNA SPLICE SITE SELECTION,0.011326,-0.16243,-0.1297,1,0
1,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.015574,-0.16334,-0.16579,1,0
1,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0027346,-0.16406,-0.13671,1,0
1,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.038561,-0.16513,-0.1283,1,0
1,SECRETION,0.00087311,-0.17121,-0.15486,1,0
1,REACTOME G ALPHA S SIGNALLING EVENTS,0.001662,-0.17162,-0.16278,1,0
1,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.011326,-0.1725,-0.20943,1,0
1,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00079435,-0.17696,-0.16637,1,0
1,GAMETE GENERATION,0.00014935,-0.17986,-0.17144,1,0
1,MICROTUBULE BINDING,0.0017641,-0.18259,-0.20016,1,0
1,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.0051916,-0.183,-0.19391,1,0
1,REACTOME SIGNAL ATTENUATION,0.034637,-0.18406,-0.17658,1,0
1,COATED VESICLE,0.0028141,-0.18561,-0.1393,1,0
1,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.0010528,-0.1873,-0.19034,1,0
1,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.0017641,-0.18971,-0.20343,1,0
1,MONOOXYGENASE ACTIVITY,0.015203,-0.19031,-0.15721,1,0
1,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.038561,-0.19591,-0.10657,1,0
1,BIOCARTA TCRA PATHWAY,0.010245,-0.1981,-0.20201,1,0
1,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.0040578,-0.19912,-0.23711,1,0
1,LIGAND GATED CHANNEL ACTIVITY,0.00026003,-0.19932,-0.23244,1,0
1,REACTOME CD28 CO STIMULATION,0.031059,-0.19935,-0.11574,1,0
1,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.001662,-0.19969,-0.1978,1,0
1,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.0045306,-0.20045,-0.37433,1,0
1,KEGG ALPHA LINOLENIC ACID METABOLISM,0.0031536,-0.20618,-0.22708,1,0
1,REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.0026572,-0.20733,-0.43583,1,0
1,REACTOME SYNTHESIS OF PC,0.033166,-0.21556,-0.17578,1,0
1,REACTOME MEIOSIS,0.027803,-0.21624,-0.16665,1,0
1,ADP BINDING,0.0073363,-0.21959,-0.25231,1,0
1,BIOCARTA IL2 PATHWAY,0.046579,-0.22033,-0.14998,1,0
1,REACTOME CD28 DEPENDENT VAV1 PATHWAY,0.007729,-0.22094,-0.24151,1,0
1,STEROID BIOSYNTHETIC PROCESS,0.0099891,-0.22119,-0.21425,1,0
1,REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,0.0037331,-0.22318,-0.22632,1,0
1,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.0046564,-0.22331,-0.20095,1,0
1,BIOCARTA BARR MAPK PATHWAY,0.0050528,-0.22602,-0.21474,1,0
1,BIOCARTA SKP2E2F PATHWAY,0.011612,-0.22983,-0.22994,1,0
1,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.024846,-0.23017,-0.14333,1,0
1,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0001165,-0.23781,-0.21643,1,0
1,MICROTUBULE MOTOR ACTIVITY,0.0025817,-0.24449,-0.29237,1,0
1,REGULATION OF PH,0.026586,-0.24499,-0.15171,1,0
1,SECRETORY GRANULE,0.0075304,-0.25349,-0.22197,1,0
1,RESPONSE TO ORGANIC SUBSTANCE,0.00092958,-0.25768,-0.21676,1,0
1,SODIUM ION TRANSPORT,0.040234,-0.26623,-0.19302,1,0
1,CHROMATIN REMODELING,0.0060989,-0.26666,-0.20618,1,0
1,MICROTUBULE ASSOCIATED COMPLEX,3.8583e-05,-0.27285,-0.32248,1,0
1,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,6.5149e-05,-0.27297,-0.28954,1,0
1,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,4.3218e-05,-0.27321,-0.34954,1,0
1,REGULATION OF MEMBRANE POTENTIAL,0.00055855,-0.27361,-0.28304,1,0
1,REACTOME EARLY PHASE OF HIV LIFE CYCLE,0.0073363,-0.27391,-0.26002,1,0
1,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.00042998,-0.27404,-0.32793,1,0
1,SA REG CASCADE OF CYCLIN EXPR,0.024846,-0.27501,-0.19898,1,0
1,PID REELINPATHWAY,0.00057693,-0.27556,-0.30082,1,0
1,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.00072223,-0.27618,-0.34205,1,0
1,PID ALPHASYNUCLEIN PATHWAY,0.0021062,-0.27649,-0.24359,1,0
1,FEEDING BEHAVIOR,6.4994e-06,-0.28046,-0.33425,1,0
1,CATION TRANSPORT,6.0504e-05,-0.28226,-0.24994,1,0
1,REACTOME RNA POL I TRANSCRIPTION,0.020205,-0.28367,-0.19858,1,0
1,REACTOME ION TRANSPORT BY P TYPE ATPASES,2.7343e-05,-0.28526,-0.33853,1,0
1,BIOCARTA BARRESTIN SRC PATHWAY,0.0010528,-0.28787,-0.25164,1,0
1,APICAL JUNCTION COMPLEX,0.027803,-0.28877,-0.22901,1,0
1,APICOLATERAL PLASMA MEMBRANE,0.027803,-0.28877,-0.22901,1,0
1,INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.031059,-0.29249,-0.31597,1,0
1,KEGG TYPE II DIABETES MELLITUS,0.00026003,-0.2966,-0.25658,1,0
1,REACTOME SIGNALING BY NOTCH4,0.011047,-0.29662,-0.2423,1,0
1,TUBE MORPHOGENESIS,0.041093,-0.29957,-0.22689,1,0
1,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.0012662,-0.2999,-0.25542,1,0
1,PURINE NUCLEOTIDE METABOLIC PROCESS,0.021165,-0.30059,-0.22558,1,0
1,CARBOXYPEPTIDASE ACTIVITY,0.0039469,-0.30702,-0.31324,1,0
1,NUCLEOTIDE KINASE ACTIVITY,0.019283,-0.30803,-0.21206,1,0
1,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.00031859,-0.31209,-0.31732,1,0
1,IMMUNOLOGICAL SYNAPSE,0.0099891,-0.31375,-0.2363,1,0
1,MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.31568,-0.18752,1,0
1,MOTOR ACTIVITY,0.0064317,-0.31574,-0.23099,1,0
1,REACTOME MEIOTIC RECOMBINATION,0.015203,-0.31733,-0.23044,1,0
1,TIGHT JUNCTION,0.015203,-0.32399,-0.26081,1,0
1,NEUROPEPTIDE BINDING,6.2786e-05,-0.32521,-0.32565,1,0
1,NEUROPEPTIDE RECEPTOR ACTIVITY,6.2786e-05,-0.32521,-0.32565,1,0
1,NEURON PROJECTION,0.00012074,-0.33604,-0.37044,1,0
1,REGULATION OF CELLULAR PH,0.0039469,-0.33662,-0.25509,1,0
1,HORMONE ACTIVITY,7.547e-05,-0.33838,-0.3961,1,0
1,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,1.8521e-05,-0.33949,-0.36729,1,0
1,METAL ION TRANSPORT,1.9263e-05,-0.33964,-0.32227,1,0
1,NEUROTRANSMITTER BINDING,1.2862e-06,-0.34164,-0.37428,1,0
1,MESODERM DEVELOPMENT,0.0067808,-0.34633,-0.28984,1,0
1,REACTOME GABA RECEPTOR ACTIVATION,2.6307e-05,-0.34681,-0.34308,1,0
1,KEGG STEROID BIOSYNTHESIS,0.00098941,-0.34714,-0.44732,1,0
1,CARBON CARBON LYASE ACTIVITY,0.00016595,-0.34861,-0.30726,1,0
1,NEUROTRANSMITTER RECEPTOR ACTIVITY,9.0221e-07,-0.35349,-0.40703,1,0
1,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.011612,-0.35824,-0.24877,1,0
1,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.00017796,-0.36055,-0.28736,1,0
1,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,2.2524e-05,-0.36356,-0.35134,1,0
1,KEGG MATURITY ONSET DIABETES OF THE YOUNG,1.5816e-05,-0.36428,-0.45699,1,0
1,REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN,0.00010462,-0.36878,-0.51039,1,0
1,REACTOME ION CHANNEL TRANSPORT,1.8958e-07,-0.37354,-0.41466,1,0
1,PID HNF3BPATHWAY,1.4039e-05,-0.37862,-0.3957,1,0
1,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,9.389e-05,-0.40352,-0.40631,1,0
1,NICOTINIC ACETYLCHOLINE GATED RECEPTOR CHANNEL COMPLEX,0.0001547,-0.41915,-0.52696,1,0
1,NICOTINIC ACETYLCHOLINE ACTIVATED CATION SELECTIVE CHANNEL ACTIVITY,0.0001547,-0.41915,-0.52696,1,0
1,REACTOME INWARDLY RECTIFYING K CHANNELS,1.0604e-05,-0.41934,-0.43287,1,0
1,CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0067808,-0.42586,-0.29127,1,0
1,REACTOME ACYL CHAIN REMODELLING OF PG,0.00092958,-0.43422,-0.31429,1,0
1,REACTOME N GLYCAN ANTENNAE ELONGATION,0.0079323,-0.44345,-0.34502,1,0
1,REACTOME CGMP EFFECTS,6.7728e-06,-0.45065,-0.42432,1,0
1,MONOVALENT INORGANIC CATION TRANSPORT,8.3127e-06,-0.45229,-0.41464,1,0
1,GLUTAMATE SIGNALING PATHWAY,1.9263e-05,-0.45372,-0.47806,1,0
1,REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,3.8583e-05,-0.45375,-0.5884,1,0
1,REACTOME RNA POL I PROMOTER OPENING,0.0069616,-0.45823,-0.34512,1,0
1,DIGESTION,0.00028792,-0.46393,-0.42896,1,0
1,REACTOME REGULATION OF KIT SIGNALING,0.0028957,-0.46553,-0.41507,1,0
1,REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS,4.1617e-05,-0.47,-0.48529,1,0
1,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,5.4121e-05,-0.47012,-0.42037,1,0
1,BIOCARTA BAD PATHWAY,0.0010206,-0.47146,-0.32954,1,0
1,CALCIUM INDEPENDENT CELL CELL ADHESION,0.0059384,-0.50268,-0.38068,1,0
1,REACTOME REGULATION OF INSULIN SECRETION,1.0779e-06,-0.50565,-0.43839,1,0
1,REGULATION OF BLOOD PRESSURE,1.2862e-06,-0.50981,-0.56224,1,0
1,NUCLEAR CHROMATIN,0.0013054,-0.51564,-0.33322,1,0
1,REACTOME CHOLESTEROL BIOSYNTHESIS,0.00026903,-0.52592,-0.61512,1,0
1,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,9.7801e-06,-0.5304,-0.59744,1,0
1,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,1.1267e-06,-0.53625,-0.54687,1,0
1,REACTOME TIGHT JUNCTION INTERACTIONS,0.0049174,-0.55011,-0.4074,1,0
1,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.00022676,-0.55363,-0.51693,1,0
1,SYNAPSE ORGANIZATION AND BIOGENESIS,0.00044439,-0.55718,-0.47322,1,0
1,POTASSIUM ION TRANSPORT,9.4334e-07,-0.5691,-0.57749,1,0
1,KINASE INHIBITOR ACTIVITY,0.016734,-0.56923,-0.35493,1,0
1,PROTEIN KINASE INHIBITOR ACTIVITY,0.017969,-0.57383,-0.37201,1,0
1,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,3.7791e-06,-0.57968,-0.5725,1,0
1,REACTOME CELL CELL JUNCTION ORGANIZATION,0.00014935,-0.61844,-0.47726,1,0
1,MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,3.1904e-06,-0.63592,-0.56701,1,0
1,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP,0.00016023,-0.64319,-0.52134,1,0
1,REACTOME REGULATION OF BETA CELL DEVELOPMENT,2.6322e-07,-0.65303,-0.64498,1,0
1,REACTOME GABA A RECEPTOR ACTIVATION,6.5896e-07,-0.66723,-0.75563,1,0
1,POTASSIUM CHANNEL REGULATOR ACTIVITY,1.0604e-05,-0.69333,-0.55296,1,0
1,REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS,0.01282,-0.71161,-0.39579,1,0
1,REACTOME AMINE DERIVED HORMONES,3.5759e-05,-0.7546,-0.63597,1,0
1,EXOCYTOSIS,3.6414e-07,-0.76757,-0.70677,1,0
1,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,5.2533e-07,-0.92626,-0.82495,1,0
1,REACTOME INSULIN SYNTHESIS AND PROCESSING,1.906e-06,-0.9328,-0.78146,1,0
1,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,3.6228e-06,-0.93556,-0.79112,1,0
1,REACTOME CRMPS IN SEMA3A SIGNALING,3.6228e-06,-1.1087,-1.0141,1,0
1,NEUROPEPTIDE HORMONE ACTIVITY,1.0779e-06,-1.1631,-1.0055,1,0
1,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0695,0.37842,0.20812,0,1
1,PID ANTHRAXPATHWAY,0.17374,0.33015,0.24462,0,1
1,RESPONSE TO VIRUS,0.04854,0.2946,0.14516,0,1
1,BIOCARTA D4GDI PATHWAY,0.1028,0.28968,0.29258,0,1
1,LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS,0.049546,0.2824,0.18329,0,1
1,BIOCARTA 41BB PATHWAY,0.085627,0.28021,0.1302,0,1
1,SENSORY ORGAN DEVELOPMENT,0.053746,0.27881,0.14737,0,1
1,SKELETAL MUSCLE DEVELOPMENT,0.055956,0.26382,0.17926,0,1
1,DEAMINASE ACTIVITY,0.068167,0.25455,0.18811,0,1
1,KEGG CITRATE CYCLE TCA CYCLE,0.13583,0.25072,0.10671,0,1
1,PID ATF2 PATHWAY,0.10465,0.24528,0.15261,0,1
1,MONOCARBOXYLIC ACID TRANSPORT,0.14285,0.24257,0.20177,0,1
1,BILE ACID METABOLIC PROCESS,0.05161,0.24045,0.13882,0,1
1,REACTOME THE NLRP3 INFLAMMASOME,0.15517,0.23948,0.1206,0,1
1,MITOTIC SPINDLE ORGANIZATION AND BIOGENESIS,0.077957,0.23493,0.17611,0,1
1,SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY,0.059411,0.2342,0.16338,0,1
1,COENZYME BINDING,0.11039,0.22975,0.11784,0,1
1,SPINDLE ORGANIZATION AND BIOGENESIS,0.088862,0.22594,0.15137,0,1
1,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.063042,0.22053,0.22193,0,1
1,BIOCARTA SHH PATHWAY,0.061812,0.21742,0.16544,0,1
1,BIOCARTA TOLL PATHWAY,0.061812,0.2163,0.14963,0,1
1,BIOCARTA MITOCHONDRIA PATHWAY,0.077957,0.21626,0.17151,0,1
1,RIBOSOME BIOGENESIS AND ASSEMBLY,0.065563,0.2127,0.20307,0,1
1,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.072231,0.20341,0.10253,0,1
1,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.04854,0.2032,0.12276,0,1
1,SINGLE STRANDED RNA BINDING,0.20309,0.1959,0.11133,0,1
1,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.055956,0.19315,0.12537,0,1
1,REACTOME PURINE CATABOLISM,0.29184,0.19276,0.23678,0,1
1,ACTIN FILAMENT BUNDLE FORMATION,0.053746,0.18176,0.19391,0,1
1,LEUKOCYTE DIFFERENTIATION,0.188,0.18035,0.09666,0,1
1,SMALL CONJUGATING PROTEIN BINDING,0.085627,0.17894,0.11459,0,1
1,PID TCRCALCIUMPATHWAY,0.33373,0.17549,0.10478,0,1
1,MITOCHONDRIAL INNER MEMBRANE,0.097379,0.1733,0.099596,0,1
1,REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES,0.093897,0.17213,0.12387,0,1
1,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.084046,0.16818,0.15368,0,1
1,REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA,0.15773,0.16685,0.095066,0,1
1,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4978,0.16663,0.062457,0,1
1,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.061812,0.16658,0.11547,0,1
1,REACTOME LYSOSOME VESICLE BIOGENESIS,0.41842,0.16399,0.041524,0,1
1,REGULATION OF SYNAPSE STRUCTURE AND ACTIVITY,0.18219,0.1632,0.13803,0,1
1,BIOCARTA PTC1 PATHWAY,0.061812,0.16207,0.16322,0,1
1,NITROGEN COMPOUND CATABOLIC PROCESS,0.052669,0.16165,0.1197,0,1
1,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.30815,0.16095,0.077483,0,1
1,BIOCARTA IL2RB PATHWAY,0.15015,0.16067,0.10128,0,1
1,REGULATION OF PROTEIN SECRETION,0.093897,0.16053,0.1314,0,1
1,REGULATION OF CELL DIFFERENTIATION,0.25729,0.15763,0.078765,0,1
1,POSITIVE REGULATION OF TRANSPORT,0.057089,0.15697,0.14279,0,1
1,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.67137,0.15661,0.0078801,0,1
1,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.066855,0.15561,0.096626,0,1
1,PEROXISOME ORGANIZATION AND BIOGENESIS,0.049546,0.1538,0.10463,0,1
1,NUCLEAR MATRIX,0.20937,0.15291,0.13915,0,1
1,SOLUTE SODIUM SYMPORTER ACTIVITY,0.17374,0.15287,0.089609,0,1
1,ENDORIBONUCLEASE ACTIVITY,0.0695,0.15181,0.054028,0,1
1,EXTRINSIC TO MEMBRANE,0.15773,0.15157,0.11628,0,1
1,REACTOME RAF MAP KINASE CASCADE,0.080955,0.14955,0.074164,0,1
1,RNA DEPENDENT ATPASE ACTIVITY,0.073629,0.14726,0.13889,0,1
1,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.066855,0.1469,0.10651,0,1
1,REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND,0.099158,0.14536,0.10082,0,1
1,RRNA PROCESSING,0.12259,0.14514,0.17289,0,1
1,CELL CORTEX PART,0.050569,0.1445,0.11598,0,1
1,RNA 3END PROCESSING,0.12908,0.14419,0.11109,0,1
1,ORGANELLE INNER MEMBRANE,0.14526,0.14387,0.07368,0,1
1,BIOCARTA TPO PATHWAY,0.13814,0.14376,0.11115,0,1
1,REACTOME PROLACTIN RECEPTOR SIGNALING,0.13583,0.14346,0.14964,0,1
1,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.057089,0.14241,0.098625,0,1
1,BIOCARTA ETS PATHWAY,0.65234,0.14035,0.036021,0,1
1,REGULATION OF RHO GTPASE ACTIVITY,0.0695,0.13649,0.10078,0,1
1,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.04854,0.13565,0.10111,0,1
1,KEGG ACUTE MYELOID LEUKEMIA,0.060602,0.13115,0.091865,0,1
1,REACTOME SEROTONIN RECEPTORS,0.38408,0.13114,0.0391,0,1
1,PID RAC1 PATHWAY,0.068167,0.13092,0.11929,0,1
1,REACTOME ACYL CHAIN REMODELLING OF PC,0.068167,0.12937,0.098675,0,1
1,MITOCHONDRIAL MEMBRANE PART,0.26471,0.12933,0.054489,0,1
1,PID CMYB PATHWAY,0.15773,0.12829,0.079305,0,1
1,KERATINOCYTE DIFFERENTIATION,0.21579,0.12531,0.12272,0,1
1,PROTEIN HOMODIMERIZATION ACTIVITY,0.073629,0.12473,0.071881,0,1
1,RRNA METABOLIC PROCESS,0.13583,0.12436,0.15458,0,1
1,BIOCARTA ATRBRCA PATHWAY,0.12259,0.12368,0.11394,0,1
1,PID ENDOTHELINPATHWAY,0.088862,0.12351,0.11368,0,1
1,REGULATION OF LIPID METABOLIC PROCESS,0.093897,0.11753,0.11593,0,1
1,REACTOME SIGNAL TRANSDUCTION BY L1,0.049546,0.11516,0.11742,0,1
1,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.087232,0.11232,0.11515,0,1
1,SIG CHEMOTAXIS,0.17099,0.11198,0.069843,0,1
1,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.17374,0.11116,0.057624,0,1
1,NEGATIVE REGULATION OF SECRETION,0.049546,0.1104,0.23599,0,1
1,REACTOME SIGNALING BY EGFR IN CANCER,0.076492,0.10944,0.066182,0,1
1,PID ER NONGENOMIC PATHWAY,0.063042,0.10827,0.10774,0,1
1,BIOCARTA NFAT PATHWAY,0.05161,0.10612,0.090765,0,1
1,KEGG HISTIDINE METABOLISM,0.32938,0.10602,0.067827,0,1
1,MITOCHONDRIAL RESPIRATORY CHAIN,0.2839,0.10598,0.085299,0,1
1,PID REG GR PATHWAY,0.29586,0.1056,0.086385,0,1
1,REACTOME GLUCOSE TRANSPORT,0.050569,0.10558,0.10956,0,1
1,BIOCARTA IGF1 PATHWAY,0.10845,0.10558,0.14937,0,1
1,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.15264,0.10547,0.060913,0,1
1,SUGAR BINDING,0.049546,0.10457,0.13571,0,1
1,SINGLE STRANDED DNA BINDING,0.10654,0.10408,0.11931,0,1
1,KEGG PRION DISEASES,0.054842,0.10402,0.1534,0,1
1,PERINUCLEAR REGION OF CYTOPLASM,0.097379,0.10378,0.11339,0,1
1,PID AURORA A PATHWAY,0.092194,0.10346,0.10587,0,1
1,KEGG INOSITOL PHOSPHATE METABOLISM,0.054842,0.10152,0.091603,0,1
1,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.10096,0.10064,0.10328,0,1
1,REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND,0.54321,0.099477,-0.0039425,0,1
1,PID LYSOPHOSPHOLIPID PATHWAY,0.072231,0.09877,0.12323,0,1
1,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.26098,0.098377,0.092048,0,1
1,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.29184,0.097819,0.044046,0,1
1,PROTEIN EXPORT FROM NUCLEUS,0.15015,0.092284,0.069675,0,1
1,UBIQUITIN BINDING,0.25363,0.091932,0.060454,0,1
1,BIOCARTA GH PATHWAY,0.17653,0.090722,0.07262,0,1
1,CYTOSKELETON,0.090515,0.089975,0.075007,0,1
1,PID FOXOPATHWAY,0.4545,0.089468,0.050679,0,1
1,ANATOMICAL STRUCTURE MORPHOGENESIS,0.063042,0.088741,0.081946,0,1
1,NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.15015,0.088539,0.15159,0,1
1,ACTIN CYTOSKELETON,0.0695,0.088239,0.1074,0,1
1,ENDODEOXYRIBONUCLEASE ACTIVITY,0.16032,0.087059,0.075057,0,1
1,NUCLEAR LUMEN,0.05824,0.085861,0.058925,0,1
1,KEGG SPLICEOSOME,0.053746,0.085083,0.093735,0,1
1,NUCLEAR BODY,0.11841,0.08316,0.088849,0,1
1,REACTOME EXTENSION OF TELOMERES,0.90599,0.082547,-0.016484,0,1
1,REACTOME ACTIVATION OF GENES BY ATF4,0.11434,0.081271,0.10282,0,1
1,KEGG RNA DEGRADATION,0.14769,0.080899,0.057008,0,1
1,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.11039,0.079858,0.069198,0,1
1,DNA DEPENDENT ATPASE ACTIVITY,0.16032,0.079835,0.10801,0,1
1,KEGG RNA POLYMERASE,0.2,0.076225,0.054143,0,1
1,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.12689,0.076186,0.11888,0,1
1,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.26847,0.075501,0.069021,0,1
1,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.25363,0.074834,0.081818,0,1
1,REACTOME HIV LIFE CYCLE,0.065563,0.074449,0.091013,0,1
1,DNA BINDING,0.21256,0.074164,0.040955,0,1
1,PID MET PATHWAY,0.10845,0.073731,0.082046,0,1
1,PID PI3KPLCTRKPATHWAY,0.21256,0.073393,0.0886,0,1
1,REACTOME MRNA SPLICING MINOR PATHWAY,0.24288,0.072052,0.050665,0,1
1,BIOPOLYMER BIOSYNTHETIC PROCESS,0.17653,0.071281,0.11307,0,1
1,ATP BINDING,0.053746,0.071236,0.061294,0,1
1,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.60272,0.069476,0.015654,0,1
1,REACTOME PERK REGULATED GENE EXPRESSION,0.070855,0.069174,0.10542,0,1
1,NUCLEAR PART,0.090515,0.069032,0.05371,0,1
1,KEGG VEGF SIGNALING PATHWAY,0.070855,0.068926,0.067857,0,1
1,BIOCARTA INSULIN PATHWAY,0.2,0.067756,0.078499,0,1
1,ORGANELLE LOCALIZATION,0.4978,0.065931,0.033562,0,1
1,REACTOME GLYCOLYSIS,0.41842,0.065433,0.085072,0,1
1,REACTOME ELONGATION ARREST AND RECOVERY,0.12689,0.062711,0.075016,0,1
1,BIOCARTA ERK5 PATHWAY,0.30402,0.062636,0.065764,0,1
1,TRANSCRIPTION ACTIVATOR ACTIVITY,0.27227,0.062482,0.032096,0,1
1,REACTOME SOS MEDIATED SIGNALLING,0.15264,0.062426,0.048868,0,1
1,PURINE RIBONUCLEOTIDE BINDING,0.068167,0.062395,0.056549,0,1
1,REACTOME SIGNALING BY FGFR MUTANTS,0.2,0.062139,0.06321,0,1
1,ADENYL NUCLEOTIDE BINDING,0.097379,0.061819,0.053022,0,1
1,LEUKOCYTE ACTIVATION,0.43883,0.061734,0.037779,0,1
1,REACTOME CELL CYCLE,0.061812,0.061631,0.060403,0,1
1,PID ERBB2ERBB3PATHWAY,0.13355,0.060456,0.056043,0,1
1,KEGG GAP JUNCTION,0.092194,0.060084,0.073989,0,1
1,REACTOME PI 3K CASCADE,0.48678,0.05632,0.024452,0,1
1,ORGANELLE ORGANIZATION AND BIOGENESIS,0.063042,0.055742,0.046299,0,1
1,TRANSCRIPTION FACTOR BINDING,0.084046,0.054599,0.058201,0,1
1,TRANSCRIPTION COFACTOR ACTIVITY,0.14048,0.049198,0.036974,0,1
1,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.44924,0.045011,0.035276,0,1
1,CELL CYCLE PROCESS,0.11039,0.04431,0.062487,0,1
1,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.13814,0.043128,0.057836,0,1
1,CELL CYCLE PHASE,0.1028,0.039535,0.062007,0,1
1,BIOCARTA FMLP PATHWAY,0.29586,0.037995,0.046787,0,1
1,CELL ACTIVATION,0.71658,0.031558,0.014224,0,1
1,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.00013433,0.52328,0.4399,0,0
1,BIOCARTA ACE2 PATHWAY,0.055956,0.49793,0.28255,0,0
1,BIOCARTA ERYTH PATHWAY,0.00063551,0.42477,0.67124,0,0
1,ARYLSULFATASE ACTIVITY,0.00074557,0.37886,0.42959,0,0
1,COPPER ION BINDING,0.00035231,0.36929,0.3421,0,0
1,SULFURIC ESTER HYDROLASE ACTIVITY,0.001986,0.34861,0.36498,0,0
1,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.31232,0.31577,0.12235,0,0
1,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,3.0689e-05,0.31467,0.41001,0,0
1,PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00035231,0.3096,0.29415,0,0
1,MUSCLE CELL DIFFERENTIATION,0.010773,0.29163,0.31144,0,0
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.0011199,0.2757,0.28488,0,0
1,PID HEDGEHOG 2PATHWAY,0.009256,0.26201,0.23847,0,0
1,CHEMOKINE ACTIVITY,0.00013433,0.25918,0.42632,0,0
1,CHEMOKINE RECEPTOR BINDING,0.00013433,0.25918,0.42632,0,0
1,REACTOME PHASE II CONJUGATION,0.0011199,0.25309,0.22562,0,0
1,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.00030804,0.25125,0.36233,0,0
1,EMBRYONIC MORPHOGENESIS,0.23589,0.23889,0.089431,0,0
1,REACTOME PYRUVATE METABOLISM,0.0097392,0.23179,0.20739,0,0
1,BIOCARTA AHSP PATHWAY,0.075049,0.23024,0.26204,0,0
1,ICOSANOID METABOLIC PROCESS,0.072231,0.22907,0.17045,0,0
1,REACTOME GLUTATHIONE CONJUGATION,0.061812,0.2234,0.19509,0,0
1,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.0040578,0.21653,0.21449,0,0
1,PROTEIN AMINO ACID LIPIDATION,0.0020453,0.21561,0.16893,0,0
1,REACTOME ERKS ARE INACTIVATED,0.0010206,0.21318,0.2487,0,0
1,BIOCARTA NKCELLS PATHWAY,0.39371,0.2108,0.081262,0,0
1,RIBOSOME,0.011047,0.20803,0.18435,0,0
1,REACTOME ZINC TRANSPORTERS,0.0033369,0.19889,0.16238,0,0
1,REACTOME P2Y RECEPTORS,0.024846,0.19731,0.13727,0,0
1,AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.085627,0.19596,0.16823,0,0
1,BIOCARTA DNAFRAGMENT PATHWAY,0.076492,0.19271,0.15263,0,0
1,BIOCARTA TCYTOTOXIC PATHWAY,0.073629,0.19217,0.24784,0,0
1,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.049546,0.18882,0.17643,0,0
1,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.004408,0.18736,0.15684,0,0
1,BIOCARTA NUCLEARRS PATHWAY,0.097379,0.18671,0.10186,0,0
1,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.24643,0.18612,0.18841,0,0
1,KEGG MELANOMA,0.00074557,0.18557,0.16278,0,0
1,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.00067758,0.18511,0.20292,0,0
1,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0032441,0.17952,0.16132,0,0
1,CARBOHYDRATE CATABOLIC PROCESS,0.0032441,0.17952,0.16132,0,0
1,BIOCARTA PITX2 PATHWAY,0.10465,0.1787,0.13072,0,0
1,KEGG PENTOSE PHOSPHATE PATHWAY,0.034637,0.17846,0.16598,0,0
1,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.17374,0.17837,0.082739,0,0
1,PHOSPHOLIPASE C ACTIVATION,0.020205,0.17485,0.16686,0,0
1,MEMBRANE ORGANIZATION AND BIOGENESIS,9.0551e-05,0.17404,0.1494,0,0
1,REACTOME PURINE SALVAGE,0.35607,0.17382,0.048198,0,0
1,CARBOHYDRATE TRANSPORT,0.012203,0.1732,0.14438,0,0
1,3 5 EXONUCLEASE ACTIVITY,0.025994,0.17095,0.17502,0,0
1,PID ARF6DOWNSTREAMPATHWAY,0.0059384,0.1709,0.18332,0,0
1,POSITIVE REGULATION OF MAPKKK CASCADE,0.15773,0.1687,0.1312,0,0
1,ANION CATION SYMPORTER ACTIVITY,0.023741,0.16847,0.17542,0,0
1,PROTEIN TETRAMERIZATION,0.075049,0.16614,0.14617,0,0
1,REACTOME NCAM1 INTERACTIONS,0.036164,0.16456,0.22554,0,0
1,REACTOME ACYL CHAIN REMODELLING OF PE,0.16294,0.16301,0.095236,0,0
1,REACTOME SIGNALING BY NOTCH3,0.73628,0.16296,0.010093,0,0
1,NOTCH SIGNALING PATHWAY,0.066855,0.1624,0.14297,0,0
1,KEGG STARCH AND SUCROSE METABOLISM,0.0085714,0.16023,0.1459,0,0
1,RESPONSE TO IONIZING RADIATION,0.075049,0.15683,0.13728,0,0
1,NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.03939,0.15589,0.13121,0,0
1,AMINE METABOLIC PROCESS,0.00032948,0.15587,0.15075,0,0
1,MYELOID CELL DIFFERENTIATION,0.38888,0.15536,0.072095,0,0
1,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.061812,0.15464,0.12958,0,0
1,TISSUE REMODELING,0.11636,0.15464,0.20034,0,0
1,ATP DEPENDENT RNA HELICASE ACTIVITY,0.090515,0.14926,0.14152,0,0
1,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.12908,0.14654,0.10443,0,0
1,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.11039,0.14638,0.16758,0,0
1,ORGANELLAR SMALL RIBOSOMAL SUBUNIT,0.030383,0.14564,0.15202,0,0
1,MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT,0.030383,0.14564,0.15202,0,0
1,SMALL RIBOSOMAL SUBUNIT,0.030383,0.14564,0.15202,0,0
1,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.26471,0.14274,0.084574,0,0
1,PROTEIN DEACETYLASE ACTIVITY,0.025414,0.14153,0.16406,0,0
1,REGIONALIZATION,0.60883,0.13973,0.028307,0,0
1,BIOCARTA P53 PATHWAY,0.14526,0.13886,0.15196,0,0
1,PID PRLSIGNALINGEVENTSPATHWAY,0.020205,0.1388,0.24753,0,0
1,KEGG TYPE I DIABETES MELLITUS,0.088862,0.13831,0.15577,0,0
1,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.12473,0.13798,0.14354,0,0
1,ANTIPORTER ACTIVITY,0.1028,0.13642,0.16257,0,0
1,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.080955,0.1358,0.19213,0,0
1,AMINE CATABOLIC PROCESS,0.095625,0.13538,0.091265,0,0
1,PID BMPPATHWAY,0.20937,0.13513,0.11288,0,0
1,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.12689,0.13352,0.14666,0,0
1,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.23937,0.13157,0.14694,0,0
1,APOPTOTIC PROGRAM,0.11235,0.13141,0.079373,0,0
1,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.075049,0.12862,0.10862,0,0
1,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.023741,0.12809,0.070473,0,0
1,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.011612,0.12808,0.14501,0,0
1,KEGG GLUTATHIONE METABOLISM,0.27999,0.12668,0.083842,0,0
1,CELLULAR CATABOLIC PROCESS,5.6174e-05,0.12547,0.12511,0,0
1,SYMPORTER ACTIVITY,0.021165,0.12459,0.12051,0,0
1,PML BODY,0.21905,0.12447,0.088571,0,0
1,PID THROMBIN PAR1 PATHWAY,0.019283,0.12401,0.13851,0,0
1,PID IL8CXCR1 PATHWAY,0.18508,0.12297,0.08438,0,0
1,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.42347,0.12199,0.044352,0,0
1,KEGG O GLYCAN BIOSYNTHESIS,0.077957,0.12184,0.087052,0,0
1,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.010773,0.12177,0.11679,0,0
1,CATABOLIC PROCESS,6.7596e-05,0.12149,0.11959,0,0
1,REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,0.29586,0.12142,0.10591,0,0
1,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.29184,0.11972,0.076018,0,0
1,KEGG PPAR SIGNALING PATHWAY,0.18508,0.1191,0.061088,0,0
1,VESICULAR FRACTION,0.0695,0.11782,0.11431,0,0
1,ST WNT CA2 CYCLIC GMP PATHWAY,0.14285,0.11776,0.081461,0,0
1,VACUOLAR PART,0.72313,0.11698,0.013289,0,0
1,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.38888,0.11599,0.080463,0,0
1,CELL MIGRATION,0.0085714,0.11449,0.13896,0,0
1,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.0051916,0.1144,0.12992,0,0
1,RIBONUCLEOPROTEIN BINDING,0.46512,0.11379,0.042525,0,0
1,PID IL2 1PATHWAY,0.36991,0.11327,0.026635,0,0
1,OXIDOREDUCTASE ACTIVITY GO 0016705,0.27227,0.11315,0.065761,0,0
1,LIPOPROTEIN BINDING,0.11039,0.11302,0.1116,0,0
1,KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS,0.11039,0.11253,0.050953,0,0
1,MAINTENANCE OF CELLULAR LOCALIZATION,0.32938,0.11238,0.076163,0,0
1,REGULATION OF CYTOKINE PRODUCTION,0.13355,0.11238,0.11766,0,0
1,KEGG CHRONIC MYELOID LEUKEMIA,0.031059,0.11221,0.13446,0,0
1,LOW DENSITY LIPOPROTEIN BINDING,0.3746,0.11219,0.058555,0,0
1,PROTEIN OLIGOMERIZATION,0.20937,0.11198,0.052745,0,0
1,PROTEIN POLYUBIQUITINATION,0.021165,0.11012,0.12965,0,0
1,VACUOLAR MEMBRANE,0.65234,0.10815,0.021061,0,0
1,MAINTENANCE OF CELLULAR PROTEIN LOCALIZATION,0.36064,0.10806,0.076899,0,0
1,PID IL2 STAT5PATHWAY,0.35153,0.10739,0.071899,0,0
1,LIPID KINASE ACTIVITY,0.053746,0.10724,0.1393,0,0
1,DNA DAMAGE CHECKPOINT,0.036948,0.10722,0.10961,0,0
1,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.070855,0.10691,0.094302,0,0
1,GABA RECEPTOR ACTIVITY,0.87833,0.10687,-0.074731,0,0
1,SA PTEN PATHWAY,0.10465,0.10635,0.11357,0,0
1,AEROBIC RESPIRATION,0.29992,0.10535,0.047979,0,0
1,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.17374,0.10514,0.11727,0,0
1,DNA DIRECTED RNA POLYMERASEII CORE COMPLEX,0.10465,0.10506,0.11181,0,0
1,INORGANIC ANION TRANSPORT,0.095625,0.10497,0.13191,0,0
1,SEROTONIN RECEPTOR ACTIVITY,0.37932,0.104,0.040546,0,0
1,REACTOME PI3K CASCADE,0.025994,0.10326,0.093652,0,0
1,BIOCARTA MYOSIN PATHWAY,0.54903,0.1028,0.032174,0,0
1,PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY,0.53167,0.10258,0.045487,0,0
1,BIOCARTA IL12 PATHWAY,0.16828,0.10241,0.10774,0,0
1,PID P38ALPHABETADOWNSTREAMPATHWAY,0.079444,0.1024,0.10584,0,0
1,REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX,0.53167,0.10072,0.047041,0,0
1,KEGG TRYPTOPHAN METABOLISM,0.36991,0.10044,0.069423,0,0
1,BIOCARTA CARM ER PATHWAY,0.038561,0.10031,0.11027,0,0
1,BIOCARTA CCR3 PATHWAY,0.26098,0.10027,0.07892,0,0
1,REACTOME SIGNALING BY ROBO RECEPTOR,0.059411,0.098407,0.12752,0,0
1,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.29992,0.097922,0.040308,0,0
1,CYTOSOLIC PART,0.14769,0.097445,0.12803,0,0
1,EXONUCLEASE ACTIVITY,0.28785,0.097421,0.049334,0,0
1,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.19393,0.096666,0.15212,0,0
1,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.021165,0.096043,0.14355,0,0
1,SIG IL4RECEPTOR IN B LYPHOCYTES,0.11636,0.095459,0.080908,0,0
1,EXTRINSIC TO PLASMA MEMBRANE,0.43883,0.09538,0.072935,0,0
1,MAINTENANCE OF LOCALIZATION,0.12689,0.095173,0.1137,0,0
1,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.20937,0.093863,0.060001,0,0
1,PID GMCSF PATHWAY,0.27999,0.093521,0.086325,0,0
1,KEGG ETHER LIPID METABOLISM,0.20621,0.093201,0.070246,0,0
1,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.20309,0.092077,0.06586,0,0
1,COFACTOR TRANSPORT,0.75615,0.091469,0.021401,0,0
1,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.4978,0.091191,0.04766,0,0
1,BIOCARTA CELLCYCLE PATHWAY,0.30815,0.090785,0.052392,0,0
1,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.5726,0.090583,0.031251,0,0
1,SMALL GTPASE REGULATOR ACTIVITY,0.059411,0.090042,0.096843,0,0
1,CELL CORTEX,0.188,0.089732,0.082682,0,0
1,PROTEIN BINDING BRIDGING,0.26847,0.089442,0.065144,0,0
1,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.188,0.089302,0.068734,0,0
1,KEGG PHENYLALANINE METABOLISM,0.98255,0.089137,-0.028711,0,0
1,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.063042,0.088895,0.078489,0,0
1,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.37932,0.088817,0.064324,0,0
1,ORGAN DEVELOPMENT,0.02843,0.088653,0.12968,0,0
1,KEGG GLYOXYLATE AND DICARBOXYLATE METABOLISM,0.11235,0.087854,0.089668,0,0
1,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.25729,0.08775,0.047816,0,0
1,INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.092194,0.087705,0.10669,0,0
1,CELL CYCLE CHECKPOINT GO 0000075,0.042857,0.087297,0.11527,0,0
1,REACTOME APOPTOTIC EXECUTION PHASE,0.22568,0.086813,0.10431,0,0
1,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.16294,0.086182,0.077583,0,0
1,BIOCARTA AKAPCENTROSOME PATHWAY,0.70355,0.086026,3.6494e-05,0,0
1,REACTOME STEROID HORMONES,0.39371,0.085651,0.047594,0,0
1,HORMONE BINDING,0.32077,0.085478,0.086922,0,0
1,CARBOHYDRATE KINASE ACTIVITY,0.97557,0.085423,-0.012644,0,0
1,REACTOME DEADENYLATION OF MRNA,0.12049,0.085422,0.11135,0,0
1,PEPTIDE BINDING,0.15517,0.084939,0.055502,0,0
1,HELICASE ACTIVITY,0.18219,0.083951,0.08824,0,0
1,BIOCARTA PAR1 PATHWAY,0.67137,0.083931,0.020168,0,0
1,REACTOME SIGNALING BY NOTCH2,0.51459,0.083618,0.06129,0,0
1,LAMELLIPODIUM,0.17653,0.083556,0.090961,0,0
1,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.050569,0.083477,0.067533,0,0
1,FEMALE PREGNANCY,0.17934,0.083306,0.063189,0,0
1,DNA RECOMBINATION,0.21579,0.083162,0.083876,0,0
1,HOMEOSTATIC PROCESS,0.055956,0.082841,0.068336,0,0
1,REACTOME REGULATION OF IFNA SIGNALING,0.42347,0.081898,0.093348,0,0
1,VESICLE MEDIATED TRANSPORT,0.023741,0.081752,0.068544,0,0
1,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.11636,0.081224,0.091243,0,0
1,BIOCARTA MPR PATHWAY,0.71006,0.080949,0.015483,0,0
1,ADAPTIVE IMMUNE RESPONSE,0.070855,0.080243,0.1313,0,0
1,OUTER MEMBRANE,0.14048,0.080061,0.040109,0,0
1,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.41341,0.079528,0.036603,0,0
1,MICROSOME,0.20309,0.079024,0.089636,0,0
1,DNA FRAGMENTATION DURING APOPTOSIS,0.69707,0.078788,-0.022134,0,0
1,BIOCARTA ATM PATHWAY,0.22905,0.0785,0.047863,0,0
1,REACTOME SIGNALING BY FGFR3 MUTANTS,0.25363,0.077565,0.10176,0,0
1,DNA INTEGRITY CHECKPOINT,0.076492,0.075997,0.083404,0,0
1,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.23937,0.075698,0.075823,0,0
1,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.082489,0.075374,0.067596,0,0
1,BIOCARTA NO1 PATHWAY,0.25729,0.074373,0.078015,0,0
1,REACTOME KINESINS,0.67137,0.074033,0.010773,0,0
1,KEGG HEDGEHOG SIGNALING PATHWAY,0.23245,0.073924,0.067964,0,0
1,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.29992,0.073564,0.052581,0,0
1,REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA,0.29586,0.073548,0.094348,0,0
1,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.10654,0.073293,0.12861,0,0
1,CYTOSKELETAL PROTEIN BINDING,0.37932,0.073177,0.036912,0,0
1,LYSOSOMAL MEMBRANE,0.49227,0.073066,0.046951,0,0
1,ST G ALPHA S PATHWAY,0.32938,0.073058,0.083042,0,0
1,N ACYLTRANSFERASE ACTIVITY,0.099158,0.072931,0.10216,0,0
1,REACTOME ACYL CHAIN REMODELLING OF PS,0.16294,0.07283,0.098915,0,0
1,HISTONE DEACETYLASE COMPLEX,0.32506,0.07253,0.051146,0,0
1,KEGG BASAL TRANSCRIPTION FACTORS,0.059411,0.072436,0.11612,0,0
1,KEGG WNT SIGNALING PATHWAY,0.011904,0.072016,0.10571,0,0
1,BIOCARTA IL17 PATHWAY,0.075049,0.072007,0.23328,0,0
1,PID P38 MK2PATHWAY,0.088862,0.071047,0.14287,0,0
1,DAMAGED DNA BINDING,0.15264,0.070988,0.060151,0,0
1,NUCLEASE ACTIVITY,0.031059,0.070567,0.07305,0,0
1,PID TRKRPATHWAY,0.060602,0.070486,0.084637,0,0
1,KEGG TYROSINE METABOLISM,0.35607,0.070219,0.036775,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.2839,0.070035,0.023945,0,0
1,BIOCARTA AT1R PATHWAY,0.20621,0.069798,0.11143,0,0
1,BIOCARTA TRKA PATHWAY,0.30815,0.069219,0.097167,0,0
1,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.16294,0.06903,0.059871,0,0
1,NADH DEHYDROGENASE COMPLEX,0.25363,0.068981,0.10485,0,0
1,MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I,0.25363,0.068981,0.10485,0,0
1,RESPIRATORY CHAIN COMPLEX I,0.25363,0.068981,0.10485,0,0
1,ST WNT BETA CATENIN PATHWAY,0.18508,0.068838,0.10647,0,0
1,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.049546,0.0687,0.069344,0,0
1,REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION,0.43883,0.068463,0.058884,0,0
1,BETA TUBULIN BINDING,0.21579,0.068409,0.093362,0,0
1,PID E2F PATHWAY,0.21905,0.06741,0.062743,0,0
1,KEGG ALZHEIMERS DISEASE,0.21256,0.067322,0.045099,0,0
1,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.31653,0.066967,0.1553,0,0
1,NUCLEOTIDE METABOLIC PROCESS,0.16294,0.066282,0.13023,0,0
1,CASPASE ACTIVATION,0.21256,0.065855,0.082653,0,0
1,BIOCARTA NO2IL12 PATHWAY,0.30402,0.065512,0.03607,0,0
1,REACTOME MRNA PROCESSING,0.080955,0.065426,0.077502,0,0
1,MEMBRANE LIPID METABOLIC PROCESS,0.32506,0.065021,0.018688,0,0
1,REGULATION OF T CELL ACTIVATION,0.42855,0.064812,0.071166,0,0
1,SPLICEOSOME,0.44924,0.064557,0.029884,0,0
1,PLASMA MEMBRANE PART,0.30402,0.064155,0.033898,0,0
1,REACTOME SYNTHESIS OF PE,0.8303,0.063989,0.029136,0,0
1,CYTOKINE SECRETION,0.35607,0.063964,0.097962,0,0
1,RNA PROCESSING,0.068167,0.063526,0.082311,0,0
1,REACTOME PKB MEDIATED EVENTS,0.075049,0.063326,0.10224,0,0
1,PROTEIN POLYMERIZATION,0.53742,0.063277,0.032979,0,0
1,HEART DEVELOPMENT,0.33812,0.062546,0.032713,0,0
1,MITOTIC SISTER CHROMATID SEGREGATION,0.25001,0.062525,0.056243,0,0
1,KEGG PANTOTHENATE AND COA BIOSYNTHESIS,0.19393,0.062437,0.081922,0,0
1,REACTOME VITAMIN B5 PANTOTHENATE METABOLISM,0.30402,0.062298,0.041691,0,0
1,PHOSPHOLIPID BINDING,0.39371,0.06223,0.025817,0,0
1,PID P38 MKK3 6PATHWAY,0.22568,0.062222,0.085442,0,0
1,LOCOMOTORY BEHAVIOR,0.56666,0.062086,0.17883,0,0
1,TRANSCRIPTION FACTOR COMPLEX,0.12049,0.062085,0.062881,0,0
1,CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.55487,0.06179,0.028241,0,0
1,BIOCARTA CDMAC PATHWAY,0.12049,0.061737,0.26201,0,0
1,PID RHOA REG PATHWAY,0.42855,0.061605,0.046594,0,0
1,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.33373,0.061261,0.060305,0,0
1,REACTOME SIGNALING BY NOTCH1,0.75615,0.061252,0.016814,0,0
1,BIOCARTA CHREBP2 PATHWAY,0.87833,0.060653,-0.0020978,0,0
1,PID WNT NONCANONICAL PATHWAY,0.36064,0.060267,0.057671,0,0
1,REACTOME RNA POL II TRANSCRIPTION,0.080955,0.060132,0.075213,0,0
1,ACTIN FILAMENT ORGANIZATION,0.18219,0.060125,0.08437,0,0
1,MEMBRANE PART,0.076492,0.059959,0.047499,0,0
1,G PROTEIN COUPLED RECEPTOR BINDING,0.15015,0.05977,0.2103,0,0
1,PEROXISOMAL PART,0.41842,0.059602,0.024778,0,0
1,MICROBODY PART,0.41842,0.059602,0.024778,0,0
1,REGULATION OF TRANSPORT,0.57857,0.059524,0.02589,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.57857,0.059203,0.0023702,0,0
1,REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES,0.33373,0.058855,0.08394,0,0
1,PID IL8CXCR2 PATHWAY,0.34702,0.058753,0.055266,0,0
1,DNA REPLICATION INITIATION,0.35153,0.058728,0.044999,0,0
1,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.48131,0.058267,0.019885,0,0
1,PID BCR 5PATHWAY,0.36064,0.058261,0.040716,0,0
1,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.57857,0.058079,0.095004,0,0
1,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.44402,0.057551,0.038034,0,0
1,IMMUNE SYSTEM DEVELOPMENT,0.23589,0.057404,0.064921,0,0
1,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.087232,0.057058,0.13115,0,0
1,CONDENSED NUCLEAR CHROMOSOME,0.69061,0.057042,0.023038,0,0
1,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.80312,0.056874,0.012424,0,0
1,REACTOME PHOSPHOLIPID METABOLISM,0.076492,0.056744,0.051361,0,0
1,THIOLESTER HYDROLASE ACTIVITY,0.23937,0.056555,0.050814,0,0
1,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.39858,0.056111,0.069804,0,0
1,BIOCARTA CXCR4 PATHWAY,0.67776,0.056061,0.023977,0,0
1,ALCOHOL METABOLIC PROCESS,0.21905,0.055705,0.047064,0,0
1,INTEGRATOR COMPLEX,0.42347,0.055138,0.034991,0,0
1,SERINE TYPE PEPTIDASE ACTIVITY,0.40843,0.054992,0.03584,0,0
1,SERINE HYDROLASE ACTIVITY,0.27227,0.054768,0.048459,0,0
1,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.44924,0.054584,0.048173,0,0
1,PID EPHBFWDPATHWAY,0.20621,0.054555,0.085346,0,0
1,REACTOME PLATELET SENSITIZATION BY LDL,0.42855,0.054104,0.064942,0,0
1,CALCIUM ION BINDING,0.13355,0.053886,0.077322,0,0
1,BIOCARTA NGF PATHWAY,0.72313,0.053866,0.04934,0,0
1,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.11434,0.053793,0.10906,0,0
1,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.33373,0.053441,0.04661,0,0
1,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.25729,0.053144,0.049279,0,0
1,REACTOME SHC MEDIATED SIGNALLING,0.52025,0.052359,0.02756,0,0
1,POSITIVE REGULATION OF T CELL ACTIVATION,0.25001,0.052013,0.12709,0,0
1,SH2 DOMAIN BINDING,0.95466,0.051763,-0.009825,0,0
1,BIOCARTA GLEEVEC PATHWAY,0.79636,0.051082,0.017507,0,0
1,MONOSACCHARIDE BINDING,0.4978,0.050401,0.036339,0,0
1,PID RET PATHWAY,0.52594,0.049628,0.028975,0,0
1,CHEMICAL HOMEOSTASIS,0.17934,0.049578,0.046379,0,0
1,INTEGRAL TO PLASMA MEMBRANE,0.15015,0.04926,0.046477,0,0
1,PID CDC42 PATHWAY,0.053746,0.049186,0.10565,0,0
1,REACTOME ERK MAPK TARGETS,0.57857,0.049016,0.039202,0,0
1,PID CDC42 REG PATHWAY,0.42347,0.049016,0.041426,0,0
1,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.54903,0.048975,0.034213,0,0
1,NEGATIVE REGULATION OF PHOSPHORYLATION,0.84397,0.048466,0.069968,0,0
1,NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.84397,0.048466,0.069968,0,0
1,RESPONSE TO ABIOTIC STIMULUS,0.084046,0.048227,0.038313,0,0
1,GOLGI ASSOCIATED VESICLE,0.41341,0.04798,0.053149,0,0
1,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.64605,0.047831,0.032302,0,0
1,INTEGRAL TO MEMBRANE,0.14048,0.047823,0.045955,0,0
1,SMOOTH MUSCLE CONTRACTION GO 0006939,0.40843,0.047763,0.19079,0,0
1,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.3746,0.047615,0.054791,0,0
1,PID NFAT 3PATHWAY,0.76281,0.047472,0.0085217,0,0
1,REACTOME SIGNALING BY INSULIN RECEPTOR,0.093897,0.047367,0.047396,0,0
1,INTRINSIC TO PLASMA MEMBRANE,0.19095,0.047323,0.043623,0,0
1,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.084046,0.047226,0.1115,0,0
1,REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS,0.76281,0.047052,0.030476,0,0
1,REACTOME ARMS MEDIATED ACTIVATION,0.56075,0.046528,0.024615,0,0
1,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.23245,0.046263,0.058376,0,0
1,ADENYL RIBONUCLEOTIDE BINDING,0.26847,0.046205,0.038154,0,0
1,PLASMA MEMBRANE,0.39858,0.045558,0.026898,0,0
1,INTRINSIC TO MEMBRANE,0.16032,0.045471,0.044575,0,0
1,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.67776,0.045305,0.0012509,0,0
1,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.91293,0.044448,-0.0057899,0,0
1,KEGG PURINE METABOLISM,0.22568,0.044237,0.046829,0,0
1,COFACTOR TRANSPORTER ACTIVITY,0.25729,0.043768,0.11858,0,0
1,PID PI3KCIPATHWAY,0.88523,0.043144,-0.010938,0,0
1,REACTOME SEMAPHORIN INTERACTIONS,0.17374,0.04287,0.0844,0,0
1,PROTEIN KINASE BINDING,0.23245,0.042813,0.043523,0,0
1,PROTEIN C TERMINUS BINDING,0.19095,0.042726,0.041918,0,0
1,LYMPHOCYTE ACTIVATION,0.69707,0.042625,0.021867,0,0
1,ORGANIC ACID TRANSPORT,0.21579,0.042193,0.089521,0,0
1,CARBOXYLIC ACID TRANSPORT,0.21579,0.042193,0.089521,0,0
1,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.05824,0.041629,0.061739,0,0
1,REACTOME POL SWITCHING,0.91987,0.041448,-0.058473,0,0
1,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.27227,0.041446,0.080147,0,0
1,STEROID METABOLIC PROCESS,0.57857,0.041372,-0.01229,0,0
1,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.53167,0.041154,0.018599,0,0
1,KEGG ARGININE AND PROLINE METABOLISM,0.7495,0.040993,0.011062,0,0
1,REACTOME AXON GUIDANCE,0.37932,0.040462,0.047826,0,0
1,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.94073,0.040395,-0.025033,0,0
1,INTERPHASE OF MITOTIC CELL CYCLE,0.69707,0.040076,0.016627,0,0
1,PID BARD1PATHWAY,0.19095,0.039802,0.075646,0,0
1,PID P53REGULATIONPATHWAY,0.16559,0.039672,0.066471,0,0
1,NUCLEAR REPLICATION FORK,0.91987,0.039533,-0.02246,0,0
1,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.55487,0.039225,0.035805,0,0
1,REACTOME MICRORNA MIRNA BIOGENESIS,0.32077,0.039206,0.04793,0,0
1,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.57857,0.038907,0.013115,0,0
1,RESPONSE TO TEMPERATURE STIMULUS,0.48131,0.037872,0.041537,0,0
1,REACTOME BASE EXCISION REPAIR,0.76948,0.037676,0.022126,0,0
1,BIOCARTA IL3 PATHWAY,0.56666,0.037168,0.065468,0,0
1,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.20309,0.037151,0.066553,0,0
1,PID FASPATHWAY,0.36991,0.036968,0.080924,0,0
1,NUCLEAR ENVELOPE,0.22568,0.036866,0.055261,0,0
1,PYROPHOSPHATASE ACTIVITY,0.053746,0.036769,0.061284,0,0
1,RECEPTOR ACTIVITY,0.16559,0.036713,0.040217,0,0
1,REACTOME IL RECEPTOR SHC SIGNALING,0.38408,0.036666,0.071519,0,0
1,DOUBLE STRANDED DNA BINDING,0.33812,0.03662,0.078287,0,0
1,BIOCARTA CCR5 PATHWAY,0.95466,0.036562,-0.034525,0,0
1,PROTEIN TARGETING TO MEMBRANE,0.72313,0.036544,0.0086443,0,0
1,CENTROSOME ORGANIZATION AND BIOGENESIS,0.40843,0.036378,0.053817,0,0
1,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.61497,0.03589,-0.039465,0,0
1,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.99651,0.035418,-0.010358,0,0
1,KEGG PROTEIN EXPORT,0.74288,0.035398,0.013762,0,0
1,REACTOME SIGNALING BY ERBB2,0.16032,0.035359,0.041537,0,0
1,PID ATM PATHWAY,0.71006,0.035067,0.019703,0,0
1,PID ATR PATHWAY,0.33812,0.035029,0.013005,0,0
1,CHROMOSOME CONDENSATION,0.68418,0.034997,0.03589,0,0
1,SA TRKA RECEPTOR,0.60272,0.034945,0.066301,0,0
1,REACTOME GAB1 SIGNALOSOME,0.86455,0.034762,0.0054736,0,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.8303,0.034715,0.029707,0,0
1,HEMOPOIESIS,0.68418,0.034672,0.019049,0,0
1,REACTOME REGULATORY RNA PATHWAYS,0.41341,0.034455,0.029052,0,0
1,ENERGY RESERVE METABOLIC PROCESS,0.77618,0.034041,0.03422,0,0
1,BIOCARTA PYK2 PATHWAY,0.4978,0.03402,0.077542,0,0
1,REGULATION OF IMMUNE SYSTEM PROCESS,0.32506,0.033579,0.077577,0,0
1,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.27999,0.033498,0.070932,0,0
1,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.070855,0.033272,0.056204,0,0
1,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.80989,0.033095,0.057131,0,0
1,PID BETACATENIN DEG PATHWAY,0.27227,0.032423,0.050128,0,0
1,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.26471,0.032402,0.067947,0,0
1,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.86455,0.032352,-0.0066409,0,0
1,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.59059,0.032058,0.030052,0,0
1,REACTOME SIGNALING BY FGFR,0.52025,0.03203,0.020141,0,0
1,CELLULAR HOMEOSTASIS,0.78962,0.03169,-0.01778,0,0
1,NUCLEAR EXPORT,0.49227,0.031672,0.018154,0,0
1,SISTER CHROMATID SEGREGATION,0.37932,0.031629,0.045442,0,0
1,PID ERBB1 INTERNALIZATION PATHWAY,0.73628,0.031456,0.018157,0,0
1,ALDO KETO REDUCTASE ACTIVITY,0.79636,0.031368,0.063106,0,0
1,EXTERNAL SIDE OF PLASMA MEMBRANE,0.4545,0.031264,0.056929,0,0
1,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.90599,0.031046,-0.011498,0,0
1,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.90599,0.031046,-0.011498,0,0
1,BIOCARTA IGF1R PATHWAY,0.5726,0.030691,0.025673,0,0
1,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.33373,0.030136,0.10319,0,0
1,PHOSPHOLIPID METABOLIC PROCESS,0.63354,0.029473,0.0089021,0,0
1,ACETYLTRANSFERASE ACTIVITY,0.23589,0.02939,0.11283,0,0
1,CELL JUNCTION,0.36526,0.029075,0.075665,0,0
1,REACTOME MITOTIC G2 G2 M PHASES,0.91293,0.029073,-0.0068221,0,0
1,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.53742,0.028912,0.015409,0,0
1,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.90599,0.028663,-0.0080969,0,0
1,G1 PHASE OF MITOTIC CELL CYCLE,0.36991,0.027993,0.073988,0,0
1,DEOXYRIBONUCLEASE ACTIVITY,0.10654,0.027445,0.073774,0,0
1,KEGG CHEMOKINE SIGNALING PATHWAY,0.17374,0.027406,0.070407,0,0
1,B CELL DIFFERENTIATION,0.9686,0.027406,-0.017604,0,0
1,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15264,0.027278,0.093445,0,0
1,REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION,0.54903,0.027185,0.054135,0,0
1,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.25729,0.026609,0.059214,0,0
1,TRANS GOLGI NETWORK,0.50896,0.026582,0.031318,0,0
1,STRUCTURE SPECIFIC DNA BINDING,0.31653,0.026565,0.059725,0,0
1,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.21579,0.026197,0.047496,0,0
1,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.16828,0.025833,0.035245,0,0
1,CENTROSOME CYCLE,0.64605,0.02573,0.032141,0,0
1,PID LKB1 PATHWAY,0.41341,0.025214,0.03344,0,0
1,TRANSCRIPTION COACTIVATOR ACTIVITY,0.75615,0.024987,0.0010906,0,0
1,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.44924,0.024946,0.062016,0,0
1,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.23589,0.024917,0.024387,0,0
1,RESPONSE TO ENDOGENOUS STIMULUS,0.24288,0.024416,0.040387,0,0
1,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.74288,0.024396,0.0059061,0,0
1,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.27999,0.02432,0.049406,0,0
1,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.13814,0.023977,0.05101,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.76281,0.023959,-0.0039734,0,0
1,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25001,0.023862,0.049167,0,0
1,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.61497,0.023561,0.021347,0,0
1,REACTOME MRNA SPLICING,0.41341,0.023557,0.040976,0,0
1,REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS,0.98255,0.02301,-0.017896,0,0
1,KEGG INSULIN SIGNALING PATHWAY,0.30402,0.022796,0.034176,0,0
1,CELLULAR CATION HOMEOSTASIS,0.95466,0.022261,-0.012902,0,0
1,CATION HOMEOSTASIS,1,0.022199,-0.0062632,0,0
1,CYTOSKELETAL PART,0.27999,0.021526,0.042975,0,0
1,KEGG NOTCH SIGNALING PATHWAY,0.80989,0.021385,0.0072718,0,0
1,POST GOLGI VESICLE MEDIATED TRANSPORT,0.50896,0.020844,0.043836,0,0
1,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.95466,0.020784,0.00038819,0,0
1,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.67137,0.020779,-0.016852,0,0
1,REACTOME RAP1 SIGNALLING,0.87833,0.020658,0.0041193,0,0
1,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.52594,0.020633,0.022389,0,0
1,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.83713,0.020038,-0.030892,0,0
1,INTERPHASE,0.69061,0.020019,0.0098867,0,0
1,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.92682,0.019882,-0.0070238,0,0
1,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.73628,0.019666,0.033096,0,0
1,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.65866,0.018974,0.029964,0,0
1,NUCLEAR MEMBRANE,0.16294,0.018942,0.089341,0,0
1,PID MAPKTRKPATHWAY,0.53167,0.018869,0.040216,0,0
1,REACTOME SIGNALING BY NODAL,0.99651,0.018586,-0.011089,0,0
1,PID TCRJNKPATHWAY,0.59664,0.018528,-0.068601,0,0
1,N ACETYLTRANSFERASE ACTIVITY,0.23245,0.018294,0.079277,0,0
1,ESTABLISHMENT OF LOCALIZATION,0.54321,0.018169,0.0090418,0,0
1,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.67137,0.018089,0.03358,0,0
1,HISTONE MODIFICATION,0.56075,0.018,-0.042776,0,0
1,BIOCARTA RAC1 PATHWAY,0.22905,0.017957,0.078844,0,0
1,PROTEIN STABILIZATION,0.71006,0.017956,-0.061315,0,0
1,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.85768,0.017657,-0.016853,0,0
1,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.36991,0.017468,0.046593,0,0
1,REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS,0.73628,0.017361,0.02955,0,0
1,DNA REPAIR,0.89907,0.017359,0.0058647,0,0
1,PID HEDGEHOG GLIPATHWAY,0.76281,0.017333,-0.023083,0,0
1,ACTIN FILAMENT BASED MOVEMENT,0.36991,0.017226,0.11192,0,0
1,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.65866,0.017102,-0.046555,0,0
1,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.80989,0.016765,0.0089492,0,0
1,TRANSPORT VESICLE,0.41341,0.016578,0.089665,0,0
1,REACTOME OLFACTORY SIGNALING PATHWAY,0.66501,0.016484,-0.042271,0,0
1,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.94073,0.01474,-0.009444,0,0
1,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.31653,0.014474,-0.1709,0,0
1,GTPASE REGULATOR ACTIVITY,0.30815,0.013811,0.043071,0,0
1,RESPONSE TO LIGHT STIMULUS,0.18219,0.013642,0.047571,0,0
1,NEGATIVE REGULATION OF ANGIOGENESIS,0.63978,0.012324,0.07978,0,0
1,NUCLEOPLASM,0.40349,0.011887,0.028482,0,0
1,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.67776,0.011653,0.040103,0,0
1,REACTOME SIGNALLING TO ERKS,0.80989,0.011175,-0.014314,0,0
1,REACTOME NEPHRIN INTERACTIONS,0.78289,0.01055,-0.013915,0,0
1,KEGG OOCYTE MEIOSIS,0.93377,0.010478,-0.005382,0,0
1,BIOCARTA SRCRPTP PATHWAY,0.70355,0.010032,0.0084308,0,0
1,NUCLEOPLASM PART,0.44924,0.0099821,0.022592,0,0
1,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.62113,0.0097709,0.030833,0,0
1,PID KITPATHWAY,0.75615,0.0095432,0.024889,0,0
1,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.57857,0.0090639,-0.030331,0,0
1,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.41842,0.0090346,0.038512,0,0
1,KEGG STEROID HORMONE BIOSYNTHESIS,0.47049,0.0090163,-0.075551,0,0
1,REACTOME G2 M CHECKPOINTS,0.80989,0.0084725,-0.010148,0,0
1,REACTOME G ALPHA Q SIGNALLING EVENTS,0.9686,0.0082797,-0.012488,0,0
1,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.76948,0.0080368,-0.024681,0,0
1,PHOSPHOLIPASE ACTIVITY,0.91293,0.0077905,0.0028282,0,0
1,BIOCARTA HDAC PATHWAY,0.91293,0.0072561,0.024212,0,0
1,REACTOME DEVELOPMENTAL BIOLOGY,0.7495,0.0068599,0.0087255,0,0
1,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.53167,0.0065299,0.063542,0,0
1,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.59664,0.0065095,0.022604,0,0
1,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.59664,0.0062238,0.072116,0,0
1,NUCLEAR ORGANIZATION AND BIOGENESIS,0.93377,0.0061767,-0.0071178,0,0
1,S PHASE,0.58456,0.0058616,-0.060904,0,0
1,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.71006,0.0055883,0.036391,0,0
1,TRANSPORT,0.83713,0.005455,0.00091424,0,0
1,SIG CD40PATHWAYMAP,0.59664,0.0051501,0.043487,0,0
1,BIOCARTA TCR PATHWAY,0.8303,0.0048765,-0.0076151,0,0
1,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.27227,0.0047249,0.10662,0,0
1,INTERMEDIATE FILAMENT CYTOSKELETON,0.88523,0.0040516,0.10583,0,0
1,INTERMEDIATE FILAMENT,0.88523,0.0040516,0.10583,0,0
1,AMINO ACID TRANSPORT,0.59059,0.0035275,0.053092,0,0
1,REPRODUCTION,0.76948,0.002881,-0.013914,0,0
1,CONDENSED CHROMOSOME,0.93377,0.0020402,-0.0013647,0,0
1,REACTOME SIGNALING BY FGFR IN DISEASE,0.96163,0.001905,0.002108,0,0
1,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.69707,0.0016318,0.044816,0,0
1,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.75615,0.0015085,-0.024069,0,0
1,PID EPOPATHWAY,0.50337,0.0013438,0.051153,0,0
1,MEIOTIC RECOMBINATION,0.76948,0.0013341,0.033626,0,0
1,ATPASE ACTIVITY,0.78289,0.0012511,0.025081,0,0
1,MRNA BINDING,0.77618,0.0010839,0.014096,0,0
1,KEGG CARDIAC MUSCLE CONTRACTION,0.98953,0.00025992,-0.0070864,0,0
1,TRANSMEMBRANE RECEPTOR ACTIVITY,0.85768,1.4611e-05,-0.0013229,0,0
1,UBIQUITIN LIGASE COMPLEX,0.68418,-2.3876e-05,0.029529,0,0
1,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.65866,-0.00011584,0.035048,0,0
1,EXOPEPTIDASE ACTIVITY,0.72969,-0.00048089,-0.026299,0,0
1,KEGG OXIDATIVE PHOSPHORYLATION,0.85768,-0.0007431,-0.0088769,0,0
1,RNA SPLICING,0.97557,-0.0008646,8.0843e-05,0,0
1,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.27227,-0.00088901,0.050978,0,0
1,PID IL3 PATHWAY,0.87144,-0.0011727,-0.040098,0,0
1,BIOCARTA BIOPEPTIDES PATHWAY,0.72969,-0.0011822,0.010183,0,0
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.53167,-0.0013422,0.04972,0,0
1,REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1,0.83713,-0.0014768,0.0019432,0,0
1,CELLULAR RESPIRATION,0.70355,-0.0018178,0.0090489,0,0
1,BIOCARTA FCER1 PATHWAY,0.60883,-0.0018866,-0.046357,0,0
1,COVALENT CHROMATIN MODIFICATION,0.62113,-0.0021227,-0.038811,0,0
1,ACTIN FILAMENT BINDING,0.75615,-0.0021716,0.021465,0,0
1,BIOCARTA PS1 PATHWAY,0.95466,-0.0023767,0.017847,0,0
1,BIOCARTA BCR PATHWAY,0.8303,-0.0031371,-0.021449,0,0
1,REACTOME SIGNALING BY NOTCH,0.36991,-0.0032331,0.048083,0,0
1,U12 DEPENDENT SPLICEOSOME,0.71658,-0.0032436,0.029711,0,0
1,MICROTUBULE ORGANIZING CENTER,0.67137,-0.0032603,-0.015365,0,0
1,KEGG DNA REPLICATION,0.93377,-0.0034315,-0.021279,0,0
1,PID NOTCH PATHWAY,0.69707,-0.0038752,0.032897,0,0
1,NUCLEAR SPECK,0.89907,-0.0039418,0.027649,0,0
1,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.98953,-0.0039968,0.0083591,0,0
1,NEGATIVE REGULATION OF TRANSLATION,0.64605,-0.0041132,0.03012,0,0
1,PID ERA GENOMIC PATHWAY,0.76281,-0.0043549,-0.026304,0,0
1,KEGG GNRH SIGNALING PATHWAY,0.55487,-0.0045822,-0.032381,0,0
1,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.77618,-0.0052375,-0.026121,0,0
1,BIOCARTA PLCE PATHWAY,0.69061,-0.0054073,0.047487,0,0
1,REGULATION OF PROTEIN STABILITY,0.53167,-0.0055455,-0.055825,0,0
1,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.49227,-0.006003,-0.031784,0,0
1,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.78962,-0.0060745,0.054573,0,0
1,KEGG MELANOGENESIS,0.93377,-0.0062879,0.0084728,0,0
1,KEGG PARKINSONS DISEASE,0.9686,-0.0062898,0.00096267,0,0
1,REACTOME GLUCONEOGENESIS,0.69061,-0.006453,-0.031717,0,0
1,S PHASE OF MITOTIC CELL CYCLE,0.73628,-0.006495,-0.036542,0,0
1,PID S1P S1P4 PATHWAY,0.97557,-0.0069036,0.0039652,0,0
1,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.74288,-0.0070094,0.029655,0,0
1,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.72969,-0.0072223,-0.029371,0,0
1,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.40843,-0.007236,-0.056293,0,0
1,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.9686,-0.00738,0.0067286,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.91987,-0.007446,0.026774,0,0
1,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.76948,-0.0078944,-0.024631,0,0
1,ION HOMEOSTASIS,0.62113,-0.0080141,-0.024178,0,0
1,POLYSACCHARIDE METABOLIC PROCESS,0.48131,-0.0086282,-0.059551,0,0
1,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.60883,-0.0087906,-0.036817,0,0
1,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.62113,-0.0089677,-0.043091,0,0
1,ATPASE ACTIVITY COUPLED,0.89907,-0.0090086,0.0074651,0,0
1,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.64605,-0.0090687,0.014491,0,0
1,RESPONSE TO DNA DAMAGE STIMULUS,0.78289,-0.0092323,0.012296,0,0
1,CARBOHYDRATE METABOLIC PROCESS,0.95466,-0.00943,-0.012097,0,0
1,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.82348,-0.0099561,0.034168,0,0
1,REACTOME LAGGING STRAND SYNTHESIS,0.80989,-0.010448,-0.071985,0,0
1,PID HIF1APATHWAY,0.99651,-0.010493,0.026525,0,0
1,T CELL DIFFERENTIATION,0.60883,-0.010763,-0.032566,0,0
1,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.98953,-0.010796,0.012628,0,0
1,REACTOME VIRAL MESSENGER RNA SYNTHESIS,0.34702,-0.011076,0.061944,0,0
1,PHOSPHOLIPASE C ACTIVITY,0.94073,-0.011391,-0.0052045,0,0
1,POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.91293,-0.012589,-0.012324,0,0
1,KEGG MISMATCH REPAIR,0.97557,-0.012658,-0.015414,0,0
1,INACTIVATION OF MAPK ACTIVITY,0.91293,-0.012682,-0.011331,0,0
1,REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER,0.98255,-0.012688,-0.00082166,0,0
1,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.94073,-0.013479,0.0041027,0,0
1,VITAMIN TRANSPORT,0.94073,-0.013558,0.014955,0,0
1,POSITIVE REGULATION OF PROTEIN SECRETION,0.71658,-0.01405,0.073449,0,0
1,MRNA METABOLIC PROCESS,0.98953,-0.014691,0.016081,0,0
1,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.8303,-0.015424,0.014383,0,0
1,DEPHOSPHORYLATION,0.96163,-0.016273,-0.0091541,0,0
1,INNATE IMMUNE RESPONSE,0.58456,-0.016936,-0.056199,0,0
1,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.63354,-0.018579,-0.020182,0,0
1,HISTONE DEACETYLASE BINDING,0.33812,-0.018638,-0.066331,0,0
1,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.81668,-0.01881,-0.012579,0,0
1,N METHYLTRANSFERASE ACTIVITY,0.36064,-0.019321,0.079534,0,0
1,REGULATION OF NEUROGENESIS,0.90599,-0.019373,-0.012101,0,0
1,REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.85082,-0.01959,-0.0066767,0,0
1,HUMORAL IMMUNE RESPONSE,0.81668,-0.019979,0.072577,0,0
1,COFACTOR BINDING,0.65866,-0.020282,-0.07205,0,0
1,DNA CATABOLIC PROCESS,0.99651,-0.020313,-0.011415,0,0
1,RNA POLYMERASE ACTIVITY,0.85768,-0.020763,-0.010841,0,0
1,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.72969,-0.021041,-0.010988,0,0
1,BIOCARTA ACH PATHWAY,0.96163,-0.021516,0.016197,0,0
1,SENSORY PERCEPTION,0.59059,-0.021668,-0.030634,0,0
1,FATTY ACID BIOSYNTHETIC PROCESS,0.72969,-0.021938,-0.034564,0,0
1,TRANSCRIPTION FACTOR ACTIVITY,0.89907,-0.022839,0.0065941,0,0
1,LIPASE ACTIVITY,0.77618,-0.023157,-0.011567,0,0
1,REACTOME SIGNALLING BY NGF,0.70355,-0.023931,-0.0099483,0,0
1,ADENYLATE CYCLASE ACTIVATION,0.88523,-0.023984,0.0095299,0,0
1,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.62732,-0.024412,-0.045269,0,0
1,LIPID BIOSYNTHETIC PROCESS,0.85082,-0.024505,-0.03016,0,0
1,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.50337,-0.02452,-0.023298,0,0
1,REACTOME SHC RELATED EVENTS,0.42855,-0.024582,-0.034513,0,0
1,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.62732,-0.025349,-0.050761,0,0
1,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.71658,-0.025495,-0.023585,0,0
1,KEGG CALCIUM SIGNALING PATHWAY,0.65234,-0.02597,-0.023214,0,0
1,PID AJDISS 2PATHWAY,0.63354,-0.025999,-0.035465,0,0
1,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.85768,-0.026068,0.033462,0,0
1,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.73628,-0.026723,-0.0099275,0,0
1,REACTOME SIGNALLING TO RAS,0.44402,-0.026933,-0.03599,0,0
1,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.43883,-0.026984,-0.058219,0,0
1,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.86455,-0.027077,-0.031409,0,0
1,REACTOME MRNA 3 END PROCESSING,0.60272,-0.02736,-0.021487,0,0
1,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.80989,-0.027431,0.012433,0,0
1,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.16828,-0.02808,-0.067269,0,0
1,KEGG ERBB SIGNALING PATHWAY,0.73628,-0.02842,0.01304,0,0
1,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.33373,-0.028604,-0.053417,0,0
1,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.98953,-0.028731,-0.018012,0,0
1,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.98953,-0.028731,-0.018012,0,0
1,CELL PROJECTION,0.56075,-0.02927,-0.027799,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.97557,-0.029585,0.013253,0,0
1,PATTERN SPECIFICATION PROCESS,1,-0.029603,0.012177,0,0
1,MACROMOLECULAR COMPLEX DISASSEMBLY,0.88523,-0.030915,0.022596,0,0
1,REACTOME INFLAMMASOMES,0.4545,-0.031323,-0.17698,0,0
1,INSULIN RECEPTOR SIGNALING PATHWAY,0.36064,-0.031369,-0.07909,0,0
1,REACTOME FANCONI ANEMIA PATHWAY,0.73628,-0.031642,0.0039861,0,0
1,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.60272,-0.031743,0.032447,0,0
1,BASE EXCISION REPAIR,0.82348,-0.031839,-0.032024,0,0
1,PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY,0.72969,-0.032149,-0.036106,0,0
1,REACTOME CELL JUNCTION ORGANIZATION,0.88523,-0.032304,-0.013225,0,0
1,PID HDAC CLASSII PATHWAY,0.56075,-0.032864,-0.0093452,0,0
1,KEGG LYSINE DEGRADATION,0.65234,-0.032949,0.056131,0,0
1,MRNA PROCESSING GO 0006397,0.56075,-0.03304,-0.0079798,0,0
1,BIOCARTA NDKDYNAMIN PATHWAY,0.40843,-0.03445,-0.053107,0,0
1,REACTOME SIGNALING BY GPCR,0.188,-0.034525,-0.043986,0,0
1,MEMBRANE BOUND VESICLE,0.27611,-0.03505,-0.041378,0,0
1,INSOLUBLE FRACTION,0.63354,-0.035349,-0.003086,0,0
1,BIOCARTA CFTR PATHWAY,0.58456,-0.035701,-0.066922,0,0
1,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.71006,-0.035841,-0.014353,0,0
1,THYROID HORMONE RECEPTOR BINDING,0.91987,-0.035888,0.018698,0,0
1,REGULATION OF CYTOKINE SECRETION,0.89215,-0.035996,0.052155,0,0
1,CHROMOSOME SEGREGATION,0.78289,-0.036114,-0.017675,0,0
1,REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE,0.23589,-0.036242,-0.2022,0,0
1,PHOSPHATASE REGULATOR ACTIVITY,0.85768,-0.036258,0.015382,0,0
1,PID ALK2PATHWAY,0.59059,-0.036261,-0.095964,0,0
1,PROTEIN COMPLEX DISASSEMBLY,0.70355,-0.036351,0.024872,0,0
1,CORTICAL CYTOSKELETON,0.86455,-0.036744,0.0062074,0,0
1,POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.60883,-0.036808,-0.028434,0,0
1,IMMUNE EFFECTOR PROCESS,0.69707,-0.036844,-0.017421,0,0
1,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.24288,-0.036957,-0.045524,0,0
1,REACTOME ALPHA LINOLENIC ACID ALA METABOLISM,0.32077,-0.037173,-0.17014,0,0
1,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.91987,-0.037636,-0.0088929,0,0
1,SECOND MESSENGER MEDIATED SIGNALING,0.40843,-0.038039,-0.035613,0,0
1,MEDIATOR COMPLEX,0.4978,-0.038691,-0.025436,0,0
1,REACTOME ACTIVATION OF RAC,0.60272,-0.039379,-0.034463,0,0
1,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.35153,-0.03991,-0.049668,0,0
1,REGULATION OF RESPONSE TO STIMULUS,0.40843,-0.040722,-0.037409,0,0
1,REACTOME DNA STRAND ELONGATION,0.36064,-0.040745,-0.11072,0,0
1,HORMONE METABOLIC PROCESS,0.69707,-0.041077,-0.032692,0,0
1,VESICLE,0.27227,-0.041122,-0.038977,0,0
1,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.69707,-0.041283,-0.022982,0,0
1,RESPONSE TO HYPOXIA,0.41842,-0.041555,-0.07872,0,0
1,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27999,-0.041851,-0.047873,0,0
1,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.87144,-0.042815,0.0026829,0,0
1,TELOMERIC DNA BINDING,0.65866,-0.043274,-0.020392,0,0
1,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.8303,-0.043533,0.026421,0,0
1,ER NUCLEAR SIGNALING PATHWAY,0.74288,-0.043677,-0.010332,0,0
1,BEHAVIOR,0.75615,-0.043798,0.033424,0,0
1,REACTOME DARPP 32 EVENTS,0.47588,-0.044835,-0.0401,0,0
1,REACTOME PI3K AKT ACTIVATION,0.079444,-0.044948,-0.08961,0,0
1,SA B CELL RECEPTOR COMPLEXES,0.64605,-0.045193,-0.050341,0,0
1,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.49227,-0.045345,-0.033738,0,0
1,REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,0.89907,-0.045381,-0.011651,0,0
1,NUCLEAR UBIQUITIN LIGASE COMPLEX,0.40843,-0.045645,-0.043863,0,0
1,ENDOTHELIAL CELL MIGRATION,0.80989,-0.04606,-0.083219,0,0
1,APOPTOTIC NUCLEAR CHANGES,0.26471,-0.046163,-0.10274,0,0
1,CHROMOSOMAL PART,0.41842,-0.046309,-0.035015,0,0
1,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.47588,-0.046487,-0.066822,0,0
1,RNA EXPORT FROM NUCLEUS,0.42347,-0.046847,-0.040528,0,0
1,REACTOME G ALPHA Z SIGNALLING EVENTS,0.42347,-0.046886,-0.048959,0,0
1,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.69707,-0.047422,-0.015116,0,0
1,PID HDAC CLASSIII PATHWAY,0.97557,-0.047872,0.0070129,0,0
1,REGULATION OF CHROMOSOME ORGANIZATION AND BIOGENESIS,0.090515,-0.047874,-0.12517,0,0
1,CELLULAR RESPONSE TO STIMULUS,0.87833,-0.048825,-0.021239,0,0
1,CYTOPLASMIC VESICLE,0.19095,-0.049458,-0.047112,0,0
1,REACTOME GPCR DOWNSTREAM SIGNALING,0.16032,-0.049468,-0.046661,0,0
1,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.69061,-0.050045,-0.05629,0,0
1,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.30402,-0.050158,-0.037636,0,0
1,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.097379,-0.050177,-0.059974,0,0
1,ANATOMICAL STRUCTURE DEVELOPMENT,0.87833,-0.050499,-0.0029938,0,0
1,PID S1P S1P3 PATHWAY,0.85768,-0.050687,0.016182,0,0
1,GLAND DEVELOPMENT,0.89215,-0.050696,-0.035632,0,0
1,DETECTION OF EXTERNAL STIMULUS,0.51459,-0.050949,-0.041513,0,0
1,REACTOME SIGNAL AMPLIFICATION,0.82348,-0.050968,-0.0019316,0,0
1,REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX,0.49227,-0.051091,-0.0504,0,0
1,DETECTION OF ABIOTIC STIMULUS,0.39371,-0.05116,-0.057493,0,0
1,FEMALE GAMETE GENERATION,0.53742,-0.051526,-0.0037959,0,0
1,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.54321,-0.052296,-0.066492,0,0
1,T CELL ACTIVATION,0.26471,-0.052376,-0.057643,0,0
1,SA G1 AND S PHASES,0.44402,-0.052665,-0.06813,0,0
1,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.23589,-0.052866,-0.063608,0,0
1,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.17653,-0.053088,-0.16415,0,0
1,HISTONE ACETYLTRANSFERASE ACTIVITY,0.87833,-0.0536,0.020169,0,0
1,SIG BCR SIGNALING PATHWAY,0.31653,-0.053684,-0.059137,0,0
1,JNK CASCADE,0.30402,-0.053749,-0.04115,0,0
1,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.34256,-0.053954,-0.03795,0,0
1,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.82348,-0.054156,0.07065,0,0
1,HYDRO LYASE ACTIVITY,0.27999,-0.054565,-0.081455,0,0
1,G2 M TRANSITION OF MITOTIC CELL CYCLE,0.61497,-0.05476,-0.11029,0,0
1,REACTOME TIE2 SIGNALING,0.80989,-0.054973,0.041656,0,0
1,HISTONE METHYLTRANSFERASE ACTIVITY,0.29586,-0.054993,-0.052016,0,0
1,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.15264,-0.055118,-0.076335,0,0
1,KEGG CELL ADHESION MOLECULES CAMS,0.30815,-0.055225,-0.05789,0,0
1,REPLICATION FORK,0.11841,-0.055769,-0.11907,0,0
1,PID CONE PATHWAY,0.070855,-0.056502,-0.10461,0,0
1,SPINDLE MICROTUBULE,0.44402,-0.056551,-0.030836,0,0
1,MICROTUBULE BASED PROCESS,0.4545,-0.056864,-0.041937,0,0
1,DEVELOPMENTAL MATURATION,0.73628,-0.056922,-0.031268,0,0
1,BIOCARTA RAB PATHWAY,0.85768,-0.057181,-0.0067365,0,0
1,SPECIFIC TRANSCRIPTIONAL REPRESSOR ACTIVITY,0.62732,-0.057592,-0.0012434,0,0
1,CHROMATIN BINDING,0.46512,-0.057806,-0.054349,0,0
1,REACTOME G ALPHA I SIGNALLING EVENTS,0.32077,-0.058344,-0.023005,0,0
1,BIOGENIC AMINE METABOLIC PROCESS,0.060602,-0.058346,-0.13434,0,0
1,REACTOME GPCR LIGAND BINDING,0.33373,-0.059177,-0.033049,0,0
1,CARBON OXYGEN LYASE ACTIVITY,0.21905,-0.060016,-0.082698,0,0
1,BIOCARTA EPO PATHWAY,0.66501,-0.060166,0.00047609,0,0
1,PROTEIN METHYLTRANSFERASE ACTIVITY,0.31653,-0.060573,-0.043634,0,0
1,NEURON DEVELOPMENT,0.075049,-0.060881,-0.20582,0,0
1,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.15517,-0.061347,-0.055079,0,0
1,REACTOME MYOGENESIS,0.4545,-0.061436,-0.052341,0,0
1,NEURITE DEVELOPMENT,0.05824,-0.061904,-0.23089,0,0
1,REGULATION OF HEART CONTRACTION,0.53167,-0.06199,-0.044762,0,0
1,BIOCARTA AGPCR PATHWAY,0.52594,-0.062215,-0.048556,0,0
1,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.85768,-0.062456,-0.0092443,0,0
1,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.10654,-0.063002,-0.051485,0,0
1,BIOCARTA SPPA PATHWAY,0.62113,-0.063423,-0.013937,0,0
1,REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY,0.12259,-0.065172,-0.16975,0,0
1,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.91293,-0.065872,-0.0074402,0,0
1,INTERCELLULAR JUNCTION,0.77618,-0.066118,-0.0071611,0,0
1,REACTOME TRANSCRIPTION,0.087232,-0.06656,-0.064539,0,0
1,EXCRETION,0.40349,-0.067301,-0.060065,0,0
1,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.46512,-0.067664,-0.086331,0,0
1,KEGG GLYCEROLIPID METABOLISM,0.12689,-0.068282,-0.078466,0,0
1,BIOCARTA MTA3 PATHWAY,0.22905,-0.068861,-0.091417,0,0
1,BIOCARTA CTLA4 PATHWAY,0.26098,-0.069374,-0.07266,0,0
1,PID RANBP2PATHWAY,0.35153,-0.06966,-0.061591,0,0
1,T CELL PROLIFERATION,0.19393,-0.070056,-0.039622,0,0
1,REACTOME PROCESSING OF INTRONLESS PRE MRNAS,0.42347,-0.070132,-0.047204,0,0
1,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.47588,-0.070217,-0.056289,0,0
1,KEGG AXON GUIDANCE,0.60272,-0.070385,-0.029992,0,0
1,TRANSCRIPTION ELONGATION REGULATOR ACTIVITY,0.15773,-0.07047,-0.07939,0,0
1,ST JNK MAPK PATHWAY,0.03245,-0.070791,-0.13407,0,0
1,LYASE ACTIVITY,0.29586,-0.070942,-0.059509,0,0
1,SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.12049,-0.071928,-0.097213,0,0
1,CELLULAR COMPONENT DISASSEMBLY,0.26471,-0.072037,-0.072073,0,0
1,REACTOME RNA POL III TRANSCRIPTION,0.25363,-0.072256,-0.039985,0,0
1,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.15015,-0.072274,-0.093583,0,0
1,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38408,-0.072496,-0.066941,0,0
1,PROTEIN PROCESSING,0.19393,-0.072504,-0.05516,0,0
1,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.48131,-0.072589,-0.06517,0,0
1,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.29184,-0.073038,-0.22047,0,0
1,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.2,-0.073385,-0.093187,0,0
1,ANDROGEN RECEPTOR SIGNALING PATHWAY,0.10845,-0.073458,-0.091599,0,0
1,MAPKKK CASCADE GO 0000165,0.20621,-0.073488,-0.050338,0,0
1,PHOSPHOLIPASE A2 ACTIVITY,0.20621,-0.073509,-0.081535,0,0
1,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.33373,-0.073561,-0.049537,0,0
1,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.17374,-0.074535,-0.081355,0,0
1,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.17653,-0.074606,-0.056741,0,0
1,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.023741,-0.074622,-0.13701,0,0
1,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.080955,-0.075139,-0.067561,0,0
1,NLS BEARING SUBSTRATE IMPORT INTO NUCLEUS,0.74288,-0.075334,0.11795,0,0
1,PID AR TF PATHWAY,0.33812,-0.075449,-0.027629,0,0
1,KEGG BETA ALANINE METABOLISM,0.41341,-0.075545,-0.058189,0,0
1,LYMPHOCYTE DIFFERENTIATION,0.41842,-0.075553,-0.04557,0,0
1,ENDOTHELIAL CELL PROLIFERATION,0.78962,-0.075614,-0.085756,0,0
1,PID P38GAMMADELTAPATHWAY,0.41842,-0.07574,-0.10533,0,0
1,CHROMOSOME,0.27999,-0.07659,-0.044228,0,0
1,CENTROSOME,0.25363,-0.076873,-0.050143,0,0
1,PHOTOTRANSDUCTION,0.52025,-0.076933,-0.061393,0,0
1,CARBOXYLESTERASE ACTIVITY,0.25363,-0.077036,-0.053908,0,0
1,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.19095,-0.077985,-0.054169,0,0
1,PROTEIN DNA COMPLEX ASSEMBLY,0.063042,-0.078118,-0.081897,0,0
1,KEGG LINOLEIC ACID METABOLISM,0.093897,-0.078123,-0.13088,0,0
1,REACTOME PI METABOLISM,0.10096,-0.078229,-0.075354,0,0
1,BIOCARTA IL7 PATHWAY,0.24643,-0.079102,-0.10921,0,0
1,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.22568,-0.079471,-0.081594,0,0
1,KEGG REGULATION OF AUTOPHAGY,0.66501,-0.080318,-0.02583,0,0
1,SYSTEM DEVELOPMENT,0.56666,-0.080358,-0.025344,0,0
1,TRANSCRIPTION INITIATION,0.18219,-0.081007,-0.048361,0,0
1,PID HNF3APATHWAY,0.17099,-0.081017,-0.089606,0,0
1,VOLTAGE GATED SODIUM CHANNEL ACTIVITY,0.21579,-0.081086,-0.10589,0,0
1,MICROTUBULE CYTOSKELETON,0.070855,-0.081317,-0.08921,0,0
1,G1 PHASE,0.97557,-0.082115,-0.0086295,0,0
1,AMINE TRANSPORT,0.25729,-0.08261,-0.066368,0,0
1,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.024846,-0.08309,-0.10541,0,0
1,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GLOBO SERIES,0.44402,-0.083146,-0.07849,0,0
1,REGULATION OF GENE EXPRESSION EPIGENETIC,0.13814,-0.08321,-0.10074,0,0
1,REACTOME SIGNALING BY FGFR1 MUTANTS,0.36991,-0.083276,-0.045739,0,0
1,PID S1P S1P2 PATHWAY,0.29586,-0.083639,-0.085202,0,0
1,REGULATION OF ACTION POTENTIAL,0.20937,-0.084367,-0.081049,0,0
1,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.32938,-0.084426,-0.057104,0,0
1,REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE,0.31232,-0.084515,-0.081566,0,0
1,PID FANCONI PATHWAY,0.48131,-0.084903,-0.056429,0,0
1,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.21579,-0.085181,-0.1255,0,0
1,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.20621,-0.085257,-0.17172,0,0
1,GLUCOSE METABOLIC PROCESS,0.17374,-0.08651,-0.093755,0,0
1,BIOCARTA G2 PATHWAY,0.15264,-0.087229,-0.14263,0,0
1,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.20937,-0.087607,-0.082647,0,0
1,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.12259,-0.088487,-0.070924,0,0
1,KEGG ARACHIDONIC ACID METABOLISM,0.14048,-0.088711,-0.12203,0,0
1,GALACTOSYLTRANSFERASE ACTIVITY,0.15773,-0.088964,-0.13411,0,0
1,APICAL PLASMA MEMBRANE,0.48131,-0.089973,-0.082098,0,0
1,LEARNING AND OR MEMORY,0.62732,-0.090337,-0.035245,0,0
1,MEIOSIS I,0.92682,-0.090375,0.0086217,0,0
1,REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION,0.30402,-0.091076,-0.10965,0,0
1,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.15264,-0.091354,-0.082766,0,0
1,REACTOME P38MAPK EVENTS,0.27611,-0.092144,-0.069233,0,0
1,SECRETION BY CELL,0.063042,-0.093189,-0.091101,0,0
1,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.17653,-0.093696,-0.050808,0,0
1,RESPONSE TO NUTRIENT,0.099158,-0.094003,-0.15802,0,0
1,ANION CHANNEL ACTIVITY,0.67137,-0.095335,-0.016919,0,0
1,CHLORIDE CHANNEL ACTIVITY,0.67137,-0.095335,-0.016919,0,0
1,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.15773,-0.095512,-0.064557,0,0
1,ANTIOXIDANT ACTIVITY,0.42855,-0.095574,-0.093508,0,0
1,BIOCARTA GPCR PATHWAY,0.24288,-0.096286,-0.08562,0,0
1,KEGG TAURINE AND HYPOTAURINE METABOLISM,0.20937,-0.098442,-0.12203,0,0
1,DNA PACKAGING,0.11434,-0.098699,-0.078926,0,0
1,SH3 SH2 ADAPTOR ACTIVITY,0.20309,-0.098912,-0.09617,0,0
1,PID IL5 PATHWAY,0.38408,-0.099802,-0.090839,0,0
1,REGULATION OF IMMUNE EFFECTOR PROCESS,0.31653,-0.099865,-0.064704,0,0
1,MAGNESIUM ION BINDING,0.077957,-0.10015,-0.079864,0,0
1,MICROTUBULE,0.027803,-0.10037,-0.097295,0,0
1,REACTOME ADP SIGNALLING THROUGH P2RY12,0.49227,-0.10074,-0.040598,0,0
1,BIOCARTA CSK PATHWAY,0.054842,-0.10136,-0.11669,0,0
1,PID RHODOPSIN PATHWAY,0.046579,-0.10245,-0.14006,0,0
1,REACTOME PD1 SIGNALING,0.32938,-0.10452,-0.068911,0,0
1,BIOCARTA P27 PATHWAY,0.40843,-0.10474,-0.055407,0,0
1,REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE,0.188,-0.10511,-0.099477,0,0
1,PID NFKAPPABATYPICALPATHWAY,0.21579,-0.10537,-0.098345,0,0
1,HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS,0.24288,-0.10541,-0.076286,0,0
1,CELL CELL ADHESION,0.068167,-0.10579,-0.14904,0,0
1,RNA POLYMERASE II TRANSCRIPTION MEDIATOR ACTIVITY,0.073629,-0.10646,-0.11836,0,0
1,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.11434,-0.1072,-0.1389,0,0
1,PROTEIN AUTOPROCESSING,0.12689,-0.10722,-0.059206,0,0
1,KEGG LONG TERM POTENTIATION,0.0036303,-0.10748,-0.14942,0,0
1,PID PI3KCIAKTPATHWAY,0.19095,-0.10821,-0.09546,0,0
1,PHOSPHATASE BINDING,0.37932,-0.10833,-0.032947,0,0
1,MOLECULAR ADAPTOR ACTIVITY,0.085627,-0.10874,-0.11558,0,0
1,ANCHORED TO MEMBRANE,0.29184,-0.11053,-0.09516,0,0
1,ANCHORED TO PLASMA MEMBRANE,0.29184,-0.11053,-0.09516,0,0
1,PID EPHRINBREVPATHWAY,0.041967,-0.11157,-0.1414,0,0
1,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.20621,-0.11394,-0.048016,0,0
1,REACTOME RETROGRADE NEUROTROPHIN SIGNALLING,0.060602,-0.11508,-0.12237,0,0
1,BIOCARTA CALCINEURIN PATHWAY,0.33373,-0.1151,-0.12305,0,0
1,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.30402,-0.11528,-0.076434,0,0
1,APICAL PART OF CELL,0.2,-0.11575,-0.13455,0,0
1,MICROTUBULE ORGANIZING CENTER PART,0.066855,-0.11607,-0.082151,0,0
1,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.2839,-0.11615,-0.10349,0,0
1,PROTEIN DOMAIN SPECIFIC BINDING,0.0011199,-0.11688,-0.13584,0,0
1,REACTOME DEFENSINS,0.26098,-0.11696,-0.098796,0,0
1,PEPTIDE RECEPTOR ACTIVITY,0.053746,-0.11726,-0.10812,0,0
1,BIOCARTA CDK5 PATHWAY,0.72313,-0.11823,0.024501,0,0
1,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2,-0.11983,-0.084553,0,0
1,SYNAPSE PART,0.092194,-0.1202,-0.10709,0,0
1,PHOSPHOINOSITIDE BINDING,0.30815,-0.12031,-0.060785,0,0
1,KEGG MTOR SIGNALING PATHWAY,0.034637,-0.12069,-0.077971,0,0
1,RESPONSE TO NUTRIENT LEVELS,0.033166,-0.12079,-0.16714,0,0
1,RIBONUCLEOTIDE METABOLIC PROCESS,0.83713,-0.12104,-0.00049473,0,0
1,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.085627,-0.12212,-0.12093,0,0
1,PROTEIN HOMOOLIGOMERIZATION,0.32938,-0.12285,-0.075232,0,0
1,REACTOME DAG AND IP3 SIGNALING,0.063042,-0.123,-0.10823,0,0
1,REACTOME RECYCLING PATHWAY OF L1,0.077957,-0.12368,-0.11249,0,0
1,RESPONSE TO EXTRACELLULAR STIMULUS,0.066855,-0.12513,-0.1384,0,0
1,AXONOGENESIS,0.02068,-0.12526,-0.32587,0,0
1,REACTOME L1CAM INTERACTIONS,0.064293,-0.12586,-0.11412,0,0
1,CELL MATURATION,0.40843,-0.12587,-0.09219,0,0
1,REACTOME CELL CELL COMMUNICATION,0.41842,-0.12615,-0.047616,0,0
1,BIOCARTA ARENRF2 PATHWAY,0.62732,-0.12633,0.0054726,0,0
1,REGULATION OF IMMUNE RESPONSE,0.093897,-0.12673,-0.11775,0,0
1,BIOCARTA RB PATHWAY,0.25729,-0.12676,-0.10644,0,0
1,BIOCARTA NOS1 PATHWAY,0.2,-0.12698,-0.10463,0,0
1,REACTOME NETRIN1 SIGNALING,0.40843,-0.12731,-0.061231,0,0
1,APOPTOTIC MITOCHONDRIAL CHANGES,0.55487,-0.12857,-0.089568,0,0
1,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.32077,-0.12908,-0.054181,0,0
1,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.017549,-0.12931,-0.10417,0,0
1,ACTIN FILAMENT,0.18219,-0.12932,-0.12807,0,0
1,REACTOME INSULIN RECEPTOR RECYCLING,0.17934,-0.12958,-0.091045,0,0
1,NEURON DIFFERENTIATION,0.0075304,-0.12978,-0.29857,0,0
1,REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX,0.080955,-0.12979,-0.1172,0,0
1,CELLULAR RESPONSE TO STRESS,0.092194,-0.13035,-0.15946,0,0
1,MEIOTIC CELL CYCLE,0.076492,-0.13096,-0.11141,0,0
1,REACTOME IL 2 SIGNALING,0.1313,-0.13137,-0.099963,0,0
1,PID NETRIN PATHWAY,0.11235,-0.13151,-0.10615,0,0
1,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.076492,-0.13185,-0.075847,0,0
1,SYSTEM PROCESS,0.00092958,-0.13239,-0.11912,0,0
1,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.21905,-0.13249,-0.075668,0,0
1,REACTOME CHROMOSOME MAINTENANCE,0.047551,-0.13314,-0.13227,0,0
1,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.02068,-0.13456,-0.28391,0,0
1,REACTOME BILE ACID AND BILE SALT METABOLISM,0.080955,-0.13479,-0.16917,0,0
1,SPLICEOSOME ASSEMBLY,0.013798,-0.13486,-0.12172,0,0
1,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.12049,-0.1352,-0.10078,0,0
1,REGULATION OF MAPKKK CASCADE,0.22235,-0.13538,-0.089571,0,0
1,ACTIVATION OF IMMUNE RESPONSE,0.082489,-0.1357,-0.095696,0,0
1,CALMODULIN BINDING,0.18219,-0.13633,-0.11141,0,0
1,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.05824,-0.13681,-0.088722,0,0
1,DNA MODIFICATION,0.62732,-0.1381,-0.080865,0,0
1,PID LPA4 PATHWAY,0.11235,-0.13952,-0.11581,0,0
1,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.092194,-0.1402,-0.17578,0,0
1,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.057089,-0.14069,-0.1091,0,0
1,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.064293,-0.14088,-0.13845,0,0
1,PID EPHA FWDPATHWAY,0.44402,-0.14093,-0.056662,0,0
1,AMINE RECEPTOR ACTIVITY,0.017969,-0.14116,-0.12518,0,0
1,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.25363,-0.14141,-0.098376,0,0
1,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE ACTIVITY,0.78289,-0.14226,-0.0040762,0,0
1,REGULATION OF PROTEIN POLYMERIZATION,0.084046,-0.14295,-0.13236,0,0
1,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.076492,-0.14467,-0.17251,0,0
1,REGULATION OF GENE SPECIFIC TRANSCRIPTION,0.3746,-0.1447,-0.027473,0,0
1,LEUKOCYTE MIGRATION,0.53167,-0.14481,-0.081334,0,0
1,RESPIRATORY GASEOUS EXCHANGE,0.36526,-0.14619,0.0021743,0,0
1,LEUKOCYTE CHEMOTAXIS,0.3746,-0.14651,-0.14479,0,0
1,REACTOME OPIOID SIGNALLING,0.0022332,-0.14801,-0.17178,0,0
1,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.0071468,-0.14847,-0.19374,0,0
1,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.019739,-0.14853,-0.14296,0,0
1,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.14769,-0.14895,-0.1749,0,0
1,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.22568,-0.1495,-0.1561,0,0
1,STRIATED MUSCLE CONTRACTION GO 0006941,0.13583,-0.15066,-0.10917,0,0
1,CHROMATIN MODIFICATION,0.076492,-0.15095,-0.079966,0,0
1,REACTOME AMINE LIGAND BINDING RECEPTORS,0.015203,-0.15226,-0.13188,0,0
1,BIOCARTA DREAM PATHWAY,0.1028,-0.153,-0.15198,0,0
1,CYTOCHROME C OXIDASE ACTIVITY,0.072231,-0.15352,-0.12559,0,0
1,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.049546,-0.15371,-0.12593,0,0
1,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.18508,-0.15485,-0.068698,0,0
1,PROTEIN TRANSPORTER ACTIVITY,0.055956,-0.15647,-0.11316,0,0
1,BIOCARTA BARRESTIN PATHWAY,0.054842,-0.15656,-0.21311,0,0
1,NUCLEOSOME ASSEMBLY,0.060602,-0.15689,-0.17691,0,0
1,CLATHRIN COATED VESICLE,0.01282,-0.15748,-0.12577,0,0
1,REGULATION OF MYELOID CELL DIFFERENTIATION,0.15015,-0.15904,-0.16512,0,0
1,SODIUM CHANNEL ACTIVITY,0.26847,-0.15954,-0.12007,0,0
1,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.013798,-0.15969,-0.19307,0,0
1,SIALYLTRANSFERASE ACTIVITY,0.18508,-0.15993,-0.1419,0,0
1,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.04854,-0.16001,-0.13118,0,0
1,NUCLEAR CHROMOSOME,0.00098941,-0.1612,-0.15474,0,0
1,REGULATION OF NEURON APOPTOSIS,0.099158,-0.16367,-0.11467,0,0
1,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.05824,-0.16471,-0.12999,0,0
1,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.019283,-0.16478,-0.16709,0,0
1,REACTOME IL 3 5 AND GM CSF SIGNALING,0.33812,-0.16513,-0.052361,0,0
1,PID AR NONGENOMIC PATHWAY,0.0029794,-0.16517,-0.16691,0,0
1,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.54903,-0.16581,-0.021475,0,0
1,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.0083534,-0.16673,-0.23402,0,0
1,ST GRANULE CELL SURVIVAL PATHWAY,0.13814,-0.1697,-0.098741,0,0
1,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.013798,-0.17043,-0.13318,0,0
1,PID CXCR3PATHWAY,0.02166,-0.171,-0.1065,0,0
1,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.26847,-0.171,0.010718,0,0
1,DENDRITE,0.0094949,-0.17229,-0.21463,0,0
1,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.093897,-0.17275,-0.12478,0,0
1,SA PROGRAMMED CELL DEATH,0.22235,-0.17432,-0.099958,0,0
1,PID NEPHRIN NEPH1 PATHWAY,0.0027346,-0.1744,-0.14593,0,0
1,KEGG LONG TERM DEPRESSION,9.7346e-05,-0.17443,-0.18343,0,0
1,POSITIVE REGULATION OF IMMUNE RESPONSE,0.05824,-0.17569,-0.13957,0,0
1,SECRETORY PATHWAY,2.8418e-05,-0.17702,-0.19133,0,0
1,PID P38ALPHABETAPATHWAY,0.02268,-0.17706,-0.12423,0,0
1,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.29184,-0.17771,-0.078217,0,0
1,CORTICAL ACTIN CYTOSKELETON,0.17374,-0.17982,-0.15602,0,0
1,REACTOME SIGNALING BY SCF KIT,0.0053338,-0.18119,-0.16964,0,0
1,RESPONSE TO CARBOHYDRATE STIMULUS,0.44924,-0.1841,-0.031995,0,0
1,REACTOME ADP SIGNALLING THROUGH P2RY1,0.072231,-0.18571,-0.14612,0,0
1,TISSUE MORPHOGENESIS,0.188,-0.18594,-0.11991,0,0
1,REACTOME REGULATION OF SIGNALING BY CBL,0.11235,-0.18959,-0.10718,0,0
1,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.082489,-0.1901,-0.13856,0,0
1,CELL CELL SIGNALING,0.00084609,-0.19017,-0.1743,0,0
1,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.57857,-0.19018,-0.065842,0,0
1,REACTOME DSCAM INTERACTIONS,0.010245,-0.19264,-0.23499,0,0
1,BIOCARTA MCM PATHWAY,0.068167,-0.19484,-0.11009,0,0
1,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.5759e-05,-0.19541,-0.20199,0,0
1,REGULATION OF HOMEOSTATIC PROCESS,0.27999,-0.19627,-0.11753,0,0
1,NEUROLOGICAL SYSTEM PROCESS,2.0033e-05,-0.19693,-0.19088,0,0
1,REACTOME PLC BETA MEDIATED EVENTS,0.00016023,-0.19706,-0.2069,0,0
1,PID HES HEYPATHWAY,0.29586,-0.19892,-0.049514,0,0
1,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.017549,-0.20132,-0.20804,0,0
1,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.00020448,-0.20405,-0.2112,0,0
1,GLYCOLIPID METABOLIC PROCESS,0.077957,-0.20409,-0.19767,0,0
1,MORPHOGENESIS OF AN EPITHELIUM,0.40349,-0.20409,-0.074904,0,0
1,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.026586,-0.20523,-0.20934,0,0
1,CHROMATIN ASSEMBLY,0.020205,-0.20591,-0.17108,0,0
1,PID RAC1 REG PATHWAY,0.0028141,-0.20795,-0.24204,0,0
1,REACTOME UNWINDING OF DNA,0.037747,-0.20934,-0.17764,0,0
1,REACTOME G0 AND EARLY G1,0.0013457,-0.21268,-0.25416,0,0
1,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.00063551,-0.21334,-0.20698,0,0
1,REACTOME CA DEPENDENT EVENTS,0.0067808,-0.214,-0.15075,0,0
1,CELL PROJECTION PART,0.015953,-0.21537,-0.1757,0,0
1,TUBE DEVELOPMENT,0.068167,-0.21848,-0.19949,0,0
1,BIOCARTA CREB PATHWAY,0.0049174,-0.22286,-0.21002,0,0
1,REACTOME GABA B RECEPTOR ACTIVATION,0.0012662,-0.22518,-0.24095,0,0
1,KINESIN COMPLEX,0.05824,-0.22573,-0.13397,0,0
1,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.024288,-0.22967,-0.19887,0,0
1,PID THROMBIN PAR4 PATHWAY,0.0059384,-0.22996,-0.23095,0,0
1,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.013798,-0.23,-0.18681,0,0
1,EMBRYONIC DEVELOPMENT,0.027803,-0.23031,-0.17396,0,0
1,AMINE BINDING,0.0014738,-0.23187,-0.26555,0,0
1,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.010773,-0.23631,-0.17679,0,0
1,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,4.4878e-05,-0.23652,-0.26496,0,0
1,REGULATION OF JNK CASCADE,0.026586,-0.23791,-0.18549,0,0
1,PID LIS1PATHWAY,0.0034322,-0.23816,-0.18626,0,0
1,BIOCARTA PGC1A PATHWAY,0.03245,-0.24248,-0.15365,0,0
1,BIOCARTA PARKIN PATHWAY,0.05161,-0.24262,-0.20819,0,0
1,CALCIUM ION TRANSPORT,0.0037331,-0.24517,-0.21781,0,0
1,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.068167,-0.2465,-0.16782,0,0
1,CATION TRANSPORTING ATPASE ACTIVITY,0.00353,-0.25049,-0.2598,0,0
1,REACTOME PLATELET HOMEOSTASIS,9.7346e-05,-0.25213,-0.21417,0,0
1,REACTOME AMYLOIDS,0.1028,-0.25238,-0.1749,0,0
1,PID ERB GENOMIC PATHWAY,0.054842,-0.25272,-0.15513,0,0
1,BIOCARTA P35ALZHEIMERS PATHWAY,0.0079323,-0.25388,-0.19366,0,0
1,GLYCOSPHINGOLIPID METABOLIC PROCESS,0.05161,-0.25412,-0.18588,0,0
1,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0075304,-0.25461,-0.22916,0,0
1,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.01282,-0.25619,-0.18834,0,0
1,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.087232,-0.2562,-0.13963,0,0
1,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.084046,-0.25855,-0.1748,0,0
1,CELL RECOGNITION,0.11235,-0.25876,-0.21493,0,0
1,BRAIN DEVELOPMENT,0.00079435,-0.26589,-0.33448,0,0
1,SYNAPSE,0.00021909,-0.26632,-0.23943,0,0
1,REGULATION OF AXONOGENESIS,0.53742,-0.26738,-0.11486,0,0
1,VESICLE LOCALIZATION,0.079444,-0.26883,-0.18524,0,0
1,BIOCARTA CACAM PATHWAY,0.0019282,-0.27336,-0.25406,0,0
1,CELL FATE COMMITMENT,0.0081404,-0.28126,-0.24457,0,0
1,REACTOME MEIOTIC SYNAPSIS,0.011612,-0.28446,-0.22836,0,0
1,PID SYNDECAN 3 PATHWAY,0.13355,-0.28491,-0.17878,0,0
1,KEGG BUTANOATE METABOLISM,0.03939,-0.28909,-0.20238,0,0
1,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.03939,-0.2892,-0.24761,0,0
1,OLIGOSACCHARIDE METABOLIC PROCESS,0.017549,-0.29272,-0.27433,0,0
1,NERVOUS SYSTEM DEVELOPMENT,3.1888e-05,-0.29397,-0.28908,0,0
1,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,1.104e-05,-0.30525,-0.31288,0,0
1,REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS,0.00079435,-0.30793,-0.28367,0,0
1,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,6.7728e-06,-0.31183,-0.31885,0,0
1,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL,0.013798,-0.3147,-0.24923,0,0
1,ACETYLCHOLINE BINDING,2.9532e-05,-0.31616,-0.43635,0,0
1,POSITIVE REGULATION OF SECRETION,0.001662,-0.31944,-0.29226,0,0
1,REACTOME BOTULINUM NEUROTOXICITY,0.00012964,-0.31955,-0.29219,0,0
1,CALCIUM CHANNEL ACTIVITY,7.8282e-05,-0.32048,-0.3738,0,0
1,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1493e-05,-0.33315,-0.32995,0,0
1,ION CHANNEL ACTIVITY,7.6603e-06,-0.33603,-0.34899,0,0
1,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,9.0179e-06,-0.33708,-0.33981,0,0
1,TRANSMISSION OF NERVE IMPULSE,7.889e-07,-0.33776,-0.33977,0,0
1,KEGG NITROGEN METABOLISM,0.0012662,-0.33836,-0.29807,0,0
1,KINASE ACTIVATOR ACTIVITY,0.00032948,-0.34589,-0.37719,0,0
1,REACTOME G PROTEIN ACTIVATION,0.00034072,-0.34876,-0.30088,0,0
1,HOMOPHILIC CELL ADHESION,0.0066042,-0.35138,-0.3223,0,0
1,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,3.7791e-06,-0.35208,-0.31295,0,0
1,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0083534,-0.35584,-0.25098,0,0
1,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.0062634,-0.36078,-0.24583,0,0
1,DETECTION OF STIMULUS,3.1904e-06,-0.3617,-0.32658,0,0
1,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.00079435,-0.36233,-0.33371,0,0
1,REACTOME TELOMERE MAINTENANCE,0.0040578,-0.36303,-0.24535,0,0
1,SH3 DOMAIN BINDING,4.1617e-05,-0.36855,-0.37678,0,0
1,GLUTATHIONE TRANSFERASE ACTIVITY,0.1028,-0.36994,-0.20044,0,0
1,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.0094949,-0.37842,-0.28759,0,0
1,SYNAPTIC TRANSMISSION,3.9926e-07,-0.38172,-0.38135,0,0
1,KINASE REGULATOR ACTIVITY,0.001872,-0.39035,-0.31912,0,0
1,NEURON APOPTOSIS,0.00049035,-0.39492,-0.32905,0,0
1,CARBONATE DEHYDRATASE ACTIVITY,0.0094949,-0.39522,-0.33391,0,0
1,CARBOXY LYASE ACTIVITY,4.1112e-06,-0.3958,-0.37392,0,0
1,VITAMIN BINDING,0.00011241,-0.39753,-0.41619,0,0
1,MICROTUBULE BASED MOVEMENT,7.2754e-05,-0.40141,-0.45655,0,0
1,BIOCARTA STATHMIN PATHWAY,0.0013054,-0.40164,-0.35026,0,0
1,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,1.5201e-05,-0.40329,-0.39475,0,0
1,REACTOME ENDOGENOUS STEROLS,0.045624,-0.40354,-0.23873,0,0
1,GATED CHANNEL ACTIVITY,2.9301e-06,-0.40463,-0.40645,0,0
1,CHROMATIN REMODELING COMPLEX,4.4878e-05,-0.40647,-0.35956,0,0
1,AXON,0.00050664,-0.40895,-0.48868,0,0
1,REACTOME INTEGRATION OF ENERGY METABOLISM,2.9301e-06,-0.40912,-0.33545,0,0
1,MAP KINASE ACTIVITY,9.7346e-05,-0.42022,-0.39122,0,0
1,CATION CHANNEL ACTIVITY,4.6623e-06,-0.43823,-0.41343,0,0
1,CENTRAL NERVOUS SYSTEM DEVELOPMENT,8.628e-07,-0.44542,-0.39687,0,0
1,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.00028792,-0.45585,-0.43343,0,0
1,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,4.1802e-07,-0.46096,-0.41741,0,0
1,REGULATION OF SECRETION,0.00019753,-0.46118,-0.32134,0,0
1,REACTOME PACKAGING OF TELOMERE ENDS,0.0029794,-0.46694,-0.38267,0,0
1,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.00079435,-0.47291,-0.3279,0,0
1,REACTOME PEPTIDE HORMONE BIOSYNTHESIS,0.00065623,-0.48896,-0.55057,0,0
1,PROTEIN KINASE REGULATOR ACTIVITY,0.0018173,-0.4904,-0.36924,0,0
1,AXON GUIDANCE,0.00012512,-0.49074,-0.53609,0,0
1,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,7.0571e-06,-0.49323,-0.56078,0,0
1,REACTOME NEURONAL SYSTEM,2.6322e-07,-0.50327,-0.44335,0,0
1,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.00018427,-0.51534,-0.40463,0,0
1,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,5.9841e-06,-0.51608,-0.48749,0,0
1,OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR,0.059411,-0.5185,-0.34817,0,0
1,KEGG TASTE TRANSDUCTION,7.2111e-07,-0.52093,-0.48433,0,0
1,VOLTAGE GATED CHANNEL ACTIVITY,5.0683e-06,-0.52204,-0.51075,0,0
1,PDZ DOMAIN BINDING,1.7806e-05,-0.55815,-0.5328,0,0
1,PHOSPHATASE INHIBITOR ACTIVITY,0.013465,-0.56426,-0.37237,0,0
1,CHANNEL REGULATOR ACTIVITY,0.00010845,-0.56607,-0.41062,0,0
1,NEUROPEPTIDE SIGNALING PATHWAY,0.0039469,-0.57,-0.35504,0,0
1,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,2.3418e-05,-0.57306,-0.54682,0,0
1,REACTOME ADHERENS JUNCTIONS INTERACTIONS,5.8301e-05,-0.58365,-0.55319,0,0
1,VOLTAGE GATED CATION CHANNEL ACTIVITY,5.2837e-06,-0.5932,-0.55391,0,0
1,CELL SOMA,9.389e-05,-0.59929,-0.50499,0,0
1,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,2.7343e-05,-0.61669,-0.6167,0,0
1,POTASSIUM CHANNEL ACTIVITY,2.4692e-06,-0.6309,-0.57868,0,0
1,BIOCARTA CK1 PATHWAY,3.7145e-05,-0.63356,-0.53292,0,0
1,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,1.4044e-06,-0.64621,-0.61355,0,0
1,REACTOME POTASSIUM CHANNELS,4.1802e-07,-0.64921,-0.59467,0,0
1,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,1.4674e-06,-0.6614,-0.67096,0,0
1,DETECTION OF CHEMICAL STIMULUS,1.906e-06,-0.68271,-0.61273,0,0
1,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,4.2876e-06,-0.70786,-0.74038,0,0
1,SITE OF POLARIZED GROWTH,0.00034072,-0.72076,-0.67181,0,0
1,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,8.4205e-05,-0.72753,-0.5306,0,0
1,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,5.2837e-06,-0.74521,-0.78628,0,0
1,REACTOME NEUROTRANSMITTER RELEASE CYCLE,3.17e-07,-0.7953,-0.72646,0,0
1,GLUTAMATE RECEPTOR ACTIVITY,1.6015e-06,-0.80401,-0.75974,0,0
1,REGULATION OF NEUROTRANSMITTER LEVELS,1.4674e-06,-0.8074,-0.73947,0,0
1,GROWTH CONE,0.00026903,-0.84746,-0.73996,0,0
1,IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY,1.6015e-06,-0.85919,-0.90118,0,0
1,REGULATION OF HORMONE SECRETION,8.1192e-05,-0.87011,-0.63595,0,0
1,SYNAPTIC VESICLE,2.6322e-07,-0.88743,-0.80272,0,0
1,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,1.5331e-06,-0.9049,-0.84807,0,0
1,HORMONE SECRETION,7.8282e-05,-0.97257,-0.69647,0,0
1,REGULATED SECRETORY PATHWAY,1.8084e-07,-1.0106,-0.98868,0,0
1,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,3.4772e-07,-1.0297,-0.99321,0,0
1,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,4.5813e-07,-1.1393,-0.94085,0,0
1,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,1.4963e-07,-1.2527,-1.1199,0,0
1,NEUROTRANSMITTER SECRETION,1.2971e-07,-1.3064,-1.2455,0,0
1,REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE,2.0829e-07,-1.3783,-1.2814,0,0
1,REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE,1.2366e-07,-1.7545,-1.5849,0,0
2,REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS,3.4421e-05,0.81064,0.86255,1,1
2,PID INTEGRIN4 PATHWAY,0.0006154,0.74435,0.68278,1,1
2,VESICLE LOCALIZATION,1.4039e-05,0.73002,0.70196,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.0006154,0.67269,0.57188,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PI,1.6729e-06,0.65639,0.5735,1,1
2,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,2.3418e-05,0.65201,0.51126,1,1
2,KEGG ALLOGRAFT REJECTION,0.0028141,0.6126,0.44071,1,1
2,MESODERM DEVELOPMENT,0.00054072,0.61159,0.47098,1,1
2,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,1.6455e-05,0.611,0.51181,1,1
2,GLAND DEVELOPMENT,0.0030654,0.6,0.44663,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON SULFUR GROUP OF DONORS,0.00040247,0.58906,0.38235,1,1
2,MORPHOGENESIS OF AN EPITHELIUM,0.00017186,0.58826,0.52381,1,1
2,G1 PHASE OF MITOTIC CELL CYCLE,1.8251e-06,0.56644,0.53778,1,1
2,INTERCELLULAR JUNCTION ASSEMBLY,0.00050664,0.5497,0.49676,1,1
2,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,6.5149e-05,0.54276,0.41615,1,1
2,TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.0033e-05,0.53113,0.43289,1,1
2,ICOSANOID METABOLIC PROCESS,0.0050528,0.52983,0.37542,1,1
2,COENZYME BIOSYNTHETIC PROCESS,0.00025131,0.5276,0.48531,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PS,1.1267e-06,0.52368,0.52828,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.00047456,0.52161,0.46654,1,1
2,POSITIVE REGULATION OF PHOSPHORYLATION,5.4121e-05,0.51163,0.41533,1,1
2,SA MMP CYTOKINE CONNECTION,3.5759e-05,0.51158,0.43959,1,1
2,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00012964,0.50994,0.47221,1,1
2,REACTOME METABOLISM OF PORPHYRINS,0.0027346,0.50668,0.34176,1,1
2,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00013917,0.50596,0.39757,1,1
2,COENZYME METABOLIC PROCESS,2.1663e-05,0.48368,0.37322,1,1
2,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.00021167,0.46957,0.41693,1,1
2,CORNIFIED ENVELOPE,0.00024286,0.46667,0.41795,1,1
2,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,6.7596e-05,0.46495,0.34305,1,1
2,COFACTOR METABOLIC PROCESS,4.1617e-05,0.46412,0.34052,1,1
2,DEAMINASE ACTIVITY,0.00040247,0.46345,0.39382,1,1
2,REACTOME PLATELET SENSITIZATION BY LDL,1.0207e-07,0.46097,0.47143,1,1
2,N TERMINAL PROTEIN AMINO ACID MODIFICATION,3.1904e-06,0.45144,0.39812,1,1
2,SMOOTH MUSCLE CONTRACTION GO 0006939,1.8251e-06,0.45092,0.43943,1,1
2,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,1.6455e-05,0.44385,0.4343,1,1
2,BIOCARTA AHSP PATHWAY,0.0059384,0.44291,0.39643,1,1
2,REACTOME GLUTATHIONE CONJUGATION,0.00026903,0.43775,0.47973,1,1
2,CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0069616,0.4334,0.34514,1,1
2,COFACTOR BIOSYNTHETIC PROCESS,4.6597e-05,0.43142,0.38949,1,1
2,POSITIVE REGULATION OF CELL ADHESION,2.4346e-05,0.43141,0.3868,1,1
2,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.00049035,0.42987,0.4204,1,1
2,BIOCARTA SPPA PATHWAY,4.6623e-06,0.42816,0.37701,1,1
2,PID ERBB NETWORK PATHWAY,0.00038934,0.42501,0.37707,1,1
2,BIOCARTA DEATH PATHWAY,0.013139,0.42174,0.27782,1,1
2,REACTOME APOPTOTIC EXECUTION PHASE,4.2876e-06,0.4175,0.38349,1,1
2,BIOCARTA ARF PATHWAY,0.0014738,0.41487,0.29805,1,1
2,PID RHOA REG PATHWAY,0.00047456,0.41345,0.3063,1,1
2,ISOPRENOID METABOLIC PROCESS,0.00021167,0.40532,0.34594,1,1
2,KEGG ETHER LIPID METABOLISM,3.6228e-06,0.40396,0.40327,1,1
2,REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS,0.0036303,0.40276,0.36538,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PG,0.00032948,0.40115,0.34311,1,1
2,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.00090094,0.39792,0.32481,1,1
2,GLIOGENESIS,0.0053338,0.39738,0.29791,1,1
2,KERATINOCYTE DIFFERENTIATION,0.00032948,0.39661,0.41266,1,1
2,BIOCARTA IL4 PATHWAY,0.00025131,0.39501,0.36466,1,1
2,PID IL2 STAT5PATHWAY,0.00013917,0.39283,0.30867,1,1
2,INTERCELLULAR JUNCTION ASSEMBLY AND MAINTENANCE,0.001872,0.39267,0.35436,1,1
2,REGULATION OF CELL SHAPE,0.00079435,0.39255,0.29386,1,1
2,KEGG VIRAL MYOCARDITIS,0.0013054,0.39016,0.26859,1,1
2,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.0045306,0.38476,0.29051,1,1
2,HORMONE BINDING,0.011612,0.38316,0.33101,1,1
2,ENDOPLASMIC RETICULUM LUMEN,0.0018173,0.38107,0.32236,1,1
2,BIOCARTA TH1TH2 PATHWAY,0.0015653,0.37978,0.28172,1,1
2,ANTIOXIDANT ACTIVITY,0.016734,0.37913,0.22151,1,1
2,ORGANELLE LOCALIZATION,3.4421e-05,0.37011,0.29714,1,1
2,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00032948,0.36798,0.35894,1,1
2,MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0046564,0.36637,0.30058,1,1
2,RESPONSE TO HEAT,0.00019753,0.36357,0.29002,1,1
2,BIOCARTA TEL PATHWAY,0.0025083,0.3633,0.3094,1,1
2,KEGG LINOLEIC ACID METABOLISM,0.00021909,0.36216,0.27167,1,1
2,PROTEIN BINDING BRIDGING,5.2837e-06,0.36206,0.32363,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PE,2.6307e-05,0.36124,0.35791,1,1
2,REGULATION OF CELL MORPHOGENESIS,0.0012662,0.36009,0.26217,1,1
2,RRNA PROCESSING,0.0016129,0.35701,0.301,1,1
2,BIOCARTA MITOCHONDRIA PATHWAY,0.022165,0.35674,0.22474,1,1
2,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.00081984,0.35543,0.28191,1,1
2,BIOCARTA RHO PATHWAY,0.00069957,0.35488,0.27883,1,1
2,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.0081404,0.34931,0.24321,1,1
2,REACTOME CALNEXIN CALRETICULIN CYCLE,0.0031536,0.34831,0.263,1,1
2,RIBOSOME BIOGENESIS AND ASSEMBLY,0.0011549,0.34774,0.31214,1,1
2,KEGG PROPANOATE METABOLISM,0.0067808,0.34727,0.27099,1,1
2,REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,0.00049035,0.3465,0.29814,1,1
2,SINGLE STRANDED RNA BINDING,0.00028792,0.34455,0.30099,1,1
2,RIBONUCLEOPROTEIN BINDING,0.00037661,0.34077,0.27696,1,1
2,FATTY ACID METABOLIC PROCESS,0.00012512,0.33916,0.29627,1,1
2,KEGG PROTEASOME,0.001986,0.33841,0.26367,1,1
2,KEGG PYRUVATE METABOLISM,0.033894,0.33821,0.27223,1,1
2,BIOCARTA VDR PATHWAY,1.5201e-05,0.33705,0.34864,1,1
2,TRANSLATION REGULATOR ACTIVITY,0.001228,0.33547,0.25921,1,1
2,PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.007729,0.33465,0.27504,1,1
2,PID EPHA FWDPATHWAY,3.3132e-05,0.33445,0.30143,1,1
2,RAS GTPASE ACTIVATOR ACTIVITY,0.0037331,0.33216,0.26339,1,1
2,MEIOTIC RECOMBINATION,0.0047853,0.3302,0.24069,1,1
2,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.0020453,0.32896,0.23627,1,1
2,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0019282,0.32722,0.32223,1,1
2,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.00063551,0.32538,0.25609,1,1
2,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.0022332,0.32456,0.23369,1,1
2,RRNA METABOLIC PROCESS,0.001986,0.32163,0.27785,1,1
2,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.0014299,0.32133,0.27393,1,1
2,ADHERENS JUNCTION,0.00022676,0.32086,0.32902,1,1
2,REACTOME APOPTOSIS,0.00035231,0.31738,0.21675,1,1
2,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.00050664,0.31616,0.30182,1,1
2,BIOCARTA PITX2 PATHWAY,0.0053338,0.31562,0.24453,1,1
2,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.0073363,0.31461,0.22907,1,1
2,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.00067758,0.31311,0.32503,1,1
2,KEGG GLUTATHIONE METABOLISM,0.00057693,0.31282,0.26863,1,1
2,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.001191,0.31272,0.24733,1,1
2,MEIOSIS I,0.0060989,0.31236,0.21924,1,1
2,BIOCARTA WNT PATHWAY,0.00041602,0.31198,0.28682,1,1
2,KEGG ALPHA LINOLENIC ACID METABOLISM,0.00012512,0.31192,0.33956,1,1
2,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.038561,0.31008,0.20198,1,1
2,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.0057817,0.30758,0.23958,1,1
2,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.0039469,0.30749,0.2261,1,1
2,EMBRYONIC MORPHOGENESIS,0.0094949,0.30617,0.23216,1,1
2,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.0038387,0.30568,0.20214,1,1
2,ORGANELLE OUTER MEMBRANE,9.7801e-06,0.30513,0.26564,1,1
2,TISSUE DEVELOPMENT,0.00069957,0.30195,0.2401,1,1
2,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.001986,0.30194,0.21928,1,1
2,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.00092958,0.30058,0.25512,1,1
2,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,8.4205e-05,0.29718,0.2452,1,1
2,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.0040578,0.29707,0.2064,1,1
2,CELL PROJECTION BIOGENESIS,2.9532e-05,0.29701,0.26794,1,1
2,REGULATION OF PROTEIN MODIFICATION PROCESS,0.0021689,0.29605,0.22925,1,1
2,SPHINGOID METABOLIC PROCESS,0.0028141,0.29537,0.20375,1,1
2,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.0033369,0.29489,0.20423,1,1
2,PROTEIN IMPORT INTO NUCLEUS,0.00057693,0.29428,0.24091,1,1
2,CASPASE REGULATOR ACTIVITY,0.047551,0.29397,0.1609,1,1
2,REACTOME SULFUR AMINO ACID METABOLISM,3.7145e-05,0.29238,0.32667,1,1
2,NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.025994,0.29237,0.1877,1,1
2,REACTOME SYNTHESIS OF PA,0.00013917,0.29234,0.28945,1,1
2,KEGG LYSINE DEGRADATION,0.00045924,0.29164,0.24117,1,1
2,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.00010462,0.29133,0.2889,1,1
2,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.013798,0.29108,0.18975,1,1
2,PID HIF2PATHWAY,0.0010859,0.28814,0.24422,1,1
2,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.0062634,0.2881,0.22783,1,1
2,BIOCARTA PROTEASOME PATHWAY,0.0054795,0.2872,0.22927,1,1
2,TRANSLATION INITIATION FACTOR ACTIVITY,0.0014299,0.28668,0.28205,1,1
2,SECONDARY METABOLIC PROCESS,4.3218e-05,0.28646,0.29595,1,1
2,PIGMENT METABOLIC PROCESS,0.00019079,0.28492,0.29085,1,1
2,POSITIVE REGULATION OF ANGIOGENESIS,0.011326,0.28444,0.31977,1,1
2,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.0022992,0.2839,0.209,1,1
2,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.001662,0.28372,0.24097,1,1
2,RESPONSE TO CARBOHYDRATE STIMULUS,0.024288,0.28347,0.17153,1,1
2,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00020448,0.28197,0.2362,1,1
2,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.0017123,0.28108,0.2062,1,1
2,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.001228,0.28074,0.32527,1,1
2,NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0030654,0.2793,0.35984,1,1
2,KEGG THYROID CANCER,0.00012964,0.27783,0.30122,1,1
2,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.016734,0.27674,0.20924,1,1
2,REACTOME SIGNALING BY HIPPO,0.011612,0.27654,0.38977,1,1
2,FOCAL ADHESION,0.0036303,0.27509,0.29807,1,1
2,NEGATIVE REGULATION OF ANGIOGENESIS,0.025414,0.27383,0.25808,1,1
2,OUTER MEMBRANE,3.7145e-05,0.27348,0.23076,1,1
2,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.00047456,0.27312,0.22887,1,1
2,REACTOME ACYL CHAIN REMODELLING OF PC,5.2139e-05,0.27288,0.27751,1,1
2,ADP BINDING,0.0031536,0.27262,0.27238,1,1
2,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.011047,0.27123,0.26388,1,1
2,SA CASPASE CASCADE,0.031748,0.27058,0.21481,1,1
2,KEGG RETINOL METABOLISM,0.00067758,0.2704,0.2686,1,1
2,MITOCHONDRIAL MATRIX,0.0015653,0.26892,0.23325,1,1
2,MITOCHONDRIAL LUMEN,0.0015653,0.26892,0.23325,1,1
2,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.0027346,0.26793,0.18039,1,1
2,CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,0.26698,0.16453,1,1
2,BIOCARTA RARRXR PATHWAY,0.00016595,0.2653,0.24807,1,1
2,REACTOME REGULATION OF APOPTOSIS,0.0079323,0.26518,0.15337,1,1
2,MITOCHONDRIAL TRANSPORT,0.00037661,0.26499,0.26491,1,1
2,RESPONSE TO OXIDATIVE STRESS,0.00018427,0.26465,0.24959,1,1
2,HEPARIN BINDING,0.0097392,0.26445,0.21787,1,1
2,REACTOME SYNTHESIS OF PE,0.0010859,0.2642,0.2486,1,1
2,DRUG BINDING,4.8379e-05,0.26408,0.28585,1,1
2,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.0015189,0.26389,0.21251,1,1
2,BIOCARTA EIF PATHWAY,0.00010092,0.26369,0.30757,1,1
2,MITOCHONDRIAL OUTER MEMBRANE,0.00031859,0.26324,0.25163,1,1
2,POSITIVE REGULATION OF CELL CYCLE,0.0041716,0.26309,0.29027,1,1
2,FATTY ACID BIOSYNTHETIC PROCESS,0.0075304,0.2629,0.3088,1,1
2,BIOCARTA PML PATHWAY,0.03939,0.26195,0.16034,1,1
2,PID IL2 PI3KPATHWAY,0.00014935,0.26134,0.26253,1,1
2,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0038387,0.25972,0.15103,1,1
2,PID INTEGRIN CS PATHWAY,0.041093,0.25967,0.22855,1,1
2,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00063551,0.25859,0.22796,1,1
2,PEPTIDYL TYROSINE PHOSPHORYLATION,0.00067758,0.25842,0.25173,1,1
2,REGULATION OF MUSCLE CONTRACTION,0.0017123,0.25794,0.20346,1,1
2,REACTOME LYSOSOME VESICLE BIOGENESIS,0.013798,0.25758,0.2076,1,1
2,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0083534,0.25758,0.21326,1,1
2,REGULATION OF CELL ADHESION,4.3218e-05,0.25708,0.27106,1,1
2,G1 PHASE,0.00021167,0.25675,0.33841,1,1
2,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.00095906,0.25631,0.21317,1,1
2,BIOCARTA CYTOKINE PATHWAY,7.3528e-06,0.25574,0.21687,1,1
2,PID MYC PATHWAY,0.00024286,0.25559,0.26602,1,1
2,BIOCARTA LONGEVITY PATHWAY,0.00017796,0.25441,0.31687,1,1
2,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.011612,0.25306,0.17323,1,1
2,AMINOPEPTIDASE ACTIVITY,0.021165,0.25262,0.18974,1,1
2,OXYGEN BINDING,0.0038387,0.24996,0.21595,1,1
2,RNA HELICASE ACTIVITY,8.1192e-05,0.24958,0.23833,1,1
2,BIOCARTA PS1 PATHWAY,0.001662,0.24946,0.21291,1,1
2,STEROID BINDING,0.00036427,0.24945,0.31964,1,1
2,CYTOKINE METABOLIC PROCESS,0.0069616,0.24907,0.14622,1,1
2,PROTEIN IMPORT,7.547e-05,0.24894,0.22135,1,1
2,RNA 3END PROCESSING,0.0033369,0.2486,0.19853,1,1
2,BIOCARTA PAR1 PATHWAY,0.0013457,0.2482,0.19615,1,1
2,PID EPOPATHWAY,0.00029782,0.2477,0.25129,1,1
2,CELL CYCLE ARREST GO 0007050,1.1964e-05,0.2469,0.21736,1,1
2,REACTOME SIGNALING BY WNT,0.00353,0.24685,0.17083,1,1
2,BIOCARTA CARM1 PATHWAY,0.013798,0.24629,0.20293,1,1
2,REACTOME PEROXISOMAL LIPID METABOLISM,0.001228,0.24551,0.23882,1,1
2,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.0079323,0.24546,0.1663,1,1
2,U12 DEPENDENT SPLICEOSOME,3.8583e-05,0.24515,0.24852,1,1
2,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.00040247,0.24503,0.22557,1,1
2,KEGG INOSITOL PHOSPHATE METABOLISM,1.4674e-06,0.24502,0.23435,1,1
2,PHOSPHOLIPASE C ACTIVITY,0.0042883,0.24471,0.19739,1,1
2,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.00030804,0.24446,0.25118,1,1
2,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.00057693,0.24439,0.2187,1,1
2,BIOCARTA EIF2 PATHWAY,0.00072223,0.24437,0.24312,1,1
2,ACTIN FILAMENT POLYMERIZATION,0.0069616,0.24352,0.2874,1,1
2,KEGG DRUG METABOLISM CYTOCHROME P450,0.00016595,0.24244,0.28039,1,1
2,PIGMENT BIOSYNTHETIC PROCESS,0.00023468,0.24217,0.27214,1,1
2,OXIDOREDUCTASE ACTIVITY,0.00026903,0.24169,0.22072,1,1
2,NUCLEAR MEMBRANE,4.1112e-06,0.24157,0.24979,1,1
2,BIOCARTA RANMS PATHWAY,0.027803,0.2412,0.15568,1,1
2,PEPTIDYL TYROSINE MODIFICATION,0.0010859,0.24015,0.22718,1,1
2,BIOCARTA ARAP PATHWAY,0.0083534,0.23979,0.13342,1,1
2,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.00050664,0.23588,0.23453,1,1
2,KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS,0.030383,0.23563,0.17268,1,1
2,BIOCARTA CHEMICAL PATHWAY,0.012203,0.23497,0.15777,1,1
2,SH3 SH2 ADAPTOR ACTIVITY,0.00065623,0.23435,0.21517,1,1
2,PID ECADHERIN STABILIZATION PATHWAY,0.0041716,0.23418,0.20918,1,1
2,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.00067758,0.23401,0.19835,1,1
2,REACTOME SMOOTH MUSCLE CONTRACTION,0.023205,0.23336,0.25288,1,1
2,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.00084609,0.23255,0.25687,1,1
2,BIOCARTA RAC1 PATHWAY,0.017969,0.23225,0.17483,1,1
2,ENDORIBONUCLEASE ACTIVITY,0.00055855,0.23125,0.26151,1,1
2,NUCLEAR IMPORT,0.00059588,0.23047,0.21702,1,1
2,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.001191,0.22897,0.19926,1,1
2,REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND,0.0090226,0.2283,0.16518,1,1
2,REACTOME INFLUENZA LIFE CYCLE,0.033894,0.22763,0.19273,1,1
2,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.0034322,0.22736,0.15999,1,1
2,REACTOME PURINE CATABOLISM,0.042857,0.2266,0.11961,1,1
2,INTEGRATOR COMPLEX,0.0001165,0.22647,0.2018,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,3.4421e-05,0.226,0.23418,1,1
2,SIG BCR SIGNALING PATHWAY,0.0037331,0.22563,0.19298,1,1
2,REGULATION OF TRANSLATION,0.00013917,0.22494,0.19913,1,1
2,REGULATION OF ENDOCYTOSIS,0.029719,0.2246,0.14574,1,1
2,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.00041602,0.22448,0.20211,1,1
2,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.00031859,0.22384,0.25486,1,1
2,INTERFERON GAMMA PRODUCTION,0.0037331,0.22382,0.18147,1,1
2,REACTOME RNA POL I TRANSCRIPTION INITIATION,7.8282e-05,0.22349,0.23866,1,1
2,NUCLEOTIDE KINASE ACTIVITY,0.042857,0.22136,0.23562,1,1
2,ST T CELL SIGNAL TRANSDUCTION,0.0013054,0.22132,0.17622,1,1
2,TRANSITION METAL ION TRANSPORT,0.0087944,0.22096,0.16755,1,1
2,RESPONSE TO HORMONE STIMULUS,0.00050664,0.22019,0.31197,1,1
2,NEGATIVE REGULATION OF CELL CYCLE,2.5308e-05,0.21919,0.21156,1,1
2,PID WNT CANONICAL PATHWAY,5.2139e-05,0.21835,0.21502,1,1
2,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.00025131,0.21743,0.17703,1,1
2,HISTONE DEACETYLASE BINDING,0.0094949,0.21691,0.20696,1,1
2,HELICASE ACTIVITY,8.7323e-05,0.21687,0.18543,1,1
2,KEGG APOPTOSIS,0.041967,0.21642,0.14276,1,1
2,PID IL8CXCR2 PATHWAY,0.0064317,0.21622,0.24991,1,1
2,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.00047456,0.21592,0.17231,1,1
2,KEGG GLYOXYLATE AND DICARBOXYLATE METABOLISM,0.007729,0.21483,0.22418,1,1
2,CELL CORTEX,0.0013054,0.21465,0.16267,1,1
2,OVULATION CYCLE,0.0016129,0.21388,0.18393,1,1
2,BIOCARTA DC PATHWAY,0.0056288,0.21376,0.14896,1,1
2,OXIDOREDUCTASE ACTIVITY GO 0016616,0.0024367,0.21246,0.21611,1,1
2,REACTOME BIOLOGICAL OXIDATIONS,0.00014418,0.2121,0.24578,1,1
2,REACTOME MEMBRANE TRAFFICKING,0.00024286,0.21197,0.18147,1,1
2,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.0013457,0.21177,0.22117,1,1
2,BIOCARTA FCER1 PATHWAY,0.0029794,0.21142,0.18779,1,1
2,PID P38ALPHABETADOWNSTREAMPATHWAY,0.00067758,0.21106,0.18123,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.0045306,0.21013,0.19455,1,1
2,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.0031536,0.20985,0.17639,1,1
2,PID S1P S1P1 PATHWAY,0.013139,0.20932,0.16908,1,1
2,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.041967,0.20929,0.11959,1,1
2,TRANSCRIPTION ELONGATION REGULATOR ACTIVITY,0.00057693,0.20925,0.18831,1,1
2,REACTOME SYNTHESIS OF PC,0.01282,0.20919,0.17045,1,1
2,CHAPERONE BINDING,0.012508,0.20814,0.18393,1,1
2,BIOCARTA CTCF PATHWAY,0.0085714,0.20795,0.21175,1,1
2,PEROXISOMAL MEMBRANE,0.0097392,0.20742,0.15449,1,1
2,MICROBODY MEMBRANE,0.0097392,0.20742,0.15449,1,1
2,KEGG ENDOCYTOSIS,0.00084609,0.20704,0.16164,1,1
2,BIOCARTA P38MAPK PATHWAY,0.001986,0.20639,0.18657,1,1
2,KEGG ARACHIDONIC ACID METABOLISM,0.001662,0.20617,0.22261,1,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.0022332,0.20604,0.21007,1,1
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.0046564,0.20578,0.16682,1,1
2,BIOCARTA GCR PATHWAY,0.024288,0.20423,0.1623,1,1
2,INTERACTION WITH HOST,0.02268,0.20363,0.15784,1,1
2,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00036427,0.20215,0.16034,1,1
2,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.0021689,0.20205,0.23314,1,1
2,PID FAK PATHWAY,0.0059384,0.20197,0.1497,1,1
2,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.0010859,0.20173,0.17001,1,1
2,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,5.7413e-06,0.2011,0.21534,1,1
2,PEROXISOMAL PART,0.0013872,0.20028,0.20451,1,1
2,MICROBODY PART,0.0013872,0.20028,0.20451,1,1
2,REACTOME DEADENYLATION OF MRNA,4.8612e-06,0.20017,0.24319,1,1
2,SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.046579,0.19991,0.26097,1,1
2,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.00049035,0.19968,0.18128,1,1
2,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.0040578,0.1992,0.14214,1,1
2,CARBOXYLIC ACID METABOLIC PROCESS,0.00019753,0.199,0.21249,1,1
2,REACTOME PHOSPHORYLATION OF THE APC C,0.0017641,0.19895,0.1648,1,1
2,REGULATION OF RAS GTPASE ACTIVITY,0.00059588,0.19873,0.16779,1,1
2,BIOCARTA UCALPAIN PATHWAY,0.012508,0.1981,0.14773,1,1
2,PEPTIDYL AMINO ACID MODIFICATION,6.0504e-05,0.19739,0.17354,1,1
2,KEGG NON SMALL CELL LUNG CANCER,0.00050664,0.1972,0.16552,1,1
2,ANTI APOPTOSIS,0.00050664,0.19633,0.18405,1,1
2,PROTEASOME COMPLEX,0.011047,0.19628,0.20668,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,3.1888e-05,0.19576,0.17701,1,1
2,LIGASE ACTIVITY,1.1493e-05,0.1956,0.19763,1,1
2,NUCLEAR MEMBRANE PART,5.7413e-06,0.19457,0.23794,1,1
2,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00019753,0.19456,0.18446,1,1
2,KEGG SMALL CELL LUNG CANCER,0.0051916,0.19402,0.2135,1,1
2,VIRAL GENOME REPLICATION,0.046579,0.19335,0.1134,1,1
2,REACTOME MRNA SPLICING MINOR PATHWAY,0.0013054,0.19334,0.16229,1,1
2,ORGANIC ACID METABOLIC PROCESS,0.0001547,0.19318,0.21662,1,1
2,PID KITPATHWAY,0.0075304,0.19227,0.15692,1,1
2,REACTOME PKB MEDIATED EVENTS,0.00057693,0.19214,0.18177,1,1
2,MAINTENANCE OF CELLULAR LOCALIZATION,0.027188,0.19207,0.15405,1,1
2,PID CD8TCRPATHWAY,0.02068,0.19202,0.13999,1,1
2,REACTOME METABOLISM OF RNA,0.0017123,0.19168,0.19289,1,1
2,KEGG PRIMARY IMMUNODEFICIENCY,0.02268,0.19105,0.1337,1,1
2,NUCLEAR TRANSPORT,0.00017186,0.18982,0.19257,1,1
2,BIOCARTA CELL2CELL PATHWAY,0.011904,0.18948,0.20118,1,1
2,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.0036303,0.18938,0.16613,1,1
2,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.015203,0.18905,0.25004,1,1
2,REACTOME SIGNALING BY RHO GTPASES,0.0053338,0.18867,0.13198,1,1
2,KEGG CYSTEINE AND METHIONINE METABOLISM,0.0027346,0.18821,0.18968,1,1
2,PID CERAMIDE PATHWAY,0.0047853,0.18814,0.15566,1,1
2,BIOCARTA CERAMIDE PATHWAY,0.046579,0.18813,0.15919,1,1
2,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0001547,0.18759,0.18055,1,1
2,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.0037331,0.18717,0.19839,1,1
2,NUCLEAR PORE,1.0184e-05,0.18715,0.24693,1,1
2,MEMBRANE FUSION,0.0012662,0.18672,0.22856,1,1
2,VITAMIN METABOLIC PROCESS,0.0020453,0.18657,0.25272,1,1
2,VESICLE MEMBRANE,0.0031536,0.18549,0.14508,1,1
2,SOLUTE SODIUM SYMPORTER ACTIVITY,0.015203,0.18537,0.22894,1,1
2,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.004408,0.18536,0.14068,1,1
2,DNA HELICASE ACTIVITY,0.00012512,0.18526,0.19151,1,1
2,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0031536,0.18483,0.13907,1,1
2,MOLECULAR ADAPTOR ACTIVITY,0.0023671,0.18481,0.18904,1,1
2,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.00030804,0.1842,0.14805,1,1
2,REGULATION OF PROTEIN METABOLIC PROCESS,0.00038934,0.18315,0.14969,1,1
2,REACTOME TCR SIGNALING,0.00092958,0.18311,0.14337,1,1
2,DNA POLYMERASE ACTIVITY,0.00041602,0.18306,0.1767,1,1
2,PID RXR VDR PATHWAY,0.017969,0.18303,0.153,1,1
2,INTERPHASE OF MITOTIC CELL CYCLE,0.0010206,0.18285,0.14823,1,1
2,JAK STAT CASCADE,0.0085714,0.1826,0.17906,1,1
2,PORE COMPLEX,2.1663e-05,0.18253,0.23159,1,1
2,REACTOME IL1 SIGNALING,0.00045924,0.18251,0.19359,1,1
2,CELL SUBSTRATE ADHERENS JUNCTION,0.015203,0.18234,0.22489,1,1
2,BIOCARTA SARS PATHWAY,0.02166,0.18193,0.17807,1,1
2,ORGANELLE MEMBRANE,0.0001165,0.18176,0.13941,1,1
2,NUCLEOCYTOPLASMIC TRANSPORT,0.00018427,0.18058,0.19175,1,1
2,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.00026003,0.18004,0.1729,1,1
2,PID AR PATHWAY,0.00353,0.17984,0.20705,1,1
2,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.00028792,0.17928,0.17508,1,1
2,DNA REPLICATION INITIATION,0.00067758,0.17879,0.19419,1,1
2,ENDOPLASMIC RETICULUM PART,0.001872,0.17879,0.15127,1,1
2,REGULATION OF PH,0.036164,0.17681,0.15229,1,1
2,REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA,0.010773,0.17593,0.18124,1,1
2,BIOCARTA VIP PATHWAY,0.017549,0.17564,0.13834,1,1
2,BIOCARTA GH PATHWAY,0.0046564,0.17468,0.15816,1,1
2,POSITIVE REGULATION OF TRANSLATION,0.0015653,0.17451,0.14131,1,1
2,PROTEIN AMINO ACID ADP RIBOSYLATION,0.00018427,0.17441,0.25788,1,1
2,NUCLEAR ENVELOPE,2.4346e-05,0.17334,0.17088,1,1
2,VIRAL REPRODUCTIVE PROCESS,0.0064317,0.17302,0.13208,1,1
2,PROTEIN TARGETING,0.0017641,0.17273,0.14382,1,1
2,ORGANELLE ENVELOPE,4.4878e-05,0.17253,0.16437,1,1
2,ENVELOPE,4.4878e-05,0.17253,0.16437,1,1
2,KEGG NON HOMOLOGOUS END JOINING,0.03939,0.17196,0.13246,1,1
2,DOUBLE STRANDED RNA BINDING,0.00028792,0.17185,0.19646,1,1
2,DEFENSE RESPONSE TO BACTERIUM,0.00020448,0.17154,0.18756,1,1
2,REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES,0.017137,0.17117,0.10973,1,1
2,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,2.7343e-05,0.17059,0.14933,1,1
2,AROMATIC COMPOUND METABOLIC PROCESS,0.010245,0.16998,0.14484,1,1
2,BASAL LAMINA,0.02843,0.16967,0.24547,1,1
2,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.0099891,0.16937,0.11606,1,1
2,PROTEIN RNA COMPLEX ASSEMBLY,0.0049174,0.16907,0.16927,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.00026903,0.16905,0.20177,1,1
2,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.00031859,0.1687,0.16984,1,1
2,REACTOME RAF MAP KINASE CASCADE,0.012508,0.16828,0.11525,1,1
2,PID VEGFR1 2 PATHWAY,0.004408,0.16779,0.12543,1,1
2,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.0013054,0.16756,0.21103,1,1
2,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.0045306,0.16724,0.15435,1,1
2,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.00040247,0.16687,0.18479,1,1
2,KEGG FC EPSILON RI SIGNALING PATHWAY,0.0038387,0.16683,0.19673,1,1
2,PID ECADHERIN NASCENTAJ PATHWAY,0.043763,0.16662,0.14384,1,1
2,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.0016129,0.16586,0.13231,1,1
2,NUCLEAR HORMONE RECEPTOR BINDING,0.0010859,0.16526,0.12471,1,1
2,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.00074557,0.16426,0.17159,1,1
2,AMINO ACID CATABOLIC PROCESS,0.040234,0.16414,0.12557,1,1
2,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.024846,0.16398,0.1927,1,1
2,ENDOMEMBRANE SYSTEM,0.00021167,0.16397,0.13467,1,1
2,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.02268,0.16314,0.10313,1,1
2,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0033369,0.16306,0.13085,1,1
2,REACTOME HIV LIFE CYCLE,0.00095906,0.16281,0.12612,1,1
2,ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0010528,0.16264,0.19283,1,1
2,NEGATIVE REGULATION OF CELL ADHESION,0.012203,0.16236,0.22667,1,1
2,SPLICEOSOME,0.00019079,0.16207,0.19016,1,1
2,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.00044439,0.16197,0.18902,1,1
2,NITROGEN COMPOUND CATABOLIC PROCESS,0.026586,0.16183,0.14776,1,1
2,REACTOME S PHASE,0.0053338,0.16181,0.14456,1,1
2,KEGG PEROXISOME,0.0017123,0.16172,0.16545,1,1
2,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.00087311,0.16125,0.18043,1,1
2,KEGG HOMOLOGOUS RECOMBINATION,0.0010528,0.16058,0.16149,1,1
2,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.00026003,0.15989,0.15989,1,1
2,REACTOME M G1 TRANSITION,0.0071468,0.15952,0.14605,1,1
2,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.00031859,0.15929,0.18729,1,1
2,KEGG BASE EXCISION REPAIR,0.0053338,0.15868,0.14592,1,1
2,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.00069957,0.15845,0.15416,1,1
2,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.0087944,0.15787,0.11265,1,1
2,BIOCARTA ATRBRCA PATHWAY,0.031059,0.15784,0.13918,1,1
2,RAS GTPASE BINDING,0.00074557,0.15734,0.16124,1,1
2,KEGG PPAR SIGNALING PATHWAY,0.018836,0.15726,0.12106,1,1
2,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.0025817,0.15684,0.17958,1,1
2,KEGG VEGF SIGNALING PATHWAY,0.00081984,0.15668,0.15616,1,1
2,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.017549,0.15638,0.093829,1,1
2,ANTIGEN BINDING,0.010245,0.15585,0.14159,1,1
2,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.041967,0.15581,0.12807,1,1
2,BIOCARTA INTEGRIN PATHWAY,0.009256,0.15576,0.10565,1,1
2,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.0022992,0.1553,0.099335,1,1
2,PID RAC1 PATHWAY,0.0047853,0.15503,0.15006,1,1
2,SMALL GTPASE BINDING,0.0014299,0.1545,0.14107,1,1
2,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.00084609,0.15441,0.15119,1,1
2,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.00069957,0.15414,0.17348,1,1
2,REACTOME LATE PHASE OF HIV LIFE CYCLE,5.6174e-05,0.15374,0.15247,1,1
2,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.00095906,0.15359,0.13413,1,1
2,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.00087311,0.15353,0.12772,1,1
2,HORMONE RECEPTOR BINDING,0.00090094,0.15344,0.13272,1,1
2,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0039469,0.15317,0.10185,1,1
2,DNA DIRECTED DNA POLYMERASE ACTIVITY,0.00074557,0.15285,0.1614,1,1
2,REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS,0.00018427,0.15164,0.21464,1,1
2,PID TELOMERASEPATHWAY,0.00035231,0.1516,0.15966,1,1
2,BIOCARTA AKAP95 PATHWAY,0.038561,0.15157,0.16002,1,1
2,KEGG SPLICEOSOME,0.001662,0.15144,0.15182,1,1
2,REGULATION OF CELL MIGRATION,0.038561,0.15062,0.2021,1,1
2,PID NFKAPPABCANONICALPATHWAY,0.0066042,0.15022,0.17105,1,1
2,BIOCARTA BARRESTIN SRC PATHWAY,0.00098941,0.14999,0.25427,1,1
2,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0079323,0.1497,0.14384,1,1
2,GLUCOSAMINE METABOLIC PROCESS,0.044685,0.1494,0.10262,1,1
2,TRANSCRIPTION FACTOR COMPLEX,0.00095906,0.14931,0.12428,1,1
2,ENDOPLASMIC RETICULUM MEMBRANE,0.011612,0.14864,0.11856,1,1
2,KEGG ADHERENS JUNCTION,0.017969,0.14773,0.14494,1,1
2,LIPID METABOLIC PROCESS,0.0046564,0.14744,0.12198,1,1
2,ACID AMINO ACID LIGASE ACTIVITY,0.00090094,0.14736,0.1271,1,1
2,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.001191,0.14734,0.16698,1,1
2,PROTEIN N TERMINUS BINDING,6.4994e-06,0.14732,0.19807,1,1
2,RESPONSE TO BACTERIUM,0.00010092,0.14725,0.15497,1,1
2,REACTOME MRNA PROCESSING,0.00010462,0.14693,0.17065,1,1
2,REACTOME GLUCOSE TRANSPORT,0.0022992,0.14685,0.13429,1,1
2,STEROID HORMONE RECEPTOR BINDING,0.045624,0.14661,0.14492,1,1
2,REGULATION OF RHO GTPASE ACTIVITY,0.004408,0.14578,0.13786,1,1
2,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.00079435,0.14574,0.17003,1,1
2,CYTOPLASMIC VESICLE MEMBRANE,0.0099891,0.1457,0.11751,1,1
2,CYTOPLASMIC VESICLE PART,0.0099891,0.1457,0.11751,1,1
2,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.0036303,0.1453,0.1298,1,1
2,BIOCARTA MAL PATHWAY,0.014486,0.14472,0.086584,1,1
2,INTRACELLULAR PROTEIN TRANSPORT,0.0022332,0.14417,0.12432,1,1
2,REACTOME IMMUNE SYSTEM,0.0087944,0.14367,0.094159,1,1
2,DNA RECOMBINATION,0.00055855,0.14362,0.17207,1,1
2,RNA BINDING,0.0015189,0.1436,0.14562,1,1
2,PROTEIN HETERODIMERIZATION ACTIVITY,0.0020453,0.1433,0.1305,1,1
2,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.041093,0.1431,0.1241,1,1
2,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0094949,0.14259,0.11725,1,1
2,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.00054072,0.14257,0.16241,1,1
2,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.00021909,0.14189,0.20037,1,1
2,ST B CELL ANTIGEN RECEPTOR,0.0036303,0.14146,0.17204,1,1
2,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.0045306,0.14087,0.14656,1,1
2,MEDIATOR COMPLEX,0.0029794,0.14043,0.13167,1,1
2,NUCLEOTIDE EXCISION REPAIR,0.0050528,0.1385,0.1191,1,1
2,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.001872,0.13819,0.13481,1,1
2,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.0030654,0.1381,0.12474,1,1
2,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.001662,0.1379,0.11382,1,1
2,GTPASE BINDING,0.0018173,0.13728,0.1357,1,1
2,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.0079323,0.13614,0.10945,1,1
2,RNA EXPORT FROM NUCLEUS,0.00050664,0.1357,0.14342,1,1
2,BIOCARTA EDG1 PATHWAY,0.0067808,0.13538,0.14188,1,1
2,REGULATION OF GENE EXPRESSION,0.00098941,0.13525,0.10438,1,1
2,REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE,0.00098941,0.13524,0.16227,1,1
2,REACTOME MRNA 3 END PROCESSING,0.0079323,0.13471,0.15027,1,1
2,RNA POLYMERASE II TRANSCRIPTION MEDIATOR ACTIVITY,0.001872,0.13399,0.16961,1,1
2,BIOCARTA BARR MAPK PATHWAY,0.014841,0.13391,0.16677,1,1
2,REACTOME PROCESSING OF INTRONLESS PRE MRNAS,0.024288,0.13368,0.12166,1,1
2,PID FOXM1PATHWAY,0.024846,0.13368,0.14169,1,1
2,GOLGI VESICLE TRANSPORT,0.0041716,0.13302,0.1411,1,1
2,SUGAR BINDING,0.00090094,0.13186,0.1737,1,1
2,REGULATION OF RNA METABOLIC PROCESS,0.00040247,0.13133,0.11698,1,1
2,BIOCARTA EIF4 PATHWAY,0.015574,0.1313,0.11032,1,1
2,REACTOME PHOSPHOLIPID METABOLISM,0.0047853,0.13127,0.10117,1,1
2,HOMEOSTASIS OF NUMBER OF CELLS,0.015574,0.13114,0.14436,1,1
2,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.0099891,0.13086,0.093407,1,1
2,BIOCARTA HCMV PATHWAY,0.0064317,0.1307,0.14859,1,1
2,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,1.7474e-06,0.13053,0.14891,1,1
2,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.00095906,0.12956,0.13135,1,1
2,METHYLTRANSFERASE ACTIVITY,0.00084609,0.12934,0.13562,1,1
2,REACTOME HIV INFECTION,0.00026903,0.12877,0.14318,1,1
2,REACTOME NOD1 2 SIGNALING PATHWAY,0.016339,0.12861,0.14029,1,1
2,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.029068,0.12853,0.091126,1,1
2,REACTOME SOS MEDIATED SIGNALLING,0.012508,0.12784,0.10933,1,1
2,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.00044439,0.12769,0.11465,1,1
2,POSITIVE REGULATION OF METABOLIC PROCESS,0.00087311,0.12759,0.12825,1,1
2,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.026586,0.1274,0.12462,1,1
2,RIBONUCLEOPROTEIN COMPLEX,0.00021167,0.12717,0.15342,1,1
2,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.0056288,0.12663,0.098781,1,1
2,PID DNAPK PATHWAY,0.030383,0.12557,0.1047,1,1
2,REGULATION OF LYMPHOCYTE ACTIVATION,0.017969,0.12539,0.098861,1,1
2,KEGG RNA DEGRADATION,0.00026003,0.12527,0.165,1,1
2,REACTOME MRNA CAPPING,0.0062634,0.12525,0.10077,1,1
2,PID HIF1APATHWAY,0.02166,0.12304,0.16822,1,1
2,REGULATION OF CATABOLIC PROCESS,0.0051916,0.12266,0.13013,1,1
2,BIOCARTA FMLP PATHWAY,0.0022992,0.12241,0.119,1,1
2,REACTOME PI METABOLISM,0.0019282,0.12239,0.13697,1,1
2,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.0021062,0.12236,0.12091,1,1
2,REGULATION OF CELLULAR METABOLIC PROCESS,0.0011199,0.12148,0.099162,1,1
2,KEGG ENDOMETRIAL CANCER,0.037747,0.12143,0.11791,1,1
2,REACTOME RNA POL II TRANSCRIPTION,0.0011199,0.1211,0.12797,1,1
2,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.014486,0.12074,0.1277,1,1
2,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.02268,0.12003,0.15266,1,1
2,REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND,0.0040578,0.11987,0.18598,1,1
2,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.0090226,0.11976,0.11592,1,1
2,REACTOME MRNA SPLICING,0.0012662,0.11909,0.14722,1,1
2,REGULATION OF METABOLIC PROCESS,0.0015189,0.11853,0.097151,1,1
2,RNA PROCESSING,0.0013457,0.11838,0.13548,1,1
2,KEGG RNA POLYMERASE,0.045624,0.11792,0.10898,1,1
2,ENDOPLASMIC RETICULUM,0.034637,0.11771,0.073261,1,1
2,ORGANELLE LUMEN,4.1617e-05,0.11697,0.12473,1,1
2,MEMBRANE ENCLOSED LUMEN,4.1617e-05,0.11697,0.12473,1,1
2,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.02166,0.11693,0.081768,1,1
2,PROTEIN TRANSPORT,0.0042883,0.11543,0.10749,1,1
2,MITOTIC CELL CYCLE,0.012203,0.11506,0.10056,1,1
2,RNA SPLICING,0.00041602,0.11498,0.14775,1,1
2,MUSCLE DEVELOPMENT,0.026586,0.11475,0.10827,1,1
2,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.023205,0.11342,0.07781,1,1
2,MACROMOLECULAR COMPLEX ASSEMBLY,0.0029794,0.11229,0.091149,1,1
2,PID P53REGULATIONPATHWAY,0.0011199,0.10907,0.11676,1,1
2,PERINUCLEAR REGION OF CYTOPLASM,0.0056288,0.10901,0.12948,1,1
2,PID FCER1PATHWAY,0.011612,0.10843,0.12558,1,1
2,CYTOSOL,0.012508,0.10662,0.093441,1,1
2,RECEPTOR MEDIATED ENDOCYTOSIS,0.027803,0.10606,0.098466,1,1
2,ENZYME ACTIVATOR ACTIVITY,0.001986,0.10576,0.14379,1,1
2,HISTONE DEACETYLASE COMPLEX,0.016734,0.10441,0.11934,1,1
2,REACTOME GLOBAL GENOMIC NER GG NER,0.011904,0.10438,0.086063,1,1
2,NUCLEAR EXPORT,0.0051916,0.10403,0.11312,1,1
2,GOLGI ASSOCIATED VESICLE,0.027188,0.10388,0.12081,1,1
2,REGULATION OF TRANSCRIPTION,0.0069616,0.10351,0.093351,1,1
2,ADENYL NUCLEOTIDE BINDING,0.0081404,0.10347,0.081501,1,1
2,PID HDAC CLASSI PATHWAY,0.0025083,0.10282,0.09425,1,1
2,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.011612,0.10263,0.089164,1,1
2,INTRACELLULAR TRANSPORT,0.00022676,0.1026,0.12038,1,1
2,THYROID HORMONE RECEPTOR BINDING,0.018398,0.10178,0.12617,1,1
2,DNA INTEGRITY CHECKPOINT,0.016339,0.10171,0.11639,1,1
2,CELL CYCLE GO 0007049,0.0014738,0.10148,0.10071,1,1
2,PROTEIN METABOLIC PROCESS,0.010506,0.10133,0.076096,1,1
2,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.024288,0.10124,0.11199,1,1
2,INTERPHASE,0.0073363,0.10101,0.11517,1,1
2,NUCLEAR PART,0.00013433,0.099583,0.10998,1,1
2,PID RB 1PATHWAY,0.041093,0.099448,0.089133,1,1
2,REGULATION OF CELL CYCLE,0.00012964,0.09932,0.13521,1,1
2,RNA METABOLIC PROCESS,9.7346e-05,0.099311,0.10902,1,1
2,ST GA12 PATHWAY,0.03939,0.09929,0.11885,1,1
2,CELLULAR PROTEIN CATABOLIC PROCESS,0.0097392,0.099242,0.10889,1,1
2,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0045306,0.099194,0.090505,1,1
2,ACETYLTRANSFERASE ACTIVITY,0.0045306,0.098967,0.14673,1,1
2,PID PDGFRBPATHWAY,0.015953,0.098628,0.092868,1,1
2,RNA BIOSYNTHETIC PROCESS,0.0021062,0.098513,0.098984,1,1
2,REACTOME SIGNALING BY FGFR MUTANTS,0.015953,0.09794,0.14814,1,1
2,POSITIVE REGULATION OF DNA BINDING,0.045624,0.097578,0.089378,1,1
2,CERAMIDE METABOLIC PROCESS,0.010773,0.097341,0.1409,1,1
2,TRANSCRIPTION DNA DEPENDENT,0.0021689,0.097251,0.09864,1,1
2,CARBOHYDRATE BINDING,0.027188,0.097181,0.10667,1,1
2,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.014138,0.096754,0.10857,1,1
2,CELLULAR COMPONENT ASSEMBLY,0.00353,0.096455,0.09067,1,1
2,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.03939,0.096429,0.11512,1,1
2,CELLULAR PROTEIN METABOLIC PROCESS,0.009256,0.095363,0.074585,1,1
2,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.0039469,0.095095,0.141,1,1
2,REACTOME SPRY REGULATION OF FGF SIGNALING,0.0025083,0.094391,0.18044,1,1
2,NUCLEOPLASM PART,0.0001547,0.093239,0.10152,1,1
2,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.0099891,0.092307,0.083177,1,1
2,KEGG NUCLEOTIDE EXCISION REPAIR,0.027803,0.089399,0.075197,1,1
2,ORGANELLE PART,0.00030804,0.08887,0.084322,1,1
2,INTRACELLULAR ORGANELLE PART,0.00027832,0.088842,0.084986,1,1
2,ADENYL RIBONUCLEOTIDE BINDING,0.0099891,0.08835,0.080798,1,1
2,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.010506,0.088236,0.071742,1,1
2,ATP BINDING,0.03939,0.087686,0.060607,1,1
2,KEGG ERBB SIGNALING PATHWAY,0.0083534,0.086588,0.10574,1,1
2,KEGG BASAL TRANSCRIPTION FACTORS,0.0024367,0.086511,0.13709,1,1
2,PID PS1PATHWAY,0.022165,0.086444,0.095573,1,1
2,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.0053338,0.085481,0.090614,1,1
2,MACROMOLECULE LOCALIZATION,0.033166,0.085243,0.071843,1,1
2,TRANSCRIPTION,0.010773,0.084646,0.083103,1,1
2,MRNA METABOLIC PROCESS,0.017137,0.083271,0.098341,1,1
2,RHYTHMIC PROCESS,0.043763,0.081643,0.066124,1,1
2,CHROMATIN REMODELING,0.025994,0.08123,0.13708,1,1
2,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.00057693,0.080344,0.08839,1,1
2,PROTEIN CATABOLIC PROCESS,0.0029794,0.079992,0.11056,1,1
2,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.018836,0.078898,0.077769,1,1
2,BIOPOLYMER METABOLIC PROCESS,0.0007696,0.077304,0.079824,1,1
2,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.0017641,0.076867,0.14051,1,1
2,CELL CYCLE PHASE,0.02843,0.075843,0.080156,1,1
2,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0014738,0.071676,0.14984,1,1
2,NUCLEOPLASM,0.00095906,0.071336,0.091347,1,1
2,PID ANGIOPOIETINRECEPTOR PATHWAY,0.022165,0.069294,0.13162,1,1
2,PURINE RIBONUCLEOTIDE BINDING,0.044685,0.068427,0.058098,1,1
2,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.043763,0.067487,0.074667,1,1
2,NUCLEUS,0.00090094,0.067417,0.078782,1,1
2,ORGANELLE ORGANIZATION AND BIOGENESIS,0.017549,0.067029,0.061768,1,1
2,PURINE NUCLEOTIDE BINDING,0.042857,0.063343,0.059351,1,1
2,PID MET PATHWAY,0.03939,0.061223,0.090812,1,1
2,CHROMATIN MODIFICATION,0.036164,0.061223,0.064436,1,1
2,RESPONSE TO ENDOGENOUS STIMULUS,0.024846,0.051901,0.079415,1,1
2,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.017969,0.52938,0.39014,1,0
2,KEGG ASTHMA,0.00042998,0.48653,0.32956,1,0
2,FATTY ACID BETA OXIDATION,0.00017186,0.45838,0.4356,1,0
2,KEGG GRAFT VERSUS HOST DISEASE,0.0056288,0.44308,0.35138,1,0
2,KEGG VALINE LEUCINE AND ISOLEUCINE BIOSYNTHESIS,0.0056288,0.43811,0.35485,1,0
2,KEGG AUTOIMMUNE THYROID DISEASE,0.018836,0.41821,0.25935,1,0
2,EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX,0.0023671,0.38453,0.38157,1,0
2,KEGG FATTY ACID METABOLISM,2.4346e-05,0.3713,0.34335,1,0
2,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.0034322,0.36018,0.26612,1,0
2,REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS,0.0045306,0.355,0.40489,1,0
2,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,6.5149e-05,0.33516,0.32659,1,0
2,HEME METABOLIC PROCESS,0.00098941,0.32774,0.32215,1,0
2,FATTY ACID OXIDATION,0.0085714,0.32549,0.26235,1,0
2,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.0023671,0.3103,0.36371,1,0
2,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.037747,0.306,0.24646,1,0
2,PROTEIN TARGETING TO MITOCHONDRION,0.0097392,0.29937,0.24249,1,0
2,BIOCARTA IL10 PATHWAY,0.015574,0.29829,0.25942,1,0
2,KEGG SELENOAMINO ACID METABOLISM,0.00021909,0.29573,0.26875,1,0
2,REACTOME TRNA AMINOACYLATION,0.0024367,0.27365,0.25933,1,0
2,REACTOME PD1 SIGNALING,0.0064317,0.27283,0.20519,1,0
2,REACTOME ER PHAGOSOME PATHWAY,0.0050528,0.26817,0.24446,1,0
2,KEGG ONE CARBON POOL BY FOLATE,0.001662,0.26162,0.33538,1,0
2,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.015203,0.25666,0.20594,1,0
2,TRANS GOLGI NETWORK TRANSPORT VESICLE,0.0017123,0.25606,0.26655,1,0
2,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.041967,0.25428,0.20448,1,0
2,KEGG CITRATE CYCLE TCA CYCLE,0.00074557,0.241,0.28956,1,0
2,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.012508,0.23688,0.19155,1,0
2,PID MYC ACTIVPATHWAY,0.001662,0.23238,0.21351,1,0
2,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.0007696,0.23168,0.18995,1,0
2,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.038561,0.23046,0.17143,1,0
2,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.0010859,0.23038,0.2187,1,0
2,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.0094949,0.22871,0.24232,1,0
2,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.029068,0.22523,0.13751,1,0
2,LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS,0.025994,0.22158,0.2561,1,0
2,COENZYME BINDING,0.0066042,0.22134,0.28938,1,0
2,PID A6B1 A6B4 INTEGRIN PATHWAY,0.0042883,0.21958,0.32666,1,0
2,REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE,0.0097392,0.21855,0.26883,1,0
2,ORGANELLAR RIBOSOME,0.010245,0.21624,0.2076,1,0
2,MITOCHONDRIAL RIBOSOME,0.010245,0.21624,0.2076,1,0
2,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.016734,0.21433,0.14577,1,0
2,REACTOME DOWNSTREAM TCR SIGNALING,0.0060989,0.21255,0.15156,1,0
2,IMMUNE SYSTEM DEVELOPMENT,0.0034322,0.2087,0.15481,1,0
2,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.017969,0.20846,0.18273,1,0
2,HETEROCYCLE METABOLIC PROCESS,0.0014299,0.20759,0.26857,1,0
2,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.0036303,0.20717,0.2267,1,0
2,REGULATION OF ANGIOGENESIS,0.0073363,0.20711,0.23918,1,0
2,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.026586,0.20414,0.17379,1,0
2,REACTOME PURINE METABOLISM,0.0022332,0.20354,0.26953,1,0
2,CELLULAR BIOSYNTHETIC PROCESS,0.0011549,0.20216,0.18297,1,0
2,MITOCHONDRIAL PART,0.00087311,0.19783,0.19352,1,0
2,PID AVB3 INTEGRIN PATHWAY,0.024288,0.19765,0.15904,1,0
2,REACTOME INTERFERON SIGNALING,0.026586,0.19666,0.13694,1,0
2,NEGATIVE REGULATION OF APOPTOSIS,0.0033369,0.19588,0.14048,1,0
2,PROTEIN TYROSINE KINASE ACTIVITY,0.013798,0.19218,0.17477,1,0
2,RIBOSOMAL SUBUNIT,0.016734,0.19206,0.18789,1,0
2,ENDONUCLEASE ACTIVITY GO 0016893,0.00087311,0.19204,0.20177,1,0
2,TRANSLATION,0.0039469,0.19171,0.20437,1,0
2,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.024288,0.19154,0.20629,1,0
2,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.0031536,0.19056,0.15268,1,0
2,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.012508,0.19002,0.15802,1,0
2,RESPONSE TO TEMPERATURE STIMULUS,0.0014738,0.18724,0.24679,1,0
2,GROWTH FACTOR ACTIVITY,0.019283,0.1866,0.1395,1,0
2,REACTOME METABOLISM OF NUCLEOTIDES,0.0032441,0.18359,0.18299,1,0
2,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.0047853,0.18273,0.16516,1,0
2,ELECTRON CARRIER ACTIVITY,0.0062634,0.18258,0.16811,1,0
2,REACTOME METABOLISM OF MRNA,0.0039469,0.18221,0.18792,1,0
2,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.0059384,0.18045,0.13568,1,0
2,TRANSLATIONAL INITIATION,0.0031536,0.17742,0.21483,1,0
2,REACTOME PURINE SALVAGE,0.021165,0.17311,0.25517,1,0
2,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.0090226,0.17154,0.12022,1,0
2,BASOLATERAL PLASMA MEMBRANE,0.017549,0.17125,0.17507,1,0
2,PID TCR PATHWAY,0.0046564,0.17118,0.17492,1,0
2,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.010506,0.17063,0.13989,1,0
2,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.026586,0.17061,0.20306,1,0
2,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.012508,0.17036,0.17076,1,0
2,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.022165,0.17027,0.1864,1,0
2,REACTOME COLLAGEN FORMATION,0.020205,0.16974,0.22458,1,0
2,HEMOPOIESIS,0.0097392,0.16965,0.12911,1,0
2,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.034637,0.16842,0.10557,1,0
2,AMINO ACID METABOLIC PROCESS,0.0017123,0.16836,0.19447,1,0
2,REACTOME MTORC1 MEDIATED SIGNALLING,0.01282,0.16728,0.20577,1,0
2,REACTOME METABOLISM OF NON CODING RNA,0.0011199,0.16722,0.19077,1,0
2,BIOCARTA VEGF PATHWAY,0.0029794,0.16685,0.13921,1,0
2,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.023741,0.16421,0.14159,1,0
2,ATP DEPENDENT HELICASE ACTIVITY,0.00095906,0.16288,0.17267,1,0
2,MITOCHONDRIAL MEMBRANE,0.0028957,0.16088,0.16518,1,0
2,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.041093,0.1602,0.17478,1,0
2,MICROBODY,0.0057817,0.15997,0.14546,1,0
2,PEROXISOME,0.0057817,0.15997,0.14546,1,0
2,MITOCHONDRIAL ENVELOPE,0.0013054,0.15697,0.17069,1,0
2,REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE,0.011326,0.15666,0.21119,1,0
2,STRUCTURAL MOLECULE ACTIVITY,0.010506,0.15566,0.15076,1,0
2,REGULATION OF TRANSLATIONAL INITIATION,0.017549,0.15545,0.17727,1,0
2,REACTOME GLUCOSE METABOLISM,0.013465,0.15483,0.15493,1,0
2,KEGG LEISHMANIA INFECTION,0.0050528,0.15261,0.15946,1,0
2,KEGG HEMATOPOIETIC CELL LINEAGE,0.0041716,0.15173,0.12965,1,0
2,REGULATION OF T CELL PROLIFERATION,0.019283,0.14963,0.14305,1,0
2,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0087944,0.14429,0.11647,1,0
2,GOLGI MEMBRANE,0.027188,0.14352,0.11893,1,0
2,KEGG RIBOFLAVIN METABOLISM,0.033166,0.14325,0.086707,1,0
2,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.0069616,0.1429,0.11783,1,0
2,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.040234,0.14274,0.088776,1,0
2,ORGANELLE INNER MEMBRANE,0.0085714,0.14246,0.12946,1,0
2,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.036948,0.14134,0.12734,1,0
2,REACTOME DOUBLE STRAND BREAK REPAIR,0.045624,0.1412,0.12228,1,0
2,PID ILK PATHWAY,0.013139,0.14031,0.11526,1,0
2,MULTI ORGANISM PROCESS,0.029068,0.1401,0.084944,1,0
2,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.041093,0.13598,0.090908,1,0
2,REACTOME METABOLISM OF POLYAMINES,0.038561,0.13553,0.12649,1,0
2,MITOCHONDRIAL INNER MEMBRANE,0.015574,0.13465,0.13448,1,0
2,RHO PROTEIN SIGNAL TRANSDUCTION,0.040234,0.13403,0.12836,1,0
2,REACTOME CELL CYCLE CHECKPOINTS,0.0057817,0.13358,0.13941,1,0
2,RAS PROTEIN SIGNAL TRANSDUCTION,0.029719,0.13332,0.12296,1,0
2,REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY,0.00010092,0.13268,0.22405,1,0
2,ATP DEPENDENT DNA HELICASE ACTIVITY,0.007729,0.13065,0.18909,1,0
2,REGULATION OF CELL DIFFERENTIATION,0.0087944,0.12997,0.16972,1,0
2,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.0087944,0.1299,0.16578,1,0
2,PID IL4 2PATHWAY,0.0041716,0.12901,0.19471,1,0
2,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.034637,0.1289,0.11143,1,0
2,GTPASE ACTIVATOR ACTIVITY,0.013465,0.12874,0.17312,1,0
2,DEFENSE RESPONSE,0.037747,0.12827,0.074029,1,0
2,INFLAMMATORY RESPONSE,0.045624,0.12804,0.092734,1,0
2,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,0.017137,0.12774,0.13167,1,0
2,PEROXISOME ORGANIZATION AND BIOGENESIS,0.017137,0.12713,0.13411,1,0
2,SIGNAL SEQUENCE BINDING,0.025414,0.12683,0.13162,1,0
2,CYTOKINE BINDING,0.041967,0.12484,0.099598,1,0
2,REACTOME INTRINSIC PATHWAY,0.02068,0.12328,0.16792,1,0
2,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.00353,0.12027,0.099821,1,0
2,POSITIVE REGULATION OF CELL PROLIFERATION,0.0079323,0.11931,0.10197,1,0
2,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.0094949,0.1189,0.17117,1,0
2,MITOCHONDRION,0.001662,0.11862,0.14189,1,0
2,KEGG FOCAL ADHESION,0.013798,0.11779,0.14662,1,0
2,VIRAL INFECTIOUS CYCLE,0.020205,0.11775,0.10583,1,0
2,EPIDERMIS DEVELOPMENT,0.02166,0.11748,0.20328,1,0
2,PID ARF 3PATHWAY,0.023741,0.11638,0.089441,1,0
2,BIOCARTA ACTINY PATHWAY,0.013139,0.11619,0.15832,1,0
2,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.017549,0.11599,0.14722,1,0
2,REACTOME INNATE IMMUNE SYSTEM,0.031059,0.11519,0.081493,1,0
2,KEGG NOTCH SIGNALING PATHWAY,0.047551,0.11496,0.090387,1,0
2,PHOSPHOLIPASE ACTIVITY,0.030383,0.11391,0.10408,1,0
2,NUCLEOLAR PART,0.017549,0.11347,0.17349,1,0
2,REACTOME NUCLEOTIDE EXCISION REPAIR,0.0094949,0.11305,0.084375,1,0
2,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.043763,0.1125,0.16768,1,0
2,PROTEIN COMPLEX ASSEMBLY,0.027803,0.11155,0.080963,1,0
2,REGULATION OF MITOSIS,0.047551,0.11051,0.085061,1,0
2,RNA CATABOLIC PROCESS,0.019739,0.11043,0.15294,1,0
2,PID IL12 2PATHWAY,0.036164,0.10916,0.076855,1,0
2,PID P73PATHWAY,0.033166,0.10785,0.10903,1,0
2,CELL PROLIFERATION GO 0008283,0.017549,0.1062,0.076533,1,0
2,KEGG BLADDER CANCER,0.011612,0.10556,0.16461,1,0
2,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.019283,0.10515,0.1328,1,0
2,PROTEIN FOLDING,0.0097392,0.10495,0.14269,1,0
2,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.024846,0.1049,0.094234,1,0
2,REACTOME METABOLISM OF PROTEINS,0.044685,0.10473,0.10057,1,0
2,LIPASE ACTIVITY,0.043763,0.10414,0.08512,1,0
2,CELLULAR LIPID METABOLIC PROCESS,0.041093,0.10345,0.083502,1,0
2,MACROMOLECULE BIOSYNTHETIC PROCESS,0.020205,0.10214,0.099866,1,0
2,PID BCR 5PATHWAY,0.027803,0.10209,0.094842,1,0
2,KEGG REGULATION OF ACTIN CYTOSKELETON,0.041967,0.10077,0.10122,1,0
2,REGULATION OF APOPTOSIS,0.026586,0.09938,0.089152,1,0
2,POSITIVE REGULATION OF TRANSCRIPTION,0.016339,0.097767,0.12552,1,0
2,REGULATION OF PROGRAMMED CELL DEATH,0.031059,0.097271,0.087191,1,0
2,CYTOPLASMIC PART,0.025414,0.097125,0.061886,1,0
2,BIOCARTA SALMONELLA PATHWAY,0.046579,0.095892,0.13144,1,0
2,NUCLEOLUS,0.0030654,0.095406,0.14636,1,0
2,CYTOPLASM,0.0079323,0.095385,0.072863,1,0
2,NITROGEN COMPOUND METABOLIC PROCESS,0.027803,0.094524,0.093511,1,0
2,BIOSYNTHETIC PROCESS,0.010245,0.094452,0.10381,1,0
2,REACTOME DNA REPAIR,0.023741,0.093683,0.068038,1,0
2,REACTOME G1 S TRANSITION,0.025994,0.09273,0.10773,1,0
2,ECTODERM DEVELOPMENT,0.041093,0.091951,0.17951,1,0
2,REACTOME METABOLISM OF CARBOHYDRATES,0.043763,0.089345,0.091667,1,0
2,KEGG GLIOMA,0.033894,0.089186,0.08823,1,0
2,REACTOME TOLL RECEPTOR CASCADES,0.03245,0.088223,0.075221,1,0
2,REACTOME SYNTHESIS OF DNA,0.041093,0.087095,0.096809,1,0
2,REACTOME MITOTIC G1 G1 S PHASES,0.035393,0.086125,0.095611,1,0
2,POSITIVE REGULATION OF CELLULAR PROCESS,0.029719,0.085964,0.083117,1,0
2,BIOPOLYMER CATABOLIC PROCESS,0.0013457,0.085169,0.11166,1,0
2,REACTOME REGULATORY RNA PATHWAYS,0.011612,0.083929,0.11804,1,0
2,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0083534,0.081738,0.10468,1,0
2,KEGG HUNTINGTONS DISEASE,0.021165,0.08087,0.084678,1,0
2,REACTOME MITOTIC M M G1 PHASES,0.036164,0.078465,0.096636,1,0
2,REACTOME SIGNALING BY ILS,0.02268,0.074468,0.12058,1,0
2,MACROMOLECULE CATABOLIC PROCESS,0.0042883,0.074107,0.10398,1,0
2,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.020205,0.06875,0.069207,1,0
2,MACROMOLECULAR COMPLEX,0.0025083,0.068696,0.068683,1,0
2,PROTEIN AMINO ACID PHOSPHORYLATION,0.013139,0.068449,0.077013,1,0
2,KEGG PANCREATIC CANCER,0.027188,0.064021,0.099106,1,0
2,POST TRANSLATIONAL PROTEIN MODIFICATION,0.018398,0.063905,0.069498,1,0
2,PROTEIN COMPLEX,0.014486,0.060821,0.056241,1,0
2,PROTEIN DIMERIZATION ACTIVITY,0.033894,0.043513,0.080665,1,0
2,GTPASE ACTIVITY,0.017549,-0.072477,-0.098351,1,0
2,BIOCARTA TCRA PATHWAY,0.027188,-0.077072,-0.17942,1,0
2,REACTOME GPCR LIGAND BINDING,0.013465,-0.079497,-0.091846,1,0
2,MICROTUBULE ORGANIZING CENTER,0.027803,-0.088774,-0.071163,1,0
2,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.010773,-0.090165,-0.096191,1,0
2,CELL CELL ADHESION,0.029068,-0.093188,-0.13445,1,0
2,KINASE BINDING,0.0036303,-0.096697,-0.11752,1,0
2,CELL PROJECTION,0.0051916,-0.099861,-0.13312,1,0
2,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.031059,-0.10375,-0.074445,1,0
2,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.043763,-0.10421,-0.079008,1,0
2,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0087944,-0.10601,-0.10848,1,0
2,MAPKKK CASCADE GO 0000165,0.016734,-0.10643,-0.12539,1,0
2,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.036164,-0.10926,-0.090293,1,0
2,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.01282,-0.10967,-0.11559,1,0
2,REACTOME DIABETES PATHWAYS,0.0097392,-0.11561,-0.1139,1,0
2,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024846,-0.1168,-0.095293,1,0
2,SECOND MESSENGER MEDIATED SIGNALING,0.0010528,-0.11724,-0.13778,1,0
2,REACTOME L1CAM INTERACTIONS,0.03939,-0.11896,-0.12623,1,0
2,SECRETION,0.0016129,-0.12308,-0.17432,1,0
2,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02068,-0.12562,-0.1822,1,0
2,REACTOME RECYCLING PATHWAY OF L1,0.023205,-0.12612,-0.15026,1,0
2,POLYSACCHARIDE METABOLIC PROCESS,0.0038387,-0.12742,-0.18731,1,0
2,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.010245,-0.12869,-0.17352,1,0
2,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.0097392,-0.13113,-0.15469,1,0
2,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0099891,-0.1319,-0.13646,1,0
2,NEURON PROJECTION,0.033166,-0.13815,-0.2269,1,0
2,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.0081404,-0.13862,-0.16716,1,0
2,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.023205,-0.14385,-0.24069,1,0
2,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.038561,-0.14718,-0.19822,1,0
2,MICROTUBULE CYTOSKELETON,0.00072223,-0.14917,-0.14472,1,0
2,PID REG GR PATHWAY,0.015574,-0.14965,-0.098606,1,0
2,MICROTUBULE BINDING,0.0011199,-0.15056,-0.20204,1,0
2,REACTOME ION CHANNEL TRANSPORT,0.0051916,-0.15258,-0.17297,1,0
2,SPHINGOLIPID METABOLIC PROCESS,0.0064317,-0.15429,-0.18317,1,0
2,PID S1P S1P4 PATHWAY,0.021165,-0.15621,-0.21347,1,0
2,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.027188,-0.15734,-0.13597,1,0
2,NUCLEAR SPECK,0.0057817,-0.15745,-0.17216,1,0
2,ION TRANSPORT,0.0028957,-0.16242,-0.14419,1,0
2,TUBULIN BINDING,0.0013054,-0.16304,-0.17333,1,0
2,MOTOR ACTIVITY,0.014486,-0.16731,-0.16929,1,0
2,PID REELINPATHWAY,0.015574,-0.16818,-0.1796,1,0
2,NEUROGENESIS,0.012508,-0.17006,-0.16466,1,0
2,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.0034322,-0.17271,-0.16402,1,0
2,SYNAPSE PART,0.018836,-0.17341,-0.20053,1,0
2,FEEDING BEHAVIOR,0.0013054,-0.17429,-0.19146,1,0
2,NEUROPEPTIDE BINDING,0.026586,-0.17505,-0.18658,1,0
2,NEUROPEPTIDE RECEPTOR ACTIVITY,0.026586,-0.17505,-0.18658,1,0
2,REACTOME SIGNALING BY NOTCH4,0.029719,-0.17579,-0.15207,1,0
2,BIOCARTA NGF PATHWAY,0.02166,-0.17628,-0.14066,1,0
2,BIOCARTA IL2 PATHWAY,0.036948,-0.17752,-0.14523,1,0
2,REACTOME CTLA4 INHIBITORY SIGNALING,0.011612,-0.17793,-0.14056,1,0
2,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.007729,-0.18101,-0.22715,1,0
2,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.011612,-0.18624,-0.18324,1,0
2,SIG CD40PATHWAYMAP,0.00016023,-0.18671,-0.20458,1,0
2,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0014738,-0.18673,-0.14235,1,0
2,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.0011549,-0.187,-0.18917,1,0
2,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.011612,-0.18979,-0.19349,1,0
2,REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS,0.033894,-0.19174,-0.2533,1,0
2,REACTOME G ALPHA S SIGNALLING EVENTS,0.0001547,-0.19253,-0.19559,1,0
2,PID S1P META PATHWAY,0.013139,-0.19556,-0.19148,1,0
2,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00012074,-0.19608,-0.21244,1,0
2,CAMP MEDIATED SIGNALING,2.7343e-05,-0.19772,-0.24412,1,0
2,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.00098941,-0.19784,-0.18317,1,0
2,NEUROTRANSMITTER BINDING,0.009256,-0.19866,-0.19418,1,0
2,KEGG TYPE II DIABETES MELLITUS,0.0085714,-0.19983,-0.16265,1,0
2,REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,0.010245,-0.20148,-0.2534,1,0
2,REACTOME CGMP EFFECTS,0.0054795,-0.20159,-0.19249,1,0
2,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0015189,-0.20214,-0.17637,1,0
2,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0097392,-0.20404,-0.19674,1,0
2,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,4.0073e-05,-0.20541,-0.24078,1,0
2,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,4.8379e-05,-0.20651,-0.21737,1,0
2,BIOCARTA CDK5 PATHWAY,0.0034322,-0.20966,-0.24373,1,0
2,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.0085714,-0.20983,-0.225,1,0
2,GENERATION OF NEURONS,0.0022992,-0.21176,-0.22284,1,0
2,PID P38 MKK3 6PATHWAY,0.010773,-0.21923,-0.1739,1,0
2,REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.023205,-0.22398,-0.28271,1,0
2,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00044439,-0.22748,-0.18107,1,0
2,REGULATION OF MEMBRANE POTENTIAL,0.001986,-0.22897,-0.25134,1,0
2,GLUTAMATE SIGNALING PATHWAY,0.024288,-0.23113,-0.21526,1,0
2,SH2 DOMAIN BINDING,0.012508,-0.23767,-0.21461,1,0
2,BIOCARTA ETS PATHWAY,0.0013872,-0.24377,-0.26845,1,0
2,SECRETORY GRANULE,0.041093,-0.24975,-0.17897,1,0
2,MICROTUBULE MOTOR ACTIVITY,0.0016129,-0.25899,-0.28332,1,0
2,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.00081984,-0.26297,-0.26521,1,0
2,LIGAND GATED CHANNEL ACTIVITY,1.5201e-05,-0.27217,-0.30329,1,0
2,PID S1P S1P2 PATHWAY,0.00028792,-0.27389,-0.27042,1,0
2,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0023671,-0.27825,-0.31908,1,0
2,CATION TRANSPORT,0.00019079,-0.27928,-0.21214,1,0
2,ANCHORED TO MEMBRANE,0.015203,-0.28646,-0.31263,1,0
2,ANCHORED TO PLASMA MEMBRANE,0.015203,-0.28646,-0.31263,1,0
2,REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN,0.014841,-0.30082,-0.28405,1,0
2,METAL ION TRANSPORT,0.00028792,-0.30299,-0.22599,1,0
2,MICROTUBULE ASSOCIATED COMPLEX,4.1112e-06,-0.31473,-0.38694,1,0
2,NICOTINIC ACETYLCHOLINE GATED RECEPTOR CHANNEL COMPLEX,0.0034322,-0.31778,-0.39721,1,0
2,NICOTINIC ACETYLCHOLINE ACTIVATED CATION SELECTIVE CHANNEL ACTIVITY,0.0034322,-0.31778,-0.39721,1,0
2,REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.0017641,-0.31943,-0.4199,1,0
2,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.0012662,-0.3222,-0.25431,1,0
2,IMMUNOLOGICAL SYNAPSE,0.0040578,-0.32264,-0.27704,1,0
2,BIOCARTA ARENRF2 PATHWAY,0.0059384,-0.3241,-0.31424,1,0
2,REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS,0.0059384,-0.32508,-0.31239,1,0
2,POTASSIUM ION TRANSPORT,0.001872,-0.33579,-0.28125,1,0
2,REACTOME GABA RECEPTOR ACTIVATION,0.00012074,-0.34885,-0.34323,1,0
2,REACTOME REGULATION OF INSULIN SECRETION,2.1663e-05,-0.35362,-0.34446,1,0
2,KINESIN COMPLEX,0.00016595,-0.35366,-0.41458,1,0
2,REACTOME INWARDLY RECTIFYING K CHANNELS,0.00067758,-0.35381,-0.33275,1,0
2,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.011904,-0.35402,-0.27525,1,0
2,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.007729,-0.35705,-0.20571,1,0
2,GABA RECEPTOR ACTIVITY,0.00084609,-0.35774,-0.39576,1,0
2,PID SYNDECAN 3 PATHWAY,0.0013054,-0.35932,-0.37759,1,0
2,SODIUM ION TRANSPORT,7.2754e-05,-0.3624,-0.372,1,0
2,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.0045306,-0.36419,-0.29585,1,0
2,MONOVALENT INORGANIC CATION TRANSPORT,0.00026903,-0.37046,-0.2799,1,0
2,MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.012203,-0.37451,-0.29865,1,0
2,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.025994,-0.38366,-0.30139,1,0
2,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.0013872,-0.38446,-0.33536,1,0
2,HORMONE ACTIVITY,4.6597e-05,-0.40087,-0.38333,1,0
2,REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,1.7118e-05,-0.40346,-0.38402,1,0
2,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.00012074,-0.40531,-0.39465,1,0
2,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,1.5816e-05,-0.40561,-0.39827,1,0
2,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.00045924,-0.40999,-0.38379,1,0
2,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,7.547e-05,-0.41171,-0.39144,1,0
2,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.00032948,-0.41991,-0.4046,1,0
2,LEUKOCYTE MIGRATION,0.009256,-0.42025,-0.28124,1,0
2,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.0013872,-0.42623,-0.39013,1,0
2,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.00026903,-0.42869,-0.42591,1,0
2,REACTOME CRMPS IN SEMA3A SIGNALING,0.042857,-0.46802,-0.4317,1,0
2,REACTOME GABA A RECEPTOR ACTIVATION,0.0010859,-0.50611,-0.47839,1,0
2,NEGATIVE REGULATION OF PHOSPHORYLATION,0.0020453,-0.5072,-0.50604,1,0
2,NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.0020453,-0.5072,-0.50604,1,0
2,KINASE INHIBITOR ACTIVITY,3.8583e-05,-0.54728,-0.5561,1,0
2,EXOCYTOSIS,1.9263e-05,-0.55527,-0.59079,1,0
2,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.00012512,-0.55694,-0.43058,1,0
2,PROTEIN KINASE INHIBITOR ACTIVITY,3.3132e-05,-0.56627,-0.57663,1,0
2,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,1.2962e-05,-0.59599,-0.64645,1,0
2,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.00065623,-0.61305,-0.63912,1,0
2,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP,2.3418e-05,-0.74369,-0.64004,1,0
2,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,1.1493e-05,-0.76006,-0.71614,1,0
2,REACTOME AMINE DERIVED HORMONES,5.0683e-06,-0.78558,-0.68525,1,0
2,REACTOME INSULIN SYNTHESIS AND PROCESSING,1.7474e-06,-0.84967,-0.77028,1,0
2,NEUROPEPTIDE HORMONE ACTIVITY,2.8418e-05,-1.0931,-0.85231,1,0
2,PID INTEGRIN5 PATHWAY,0.30402,0.46188,0.20207,0,1
2,SARCOMERE,0.14285,0.34181,0.20195,0,1
2,OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR,0.11434,0.3298,0.17402,0,1
2,BIOCARTA RELA PATHWAY,0.10096,0.32313,0.14009,0,1
2,KEGG OTHER GLYCAN DEGRADATION,0.093897,0.30451,0.17512,0,1
2,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.049546,0.30208,0.25621,0,1
2,KEGG RENIN ANGIOTENSIN SYSTEM,0.087232,0.28988,0.13973,0,1
2,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.061812,0.2849,0.23816,0,1
2,ALDO KETO REDUCTASE ACTIVITY,0.4978,0.27402,0.11485,0,1
2,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.066855,0.26496,0.16746,0,1
2,KEGG RIBOSOME,0.10654,0.26341,0.21331,0,1
2,STRUCTURAL CONSTITUENT OF RIBOSOME,0.10845,0.26341,0.20018,0,1
2,KEGG ASCORBATE AND ALDARATE METABOLISM,0.095625,0.26334,0.17477,0,1
2,MYOBLAST DIFFERENTIATION,0.13583,0.26052,0.1532,0,1
2,BIOCARTA CASPASE PATHWAY,0.079444,0.24878,0.22959,0,1
2,OXIDOREDUCTASE ACTIVITY GO 0016706,0.17934,0.24414,0.11272,0,1
2,PID TNFPATHWAY,0.15264,0.23929,0.091405,0,1
2,PID HIVNEFPATHWAY,0.11039,0.23797,0.15843,0,1
2,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.099158,0.23257,0.19339,0,1
2,REACTOME METAL ION SLC TRANSPORTERS,0.076492,0.23159,0.12351,0,1
2,BIOCARTA TFF PATHWAY,0.097379,0.23155,0.16908,0,1
2,BIOCARTA NFKB PATHWAY,0.073629,0.22953,0.12284,0,1
2,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.3746,0.22438,0.12142,0,1
2,ST TUMOR NECROSIS FACTOR PATHWAY,0.12908,0.22356,0.097269,0,1
2,CELLULAR DEFENSE RESPONSE,0.15015,0.22109,0.059418,0,1
2,PID UPA UPAR PATHWAY,0.32077,0.21467,0.084103,0,1
2,ER GOLGI INTERMEDIATE COMPARTMENT,0.066855,0.21218,0.12862,0,1
2,BIOCARTA SODD PATHWAY,0.16032,0.20615,0.17243,0,1
2,BIOCARTA LAIR PATHWAY,0.53167,0.20107,0.058878,0,1
2,EARLY ENDOSOME,0.18219,0.19854,0.10318,0,1
2,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.090515,0.19313,0.18387,0,1
2,BIOCARTA HIVNEF PATHWAY,0.1028,0.19162,0.16042,0,1
2,PID CASPASE PATHWAY,0.099158,0.18766,0.17588,0,1
2,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.14048,0.18603,0.13574,0,1
2,REACTOME STRIATED MUSCLE CONTRACTION,0.19695,0.18248,0.11091,0,1
2,BIOCARTA FIBRINOLYSIS PATHWAY,0.11039,0.18134,0.06486,0,1
2,RESPONSE TO OTHER ORGANISM,0.052669,0.18112,0.096868,0,1
2,PROTEASE INHIBITOR ACTIVITY,0.088862,0.18036,0.13663,0,1
2,PHOSPHATASE BINDING,0.077957,0.17745,0.15671,0,1
2,PROTEIN DEACETYLASE ACTIVITY,0.061812,0.1743,0.12546,0,1
2,REACTOME MUSCLE CONTRACTION,0.084046,0.17316,0.15429,0,1
2,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL,0.075049,0.16945,0.1459,0,1
2,CONTRACTILE FIBER PART,0.23245,0.16919,0.093985,0,1
2,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.079444,0.16859,0.12235,0,1
2,BIOCARTA HER2 PATHWAY,0.1028,0.16741,0.10843,0,1
2,PID NECTIN PATHWAY,0.04854,0.16566,0.16795,0,1
2,BIOCARTA CDC42RAC PATHWAY,0.20309,0.16269,0.10986,0,1
2,REACTOME ZINC TRANSPORTERS,0.054842,0.15895,0.11809,0,1
2,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.053746,0.15746,0.10274,0,1
2,COFACTOR TRANSPORTER ACTIVITY,0.23589,0.15594,0.075736,0,1
2,REACTOME GAP JUNCTION DEGRADATION,0.064293,0.15557,0.14755,0,1
2,DEACETYLASE ACTIVITY,0.052669,0.15536,0.11554,0,1
2,PID ALPHASYNUCLEIN PATHWAY,0.25729,0.15373,0.077528,0,1
2,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.10654,0.15322,0.091042,0,1
2,REACTOME BILE ACID AND BILE SALT METABOLISM,0.063042,0.14966,0.17509,0,1
2,OXIDOREDUCTASE ACTIVITY GO 0016705,0.099158,0.149,0.09076,0,1
2,REGULATION OF CELLULAR PH,0.082489,0.14832,0.15682,0,1
2,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.36991,0.14781,0.08291,0,1
2,BIOCARTA RACCYCD PATHWAY,0.077957,0.14702,0.099218,0,1
2,POST GOLGI VESICLE MEDIATED TRANSPORT,0.11841,0.1451,0.095528,0,1
2,BIOCARTA STRESS PATHWAY,0.1028,0.14482,0.10144,0,1
2,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.12908,0.1437,0.12598,0,1
2,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11636,0.14367,0.15199,0,1
2,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11636,0.14367,0.15199,0,1
2,REGULATION OF DEFENSE RESPONSE,0.43367,0.14164,0.069801,0,1
2,APICAL PART OF CELL,0.15015,0.14064,0.086535,0,1
2,N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.073629,0.14008,0.087982,0,1
2,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.088862,0.13972,0.14113,0,1
2,KEGG JAK STAT SIGNALING PATHWAY,0.066855,0.13916,0.077319,0,1
2,REACTOME LAGGING STRAND SYNTHESIS,0.066855,0.13889,0.096715,0,1
2,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.16828,0.13762,0.054923,0,1
2,REACTOME CHOLESTEROL BIOSYNTHESIS,0.47049,0.13756,0.12493,0,1
2,REACTOME BASIGIN INTERACTIONS,0.20309,0.13755,0.0505,0,1
2,PID INSULIN GLUCOSE PATHWAY,0.16828,0.13502,0.074368,0,1
2,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.068167,0.13404,0.098972,0,1
2,KEGG COMPLEMENT AND COAGULATION CASCADES,0.188,0.13393,0.036473,0,1
2,NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.15773,0.13304,0.085451,0,1
2,EXONUCLEASE ACTIVITY,0.090515,0.13291,0.12706,0,1
2,PID INTEGRIN A4B1 PATHWAY,0.075049,0.13289,0.13479,0,1
2,CYTOKINE PRODUCTION,0.1313,0.13112,0.070614,0,1
2,BIOCARTA RAS PATHWAY,0.13814,0.12945,0.06794,0,1
2,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.11636,0.12827,0.13494,0,1
2,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.068167,0.12794,0.11046,0,1
2,REGULATION OF JNK ACTIVITY,0.070855,0.12794,0.13182,0,1
2,REACTOME NUCLEAR SIGNALING BY ERBB4,0.075049,0.12739,0.085304,0,1
2,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.12908,0.12643,0.11102,0,1
2,3 5 EXONUCLEASE ACTIVITY,0.073629,0.12621,0.10573,0,1
2,REGULATION OF GTPASE ACTIVITY,0.16828,0.12613,0.085388,0,1
2,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.11636,0.12557,0.078919,0,1
2,BIOCARTA CARDIACEGF PATHWAY,0.38408,0.12509,0.019743,0,1
2,BIOCARTA IL2RB PATHWAY,0.2839,0.12495,0.064679,0,1
2,KEGG STEROID HORMONE BIOSYNTHESIS,0.34256,0.1248,0.08098,0,1
2,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.053746,0.12409,0.10957,0,1
2,T CELL DIFFERENTIATION,0.1313,0.12405,0.088093,0,1
2,MYOFIBRIL,0.2,0.12404,0.1215,0,1
2,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.063042,0.12388,0.095199,0,1
2,BIOCARTA IL1R PATHWAY,0.17653,0.12353,0.069782,0,1
2,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.18219,0.12309,0.070371,0,1
2,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.077957,0.12249,0.088334,0,1
2,REACTOME RNA POL III CHAIN ELONGATION,0.050569,0.1224,0.12528,0,1
2,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.42855,0.12214,0.027834,0,1
2,NEGATIVE REGULATION OF TRANSLATION,0.0695,0.12118,0.12154,0,1
2,KEGG ACUTE MYELOID LEUKEMIA,0.072231,0.12113,0.095124,0,1
2,MICROTUBULE BASED PROCESS,0.12049,0.1211,0.081651,0,1
2,STRIATED MUSCLE DEVELOPMENT,0.58456,0.12074,0.036991,0,1
2,PEPTIDASE ACTIVITY,0.13583,0.12043,0.041618,0,1
2,KEGG N GLYCAN BIOSYNTHESIS,0.088862,0.12006,0.052646,0,1
2,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.22235,0.11914,0.10509,0,1
2,STRUCTURAL CONSTITUENT OF MUSCLE,0.10845,0.11913,0.10435,0,1
2,SPINDLE MICROTUBULE,0.04854,0.11871,0.13342,0,1
2,BIOCARTA SPRY PATHWAY,0.066855,0.11858,0.13086,0,1
2,BIOCARTA PTDINS PATHWAY,0.14769,0.11841,0.071516,0,1
2,SKELETAL MUSCLE DEVELOPMENT,0.78289,0.11718,0.01007,0,1
2,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.25001,0.11511,0.041171,0,1
2,PID INSULIN PATHWAY,0.090515,0.11405,0.088258,0,1
2,SPECIFIC TRANSCRIPTIONAL REPRESSOR ACTIVITY,0.084046,0.11353,0.1379,0,1
2,PID TGFBRPATHWAY,0.066855,0.11294,0.10758,0,1
2,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.055956,0.11158,0.091177,0,1
2,AMINO SUGAR METABOLIC PROCESS,0.38408,0.11154,0.047832,0,1
2,PID ECADHERIN KERATINOCYTE PATHWAY,0.13814,0.1114,0.1566,0,1
2,ACTIN FILAMENT BINDING,0.13583,0.11112,0.10255,0,1
2,CORTICAL CYTOSKELETON,0.67137,0.11036,0.017702,0,1
2,AMINE CATABOLIC PROCESS,0.063042,0.11021,0.11608,0,1
2,MEMBRANE FRACTION,0.076492,0.11008,0.061467,0,1
2,SMAD BINDING,0.21579,0.10928,0.086427,0,1
2,EMBRYO IMPLANTATION,0.12908,0.10862,0.1139,0,1
2,PID PDGFRAPATHWAY,0.25363,0.10825,0.08095,0,1
2,REACTOME G2 M CHECKPOINTS,0.11434,0.10793,0.09609,0,1
2,BIOCARTA MEF2D PATHWAY,0.27227,0.10673,0.059496,0,1
2,TRANSCRIPTION FACTOR TFIID COMPLEX,0.097379,0.10588,0.087956,0,1
2,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.2839,0.10573,0.037955,0,1
2,REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX,0.14048,0.10311,0.095016,0,1
2,PID HIF1 TFPATHWAY,0.60272,0.10092,0.0072359,0,1
2,VESICULAR FRACTION,0.082489,0.10068,0.085317,0,1
2,PID SYNDECAN 2 PATHWAY,0.18219,0.099865,0.1018,0,1
2,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.082489,0.099465,0.098725,0,1
2,RESPONSE TO WOUNDING,0.11434,0.098365,0.062778,0,1
2,REACTOME THE NLRP3 INFLAMMASOME,0.4978,0.098285,0.01737,0,1
2,REACTOME GLYCOLYSIS,0.090515,0.09735,0.16292,0,1
2,RESPONSE TO UV,0.10096,0.097086,0.058178,0,1
2,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.2,0.096831,0.050932,0,1
2,MICROSOME,0.12689,0.094863,0.070631,0,1
2,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.05161,0.094755,0.13532,0,1
2,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.090515,0.092537,0.063476,0,1
2,ALCOHOL METABOLIC PROCESS,0.17374,0.091004,0.049425,0,1
2,BIOCARTA GRANULOCYTES PATHWAY,0.94769,0.089682,-0.024733,0,1
2,INTEGRAL TO ORGANELLE MEMBRANE,0.20621,0.088608,0.043195,0,1
2,SPLICEOSOME ASSEMBLY,0.23937,0.088434,0.05785,0,1
2,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.44924,0.088141,0.057005,0,1
2,MRNA SPLICE SITE SELECTION,0.25729,0.087955,0.075484,0,1
2,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.38408,0.087722,0.093347,0,1
2,PROTEOLYSIS,0.15517,0.087683,0.06419,0,1
2,REACTOME FRS2 MEDIATED CASCADE,0.097379,0.085949,0.092027,0,1
2,INTRINSIC TO ORGANELLE MEMBRANE,0.20937,0.083884,0.041644,0,1
2,KEGG REGULATION OF AUTOPHAGY,0.11434,0.083203,0.076436,0,1
2,PID BETACATENIN NUC PATHWAY,0.17934,0.082576,0.10143,0,1
2,PROTEIN UBIQUITINATION,0.13814,0.081558,0.060539,0,1
2,CELL CYCLE PROCESS,0.085627,0.081498,0.066854,0,1
2,BIOCARTA TOLL PATHWAY,0.30402,0.080875,0.011085,0,1
2,UBIQUITIN CYCLE,0.1028,0.078994,0.060511,0,1
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.69707,0.078826,0.03098,0,1
2,PROTEIN LOCALIZATION,0.068167,0.078706,0.067152,0,1
2,MRNA PROCESSING GO 0006397,0.05824,0.078653,0.077711,0,1
2,CHROMOSOME SEGREGATION,0.10654,0.077865,0.098846,0,1
2,CELL FRACTION,0.35607,0.075431,0.025027,0,1
2,LIPID BIOSYNTHETIC PROCESS,0.15517,0.075367,0.056264,0,1
2,CHROMOSOMEPERICENTRIC REGION,0.060602,0.074911,0.11511,0,1
2,PID SMAD2 3NUCLEARPATHWAY,0.16828,0.074631,0.073634,0,1
2,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.10465,0.07441,0.062729,0,1
2,REACTOME SIGNALING BY ERBB4,0.16828,0.072395,0.054525,0,1
2,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.22568,0.07155,0.021796,0,1
2,POSITIVE REGULATION OF BINDING,0.1028,0.069572,0.074384,0,1
2,PID FANCONI PATHWAY,0.42347,0.067265,0.045224,0,1
2,BIOCARTA TALL1 PATHWAY,0.066855,0.067168,0.092005,0,1
2,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.14769,0.064708,0.0632,0,1
2,RESPONSE TO ABIOTIC STIMULUS,0.15015,0.062027,0.058032,0,1
2,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.15773,0.06045,0.063315,0,1
2,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.44924,0.059547,0.054307,0,1
2,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.76281,0.057191,0.0038741,0,1
2,REACTOME SIGNALING BY INSULIN RECEPTOR,0.12689,0.056909,0.032628,0,1
2,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.049546,0.054923,0.072032,0,1
2,RESPONSE TO RADIATION,0.46512,0.039458,0.043201,0,1
2,RESPONSE TO LIGHT STIMULUS,0.50337,0.012544,0.040964,0,1
2,BIOCARTA ACE2 PATHWAY,0.19393,0.40145,0.20466,0,0
2,BIOCARTA AMI PATHWAY,0.18219,0.363,0.23919,0,0
2,BIOCARTA INTRINSIC PATHWAY,0.17374,0.34645,0.16657,0,0
2,BIOCARTA VITCB PATHWAY,0.37932,0.31637,0.13505,0,0
2,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.057089,0.30421,0.24162,0,0
2,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,0.050569,0.29878,0.30583,0,0
2,REACTOME INTERFERON ALPHA BETA SIGNALING,0.35153,0.29437,0.08651,0,0
2,REACTOME INTERFERON GAMMA SIGNALING,0.05161,0.28667,0.14368,0,0
2,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.1028,0.26761,0.22177,0,0
2,REACTOME PEPTIDE CHAIN ELONGATION,0.12473,0.25048,0.2069,0,0
2,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.00353,0.24984,0.28531,0,0
2,BIOCARTA EXTRINSIC PATHWAY,0.10465,0.247,0.20292,0,0
2,BIOCARTA INFLAM PATHWAY,0.33373,0.24617,0.081588,0,0
2,ORGANELLAR SMALL RIBOSOMAL SUBUNIT,0.0032441,0.2446,0.21547,0,0
2,MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT,0.0032441,0.2446,0.21547,0,0
2,SMALL RIBOSOMAL SUBUNIT,0.0032441,0.2446,0.21547,0,0
2,GLUTATHIONE TRANSFERASE ACTIVITY,0.14048,0.23381,0.18911,0,0
2,PID IL8CXCR1 PATHWAY,0.0023671,0.22826,0.31852,0,0
2,REACTOME TRANSLATION,0.054842,0.2222,0.19683,0,0
2,REACTOME VITAMIN B5 PANTOTHENATE METABOLISM,0.0001547,0.22186,0.23748,0,0
2,ATP DEPENDENT RNA HELICASE ACTIVITY,0.0050528,0.21278,0.16399,0,0
2,REACTOME PHASE II CONJUGATION,0.0011549,0.21138,0.25182,0,0
2,BIOCARTA DNAFRAGMENT PATHWAY,0.052669,0.2028,0.15113,0,0
2,RHO GTPASE ACTIVATOR ACTIVITY,0.04854,0.20154,0.18578,0,0
2,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.17374,0.20082,0.26746,0,0
2,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.26098,0.19814,0.10524,0,0
2,RNA DEPENDENT ATPASE ACTIVITY,0.0026572,0.19614,0.15867,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.016734,0.19466,0.15271,0,0
2,COPPER ION BINDING,0.036164,0.19291,0.16727,0,0
2,KEGG ARGININE AND PROLINE METABOLISM,0.080955,0.18776,0.11733,0,0
2,REACTOME PYRUVATE METABOLISM,0.14048,0.18663,0.11672,0,0
2,PID MYC REPRESSPATHWAY,0.054842,0.18541,0.17995,0,0
2,REACTOME EXTENSION OF TELOMERES,0.049546,0.1843,0.10476,0,0
2,TISSUE MORPHOGENESIS,0.053746,0.18356,0.25073,0,0
2,INTRINSIC TO GOLGI MEMBRANE,0.12259,0.18249,0.090527,0,0
2,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.072231,0.18205,0.14607,0,0
2,ENDOCYTIC VESICLE,0.26471,0.18135,0.095124,0,0
2,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.061812,0.18126,0.10378,0,0
2,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.16294,0.18022,0.15732,0,0
2,PID TAP63PATHWAY,0.21905,0.17955,0.12552,0,0
2,PID TCRJNKPATHWAY,0.052669,0.17554,0.13368,0,0
2,REGULATION OF INTRACELLULAR TRANSPORT,0.055956,0.17417,0.15786,0,0
2,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.12259,0.17403,0.10003,0,0
2,MUSCLE CELL DIFFERENTIATION,0.17934,0.17377,0.11535,0,0
2,KEGG PENTOSE PHOSPHATE PATHWAY,0.04854,0.17298,0.14367,0,0
2,BIOCARTA P53 PATHWAY,0.097379,0.17145,0.15106,0,0
2,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.066855,0.17081,0.25336,0,0
2,BIOCARTA GATA3 PATHWAY,0.15773,0.17077,0.057663,0,0
2,ACTIN FILAMENT BUNDLE FORMATION,0.066855,0.1686,0.17315,0,0
2,KEGG GALACTOSE METABOLISM,0.21905,0.16745,0.098756,0,0
2,REACTOME HDL MEDIATED LIPID TRANSPORT,0.04854,0.16683,0.18062,0,0
2,RIBOSOME,0.024288,0.16616,0.15212,0,0
2,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,0.057089,0.16417,0.12193,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.16032,0.16261,0.1341,0,0
2,RIBONUCLEOTIDE METABOLIC PROCESS,0.026586,0.16087,0.17887,0,0
2,REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX,0.46512,0.16073,0.044688,0,0
2,BIOCARTA BARRESTIN PATHWAY,0.043763,0.16056,0.17807,0,0
2,TRNA METABOLIC PROCESS,0.060602,0.16045,0.16066,0,0
2,PID TRAIL PATHWAY,0.064293,0.15987,0.13662,0,0
2,SULFUR METABOLIC PROCESS,0.070855,0.15943,0.11481,0,0
2,RESPONSE TO VIRUS,0.23589,0.15895,0.073764,0,0
2,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.084046,0.15874,0.10137,0,0
2,STEROID HORMONE RECEPTOR ACTIVITY,0.092194,0.15833,0.10587,0,0
2,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.14769,0.15646,0.14865,0,0
2,PID IL27PATHWAY,0.075049,0.15594,0.091533,0,0
2,PID RAC1 REG PATHWAY,0.19095,0.15589,0.10561,0,0
2,KEGG CIRCADIAN RHYTHM MAMMAL,0.33812,0.15408,0.12977,0,0
2,KEGG STARCH AND SUCROSE METABOLISM,0.02268,0.15139,0.12303,0,0
2,KEGG LYSOSOME,0.31232,0.14935,0.029808,0,0
2,REGULATION OF HOMEOSTATIC PROCESS,0.71006,0.14924,0.023279,0,0
2,PID INTEGRIN1 PATHWAY,0.12473,0.14818,0.17373,0,0
2,REACTOME LIPOPROTEIN METABOLISM,0.10465,0.14788,0.14461,0,0
2,CALMODULIN BINDING,0.057089,0.14715,0.11601,0,0
2,REACTOME ENDOGENOUS STEROLS,0.42347,0.14612,0.062393,0,0
2,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.024846,0.14543,0.16749,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.075049,0.1452,0.13214,0,0
2,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.050569,0.14501,0.11696,0,0
2,BIOCARTA TOB1 PATHWAY,0.24643,0.14463,0.075293,0,0
2,KINASE ACTIVATOR ACTIVITY,0.14285,0.14397,0.11627,0,0
2,BIOCARTA FAS PATHWAY,0.090515,0.14393,0.17773,0,0
2,DEVELOPMENTAL GROWTH,0.24643,0.14392,0.16663,0,0
2,APICAL PLASMA MEMBRANE,0.14285,0.14364,0.088605,0,0
2,MONOCARBOXYLIC ACID TRANSPORT,0.7495,0.1433,-0.0027087,0,0
2,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.17934,0.14315,0.073175,0,0
2,PROTEIN TETRAMERIZATION,0.045624,0.14187,0.18974,0,0
2,NEGATIVE REGULATION OF CELL MIGRATION,0.21579,0.14168,0.11399,0,0
2,BIOCARTA MYOSIN PATHWAY,0.016339,0.14131,0.15165,0,0
2,LOW DENSITY LIPOPROTEIN BINDING,0.39858,0.14124,0.047992,0,0
2,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.14526,0.14016,0.082879,0,0
2,DNA FRAGMENTATION DURING APOPTOSIS,0.13814,0.13791,0.11986,0,0
2,KEGG TRYPTOPHAN METABOLISM,0.0695,0.13723,0.14796,0,0
2,NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.03939,0.13703,0.12358,0,0
2,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.095625,0.13665,0.1192,0,0
2,REACTOME REGULATION OF COMPLEMENT CASCADE,0.12259,0.13616,0.049066,0,0
2,BIOCARTA P53HYPOXIA PATHWAY,0.50896,0.13605,0.059621,0,0
2,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.041967,0.1354,0.12574,0,0
2,REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE,0.23937,0.13504,0.12336,0,0
2,BIOCARTA CTL PATHWAY,0.18219,0.13477,0.062596,0,0
2,AMINE BIOSYNTHETIC PROCESS,0.42855,0.13437,0.075299,0,0
2,ST INTERLEUKIN 4 PATHWAY,0.082489,0.13382,0.11932,0,0
2,REACTOME P75NTR SIGNALS VIA NFKB,0.56075,0.13378,0.03285,0,0
2,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.072231,0.13362,0.065933,0,0
2,TRNA PROCESSING,0.21905,0.13271,0.11361,0,0
2,INTERCELLULAR JUNCTION,0.080955,0.13246,0.12972,0,0
2,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.16828,0.13231,0.080016,0,0
2,REGULATION OF SYNAPSE STRUCTURE AND ACTIVITY,0.34256,0.13165,0.071792,0,0
2,REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES,0.63978,0.13045,0.019129,0,0
2,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.23937,0.13034,0.069314,0,0
2,I KAPPAB KINASE NF KAPPAB CASCADE,0.16559,0.12991,0.07625,0,0
2,BIOCARTA COMP PATHWAY,0.25729,0.1296,0.027221,0,0
2,MITOCHONDRIAL MEMBRANE PART,0.066855,0.12789,0.096417,0,0
2,POSITIVE REGULATION OF JNK ACTIVITY,0.14526,0.1276,0.096098,0,0
2,BIOCARTA CDMAC PATHWAY,0.32506,0.12745,0.049926,0,0
2,PID SYNDECAN 1 PATHWAY,0.073629,0.12724,0.13714,0,0
2,KEGG BUTANOATE METABOLISM,0.37932,0.12721,0.046628,0,0
2,EPITHELIAL TO MESENCHYMAL TRANSITION,0.56666,0.12614,0.035043,0,0
2,PID TOLL ENDOGENOUS PATHWAY,0.20937,0.12424,0.092468,0,0
2,LIPID HOMEOSTASIS,0.31232,0.12382,0.089451,0,0
2,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.097379,0.12321,0.14261,0,0
2,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE ACTIVITY,0.065563,0.12297,0.139,0,0
2,KEGG O GLYCAN BIOSYNTHESIS,0.21256,0.12204,0.05848,0,0
2,LYMPHOCYTE DIFFERENTIATION,0.21256,0.12197,0.058465,0,0
2,MAINTENANCE OF CELLULAR PROTEIN LOCALIZATION,0.14526,0.12177,0.11779,0,0
2,KEGG DNA REPLICATION,0.11841,0.12175,0.079984,0,0
2,REGULATION OF MYELOID CELL DIFFERENTIATION,0.23589,0.12168,0.073746,0,0
2,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.11434,0.12152,0.11519,0,0
2,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.099158,0.12138,0.056253,0,0
2,KEGG TYPE I DIABETES MELLITUS,0.58456,0.12135,0.042484,0,0
2,REACTOME CELL CELL COMMUNICATION,0.26471,0.121,0.042852,0,0
2,CELL FATE COMMITMENT,0.11039,0.12049,0.16368,0,0
2,CELL MATRIX JUNCTION,0.050569,0.11983,0.1843,0,0
2,LIPID TRANSPORT,0.25729,0.11914,0.061818,0,0
2,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.061812,0.11898,0.083059,0,0
2,BIOCARTA IL3 PATHWAY,0.41341,0.11883,0.060548,0,0
2,SA PROGRAMMED CELL DEATH,0.19095,0.1183,0.1186,0,0
2,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.05161,0.11826,0.076583,0,0
2,TISSUE REMODELING,0.088862,0.1177,0.1343,0,0
2,NUCLEAR UBIQUITIN LIGASE COMPLEX,0.13355,0.11765,0.11701,0,0
2,BIOCARTA IL12 PATHWAY,0.15264,0.11741,0.079995,0,0
2,PROTEIN TRANSPORTER ACTIVITY,0.15264,0.11727,0.084992,0,0
2,PID IL6 7PATHWAY,0.077957,0.11692,0.11028,0,0
2,SENSORY ORGAN DEVELOPMENT,0.31232,0.11691,0.067238,0,0
2,BIOCARTA PARKIN PATHWAY,0.60272,0.11678,0.067286,0,0
2,NUCLEAR MATRIX,0.13583,0.11672,0.1218,0,0
2,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.21256,0.11661,0.056394,0,0
2,CELL JUNCTION,0.075049,0.11626,0.12875,0,0
2,PURINE NUCLEOTIDE METABOLIC PROCESS,0.087232,0.1159,0.16749,0,0
2,REGULATION OF PHOSPHORYLATION,0.13583,0.11495,0.074997,0,0
2,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.057089,0.11452,0.085143,0,0
2,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.11235,0.11359,0.060649,0,0
2,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.16032,0.1135,0.055599,0,0
2,MEMBRANE ORGANIZATION AND BIOGENESIS,0.014486,0.11307,0.090013,0,0
2,KEGG DRUG METABOLISM OTHER ENZYMES,0.11235,0.11299,0.084926,0,0
2,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.3746,0.11291,0.037092,0,0
2,CYTOSOLIC PART,0.064293,0.11188,0.16233,0,0
2,PID P38GAMMADELTAPATHWAY,0.16559,0.11184,0.22793,0,0
2,EXTRACELLULAR MATRIX PART,0.26098,0.11154,0.092428,0,0
2,PID ATM PATHWAY,0.012203,0.11097,0.11992,0,0
2,KEGG ECM RECEPTOR INTERACTION,0.090515,0.11095,0.2052,0,0
2,BIOCARTA AKAP13 PATHWAY,0.188,0.1108,0.11682,0,0
2,PID RETINOIC ACID PATHWAY,0.18508,0.11049,0.086505,0,0
2,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.30402,0.10986,0.079997,0,0
2,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.39371,0.10981,0.046621,0,0
2,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.052669,0.10888,0.16154,0,0
2,CORTICAL ACTIN CYTOSKELETON,0.35153,0.10859,0.082211,0,0
2,REACTOME POL SWITCHING,0.14048,0.10858,0.083298,0,0
2,PID HDAC CLASSIII PATHWAY,0.19095,0.10856,0.088432,0,0
2,APOPTOTIC PROGRAM,0.59059,0.10848,0.010521,0,0
2,PID INTEGRIN A9B1 PATHWAY,0.59664,0.10815,0.039573,0,0
2,REACTOME GLUCONEOGENESIS,0.11235,0.10771,0.12909,0,0
2,DNA DAMAGE CHECKPOINT,0.019739,0.1077,0.10791,0,0
2,BIOCARTA GLEEVEC PATHWAY,0.14526,0.1076,0.083134,0,0
2,PID AURORA B PATHWAY,0.40843,0.10753,0.073073,0,0
2,LIPID BINDING,0.053746,0.10636,0.085219,0,0
2,PHOSPHOINOSITIDE METABOLIC PROCESS,0.095625,0.10604,0.07024,0,0
2,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.10654,0.10556,0.072279,0,0
2,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16294,0.10554,0.12144,0,0
2,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.35153,0.10536,0.040617,0,0
2,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.38408,0.10528,0.16266,0,0
2,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.019283,0.10479,0.12326,0,0
2,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.059411,0.10442,0.10727,0,0
2,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.060602,0.10439,0.22283,0,0
2,ANATOMICAL STRUCTURE FORMATION,0.052669,0.10419,0.10583,0,0
2,REGULATION OF SIGNAL TRANSDUCTION,0.13355,0.10401,0.069888,0,0
2,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.13814,0.10341,0.076269,0,0
2,ER NUCLEAR SIGNALING PATHWAY,0.1313,0.10324,0.096621,0,0
2,KEGG MISMATCH REPAIR,0.30815,0.1029,0.031728,0,0
2,ELECTRON TRANSPORT GO 0006118,0.099158,0.10277,0.10673,0,0
2,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.12908,0.10124,0.080061,0,0
2,IMMUNE SYSTEM PROCESS,0.17934,0.10113,0.035827,0,0
2,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.17099,0.10111,0.0967,0,0
2,BIOCARTA NO2IL12 PATHWAY,0.027803,0.10073,0.12338,0,0
2,POSITIVE REGULATION OF MAPKKK CASCADE,0.25001,0.10023,0.10073,0,0
2,PID SYNDECAN 4 PATHWAY,0.39371,0.099929,0.080688,0,0
2,CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.17653,0.099907,0.098371,0,0
2,G2 M TRANSITION OF MITOTIC CELL CYCLE,0.27999,0.099797,0.059048,0,0
2,BIOCARTA MTOR PATHWAY,0.080955,0.09939,0.10004,0,0
2,BIOCARTA CARM ER PATHWAY,0.027803,0.099145,0.12494,0,0
2,MITOTIC CELL CYCLE CHECKPOINT,0.13583,0.099021,0.061635,0,0
2,REACTOME PI3K CASCADE,0.0026572,0.099004,0.10668,0,0
2,NUCLEAR LUMEN,0.00037661,0.098861,0.10271,0,0
2,GOLGI APPARATUS PART,0.059411,0.098596,0.072253,0,0
2,STEROID BIOSYNTHETIC PROCESS,0.44402,0.098519,0.022514,0,0
2,BIOCARTA GSK3 PATHWAY,0.19695,0.098286,0.089837,0,0
2,KEGG HISTIDINE METABOLISM,0.49227,0.098056,0.056169,0,0
2,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.68418,0.097151,0.073152,0,0
2,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.015574,0.097131,0.12316,0,0
2,PID TCPTP PATHWAY,0.055956,0.096923,0.10511,0,0
2,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.040234,0.096254,0.13847,0,0
2,ACTIN FILAMENT BASED MOVEMENT,0.059411,0.096146,0.18555,0,0
2,REACTOME P38MAPK EVENTS,0.54903,0.096073,0.0074786,0,0
2,ANION TRANSPORT,0.04854,0.096066,0.15408,0,0
2,RESPONSE TO ORGANIC SUBSTANCE,0.53167,0.096036,0.0058338,0,0
2,KEGG CHRONIC MYELOID LEUKEMIA,0.10654,0.095577,0.092142,0,0
2,DNA DIRECTED RNA POLYMERASE COMPLEX,0.082489,0.094562,0.093113,0,0
2,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.082489,0.094562,0.093113,0,0
2,RNA POLYMERASE COMPLEX,0.082489,0.094562,0.093113,0,0
2,PROTEIN STABILIZATION,0.23589,0.094314,0.078565,0,0
2,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.11841,0.094154,0.092644,0,0
2,BIOCARTA IL22BP PATHWAY,0.34702,0.094132,0.069292,0,0
2,REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS,0.14769,0.093978,0.06954,0,0
2,PID IFNGPATHWAY,0.084046,0.093849,0.099949,0,0
2,REACTOME GAP JUNCTION TRAFFICKING,0.12473,0.093414,0.073142,0,0
2,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.31653,0.093102,0.065022,0,0
2,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.27611,0.0931,0.088034,0,0
2,ST G ALPHA I PATHWAY,0.26847,0.093054,0.051392,0,0
2,B CELL DIFFERENTIATION,0.4978,0.092689,0.032414,0,0
2,STEROL BINDING,0.28785,0.092595,0.055614,0,0
2,BIOCARTA MET PATHWAY,0.070855,0.092404,0.082764,0,0
2,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.092194,0.092398,0.060613,0,0
2,PROTEIN POLYMERIZATION,0.48131,0.092175,0.090162,0,0
2,LIPID KINASE ACTIVITY,0.20937,0.092128,0.10625,0,0
2,REACTOME SHC MEDIATED CASCADE,0.088862,0.092124,0.11221,0,0
2,PID LYMPHANGIOGENESIS PATHWAY,0.93377,0.092108,-0.0070623,0,0
2,APOPTOTIC NUCLEAR CHANGES,0.24643,0.09175,0.065927,0,0
2,MONOSACCHARIDE BINDING,0.37932,0.091572,0.037999,0,0
2,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.31653,0.091324,0.09486,0,0
2,REACTOME XENOBIOTICS,0.26847,0.091241,0.042912,0,0
2,REGULATION OF DNA REPLICATION,0.15264,0.091008,0.099919,0,0
2,AMINE METABOLIC PROCESS,0.027188,0.090928,0.097087,0,0
2,BIOCARTA CHREBP2 PATHWAY,0.21579,0.090716,0.051315,0,0
2,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GLOBO SERIES,0.47588,0.090469,0.034326,0,0
2,PHOSPHOLIPASE C ACTIVATION,0.031748,0.090002,0.16189,0,0
2,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.093897,0.089735,0.1177,0,0
2,KEGG MELANOMA,0.12473,0.089147,0.071287,0,0
2,REGULATION OF CELL PROLIFERATION,0.050569,0.088956,0.065654,0,0
2,REACTOME BASE EXCISION REPAIR,0.26098,0.088916,0.082926,0,0
2,ACTIVATION OF JNK ACTIVITY,0.12473,0.08872,0.11111,0,0
2,PID ARF6 PATHWAY,0.057089,0.088397,0.14613,0,0
2,KEGG AXON GUIDANCE,0.82348,0.088094,-0.0039618,0,0
2,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.40349,0.087925,0.060777,0,0
2,KINETOCHORE,0.05824,0.08751,0.12815,0,0
2,NEGATIVE REGULATION OF CELLULAR PROCESS,0.10465,0.087475,0.05854,0,0
2,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.15773,0.086842,0.10087,0,0
2,KEGG CELL ADHESION MOLECULES CAMS,0.7495,0.086378,-0.024923,0,0
2,CARBOXYPEPTIDASE ACTIVITY,0.31232,0.086358,0.10504,0,0
2,SYMPORTER ACTIVITY,0.3746,0.086034,0.040707,0,0
2,NEGATIVE REGULATION OF TRANSPORT,0.16828,0.085787,0.09115,0,0
2,REACTOME SHC MEDIATED SIGNALLING,0.56075,0.085513,0.038383,0,0
2,REGULATION OF T CELL ACTIVATION,0.29586,0.085454,0.037041,0,0
2,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.16294,0.085296,0.074424,0,0
2,FEMALE PREGNANCY,0.21905,0.085089,0.049638,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.097379,0.085028,0.091341,0,0
2,THIOLESTER HYDROLASE ACTIVITY,0.077957,0.084673,0.11904,0,0
2,ENDONUCLEASE ACTIVITY,0.057089,0.08438,0.11551,0,0
2,PID BARD1PATHWAY,0.025994,0.084125,0.13564,0,0
2,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.10096,0.084106,0.11073,0,0
2,ORGANIC ACID TRANSPORT,0.20621,0.083594,0.10756,0,0
2,CARBOXYLIC ACID TRANSPORT,0.20621,0.083594,0.10756,0,0
2,ACTIN CYTOSKELETON,0.027803,0.08344,0.12024,0,0
2,REACTOME CIRCADIAN CLOCK,0.04854,0.083373,0.10775,0,0
2,KEGG ABC TRANSPORTERS,0.097379,0.082926,0.095884,0,0
2,ACTIN FILAMENT,0.11235,0.082845,0.12876,0,0
2,BIOCARTA BCR PATHWAY,0.20309,0.082571,0.072558,0,0
2,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.51459,0.082529,-0.0074287,0,0
2,NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.29992,0.081901,0.10413,0,0
2,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.095625,0.081896,0.078767,0,0
2,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.47049,0.081807,0.043646,0,0
2,PID PI3KCIPATHWAY,0.17934,0.081806,0.10088,0,0
2,REGULATION OF ACTIN FILAMENT LENGTH,0.31653,0.081773,0.17729,0,0
2,CONTRACTILE FIBER,0.40843,0.081306,0.057106,0,0
2,REACTOME DSCAM INTERACTIONS,0.91293,0.081275,-0.061231,0,0
2,ACTIN FILAMENT BASED PROCESS,0.16032,0.081193,0.065441,0,0
2,REACTOME P2Y RECEPTORS,0.20937,0.081105,0.082962,0,0
2,BIOCARTA ERK PATHWAY,0.15264,0.081069,0.086497,0,0
2,BIOCARTA AKT PATHWAY,0.27227,0.081047,0.095928,0,0
2,REACTOME SIGNALING BY NOTCH2,0.50896,0.08098,0.037135,0,0
2,REGULATION OF VIRAL REPRODUCTION,0.31232,0.080957,0.080038,0,0
2,REGULATION OF LIPID METABOLIC PROCESS,0.46512,0.080906,0.036928,0,0
2,CELL CYCLE CHECKPOINT GO 0000075,0.093897,0.080659,0.072303,0,0
2,REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,0.36991,0.080648,-0.002178,0,0
2,INTERLEUKIN BINDING,0.092194,0.080643,0.085876,0,0
2,CELLULAR CATABOLIC PROCESS,0.010506,0.080544,0.097946,0,0
2,VESICLE COAT,0.25729,0.080504,0.088045,0,0
2,DOUBLE STRAND BREAK REPAIR,0.11039,0.080303,0.1123,0,0
2,INTERMEDIATE FILAMENT CYTOSKELETON,0.39858,0.08009,0.13441,0,0
2,INTERMEDIATE FILAMENT,0.39858,0.08009,0.13441,0,0
2,SPINDLE,0.17653,0.079744,0.10466,0,0
2,RIBONUCLEASE ACTIVITY,0.04854,0.079706,0.15818,0,0
2,PHOSPHATASE INHIBITOR ACTIVITY,0.39858,0.079241,-0.13906,0,0
2,ST GAQ PATHWAY,0.11039,0.079007,0.096364,0,0
2,KEGG RENAL CELL CARCINOMA,0.082489,0.078947,0.082903,0,0
2,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.25729,0.078777,0.045821,0,0
2,RESPONSE TO STRESS,0.099158,0.078532,0.045611,0,0
2,REGULATION OF CELLULAR COMPONENT SIZE,0.21579,0.078494,0.17421,0,0
2,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.17934,0.078261,0.062998,0,0
2,AEROBIC RESPIRATION,0.30402,0.078113,0.088572,0,0
2,PID CD8TCRDOWNSTREAMPATHWAY,0.12259,0.07807,0.052479,0,0
2,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.21256,0.077863,0.05649,0,0
2,ST ERK1 ERK2 MAPK PATHWAY,0.4545,0.077818,0.033069,0,0
2,SIG CHEMOTAXIS,0.36064,0.07747,0.057859,0,0
2,REACTOME REGULATION OF IFNG SIGNALING,0.27999,0.077454,0.093737,0,0
2,REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,0.10654,0.077403,0.15506,0,0
2,BIOCARTA CLASSIC PATHWAY,0.29184,0.077233,0.022926,0,0
2,CATABOLIC PROCESS,0.0073363,0.077157,0.098039,0,0
2,MAINTENANCE OF PROTEIN LOCALIZATION,0.44924,0.077021,0.059906,0,0
2,PROTEIN TARGETING TO MEMBRANE,0.48131,0.076977,0.01942,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.21256,0.076966,0.02219,0,0
2,BIOCARTA TID PATHWAY,0.15264,0.076913,0.12092,0,0
2,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.059411,0.076758,0.099219,0,0
2,PID CMYB PATHWAY,0.077957,0.076228,0.093316,0,0
2,MITOCHONDRIAL RESPIRATORY CHAIN,0.15264,0.075789,0.0956,0,0
2,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.05824,0.075081,0.071065,0,0
2,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.26098,0.075007,0.035887,0,0
2,BIOCARTA NKCELLS PATHWAY,0.56075,0.074888,0.042082,0,0
2,REGULATION OF PROTEIN STABILITY,0.13355,0.074618,0.065503,0,0
2,REACTOME COMPLEMENT CASCADE,0.14285,0.074541,0.052213,0,0
2,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.25001,0.074489,0.054651,0,0
2,PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.33373,0.074402,0.092932,0,0
2,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.89215,0.074169,-0.00064297,0,0
2,SERINE TYPE PEPTIDASE ACTIVITY,0.67137,0.074127,-0.0084457,0,0
2,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.21256,0.07391,0.096867,0,0
2,GTPASE REGULATOR ACTIVITY,0.0695,0.073871,0.090152,0,0
2,REACTOME DARPP 32 EVENTS,0.34702,0.073626,0.052415,0,0
2,KEGG STEROID BIOSYNTHESIS,0.51459,0.073473,0.098617,0,0
2,MEMBRANE COAT,0.22905,0.073439,0.074418,0,0
2,COATED MEMBRANE,0.22905,0.073439,0.074418,0,0
2,KEGG VIBRIO CHOLERAE INFECTION,0.082489,0.073314,0.087884,0,0
2,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.12908,0.0733,0.07257,0,0
2,REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION,0.14526,0.073194,0.12682,0,0
2,NLS BEARING SUBSTRATE IMPORT INTO NUCLEUS,0.11039,0.072705,0.16853,0,0
2,TRANSPORT VESICLE,0.33373,0.072545,0.06313,0,0
2,DNA DEPENDENT ATPASE ACTIVITY,0.22568,0.072542,0.078741,0,0
2,REACTOME SPHINGOLIPID METABOLISM,0.91293,0.072409,-0.017422,0,0
2,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.36526,0.072123,0.02762,0,0
2,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.95466,0.071624,0.019337,0,0
2,KEGG PARKINSONS DISEASE,0.33373,0.071448,0.0505,0,0
2,REACTOME SIGNALING BY NODAL,0.03245,0.071321,0.097603,0,0
2,CYTOCHROME C OXIDASE ACTIVITY,0.50337,0.071244,0.024358,0,0
2,SEQUENCE SPECIFIC DNA BINDING,0.057089,0.070865,0.11086,0,0
2,MYELOID LEUKOCYTE DIFFERENTIATION,0.57857,0.070116,0.022253,0,0
2,LEUKOCYTE DIFFERENTIATION,0.23245,0.069958,0.042181,0,0
2,LIPOPROTEIN BINDING,0.89907,0.069809,-0.048908,0,0
2,EXTRACELLULAR MATRIX,0.57857,0.069765,0.051693,0,0
2,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.27611,0.069683,0.077157,0,0
2,REGULATION OF ACTION POTENTIAL,0.67137,0.069629,-0.0083475,0,0
2,BIOCARTA NKT PATHWAY,0.52594,0.069356,0.0097411,0,0
2,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.59059,0.068943,0.022427,0,0
2,REACTOME HS GAG DEGRADATION,0.3746,0.068497,0.12401,0,0
2,KEGG PATHWAYS IN CANCER,0.072231,0.068141,0.086608,0,0
2,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.43883,0.068117,0.073923,0,0
2,REACTOME IL 3 5 AND GM CSF SIGNALING,0.32938,0.068102,0.1109,0,0
2,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.41341,0.068054,0.042663,0,0
2,CARBOHYDRATE CATABOLIC PROCESS,0.41341,0.068054,0.042663,0,0
2,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.89907,0.067913,-0.023928,0,0
2,MEIOTIC CELL CYCLE,0.30815,0.067551,0.051837,0,0
2,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.41842,0.067214,0.042964,0,0
2,APOPTOSIS GO,0.065563,0.066913,0.070286,0,0
2,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.23245,0.066912,0.0587,0,0
2,AGING,0.27227,0.066899,0.10876,0,0
2,VIRAL REPRODUCTION,0.084046,0.066318,0.056233,0,0
2,PROTEINACEOUS EXTRACELLULAR MATRIX,0.65866,0.066185,0.04732,0,0
2,PID ARF6 TRAFFICKINGPATHWAY,0.33812,0.066158,0.044951,0,0
2,METALLOPEPTIDASE ACTIVITY,0.4978,0.066052,0.0021078,0,0
2,RESPONSE TO EXTERNAL STIMULUS,0.22568,0.065955,0.030389,0,0
2,REACTOME MICRORNA MIRNA BIOGENESIS,0.014138,0.065557,0.13543,0,0
2,GROWTH CONE,0.23937,0.06552,-0.33756,0,0
2,COATED VESICLE MEMBRANE,0.29586,0.065344,0.079977,0,0
2,REACTOME SIGNALING BY NOTCH,0.060602,0.065324,0.073,0,0
2,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.2839,0.065258,0.068582,0,0
2,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.35607,0.064958,0.060904,0,0
2,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.35153,0.064819,0.024451,0,0
2,BIOCARTA CSK PATHWAY,0.57857,0.064709,0.0096919,0,0
2,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.98953,0.06461,-0.037143,0,0
2,PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY,0.21905,0.064573,0.10737,0,0
2,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.19095,0.064537,0.073653,0,0
2,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.13355,0.064366,0.051484,0,0
2,PROGRAMMED CELL DEATH,0.079444,0.064067,0.068775,0,0
2,REPRODUCTIVE PROCESS,0.21256,0.063949,0.037007,0,0
2,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.050569,0.063596,0.057288,0,0
2,PROTEIN MODIFICATION PROCESS,0.05161,0.06359,0.052499,0,0
2,PATTERN BINDING,0.13814,0.063468,0.078697,0,0
2,ONE CARBON COMPOUND METABOLIC PROCESS,0.19695,0.063386,0.064364,0,0
2,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.17374,0.063145,0.14567,0,0
2,B CELL ACTIVATION,0.71006,0.063103,0.0093457,0,0
2,KEGG PYRIMIDINE METABOLISM,0.05161,0.063061,0.058835,0,0
2,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.053746,0.063046,0.19066,0,0
2,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.29184,0.062968,0.082744,0,0
2,SERINE HYDROLASE ACTIVITY,0.78962,0.06273,-0.015487,0,0
2,PID RANBP2PATHWAY,0.3746,0.062343,0.072126,0,0
2,REGULATION OF CYTOKINE PRODUCTION,0.65234,0.06217,0.011827,0,0
2,IMMUNE RESPONSE,0.31232,0.062169,0.0084314,0,0
2,M PHASE,0.20937,0.062115,0.051752,0,0
2,PID IGF1 PATHWAY,0.30815,0.061863,0.037831,0,0
2,BIOPOLYMER MODIFICATION,0.064293,0.061623,0.052908,0,0
2,ISOMERASE ACTIVITY,0.63354,0.061491,0.053719,0,0
2,REACTOME SHC RELATED EVENTS,0.78289,0.061394,0.016432,0,0
2,CIRCADIAN RHYTHM,1,0.061359,-0.019602,0,0
2,PID HES HEYPATHWAY,0.62113,0.061304,0.031485,0,0
2,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.42855,0.061126,0.071126,0,0
2,ENDOSOME,0.58456,0.061124,0.027392,0,0
2,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.44402,0.061119,0.034815,0,0
2,MYOSIN COMPLEX,0.20937,0.060999,0.11169,0,0
2,BASEMENT MEMBRANE,0.33812,0.060952,0.1123,0,0
2,HEART DEVELOPMENT,0.34256,0.060849,0.031057,0,0
2,KEGG ALZHEIMERS DISEASE,0.14526,0.060159,0.064938,0,0
2,NUCLEOTIDE METABOLIC PROCESS,0.14048,0.060033,0.072975,0,0
2,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.29992,0.059553,0.039143,0,0
2,CELLULAR CATION HOMEOSTASIS,0.3746,0.058813,0.016303,0,0
2,MITOSIS,0.26471,0.058703,0.051615,0,0
2,NEGATIVE REGULATION OF DNA REPLICATION,0.39858,0.058603,0.099782,0,0
2,CATION HOMEOSTASIS,0.35153,0.05849,0.020203,0,0
2,REGULATION OF MITOTIC CELL CYCLE,0.065563,0.058271,0.10839,0,0
2,PEPTIDE BINDING,0.60272,0.058218,0.012061,0,0
2,REACTOME REGULATION OF KIT SIGNALING,0.79636,0.058179,0.036978,0,0
2,EMBRYONIC DEVELOPMENT,0.65866,0.058137,0.022688,0,0
2,COLLAGEN,0.17653,0.058017,0.10496,0,0
2,ORGAN DEVELOPMENT,0.2839,0.057897,0.053854,0,0
2,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.22568,0.05781,0.036601,0,0
2,NUCLEOTIDE BINDING,0.068167,0.057672,0.051226,0,0
2,PID AR TF PATHWAY,0.11039,0.057586,0.076204,0,0
2,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.60883,0.057321,0.03884,0,0
2,REACTOME DNA STRAND ELONGATION,0.25363,0.057171,0.049444,0,0
2,REACTOME HEMOSTASIS,0.14285,0.056999,0.03446,0,0
2,PID NOTCH PATHWAY,0.38888,0.056391,0.051614,0,0
2,SA PTEN PATHWAY,0.71658,0.056322,0.014916,0,0
2,REACTOME MYOGENESIS,0.68418,0.056269,-0.0015796,0,0
2,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.72313,0.056176,0.047693,0,0
2,BIOCARTA RAB PATHWAY,0.47588,0.056043,0.016965,0,0
2,PID RAS PATHWAY,0.77618,0.055991,0.026777,0,0
2,PID FGF PATHWAY,0.17653,0.055988,0.069873,0,0
2,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.88523,0.055882,0.0052095,0,0
2,LYASE ACTIVITY,0.32938,0.055606,0.053388,0,0
2,REGULATION OF DEVELOPMENTAL PROCESS,0.066855,0.05547,0.071683,0,0
2,NEGATIVE REGULATION OF CELL PROLIFERATION,0.57857,0.055394,0.029635,0,0
2,M PHASE OF MITOTIC CELL CYCLE,0.29586,0.055376,0.050048,0,0
2,REACTOME UNFOLDED PROTEIN RESPONSE,0.21905,0.055298,0.06343,0,0
2,BIOCARTA PPARA PATHWAY,0.32077,0.055206,0.064461,0,0
2,CELLULAR RESPIRATION,0.36064,0.055096,0.058587,0,0
2,SKELETAL DEVELOPMENT,0.12049,0.054914,0.11856,0,0
2,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.27227,0.054853,0.07066,0,0
2,INTERLEUKIN RECEPTOR ACTIVITY,0.39858,0.054203,0.037028,0,0
2,REACTOME TRANSCRIPTION,0.41842,0.053845,0.040443,0,0
2,PHOSPHORYLATION,0.0695,0.053755,0.05854,0,0
2,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.64605,0.0536,0.016728,0,0
2,ST STAT3 PATHWAY,0.82348,0.053432,0.012252,0,0
2,POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.87833,0.053368,0.0040517,0,0
2,REGULATION OF DNA METABOLIC PROCESS,0.15015,0.053245,0.07294,0,0
2,N ACYLTRANSFERASE ACTIVITY,0.23589,0.052962,0.073216,0,0
2,VESICLE MEDIATED TRANSPORT,0.2839,0.052674,0.031934,0,0
2,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.54903,0.05259,0.00071573,0,0
2,MYELOID CELL DIFFERENTIATION,0.35153,0.052502,0.04441,0,0
2,REACTOME IL 6 SIGNALING,0.94769,0.051948,-0.017945,0,0
2,DNA DEPENDENT DNA REPLICATION,0.16294,0.051945,0.087272,0,0
2,KEGG PROSTATE CANCER,0.077957,0.051825,0.12339,0,0
2,REACTOME OLFACTORY SIGNALING PATHWAY,0.46512,0.05172,0.0023122,0,0
2,SITE OF POLARIZED GROWTH,0.22235,0.051617,-0.32113,0,0
2,CHROMOSOME CONDENSATION,0.35153,0.051509,0.05253,0,0
2,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.077957,0.051466,0.065883,0,0
2,VACUOLE,0.97557,0.051421,-0.023476,0,0
2,REACTOME SIGNAL AMPLIFICATION,0.97557,0.051416,-0.0089294,0,0
2,REACTOME EGFR DOWNREGULATION,0.25729,0.051238,0.07435,0,0
2,LYMPHOCYTE ACTIVATION,0.76281,0.051006,-0.014148,0,0
2,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.14526,0.050837,0.059125,0,0
2,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.05161,0.050593,0.049201,0,0
2,ADAPTIVE IMMUNE RESPONSE,0.42855,0.050462,-0.002633,0,0
2,GROWTH,0.87144,0.050235,-0.0034242,0,0
2,ST WNT CA2 CYCLIC GMP PATHWAY,0.67137,0.050164,0.055418,0,0
2,CELLULAR LOCALIZATION,0.076492,0.049902,0.045415,0,0
2,NADH DEHYDROGENASE COMPLEX,0.63978,0.049848,0.041679,0,0
2,MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I,0.63978,0.049848,0.041679,0,0
2,RESPIRATORY CHAIN COMPLEX I,0.63978,0.049848,0.041679,0,0
2,BIOCARTA HDAC PATHWAY,0.13355,0.049685,0.089737,0,0
2,MAINTENANCE OF LOCALIZATION,0.36526,0.04961,0.050421,0,0
2,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.13583,0.049459,0.10335,0,0
2,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.32077,0.049211,0.069359,0,0
2,PID THROMBIN PAR1 PATHWAY,0.52025,0.049092,0.024844,0,0
2,REACTOME PROLACTIN RECEPTOR SIGNALING,0.35607,0.049045,0.13278,0,0
2,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.2839,0.04875,0.12361,0,0
2,BIOCARTA PTEN PATHWAY,0.22905,0.048483,0.06678,0,0
2,KEGG CHEMOKINE SIGNALING PATHWAY,0.32506,0.048344,0.031637,0,0
2,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.78962,0.048169,0.0080005,0,0
2,LEUKOCYTE ACTIVATION,0.50896,0.048059,0.013602,0,0
2,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.63978,0.047936,0.011249,0,0
2,KEGG TIGHT JUNCTION,0.54903,0.047869,0.032143,0,0
2,PID TXA2PATHWAY,0.40349,0.047749,0.01561,0,0
2,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.11235,0.047747,0.05128,0,0
2,REACTOME PLC BETA MEDIATED EVENTS,0.90599,0.047725,-0.0059855,0,0
2,SINGLE STRANDED DNA BINDING,0.11039,0.047621,0.10389,0,0
2,CELL ACTIVATION,0.42855,0.046998,0.032439,0,0
2,PID PTP1BPATHWAY,0.15015,0.046852,0.084371,0,0
2,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.85082,0.046795,0.013537,0,0
2,GOLGI APPARATUS,0.12259,0.046698,0.040866,0,0
2,KINASE ACTIVITY,0.064293,0.046487,0.056738,0,0
2,ATPASE ACTIVITY,0.053746,0.046051,0.05149,0,0
2,EXOPEPTIDASE ACTIVITY,0.43883,0.045917,0.078663,0,0
2,PROTEIN AMINO ACID LIPIDATION,0.32506,0.045915,0.074198,0,0
2,GLYCOSAMINOGLYCAN BINDING,0.22568,0.045426,0.084502,0,0
2,PID INTEGRIN3 PATHWAY,0.26847,0.045136,0.10487,0,0
2,REACTOME ACTIVATION OF RAC,0.47049,0.045101,-0.094351,0,0
2,POSITIVE REGULATION OF T CELL ACTIVATION,0.63354,0.044777,0.0086375,0,0
2,REACTOME CELL JUNCTION ORGANIZATION,0.47588,0.044677,0.039366,0,0
2,KEGG OXIDATIVE PHOSPHORYLATION,0.53742,0.044458,0.036985,0,0
2,PID AMB2 NEUTROPHILS PATHWAY,0.87144,0.044223,-0.049464,0,0
2,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.16828,0.044163,0.10056,0,0
2,BIOCARTA BAD PATHWAY,0.71006,0.044155,0.039479,0,0
2,TRANSPORT,0.84397,0.044015,-0.0034528,0,0
2,BIOCARTA PYK2 PATHWAY,0.9686,0.04356,-0.031132,0,0
2,BIOCARTA STATHMIN PATHWAY,0.69707,0.04322,-0.00027829,0,0
2,BLOOD COAGULATION,0.64605,0.043203,0.027456,0,0
2,CELLULAR HOMEOSTASIS,0.91293,0.04261,-0.0090229,0,0
2,REACTOME CELL CYCLE,0.34702,0.042518,0.032681,0,0
2,REACTOME ACTIVATION OF GENES BY ATF4,0.21256,0.04239,0.092098,0,0
2,BIOCARTA CFTR PATHWAY,0.73628,0.04237,0.019422,0,0
2,BIOPOLYMER BIOSYNTHETIC PROCESS,0.95466,0.04224,-0.023882,0,0
2,KEGG MTOR SIGNALING PATHWAY,0.33812,0.041827,0.043491,0,0
2,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.34256,0.041796,0.061798,0,0
2,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.91293,0.041692,-0.02402,0,0
2,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.53167,0.041545,0.016635,0,0
2,INORGANIC ANION TRANSPORT,0.91293,0.041315,-0.00017486,0,0
2,DEPHOSPHORYLATION,0.7495,0.041001,0.0039112,0,0
2,REACTOME IRON UPTAKE AND TRANSPORT,0.4978,0.040807,0.0207,0,0
2,BIOCARTA MPR PATHWAY,0.81668,0.040768,0.014341,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.76948,0.040661,-0.011079,0,0
2,BIOCARTA RANKL PATHWAY,0.71658,0.040597,-0.080082,0,0
2,NUCLEASE ACTIVITY,0.26847,0.040379,0.065754,0,0
2,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.31232,0.039454,0.023372,0,0
2,CELL DEVELOPMENT,0.40349,0.039193,0.023857,0,0
2,ST G ALPHA S PATHWAY,0.43367,0.039161,0.043763,0,0
2,REGULATION OF BIOLOGICAL QUALITY,0.4978,0.039058,0.0014633,0,0
2,LYTIC VACUOLE,0.98953,0.039055,-0.035909,0,0
2,LYSOSOME,0.98953,0.039055,-0.035909,0,0
2,PHAGOCYTOSIS,0.46512,0.038972,0.066242,0,0
2,LIPID RAFT,0.83713,0.038912,-0.025958,0,0
2,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.98255,0.038839,-0.026026,0,0
2,PID SMAD2 3PATHWAY,0.42347,0.038794,0.038202,0,0
2,NON MEMBRANE BOUND ORGANELLE,0.35153,0.038531,0.039876,0,0
2,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.35153,0.038531,0.039876,0,0
2,LATE ENDOSOME,0.4598,0.038477,0.066453,0,0
2,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.44924,0.038472,0.018987,0,0
2,BIOCARTA G1 PATHWAY,0.8303,0.038467,0.031076,0,0
2,PID INTEGRIN2 PATHWAY,0.85082,0.038303,-0.053915,0,0
2,CYTOKINE ACTIVITY,0.81668,0.037725,0.0030037,0,0
2,HOMEOSTATIC PROCESS,0.34256,0.03771,0.024358,0,0
2,GLUCOSE METABOLIC PROCESS,0.81668,0.037653,0.0011022,0,0
2,PID ERBB4 PATHWAY,0.64605,0.037436,0.024122,0,0
2,COFACTOR BINDING,0.32938,0.037272,0.11782,0,0
2,TIGHT JUNCTION,0.36064,0.037174,0.099436,0,0
2,BIOCARTA MAPK PATHWAY,0.27999,0.037083,0.044871,0,0
2,RESPONSE TO CHEMICAL STIMULUS,0.70355,0.037041,0.009476,0,0
2,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.37932,0.037007,0.079995,0,0
2,GALACTOSYLTRANSFERASE ACTIVITY,0.37932,0.036929,0.074857,0,0
2,REACTOME RAP1 SIGNALLING,0.85082,0.036921,0.0022924,0,0
2,REACTOME CELL CYCLE MITOTIC,0.15015,0.036743,0.061347,0,0
2,NUCLEAR REPLICATION FORK,0.38888,0.036725,0.043174,0,0
2,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.2839,0.036624,0.048745,0,0
2,KEGG P53 SIGNALING PATHWAY,0.87144,0.036574,0.0038633,0,0
2,ACTIN BINDING,0.80989,0.036483,0.0072854,0,0
2,ANATOMICAL STRUCTURE MORPHOGENESIS,0.13583,0.036454,0.059555,0,0
2,BONE REMODELING,0.26847,0.036384,0.081817,0,0
2,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.9686,0.036363,-0.021129,0,0
2,IMMUNE EFFECTOR PROCESS,0.80989,0.035797,-0.0052981,0,0
2,BIOCARTA HIF PATHWAY,0.52025,0.035698,0.028268,0,0
2,ANGIOGENESIS,0.17653,0.035689,0.07852,0,0
2,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.86455,0.035316,-0.020562,0,0
2,ST GA13 PATHWAY,0.55487,0.03496,0.019976,0,0
2,REACTOME PERK REGULATED GENE EXPRESSION,0.14769,0.034635,0.10218,0,0
2,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.40843,0.034605,0.075395,0,0
2,PROTEIN KINASE ACTIVITY,0.19695,0.034583,0.044803,0,0
2,REACTOME ELONGATION ARREST AND RECOVERY,0.084046,0.034533,0.062966,0,0
2,PHOSPHOLIPID METABOLIC PROCESS,0.71006,0.034418,0.0070891,0,0
2,LIPID TRANSPORTER ACTIVITY,0.64605,0.034301,0.00096783,0,0
2,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.83713,0.034226,0.019759,0,0
2,SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY,0.93377,0.034194,-0.025059,0,0
2,ATPASE ACTIVITY COUPLED,0.20937,0.034059,0.032915,0,0
2,ACTIVATION OF MAPK ACTIVITY,0.57857,0.034051,0.020228,0,0
2,PID AVB3 OPN PATHWAY,0.54321,0.03365,-0.044098,0,0
2,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.5726,0.033496,0.032705,0,0
2,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.23589,0.032675,0.051626,0,0
2,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.87144,0.032496,-0.0032799,0,0
2,KEGG TYROSINE METABOLISM,0.44402,0.032473,0.049772,0,0
2,REACTOME PROTEIN FOLDING,0.65866,0.032464,0.01367,0,0
2,SMALL GTPASE REGULATOR ACTIVITY,0.25363,0.032236,0.064677,0,0
2,INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.32938,0.032187,0.049639,0,0
2,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.91293,0.032161,-0.025993,0,0
2,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.91293,0.032124,-0.003606,0,0
2,BIOCARTA IGF1 PATHWAY,0.70355,0.032076,0.0049595,0,0
2,RESPONSE TO BIOTIC STIMULUS,0.33373,0.032022,0.022337,0,0
2,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.61497,0.031841,0.035363,0,0
2,REACTOME RNA POL III TRANSCRIPTION,0.32938,0.031101,0.036489,0,0
2,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.8303,0.030968,-0.01144,0,0
2,CELL CORTEX PART,0.86455,0.030941,0.011108,0,0
2,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.69707,0.030567,0.013594,0,0
2,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.50337,0.030431,0.04521,0,0
2,PID BETACATENIN DEG PATHWAY,0.53167,0.030412,0.022268,0,0
2,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.40349,0.030333,-0.0035084,0,0
2,UNFOLDED PROTEIN BINDING,0.39371,0.030248,0.040894,0,0
2,BIOCARTA LECTIN PATHWAY,0.98255,0.03017,-0.060081,0,0
2,AMINO ACID TRANSPORT,0.27999,0.029949,0.11619,0,0
2,ST MYOCYTE AD PATHWAY,0.70355,0.029792,0.02589,0,0
2,REACTOME DNA REPLICATION,0.16032,0.029441,0.069591,0,0
2,REACTOME MITOTIC PROMETAPHASE,0.48131,0.029214,0.044912,0,0
2,BIOCARTA TNFR2 PATHWAY,0.96163,0.028997,-0.031186,0,0
2,BIOCARTA ECM PATHWAY,0.63354,0.028719,0.056127,0,0
2,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.50337,0.028704,0.045812,0,0
2,MEMBRANE,0.79636,0.02854,-0.0079746,0,0
2,ESTABLISHMENT OF LOCALIZATION,0.94769,0.028277,-0.0069706,0,0
2,PROTEIN C TERMINUS BINDING,0.41842,0.028144,0.022743,0,0
2,TRANSCRIPTION FACTOR ACTIVITY,0.20621,0.028134,0.034986,0,0
2,PID FOXOPATHWAY,0.32506,0.027773,0.049138,0,0
2,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.87144,0.027442,0.0094369,0,0
2,BETA TUBULIN BINDING,0.35153,0.027422,0.075352,0,0
2,BIOCARTA D4GDI PATHWAY,0.57857,0.027244,0.098347,0,0
2,REACTOME SIGNALING BY NOTCH3,0.94073,0.026803,0.0040757,0,0
2,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.40349,0.026663,0.073267,0,0
2,CONDENSED NUCLEAR CHROMOSOME,0.98255,0.02656,-0.0010045,0,0
2,DNA BINDING,0.19695,0.026546,0.046933,0,0
2,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.63354,0.026535,0.017901,0,0
2,ACTIN FILAMENT ORGANIZATION,0.33812,0.02628,0.059871,0,0
2,BIOCARTA IGF1R PATHWAY,0.59664,0.026197,0.031378,0,0
2,CELLULAR COMPONENT DISASSEMBLY,0.41842,0.025822,0.03553,0,0
2,CASPASE ACTIVATION,0.59059,0.025814,-0.034998,0,0
2,ION BINDING,0.89215,0.025731,-0.010045,0,0
2,PHOSPHOLIPASE A2 ACTIVITY,0.94769,0.025388,0.015699,0,0
2,POLYSACCHARIDE BINDING,0.28785,0.025121,0.073588,0,0
2,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.26471,0.02512,0.046217,0,0
2,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.96163,0.02486,-0.0056052,0,0
2,REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER,0.59059,0.024632,0.027443,0,0
2,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.76948,0.024613,-0.02357,0,0
2,PROTEIN HOMODIMERIZATION ACTIVITY,0.68418,0.024541,0.014247,0,0
2,MEMBRANE PART,0.85768,0.024186,-0.009293,0,0
2,KEGG GNRH SIGNALING PATHWAY,0.71006,0.024163,-0.023296,0,0
2,BIOCARTA CCR3 PATHWAY,0.93377,0.024007,-0.001248,0,0
2,SIGNAL TRANSDUCTION,0.78962,0.023928,-0.0029012,0,0
2,PROTEIN KINASE CASCADE,0.72969,0.023923,0.0091581,0,0
2,PID P53DOWNSTREAMPATHWAY,0.71658,0.023792,0.022033,0,0
2,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.65234,0.023743,-0.044552,0,0
2,PID MTOR 4PATHWAY,0.21256,0.023679,0.048225,0,0
2,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.32077,0.023264,0.043633,0,0
2,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.5726,0.022984,0.016781,0,0
2,RESPONSE TO DRUG,0.55487,0.022974,0.066655,0,0
2,ENDOPEPTIDASE ACTIVITY,0.53742,0.022756,-0.0012798,0,0
2,REACTOME IL 7 SIGNALING,0.94073,0.022747,-0.026366,0,0
2,JNK CASCADE,0.85768,0.022703,0.011842,0,0
2,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.91987,0.022218,0.0043157,0,0
2,PID CONE PATHWAY,0.35607,0.022139,0.25423,0,0
2,REGULATION OF MAP KINASE ACTIVITY,0.8303,0.022135,0.0097737,0,0
2,COAGULATION,0.94769,0.022119,0.010239,0,0
2,PID SHP2 PATHWAY,0.4598,0.021929,0.035692,0,0
2,BIOCARTA MTA3 PATHWAY,0.91293,0.021861,-0.0067857,0,0
2,CELL SUBSTRATE ADHESION,1,0.021824,-0.013313,0,0
2,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.51459,0.021806,0.040165,0,0
2,DNA CATABOLIC PROCESS,0.23937,0.021803,0.075962,0,0
2,INTEGRAL TO MEMBRANE,0.67137,0.021558,-0.026018,0,0
2,NEGATIVE REGULATION OF GROWTH,0.48131,0.021531,-0.075048,0,0
2,REACTOME REGULATION OF IFNA SIGNALING,0.58456,0.021349,0.046514,0,0
2,PID CXCR4 PATHWAY,0.44924,0.02095,0.040381,0,0
2,PID IL1PATHWAY,0.19095,0.020837,0.081235,0,0
2,CHLORIDE CHANNEL ACTIVITY,0.89907,0.020492,-0.017158,0,0
2,ANION CHANNEL ACTIVITY,0.89907,0.020492,-0.017158,0,0
2,IDENTICAL PROTEIN BINDING,0.53167,0.020261,0.01781,0,0
2,PID HEDGEHOG 2PATHWAY,0.85082,0.020248,0.056603,0,0
2,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.83713,0.020162,-0.03056,0,0
2,BIOCARTA ERK5 PATHWAY,0.4545,0.020012,0.053216,0,0
2,BASE EXCISION REPAIR,0.60883,0.019981,0.0191,0,0
2,REACTOME ACTIVATED TLR4 SIGNALLING,0.29992,0.019373,0.028601,0,0
2,CALCIUM INDEPENDENT CELL CELL ADHESION,0.75615,0.019281,0.05008,0,0
2,SA G1 AND S PHASES,0.92682,0.019096,-0.045734,0,0
2,NUCLEAR BODY,0.64605,0.018923,0.020592,0,0
2,REACTOME CA DEPENDENT EVENTS,0.85768,0.018821,0.0087335,0,0
2,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.4978,0.018712,0.012353,0,0
2,TRANSCRIPTION REPRESSOR ACTIVITY,0.49227,0.018602,0.03001,0,0
2,CHEMICAL HOMEOSTASIS,0.86455,0.018582,-0.0084809,0,0
2,REACTOME UNWINDING OF DNA,0.7495,0.018413,-0.032205,0,0
2,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.5726,0.018392,0.02827,0,0
2,PLASMA MEMBRANE PART,0.57857,0.018127,-0.030878,0,0
2,DNA REPAIR,0.70355,0.017917,0.024314,0,0
2,DNA DIRECTED RNA POLYMERASEII CORE COMPLEX,0.42855,0.017686,0.077557,0,0
2,REGULATION OF BINDING,0.3746,0.017574,0.040833,0,0
2,LIPID CATABOLIC PROCESS,0.8303,0.017505,0.0076989,0,0
2,N ACETYLTRANSFERASE ACTIVITY,0.43367,0.017463,0.060109,0,0
2,REACTOME FANCONI ANEMIA PATHWAY,0.56075,0.017402,0.028938,0,0
2,HUMORAL IMMUNE RESPONSE,0.88523,0.017328,-0.037065,0,0
2,CELLULAR LIPID CATABOLIC PROCESS,0.85082,0.01729,0.0040164,0,0
2,ST ADRENERGIC,0.69707,0.017161,0.032764,0,0
2,REACTOME TIGHT JUNCTION INTERACTIONS,0.83713,0.016583,0.054728,0,0
2,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.79636,0.016523,0.013887,0,0
2,DNA METABOLIC PROCESS,0.12049,0.016413,0.054736,0,0
2,KEGG SPHINGOLIPID METABOLISM,0.70355,0.016406,0.0059151,0,0
2,VASCULATURE DEVELOPMENT,0.37932,0.016326,0.049118,0,0
2,DAMAGED DNA BINDING,0.51459,0.016264,-0.038691,0,0
2,ION HOMEOSTASIS,0.74288,0.016164,-0.02609,0,0
2,KEGG INSULIN SIGNALING PATHWAY,0.23245,0.015946,0.033789,0,0
2,TRANSITION METAL ION BINDING,0.41341,0.01587,0.023528,0,0
2,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.52025,0.015863,0.038026,0,0
2,CARBON OXYGEN LYASE ACTIVITY,0.89907,0.015831,0.014827,0,0
2,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.63354,0.015738,-0.025981,0,0
2,BIOCARTA SHH PATHWAY,0.47049,0.015691,0.098079,0,0
2,PROTEOGLYCAN METABOLIC PROCESS,0.57857,0.015632,0.036665,0,0
2,POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.61497,0.01563,-0.01722,0,0
2,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.98953,0.015508,-0.0093068,0,0
2,BIOCARTA ALK PATHWAY,0.83713,0.01536,0.0080937,0,0
2,BIOCARTA TCYTOTOXIC PATHWAY,0.71658,0.015222,0.028007,0,0
2,BIOCARTA PDGF PATHWAY,0.52025,0.014962,0.050866,0,0
2,PID NFAT 3PATHWAY,0.39858,0.014776,0.028806,0,0
2,SENSORY PERCEPTION,0.20309,0.01428,0.076089,0,0
2,ST P38 MAPK PATHWAY,0.91987,0.013849,-0.011254,0,0
2,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.80989,0.013795,-0.005477,0,0
2,EXTRACELLULAR REGION,0.65234,0.013777,-0.034317,0,0
2,ENZYME REGULATOR ACTIVITY,0.52594,0.013718,0.019219,0,0
2,PROTEIN POLYUBIQUITINATION,0.92682,0.013663,-0.014898,0,0
2,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.81668,0.013423,-0.03471,0,0
2,NEGATIVE REGULATION OF METABOLIC PROCESS,0.60272,0.013209,-0.026119,0,0
2,METALLOEXOPEPTIDASE ACTIVITY,0.67776,0.01316,0.053143,0,0
2,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.20309,0.013093,0.11231,0,0
2,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.54321,0.013064,0.038706,0,0
2,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.69707,0.012961,0.021607,0,0
2,CELL MATRIX ADHESION,0.98255,0.012919,-0.015768,0,0
2,REACTOME PYRIMIDINE METABOLISM,0.9686,0.012836,-0.043645,0,0
2,TELOMERIC DNA BINDING,0.59664,0.012653,0.048308,0,0
2,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.7495,0.012489,-0.038507,0,0
2,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.28785,0.012355,0.099462,0,0
2,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.5726,0.012094,0.020624,0,0
2,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.26098,0.011979,0.086332,0,0
2,INTEGRAL TO PLASMA MEMBRANE,0.48131,0.01174,-0.035058,0,0
2,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.91293,0.011729,-0.013043,0,0
2,BIOCARTA INSULIN PATHWAY,0.95466,0.011658,0.0025399,0,0
2,BIOCARTA MCALPAIN PATHWAY,0.37932,0.01161,0.076146,0,0
2,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.71006,0.01159,0.036139,0,0
2,INSOLUBLE FRACTION,0.53167,0.01144,0.068072,0,0
2,ORGAN MORPHOGENESIS,0.79636,0.011173,0.021149,0,0
2,CHROMATIN BINDING,0.72313,0.011106,0.027292,0,0
2,LIPOPROTEIN METABOLIC PROCESS,0.69707,0.010624,0.037751,0,0
2,REACTOME HS GAG BIOSYNTHESIS,0.36991,0.010491,0.084436,0,0
2,NEGATIVE REGULATION OF SECRETION,0.97557,0.010469,-0.019513,0,0
2,RESPONSE TO DNA DAMAGE STIMULUS,0.41341,0.010427,0.033434,0,0
2,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.76948,0.010404,0.11741,0,0
2,TRANSCRIPTION INITIATION,0.50337,0.010384,0.047954,0,0
2,HEMOSTASIS,0.93377,0.010329,0.010472,0,0
2,INTRINSIC TO MEMBRANE,0.5726,0.010298,-0.029474,0,0
2,TRANSCRIPTION ACTIVATOR ACTIVITY,0.74288,0.010057,0.020284,0,0
2,BIOCARTA NO1 PATHWAY,0.58456,0.0099615,0.010568,0,0
2,PID AP1 PATHWAY,0.76948,0.0099352,-0.0079743,0,0
2,CALCIUM MEDIATED SIGNALING,0.39858,0.0096729,-0.079497,0,0
2,REACTOME VIRAL MESSENGER RNA SYNTHESIS,0.38408,0.0095927,0.052802,0,0
2,DNA MODIFICATION,0.79636,0.0095556,-0.047414,0,0
2,BIOCARTA CREB PATHWAY,0.63354,0.0094036,-0.042773,0,0
2,BIOCARTA IGF1MTOR PATHWAY,0.38888,0.009299,0.051843,0,0
2,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.52594,0.009184,0.033237,0,0
2,STEROID METABOLIC PROCESS,0.91987,0.0091254,-0.0047951,0,0
2,PLASMA MEMBRANE,0.59059,0.0090586,-0.031217,0,0
2,PROTEIN MATURATION,0.86455,0.0088959,-0.026096,0,0
2,KEGG WNT SIGNALING PATHWAY,0.91987,0.0085739,0.0032674,0,0
2,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.82348,0.0085599,-0.021361,0,0
2,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.38408,0.0083546,0.058157,0,0
2,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.94769,0.008271,0.0042741,0,0
2,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.7495,0.0081526,0.039301,0,0
2,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.91987,0.0080676,-0.0059409,0,0
2,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.82348,0.0078531,0.012623,0,0
2,INTEGRIN COMPLEX,0.44402,0.0078104,0.096988,0,0
2,PID MAPKTRKPATHWAY,0.76948,0.0077519,-0.023577,0,0
2,GROWTH FACTOR BINDING,0.60272,0.0073178,0.01236,0,0
2,NUCLEAR ORGANIZATION AND BIOGENESIS,0.66501,0.007162,0.01887,0,0
2,CATION BINDING,0.66501,0.007074,-0.022287,0,0
2,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.2839,0.0069662,0.061493,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.59664,0.0069288,0.03969,0,0
2,DOUBLE STRANDED DNA BINDING,0.29992,0.0068072,0.12178,0,0
2,ENERGY RESERVE METABOLIC PROCESS,0.99651,0.0067738,-0.0061941,0,0
2,BIOCARTA ATM PATHWAY,0.44402,0.0066632,-0.076439,0,0
2,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.69707,0.006647,-0.012524,0,0
2,REACTOME SEMAPHORIN INTERACTIONS,0.87144,0.0066141,-0.049943,0,0
2,INTRINSIC TO PLASMA MEMBRANE,0.38408,0.0060525,-0.039504,0,0
2,CHEMOKINE ACTIVITY,0.27227,0.0057769,0.05455,0,0
2,CHEMOKINE RECEPTOR BINDING,0.27227,0.0057769,0.05455,0,0
2,RECEPTOR ACTIVITY,0.57857,0.0057595,-0.035105,0,0
2,REPRODUCTION,0.84397,0.0057504,-0.0058567,0,0
2,CARBOHYDRATE METABOLIC PROCESS,0.67776,0.0055116,-0.028444,0,0
2,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.75615,0.0054633,-0.003042,0,0
2,PID ATR PATHWAY,0.41842,0.005388,0.053477,0,0
2,PROTEIN PROCESSING,0.88523,0.0053664,-0.01117,0,0
2,TRANSCRIPTION FACTOR BINDING,0.36991,0.0053546,0.037917,0,0
2,ZINC ION BINDING,0.69707,0.0053506,-0.0043359,0,0
2,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.67776,0.0050539,0.013182,0,0
2,DIGESTION,0.78962,0.0048273,-0.0041758,0,0
2,HYDRO LYASE ACTIVITY,0.85768,0.0046462,0.02331,0,0
2,REACTOME SIGNALLING BY NGF,0.93377,0.0042299,-0.0042808,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.94769,0.0040577,0.0058109,0,0
2,REGULATION OF KINASE ACTIVITY,0.71658,0.0040345,-0.012589,0,0
2,PID AR NONGENOMIC PATHWAY,0.34256,0.0039042,0.065119,0,0
2,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.52025,0.0038896,-0.049141,0,0
2,BIOCARTA PTC1 PATHWAY,0.69707,0.0038059,0.014784,0,0
2,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.96163,0.0037506,0.015718,0,0
2,SISTER CHROMATID SEGREGATION,0.80312,0.0036074,0.012253,0,0
2,BIOCARTA BIOPEPTIDES PATHWAY,0.50337,0.0035134,-0.041551,0,0
2,BIOCARTA CD40 PATHWAY,0.62732,0.0033504,-0.00070742,0,0
2,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.78962,0.0033441,-0.037418,0,0
2,BIOCARTA PGC1A PATHWAY,0.91987,0.0031669,-0.005156,0,0
2,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.47588,0.0031627,-0.033525,0,0
2,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.44924,0.0029063,0.024026,0,0
2,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.95466,0.002897,-0.031983,0,0
2,BIOCARTA ACH PATHWAY,0.49227,0.0026318,0.060104,0,0
2,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.52594,0.0025402,0.036533,0,0
2,RNA POLYMERASE ACTIVITY,0.71006,0.0024833,0.027954,0,0
2,WNT SIGNALING,0.82348,0.0022934,0.021158,0,0
2,REACTOME SIGNALING BY ERBB2,0.74288,0.0022013,-0.015709,0,0
2,KEGG PANTOTHENATE AND COA BIOSYNTHESIS,0.87833,0.0021232,0.014881,0,0
2,CYTOKINESIS,0.50896,0.0019352,0.076242,0,0
2,COLLAGEN BINDING,0.50337,0.0018931,-0.12514,0,0
2,REGULATION OF PROTEIN KINASE ACTIVITY,0.74288,0.0017978,-0.01436,0,0
2,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.94769,0.0013341,0.016671,0,0
2,PID RHODOPSIN PATHWAY,0.91293,0.0013018,0.10431,0,0
2,PID PI3KPLCTRKPATHWAY,0.62732,0.0012807,-0.0080985,0,0
2,BIOCARTA SRCRPTP PATHWAY,0.91987,0.0012565,0.01066,0,0
2,BIOCARTA TCR PATHWAY,0.79636,0.0012116,-0.021926,0,0
2,REACTOME HYALURONAN METABOLISM,0.76281,0.0010259,-0.026581,0,0
2,LYSOSOME ORGANIZATION AND BIOGENESIS,0.78289,0.0010206,0.047966,0,0
2,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.4598,0.0010068,-0.037586,0,0
2,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.87144,0.00064841,0.0012392,0,0
2,PID CIRCADIANPATHWAY,0.61497,0.00056655,0.044231,0,0
2,INNATE IMMUNE RESPONSE,0.19393,0.00056008,-0.14735,0,0
2,UBIQUITIN LIGASE COMPLEX,0.36991,0.00043672,0.070244,0,0
2,REACTOME GAP JUNCTION ASSEMBLY,0.8303,0.00024238,-0.0087137,0,0
2,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.98953,-4.9055e-05,-0.010459,0,0
2,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.85082,-0.00011006,0.01233,0,0
2,DNA REPLICATION,0.20937,-0.00047756,0.058162,0,0
2,REACTOME TIE2 SIGNALING,0.67137,-0.0006482,0.066956,0,0
2,REGULATION OF BODY FLUID LEVELS,0.73628,-0.00065802,-0.0060583,0,0
2,STRUCTURE SPECIFIC DNA BINDING,0.44402,-0.00086269,0.071339,0,0
2,PID EPHRINBREVPATHWAY,0.96163,-0.00090435,0.0061803,0,0
2,REGULATION OF GENE EXPRESSION EPIGENETIC,0.56075,-0.0012296,0.038243,0,0
2,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.50337,-0.0012617,-0.042635,0,0
2,PID EPHA2 FWDPATHWAY,0.72313,-0.0014758,0.03669,0,0
2,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.54903,-0.0015936,-0.027048,0,0
2,SIG IL4RECEPTOR IN B LYPHOCYTES,0.40349,-0.0016823,0.063417,0,0
2,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.94769,-0.0016834,0.00032739,0,0
2,PID TRKRPATHWAY,0.92682,-0.0018593,-0.0040037,0,0
2,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.63978,-0.0021251,-0.023562,0,0
2,CYTOSKELETON,0.98255,-0.0021632,0.014291,0,0
2,BIOCARTA NTHI PATHWAY,0.98255,-0.0022077,0.0047374,0,0
2,PID LKB1 PATHWAY,0.70355,-0.0023712,0.02223,0,0
2,REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL,0.48131,-0.0024337,-0.10576,0,0
2,BIOCARTA TNFR1 PATHWAY,0.89907,-0.0025687,0.049755,0,0
2,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.4978,-0.0026025,0.044629,0,0
2,KEGG PROTEIN EXPORT,0.97557,-0.0026171,0.0065993,0,0
2,VACUOLE ORGANIZATION AND BIOGENESIS,0.80312,-0.0026351,0.04242,0,0
2,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.91293,-0.0028126,-0.016259,0,0
2,PID IL3 PATHWAY,0.89215,-0.0029204,0.017844,0,0
2,REACTOME REGULATION OF SIGNALING BY CBL,0.82348,-0.0034143,0.10451,0,0
2,PID ERBB1 DOWNSTREAM PATHWAY,0.66501,-0.0034372,0.01944,0,0
2,TRANSCRIPTION COACTIVATOR ACTIVITY,0.79636,-0.0035505,0.021971,0,0
2,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.86455,-0.0042401,0.015426,0,0
2,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.32938,-0.0043231,-0.064538,0,0
2,PID ENDOTHELINPATHWAY,0.36064,-0.0043519,-0.043623,0,0
2,REACTOME ALPHA LINOLENIC ACID ALA METABOLISM,0.93377,-0.0043567,0.033266,0,0
2,DNA PACKAGING,1,-0.0044689,0.013892,0,0
2,BIOCARTA NFAT PATHWAY,0.58456,-0.0046172,0.022368,0,0
2,BIOCARTA ERYTH PATHWAY,0.42855,-0.004995,-0.15699,0,0
2,REACTOME SIGNALING BY NOTCH1,0.76281,-0.0050985,-0.0090672,0,0
2,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.73628,-0.0053098,-0.00054391,0,0
2,T CELL ACTIVATION,0.71658,-0.0055496,-0.042531,0,0
2,KEGG PURINE METABOLISM,0.26847,-0.0056076,0.069709,0,0
2,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.89907,-0.0057038,-0.0094843,0,0
2,PID IL12 STAT4PATHWAY,0.56666,-0.0059853,-0.080561,0,0
2,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.46512,-0.0062323,-0.043553,0,0
2,INTRACELLULAR SIGNALING CASCADE,0.94769,-0.0063214,-0.0056172,0,0
2,BIOCARTA CBL PATHWAY,0.76281,-0.0063483,0.020039,0,0
2,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.93377,-0.0064201,0.016966,0,0
2,CONDENSED CHROMOSOME,0.77618,-0.0064296,-0.0078435,0,0
2,REACTOME SIGNALING BY FGFR3 MUTANTS,0.52594,-0.0064902,-0.0683,0,0
2,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.78962,-0.0066615,0.023814,0,0
2,RECEPTOR COMPLEX,0.65866,-0.0066928,0.041053,0,0
2,REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS,0.78962,-0.0073922,-0.045715,0,0
2,PID TCRCALCIUMPATHWAY,0.86455,-0.0078543,0.0029066,0,0
2,PROTEIN DOMAIN SPECIFIC BINDING,0.91987,-0.0080266,-0.011832,0,0
2,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.69707,-0.00809,-0.014488,0,0
2,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.98953,-0.0085682,-0.0030245,0,0
2,REACTOME IL RECEPTOR SHC SIGNALING,0.71006,-0.0090871,0.068151,0,0
2,MITOTIC SISTER CHROMATID SEGREGATION,0.9686,-0.0091834,-0.013553,0,0
2,REGULATION OF CELL GROWTH,0.71658,-0.0093614,-0.037709,0,0
2,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.96163,-0.0093986,-0.00043102,0,0
2,PYROPHOSPHATASE ACTIVITY,0.67137,-0.0097233,-0.015755,0,0
2,MEMBRANE LIPID METABOLIC PROCESS,0.81668,-0.0097888,-0.019256,0,0
2,ENZYME BINDING,0.54321,-0.010075,-0.016193,0,0
2,REACTOME KERATAN SULFATE DEGRADATION,0.87144,-0.01033,-0.00067806,0,0
2,PID E2F PATHWAY,0.99651,-0.010481,0.032816,0,0
2,PID DELTANP63PATHWAY,0.98255,-0.010699,0.042003,0,0
2,KEGG OLFACTORY TRANSDUCTION,0.67776,-0.010885,-0.005695,0,0
2,REACTOME COMMON PATHWAY,0.99651,-0.011177,-0.0013112,0,0
2,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.39371,-0.011227,-0.052237,0,0
2,TRANSCRIPTION COFACTOR ACTIVITY,0.87833,-0.011238,0.0078929,0,0
2,KEGG GLYCEROLIPID METABOLISM,0.62732,-0.011516,-0.045655,0,0
2,HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS,0.81668,-0.011611,0.022597,0,0
2,PID IL23PATHWAY,0.83713,-0.0118,-0.024891,0,0
2,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.65234,-0.012111,-0.0042768,0,0
2,REACTOME SIGNALING BY ROBO RECEPTOR,0.19393,-0.012219,-0.10507,0,0
2,GOLGI STACK,0.59664,-0.012317,-0.043408,0,0
2,REGULATION OF HYDROLASE ACTIVITY,0.78962,-0.012491,-0.0084347,0,0
2,MRNA BINDING,0.47049,-0.012561,-0.039859,0,0
2,PID RHOA PATHWAY,0.78962,-0.012635,0.026163,0,0
2,BIOCARTA P27 PATHWAY,1,-0.012649,0.021399,0,0
2,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.94073,-0.012861,0.014945,0,0
2,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.59664,-0.01294,-0.029969,0,0
2,BIOCARTA AT1R PATHWAY,0.56666,-0.013444,-0.041519,0,0
2,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.44402,-0.013521,-0.093811,0,0
2,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.32938,-0.013888,-0.049987,0,0
2,REACTOME SIGNALING BY SCF KIT,0.59059,-0.014073,0.029055,0,0
2,REACTOME MITOTIC G2 G2 M PHASES,0.67137,-0.014186,-0.019936,0,0
2,APICAL JUNCTION COMPLEX,0.56075,-0.014359,0.066984,0,0
2,APICOLATERAL PLASMA MEMBRANE,0.56075,-0.014359,0.066984,0,0
2,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.99651,-0.014763,0.0072631,0,0
2,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.16828,-0.015151,-0.11226,0,0
2,DETECTION OF EXTERNAL STIMULUS,0.18219,-0.015491,-0.012122,0,0
2,BIOCARTA G2 PATHWAY,0.36064,-0.015519,-0.077086,0,0
2,REACTOME CD28 DEPENDENT VAV1 PATHWAY,0.8303,-0.015758,0.024331,0,0
2,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.66501,-0.015824,-0.016611,0,0
2,PID HDAC CLASSII PATHWAY,0.29184,-0.016038,-0.051097,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION,0.78962,-0.016175,-0.0062639,0,0
2,BIOCARTA EPONFKB PATHWAY,0.37932,-0.016583,-0.14939,0,0
2,PROTEIN COMPLEX BINDING,0.91987,-0.016837,-0.019279,0,0
2,MEMBRANE BOUND VESICLE,0.46512,-0.017331,-0.0524,0,0
2,REACTOME PI 3K CASCADE,0.72313,-0.017409,-0.0092536,0,0
2,ENDOSOME TRANSPORT,0.90599,-0.017529,0.0019601,0,0
2,MICROTUBULE,0.90599,-0.017645,-0.0043667,0,0
2,TUBE DEVELOPMENT,0.57857,-0.017815,-0.062668,0,0
2,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36064,-0.017964,0.096696,0,0
2,KEGG COLORECTAL CANCER,0.94769,-0.018536,0.024104,0,0
2,REGULATION OF TRANSFERASE ACTIVITY,0.60883,-0.018644,-0.018241,0,0
2,RECEPTOR BINDING,0.48678,-0.018679,-0.033935,0,0
2,GUANYL NUCLEOTIDE BINDING,0.79636,-0.01872,-0.0056373,0,0
2,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.97557,-0.018949,0.0082048,0,0
2,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.92682,-0.019018,0.0092851,0,0
2,KEGG CELL CYCLE,0.91987,-0.019153,0.021086,0,0
2,PROTEIN COMPLEX DISASSEMBLY,0.64605,-0.019351,0.049266,0,0
2,PID CD40 PATHWAY,0.73628,-0.019696,-0.034168,0,0
2,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.43367,-0.019742,-0.084353,0,0
2,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.54903,-0.019812,-0.019015,0,0
2,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.58456,-0.019867,-0.017057,0,0
2,MITOTIC SPINDLE ORGANIZATION AND BIOGENESIS,0.83713,-0.019956,-0.011287,0,0
2,PID CDC42 PATHWAY,0.81668,-0.020112,-0.0051534,0,0
2,PID CDC42 REG PATHWAY,0.44402,-0.020304,-0.02661,0,0
2,BIOCARTA AGR PATHWAY,0.83713,-0.020652,0.0076219,0,0
2,CELL MIGRATION,0.96163,-0.020681,-0.0060261,0,0
2,REGULATION OF DNA BINDING,0.39858,-0.020979,0.042194,0,0
2,BIOCARTA TGFB PATHWAY,0.98255,-0.021127,0.014985,0,0
2,MONOOXYGENASE ACTIVITY,0.98255,-0.021172,0.0075537,0,0
2,REACTOME SIGNALING BY FGFR IN DISEASE,0.89907,-0.021272,0.0032475,0,0
2,REACTOME ADP SIGNALLING THROUGH P2RY1,0.5726,-0.021344,-0.026819,0,0
2,BIOCARTA AKAPCENTROSOME PATHWAY,0.76948,-0.021794,-0.0067442,0,0
2,BIOCARTA THELPER PATHWAY,0.99651,-0.022809,-0.0059851,0,0
2,WOUND HEALING,0.94769,-0.022884,0.010803,0,0
2,BIOCARTA EGF PATHWAY,0.91987,-0.022968,0.0068422,0,0
2,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.63978,-0.023153,-0.01408,0,0
2,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.86455,-0.023486,-0.00091868,0,0
2,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.23245,-0.023547,-0.062789,0,0
2,PML BODY,0.80312,-0.023703,-0.029898,0,0
2,MACROMOLECULAR COMPLEX DISASSEMBLY,0.47049,-0.024619,0.063596,0,0
2,CYTOSKELETAL PART,0.32077,-0.024658,-0.02188,0,0
2,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.91987,-0.024705,0.022749,0,0
2,KEGG NITROGEN METABOLISM,0.91987,-0.02483,0.046722,0,0
2,PID PLK1 PATHWAY,0.89215,-0.025065,0.001752,0,0
2,TRANSMEMBRANE RECEPTOR ACTIVITY,0.19393,-0.025065,-0.064413,0,0
2,REGULATION OF CHROMOSOME ORGANIZATION AND BIOGENESIS,0.49227,-0.02524,-0.037146,0,0
2,AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.75615,-0.025261,-0.034594,0,0
2,CARBOHYDRATE KINASE ACTIVITY,0.54321,-0.025595,-0.070142,0,0
2,REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA,0.94073,-0.025677,0.0097945,0,0
2,MAGNESIUM ION BINDING,0.59664,-0.026108,-0.019926,0,0
2,CHROMOSOME,0.65866,-0.02645,0.0060338,0,0
2,EXTRACELLULAR REGION PART,0.38888,-0.026486,-0.059764,0,0
2,BIOCARTA CTLA4 PATHWAY,0.64605,-0.026851,-0.039349,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.25729,-0.02711,-0.13112,0,0
2,PID HEDGEHOG GLIPATHWAY,0.54321,-0.027268,-0.011559,0,0
2,REACTOME G1 PHASE,0.92682,-0.027672,0.010505,0,0
2,REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1,0.77618,-0.027715,0.054396,0,0
2,UBIQUITIN BINDING,0.14769,-0.027727,-0.093184,0,0
2,PID FRA PATHWAY,0.75615,-0.028026,-0.014135,0,0
2,COATED VESICLE,0.20309,-0.028378,-0.063165,0,0
2,ANATOMICAL STRUCTURE DEVELOPMENT,0.87144,-0.028714,-0.0095187,0,0
2,BIOCARTA KERATINOCYTE PATHWAY,0.76281,-0.028814,0.01364,0,0
2,PROTEIN OLIGOMERIZATION,0.61497,-0.028885,0.039852,0,0
2,CHROMOSOMAL PART,0.62113,-0.028917,0.0066971,0,0
2,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.60883,-0.028918,-0.035284,0,0
2,REACTOME ARMS MEDIATED ACTIVATION,0.38408,-0.02907,-0.039992,0,0
2,BIOCARTA CXCR4 PATHWAY,0.41341,-0.029287,-0.050849,0,0
2,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.3746,-0.030328,-0.069858,0,0
2,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.3746,-0.030328,-0.069858,0,0
2,RESPONSE TO IONIZING RADIATION,0.91987,-0.030373,-0.018065,0,0
2,KEGG TGF BETA SIGNALING PATHWAY,0.71658,-0.030524,-0.0079961,0,0
2,KEGG BASAL CELL CARCINOMA,0.4598,-0.031192,-0.061623,0,0
2,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.17099,-0.031662,-0.09273,0,0
2,NOTCH SIGNALING PATHWAY,0.16559,-0.031782,-0.11474,0,0
2,POSITIVE REGULATION OF TRANSPORT,0.83713,-0.031893,-0.011054,0,0
2,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.52594,-0.032067,-0.025128,0,0
2,VESICLE,0.3746,-0.032102,-0.055177,0,0
2,PROTEIN METHYLTRANSFERASE ACTIVITY,0.81668,-0.032206,0.010416,0,0
2,REACTOME SIGNALING BY BMP,0.78962,-0.032503,0.079111,0,0
2,KEGG OOCYTE MEIOSIS,0.35607,-0.032945,-0.025394,0,0
2,PROTEIN DNA COMPLEX ASSEMBLY,0.52594,-0.033025,-0.0030831,0,0
2,PID ERA GENOMIC PATHWAY,0.73628,-0.033302,-0.012316,0,0
2,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.48131,-0.033304,-0.039688,0,0
2,MANNOSYLTRANSFERASE ACTIVITY,0.54321,-0.033432,-0.022615,0,0
2,BIOCARTA IL7 PATHWAY,0.85082,-0.033517,0.018516,0,0
2,REACTOME REGULATED PROTEOLYSIS OF P75NTR,0.63354,-0.033771,-0.060802,0,0
2,PID P75NTRPATHWAY,0.57857,-0.033789,-0.029435,0,0
2,BIOCARTA AGPCR PATHWAY,0.55487,-0.033965,0.1021,0,0
2,KEGG DORSO VENTRAL AXIS FORMATION,0.98953,-0.034487,-0.0096718,0,0
2,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.53742,-0.034608,-0.019157,0,0
2,AMINE TRANSPORT,0.91987,-0.034839,0.016051,0,0
2,SPINDLE POLE,0.80989,-0.035047,0.042727,0,0
2,OLIGOSACCHARYL TRANSFERASE COMPLEX,0.98255,-0.035174,0.0035727,0,0
2,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.91987,-0.035748,-0.0016835,0,0
2,EXTERNAL SIDE OF PLASMA MEMBRANE,0.71658,-0.036118,-0.023531,0,0
2,PID VEGFR1 PATHWAY,0.41341,-0.036172,-0.066586,0,0
2,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR BINDING,0.23937,-0.036295,-0.084535,0,0
2,REACTOME SIGNALING BY FGFR1 MUTANTS,0.87833,-0.036845,0.013345,0,0
2,REACTOME G ALPHA Q SIGNALLING EVENTS,0.4545,-0.036852,-0.021737,0,0
2,SPINDLE ORGANIZATION AND BIOGENESIS,0.85768,-0.037118,-0.0068457,0,0
2,BIOCARTA HSP27 PATHWAY,0.83713,-0.037139,0.063928,0,0
2,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.94769,-0.037544,-0.025531,0,0
2,PHOSPHOLIPID BINDING,0.70355,-0.037839,-0.018541,0,0
2,CYTOSKELETAL PROTEIN BINDING,0.23937,-0.038241,-0.061133,0,0
2,PROTEIN AUTOPROCESSING,0.9686,-0.038269,0.0055519,0,0
2,ST FAS SIGNALING PATHWAY,0.17099,-0.038383,-0.10075,0,0
2,SEXUAL REPRODUCTION,0.21579,-0.039179,-0.049418,0,0
2,REACTOME SIGNALING BY GPCR,0.085627,-0.039784,-0.054404,0,0
2,REACTOME IL 2 SIGNALING,0.78962,-0.041273,0.011395,0,0
2,REACTOME INFLAMMASOMES,0.64605,-0.041343,-0.099416,0,0
2,PID NCADHERINPATHWAY,0.44402,-0.041356,-0.049008,0,0
2,REACTOME SIGNALING BY EGFR IN CANCER,0.16559,-0.041454,-0.046806,0,0
2,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.041637,-0.066185,0,0
2,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.84397,-0.04187,-0.0036574,0,0
2,REACTOME SIGNALLING TO RAS,0.21579,-0.04209,-0.057737,0,0
2,PID BMPPATHWAY,0.85768,-0.042221,0.053067,0,0
2,NEURON APOPTOSIS,0.40843,-0.042301,-0.086574,0,0
2,REGULATION OF IMMUNE SYSTEM PROCESS,0.17934,-0.042721,-0.071238,0,0
2,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.62732,-0.043234,-0.016612,0,0
2,PROTEIN EXPORT FROM NUCLEUS,0.57857,-0.0435,-0.018121,0,0
2,REGULATION OF HEART CONTRACTION,0.23589,-0.043526,-0.078228,0,0
2,ENDODEOXYRIBONUCLEASE ACTIVITY,0.59664,-0.043561,-0.035159,0,0
2,T CELL PROLIFERATION,0.30815,-0.043861,-0.092188,0,0
2,GTP BINDING,0.5726,-0.043997,-0.018684,0,0
2,NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.89907,-0.044079,0.048674,0,0
2,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.35607,-0.044471,-0.019359,0,0
2,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.54321,-0.044613,-0.028626,0,0
2,CYTOPLASMIC VESICLE,0.23937,-0.044617,-0.065664,0,0
2,PID NFAT TFPATHWAY,0.54903,-0.044632,-0.02397,0,0
2,MICROTUBULE BASED MOVEMENT,0.11841,-0.04477,-0.085785,0,0
2,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.72969,-0.045216,0.023748,0,0
2,REGULATION OF MOLECULAR FUNCTION,0.32077,-0.045494,-0.028406,0,0
2,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.47049,-0.045787,-0.029084,0,0
2,BIOCARTA CACAM PATHWAY,0.4545,-0.046146,-0.045389,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.87144,-0.046314,0.02875,0,0
2,REACTOME GPCR DOWNSTREAM SIGNALING,0.054842,-0.04643,-0.060724,0,0
2,EXCRETION,0.63354,-0.046803,-0.03661,0,0
2,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.34256,-0.046878,-0.075255,0,0
2,LAMELLIPODIUM,0.34256,-0.046982,-0.095976,0,0
2,REPLICATION FORK,0.19695,-0.047091,-0.063987,0,0
2,SOLUBLE FRACTION,0.21579,-0.047123,-0.062611,0,0
2,REGULATION OF GENE SPECIFIC TRANSCRIPTION,0.59664,-0.04739,-0.010015,0,0
2,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.67776,-0.047466,-0.015669,0,0
2,PID ALK1PATHWAY,0.47588,-0.048216,-0.072411,0,0
2,ST INTEGRIN SIGNALING PATHWAY,0.52594,-0.048304,-0.033402,0,0
2,KEGG PRION DISEASES,0.32938,-0.048328,-0.046129,0,0
2,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.29586,-0.048455,-0.027066,0,0
2,HORMONE METABOLIC PROCESS,0.73628,-0.048577,-0.030852,0,0
2,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.11434,-0.048641,-0.063078,0,0
2,GLYCOPROTEIN METABOLIC PROCESS,0.12908,-0.048913,-0.094817,0,0
2,REACTOME SIGNALLING TO ERKS,0.12908,-0.048952,-0.05909,0,0
2,N METHYLTRANSFERASE ACTIVITY,0.51459,-0.04898,-0.049778,0,0
2,BIOCARTA PLCE PATHWAY,0.69061,-0.049193,-0.024547,0,0
2,SYSTEM DEVELOPMENT,0.36526,-0.049489,-0.040324,0,0
2,BIOCARTA EPO PATHWAY,0.29184,-0.049496,-0.081013,0,0
2,KEGG CALCIUM SIGNALING PATHWAY,0.15773,-0.049797,-0.05947,0,0
2,CELLULAR RESPONSE TO STRESS,0.65234,-0.049832,0.013661,0,0
2,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.32938,-0.049836,-0.059847,0,0
2,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.50337,-0.049964,-0.0071032,0,0
2,SMALL CONJUGATING PROTEIN BINDING,0.10654,-0.050221,-0.099894,0,0
2,TRANS GOLGI NETWORK,0.50896,-0.05059,0.049915,0,0
2,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.72313,-0.050913,-0.029895,0,0
2,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.20621,-0.05102,-0.13675,0,0
2,REACTOME CELL CELL JUNCTION ORGANIZATION,0.39371,-0.051242,-0.048579,0,0
2,CALCIUM ION BINDING,0.12908,-0.051414,-0.076797,0,0
2,TRANSCRIPTION COREPRESSOR ACTIVITY,0.15015,-0.051487,-0.052341,0,0
2,STRIATED MUSCLE CONTRACTION GO 0006941,0.33812,-0.051516,-0.10218,0,0
2,NUCLEAR CHROMATIN,0.76281,-0.051606,-0.0070417,0,0
2,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.19393,-0.052129,-0.048855,0,0
2,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.25001,-0.052256,-0.079467,0,0
2,LYSOSOMAL TRANSPORT,0.47588,-0.052353,-0.11272,0,0
2,CHANNEL REGULATOR ACTIVITY,0.11841,-0.052398,-0.10759,0,0
2,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.15015,-0.052479,-0.060802,0,0
2,PID ARF6DOWNSTREAMPATHWAY,0.62732,-0.052943,-0.01385,0,0
2,KEGG MELANOGENESIS,0.049546,-0.052977,-0.080126,0,0
2,ENZYME INHIBITOR ACTIVITY,0.16828,-0.053171,-0.078103,0,0
2,PID GMCSF PATHWAY,0.65866,-0.053398,-0.017298,0,0
2,PATTERN SPECIFICATION PROCESS,0.58456,-0.053634,-0.056657,0,0
2,KEGG MAPK SIGNALING PATHWAY,0.090515,-0.053696,-0.061263,0,0
2,S PHASE,0.32938,-0.053839,-0.070858,0,0
2,BIOCARTA NDKDYNAMIN PATHWAY,0.04854,-0.054011,-0.14761,0,0
2,REACTOME OPIOID SIGNALLING,0.27227,-0.054298,-0.057522,0,0
2,REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE,0.4545,-0.054299,-0.075725,0,0
2,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.5726,-0.054349,-0.013609,0,0
2,REACTOME G0 AND EARLY G1,0.41842,-0.055011,-0.044602,0,0
2,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.33812,-0.055284,-0.035921,0,0
2,REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX,0.85082,-0.055563,0.010743,0,0
2,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.42855,-0.055565,-0.028036,0,0
2,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.28785,-0.055625,-0.05211,0,0
2,REACTOME DEFENSINS,0.82348,-0.055765,-0.053077,0,0
2,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.2,-0.057397,-0.077795,0,0
2,SA B CELL RECEPTOR COMPLEXES,0.44402,-0.057617,-0.032061,0,0
2,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.43367,-0.057859,-0.064554,0,0
2,PID PRLSIGNALINGEVENTSPATHWAY,0.33373,-0.057937,-0.084657,0,0
2,POSITIVE REGULATION OF CASPASE ACTIVITY,0.82348,-0.058093,-0.013781,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.29586,-0.058286,-0.058124,0,0
2,INTEGRIN BINDING,0.99651,-0.059284,-0.02837,0,0
2,LOCOMOTORY BEHAVIOR,0.24288,-0.059435,-0.063006,0,0
2,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.72969,-0.05953,0.082187,0,0
2,REGULATION OF CATALYTIC ACTIVITY,0.18219,-0.06,-0.045179,0,0
2,ANTIPORTER ACTIVITY,0.8303,-0.061634,-0.0097467,0,0
2,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.95466,-0.06177,-0.013022,0,0
2,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.60272,-0.061992,-0.014215,0,0
2,REGULATION OF TRANSPORT,0.046579,-0.06202,-0.10488,0,0
2,BILE ACID METABOLIC PROCESS,0.73628,-0.062212,0.11588,0,0
2,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.67137,-0.063025,-0.037316,0,0
2,PID EPHBFWDPATHWAY,0.33373,-0.06316,-0.040821,0,0
2,CARBOXYLESTERASE ACTIVITY,0.53742,-0.063742,-0.046906,0,0
2,FEMALE GAMETE GENERATION,0.15264,-0.063781,-0.074787,0,0
2,EXTRINSIC TO PLASMA MEMBRANE,0.65234,-0.064245,-0.056418,0,0
2,BIOCARTA IL6 PATHWAY,0.9686,-0.065203,-0.016144,0,0
2,BIOCARTA 41BB PATHWAY,0.40843,-0.065438,-0.065463,0,0
2,NUCLEAR CHROMOSOME PART,0.69707,-0.065751,-0.019439,0,0
2,REACTOME SIGNALING BY FGFR,0.35153,-0.06634,-0.026383,0,0
2,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.061812,-0.066531,-0.07791,0,0
2,EXTRACELLULAR SPACE,0.14285,-0.06678,-0.097627,0,0
2,REACTOME NEPHRIN INTERACTIONS,0.66501,-0.066903,-0.0087489,0,0
2,REACTOME G ALPHA I SIGNALLING EVENTS,0.036948,-0.067256,-0.082169,0,0
2,PID AURORA A PATHWAY,0.35607,-0.067411,-0.057165,0,0
2,HISTONE METHYLTRANSFERASE ACTIVITY,0.50896,-0.067779,-0.016176,0,0
2,KEGG GAP JUNCTION,0.23245,-0.068293,-0.061061,0,0
2,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.71658,-0.068969,-0.019451,0,0
2,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.43883,-0.070045,-0.024555,0,0
2,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.11434,-0.070162,-0.089794,0,0
2,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.25363,-0.070189,-0.055035,0,0
2,CHROMATIN,0.8303,-0.07058,0.011012,0,0
2,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.54903,-0.070762,-0.036715,0,0
2,REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.71006,-0.071101,-0.014591,0,0
2,REACTOME SIGNALING BY PDGF,0.63354,-0.07124,0.00073164,0,0
2,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.35607,-0.071421,-0.045816,0,0
2,CLATHRIN COATED VESICLE,0.29586,-0.071435,-0.057025,0,0
2,PID WNT NONCANONICAL PATHWAY,0.22905,-0.071555,-0.06946,0,0
2,REACTOME GAB1 SIGNALOSOME,0.21256,-0.07174,-0.054511,0,0
2,REACTOME KINESINS,0.29586,-0.071997,-0.14336,0,0
2,VITAMIN TRANSPORT,0.4598,-0.072318,-0.051137,0,0
2,REACTOME EARLY PHASE OF HIV LIFE CYCLE,0.40843,-0.072385,-0.075915,0,0
2,KEGG LONG TERM POTENTIATION,0.099158,-0.07257,-0.074675,0,0
2,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.15773,-0.074433,-0.09582,0,0
2,NF KAPPAB BINDING,0.60883,-0.074611,0.017425,0,0
2,CENTROSOME ORGANIZATION AND BIOGENESIS,0.068167,-0.075153,-0.070816,0,0
2,PID NFKAPPABATYPICALPATHWAY,0.36991,-0.075532,-0.063858,0,0
2,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.077957,-0.076661,-0.060702,0,0
2,SULFOTRANSFERASE ACTIVITY,0.8303,-0.077312,-0.011388,0,0
2,GLYCOPROTEIN CATABOLIC PROCESS,0.77618,-0.077376,-0.0021715,0,0
2,REGULATION OF BLOOD PRESSURE,0.26098,-0.077464,-0.13841,0,0
2,RUFFLE,0.67137,-0.077532,0.029411,0,0
2,BIOCARTA TPO PATHWAY,0.41341,-0.077747,-0.052978,0,0
2,CHROMATIN ASSEMBLY,0.60272,-0.078111,-0.017008,0,0
2,REACTOME STEROID HORMONES,0.18508,-0.078273,-0.073525,0,0
2,REGULATION OF NEURON APOPTOSIS,0.084046,-0.078699,-0.14648,0,0
2,PEPTIDE RECEPTOR ACTIVITY,0.29184,-0.078839,-0.085852,0,0
2,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.15517,-0.079147,-0.047342,0,0
2,REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN,0.86455,-0.079351,-0.011192,0,0
2,PID IL5 PATHWAY,0.36526,-0.079645,-0.078312,0,0
2,BIOCARTA IL17 PATHWAY,0.11235,-0.079891,-0.10739,0,0
2,PID TCRRASPATHWAY,0.42347,-0.079969,-0.062635,0,0
2,CELL DIVISION,0.76948,-0.080069,0.052281,0,0
2,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.02166,-0.080351,-0.15089,0,0
2,PHOTOTRANSDUCTION,0.17099,-0.081385,-0.011622,0,0
2,LYSOSOMAL MEMBRANE,0.11235,-0.081492,-0.17948,0,0
2,MICROTUBULE ORGANIZING CENTER PART,0.24643,-0.081606,-0.040501,0,0
2,NUCLEOSOME ASSEMBLY,0.4598,-0.081652,-0.051297,0,0
2,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.13814,-0.082122,-0.049691,0,0
2,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.1313,-0.082577,-0.067738,0,0
2,CENTROSOME,0.075049,-0.082656,-0.066704,0,0
2,CELL SURFACE,0.91293,-0.083035,0.011279,0,0
2,PID ER NONGENOMIC PATHWAY,0.045624,-0.084298,-0.11364,0,0
2,PID IL2 1PATHWAY,0.23589,-0.084391,-0.055514,0,0
2,LEADING EDGE,0.36064,-0.08456,-0.044174,0,0
2,REACTOME DEVELOPMENTAL BIOLOGY,0.19393,-0.086273,-0.057208,0,0
2,CARBOHYDRATE TRANSPORT,0.47049,-0.086329,-0.053636,0,0
2,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.75615,-0.08644,0.0059167,0,0
2,PID WNT SIGNALING PATHWAY,0.55487,-0.086819,-0.097993,0,0
2,TUBE MORPHOGENESIS,0.69061,-0.086975,-0.043079,0,0
2,BIOCARTA NUCLEARRS PATHWAY,0.30402,-0.087293,-0.057591,0,0
2,REACTOME ERK MAPK TARGETS,0.095625,-0.08751,-0.10099,0,0
2,CENTROSOME CYCLE,0.080955,-0.087571,-0.084966,0,0
2,REACTOME AXON GUIDANCE,0.20309,-0.08776,-0.068508,0,0
2,VACUOLAR MEMBRANE,0.16294,-0.088036,-0.14864,0,0
2,REACTOME ENOS ACTIVATION AND REGULATION,0.42855,-0.088038,-0.040354,0,0
2,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.12259,-0.088306,-0.10163,0,0
2,HISTONE ACETYLTRANSFERASE ACTIVITY,0.21256,-0.088405,-0.040766,0,0
2,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.087232,-0.089342,-0.12968,0,0
2,CELL RECOGNITION,0.17099,-0.089408,-0.24746,0,0
2,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.18508,-0.089474,-0.069442,0,0
2,REGULATION OF GROWTH,0.17374,-0.089506,-0.080119,0,0
2,RESPIRATORY GASEOUS EXCHANGE,0.46512,-0.089716,-0.055669,0,0
2,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.25363,-0.089833,-0.061882,0,0
2,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.25001,-0.090119,-0.061306,0,0
2,BIOCARTA GPCR PATHWAY,0.2,-0.090744,-0.077601,0,0
2,KEGG PHENYLALANINE METABOLISM,0.50896,-0.091696,-0.074558,0,0
2,GAMETE GENERATION,0.12259,-0.092937,-0.063429,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.13814,-0.093004,-0.11388,0,0
2,REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION,0.36991,-0.093227,-0.063213,0,0
2,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.8303,-0.093259,-0.0033643,0,0
2,NUCLEAR CHROMOSOME,0.11636,-0.093347,-0.064914,0,0
2,REACTOME CD28 CO STIMULATION,0.16294,-0.093617,-0.04214,0,0
2,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.10465,-0.093678,-0.063796,0,0
2,BIOCARTA MCM PATHWAY,0.59664,-0.095552,-0.015796,0,0
2,RESPONSE TO NUTRIENT,0.1028,-0.096208,-0.18116,0,0
2,BIOCARTA RB PATHWAY,0.95466,-0.096404,0.013689,0,0
2,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.066855,-0.097713,-0.16561,0,0
2,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.50337,-0.098025,-0.043276,0,0
2,DETECTION OF ABIOTIC STIMULUS,0.075049,-0.098267,-0.027434,0,0
2,VACUOLAR PART,0.15264,-0.099009,-0.14159,0,0
2,KEGG BETA ALANINE METABOLISM,0.14285,-0.099607,-0.1302,0,0
2,REGULATION OF RESPONSE TO STIMULUS,0.05161,-0.10099,-0.081769,0,0
2,REGULATION OF CYTOKINE SECRETION,0.41341,-0.10132,-0.049441,0,0
2,S PHASE OF MITOTIC CELL CYCLE,0.14048,-0.10221,-0.12219,0,0
2,RESPONSE TO HYPOXIA,0.25729,-0.1028,-0.10266,0,0
2,BIOCARTA BCELLSURVIVAL PATHWAY,0.40349,-0.10333,-0.081897,0,0
2,BIOCARTA PLATELETAPP PATHWAY,0.85082,-0.1036,0.070699,0,0
2,RESPONSE TO NUTRIENT LEVELS,0.15015,-0.10425,-0.090433,0,0
2,KEGG LONG TERM DEPRESSION,0.1313,-0.10441,-0.072202,0,0
2,AXON GUIDANCE,0.17934,-0.10455,-0.16429,0,0
2,REACTOME SIGNAL TRANSDUCTION BY L1,0.060602,-0.10476,-0.10542,0,0
2,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.39858,-0.105,-0.12362,0,0
2,REACTOME CS DS DEGRADATION,0.36526,-0.10543,-0.14393,0,0
2,PID RET PATHWAY,0.038561,-0.10581,-0.095802,0,0
2,CYTOKINE SECRETION,0.36991,-0.10711,-0.05585,0,0
2,DEOXYRIBONUCLEASE ACTIVITY,0.057089,-0.10734,-0.099862,0,0
2,COFACTOR TRANSPORT,0.16294,-0.10742,-0.13188,0,0
2,REACTOME NETRIN1 SIGNALING,0.077957,-0.10754,-0.12854,0,0
2,SIALYLTRANSFERASE ACTIVITY,0.48131,-0.10765,-0.095012,0,0
2,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.22568,-0.10795,-0.079653,0,0
2,RESPONSE TO EXTRACELLULAR STIMULUS,0.16032,-0.10837,-0.1096,0,0
2,REACTOME ERKS ARE INACTIVATED,0.30402,-0.10891,-0.078132,0,0
2,METALLOENDOPEPTIDASE ACTIVITY,0.19095,-0.10977,-0.10526,0,0
2,SECRETORY PATHWAY,0.0014738,-0.10991,-0.17589,0,0
2,PID ERBB2ERBB3PATHWAY,0.11039,-0.11012,-0.054414,0,0
2,SEROTONIN RECEPTOR ACTIVITY,0.02268,-0.11028,-0.093889,0,0
2,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.027188,-0.11061,-0.1642,0,0
2,REACTOME CHROMOSOME MAINTENANCE,0.16032,-0.11121,-0.075676,0,0
2,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.0075304,-0.11175,-0.1362,0,0
2,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.087232,-0.11202,-0.086825,0,0
2,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.29992,-0.11247,-0.10491,0,0
2,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.11636,-0.11277,-0.1231,0,0
2,REACTOME PLATELET HOMEOSTASIS,0.17374,-0.11284,-0.072944,0,0
2,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.044685,-0.11307,-0.19096,0,0
2,KEGG DILATED CARDIOMYOPATHY,0.12689,-0.11426,-0.09356,0,0
2,HISTONE MODIFICATION,0.010245,-0.11467,-0.08682,0,0
2,REGULATION OF IMMUNE EFFECTOR PROCESS,0.5726,-0.11488,-0.056143,0,0
2,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0094949,-0.11557,-0.12439,0,0
2,G PROTEIN COUPLED RECEPTOR BINDING,0.35153,-0.11645,-0.052469,0,0
2,ANION CATION SYMPORTER ACTIVITY,0.34256,-0.11701,-0.091855,0,0
2,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.12473,-0.11843,-0.13232,0,0
2,BIOCARTA NOS1 PATHWAY,0.057089,-0.11906,-0.15936,0,0
2,POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.30815,-0.11969,-0.055084,0,0
2,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.26098,-0.11971,-0.071023,0,0
2,SYSTEM PROCESS,0.0071468,-0.11972,-0.10187,0,0
2,SA REG CASCADE OF CYCLIN EXPR,0.082489,-0.12035,-0.18214,0,0
2,ST JNK MAPK PATHWAY,0.0037331,-0.12065,-0.1592,0,0
2,PID AJDISS 2PATHWAY,0.19095,-0.121,-0.076785,0,0
2,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.047551,-0.12112,-0.10557,0,0
2,COVALENT CHROMATIN MODIFICATION,0.013465,-0.12113,-0.084674,0,0
2,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.0022992,-0.12139,-0.10703,0,0
2,REACTOME RNA POL I TRANSCRIPTION,0.50896,-0.12191,-0.044882,0,0
2,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.066855,-0.12249,-0.11974,0,0
2,REACTOME SIGNAL ATTENUATION,0.14285,-0.12254,-0.16581,0,0
2,PID ERB GENOMIC PATHWAY,0.31232,-0.12275,-0.075915,0,0
2,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0081404,-0.12298,-0.12804,0,0
2,REGULATION OF MAPKKK CASCADE,0.10654,-0.12368,-0.097595,0,0
2,REGULATION OF JNK CASCADE,0.2,-0.12383,-0.11033,0,0
2,EXTRINSIC TO MEMBRANE,0.41341,-0.1243,-0.075479,0,0
2,REACTOME SEROTONIN RECEPTORS,0.015953,-0.12491,-0.10404,0,0
2,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.8303,-0.12496,0.020766,0,0
2,KEGG SULFUR METABOLISM,0.29586,-0.12564,-0.067833,0,0
2,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.35153,-0.12637,-0.067795,0,0
2,CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.076492,-0.12659,-0.18407,0,0
2,BIOCARTA CALCINEURIN PATHWAY,0.188,-0.12693,-0.13447,0,0
2,PID NEPHRIN NEPH1 PATHWAY,0.15015,-0.12794,-0.084623,0,0
2,REGULATION OF PROTEIN SECRETION,0.25001,-0.1283,-0.077327,0,0
2,PID CXCR3PATHWAY,0.02843,-0.12836,-0.10371,0,0
2,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.055956,-0.1292,-0.095462,0,0
2,PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY,0.072231,-0.12935,-0.11625,0,0
2,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.42347,-0.12948,-0.083706,0,0
2,PROTEIN KINASE BINDING,0.00028792,-0.13072,-0.14947,0,0
2,REACTOME ADP SIGNALLING THROUGH P2RY12,0.064293,-0.13079,-0.18408,0,0
2,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.26471,-0.13233,-0.040725,0,0
2,NEURON DEVELOPMENT,0.023741,-0.13386,-0.18045,0,0
2,REACTOME NCAM1 INTERACTIONS,0.52025,-0.13477,-0.060274,0,0
2,NEURITE DEVELOPMENT,0.037747,-0.13596,-0.20303,0,0
2,NEUROLOGICAL SYSTEM PROCESS,0.007729,-0.13599,-0.11275,0,0
2,SECRETION BY CELL,0.00087311,-0.13701,-0.16798,0,0
2,PID P38ALPHABETAPATHWAY,0.029719,-0.13941,-0.11685,0,0
2,REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION,0.12689,-0.14169,-0.15461,0,0
2,CHROMATIN REMODELING COMPLEX,0.10096,-0.14303,-0.10135,0,0
2,REACTOME MEIOSIS,0.16828,-0.14323,-0.095672,0,0
2,POSITIVE REGULATION OF PROTEIN SECRETION,0.2839,-0.14358,-0.065115,0,0
2,PID ATF2 PATHWAY,0.087232,-0.14444,-0.10829,0,0
2,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.02843,-0.14543,-0.18837,0,0
2,PID ERBB1 INTERNALIZATION PATHWAY,0.02068,-0.14575,-0.10906,0,0
2,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010859,-0.14577,-0.17585,0,0
2,PID NETRIN PATHWAY,0.065563,-0.14612,-0.11424,0,0
2,PID FASPATHWAY,0.13583,-0.14643,-0.083209,0,0
2,PID PI3KCIAKTPATHWAY,0.0075304,-0.14757,-0.10839,0,0
2,BEHAVIOR,0.013139,-0.14843,-0.10106,0,0
2,ENDOTHELIAL CELL PROLIFERATION,0.17653,-0.14915,-0.19863,0,0
2,REACTOME PI3K AKT ACTIVATION,0.0094949,-0.14981,-0.12938,0,0
2,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.073629,-0.15072,-0.10035,0,0
2,PROTEIN HOMOOLIGOMERIZATION,0.30402,-0.15082,-0.060333,0,0
2,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.023741,-0.15132,-0.13399,0,0
2,NEGATIVE REGULATION OF BINDING,0.21905,-0.15146,-0.1009,0,0
2,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00047456,-0.15146,-0.18303,0,0
2,BIOCARTA EGFR SMRTE PATHWAY,0.84397,-0.15168,-0.0051588,0,0
2,KEGG CARDIAC MUSCLE CONTRACTION,0.018398,-0.15171,-0.12843,0,0
2,PID ANTHRAXPATHWAY,0.64605,-0.15308,-0.0058085,0,0
2,INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.80989,-0.15318,-0.12971,0,0
2,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.22235,-0.15377,-0.17987,0,0
2,PID ALK2PATHWAY,0.20309,-0.15405,-0.13979,0,0
2,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.11039,-0.15469,-0.12732,0,0
2,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.05161,-0.15475,-0.18701,0,0
2,AMINE BINDING,0.033894,-0.15495,-0.14698,0,0
2,PHOSPHATASE REGULATOR ACTIVITY,0.10096,-0.15547,-0.089064,0,0
2,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.057089,-0.15614,-0.16087,0,0
2,PID GLYPICAN 1PATHWAY,0.18508,-0.15773,-0.11954,0,0
2,PID HNF3APATHWAY,0.10465,-0.15846,-0.13097,0,0
2,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.27227,-0.15961,-0.095099,0,0
2,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.024288,-0.16034,-0.16728,0,0
2,AXONOGENESIS,0.011904,-0.16055,-0.26087,0,0
2,PID HNF3BPATHWAY,0.076492,-0.16061,-0.12123,0,0
2,LEARNING AND OR MEMORY,0.043763,-0.16164,-0.15521,0,0
2,PID P38 MK2PATHWAY,0.0010528,-0.1623,-0.20714,0,0
2,PHOSPHOINOSITIDE BINDING,0.23589,-0.16327,-0.075759,0,0
2,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.02843,-0.16334,-0.18559,0,0
2,PROTEIN SECRETION,0.12259,-0.16371,-0.14597,0,0
2,ARYLSULFATASE ACTIVITY,0.33373,-0.16404,-0.16064,0,0
2,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.52594,-0.16636,-0.032254,0,0
2,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.31232,-0.1667,-0.11952,0,0
2,BIOCARTA CK1 PATHWAY,1,-0.16692,0.04844,0,0
2,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.059411,-0.16694,-0.13677,0,0
2,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.0090226,-0.16725,-0.15739,0,0
2,REGIONALIZATION,0.072231,-0.1693,-0.17511,0,0
2,CATION TRANSPORTING ATPASE ACTIVITY,0.050569,-0.16948,-0.1682,0,0
2,NEGATIVE REGULATION OF DNA BINDING,0.15517,-0.17018,-0.13076,0,0
2,PID THROMBIN PAR4 PATHWAY,0.031748,-0.17077,-0.14088,0,0
2,KEGG TASTE TRANSDUCTION,0.54903,-0.17079,0.01546,0,0
2,CELLULAR RESPONSE TO STIMULUS,0.15015,-0.17191,-0.068233,0,0
2,REACTOME INSULIN RECEPTOR RECYCLING,0.011326,-0.17193,-0.18684,0,0
2,CALCIUM ION TRANSPORT,0.004408,-0.17223,-0.21196,0,0
2,DEVELOPMENTAL MATURATION,0.40349,-0.17268,-0.057913,0,0
2,VOLTAGE GATED SODIUM CHANNEL ACTIVITY,0.017969,-0.17355,-0.21917,0,0
2,KEGG HEDGEHOG SIGNALING PATHWAY,0.031059,-0.17501,-0.12265,0,0
2,POSITIVE REGULATION OF SECRETION,0.016339,-0.1752,-0.18242,0,0
2,PID LIS1PATHWAY,0.02268,-0.18111,-0.13867,0,0
2,BIOCARTA CELLCYCLE PATHWAY,0.085627,-0.18433,-0.12293,0,0
2,REACTOME TELOMERE MAINTENANCE,0.22235,-0.18498,-0.091829,0,0
2,NERVOUS SYSTEM DEVELOPMENT,0.00028792,-0.18644,-0.22513,0,0
2,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.15264,-0.18672,-0.12583,0,0
2,REACTOME DAG AND IP3 SIGNALING,0.0028141,-0.18823,-0.18305,0,0
2,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.014841,-0.18825,-0.2331,0,0
2,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.04854,-0.18825,-0.14309,0,0
2,CELL CELL SIGNALING,6.0504e-05,-0.18826,-0.18704,0,0
2,REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS,0.14285,-0.18903,-0.14531,0,0
2,SYNAPSE ORGANIZATION AND BIOGENESIS,0.050569,-0.1911,-0.21026,0,0
2,VACUOLAR TRANSPORT,0.10845,-0.1912,-0.1463,0,0
2,PID LYSOPHOSPHOLIPID PATHWAY,0.0010859,-0.1922,-0.17699,0,0
2,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.001191,-0.19475,-0.23112,0,0
2,CELL MATURATION,0.23589,-0.19542,-0.10181,0,0
2,REACTOME N GLYCAN ANTENNAE ELONGATION,0.15517,-0.19672,-0.16066,0,0
2,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.0057817,-0.19718,-0.17111,0,0
2,INSULIN RECEPTOR SIGNALING PATHWAY,0.0062634,-0.19869,-0.21786,0,0
2,REACTOME AMINE LIGAND BINDING RECEPTORS,0.00021909,-0.20074,-0.17109,0,0
2,REACTOME INTEGRATION OF ENERGY METABOLISM,0.00017186,-0.20118,-0.22607,0,0
2,BIOCARTA DREAM PATHWAY,0.013465,-0.20398,-0.19113,0,0
2,REGULATION OF PROTEIN POLYMERIZATION,0.11841,-0.20477,-0.1037,0,0
2,REACTOME MEIOTIC SYNAPSIS,0.085627,-0.20534,-0.15638,0,0
2,AXON,0.020205,-0.20708,-0.34071,0,0
2,REACTOME MEIOTIC RECOMBINATION,0.24288,-0.20982,-0.10119,0,0
2,REACTOME G ALPHA Z SIGNALLING EVENTS,0.00055855,-0.21032,-0.25788,0,0
2,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.001986,-0.21178,-0.18292,0,0
2,MAP KINASE ACTIVITY,0.14285,-0.21218,-0.13881,0,0
2,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.072231,-0.21319,-0.17937,0,0
2,REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES,0.034637,-0.2189,-0.12932,0,0
2,REGULATION OF IMMUNE RESPONSE,0.0069616,-0.22042,-0.17301,0,0
2,BIOCARTA SKP2E2F PATHWAY,0.05824,-0.22202,-0.16344,0,0
2,PID LPA4 PATHWAY,0.00353,-0.22242,-0.23194,0,0
2,ADENYLATE CYCLASE ACTIVATION,0.095625,-0.22246,-0.17411,0,0
2,ST WNT BETA CATENIN PATHWAY,0.0015653,-0.22274,-0.27331,0,0
2,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,1.1776e-06,-0.22352,-0.25485,0,0
2,REACTOME GABA B RECEPTOR ACTIVATION,0.00021909,-0.22577,-0.32815,0,0
2,AMINE RECEPTOR ACTIVITY,0.00012074,-0.22579,-0.19675,0,0
2,GLYCOLIPID METABOLIC PROCESS,0.013798,-0.22861,-0.21127,0,0
2,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.0099891,-0.23341,-0.25357,0,0
2,CARBON CARBON LYASE ACTIVITY,0.070855,-0.23557,-0.16311,0,0
2,REACTOME RETROGRADE NEUROTROPHIN SIGNALLING,0.00041602,-0.23612,-0.2574,0,0
2,NEURON DIFFERENTIATION,0.00069957,-0.23659,-0.27732,0,0
2,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.063042,-0.23693,-0.17011,0,0
2,PID S1P S1P3 PATHWAY,0.0054795,-0.23744,-0.22004,0,0
2,SH3 DOMAIN BINDING,0.63978,-0.23939,-0.0377,0,0
2,SODIUM CHANNEL ACTIVITY,0.05824,-0.24026,-0.20066,0,0
2,PDZ DOMAIN BINDING,0.0013872,-0.24151,-0.26949,0,0
2,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.064293,-0.24571,-0.16833,0,0
2,SULFURIC ESTER HYDROLASE ACTIVITY,0.046579,-0.24652,-0.2505,0,0
2,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.0038387,-0.2479,-0.24968,0,0
2,BIOCARTA P35ALZHEIMERS PATHWAY,0.0073363,-0.24794,-0.24288,0,0
2,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.0021062,-0.24806,-0.20506,0,0
2,REACTOME AMYLOIDS,0.14048,-0.24899,-0.13491,0,0
2,ACETYLCHOLINE BINDING,0.0022332,-0.24918,-0.2971,0,0
2,BIOCARTA TRKA PATHWAY,0.007729,-0.25035,-0.21483,0,0
2,INACTIVATION OF MAPK ACTIVITY,0.0014738,-0.25332,-0.33246,0,0
2,VITAMIN BINDING,0.016734,-0.26407,-0.23088,0,0
2,APOPTOTIC MITOCHONDRIAL CHANGES,0.0045306,-0.26571,-0.36245,0,0
2,BIOGENIC AMINE METABOLIC PROCESS,0.00087311,-0.26704,-0.22434,0,0
2,REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY,0.0067808,-0.26861,-0.29726,0,0
2,REACTOME RNA POL I PROMOTER OPENING,0.20309,-0.26978,-0.15959,0,0
2,ACTIVATION OF IMMUNE RESPONSE,0.00047456,-0.27598,-0.23316,0,0
2,POSITIVE REGULATION OF IMMUNE RESPONSE,0.00074557,-0.27828,-0.24377,0,0
2,DETECTION OF STIMULUS,0.001872,-0.27979,-0.21374,0,0
2,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.13583,-0.28209,-0.15208,0,0
2,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00027832,-0.28239,-0.25005,0,0
2,BIOCARTA CCR5 PATHWAY,0.00023468,-0.28664,-0.40171,0,0
2,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.0013054,-0.28896,-0.2782,0,0
2,KINASE REGULATOR ACTIVITY,0.00072223,-0.2961,-0.28399,0,0
2,ION CHANNEL ACTIVITY,0.00010845,-0.29754,-0.27119,0,0
2,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.0001165,-0.30345,-0.26697,0,0
2,REGULATION OF NEUROGENESIS,0.050569,-0.31396,-0.26322,0,0
2,REGULATION OF SECRETION,7.013e-05,-0.31476,-0.32777,0,0
2,ST GRANULE CELL SURVIVAL PATHWAY,1.6455e-05,-0.3162,-0.30905,0,0
2,TRANSMISSION OF NERVE IMPULSE,2.2524e-05,-0.3164,-0.29458,0,0
2,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.00054072,-0.31972,-0.26703,0,0
2,CARBOXY LYASE ACTIVITY,0.00040247,-0.3203,-0.28616,0,0
2,CELL PROJECTION PART,0.00013917,-0.32299,-0.30692,0,0
2,SYNAPTIC TRANSMISSION,3.4421e-05,-0.32483,-0.31812,0,0
2,CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.4421e-05,-0.32892,-0.27501,0,0
2,KEGG TAURINE AND HYPOTAURINE METABOLISM,0.0006154,-0.3293,-0.33562,0,0
2,OLIGOSACCHARIDE METABOLIC PROCESS,0.016339,-0.33905,-0.29753,0,0
2,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.00081984,-0.34507,-0.27161,0,0
2,SA TRKA RECEPTOR,2.0784e-06,-0.34726,-0.43411,0,0
2,CARBONATE DEHYDRATASE ACTIVITY,0.00072223,-0.34822,-0.36947,0,0
2,GATED CHANNEL ACTIVITY,2.4346e-05,-0.34999,-0.33866,0,0
2,REACTOME NEURONAL SYSTEM,9.0551e-05,-0.36053,-0.29576,0,0
2,REACTOME G PROTEIN ACTIVATION,0.0028957,-0.36444,-0.29699,0,0
2,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.013465,-0.3661,-0.29009,0,0
2,SYNAPSE,0.00010845,-0.3678,-0.32408,0,0
2,BRAIN DEVELOPMENT,0.00059588,-0.36829,-0.29921,0,0
2,PROTEIN KINASE REGULATOR ACTIVITY,0.00055855,-0.3717,-0.3525,0,0
2,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.00054072,-0.37619,-0.464,0,0
2,CATION CHANNEL ACTIVITY,3.1888e-05,-0.37901,-0.33278,0,0
2,GLYCOSPHINGOLIPID METABOLIC PROCESS,4.8379e-05,-0.38811,-0.38454,0,0
2,DENDRITE,0.00037661,-0.39076,-0.35963,0,0
2,VOLTAGE GATED CHANNEL ACTIVITY,9.389e-05,-0.39922,-0.37465,0,0
2,REACTOME PEPTIDE HORMONE BIOSYNTHESIS,0.0059384,-0.40009,-0.41091,0,0
2,REACTOME PACKAGING OF TELOMERE ENDS,0.076492,-0.40184,-0.20978,0,0
2,DETECTION OF CHEMICAL STIMULUS,0.0026572,-0.40798,-0.35183,0,0
2,ENDOTHELIAL CELL MIGRATION,0.16294,-0.41392,-0.27773,0,0
2,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.00016595,-0.42504,-0.3682,0,0
2,CALCIUM CHANNEL ACTIVITY,1.8251e-06,-0.42683,-0.47101,0,0
2,POTASSIUM CHANNEL ACTIVITY,0.004408,-0.43126,-0.29146,0,0
2,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.0028141,-0.43615,-0.38659,0,0
2,REACTOME BOTULINUM NEUROTOXICITY,1.8521e-05,-0.44522,-0.44376,0,0
2,VOLTAGE GATED CATION CHANNEL ACTIVITY,4.6597e-05,-0.46249,-0.4113,0,0
2,HOMOPHILIC CELL ADHESION,1.5816e-05,-0.465,-0.58453,0,0
2,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.0027346,-0.49384,-0.40763,0,0
2,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.0013457,-0.49565,-0.35842,0,0
2,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.0013054,-0.50542,-0.43434,0,0
2,REACTOME POTASSIUM CHANNELS,9.0179e-06,-0.51804,-0.41538,0,0
2,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.004408,-0.52572,-0.37668,0,0
2,REGULATION OF AXONOGENESIS,0.0030654,-0.546,-0.57207,0,0
2,LEUKOCYTE CHEMOTAXIS,0.0047853,-0.54639,-0.37796,0,0
2,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.00021167,-0.57973,-0.51667,0,0
2,GLUTAMATE RECEPTOR ACTIVITY,0.00021909,-0.5822,-0.55532,0,0
2,SYNAPTIC VESICLE,0.0031536,-0.60488,-0.43336,0,0
2,IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY,0.0028141,-0.61322,-0.56004,0,0
2,NEUROPEPTIDE SIGNALING PATHWAY,0.0032441,-0.61958,-0.40331,0,0
2,REGULATION OF NEUROTRANSMITTER LEVELS,4.4712e-06,-0.64347,-0.59227,0,0
2,HORMONE SECRETION,0.00035231,-0.67908,-0.53607,0,0
2,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.628e-07,-0.75107,-0.8113,0,0
2,REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE,0.0075304,-0.77994,-0.69289,0,0
2,CELL SOMA,8.1192e-05,-0.78408,-0.60046,0,0
2,REGULATION OF HORMONE SECRETION,7.3528e-06,-0.82943,-0.70779,0,0
2,REGULATED SECRETORY PATHWAY,7.0571e-06,-0.86164,-0.73479,0,0
2,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,1.7806e-05,-0.92351,-0.70412,0,0
2,NEUROTRANSMITTER SECRETION,6.4994e-06,-1.1002,-0.92079,0,0
2,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,1.6729e-06,-1.1971,-0.91727,0,0
2,REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE,2.9532e-05,-1.5541,-1.1646,0,0
3,INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY,5.1671e-08,1.1507,1.1105,1,1
3,REACTOME GABA A RECEPTOR ACTIVATION,3.1904e-06,1.0322,0.91935,1,1
3,NICOTINIC ACETYLCHOLINE GATED RECEPTOR CHANNEL COMPLEX,3.9418e-06,0.8507,0.83133,1,1
3,NICOTINIC ACETYLCHOLINE ACTIVATED CATION SELECTIVE CHANNEL ACTIVITY,3.9418e-06,0.8507,0.83133,1,1
3,REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,2.1663e-05,0.83024,0.76691,1,1
3,ANCHORED TO MEMBRANE,4.1112e-06,0.75566,0.65851,1,1
3,ANCHORED TO PLASMA MEMBRANE,4.1112e-06,0.75566,0.65851,1,1
3,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,2.0833e-05,0.7335,0.67739,1,1
3,REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,8.3127e-06,0.72903,0.74257,1,1
3,GABA RECEPTOR ACTIVITY,7.5427e-07,0.72894,0.70688,1,1
3,REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS,7.013e-05,0.68154,0.52636,1,1
3,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,2.0033e-05,0.6678,0.62209,1,1
3,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,1.2962e-05,0.65925,0.65732,1,1
3,SIALYLTRANSFERASE ACTIVITY,0.0010859,0.62299,0.54314,1,1
3,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,2.8418e-05,0.5475,0.50622,1,1
3,GLUTAMATE SIGNALING PATHWAY,1.349e-05,0.51275,0.50403,1,1
3,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.00010092,0.51129,0.46348,1,1
3,REACTOME PEPTIDE CHAIN ELONGATION,0.0041716,0.49802,0.46591,1,1
3,KEGG RIBOSOME,0.0039469,0.49602,0.45458,1,1
3,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,7.3528e-06,0.49102,0.38655,1,1
3,STRUCTURAL CONSTITUENT OF RIBOSOME,0.0034322,0.48081,0.44148,1,1
3,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,1.9263e-05,0.48053,0.49694,1,1
3,REACTOME INWARDLY RECTIFYING K CHANNELS,3.5759e-05,0.47661,0.43879,1,1
3,MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.2876e-06,0.47541,0.4858,1,1
3,BIOCARTA NO1 PATHWAY,9.0179e-06,0.46034,0.39123,1,1
3,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.0033369,0.45444,0.39615,1,1
3,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.00353,0.44972,0.40435,1,1
3,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.0028141,0.44779,0.41784,1,1
3,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.0045306,0.44187,0.43022,1,1
3,COFACTOR TRANSPORTER ACTIVITY,0.0075304,0.43796,0.34399,1,1
3,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.00016023,0.42832,0.42653,1,1
3,REACTOME GABA RECEPTOR ACTIVATION,1.4674e-06,0.40825,0.40776,1,1
3,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,2.5308e-05,0.40663,0.42283,1,1
3,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.4421e-05,0.40076,0.46851,1,1
3,POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.00037661,0.38614,0.32668,1,1
3,CARBOHYDRATE KINASE ACTIVITY,0.00013917,0.38317,0.32561,1,1
3,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.00012964,0.37875,0.44895,1,1
3,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.00038934,0.37345,0.42166,1,1
3,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0001547,0.36786,0.3513,1,1
3,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,2.6307e-05,0.36769,0.3805,1,1
3,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.01282,0.36751,0.32406,1,1
3,REACTOME INFLUENZA LIFE CYCLE,0.0022992,0.36743,0.32939,1,1
3,PROTEIN TARGETING TO MITOCHONDRION,0.00057693,0.36671,0.32632,1,1
3,NEUROTRANSMITTER RECEPTOR ACTIVITY,8.4205e-05,0.3621,0.29515,1,1
3,PROTEIN POLYMERIZATION,5.0683e-06,0.35716,0.36378,1,1
3,NEUROTRANSMITTER BINDING,5.6174e-05,0.35595,0.29214,1,1
3,DEVELOPMENTAL GROWTH,0.00018427,0.35272,0.35889,1,1
3,GENERATION OF NEURONS,1.6455e-05,0.3517,0.3352,1,1
3,TRANSLATION INITIATION FACTOR ACTIVITY,0.00030804,0.34795,0.323,1,1
3,LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS,0.0027346,0.34666,0.33277,1,1
3,CYTOCHROME C OXIDASE ACTIVITY,0.0017641,0.34272,0.25505,1,1
3,REACTOME TRANSLATION,0.0073363,0.34223,0.32018,1,1
3,REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX,9.0179e-06,0.34134,0.32816,1,1
3,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,4.6597e-05,0.33966,0.31472,1,1
3,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.0056288,0.33655,0.35678,1,1
3,RESPONSE TO TEMPERATURE STIMULUS,0.0014299,0.33387,0.23909,1,1
3,PID MYC PATHWAY,0.0083534,0.33355,0.21495,1,1
3,SYNAPSE ORGANIZATION AND BIOGENESIS,0.0028957,0.33198,0.28951,1,1
3,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.0033369,0.32779,0.24599,1,1
3,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.00016023,0.32773,0.2963,1,1
3,REGULATION OF PROTEIN POLYMERIZATION,0.0013872,0.32487,0.27997,1,1
3,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0010206,0.32366,0.26602,1,1
3,REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS,0.0041716,0.32359,0.28908,1,1
3,RESPONSE TO HEAT,0.001191,0.32214,0.23138,1,1
3,RESPIRATORY GASEOUS EXCHANGE,0.042857,0.32128,0.17104,1,1
3,NEUROGENESIS,3.0576e-06,0.32,0.33964,1,1
3,EXTRINSIC TO PLASMA MEMBRANE,0.0034322,0.31926,0.27882,1,1
3,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,6.0198e-07,0.30899,0.28139,1,1
3,BIOCARTA EIF PATHWAY,0.00026903,0.30654,0.29039,1,1
3,REACTOME PURINE METABOLISM,0.00057693,0.30427,0.27299,1,1
3,LIGAND GATED CHANNEL ACTIVITY,0.0025083,0.30233,0.26844,1,1
3,PID MYC ACTIVPATHWAY,0.001228,0.30193,0.24805,1,1
3,REACTOME PURINE SALVAGE,0.0085714,0.30131,0.26272,1,1
3,ACTIN FILAMENT POLYMERIZATION,0.00079435,0.29981,0.27528,1,1
3,REACTOME GLYCOLYSIS,0.0050528,0.29967,0.29578,1,1
3,BIOCARTA NDKDYNAMIN PATHWAY,0.001191,0.29855,0.25058,1,1
3,PURINE NUCLEOTIDE METABOLIC PROCESS,0.00042998,0.29402,0.31848,1,1
3,POTASSIUM ION TRANSPORT,0.0015189,0.28899,0.27497,1,1
3,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.0028141,0.2881,0.23216,1,1
3,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.0016129,0.28716,0.19925,1,1
3,GLIOGENESIS,0.00098941,0.2855,0.29977,1,1
3,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.0023671,0.28489,0.24078,1,1
3,RRNA PROCESSING,0.0012662,0.28459,0.36143,1,1
3,EXOCYTOSIS,0.011904,0.28376,0.29208,1,1
3,FOCAL ADHESION,0.043763,0.28313,0.20255,1,1
3,CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0029794,0.28176,0.23817,1,1
3,BIOCARTA RANMS PATHWAY,0.0057817,0.2807,0.2078,1,1
3,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.0026572,0.28009,0.20554,1,1
3,PEPTIDE RECEPTOR ACTIVITY,0.0007696,0.27831,0.2176,1,1
3,REGULATION OF TRANSLATIONAL INITIATION,0.0036303,0.27519,0.20725,1,1
3,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.001191,0.27197,0.24785,1,1
3,RIBOSOME BIOGENESIS AND ASSEMBLY,0.00079435,0.27074,0.35811,1,1
3,PID P38GAMMADELTAPATHWAY,0.013465,0.26913,0.26855,1,1
3,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.00072223,0.26909,0.32266,1,1
3,MAINTENANCE OF PROTEIN LOCALIZATION,0.00084609,0.26829,0.28041,1,1
3,NEURON PROJECTION,0.0049174,0.2674,0.26602,1,1
3,NEUROPEPTIDE RECEPTOR ACTIVITY,0.0032441,0.26722,0.21849,1,1
3,NEUROPEPTIDE BINDING,0.0032441,0.26722,0.21849,1,1
3,AMINO ACID TRANSPORT,0.00092958,0.26682,0.24662,1,1
3,INTEGRIN BINDING,0.0034322,0.26568,0.2369,1,1
3,NLS BEARING SUBSTRATE IMPORT INTO NUCLEUS,0.00026003,0.26567,0.25081,1,1
3,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.001191,0.26153,0.24932,1,1
3,EXTRINSIC TO MEMBRANE,0.0012662,0.26099,0.28647,1,1
3,SYNAPSE PART,7.547e-05,0.25804,0.28851,1,1
3,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.0059384,0.25456,0.21043,1,1
3,TRANSLATIONAL INITIATION,0.00092958,0.25454,0.22768,1,1
3,ISOMERASE ACTIVITY,0.00019079,0.25242,0.20856,1,1
3,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.0067808,0.25237,0.2683,1,1
3,RRNA METABOLIC PROCESS,0.0017123,0.25226,0.3346,1,1
3,KEGG PYRUVATE METABOLISM,0.011326,0.25177,0.21236,1,1
3,PIGMENT METABOLIC PROCESS,0.0010859,0.25125,0.21734,1,1
3,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.0010528,0.25101,0.20992,1,1
3,CHAPERONE BINDING,0.0030654,0.24689,0.21419,1,1
3,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,4.1617e-05,0.24645,0.22401,1,1
3,MITOCHONDRIAL MEMBRANE PART,0.00084609,0.24455,0.19703,1,1
3,HEME METABOLIC PROCESS,0.0069616,0.23953,0.2599,1,1
3,RESPONSE TO CARBOHYDRATE STIMULUS,0.011612,0.2393,0.21521,1,1
3,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,3.8583e-05,0.23902,0.22685,1,1
3,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.0054795,0.23834,0.17695,1,1
3,KEGG CITRATE CYCLE TCA CYCLE,0.0013872,0.23808,0.24182,1,1
3,RIBOSOMAL SUBUNIT,0.0083534,0.2359,0.19554,1,1
3,MITOCHONDRIAL INNER MEMBRANE,0.00016023,0.23474,0.23434,1,1
3,KEGG ARGININE AND PROLINE METABOLISM,0.0046564,0.23331,0.22027,1,1
3,CYTOSOLIC PART,0.0011199,0.22759,0.21628,1,1
3,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.00021167,0.22696,0.21666,1,1
3,REACTOME GLUCONEOGENESIS,0.013139,0.22654,0.17754,1,1
3,PROTEIN RNA COMPLEX ASSEMBLY,0.00026003,0.22566,0.19189,1,1
3,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.00010462,0.22474,0.25213,1,1
3,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.00049035,0.21999,0.29871,1,1
3,MAINTENANCE OF CELLULAR LOCALIZATION,0.0066042,0.21874,0.25002,1,1
3,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.00010092,0.21701,0.23755,1,1
3,REACTOME METABOLISM OF NUCLEOTIDES,0.00047456,0.2142,0.21232,1,1
3,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.0032441,0.21187,0.20304,1,1
3,CAMP MEDIATED SIGNALING,0.001191,0.21078,0.17296,1,1
3,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,1.0184e-05,0.20941,0.20932,1,1
3,REACTOME L1CAM INTERACTIONS,0.00013917,0.20931,0.23215,1,1
3,CELL MATRIX ADHESION,0.019739,0.20758,0.14045,1,1
3,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.0032441,0.20664,0.1982,1,1
3,REACTOME METABOLISM OF RNA,0.0057817,0.20511,0.18374,1,1
3,TRANSLATION REGULATOR ACTIVITY,0.0049174,0.20447,0.1918,1,1
3,RIBONUCLEOPROTEIN BINDING,0.0073363,0.20418,0.18252,1,1
3,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.20385,0.18464,1,1
3,RESPONSE TO ORGANIC SUBSTANCE,0.018398,0.20381,0.12395,1,1
3,PID REELINPATHWAY,0.022165,0.20374,0.18477,1,1
3,ATP DEPENDENT DNA HELICASE ACTIVITY,0.0047853,0.20369,0.17699,1,1
3,REACTOME RNA POL III CHAIN ELONGATION,0.00022676,0.20329,0.22049,1,1
3,AMINO SUGAR METABOLIC PROCESS,0.00030804,0.20308,0.21027,1,1
3,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.00026003,0.20296,0.37269,1,1
3,PID S1P S1P4 PATHWAY,0.027803,0.20277,0.17845,1,1
3,BIOCARTA CHREBP2 PATHWAY,0.0049174,0.20168,0.16137,1,1
3,REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX,0.00010845,0.20028,0.29298,1,1
3,CELL SUBSTRATE ADHESION,0.018836,0.19956,0.13469,1,1
3,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00090094,0.19818,0.1822,1,1
3,REGULATION OF CELL MIGRATION,0.033166,0.19755,0.13984,1,1
3,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00079435,0.197,0.23102,1,1
3,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00079435,0.197,0.23102,1,1
3,REACTOME INTRINSIC PATHWAY,0.0083534,0.19634,0.15922,1,1
3,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.00016023,0.19619,0.21065,1,1
3,ORGANELLE INNER MEMBRANE,0.00019079,0.19559,0.18358,1,1
3,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.00012512,0.19535,0.24895,1,1
3,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.0016129,0.19485,0.17083,1,1
3,NADH DEHYDROGENASE COMPLEX,0.0056288,0.19471,0.19709,1,1
3,MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I,0.0056288,0.19471,0.19709,1,1
3,RESPIRATORY CHAIN COMPLEX I,0.0056288,0.19471,0.19709,1,1
3,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.023205,0.19324,0.14752,1,1
3,BIOCARTA SARS PATHWAY,0.019283,0.19188,0.17857,1,1
3,MAINTENANCE OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.19171,0.27568,1,1
3,REACTOME GLUCOSE TRANSPORT,0.011612,0.19036,0.13703,1,1
3,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.00010845,0.19024,0.17829,1,1
3,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.00035231,0.19017,0.15439,1,1
3,POSITIVE REGULATION OF DNA BINDING,1.4609e-05,0.19009,0.20014,1,1
3,ORGANIC ACID TRANSPORT,0.00059588,0.18963,0.21541,1,1
3,CARBOXYLIC ACID TRANSPORT,0.00059588,0.18963,0.21541,1,1
3,HETEROCYCLE METABOLIC PROCESS,0.0046564,0.1872,0.19957,1,1
3,MITOCHONDRIAL RESPIRATORY CHAIN,0.00052342,0.18606,0.22219,1,1
3,MICROTUBULE BINDING,0.00016023,0.18089,0.21891,1,1
3,AMINE TRANSPORT,0.001872,0.18071,0.18085,1,1
3,REACTOME METABOLISM OF MRNA,0.014486,0.18049,0.17881,1,1
3,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.0015189,0.17978,0.15623,1,1
3,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.00063551,0.17895,0.19258,1,1
3,MITOCHONDRIAL PART,0.0087944,0.17656,0.14217,1,1
3,FEEDING BEHAVIOR,0.017137,0.17619,0.18047,1,1
3,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.035393,0.17612,0.1231,1,1
3,REGULATION OF GTPASE ACTIVITY,0.03939,0.17542,0.13231,1,1
3,METHYLTRANSFERASE ACTIVITY,0.00041602,0.17525,0.19005,1,1
3,PID HDAC CLASSIII PATHWAY,0.0047853,0.17482,0.21313,1,1
3,PID CDC42 REG PATHWAY,0.0047853,0.17408,0.14081,1,1
3,MITOCHONDRIAL ENVELOPE,0.0031536,0.17307,0.1354,1,1
3,REACTOME MTORC1 MEDIATED SIGNALLING,0.022165,0.17189,0.20082,1,1
3,REACTOME PROTEIN FOLDING,0.0017123,0.16972,0.13379,1,1
3,NUCLEOLAR PART,0.02166,0.16646,0.17531,1,1
3,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.018836,0.16435,0.16793,1,1
3,SPLICEOSOME,0.0015189,0.16395,0.16344,1,1
3,REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION,0.0083534,0.16322,0.19012,1,1
3,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.0097392,0.16297,0.1368,1,1
3,TRANSLATION,0.043763,0.15937,0.14391,1,1
3,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0087944,0.15911,0.13894,1,1
3,DNA HELICASE ACTIVITY,0.00052342,0.15905,0.15344,1,1
3,MITOCHONDRIAL MEMBRANE,0.0057817,0.15814,0.12644,1,1
3,PID TELOMERASEPATHWAY,0.00055855,0.15803,0.12908,1,1
3,REACTOME RECYCLING PATHWAY OF L1,0.014841,0.1568,0.13588,1,1
3,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.0049174,0.15544,0.17337,1,1
3,PIGMENT BIOSYNTHETIC PROCESS,0.013139,0.15501,0.15128,1,1
3,REACTOME PROCESSING OF INTRONLESS PRE MRNAS,0.010773,0.15487,0.14427,1,1
3,REACTOME G1 PHASE,0.027188,0.15456,0.11653,1,1
3,DNA REPLICATION INITIATION,0.014486,0.15348,0.12082,1,1
3,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.00098941,0.15253,0.16152,1,1
3,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.043763,0.15175,0.12072,1,1
3,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.013465,0.15174,0.12027,1,1
3,BIOCARTA EIF2 PATHWAY,0.010506,0.15065,0.15832,1,1
3,KEGG PURINE METABOLISM,0.00065623,0.14872,0.14577,1,1
3,SMOOTH MUSCLE CONTRACTION GO 0006939,0.02068,0.14765,0.13791,1,1
3,SECONDARY METABOLIC PROCESS,0.02068,0.14749,0.12004,1,1
3,DNA INTEGRITY CHECKPOINT,0.019283,0.14739,0.1168,1,1
3,SECOND MESSENGER MEDIATED SIGNALING,0.0018173,0.14704,0.12562,1,1
3,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.011612,0.14596,0.13856,1,1
3,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.0013872,0.14491,0.1241,1,1
3,METALLOENDOPEPTIDASE ACTIVITY,0.0069616,0.14461,0.14467,1,1
3,KEGG HOMOLOGOUS RECOMBINATION,0.0085714,0.14419,0.1362,1,1
3,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024288,0.14377,0.089888,1,1
3,MAINTENANCE OF LOCALIZATION,0.0085714,0.14327,0.17029,1,1
3,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.0010528,0.14308,0.13708,1,1
3,OVULATION CYCLE,0.0022332,0.14264,0.11042,1,1
3,REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS,0.027803,0.13978,0.10157,1,1
3,POSITIVE REGULATION OF BINDING,6.0504e-05,0.13821,0.15286,1,1
3,HELICASE ACTIVITY,0.001872,0.13759,0.15474,1,1
3,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0097392,0.13722,0.10661,1,1
3,KEGG RNA POLYMERASE,0.0040578,0.13655,0.14793,1,1
3,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.035393,0.13536,0.13081,1,1
3,KEGG GLYCEROLIPID METABOLISM,0.0039469,0.13433,0.14292,1,1
3,REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY,0.018398,0.13384,0.12933,1,1
3,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.015574,0.13036,0.13357,1,1
3,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0069616,0.12991,0.091998,1,1
3,REACTOME FANCONI ANEMIA PATHWAY,0.00065623,0.1295,0.15476,1,1
3,REGULATION OF NEURON APOPTOSIS,0.037747,0.1284,0.1316,1,1
3,ENDONUCLEASE ACTIVITY GO 0016893,0.015953,0.12807,0.14854,1,1
3,ENDORIBONUCLEASE ACTIVITY,0.012203,0.12802,0.14377,1,1
3,REACTOME PKB MEDIATED EVENTS,0.015953,0.12292,0.11397,1,1
3,RNA POLYMERASE ACTIVITY,0.030383,0.12167,0.12141,1,1
3,DNA DEPENDENT DNA REPLICATION,0.0067808,0.12127,0.10415,1,1
3,REACTOME G2 M CHECKPOINTS,0.038561,0.12048,0.098967,1,1
3,CENTROSOME ORGANIZATION AND BIOGENESIS,0.02166,0.12035,0.12322,1,1
3,DNA DEPENDENT ATPASE ACTIVITY,0.0051916,0.11992,0.14091,1,1
3,PID LKB1 PATHWAY,0.0019282,0.11871,0.12951,1,1
3,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.02068,0.11773,0.11922,1,1
3,REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS,0.014138,0.11421,0.13617,1,1
3,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.0040578,0.11417,0.09858,1,1
3,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.03939,0.11371,0.10542,1,1
3,REACTOME RAP1 SIGNALLING,0.033166,0.11223,0.19134,1,1
3,CARBOXYPEPTIDASE ACTIVITY,0.043763,0.11167,0.20908,1,1
3,ENVELOPE,0.0099891,0.11118,0.082787,1,1
3,ORGANELLE ENVELOPE,0.0099891,0.11118,0.082787,1,1
3,RNA BINDING,0.031059,0.10986,0.12396,1,1
3,ST INTEGRIN SIGNALING PATHWAY,0.033894,0.10917,0.089817,1,1
3,RIBONUCLEOPROTEIN COMPLEX,0.0066042,0.10531,0.12517,1,1
3,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.019739,0.1046,0.12551,1,1
3,PID HDAC CLASSII PATHWAY,0.02843,0.10438,0.10439,1,1
3,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.0013872,0.10374,0.1606,1,1
3,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.029719,0.1037,0.11108,1,1
3,REACTOME REGULATORY RNA PATHWAYS,0.019739,0.10341,0.10493,1,1
3,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.015203,0.10293,0.081846,1,1
3,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.013139,0.1028,0.10498,1,1
3,NUCLEAR ORGANIZATION AND BIOGENESIS,0.046579,0.1005,0.076104,1,1
3,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.0025817,0.10025,0.09436,1,1
3,RIBONUCLEASE ACTIVITY,0.017549,0.10007,0.10056,1,1
3,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.0032441,0.097771,0.11304,1,1
3,REACTOME MRNA 3 END PROCESSING,0.041967,0.097387,0.099278,1,1
3,NUCLEOLUS,0.0062634,0.09717,0.12263,1,1
3,NUCLEAR PORE,0.012203,0.09359,0.12592,1,1
3,REACTOME HIV LIFE CYCLE,0.0054795,0.09225,0.086376,1,1
3,REACTOME MRNA PROCESSING,0.0030654,0.092083,0.11938,1,1
3,KEGG RNA DEGRADATION,0.0085714,0.091659,0.09447,1,1
3,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.021165,0.09051,0.10281,1,1
3,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.047551,0.089525,0.076333,1,1
3,PORE COMPLEX,0.03939,0.088225,0.094711,1,1
3,RNA PROCESSING,0.0013872,0.087119,0.12141,1,1
3,REACTOME RNA POL II TRANSCRIPTION,0.013465,0.083998,0.081794,1,1
3,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.017549,0.083629,0.077614,1,1
3,KEGG SPLICEOSOME,0.029719,0.083362,0.0894,1,1
3,SMALL GTPASE BINDING,0.023205,0.080905,0.085477,1,1
3,MEDIATOR COMPLEX,0.036948,0.079462,0.092741,1,1
3,TRANSITION METAL ION BINDING,0.033894,0.079385,0.059175,1,1
3,DNA REPLICATION,0.023205,0.078142,0.063562,1,1
3,GTPASE REGULATOR ACTIVITY,0.018836,0.076419,0.094205,1,1
3,TRANSCRIPTION COREPRESSOR ACTIVITY,0.015574,0.072388,0.083118,1,1
3,REACTOME MRNA SPLICING,0.0087944,0.071026,0.11231,1,1
3,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.02166,0.066236,0.076878,1,1
3,MRNA METABOLIC PROCESS,0.0064317,0.061385,0.082404,1,1
3,RESPONSE TO ABIOTIC STIMULUS,0.018398,0.058687,0.054211,1,1
3,REACTOME ELONGATION ARREST AND RECOVERY,0.025414,0.057685,0.093201,1,1
3,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.031748,0.055882,0.060233,1,1
3,KEGG VALINE LEUCINE AND ISOLEUCINE BIOSYNTHESIS,0.014841,0.27478,0.37148,1,0
3,ADENYLATE CYCLASE ACTIVATION,0.023205,0.25075,0.2234,1,0
3,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.0038387,0.25005,0.32797,1,0
3,VACUOLE ORGANIZATION AND BIOGENESIS,0.011612,0.24577,0.21602,1,0
3,PROTEOGLYCAN METABOLIC PROCESS,0.0099891,0.23945,0.20483,1,0
3,KEGG ONE CARBON POOL BY FOLATE,0.020205,0.23811,0.19073,1,0
3,LYSOSOMAL TRANSPORT,0.010245,0.22336,0.2449,1,0
3,COLLAGEN BINDING,0.042857,0.20517,0.11049,1,0
3,REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL,0.029068,0.19362,0.13248,1,0
3,PID ILK PATHWAY,0.0025083,0.17588,0.13186,1,0
3,VACUOLAR TRANSPORT,0.0036303,0.17539,0.22304,1,0
3,REACTOME TRNA AMINOACYLATION,0.031748,0.17515,0.18742,1,0
3,REACTOME METABOLISM OF NON CODING RNA,0.0010859,0.17251,0.19541,1,0
3,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.16981,0.13744,1,0
3,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.030383,0.167,0.11791,1,0
3,MITOCHONDRIAL MATRIX,0.033894,0.16135,0.15902,1,0
3,MITOCHONDRIAL LUMEN,0.033894,0.16135,0.15902,1,0
3,PROTEIN FOLDING,0.0094949,0.15859,0.11947,1,0
3,PEPTIDE BINDING,0.0033369,0.15657,0.12857,1,0
3,PROTEIN COMPLEX BINDING,0.043763,0.15623,0.097443,1,0
3,PHAGOCYTOSIS,0.0042883,0.15294,0.21179,1,0
3,CELLULAR BIOSYNTHETIC PROCESS,0.041967,0.1526,0.1141,1,0
3,ORGANELLAR RIBOSOME,0.022165,0.15224,0.17505,1,0
3,MITOCHONDRIAL RIBOSOME,0.022165,0.15224,0.17505,1,0
3,SIGNAL SEQUENCE BINDING,0.0097392,0.14923,0.12778,1,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.017137,0.14717,0.16485,1,0
3,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020205,0.14466,0.17575,1,0
3,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.00034072,0.13873,0.19573,1,0
3,REACTOME M G1 TRANSITION,0.047551,0.13648,0.10072,1,0
3,REACTOME METABOLISM OF PROTEINS,0.025994,0.13494,0.10911,1,0
3,BIOCARTA MTOR PATHWAY,0.026586,0.12788,0.10359,1,0
3,KEGG SELENOAMINO ACID METABOLISM,0.033894,0.12788,0.15214,1,0
3,PID FOXM1PATHWAY,0.024288,0.12345,0.0988,1,0
3,TRNA METABOLIC PROCESS,0.021165,0.12161,0.17537,1,0
3,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.037747,0.12076,0.090376,1,0
3,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.034637,0.11981,0.16585,1,0
3,CARBOHYDRATE METABOLIC PROCESS,0.045624,0.11132,0.062176,1,0
3,BASAL LAMINA,0.021165,0.10754,0.24961,1,0
3,EMBRYO IMPLANTATION,0.036948,0.099673,0.060963,1,0
3,NEGATIVE REGULATION OF CELL ADHESION,0.046579,0.098586,0.1333,1,0
3,BIOCARTA CARM1 PATHWAY,0.036164,0.096011,0.1693,1,0
3,ST G ALPHA I PATHWAY,0.046579,0.094534,0.10705,1,0
3,REACTOME G1 S TRANSITION,0.019739,0.090877,0.094995,1,0
3,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0081404,0.087828,0.087634,1,0
3,MITOCHONDRION,0.045624,0.085463,0.089409,1,0
3,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.0060989,0.080314,0.11514,1,0
3,REACTOME MITOTIC G1 G1 S PHASES,0.013798,0.079613,0.092434,1,0
3,RNA SPLICING,0.004408,0.077856,0.11649,1,0
3,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.031748,0.064437,0.068608,1,0
3,GTPASE BINDING,0.033894,0.061498,0.079693,1,0
3,PID P53REGULATIONPATHWAY,0.040234,0.05872,0.069278,1,0
3,ATP DEPENDENT HELICASE ACTIVITY,0.036164,0.0454,0.14358,1,0
3,MACROMOLECULAR COMPLEX,0.033894,0.042792,0.041587,1,0
3,KEGG PATHWAYS IN CANCER,0.042857,-0.034459,-0.10383,1,0
3,MULTI ORGANISM PROCESS,0.03245,-0.043918,-0.10499,1,0
3,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.045624,-0.052139,-0.07209,1,0
3,MACROMOLECULE LOCALIZATION,0.030383,-0.057283,-0.073538,1,0
3,IDENTICAL PROTEIN BINDING,0.0028141,-0.058571,-0.096698,1,0
3,PURINE RIBONUCLEOTIDE BINDING,0.0081404,-0.058794,-0.071576,1,0
3,REACTOME ADAPTIVE IMMUNE SYSTEM,0.017549,-0.063292,-0.087496,1,0
3,IMMUNE RESPONSE,0.014841,-0.064835,-0.12797,1,0
3,PURINE NUCLEOTIDE BINDING,0.0069616,-0.066887,-0.074815,1,0
3,POST TRANSLATIONAL PROTEIN MODIFICATION,0.0090226,-0.069976,-0.069271,1,0
3,RESPONSE TO CHEMICAL STIMULUS,0.026586,-0.070077,-0.084144,1,0
3,PROTEIN LOCALIZATION,0.029068,-0.070706,-0.081576,1,0
3,PROTEIN HOMODIMERIZATION ACTIVITY,0.022165,-0.070707,-0.088018,1,0
3,NUCLEOTIDE BINDING,0.0079323,-0.070889,-0.073979,1,0
3,GTPASE ACTIVITY,0.027803,-0.072673,-0.081859,1,0
3,EXTRACELLULAR REGION,0.041093,-0.0732,-0.10441,1,0
3,REACTOME SPHINGOLIPID METABOLISM,0.015574,-0.075512,-0.14611,1,0
3,PID ERBB1 DOWNSTREAM PATHWAY,0.01282,-0.076015,-0.11749,1,0
3,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.043763,-0.077577,-0.070394,1,0
3,PROTEIN UBIQUITINATION,0.029068,-0.078279,-0.091789,1,0
3,BIOPOLYMER MODIFICATION,0.0047853,-0.078305,-0.082058,1,0
3,PID NFAT TFPATHWAY,0.042857,-0.07831,-0.11443,1,0
3,PROTEIN MODIFICATION PROCESS,0.0025817,-0.079601,-0.086682,1,0
3,RECEPTOR BINDING,0.025994,-0.080705,-0.082712,1,0
3,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.024846,-0.080902,-0.10648,1,0
3,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0025817,-0.081274,-0.097524,1,0
3,CYTOSKELETAL PART,0.013465,-0.082307,-0.066942,1,0
3,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.022165,-0.0834,-0.1299,1,0
3,PEPTIDASE ACTIVITY,0.0075304,-0.083618,-0.088791,1,0
3,REACTOME PHOSPHOLIPID METABOLISM,0.0066042,-0.084447,-0.1013,1,0
3,INTRINSIC TO ORGANELLE MEMBRANE,0.015203,-0.084641,-0.1149,1,0
3,RESPONSE TO OTHER ORGANISM,0.0032441,-0.085306,-0.13182,1,0
3,TRANSCRIPTION FACTOR COMPLEX,0.0041716,-0.085341,-0.081893,1,0
3,NEGATIVE REGULATION OF CELLULAR PROCESS,0.010506,-0.086965,-0.084524,1,0
3,IMMUNE SYSTEM PROCESS,0.0030654,-0.090123,-0.13746,1,0
3,PID IL1PATHWAY,0.02268,-0.091211,-0.12849,1,0
3,PID CD8TCRDOWNSTREAMPATHWAY,0.02843,-0.091926,-0.10593,1,0
3,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.0081404,-0.091986,-0.10808,1,0
3,KEGG STEROID HORMONE BIOSYNTHESIS,0.041967,-0.092086,-0.18632,1,0
3,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.0083534,-0.092149,-0.088413,1,0
3,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.03939,-0.092571,-0.10184,1,0
3,BIOCARTA MAL PATHWAY,0.013798,-0.095041,-0.10818,1,0
3,GOLGI APPARATUS,0.00067758,-0.09513,-0.11522,1,0
3,REACTOME DIABETES PATHWAYS,0.0085714,-0.09548,-0.14714,1,0
3,LIPID BINDING,0.0054795,-0.095744,-0.1376,1,0
3,PROTEIN KINASE ACTIVITY,0.0062634,-0.095902,-0.091086,1,0
3,STEROID METABOLIC PROCESS,0.036948,-0.096771,-0.14044,1,0
3,BIOCARTA GRANULOCYTES PATHWAY,0.016339,-0.09699,-0.15828,1,0
3,REACTOME IMMUNE SYSTEM,0.00092958,-0.097121,-0.1337,1,0
3,SUGAR BINDING,0.011047,-0.097995,-0.1479,1,0
3,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027803,-0.098152,-0.12343,1,0
3,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.038561,-0.098249,-0.20174,1,0
3,GOLGI ASSOCIATED VESICLE,0.024288,-0.099722,-0.11516,1,0
3,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.0036303,-0.099844,-0.16819,1,0
3,NEGATIVE REGULATION OF METABOLIC PROCESS,0.00021909,-0.09993,-0.11882,1,0
3,REACTOME COMMON PATHWAY,0.027188,-0.10012,-0.21472,1,0
3,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.00021167,-0.10149,-0.11926,1,0
3,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.00021909,-0.10206,-0.11905,1,0
3,BIOCARTA ACH PATHWAY,0.011904,-0.10251,-0.14469,1,0
3,PROTEIN DIMERIZATION ACTIVITY,0.00087311,-0.10339,-0.11629,1,0
3,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.016339,-0.10359,-0.15482,1,0
3,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.0019282,-0.10422,-0.14789,1,0
3,REACTOME DOWNSTREAM TCR SIGNALING,0.0090226,-0.10425,-0.14401,1,0
3,ENDOMEMBRANE SYSTEM,0.0016129,-0.10444,-0.11088,1,0
3,INTEGRAL TO ORGANELLE MEMBRANE,0.0062634,-0.10472,-0.12839,1,0
3,ANTI APOPTOSIS,0.037747,-0.10546,-0.11726,1,0
3,PID PI3KPLCTRKPATHWAY,0.012508,-0.10576,-0.11335,1,0
3,KEGG ETHER LIPID METABOLISM,0.019283,-0.10647,-0.13372,1,0
3,ENZYME ACTIVATOR ACTIVITY,0.029719,-0.10693,-0.087894,1,0
3,KEGG VEGF SIGNALING PATHWAY,0.012203,-0.10758,-0.10446,1,0
3,UBIQUITIN CYCLE,0.0040578,-0.10781,-0.12405,1,0
3,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.024846,-0.10802,-0.13617,1,0
3,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.004408,-0.10817,-0.12403,1,0
3,PID SHP2 PATHWAY,0.0094949,-0.10838,-0.16055,1,0
3,GROWTH FACTOR ACTIVITY,0.017549,-0.10852,-0.17151,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION,0.00067758,-0.109,-0.12144,1,0
3,BIOCARTA D4GDI PATHWAY,0.033166,-0.10916,-0.21409,1,0
3,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.0090226,-0.10971,-0.19828,1,0
3,FATTY ACID METABOLIC PROCESS,0.046579,-0.11015,-0.14652,1,0
3,PID TGFBRPATHWAY,0.014841,-0.11015,-0.16223,1,0
3,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.041967,-0.11048,-0.12714,1,0
3,KEGG LYSOSOME,0.033894,-0.1108,-0.19754,1,0
3,KEGG O GLYCAN BIOSYNTHESIS,0.038561,-0.11142,-0.1697,1,0
3,REACTOME CALNEXIN CALRETICULIN CYCLE,0.031748,-0.11149,-0.25641,1,0
3,PROTEIN MATURATION,0.010245,-0.11167,-0.15198,1,0
3,DOUBLE STRANDED RNA BINDING,0.0067808,-0.11186,-0.13263,1,0
3,COFACTOR BINDING,0.033166,-0.11354,-0.1689,1,0
3,RESPONSE TO EXTERNAL STIMULUS,0.0010528,-0.11369,-0.1345,1,0
3,CELL PROJECTION,0.0019282,-0.11386,-0.13603,1,0
3,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.0094949,-0.11452,-0.13056,1,0
3,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.001662,-0.11482,-0.09307,1,0
3,REGULATION OF ANGIOGENESIS,0.013798,-0.11539,-0.19371,1,0
3,PID IL12 2PATHWAY,0.034637,-0.11602,-0.13078,1,0
3,ADAPTIVE IMMUNE RESPONSE,0.0054795,-0.11652,-0.15876,1,0
3,KEGG GNRH SIGNALING PATHWAY,0.01282,-0.11721,-0.088687,1,0
3,PROTEIN TARGETING TO MEMBRANE,0.025994,-0.11735,-0.12697,1,0
3,BIOCARTA EPO PATHWAY,0.011326,-0.11738,-0.18966,1,0
3,KEGG CELL ADHESION MOLECULES CAMS,0.0051916,-0.11766,-0.18511,1,0
3,REACTOME SYNTHESIS OF PE,0.031059,-0.11767,-0.17313,1,0
3,PID RAC1 PATHWAY,0.0011199,-0.11767,-0.18534,1,0
3,REACTOME OLFACTORY SIGNALING PATHWAY,0.00353,-0.11868,-0.11889,1,0
3,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.0034322,-0.119,-0.16202,1,0
3,COATED VESICLE,0.0062634,-0.11964,-0.1075,1,0
3,PID MET PATHWAY,0.0040578,-0.11975,-0.11811,1,0
3,KEGG RETINOL METABOLISM,0.016734,-0.12021,-0.14871,1,0
3,DIGESTION,0.041967,-0.12081,-0.16816,1,0
3,SECRETION,0.0028141,-0.12089,-0.13911,1,0
3,KEGG HEMATOPOIETIC CELL LINEAGE,0.00038934,-0.12123,-0.19612,1,0
3,PID PTP1BPATHWAY,0.0079323,-0.1218,-0.16236,1,0
3,REACTOME GAP JUNCTION ASSEMBLY,0.023205,-0.12205,-0.15661,1,0
3,ST WNT CA2 CYCLIC GMP PATHWAY,0.041967,-0.12219,-0.12465,1,0
3,REACTOME ACTIVATED TLR4 SIGNALLING,0.001191,-0.12324,-0.14705,1,0
3,MAGNESIUM ION BINDING,0.0051916,-0.12383,-0.10613,1,0
3,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.00026003,-0.12405,-0.17955,1,0
3,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.025994,-0.125,-0.14894,1,0
3,REACTOME RAF MAP KINASE CASCADE,0.02268,-0.12558,-0.10595,1,0
3,KEGG VIBRIO CHOLERAE INFECTION,0.011326,-0.12637,-0.13116,1,0
3,CHROMOSOME CONDENSATION,0.035393,-0.12694,-0.15249,1,0
3,ACID AMINO ACID LIGASE ACTIVITY,0.00024286,-0.12753,-0.13575,1,0
3,KEGG FC EPSILON RI SIGNALING PATHWAY,0.0054795,-0.12778,-0.12176,1,0
3,BIOCARTA COMP PATHWAY,0.0090226,-0.12797,-0.22826,1,0
3,NUCLEAR CHROMOSOME PART,0.0015653,-0.12886,-0.15522,1,0
3,REGULATION OF T CELL ACTIVATION,0.030383,-0.12942,-0.14586,1,0
3,POSITIVE REGULATION OF CELLULAR PROCESS,0.00090094,-0.13134,-0.12982,1,0
3,PID HES HEYPATHWAY,0.017137,-0.1326,-0.11681,1,0
3,RESPONSE TO BIOTIC STIMULUS,0.0007696,-0.13271,-0.13267,1,0
3,REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,-0.13324,-0.1613,1,0
3,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.001872,-0.13362,-0.15364,1,0
3,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.0014738,-0.13403,-0.18794,1,0
3,TRANSCRIPTION FACTOR TFIID COMPLEX,0.011904,-0.13418,-0.093995,1,0
3,PID HNF3APATHWAY,0.03939,-0.13444,-0.11649,1,0
3,ST FAS SIGNALING PATHWAY,0.0016129,-0.13452,-0.12273,1,0
3,BIOCARTA LECTIN PATHWAY,0.0060989,-0.13477,-0.18648,1,0
3,ENZYME INHIBITOR ACTIVITY,0.0037331,-0.13477,-0.14565,1,0
3,PID TCR PATHWAY,0.0014738,-0.13533,-0.15043,1,0
3,PID IL3 PATHWAY,0.010506,-0.13537,-0.1427,1,0
3,CYTOKINE BIOSYNTHETIC PROCESS,0.0015189,-0.13591,-0.19791,1,0
3,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.00081984,-0.13593,-0.12516,1,0
3,PID IL2 1PATHWAY,0.010245,-0.13615,-0.13847,1,0
3,REACTOME GAP JUNCTION TRAFFICKING,0.015574,-0.13635,-0.12928,1,0
3,PID ANGIOPOIETINRECEPTOR PATHWAY,0.017969,-0.13659,-0.17175,1,0
3,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.009256,-0.13662,-0.23259,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.020205,-0.13744,-0.10189,1,0
3,PID BCR 5PATHWAY,0.00027832,-0.13896,-0.17336,1,0
3,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.0022992,-0.13906,-0.19928,1,0
3,BIOCARTA TGFB PATHWAY,0.03245,-0.13938,-0.16782,1,0
3,APOPTOSIS GO,0.00017796,-0.14003,-0.14628,1,0
3,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.0062634,-0.14008,-0.11862,1,0
3,REGULATION OF HYDROLASE ACTIVITY,0.0040578,-0.14013,-0.11997,1,0
3,REACTOME TOLL RECEPTOR CASCADES,0.00049035,-0.14029,-0.16225,1,0
3,PID VEGFR1 2 PATHWAY,0.023741,-0.14036,-0.11888,1,0
3,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.016339,-0.14072,-0.31318,1,0
3,PID GMCSF PATHWAY,0.004408,-0.14092,-0.16674,1,0
3,KEGG P53 SIGNALING PATHWAY,0.0081404,-0.14133,-0.16883,1,0
3,PID FOXOPATHWAY,0.010773,-0.14137,-0.11381,1,0
3,KEGG NOTCH SIGNALING PATHWAY,0.0038387,-0.14188,-0.15204,1,0
3,REACTOME COMPLEMENT CASCADE,0.0010206,-0.1425,-0.26922,1,0
3,LEUKOCYTE DIFFERENTIATION,0.0066042,-0.14259,-0.18409,1,0
3,EXTRACELLULAR SPACE,0.00050664,-0.14262,-0.1661,1,0
3,ENDOPLASMIC RETICULUM PART,0.0033369,-0.14366,-0.16995,1,0
3,VESICLE MEMBRANE,0.0024367,-0.14367,-0.1624,1,0
3,BIOCARTA EDG1 PATHWAY,0.016339,-0.14382,-0.17781,1,0
3,BIOCARTA NFKB PATHWAY,0.0022992,-0.14384,-0.24011,1,0
3,REACTOME MEMBRANE TRAFFICKING,0.00017186,-0.14418,-0.1737,1,0
3,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.035393,-0.14454,-0.19237,1,0
3,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.0010528,-0.14536,-0.19173,1,0
3,HUMORAL IMMUNE RESPONSE,0.0040578,-0.14585,-0.18514,1,0
3,FEMALE GAMETE GENERATION,0.016339,-0.14604,-0.2327,1,0
3,PID ECADHERIN STABILIZATION PATHWAY,0.0097392,-0.14659,-0.21171,1,0
3,CYTOKINE METABOLIC PROCESS,0.001191,-0.14665,-0.20425,1,0
3,PROGRAMMED CELL DEATH,0.00016023,-0.14685,-0.15083,1,0
3,REACTOME PI METABOLISM,0.00057693,-0.14745,-0.1326,1,0
3,PID MAPKTRKPATHWAY,0.030383,-0.14803,-0.11701,1,0
3,ER GOLGI INTERMEDIATE COMPARTMENT,0.037747,-0.14814,-0.19833,1,0
3,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.012508,-0.14836,-0.16192,1,0
3,GOLGI VESICLE TRANSPORT,0.00025131,-0.14837,-0.19043,1,0
3,CHROMATIN,0.022165,-0.1494,-0.11881,1,0
3,RESPONSE TO WOUNDING,0.0028957,-0.14974,-0.1538,1,0
3,REGULATION OF DEVELOPMENTAL PROCESS,0.00028792,-0.15018,-0.13854,1,0
3,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.0007696,-0.15089,-0.18957,1,0
3,PID TXA2PATHWAY,0.0020453,-0.15177,-0.16132,1,0
3,BIOCARTA GH PATHWAY,0.0071468,-0.15227,-0.14922,1,0
3,REGULATION OF APOPTOSIS,0.00010845,-0.15254,-0.16406,1,0
3,REACTOME GAP JUNCTION DEGRADATION,0.047551,-0.1534,-0.17511,1,0
3,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.036948,-0.15392,-0.18265,1,0
3,CELLULAR DEFENSE RESPONSE,0.00031859,-0.15392,-0.26886,1,0
3,PROTEIN BINDING BRIDGING,0.0031536,-0.15412,-0.19194,1,0
3,ENDOPLASMIC RETICULUM MEMBRANE,0.0017123,-0.15425,-0.1693,1,0
3,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.001872,-0.15458,-0.17303,1,0
3,BIOCARTA TCRA PATHWAY,0.0024367,-0.15461,-0.19467,1,0
3,PROTEIN KINASE CASCADE,0.00040247,-0.15467,-0.17645,1,0
3,KEGG PRIMARY IMMUNODEFICIENCY,0.007729,-0.15484,-0.17089,1,0
3,G PROTEIN COUPLED RECEPTOR BINDING,0.0032441,-0.15549,-0.17341,1,0
3,ISOPRENOID METABOLIC PROCESS,0.031059,-0.15645,-0.16701,1,0
3,REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE,0.036948,-0.15668,-0.18683,1,0
3,REACTOME BIOLOGICAL OXIDATIONS,0.0067808,-0.15704,-0.15392,1,0
3,GOLGI APPARATUS PART,0.00012964,-0.15733,-0.15653,1,0
3,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,5.2139e-05,-0.158,-0.14873,1,0
3,PROTEIN HETERODIMERIZATION ACTIVITY,0.00072223,-0.1581,-0.13755,1,0
3,PID FGF PATHWAY,0.027188,-0.15822,-0.13095,1,0
3,UBIQUITIN PROTEIN LIGASE ACTIVITY,2.7343e-05,-0.15871,-0.15248,1,0
3,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.036164,-0.15909,-0.1642,1,0
3,KEGG SPHINGOLIPID METABOLISM,0.00044439,-0.15941,-0.22104,1,0
3,B CELL ACTIVATION,0.013139,-0.15963,-0.17211,1,0
3,CYTOKINE ACTIVITY,0.0054795,-0.16004,-0.17206,1,0
3,PID INTEGRIN A9B1 PATHWAY,0.03245,-0.16049,-0.21056,1,0
3,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00084609,-0.16058,-0.19595,1,0
3,REACTOME ENOS ACTIVATION AND REGULATION,0.013465,-0.16065,-0.15597,1,0
3,REGULATION OF PROGRAMMED CELL DEATH,9.0551e-05,-0.1609,-0.16974,1,0
3,ST INTERLEUKIN 4 PATHWAY,0.010245,-0.16101,-0.20125,1,0
3,REPRODUCTION,8.1192e-05,-0.16103,-0.162,1,0
3,PROTEOLYSIS,3.17e-07,-0.16124,-0.20902,1,0
3,BIOCARTA TFF PATHWAY,0.010506,-0.16156,-0.20744,1,0
3,BIOCARTA CSK PATHWAY,0.0067808,-0.16162,-0.15253,1,0
3,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.009256,-0.16213,-0.17551,1,0
3,REACTOME SIGNALING BY FGFR MUTANTS,0.0010206,-0.16232,-0.15187,1,0
3,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,3.0689e-05,-0.16245,-0.15183,1,0
3,PID CD8TCRPATHWAY,0.00047456,-0.16252,-0.17496,1,0
3,PID INTEGRIN2 PATHWAY,0.0079323,-0.16259,-0.2334,1,0
3,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.0027346,-0.16321,-0.12899,1,0
3,GTP BINDING,0.0038387,-0.16347,-0.11783,1,0
3,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011612,-0.16424,-0.14876,1,0
3,LOCOMOTORY BEHAVIOR,0.0028141,-0.16478,-0.15273,1,0
3,PID WNT CANONICAL PATHWAY,0.0057817,-0.16479,-0.1351,1,0
3,SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0025083,-0.16522,-0.16838,1,0
3,REACTOME APOPTOSIS,4.8379e-05,-0.16526,-0.19444,1,0
3,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0034322,-0.16582,-0.14473,1,0
3,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,6.2786e-05,-0.16648,-0.17065,1,0
3,MICROBODY,0.007729,-0.16673,-0.14157,1,0
3,PEROXISOME,0.007729,-0.16673,-0.14157,1,0
3,NEGATIVE REGULATION OF ANGIOGENESIS,0.011612,-0.16709,-0.22923,1,0
3,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.0028957,-0.16812,-0.19777,1,0
3,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00034072,-0.16853,-0.19011,1,0
3,PEROXISOMAL PART,0.014486,-0.16924,-0.16755,1,0
3,MICROBODY PART,0.014486,-0.16924,-0.16755,1,0
3,CYTOPLASMIC VESICLE MEMBRANE,0.0022332,-0.16995,-0.16435,1,0
3,CYTOPLASMIC VESICLE PART,0.0022332,-0.16995,-0.16435,1,0
3,PID ECADHERIN NASCENTAJ PATHWAY,1.2454e-05,-0.17002,-0.22438,1,0
3,MICROBODY MEMBRANE,0.0047853,-0.17026,-0.18535,1,0
3,PEROXISOMAL MEMBRANE,0.0047853,-0.17026,-0.18535,1,0
3,BIOCARTA PAR1 PATHWAY,0.013465,-0.17071,-0.14878,1,0
3,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02068,-0.17073,-0.24785,1,0
3,KEGG ENDOMETRIAL CANCER,0.0085714,-0.17133,-0.12864,1,0
3,PID FCER1PATHWAY,1.5201e-05,-0.17145,-0.21597,1,0
3,IMMUNE EFFECTOR PROCESS,0.00012074,-0.17187,-0.21708,1,0
3,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,5.7413e-06,-0.17203,-0.19784,1,0
3,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00065623,-0.17234,-0.20252,1,0
3,KEGG ALPHA LINOLENIC ACID METABOLISM,0.034637,-0.17306,-0.13589,1,0
3,BIOCARTA RAS PATHWAY,0.00087311,-0.17313,-0.1521,1,0
3,NEGATIVE REGULATION OF TRANSLATION,0.0013457,-0.17321,-0.20685,1,0
3,REACTOME SIGNALLING TO RAS,0.00036427,-0.17364,-0.15616,1,0
3,GAMETE GENERATION,0.00028792,-0.1738,-0.21335,1,0
3,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,7.2754e-05,-0.17396,-0.23881,1,0
3,VASCULATURE DEVELOPMENT,0.014138,-0.175,-0.15232,1,0
3,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00042998,-0.17538,-0.1983,1,0
3,PID TCRJNKPATHWAY,0.0067808,-0.17543,-0.19332,1,0
3,KEGG DRUG METABOLISM CYTOCHROME P450,0.016734,-0.17622,-0.15906,1,0
3,REACTOME IL1 SIGNALING,0.00017186,-0.17656,-0.19758,1,0
3,REGULATION OF DEFENSE RESPONSE,0.0050528,-0.17696,-0.18574,1,0
3,PID IL23PATHWAY,4.4878e-05,-0.17714,-0.23096,1,0
3,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.00010845,-0.17753,-0.24862,1,0
3,KEGG RENIN ANGIOTENSIN SYSTEM,0.014841,-0.17881,-0.24173,1,0
3,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,4.0073e-05,-0.17924,-0.19615,1,0
3,HISTONE DEACETYLASE COMPLEX,0.023741,-0.17955,-0.10475,1,0
3,REPRODUCTIVE PROCESS,0.00054072,-0.1811,-0.14586,1,0
3,GUANYL NUCLEOTIDE BINDING,0.0020453,-0.1813,-0.13242,1,0
3,BIOCARTA SALMONELLA PATHWAY,0.0090226,-0.18139,-0.1976,1,0
3,BIOCARTA TCR PATHWAY,0.0011199,-0.18151,-0.15152,1,0
3,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01282,-0.18153,-0.22251,1,0
3,INFLAMMATORY RESPONSE,2.9532e-05,-0.18159,-0.22661,1,0
3,ENDOSOME,9.7801e-06,-0.18181,-0.20539,1,0
3,IMMUNE SYSTEM DEVELOPMENT,4.3218e-05,-0.18198,-0.19793,1,0
3,BIOCARTA PDGF PATHWAY,0.015574,-0.1824,-0.15941,1,0
3,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.0038387,-0.18305,-0.16222,1,0
3,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.02268,-0.18343,-0.18012,1,0
3,BIOCARTA BCR PATHWAY,0.0051916,-0.18391,-0.16476,1,0
3,PID TCPTP PATHWAY,0.0040578,-0.18418,-0.21461,1,0
3,LYTIC VACUOLE,0.0090226,-0.18443,-0.16714,1,0
3,LYSOSOME,0.0090226,-0.18443,-0.16714,1,0
3,BIOCARTA MCALPAIN PATHWAY,0.012508,-0.18452,-0.19277,1,0
3,BIOCARTA CTLA4 PATHWAY,0.00017186,-0.18554,-0.2167,1,0
3,PID TNFPATHWAY,0.00098941,-0.18567,-0.2097,1,0
3,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.7596e-05,-0.18662,-0.23307,1,0
3,ECTODERM DEVELOPMENT,0.0028141,-0.18725,-0.19169,1,0
3,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.0037331,-0.18734,-0.18509,1,0
3,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00069957,-0.18757,-0.18578,1,0
3,NEGATIVE REGULATION OF APOPTOSIS,0.0021062,-0.1887,-0.16347,1,0
3,REGULATION OF CELLULAR COMPONENT SIZE,0.015574,-0.1896,-0.28744,1,0
3,BIOCARTA FCER1 PATHWAY,0.0051916,-0.18994,-0.15719,1,0
3,KEGG SULFUR METABOLISM,0.017137,-0.18998,-0.20329,1,0
3,BIOCARTA BIOPEPTIDES PATHWAY,0.041967,-0.19025,-0.11816,1,0
3,BIOCARTA UCALPAIN PATHWAY,0.027803,-0.19128,-0.19218,1,0
3,OXYGEN BINDING,0.016339,-0.19207,-0.16379,1,0
3,BIOCARTA BCELLSURVIVAL PATHWAY,0.018836,-0.19219,-0.21758,1,0
3,PID TCRRASPATHWAY,0.016339,-0.19246,-0.16637,1,0
3,CYTOKINE PRODUCTION,0.00026903,-0.19246,-0.20615,1,0
3,REACTOME INTERFERON SIGNALING,0.00016023,-0.19323,-0.28957,1,0
3,REACTOME METABOLISM OF POLYAMINES,0.03245,-0.19338,-0.14768,1,0
3,EPIDERMIS DEVELOPMENT,0.0028957,-0.1938,-0.2087,1,0
3,ANTIOXIDANT ACTIVITY,0.037747,-0.19447,-0.17475,1,0
3,BIOCARTA HSP27 PATHWAY,0.00037661,-0.19465,-0.24982,1,0
3,BIOCARTA NUCLEARRS PATHWAY,0.00055855,-0.19494,-0.28915,1,0
3,KEGG ADHERENS JUNCTION,5.0683e-06,-0.19572,-0.23874,1,0
3,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00059588,-0.1962,-0.19363,1,0
3,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.0010859,-0.19636,-0.29097,1,0
3,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.0069616,-0.19671,-0.27961,1,0
3,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.044685,-0.19747,-0.26006,1,0
3,MEMBRANE COAT,0.0012662,-0.19747,-0.22391,1,0
3,COATED MEMBRANE,0.0012662,-0.19747,-0.22391,1,0
3,LIPID HOMEOSTASIS,0.031748,-0.19763,-0.25173,1,0
3,ANGIOGENESIS,0.0016129,-0.19774,-0.21196,1,0
3,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0071468,-0.19811,-0.17222,1,0
3,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.0015653,-0.19939,-0.17633,1,0
3,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.024846,-0.19965,-0.28487,1,0
3,PID NFKAPPABATYPICALPATHWAY,0.001191,-0.20085,-0.24999,1,0
3,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,2.0833e-05,-0.20144,-0.23452,1,0
3,BIOCARTA CTL PATHWAY,0.007729,-0.20218,-0.2573,1,0
3,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.00016595,-0.20297,-0.22262,1,0
3,PID ALPHASYNUCLEIN PATHWAY,0.0073363,-0.20438,-0.17731,1,0
3,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.00067758,-0.20445,-0.26929,1,0
3,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.0056288,-0.20454,-0.17542,1,0
3,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR BINDING,0.00057693,-0.20497,-0.21164,1,0
3,INTEGRIN COMPLEX,0.0051916,-0.20514,-0.2393,1,0
3,REACTOME INNATE IMMUNE SYSTEM,2.1702e-06,-0.2069,-0.23531,1,0
3,GLYCOPROTEIN METABOLIC PROCESS,9.389e-05,-0.20703,-0.22451,1,0
3,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,6.7728e-06,-0.20737,-0.21304,1,0
3,BIOCARTA ARENRF2 PATHWAY,0.034637,-0.20745,-0.23115,1,0
3,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,2.6307e-05,-0.20836,-0.25099,1,0
3,BIOCARTA ECM PATHWAY,0.00067758,-0.20846,-0.25926,1,0
3,KEGG APOPTOSIS,9.0551e-05,-0.20897,-0.2422,1,0
3,BIOCARTA CDC42RAC PATHWAY,0.02068,-0.20915,-0.234,1,0
3,LATE ENDOSOME,0.00098941,-0.21004,-0.20107,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PC,0.00092958,-0.21091,-0.25877,1,0
3,SIG PIP3 SIGNALING IN B LYMPHOCYTES,6.7596e-05,-0.21093,-0.2431,1,0
3,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00031859,-0.21213,-0.22852,1,0
3,COATED VESICLE MEMBRANE,0.0018173,-0.21247,-0.21487,1,0
3,APOPTOTIC PROGRAM,0.0001165,-0.21263,-0.19754,1,0
3,RESPONSE TO VIRUS,0.00079435,-0.21351,-0.20092,1,0
3,BIOCARTA TPO PATHWAY,0.0059384,-0.21399,-0.17316,1,0
3,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.0036303,-0.21588,-0.19075,1,0
3,BIOCARTA AMI PATHWAY,0.0099891,-0.21596,-0.35163,1,0
3,PEROXISOME ORGANIZATION AND BIOGENESIS,0.00044439,-0.21608,-0.21175,1,0
3,TRANSPORT VESICLE,0.00031859,-0.21633,-0.2213,1,0
3,REGULATION OF SIGNAL TRANSDUCTION,2.5308e-05,-0.21641,-0.22449,1,0
3,REGULATION OF CELL DIFFERENTIATION,0.0001165,-0.21641,-0.22719,1,0
3,BIOCARTA IL2RB PATHWAY,0.00019079,-0.2174,-0.23062,1,0
3,PID NFKAPPABCANONICALPATHWAY,0.0042883,-0.21786,-0.20613,1,0
3,CELL CELL ADHESION,0.00059588,-0.21903,-0.19903,1,0
3,ANATOMICAL STRUCTURE FORMATION,0.0016129,-0.21996,-0.19329,1,0
3,ICOSANOID METABOLIC PROCESS,0.0041716,-0.22173,-0.41597,1,0
3,DEFENSE RESPONSE,3.4728e-06,-0.22223,-0.24234,1,0
3,BIOCARTA GSK3 PATHWAY,0.0064317,-0.22242,-0.19327,1,0
3,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.0051916,-0.22262,-0.17344,1,0
3,REACTOME LYSOSOME VESICLE BIOGENESIS,0.0017123,-0.22327,-0.25658,1,0
3,PID P38ALPHABETADOWNSTREAMPATHWAY,0.00081984,-0.22351,-0.19922,1,0
3,KEGG VIRAL MYOCARDITIS,0.00095906,-0.22381,-0.28677,1,0
3,KINASE INHIBITOR ACTIVITY,0.038561,-0.22385,-0.18454,1,0
3,VESICLE LOCALIZATION,0.0054795,-0.22421,-0.3105,1,0
3,PID HNF3BPATHWAY,0.0025083,-0.22448,-0.21674,1,0
3,PID PI3KCIPATHWAY,0.0001165,-0.2253,-0.21588,1,0
3,HEMOPOIESIS,1.5816e-05,-0.22598,-0.22364,1,0
3,G1 PHASE,0.014486,-0.22696,-0.20137,1,0
3,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.0056288,-0.22745,-0.17456,1,0
3,BIOCARTA RELA PATHWAY,0.0051916,-0.22765,-0.21998,1,0
3,NUCLEAR SPECK,0.00010462,-0.22776,-0.23175,1,0
3,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.0073363,-0.22811,-0.23424,1,0
3,REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,0.017137,-0.22851,-0.22013,1,0
3,SEXUAL REPRODUCTION,1.7806e-05,-0.22977,-0.24168,1,0
3,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.016734,-0.22985,-0.18478,1,0
3,VACUOLE,7.8282e-05,-0.2299,-0.25105,1,0
3,PID ERB GENOMIC PATHWAY,0.0073363,-0.23044,-0.19939,1,0
3,KEGG TIGHT JUNCTION,8.2505e-07,-0.23071,-0.23872,1,0
3,CALCIUM MEDIATED SIGNALING,0.0019282,-0.23202,-0.23295,1,0
3,ENDOTHELIAL CELL PROLIFERATION,0.0079323,-0.23435,-0.4334,1,0
3,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010528,-0.23455,-0.21738,1,0
3,POSITIVE REGULATION OF CASPASE ACTIVITY,0.00012074,-0.23486,-0.25098,1,0
3,TRANSITION METAL ION TRANSPORT,0.009256,-0.23504,-0.21018,1,0
3,SH2 DOMAIN BINDING,0.0041716,-0.2373,-0.27905,1,0
3,REACTOME REGULATION OF INSULIN SECRETION,0.013465,-0.23734,-0.1517,1,0
3,PID TAP63PATHWAY,0.0041716,-0.2379,-0.24797,1,0
3,REACTOME CELL CELL COMMUNICATION,9.7346e-05,-0.23795,-0.24255,1,0
3,BIOCARTA HER2 PATHWAY,7.2754e-05,-0.23867,-0.24301,1,0
3,PHOSPHOINOSITIDE BINDING,0.011612,-0.23957,-0.16765,1,0
3,BIOCARTA SPPA PATHWAY,0.00072223,-0.24019,-0.2512,1,0
3,GOLGI MEMBRANE,6.7596e-05,-0.2415,-0.24171,1,0
3,BIOCARTA TNFR1 PATHWAY,0.0018173,-0.24189,-0.21216,1,0
3,REACTOME SIGNALING BY ILS,4.1112e-06,-0.24223,-0.24358,1,0
3,DEAMINASE ACTIVITY,0.016734,-0.24248,-0.24434,1,0
3,VESICLE COAT,0.00052342,-0.24381,-0.24932,1,0
3,BIOCARTA IL2 PATHWAY,0.0036303,-0.24477,-0.22296,1,0
3,BIOCARTA TID PATHWAY,0.025994,-0.24581,-0.18626,1,0
3,REACTOME XENOBIOTICS,0.00037661,-0.24646,-0.24568,1,0
3,REACTOME N GLYCAN ANTENNAE ELONGATION,0.015203,-0.24714,-0.19692,1,0
3,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,3.9418e-06,-0.2472,-0.27335,1,0
3,BIOCARTA EGF PATHWAY,0.0015189,-0.24903,-0.22356,1,0
3,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.00069957,-0.24946,-0.18719,1,0
3,REGULATION OF PROTEIN SECRETION,0.00059588,-0.24998,-0.21298,1,0
3,GOLGI STACK,3.5759e-05,-0.25349,-0.31327,1,0
3,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,8.7323e-05,-0.2545,-0.28534,1,0
3,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,1.349e-05,-0.25788,-0.2761,1,0
3,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.00021167,-0.25801,-0.33194,1,0
3,BIOCARTA CLASSIC PATHWAY,0.00036427,-0.25875,-0.3152,1,0
3,SODIUM ION TRANSPORT,0.0085714,-0.26206,-0.2456,1,0
3,STEROID BINDING,0.0067808,-0.26255,-0.24349,1,0
3,CASPASE ACTIVATION,0.00010462,-0.26358,-0.2509,1,0
3,BIOCARTA RHO PATHWAY,0.0023671,-0.26378,-0.24658,1,0
3,REACTOME SIGNALING BY HIPPO,0.0017641,-0.26555,-0.31144,1,0
3,BILE ACID METABOLIC PROCESS,0.0051916,-0.26586,-0.27682,1,0
3,REGULATION OF ACTIN FILAMENT LENGTH,0.0087944,-0.26607,-0.32173,1,0
3,AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.00063551,-0.26657,-0.38329,1,0
3,SIG BCR SIGNALING PATHWAY,2.0833e-05,-0.26807,-0.25739,1,0
3,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,6.7728e-06,-0.26893,-0.30797,1,0
3,SA MMP CYTOKINE CONNECTION,0.00098941,-0.26929,-0.35306,1,0
3,BIOCARTA SPRY PATHWAY,5.0226e-05,-0.26989,-0.35282,1,0
3,REACTOME CELL JUNCTION ORGANIZATION,2.1663e-05,-0.27053,-0.32517,1,0
3,GLYCOPROTEIN CATABOLIC PROCESS,0.0042883,-0.27055,-0.25228,1,0
3,REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,0.0025817,-0.27134,-0.28647,1,0
3,REACTOME CD28 DEPENDENT VAV1 PATHWAY,0.0022992,-0.27298,-0.24391,1,0
3,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,3.8583e-05,-0.27335,-0.34969,1,0
3,MYELOID CELL DIFFERENTIATION,1.1493e-05,-0.27476,-0.31946,1,0
3,TRANS GOLGI NETWORK TRANSPORT VESICLE,0.00016023,-0.27531,-0.27543,1,0
3,OLIGOSACCHARYL TRANSFERASE COMPLEX,0.0011549,-0.27543,-0.26312,1,0
3,PID FASPATHWAY,0.0001547,-0.27578,-0.26977,1,0
3,PID A6B1 A6B4 INTEGRIN PATHWAY,0.0017641,-0.27633,-0.33145,1,0
3,MICROTUBULE MOTOR ACTIVITY,0.0036303,-0.27693,-0.19808,1,0
3,REACTOME REGULATION OF IFNG SIGNALING,0.017969,-0.27703,-0.18806,1,0
3,LIPID RAFT,0.00032948,-0.27915,-0.3262,1,0
3,PID KITPATHWAY,3.9418e-06,-0.28047,-0.28061,1,0
3,REACTOME INTERFERON GAMMA SIGNALING,0.00012074,-0.28261,-0.40192,1,0
3,DEVELOPMENTAL MATURATION,0.0073363,-0.28275,-0.27417,1,0
3,CELL MATURATION,0.042857,-0.28468,-0.20641,1,0
3,PID IL4 2PATHWAY,1.0604e-05,-0.28573,-0.31213,1,0
3,KEGG RIBOFLAVIN METABOLISM,5.8301e-05,-0.2862,-0.29112,1,0
3,REACTOME REGULATION OF COMPLEMENT CASCADE,0.00021909,-0.28687,-0.44906,1,0
3,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,9.4334e-07,-0.28945,-0.33493,1,0
3,KEGG AUTOIMMUNE THYROID DISEASE,0.0069616,-0.28985,-0.37126,1,0
3,REACTOME IL 2 SIGNALING,2.3654e-06,-0.29322,-0.33889,1,0
3,LYSOSOMAL MEMBRANE,0.0015189,-0.29593,-0.28893,1,0
3,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.00010462,-0.29671,-0.33092,1,0
3,I KAPPAB KINASE NF KAPPAB CASCADE,1.4674e-06,-0.29829,-0.36496,1,0
3,PROTEIN SECRETION,0.00090094,-0.29963,-0.26378,1,0
3,REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS,0.0099891,-0.30072,-0.30602,1,0
3,BIOCARTA FAS PATHWAY,7.547e-05,-0.30143,-0.33328,1,0
3,VACUOLAR PART,0.00081984,-0.30439,-0.28234,1,0
3,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,6.0504e-05,-0.30519,-0.27974,1,0
3,CELL JUNCTION,4.6623e-06,-0.30552,-0.30044,1,0
3,VACUOLAR MEMBRANE,0.00092958,-0.30717,-0.29325,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PE,6.2786e-05,-0.30773,-0.32645,1,0
3,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,1.7806e-05,-0.30888,-0.29839,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PI,0.00010092,-0.3131,-0.37974,1,0
3,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,6.2786e-05,-0.31344,-0.31438,1,0
3,BIOCARTA CBL PATHWAY,0.0021689,-0.31924,-0.26641,1,0
3,PID TRAIL PATHWAY,2.9532e-05,-0.32009,-0.32677,1,0
3,CONTRACTILE FIBER,7.547e-05,-0.3204,-0.30912,1,0
3,CONTRACTILE FIBER PART,3.1888e-05,-0.3205,-0.35976,1,0
3,TUBE DEVELOPMENT,0.00037661,-0.32345,-0.30499,1,0
3,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.0020453,-0.32411,-0.34815,1,0
3,REACTOME NOD1 2 SIGNALING PATHWAY,5.2533e-07,-0.32666,-0.38096,1,0
3,PROTEASE INHIBITOR ACTIVITY,0.00024286,-0.329,-0.3743,1,0
3,ST TUMOR NECROSIS FACTOR PATHWAY,7.0571e-06,-0.32966,-0.35248,1,0
3,BIOCARTA HIVNEF PATHWAY,5.2837e-06,-0.33059,-0.36584,1,0
3,REACTOME ACYL CHAIN REMODELLING OF PS,0.0001547,-0.33155,-0.34022,1,0
3,BIOCARTA GATA3 PATHWAY,0.0036303,-0.33502,-0.2448,1,0
3,GALACTOSYLTRANSFERASE ACTIVITY,0.0013457,-0.33932,-0.33207,1,0
3,EARLY ENDOSOME,2.6307e-05,-0.34052,-0.3278,1,0
3,KEGG GRAFT VERSUS HOST DISEASE,0.001191,-0.34209,-0.43064,1,0
3,REGULATION OF MYELOID CELL DIFFERENTIATION,0.00025131,-0.34297,-0.38265,1,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR,0.02068,-0.34341,-0.25399,1,0
3,SECRETORY GRANULE,0.00017796,-0.34348,-0.33625,1,0
3,MYELOID LEUKOCYTE DIFFERENTIATION,0.00050664,-0.34367,-0.44488,1,0
3,REACTOME REGULATION OF IFNA SIGNALING,0.0023671,-0.34426,-0.33301,1,0
3,LIPID TRANSPORTER ACTIVITY,5.508e-06,-0.34582,-0.35252,1,0
3,REACTOME APOPTOTIC EXECUTION PHASE,5.2533e-07,-0.34836,-0.36883,1,0
3,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0022992,-0.34884,-0.32747,1,0
3,REACTOME GLUTATHIONE CONJUGATION,0.0097392,-0.3494,-0.29862,1,0
3,STRUCTURAL CONSTITUENT OF MUSCLE,1.1776e-06,-0.35273,-0.39676,1,0
3,PID EPOPATHWAY,3.4728e-06,-0.35437,-0.33412,1,0
3,BIOCARTA KERATINOCYTE PATHWAY,6.7728e-06,-0.35679,-0.32651,1,0
3,REACTOME PD1 SIGNALING,6.5149e-05,-0.35681,-0.32047,1,0
3,REACTOME IL 6 SIGNALING,0.0056288,-0.35831,-0.31885,1,0
3,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.025414,-0.36139,-0.30472,1,0
3,TUBE MORPHOGENESIS,1.9263e-05,-0.36149,-0.3932,1,0
3,HORMONE ACTIVITY,0.0031536,-0.36489,-0.30465,1,0
3,ACTIN FILAMENT BINDING,0.0029794,-0.365,-0.2525,1,0
3,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,5.753e-07,-0.36709,-0.41736,1,0
3,MYOFIBRIL,0.00018427,-0.36756,-0.34528,1,0
3,BIOCARTA PLATELETAPP PATHWAY,0.03245,-0.36826,-0.3798,1,0
3,INTERCELLULAR JUNCTION,4.6623e-06,-0.36844,-0.35404,1,0
3,NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00018427,-0.36858,-0.3648,1,0
3,BIOCARTA IL22BP PATHWAY,0.00031859,-0.37206,-0.40146,1,0
3,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,1.5331e-06,-0.37221,-0.36613,1,0
3,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,5.753e-07,-0.37285,-0.42019,1,0
3,PID AJDISS 2PATHWAY,2.3418e-05,-0.37821,-0.34348,1,0
3,KEGG CIRCADIAN RHYTHM MAMMAL,0.014486,-0.38178,-0.24952,1,0
3,MOTOR ACTIVITY,0.00026003,-0.3853,-0.30209,1,0
3,BIOCARTA CERAMIDE PATHWAY,2.9301e-06,-0.38575,-0.36219,1,0
3,PID ECADHERIN KERATINOCYTE PATHWAY,5.0194e-07,-0.38756,-0.45108,1,0
3,REACTOME AMINE DERIVED HORMONES,0.035393,-0.38806,-0.30713,1,0
3,PID CASPASE PATHWAY,1.104e-05,-0.38944,-0.39354,1,0
3,BIOCARTA IL7 PATHWAY,5.9841e-06,-0.39213,-0.41751,1,0
3,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,3.3132e-05,-0.39283,-0.41548,1,0
3,IMMUNOLOGICAL SYNAPSE,0.00035231,-0.39844,-0.34843,1,0
3,KEGG ALLOGRAFT REJECTION,0.0027346,-0.39877,-0.45916,1,0
3,REACTOME CELL CELL JUNCTION ORGANIZATION,0.00017796,-0.40452,-0.39703,1,0
3,ADP BINDING,0.00013917,-0.40504,-0.42734,1,0
3,BIOCARTA IL3 PATHWAY,4.1617e-05,-0.41614,-0.35954,1,0
3,SA PROGRAMMED CELL DEATH,5.4121e-05,-0.41711,-0.37308,1,0
3,POSITIVE REGULATION OF CELL DIFFERENTIATION,4.0073e-05,-0.41778,-0.43014,1,0
3,PID DELTANP63PATHWAY,5.2139e-05,-0.41851,-0.38738,1,0
3,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,1.7474e-06,-0.41855,-0.38593,1,0
3,NUCLEAR CHROMATIN,0.00055855,-0.42221,-0.33088,1,0
3,REACTOME SIGNALING BY NOTCH3,6.2985e-07,-0.42457,-0.49543,1,0
3,KEGG TYPE I DIABETES MELLITUS,8.4205e-05,-0.42534,-0.41667,1,0
3,BIOCARTA CHEMICAL PATHWAY,1.2962e-05,-0.42762,-0.38332,1,0
3,KEGG DORSO VENTRAL AXIS FORMATION,2.3654e-06,-0.43129,-0.38491,1,0
3,HORMONE BINDING,0.00023468,-0.44387,-0.40457,1,0
3,BIOCARTA DEATH PATHWAY,9.0221e-07,-0.44459,-0.50958,1,0
3,REACTOME SIGNALING BY NOTCH2,2.0829e-07,-0.44515,-0.5272,1,0
3,MYOSIN COMPLEX,1.6452e-07,-0.44637,-0.4861,1,0
3,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.0013872,-0.44694,-0.39853,1,0
3,UDP GLYCOSYLTRANSFERASE ACTIVITY,3.0689e-05,-0.44695,-0.41124,1,0
3,CORNIFIED ENVELOPE,1.4039e-05,-0.44718,-0.50115,1,0
3,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP,0.00014935,-0.44809,-0.43491,1,0
3,SA CASPASE CASCADE,2.0833e-05,-0.45415,-0.42194,1,0
3,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,3.3202e-07,-0.46943,-0.48507,1,0
3,APICAL PART OF CELL,7.2111e-07,-0.47691,-0.48223,1,0
3,BIOCARTA BAD PATHWAY,4.4878e-05,-0.48242,-0.38589,1,0
3,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,1.3605e-07,-0.4861,-0.53988,1,0
3,PID HIVNEFPATHWAY,3.4772e-07,-0.48947,-0.4828,1,0
3,POST GOLGI VESICLE MEDIATED TRANSPORT,2.1831e-07,-0.49914,-0.49293,1,0
3,BIOCARTA CASPASE PATHWAY,5.0194e-07,-0.50025,-0.54949,1,0
3,REACTOME SIGNALING BY NOTCH4,1.0779e-06,-0.50586,-0.52626,1,0
3,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.00010845,-0.5075,-0.51809,1,0
3,APICAL PLASMA MEMBRANE,4.1802e-07,-0.51004,-0.51538,1,0
3,KERATINOCYTE DIFFERENTIATION,3.4728e-06,-0.52068,-0.55751,1,0
3,BIOCARTA NKCELLS PATHWAY,4.7955e-07,-0.52749,-0.61419,1,0
3,MORPHOGENESIS OF AN EPITHELIUM,2.2658e-06,-0.52853,-0.55229,1,0
3,APICAL JUNCTION COMPLEX,1.6729e-06,-0.5298,-0.51428,1,0
3,APICOLATERAL PLASMA MEMBRANE,1.6729e-06,-0.5298,-0.51428,1,0
3,TIGHT JUNCTION,3.7791e-06,-0.53136,-0.51908,1,0
3,LEUKOCYTE MIGRATION,0.00038934,-0.53149,-0.4113,1,0
3,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.0018173,-0.53512,-0.60709,1,0
3,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,5.753e-07,-0.53653,-0.52374,1,0
3,BIOCARTA MITOCHONDRIA PATHWAY,4.3763e-07,-0.54212,-0.55164,1,0
3,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,4.5813e-07,-0.54538,-0.64904,1,0
3,PID NECTIN PATHWAY,5.2533e-07,-0.60035,-0.50758,1,0
3,REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN,8.6584e-06,-0.60505,-0.61337,1,0
3,REACTOME REGULATION OF KIT SIGNALING,5.7413e-06,-0.61229,-0.5946,1,0
3,BIOCARTA SODD PATHWAY,3.6414e-07,-0.61958,-0.6676,1,0
3,REACTOME INTERFERON ALPHA BETA SIGNALING,1.349e-05,-0.62476,-0.70245,1,0
3,GLAND DEVELOPMENT,4.6597e-05,-0.62917,-0.5889,1,0
3,PHOSPHOLIPID TRANSPORTER ACTIVITY,2.1702e-06,-0.63885,-0.55341,1,0
3,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,3.3287e-06,-0.65995,-0.63495,1,0
3,NEUROPEPTIDE HORMONE ACTIVITY,0.0081404,-0.70595,-0.51494,1,0
3,CALCIUM INDEPENDENT CELL CELL ADHESION,6.5149e-05,-0.70687,-0.62907,1,0
3,REACTOME TIGHT JUNCTION INTERACTIONS,3.0689e-05,-0.78528,-0.66527,1,0
3,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,3.4772e-07,-0.79014,-0.80764,1,0
3,REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS,5.9841e-06,-0.82593,-1.0836,1,0
3,REACTOME CS DS DEGRADATION,0.093897,0.38816,0.15646,0,1
3,NUCLEOSOME ASSEMBLY,0.050569,0.29047,0.17023,0,1
3,BIOCARTA AHSP PATHWAY,0.10845,0.28718,0.22592,0,1
3,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.065563,0.26652,0.1422,0,1
3,CELL SUBSTRATE ADHERENS JUNCTION,0.076492,0.24141,0.14354,0,1
3,CELL MATRIX JUNCTION,0.12473,0.23939,0.11611,0,1
3,REGULATION OF ENDOCYTOSIS,0.092194,0.21298,0.11982,0,1
3,BIOCARTA ARF PATHWAY,0.092194,0.20978,0.17063,0,1
3,PID S1P S1P2 PATHWAY,0.075049,0.20945,0.11883,0,1
3,BIOCARTA THELPER PATHWAY,0.46512,0.20041,0.04035,0,1
3,CHROMATIN REMODELING COMPLEX,0.087232,0.19928,0.12078,0,1
3,PROTEIN TRANSPORTER ACTIVITY,0.36526,0.1956,0.047626,0,1
3,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.04854,0.18849,0.13033,0,1
3,MACROMOLECULAR COMPLEX DISASSEMBLY,0.13355,0.1858,0.10272,0,1
3,REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE,0.04854,0.18451,0.14674,0,1
3,CHROMATIN ASSEMBLY,0.049546,0.18257,0.12404,0,1
3,PROTEIN COMPLEX DISASSEMBLY,0.072231,0.18171,0.12714,0,1
3,KEGG PROPANOATE METABOLISM,0.0695,0.15978,0.13417,0,1
3,N METHYLTRANSFERASE ACTIVITY,0.070855,0.15976,0.11854,0,1
3,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.072231,0.15835,0.11346,0,1
3,PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY,0.055956,0.15434,0.13562,0,1
3,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.11841,0.14916,0.18613,0,1
3,NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.11434,0.14538,0.15544,0,1
3,CORTICAL CYTOSKELETON,0.085627,0.14352,0.1737,0,1
3,CARBON OXYGEN LYASE ACTIVITY,0.15015,0.13823,0.08038,0,1
3,MITOTIC SPINDLE ORGANIZATION AND BIOGENESIS,0.12908,0.13594,0.10916,0,1
3,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.33812,0.13544,0.078632,0,1
3,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.30402,0.135,0.037974,0,1
3,SPINDLE ORGANIZATION AND BIOGENESIS,0.10096,0.13455,0.11336,0,1
3,CELLULAR RESPIRATION,0.057089,0.13311,0.11126,0,1
3,CELLULAR COMPONENT DISASSEMBLY,0.16559,0.13302,0.073466,0,1
3,DNA FRAGMENTATION DURING APOPTOSIS,0.14048,0.12416,0.11577,0,1
3,ONE CARBON COMPOUND METABOLIC PROCESS,0.17653,0.12358,0.06178,0,1
3,APOPTOTIC NUCLEAR CHANGES,0.085627,0.12352,0.088863,0,1
3,BIOCARTA HDAC PATHWAY,0.14526,0.11999,0.07486,0,1
3,LAMELLIPODIUM,0.23245,0.1178,0.059092,0,1
3,REACTOME G ALPHA I SIGNALLING EVENTS,0.059411,0.11642,0.059154,0,1
3,HYDRO LYASE ACTIVITY,0.12689,0.11403,0.083456,0,1
3,KEGG CYSTEINE AND METHIONINE METABOLISM,0.11841,0.11325,0.094372,0,1
3,CENTROSOME CYCLE,0.049546,0.113,0.12693,0,1
3,CELL SURFACE,0.085627,0.11159,0.10902,0,1
3,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.14769,0.10887,0.07808,0,1
3,REACTOME EXTENSION OF TELOMERES,0.057089,0.10654,0.11643,0,1
3,BIOCARTA P27 PATHWAY,0.095625,0.10229,0.11963,0,1
3,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.2839,0.10077,0.084998,0,1
3,KEGG PRION DISEASES,0.065563,0.093319,0.085179,0,1
3,BIOCARTA VIP PATHWAY,0.27611,0.091055,0.053232,0,1
3,REACTOME VIRAL MESSENGER RNA SYNTHESIS,0.052669,0.089285,0.085354,0,1
3,BIOCARTA IGF1MTOR PATHWAY,0.47049,0.089069,0.025717,0,1
3,CELL CORTEX PART,0.12049,0.08697,0.13651,0,1
3,MEIOSIS I,0.46512,0.086896,0.036592,0,1
3,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.12689,0.082623,0.071846,0,1
3,ENDODEOXYRIBONUCLEASE ACTIVITY,0.26847,0.081417,0.047521,0,1
3,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.068167,0.080927,0.064515,0,1
3,ENDONUCLEASE ACTIVITY,0.095625,0.079881,0.051842,0,1
3,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.19695,0.078704,0.068855,0,1
3,REACTOME GLOBAL GENOMIC NER GG NER,0.13355,0.076754,0.059417,0,1
3,PID AURORA A PATHWAY,0.4545,0.074773,0.039637,0,1
3,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.36526,0.072096,0.058226,0,1
3,PID CXCR3PATHWAY,0.080955,0.069869,0.086214,0,1
3,REACTOME MICRORNA MIRNA BIOGENESIS,0.068167,0.069639,0.079254,0,1
3,CHROMOSOMEPERICENTRIC REGION,0.25001,0.069097,0.050428,0,1
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.22905,0.068318,0.030486,0,1
3,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.12049,0.066313,0.061207,0,1
3,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.087232,0.062727,0.077008,0,1
3,REACTOME MRNA CAPPING,0.054842,0.062574,0.071594,0,1
3,COVALENT CHROMATIN MODIFICATION,0.33812,0.062488,0.0468,0,1
3,REACTOME PI3K AKT ACTIVATION,0.13814,0.061787,0.072333,0,1
3,BIOCARTA CELLCYCLE PATHWAY,0.7495,0.061761,0.018528,0,1
3,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.061812,0.060317,0.067989,0,1
3,REACTOME SIGNALLING BY NGF,0.095625,0.059623,0.049983,0,1
3,KEGG BASE EXCISION REPAIR,0.13583,0.057015,0.054971,0,1
3,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.39371,0.056457,0.035237,0,1
3,HISTONE MODIFICATION,0.30815,0.056059,0.045944,0,1
3,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.087232,0.054559,0.052453,0,1
3,KEGG INSULIN SIGNALING PATHWAY,0.11636,0.054121,0.051263,0,1
3,DNA RECOMBINATION,0.16032,0.050479,0.054598,0,1
3,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.075049,0.049535,0.058962,0,1
3,KEGG NUCLEOTIDE EXCISION REPAIR,0.3746,0.043701,0.035592,0,1
3,REACTOME DNA REPAIR,0.063042,0.043435,0.050645,0,1
3,REACTOME CELL CYCLE MITOTIC,0.22568,0.042556,0.038406,0,1
3,PID FANCONI PATHWAY,0.52594,0.041797,0.028626,0,1
3,REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE,0.00024286,0.53112,0.56774,0,0
3,AXONOGENESIS,1.7118e-05,0.49432,0.4686,0,0
3,GROWTH CONE,0.013465,0.48035,0.52457,0,0
3,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,1.349e-05,0.47531,0.53801,0,0
3,NEURITE DEVELOPMENT,1.0184e-05,0.46032,0.44131,0,0
3,IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY,0.0023671,0.45664,0.54923,0,0
3,SITE OF POLARIZED GROWTH,0.0097392,0.44924,0.50478,0,0
3,GLUTAMATE RECEPTOR ACTIVITY,6.7596e-05,0.44523,0.50425,0,0
3,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,2.8418e-05,0.41688,0.40566,0,0
3,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.0011549,0.4122,0.39339,0,0
3,NEURON DIFFERENTIATION,2.0833e-05,0.40946,0.38644,0,0
3,REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE,0.0046564,0.39136,0.53168,0,0
3,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.0025817,0.37816,0.34225,0,0
3,AXON GUIDANCE,0.0028957,0.3618,0.34825,0,0
3,NEURON DEVELOPMENT,3.8583e-05,0.35745,0.34154,0,0
3,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.0022992,0.32548,0.34041,0,0
3,REACTOME GABA B RECEPTOR ACTIVATION,0.00047456,0.31246,0.28393,0,0
3,REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS,0.0042883,0.30732,0.24801,0,0
3,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,7.2754e-05,0.29128,0.25927,0,0
3,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.00074557,0.28997,0.36845,0,0
3,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.00052342,0.28724,0.32881,0,0
3,REGULATION OF AXONOGENESIS,0.055956,0.28551,0.34679,0,0
3,BIOCARTA CACAM PATHWAY,0.00037661,0.2825,0.29362,0,0
3,ACETYLCHOLINE BINDING,0.0059384,0.27884,0.28248,0,0
3,LYSOSOME ORGANIZATION AND BIOGENESIS,0.075049,0.26163,0.17903,0,0
3,POTASSIUM CHANNEL ACTIVITY,0.0054795,0.24994,0.2694,0,0
3,REACTOME METABOLISM OF PORPHYRINS,0.049546,0.24797,0.21392,0,0
3,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.00022676,0.24766,0.24424,0,0
3,ARYLSULFATASE ACTIVITY,0.021165,0.23293,0.22993,0,0
3,BIOCARTA NKT PATHWAY,0.077957,0.23243,0.13585,0,0
3,VOLTAGE GATED CHANNEL ACTIVITY,0.00069957,0.23203,0.28948,0,0
3,REACTOME NEURONAL SYSTEM,0.00087311,0.23077,0.21157,0,0
3,BIOCARTA CDMAC PATHWAY,0.1028,0.22835,0.11525,0,0
3,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.04854,0.22458,0.12848,0,0
3,SYNAPTIC TRANSMISSION,0.00017796,0.21849,0.22104,0,0
3,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.00055855,0.21303,0.26376,0,0
3,EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX,0.049546,0.21132,0.2419,0,0
3,REACTOME POTASSIUM CHANNELS,0.0026572,0.20475,0.24481,0,0
3,CATION CHANNEL ACTIVITY,0.0022992,0.19902,0.23563,0,0
3,PID NETRIN PATHWAY,0.0029794,0.19732,0.22094,0,0
3,TRANSMISSION OF NERVE IMPULSE,0.00038934,0.1965,0.19736,0,0
3,GATED CHANNEL ACTIVITY,0.001662,0.19468,0.23397,0,0
3,AXON,0.39371,0.19419,0.095669,0,0
3,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.038561,0.19396,0.21501,0,0
3,COPPER ION BINDING,0.059411,0.19295,0.14245,0,0
3,MONOCARBOXYLIC ACID TRANSPORT,0.16294,0.18968,0.12387,0,0
3,REACTOME NETRIN1 SIGNALING,0.019739,0.18882,0.15964,0,0
3,PDZ DOMAIN BINDING,0.021165,0.1855,0.15749,0,0
3,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.10096,0.1853,0.1741,0,0
3,REACTOME MYOGENESIS,0.026586,0.18524,0.22306,0,0
3,N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.12259,0.18293,0.093156,0,0
3,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.017549,0.18208,0.14345,0,0
3,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.052669,0.18062,0.10867,0,0
3,RIBONUCLEOTIDE METABOLIC PROCESS,0.0075304,0.18047,0.17658,0,0
3,RIBOSOME,0.011047,0.17749,0.20718,0,0
3,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.32938,0.17173,0.080467,0,0
3,AMINE BINDING,0.018836,0.1715,0.18351,0,0
3,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.085627,0.17021,0.14516,0,0
3,REGULATION OF NEUROGENESIS,0.088862,0.16985,0.21982,0,0
3,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.0060989,0.1675,0.18151,0,0
3,PID RAC1 REG PATHWAY,0.0026572,0.16501,0.1964,0,0
3,RHO GTPASE ACTIVATOR ACTIVITY,0.17653,0.16347,0.12652,0,0
3,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.018836,0.16173,0.15742,0,0
3,REACTOME REGULATION OF APOPTOSIS,0.11434,0.16105,0.075407,0,0
3,BIOCARTA PROTEASOME PATHWAY,0.061812,0.16091,0.13241,0,0
3,KEGG AXON GUIDANCE,0.029068,0.1604,0.13006,0,0
3,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.17653,0.16003,0.23786,0,0
3,PID INTEGRIN4 PATHWAY,0.49227,0.15914,0.027445,0,0
3,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.037747,0.15907,0.21293,0,0
3,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.082489,0.15889,0.1479,0,0
3,REACTOME RNA POL III TRANSCRIPTION,8.4205e-05,0.15874,0.15617,0,0
3,RESPONSE TO OXIDATIVE STRESS,0.11636,0.15855,0.071247,0,0
3,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.14769,0.15716,0.087012,0,0
3,BIOCARTA NOS1 PATHWAY,0.0079323,0.15689,0.24712,0,0
3,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.19393,0.15625,0.074356,0,0
3,REACTOME SIGNALING BY ROBO RECEPTOR,0.033894,0.15608,0.16765,0,0
3,REACTOME HDL MEDIATED LIPID TRANSPORT,0.066855,0.15533,0.14195,0,0
3,SYNAPSE,0.0045306,0.155,0.17585,0,0
3,REACTOME PURINE CATABOLISM,0.10654,0.15481,0.061279,0,0
3,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.40843,0.15481,0.033826,0,0
3,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.14769,0.15372,0.1029,0,0
3,SA TRKA RECEPTOR,0.029068,0.15369,0.21553,0,0
3,REACTOME LIPOPROTEIN METABOLISM,0.12049,0.15361,0.092194,0,0
3,SOLUTE SODIUM SYMPORTER ACTIVITY,0.068167,0.15358,0.15584,0,0
3,AMINE BIOSYNTHETIC PROCESS,0.64605,0.15319,0.02122,0,0
3,REGULATION OF MAPKKK CASCADE,0.077957,0.15262,0.11129,0,0
3,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.082489,0.15261,0.090424,0,0
3,RESPONSE TO IONIZING RADIATION,0.11235,0.15203,0.09742,0,0
3,KEGG GALACTOSE METABOLISM,0.092194,0.15075,0.12323,0,0
3,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.077957,0.14886,0.10657,0,0
3,BIOCARTA TCYTOTOXIC PATHWAY,0.99651,0.14859,-0.018408,0,0
3,CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.17374,0.14764,0.1136,0,0
3,BIOCARTA IL12 PATHWAY,0.072231,0.14523,0.091218,0,0
3,BIOCARTA NO2IL12 PATHWAY,0.0050528,0.14491,0.1711,0,0
3,REGIONALIZATION,0.48678,0.1446,0.058245,0,0
3,PID RXR VDR PATHWAY,0.15015,0.14392,0.091452,0,0
3,KEGG CARDIAC MUSCLE CONTRACTION,0.0029794,0.14338,0.15096,0,0
3,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.076492,0.14274,0.094529,0,0
3,STRUCTURAL MOLECULE ACTIVITY,0.10096,0.14145,0.095384,0,0
3,NUCLEOTIDE METABOLIC PROCESS,0.036948,0.13871,0.09876,0,0
3,HEPARIN BINDING,0.25729,0.13823,0.050447,0,0
3,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.016734,0.13738,0.17793,0,0
3,INSULIN RECEPTOR SIGNALING PATHWAY,0.17374,0.13673,0.081586,0,0
3,REACTOME THE NLRP3 INFLAMMASOME,0.084046,0.13609,0.13127,0,0
3,BIOCARTA EGFR SMRTE PATHWAY,0.097379,0.13523,0.13538,0,0
3,BIOCARTA WNT PATHWAY,0.59664,0.1344,0.023706,0,0
3,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.0041716,0.13268,0.13569,0,0
3,ION CHANNEL ACTIVITY,0.009256,0.13218,0.17498,0,0
3,BIOCARTA ERK PATHWAY,0.20621,0.1317,0.059326,0,0
3,REACTOME BOTULINUM NEUROTOXICITY,0.031748,0.13156,0.15472,0,0
3,REGULATION OF CELL ADHESION,0.22568,0.13072,0.028247,0,0
3,KEGG FATTY ACID METABOLISM,0.23937,0.12851,0.02827,0,0
3,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.50337,0.12848,0.025784,0,0
3,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.011904,0.12836,0.25888,0,0
3,SULFUR METABOLIC PROCESS,0.10465,0.12804,0.080984,0,0
3,BIOCARTA CDK5 PATHWAY,0.15015,0.12766,0.092211,0,0
3,REGULATION OF HEART CONTRACTION,0.29184,0.12712,0.034517,0,0
3,PROTEASOME COMPLEX,0.27227,0.12703,0.037535,0,0
3,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.21905,0.12631,0.11694,0,0
3,COFACTOR METABOLIC PROCESS,0.076492,0.12606,0.092053,0,0
3,KEGG PARKINSONS DISEASE,0.025994,0.12498,0.10034,0,0
3,PID PDGFRAPATHWAY,0.23937,0.12457,0.12108,0,0
3,KEGG PROTEASOME,0.64605,0.12454,0.0093192,0,0
3,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.26098,0.12334,0.051045,0,0
3,SYNAPTIC VESICLE,0.16559,0.12296,0.1758,0,0
3,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.15773,0.12285,0.084022,0,0
3,PROTEIN DEACETYLASE ACTIVITY,0.26471,0.12206,0.075862,0,0
3,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.48131,0.12174,0.035318,0,0
3,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.91987,0.12157,-0.025007,0,0
3,REACTOME BASIGIN INTERACTIONS,0.065563,0.12156,0.10954,0,0
3,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.19095,0.1215,0.061864,0,0
3,PID RAS PATHWAY,0.17099,0.12079,0.10667,0,0
3,REACTOME P75NTR SIGNALS VIA NFKB,0.23245,0.12063,0.047328,0,0
3,NOTCH SIGNALING PATHWAY,0.32506,0.11998,0.07032,0,0
3,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.15517,0.11987,0.060835,0,0
3,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.011047,0.1193,0.11734,0,0
3,SMALL GTPASE REGULATOR ACTIVITY,0.037747,0.11887,0.10081,0,0
3,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.53742,0.11872,0.016654,0,0
3,SODIUM CHANNEL ACTIVITY,0.23589,0.11817,0.1425,0,0
3,NERVOUS SYSTEM DEVELOPMENT,0.0059384,0.11778,0.16039,0,0
3,REACTOME GLUCOSE METABOLISM,0.052669,0.11746,0.11109,0,0
3,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.12689,0.11665,0.1149,0,0
3,RNA 3END PROCESSING,0.20937,0.11617,0.095718,0,0
3,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.47588,0.11605,0.027164,0,0
3,HEART DEVELOPMENT,0.0045306,0.11573,0.16012,0,0
3,CELL SOMA,0.17374,0.11557,0.175,0,0
3,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.34702,0.11548,0.073123,0,0
3,AEROBIC RESPIRATION,0.063042,0.1144,0.13353,0,0
3,GLYCOLIPID METABOLIC PROCESS,0.29992,0.11431,0.089208,0,0
3,PID HEDGEHOG 2PATHWAY,0.22235,0.11414,0.05824,0,0
3,PID ARF 3PATHWAY,0.11841,0.11412,0.071749,0,0
3,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.097379,0.11386,0.17994,0,0
3,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.82348,0.11343,-0.00070238,0,0
3,SPHINGOID METABOLIC PROCESS,0.29184,0.11272,0.044252,0,0
3,REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES,0.15773,0.11128,0.077673,0,0
3,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.47588,0.11064,0.026452,0,0
3,REACTOME HS GAG BIOSYNTHESIS,0.44924,0.11013,0.050413,0,0
3,ANTIGEN BINDING,0.16828,0.10919,0.056425,0,0
3,ST WNT BETA CATENIN PATHWAY,0.13814,0.10866,0.09883,0,0
3,CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.063042,0.10853,0.067618,0,0
3,JNK CASCADE,0.010506,0.10779,0.10596,0,0
3,PID AR TF PATHWAY,0.013798,0.10695,0.10119,0,0
3,DEACETYLASE ACTIVITY,0.30402,0.1067,0.06363,0,0
3,AROMATIC COMPOUND METABOLIC PROCESS,0.20309,0.10658,0.067245,0,0
3,REGULATION OF JNK CASCADE,0.23937,0.10643,0.080848,0,0
3,REACTOME REGULATED PROTEOLYSIS OF P75NTR,0.29586,0.10637,0.069772,0,0
3,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.59059,0.10624,0.011498,0,0
3,KEGG CALCIUM SIGNALING PATHWAY,0.0087944,0.10589,0.11709,0,0
3,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.67776,0.10542,0.016168,0,0
3,MITOCHONDRIAL TRANSPORT,0.04854,0.10509,0.090644,0,0
3,REACTOME ERKS ARE INACTIVATED,0.58456,0.10496,0.044201,0,0
3,EXTRACELLULAR MATRIX,0.095625,0.10469,0.073529,0,0
3,COFACTOR TRANSPORT,0.62113,0.10426,0.036069,0,0
3,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.061812,0.1042,0.070011,0,0
3,BONE REMODELING,0.080955,0.10396,0.15589,0,0
3,REACTOME SIGNALING BY WNT,0.47588,0.10396,0.018787,0,0
3,REACTOME KINESINS,0.26847,0.10352,0.089593,0,0
3,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.20937,0.10323,0.050341,0,0
3,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.052669,0.10314,0.082022,0,0
3,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.35607,0.10301,0.026782,0,0
3,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.14048,0.10283,0.065924,0,0
3,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.37932,0.10277,0.040338,0,0
3,PID LIS1PATHWAY,0.0097392,0.10174,0.17328,0,0
3,DNA CATABOLIC PROCESS,0.27611,0.10096,0.041663,0,0
3,BIOCARTA PGC1A PATHWAY,0.11841,0.10045,0.12097,0,0
3,PROTEINACEOUS EXTRACELLULAR MATRIX,0.11039,0.10005,0.069656,0,0
3,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.35607,0.099896,0.053683,0,0
3,BIOCARTA BARR MAPK PATHWAY,0.12049,0.099708,0.1199,0,0
3,REACTOME PYRUVATE METABOLISM,0.17374,0.099619,0.12627,0,0
3,RESPONSE TO DRUG,0.76948,0.09936,-0.008636,0,0
3,REACTOME AXON GUIDANCE,0.024288,0.098766,0.10133,0,0
3,PROTEIN IMPORT INTO NUCLEUS,0.14285,0.098481,0.043888,0,0
3,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.064293,0.098413,0.092032,0,0
3,CARBOHYDRATE CATABOLIC PROCESS,0.064293,0.098413,0.092032,0,0
3,U12 DEPENDENT SPLICEOSOME,0.10096,0.098133,0.10408,0,0
3,COENZYME METABOLIC PROCESS,0.076492,0.097317,0.089735,0,0
3,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.29184,0.096712,0.064654,0,0
3,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.32077,0.095929,0.052817,0,0
3,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.46512,0.095811,0.015684,0,0
3,REACTOME EGFR DOWNREGULATION,0.27611,0.094835,0.053767,0,0
3,NEGATIVE REGULATION OF DNA REPLICATION,0.26098,0.094746,0.11739,0,0
3,REACTOME RETROGRADE NEUROTROPHIN SIGNALLING,0.10096,0.094743,0.11076,0,0
3,RAS GTPASE BINDING,0.10465,0.094475,0.067442,0,0
3,BIOCARTA ATM PATHWAY,0.19393,0.094293,0.085977,0,0
3,KEGG OXIDATIVE PHOSPHORYLATION,0.11235,0.094249,0.071606,0,0
3,POSITIVE REGULATION OF MAPKKK CASCADE,0.31232,0.094118,0.10311,0,0
3,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.92682,0.093722,-0.015203,0,0
3,REGULATION OF VIRAL REPRODUCTION,0.39371,0.093669,0.035083,0,0
3,PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY,0.69707,0.093457,0.0048576,0,0
3,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.43367,0.093091,0.074912,0,0
3,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.079444,0.093087,0.12361,0,0
3,RNA HELICASE ACTIVITY,0.14048,0.092458,0.098443,0,0
3,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.0094949,0.092371,0.10509,0,0
3,NUCLEOTIDE KINASE ACTIVITY,0.32506,0.091915,0.088511,0,0
3,KEGG PENTOSE PHOSPHATE PATHWAY,0.15015,0.091593,0.12193,0,0
3,PID FRA PATHWAY,0.17099,0.091287,0.030664,0,0
3,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.86455,0.091012,-0.01583,0,0
3,BIOCARTA HIF PATHWAY,0.14048,0.090984,0.073012,0,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.72313,0.090543,0.0011068,0,0
3,REACTOME NEPHRIN INTERACTIONS,0.46512,0.090374,0.033192,0,0
3,MRNA BINDING,0.13814,0.090163,0.093112,0,0
3,GLUCOSE METABOLIC PROCESS,0.50337,0.090139,0.026607,0,0
3,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.36991,0.089767,0.039186,0,0
3,BRAIN DEVELOPMENT,0.15264,0.089763,0.13578,0,0
3,TRNA PROCESSING,0.11636,0.089265,0.12794,0,0
3,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.67137,0.089232,-0.00077707,0,0
3,ST MYOCYTE AD PATHWAY,0.17099,0.088816,0.080486,0,0
3,REACTOME NCAM1 INTERACTIONS,0.13583,0.08751,0.13135,0,0
3,KEGG DNA REPLICATION,0.055956,0.087406,0.090094,0,0
3,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.19095,0.086905,0.073422,0,0
3,REACTOME ZINC TRANSPORTERS,0.2,0.086478,0.070922,0,0
3,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.049546,0.08611,0.10089,0,0
3,REACTOME S PHASE,0.05161,0.086106,0.084793,0,0
3,REACTOME COLLAGEN FORMATION,0.4545,0.085223,0.01022,0,0
3,DNA MODIFICATION,0.29992,0.085178,0.061456,0,0
3,ACTIVATION OF IMMUNE RESPONSE,0.13583,0.08497,0.086411,0,0
3,BIOCARTA DC PATHWAY,0.36064,0.084842,0.00052793,0,0
3,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.097379,0.084149,0.065148,0,0
3,SKELETAL DEVELOPMENT,0.27999,0.084119,0.048586,0,0
3,SPLICEOSOME ASSEMBLY,0.050569,0.083839,0.088458,0,0
3,PROTEIN METHYLTRANSFERASE ACTIVITY,0.21256,0.083614,0.05817,0,0
3,PID ARF6DOWNSTREAMPATHWAY,0.11039,0.083304,0.06212,0,0
3,POSITIVE REGULATION OF CELL ADHESION,0.16828,0.083152,0.095573,0,0
3,REGULATION OF DNA REPLICATION,0.17099,0.082949,0.086178,0,0
3,MONOVALENT INORGANIC CATION TRANSPORT,0.37932,0.082716,0.084781,0,0
3,PID S1P META PATHWAY,0.4545,0.08264,0.028805,0,0
3,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.060602,0.082457,0.14725,0,0
3,REACTOME SYNTHESIS OF PC,0.83713,0.081981,-0.012719,0,0
3,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.67776,0.081795,0.059974,0,0
3,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.23245,0.081588,0.061943,0,0
3,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.093897,0.081273,0.044006,0,0
3,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.42347,0.081269,0.030507,0,0
3,REACTOME NUCLEOTIDE EXCISION REPAIR,0.050569,0.081083,0.058771,0,0
3,KEGG LONG TERM DEPRESSION,0.05824,0.080526,0.081757,0,0
3,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.65234,0.080144,0.01002,0,0
3,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE ACTIVITY,0.65866,0.079789,0.012625,0,0
3,REACTOME DEADENYLATION OF MRNA,0.14285,0.079701,0.052484,0,0
3,REACTOME SIGNALING BY RHO GTPASES,0.04854,0.079489,0.079601,0,0
3,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.0090226,0.07917,0.091502,0,0
3,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.34702,0.078955,0.030162,0,0
3,AMINE METABOLIC PROCESS,0.017969,0.078231,0.092644,0,0
3,TUBULIN BINDING,0.072231,0.077965,0.093244,0,0
3,KEGG GLYOXYLATE AND DICARBOXYLATE METABOLISM,0.188,0.077938,0.083084,0,0
3,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.31232,0.077846,0.069689,0,0
3,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.82348,0.076467,-0.034591,0,0
3,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.35607,0.076331,0.056042,0,0
3,MEIOTIC RECOMBINATION,0.36064,0.076234,0.059778,0,0
3,NEGATIVE REGULATION OF TRANSPORT,0.34702,0.076232,0.058717,0,0
3,REGULATION OF DNA BINDING,0.13355,0.076221,0.049183,0,0
3,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.56666,0.07616,0.014272,0,0
3,GLUCOSAMINE METABOLIC PROCESS,0.40843,0.076014,0.018804,0,0
3,ORGANELLAR SMALL RIBOSOMAL SUBUNIT,0.20309,0.076006,0.090867,0,0
3,MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT,0.20309,0.076006,0.090867,0,0
3,SMALL RIBOSOMAL SUBUNIT,0.20309,0.076006,0.090867,0,0
3,PID RHOA REG PATHWAY,0.23589,0.075641,0.026687,0,0
3,PID E2F PATHWAY,0.061812,0.075499,0.069528,0,0
3,REGULATION OF CELLULAR PH,0.94073,0.075489,-0.011704,0,0
3,COFACTOR BIOSYNTHETIC PROCESS,0.3746,0.074515,0.045486,0,0
3,PID ER NONGENOMIC PATHWAY,0.49227,0.07444,0.025058,0,0
3,REGULATION OF PHOSPHORYLATION,0.47588,0.074372,0.01611,0,0
3,REACTOME MRNA SPLICING MINOR PATHWAY,0.065563,0.074345,0.09289,0,0
3,NUCLEAR IMPORT,0.34256,0.07425,0.021693,0,0
3,NITROGEN COMPOUND METABOLIC PROCESS,0.097379,0.073968,0.067846,0,0
3,REACTOME DEVELOPMENTAL BIOLOGY,0.031059,0.073796,0.074655,0,0
3,BIOCARTA BARRESTIN PATHWAY,0.37932,0.073361,0.088007,0,0
3,PID ANTHRAXPATHWAY,0.049546,0.073261,0.091068,0,0
3,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.17934,0.073234,0.093091,0,0
3,ANION CATION SYMPORTER ACTIVITY,0.72313,0.073065,-0.013099,0,0
3,SPINDLE POLE,0.29992,0.07266,0.046418,0,0
3,BIOCARTA AKT PATHWAY,0.19393,0.072654,0.054348,0,0
3,STRIATED MUSCLE CONTRACTION GO 0006941,0.082489,0.072211,0.13974,0,0
3,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.14285,0.071974,0.086769,0,0
3,CERAMIDE METABOLIC PROCESS,0.38408,0.07175,0.044963,0,0
3,PID P73PATHWAY,0.33373,0.071497,0.036383,0,0
3,NEUROLOGICAL SYSTEM PROCESS,0.068167,0.071289,0.067724,0,0
3,REACTOME GPCR DOWNSTREAM SIGNALING,0.090515,0.071219,0.048035,0,0
3,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.060602,0.07086,0.059568,0,0
3,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.8303,0.070306,0.026135,0,0
3,RESPONSE TO UV,0.053746,0.070181,0.069125,0,0
3,PID CONE PATHWAY,0.049546,0.06946,0.039457,0,0
3,PHOSPHOLIPASE ACTIVITY,0.24288,0.069454,0.051329,0,0
3,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.58456,0.069245,0.085132,0,0
3,CORTICAL ACTIN CYTOSKELETON,0.3746,0.068851,0.097563,0,0
3,WNT SIGNALING,0.099158,0.068844,0.075697,0,0
3,TRANSMEMBRANE RECEPTOR ACTIVITY,0.35153,0.068439,0.019367,0,0
3,NUCLEAR MEMBRANE PART,0.12908,0.068301,0.057592,0,0
3,MICROTUBULE,0.052669,0.067603,0.098398,0,0
3,LYASE ACTIVITY,0.41842,0.067463,0.026279,0,0
3,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.28785,0.067435,0.056271,0,0
3,REACTOME PI3K CASCADE,0.11434,0.067227,0.054595,0,0
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.44402,0.067191,0.032128,0,0
3,PID LYSOPHOSPHOLIPID PATHWAY,0.69061,0.067158,0.013108,0,0
3,KEGG ASCORBATE AND ALDARATE METABOLISM,0.4598,0.067064,0.024085,0,0
3,ST GA12 PATHWAY,0.42347,0.067003,0.037342,0,0
3,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.39371,0.066387,0.027382,0,0
3,PID HIF1APATHWAY,0.42347,0.066169,0.064285,0,0
3,PROTEIN POLYUBIQUITINATION,0.29586,0.066027,0.029649,0,0
3,REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX,0.22905,0.065895,0.097588,0,0
3,NUCLEOCYTOPLASMIC TRANSPORT,0.13814,0.065796,0.043691,0,0
3,LIPID KINASE ACTIVITY,0.51459,0.065529,0.040388,0,0
3,ELECTRON TRANSPORT GO 0006118,0.14526,0.065389,0.077362,0,0
3,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.34256,0.065349,0.047706,0,0
3,EPITHELIAL TO MESENCHYMAL TRANSITION,0.32077,0.065238,0.11425,0,0
3,OXIDOREDUCTASE ACTIVITY GO 0016705,0.37932,0.064985,0.040917,0,0
3,POSITIVE REGULATION OF PHOSPHORYLATION,0.52025,0.064905,0.035076,0,0
3,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.40349,0.064696,0.0030957,0,0
3,DNA DAMAGE CHECKPOINT,0.28785,0.064211,0.032923,0,0
3,MRNA PROCESSING GO 0006397,0.0049174,0.063494,0.098373,0,0
3,KEGG DILATED CARDIOMYOPATHY,0.26471,0.063482,0.050571,0,0
3,PROTEIN DNA COMPLEX ASSEMBLY,0.29184,0.062813,0.044003,0,0
3,BIOCARTA INFLAM PATHWAY,0.12908,0.062591,0.023347,0,0
3,BIOCARTA ARAP PATHWAY,0.19393,0.062578,0.037871,0,0
3,N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.67776,0.062555,0.0043106,0,0
3,INTERPHASE OF MITOTIC CELL CYCLE,0.35607,0.062403,0.030513,0,0
3,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.12049,0.062333,0.099483,0,0
3,STEROID HORMONE RECEPTOR ACTIVITY,0.32938,0.06193,0.078028,0,0
3,REACTOME METABOLISM OF CARBOHYDRATES,0.1313,0.061929,0.057213,0,0
3,KEGG PYRIMIDINE METABOLISM,0.084046,0.061917,0.044744,0,0
3,ST GRANULE CELL SURVIVAL PATHWAY,0.40349,0.061803,0.056825,0,0
3,PROTEIN IMPORT,0.092194,0.061455,0.042579,0,0
3,ZINC ION BINDING,0.12908,0.061336,0.03992,0,0
3,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.58456,0.061101,-0.0043616,0,0
3,BIOCARTA LAIR PATHWAY,0.21905,0.061001,0.00054336,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.19095,0.060094,0.11944,0,0
3,SKELETAL MUSCLE DEVELOPMENT,0.57857,0.060061,0.023374,0,0
3,KEGG MTOR SIGNALING PATHWAY,0.087232,0.060031,0.050909,0,0
3,REACTOME VITAMIN B5 PANTOTHENATE METABOLISM,0.188,0.059803,0.064513,0,0
3,INTRINSIC TO PLASMA MEMBRANE,0.24643,0.059716,0.033252,0,0
3,KEGG ALZHEIMERS DISEASE,0.41341,0.05969,0.02982,0,0
3,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.42347,0.059614,0.027714,0,0
3,RECEPTOR ACTIVITY,0.15773,0.059292,0.039533,0,0
3,PROTEIN AMINO ACID ADP RIBOSYLATION,0.42855,0.058803,0.0061809,0,0
3,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.19095,0.058654,0.061018,0,0
3,PID ATR PATHWAY,0.35607,0.05865,0.037594,0,0
3,REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS,0.76948,0.058489,0.024425,0,0
3,REACTOME G ALPHA S SIGNALLING EVENTS,0.097379,0.058332,0.080695,0,0
3,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.51459,0.058321,-0.14982,0,0
3,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.99651,0.058077,0.0080279,0,0
3,CYTOKINESIS,0.10096,0.058024,0.12326,0,0
3,BIOCARTA VEGF PATHWAY,0.32506,0.057633,0.044014,0,0
3,REACTOME GPCR LIGAND BINDING,0.37932,0.057605,0.023975,0,0
3,ACTIN FILAMENT ORGANIZATION,0.14285,0.057334,0.090759,0,0
3,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.53742,0.057275,0.011737,0,0
3,REACTOME SYNTHESIS OF DNA,0.2,0.057209,0.050644,0,0
3,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.8303,0.056987,-0.032822,0,0
3,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.22235,0.056647,0.047882,0,0
3,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.52594,0.056549,0.023668,0,0
3,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.1313,0.055881,0.063749,0,0
3,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.67776,0.055739,0.0027278,0,0
3,INORGANIC ANION TRANSPORT,0.89907,0.055675,-0.013272,0,0
3,BIOCARTA EIF4 PATHWAY,0.35607,0.055526,0.027171,0,0
3,KEGG PANTOTHENATE AND COA BIOSYNTHESIS,0.32077,0.055417,0.056487,0,0
3,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.59664,0.055247,0.02262,0,0
3,COENZYME BIOSYNTHETIC PROCESS,0.51459,0.055214,-0.0059991,0,0
3,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.14285,0.054856,0.05568,0,0
3,NUCLEAR TRANSPORT,0.16032,0.054622,0.040082,0,0
3,REGULATION OF CATABOLIC PROCESS,0.34256,0.054355,0.039563,0,0
3,SYSTEM PROCESS,0.076492,0.054147,0.058473,0,0
3,SPINDLE,0.42347,0.054021,0.040686,0,0
3,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.11434,0.053698,0.048859,0,0
3,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.51459,0.053575,0.042341,0,0
3,HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS,0.41341,0.053195,0.045491,0,0
3,PID AURORA B PATHWAY,0.39371,0.052999,0.056097,0,0
3,BIOCARTA NGF PATHWAY,0.50896,0.052756,0.043664,0,0
3,PID PS1PATHWAY,0.35153,0.052751,0.028437,0,0
3,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.67137,0.052597,0.033057,0,0
3,UNFOLDED PROTEIN BINDING,0.81668,0.052139,0.0082552,0,0
3,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.86455,0.051922,-0.032841,0,0
3,CARBOXYLESTERASE ACTIVITY,0.37932,0.051896,0.041707,0,0
3,REACTOME ION CHANNEL TRANSPORT,0.13355,0.05158,0.096636,0,0
3,INTEGRAL TO PLASMA MEMBRANE,0.38888,0.051418,0.022728,0,0
3,BIOCARTA PTDINS PATHWAY,0.63978,0.051334,0.029577,0,0
3,PID ARF6 TRAFFICKINGPATHWAY,0.32077,0.051252,0.040929,0,0
3,CARBOHYDRATE TRANSPORT,0.34256,0.051172,0.053185,0,0
3,DENDRITE,0.67776,0.051168,0.014748,0,0
3,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.26098,0.051033,0.12029,0,0
3,BIOCARTA ERK5 PATHWAY,0.51459,0.050837,0.053088,0,0
3,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.32938,0.050619,0.046571,0,0
3,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.16032,0.050426,0.069152,0,0
3,BIOCARTA GCR PATHWAY,0.53167,0.05029,0.026194,0,0
3,AMINO ACID METABOLIC PROCESS,0.34702,0.050182,0.070399,0,0
3,CELL PROJECTION BIOGENESIS,0.94073,0.049749,-0.0090512,0,0
3,RHYTHMIC PROCESS,0.26471,0.049493,0.039704,0,0
3,PID S1P S1P3 PATHWAY,0.63354,0.049234,-0.036406,0,0
3,BIOCARTA CTCF PATHWAY,0.53742,0.048899,0.03585,0,0
3,HISTONE METHYLTRANSFERASE ACTIVITY,0.67137,0.048861,0.016578,0,0
3,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.50337,0.048679,0.030584,0,0
3,STEROID HORMONE RECEPTOR BINDING,0.95466,0.048611,-0.045108,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.43367,0.0483,0.011286,0,0
3,KEGG DRUG METABOLISM OTHER ENZYMES,0.25001,0.047747,0.039468,0,0
3,MRNA SPLICE SITE SELECTION,0.075049,0.04765,0.095869,0,0
3,KEGG HUNTINGTONS DISEASE,0.42347,0.047621,0.01841,0,0
3,SENSORY ORGAN DEVELOPMENT,0.43883,0.047403,0.13981,0,0
3,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.76948,0.047177,0.0022996,0,0
3,BIOCARTA ALK PATHWAY,0.71658,0.047118,0.011003,0,0
3,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.13355,0.04699,0.063636,0,0
3,REACTOME DARPP 32 EVENTS,0.17934,0.046953,0.090214,0,0
3,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.63354,0.046778,-0.020968,0,0
3,REACTOME PROLACTIN RECEPTOR SIGNALING,0.20309,0.046488,0.06965,0,0
3,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.63978,0.046269,0.019951,0,0
3,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.40843,0.046263,0.059816,0,0
3,VESICULAR FRACTION,0.67137,0.04614,-0.043149,0,0
3,BIOCARTA CARDIACEGF PATHWAY,0.39858,0.046069,-0.0063406,0,0
3,BIOCARTA TH1TH2 PATHWAY,0.7495,0.045895,-0.029887,0,0
3,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.41341,0.045702,-0.0064664,0,0
3,COLLAGEN,0.8303,0.045324,-0.065653,0,0
3,BIOCARTA INTEGRIN PATHWAY,0.98953,0.045256,-0.024037,0,0
3,CELL MIGRATION,0.35153,0.044911,0.058516,0,0
3,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.36991,0.044833,0.030654,0,0
3,BIOCARTA AKAPCENTROSOME PATHWAY,0.39371,0.04451,0.046816,0,0
3,SULFURIC ESTER HYDROLASE ACTIVITY,0.19393,0.044213,0.11037,0,0
3,REACTOME OPIOID SIGNALLING,0.54321,0.043796,0.039039,0,0
3,INTERFERON GAMMA PRODUCTION,0.18219,0.043737,0.014854,0,0
3,KEGG COLORECTAL CANCER,0.53742,0.043678,0.024599,0,0
3,SH3 SH2 ADAPTOR ACTIVITY,0.16828,0.043474,-0.099061,0,0
3,PLASMA MEMBRANE PART,0.61497,0.043347,0.010543,0,0
3,KEGG NON SMALL CELL LUNG CANCER,0.60883,0.043282,0.022629,0,0
3,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.25363,0.042758,0.051606,0,0
3,S PHASE OF MITOTIC CELL CYCLE,0.21905,0.042619,0.12627,0,0
3,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.53167,0.04246,0.0040638,0,0
3,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.72313,0.042391,0.016047,0,0
3,NUCLEOTIDE EXCISION REPAIR,0.090515,0.042073,0.070678,0,0
3,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.74288,0.042028,-0.022272,0,0
3,BIOCARTA RARRXR PATHWAY,0.33373,0.041797,0.05795,0,0
3,POSITIVE REGULATION OF ANGIOGENESIS,0.87144,0.041648,-0.096387,0,0
3,S PHASE,0.23245,0.04157,0.11133,0,0
3,KINETOCHORE,0.36526,0.041472,0.03683,0,0
3,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.85768,0.04141,-0.035317,0,0
3,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.98953,0.041249,-0.048109,0,0
3,KEGG MISMATCH REPAIR,0.38888,0.041075,0.036539,0,0
3,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.52594,0.041054,0.018099,0,0
3,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.64605,0.040941,0.0017377,0,0
3,OXIDOREDUCTASE ACTIVITY GO 0016616,0.53167,0.040787,-0.00045512,0,0
3,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.5726,0.040591,0.016376,0,0
3,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.29992,0.040336,0.088882,0,0
3,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.36526,0.040181,0.048672,0,0
3,HISTONE DEACETYLASE BINDING,0.67137,0.039842,0.0063653,0,0
3,BIOCARTA P35ALZHEIMERS PATHWAY,0.23245,0.039681,0.14083,0,0
3,REACTOME PERK REGULATED GENE EXPRESSION,0.25729,0.039574,0.078881,0,0
3,SULFOTRANSFERASE ACTIVITY,0.66501,0.039293,0.032012,0,0
3,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.63354,0.039167,0.019052,0,0
3,REACTOME MITOTIC M M G1 PHASES,0.16294,0.039004,0.051418,0,0
3,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.26847,0.038804,0.034145,0,0
3,KEGG GAP JUNCTION,0.4598,0.038735,0.016901,0,0
3,BIOCARTA MCM PATHWAY,0.39371,0.038699,0.067881,0,0
3,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.76948,0.038489,-0.050563,0,0
3,MACROMOLECULE BIOSYNTHETIC PROCESS,0.30815,0.038047,0.045534,0,0
3,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.25729,0.037831,0.025393,0,0
3,REACTOME METAL ION SLC TRANSPORTERS,0.85768,0.037253,-0.016493,0,0
3,REACTOME SPRY REGULATION OF FGF SIGNALING,0.66501,0.036985,-0.025674,0,0
3,REGULATION OF T CELL PROLIFERATION,0.72969,0.036941,0.016881,0,0
3,REGULATION OF PROTEIN MODIFICATION PROCESS,0.28785,0.036725,0.022881,0,0
3,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.84397,0.036598,-0.0028272,0,0
3,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.14285,0.036591,0.046284,0,0
3,T CELL DIFFERENTIATION,0.75615,0.036577,-0.028687,0,0
3,REACTOME ACTIVATION OF GENES BY ATF4,0.23937,0.036535,0.090385,0,0
3,REACTOME CGMP EFFECTS,0.49227,0.036467,0.054897,0,0
3,PID EPHA FWDPATHWAY,0.27611,0.035943,0.073318,0,0
3,KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS,0.82348,0.035861,-0.0083743,0,0
3,KEGG BLADDER CANCER,0.39371,0.035493,0.01959,0,0
3,DRUG BINDING,0.50896,0.035372,0.041635,0,0
3,REACTOME CA DEPENDENT EVENTS,0.98255,0.035251,-0.0031033,0,0
3,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.76948,0.035011,0.0030965,0,0
3,DNA REPAIR,0.068167,0.034797,0.041883,0,0
3,INSOLUBLE FRACTION,0.95466,0.034736,-0.022702,0,0
3,PROTEIN COMPLEX,0.10654,0.034708,0.027316,0,0
3,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.063042,0.034303,0.093836,0,0
3,MUSCLE DEVELOPMENT,0.4545,0.03421,0.022156,0,0
3,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.32506,0.034078,0.082779,0,0
3,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.68418,0.033991,0.023887,0,0
3,CELL FATE COMMITMENT,0.68418,0.033983,-0.070836,0,0
3,KEGG ERBB SIGNALING PATHWAY,0.85768,0.033967,0.0010554,0,0
3,REGULATION OF CHROMOSOME ORGANIZATION AND BIOGENESIS,0.22568,0.033907,0.068155,0,0
3,PID NEPHRIN NEPH1 PATHWAY,0.47049,0.033744,0.02967,0,0
3,CIRCADIAN RHYTHM,0.93377,0.033741,0.012429,0,0
3,PHOSPHOLIPASE A2 ACTIVITY,0.60883,0.033662,0.050866,0,0
3,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.80989,0.033529,0.011516,0,0
3,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.54903,0.032772,0.01977,0,0
3,REACTOME HS GAG DEGRADATION,0.91293,0.032771,-0.048741,0,0
3,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.56075,0.032698,0.021334,0,0
3,NUCLEAR HORMONE RECEPTOR BINDING,0.4545,0.032307,0.040266,0,0
3,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.85768,0.031869,-0.023133,0,0
3,REACTOME GAB1 SIGNALOSOME,0.82348,0.031869,0.013917,0,0
3,CARBOXYLIC ACID METABOLIC PROCESS,0.75615,0.031777,0.011276,0,0
3,HISTONE ACETYLTRANSFERASE ACTIVITY,0.94073,0.031362,0.0003245,0,0
3,CALCIUM CHANNEL ACTIVITY,0.54903,0.031331,0.067975,0,0
3,REACTOME G ALPHA Q SIGNALLING EVENTS,0.43883,0.031325,0.0348,0,0
3,REACTOME SIGNALING BY GPCR,0.25001,0.031314,0.031859,0,0
3,REACTOME MUSCLE CONTRACTION,0.87144,0.031279,-0.051795,0,0
3,KEGG WNT SIGNALING PATHWAY,0.27227,0.031107,0.034211,0,0
3,REACTOME SIGNALING BY EGFR IN CANCER,0.65866,0.031069,0.0094592,0,0
3,BIOCARTA CK1 PATHWAY,0.47588,0.031041,0.098382,0,0
3,BIOCARTA TEL PATHWAY,0.98255,0.030979,-0.024387,0,0
3,MICROTUBULE ORGANIZING CENTER PART,0.21256,0.030585,0.068907,0,0
3,MICROSOME,0.59664,0.030531,-0.046578,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.89215,0.030436,-0.012942,0,0
3,TRANS GOLGI NETWORK,0.66501,0.030211,0.018941,0,0
3,KEGG BASAL CELL CARCINOMA,0.88523,0.030064,-0.01318,0,0
3,SINGLE STRANDED DNA BINDING,0.36526,0.029949,0.026392,0,0
3,BIOCARTA DREAM PATHWAY,0.29184,0.029931,0.12781,0,0
3,REACTOME KERATAN SULFATE DEGRADATION,0.71006,0.029899,-0.07865,0,0
3,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.26471,0.029887,0.046937,0,0
3,REACTOME CELL CYCLE CHECKPOINTS,0.47588,0.029883,0.027033,0,0
3,SYMPORTER ACTIVITY,0.70355,0.029789,-0.005871,0,0
3,ORGANIC ACID METABOLIC PROCESS,0.72313,0.029778,0.014262,0,0
3,BIOCARTA CARM ER PATHWAY,0.75615,0.02976,0.012588,0,0
3,RESPONSE TO RADIATION,0.27999,0.029753,0.028077,0,0
3,REACTOME PLATELET HOMEOSTASIS,0.29586,0.029539,0.057151,0,0
3,NUCLEAR MATRIX,0.41842,0.029294,0.054255,0,0
3,REACTOME BASE EXCISION REPAIR,0.54321,0.02907,0.017935,0,0
3,REGULATION OF PH,0.78289,0.028909,0.01864,0,0
3,REACTOME SIGNAL ATTENUATION,0.89907,0.02862,-0.026015,0,0
3,PID ERBB1 INTERNALIZATION PATHWAY,0.91987,0.028484,-0.0010152,0,0
3,REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN,0.9686,0.028425,-0.013806,0,0
3,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.78289,0.028338,-0.021868,0,0
3,ION TRANSPORT,0.9686,0.028235,-0.0016331,0,0
3,PHOSPHATASE BINDING,0.73628,0.02817,0.020007,0,0
3,CARBONATE DEHYDRATASE ACTIVITY,0.97557,0.028028,-0.014666,0,0
3,VOLTAGE GATED SODIUM CHANNEL ACTIVITY,0.41842,0.027808,0.06576,0,0
3,INTRINSIC TO MEMBRANE,0.53742,0.027751,0.010505,0,0
3,BIOCARTA SKP2E2F PATHWAY,0.65866,0.027141,-0.035752,0,0
3,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.43883,0.027134,0.039285,0,0
3,BIOCARTA CYTOKINE PATHWAY,0.94769,0.026717,-0.047466,0,0
3,DNA METABOLIC PROCESS,0.10845,0.02636,0.033961,0,0
3,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.65234,0.026281,-0.065394,0,0
3,BIOCARTA VDR PATHWAY,0.60272,0.026141,0.029857,0,0
3,EXCRETION,0.58456,0.026131,-0.055516,0,0
3,REACTOME PYRIMIDINE METABOLISM,0.2839,0.025312,0.027176,0,0
3,REGULATION OF TRANSPORT,0.97557,0.025192,0.0019673,0,0
3,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.93377,0.025015,0.0018268,0,0
3,PLASMA MEMBRANE,0.79636,0.024849,0.0025501,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.62732,0.024848,0.011397,0,0
3,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.69707,0.024755,-0.033996,0,0
3,PID THROMBIN PAR1 PATHWAY,0.64605,0.024665,0.031386,0,0
3,RNA EXPORT FROM NUCLEUS,0.49227,0.024577,0.011988,0,0
3,ST GA13 PATHWAY,0.80312,0.024442,-0.022332,0,0
3,MACROMOLECULAR COMPLEX ASSEMBLY,0.1313,0.024304,0.036615,0,0
3,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.69061,0.024231,0.00093791,0,0
3,PID SMAD2 3NUCLEARPATHWAY,0.32077,0.024023,0.038165,0,0
3,ST ADRENERGIC,0.56666,0.024016,0.034449,0,0
3,REACTOME ARMS MEDIATED ACTIVATION,0.38408,0.023946,0.038676,0,0
3,REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND,0.40843,0.023874,0.048737,0,0
3,TRANSCRIPTION FACTOR ACTIVITY,0.10654,0.023834,0.037171,0,0
3,REGULATION OF BINDING,0.96163,0.023787,-0.017209,0,0
3,REACTOME EARLY PHASE OF HIV LIFE CYCLE,0.67776,0.023671,0.025167,0,0
3,SIG CHEMOTAXIS,0.31653,0.023621,0.045396,0,0
3,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.59664,0.022807,0.019487,0,0
3,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.63354,0.022612,-0.079061,0,0
3,BIOCARTA NTHI PATHWAY,1,0.022492,-0.025613,0,0
3,REACTOME POL SWITCHING,0.62732,0.022462,0.045747,0,0
3,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.40843,0.022326,0.026325,0,0
3,MANNOSYLTRANSFERASE ACTIVITY,0.9686,0.022239,-0.018207,0,0
3,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.4978,0.022105,0.013289,0,0
3,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.72969,0.022041,0.022884,0,0
3,GLUTATHIONE TRANSFERASE ACTIVITY,0.43883,0.021949,0.093094,0,0
3,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.72313,0.021792,-0.0053491,0,0
3,B CELL DIFFERENTIATION,0.48131,0.021465,0.036212,0,0
3,INTEGRAL TO MEMBRANE,0.71006,0.021374,0.002022,0,0
3,RNA POLYMERASE II TRANSCRIPTION MEDIATOR ACTIVITY,0.66501,0.021324,0.020832,0,0
3,TRANSCRIPTION ELONGATION REGULATOR ACTIVITY,0.78289,0.021301,0.012533,0,0
3,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.21579,0.02106,0.072601,0,0
3,CELL CYCLE CHECKPOINT GO 0000075,0.89215,0.021049,-0.012243,0,0
3,PID BARD1PATHWAY,0.47049,0.021005,0.033494,0,0
3,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.85082,0.020718,0.0011941,0,0
3,KEGG LINOLEIC ACID METABOLISM,0.60272,0.020608,-0.043992,0,0
3,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.8303,0.020296,-0.0034423,0,0
3,HORMONE RECEPTOR BINDING,0.4598,0.020156,0.041975,0,0
3,BIOCARTA ACTINY PATHWAY,0.71006,0.019947,0.018704,0,0
3,RNA METABOLIC PROCESS,0.25363,0.019862,0.019876,0,0
3,PID ARF6 PATHWAY,0.51459,0.019609,0.037108,0,0
3,MOLECULAR ADAPTOR ACTIVITY,0.25363,0.01959,-0.077686,0,0
3,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.67776,0.019503,0.01089,0,0
3,BIOSYNTHETIC PROCESS,0.35153,0.019481,0.039658,0,0
3,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.40843,0.019435,0.015721,0,0
3,DNA DIRECTED DNA POLYMERASE ACTIVITY,0.83713,0.019263,-0.0013776,0,0
3,TRANSPORT,0.47049,0.019004,0.0085774,0,0
3,KEGG BASAL TRANSCRIPTION FACTORS,0.89907,0.018945,-0.00034415,0,0
3,OUTER MEMBRANE,0.69061,0.018944,-0.015067,0,0
3,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.77618,0.018828,0.017145,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.39858,0.0184,-0.13789,0,0
3,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.77618,0.01835,-0.068403,0,0
3,SECRETORY PATHWAY,0.98953,0.018208,-0.0065614,0,0
3,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.48678,0.01802,0.019499,0,0
3,KEGG LYSINE DEGRADATION,0.66501,0.017396,0.012825,0,0
3,BIOCARTA MTA3 PATHWAY,0.85082,0.017231,0.0069853,0,0
3,T CELL PROLIFERATION,0.82348,0.01721,-0.044713,0,0
3,MICROTUBULE ASSOCIATED COMPLEX,0.37932,0.017173,0.084874,0,0
3,CELL DIVISION,0.85082,0.017107,0.013747,0,0
3,BIOCARTA TOB1 PATHWAY,0.87833,0.016936,-0.053134,0,0
3,SYSTEM DEVELOPMENT,0.51459,0.016582,0.025427,0,0
3,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.70355,0.016565,-0.033334,0,0
3,MICROTUBULE BASED MOVEMENT,0.75615,0.016534,0.048384,0,0
3,PID EPHBFWDPATHWAY,0.98255,0.016482,-0.0065255,0,0
3,NUCLEAR ENVELOPE,0.93377,0.016337,-0.0084916,0,0
3,SA G1 AND S PHASES,0.82348,0.016142,0.0013721,0,0
3,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.5726,0.015851,-0.047564,0,0
3,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.85082,0.015841,0.0029193,0,0
3,PID CD40 PATHWAY,0.81668,0.01565,-0.052016,0,0
3,KINASE BINDING,0.85082,0.014855,-0.015551,0,0
3,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.94073,0.014717,0.001337,0,0
3,REACTOME MITOTIC G2 G2 M PHASES,0.83713,0.01466,0.01578,0,0
3,REGULATION OF DNA METABOLIC PROCESS,0.39371,0.014631,0.013632,0,0
3,PID RB 1PATHWAY,0.75615,0.014585,0.0075196,0,0
3,KEGG PANCREATIC CANCER,0.80989,0.014418,-0.0075959,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.44402,0.014361,0.017231,0,0
3,EXTERNAL SIDE OF PLASMA MEMBRANE,0.72969,0.014091,-0.021804,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.3746,0.013981,0.036788,0,0
3,PROTEIN TARGETING,0.68418,0.013942,0.0030345,0,0
3,VESICLE,0.67776,0.013854,-0.029748,0,0
3,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.25363,0.01367,0.066043,0,0
3,BIOCARTA IL1R PATHWAY,0.50896,0.01332,-0.017699,0,0
3,ACTIN FILAMENT BASED MOVEMENT,0.34256,0.013282,-0.15159,0,0
3,LIPASE ACTIVITY,0.63978,0.013257,0.021742,0,0
3,KEGG ABC TRANSPORTERS,0.76948,0.012898,0.0081955,0,0
3,CATABOLIC PROCESS,0.80989,0.012858,0.0011234,0,0
3,CYTOPLASMIC VESICLE,0.68418,0.012831,-0.028657,0,0
3,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.4978,0.012533,0.035166,0,0
3,LIGASE ACTIVITY,0.43883,0.012446,0.019225,0,0
3,REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND,0.88523,0.012321,0.010746,0,0
3,PID SYNDECAN 1 PATHWAY,0.80312,0.012282,-0.091565,0,0
3,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.46512,0.01204,-0.099149,0,0
3,PEPTIDYL TYROSINE MODIFICATION,0.7495,0.011989,-0.053021,0,0
3,ACETYLTRANSFERASE ACTIVITY,0.80989,0.011829,0.0081856,0,0
3,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.96163,0.011532,-0.01487,0,0
3,REACTOME DNA REPLICATION,0.30815,0.011527,0.037382,0,0
3,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.63978,0.011263,-0.043855,0,0
3,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.89215,0.010898,-0.00078537,0,0
3,MACROMOLECULE CATABOLIC PROCESS,0.71006,0.010765,0.00025972,0,0
3,REACTOME STRIATED MUSCLE CONTRACTION,0.82348,0.0105,-0.026357,0,0
3,NUCLEASE ACTIVITY,0.78289,0.010436,0.0065124,0,0
3,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.62732,0.010336,-0.066389,0,0
3,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.46512,0.010322,0.029307,0,0
3,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.49227,0.010315,0.01246,0,0
3,REACTOME SYNTHESIS OF PA,0.48131,0.010082,-0.05609,0,0
3,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.69061,0.0098944,0.030147,0,0
3,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.43883,0.0097244,0.033841,0,0
3,BIOPOLYMER CATABOLIC PROCESS,0.77618,0.0096668,-0.012168,0,0
3,NUCLEAR LUMEN,0.3746,0.0095701,0.024559,0,0
3,BIOCARTA IGF1 PATHWAY,0.85082,0.0093879,-0.0044652,0,0
3,OXIDOREDUCTASE ACTIVITY,0.90599,0.0093613,-0.020742,0,0
3,CELLULAR CATABOLIC PROCESS,0.83713,0.0093104,0.0006841,0,0
3,PID AR PATHWAY,0.68418,0.0092789,-0.041067,0,0
3,BIOCARTA SHH PATHWAY,0.43883,0.0092335,0.039843,0,0
3,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.33812,0.0089419,0.06819,0,0
3,PID BETACATENIN NUC PATHWAY,0.93377,0.0088917,-0.0080512,0,0
3,REGULATION OF MUSCLE CONTRACTION,0.72969,0.0088827,-0.053575,0,0
3,REACTOME HIV INFECTION,0.44924,0.0086676,0.020476,0,0
3,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.61497,0.0086103,0.016106,0,0
3,THIOLESTER HYDROLASE ACTIVITY,0.60272,0.0085837,-0.046742,0,0
3,REGULATION OF CATALYTIC ACTIVITY,0.85082,0.0084588,-0.011403,0,0
3,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.9686,0.0082019,-0.0070906,0,0
3,PID S1P S1P1 PATHWAY,0.69707,0.0081238,0.021248,0,0
3,TELOMERIC DNA BINDING,0.50337,0.0081131,0.037959,0,0
3,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.47049,0.0080518,0.030389,0,0
3,REACTOME SIGNALING BY NOTCH1,0.85768,0.0079433,0.0088975,0,0
3,PEPTIDYL TYROSINE PHOSPHORYLATION,1,0.0077314,-0.033037,0,0
3,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.76948,0.0076937,0.0078085,0,0
3,NUCLEAR PART,0.4598,0.0076714,0.020802,0,0
3,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.54321,0.0075944,0.0094858,0,0
3,EXTRACELLULAR MATRIX PART,0.27611,0.0075327,0.045233,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON SULFUR GROUP OF DONORS,0.57857,0.0074822,-0.15159,0,0
3,KEGG MAPK SIGNALING PATHWAY,0.52594,0.0074305,0.026736,0,0
3,REGULATION OF SYNAPSE STRUCTURE AND ACTIVITY,0.72313,0.0073174,0.032394,0,0
3,BIOCARTA FMLP PATHWAY,0.69061,0.0071553,0.016886,0,0
3,CELLULAR RESPONSE TO STIMULUS,0.98953,0.0071522,0.040953,0,0
3,T CELL ACTIVATION,0.27611,0.0071453,-0.071011,0,0
3,BIOCARTA P38MAPK PATHWAY,0.85768,0.0070481,0.0052215,0,0
3,GROWTH,0.9686,0.0070076,-0.024963,0,0
3,RECEPTOR COMPLEX,0.85768,0.0068599,-0.027279,0,0
3,RESPONSE TO LIGHT STIMULUS,0.47588,0.006791,0.024906,0,0
3,KEGG OLFACTORY TRANSDUCTION,0.62732,0.0067749,0.0034764,0,0
3,ORGANELLE LUMEN,0.19695,0.0067008,0.038015,0,0
3,MEMBRANE ENCLOSED LUMEN,0.19695,0.0067008,0.038015,0,0
3,RESPONSE TO BACTERIUM,0.89907,0.0066404,-0.025663,0,0
3,BIOCARTA CD40 PATHWAY,0.77618,0.0065855,-0.095222,0,0
3,KEGG STARCH AND SUCROSE METABOLISM,0.97557,0.0065623,-0.006371,0,0
3,CATION BINDING,0.62732,0.006498,0.017444,0,0
3,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37932,0.0064656,0.031758,0,0
3,METAL ION TRANSPORT,0.65866,0.0062962,0.04049,0,0
3,REACTOME MITOTIC PROMETAPHASE,0.87833,0.0062657,0.0076962,0,0
3,DNA PACKAGING,0.76948,0.0058674,0.0050383,0,0
3,REACTOME PLC BETA MEDIATED EVENTS,0.85082,0.0054925,0.03252,0,0
3,PID PI3KCIAKTPATHWAY,0.98255,0.0051166,0.00068183,0,0
3,DNA BINDING,0.85768,0.0049801,0.0010561,0,0
3,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.65234,0.0047785,0.015019,0,0
3,INTERLEUKIN BINDING,0.53167,0.0046083,-0.084314,0,0
3,BEHAVIOR,1,0.0045183,-0.011823,0,0
3,POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.82348,0.004511,-0.063602,0,0
3,PID CXCR4 PATHWAY,0.94073,0.0044408,-0.0080093,0,0
3,BIOCARTA HCMV PATHWAY,0.85082,0.004437,-0.025016,0,0
3,REACTOME DNA STRAND ELONGATION,0.42855,0.0044114,0.076429,0,0
3,BIOCARTA AGR PATHWAY,0.72969,0.0041992,-0.022219,0,0
3,CELL CYCLE ARREST GO 0007050,0.80312,0.00413,-0.0050187,0,0
3,KEGG CHEMOKINE SIGNALING PATHWAY,0.69061,0.0039872,0.011987,0,0
3,CELLULAR COMPONENT ASSEMBLY,0.4598,0.0039519,0.018578,0,0
3,KINESIN COMPLEX,0.74288,0.003912,0.065998,0,0
3,NEGATIVE REGULATION OF CELL CYCLE,0.88523,0.0037392,-0.004635,0,0
3,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.85768,0.0032337,-0.018,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.80989,0.003129,-0.028126,0,0
3,PID ATM PATHWAY,0.56666,0.0028319,-0.030693,0,0
3,RNA BIOSYNTHETIC PROCESS,0.87833,0.0025662,-0.0072461,0,0
3,BIOCARTA NFAT PATHWAY,0.98255,0.0024992,0.0050398,0,0
3,LYMPHOCYTE DIFFERENTIATION,0.60883,0.0019881,-0.035977,0,0
3,NUCLEUS,0.85768,0.0019231,0.0055965,0,0
3,PROTEIN COMPLEX ASSEMBLY,0.55487,0.0015323,-0.031911,0,0
3,GROWTH FACTOR BINDING,0.90599,0.00138,-0.029499,0,0
3,TRANSCRIPTION DNA DEPENDENT,0.87144,0.0013256,-0.0077963,0,0
3,GLYCOSAMINOGLYCAN BINDING,0.87144,0.0012757,0.023289,0,0
3,REACTOME DEFENSINS,0.79636,0.0011204,-0.031109,0,0
3,DNA POLYMERASE ACTIVITY,0.60883,0.0010197,0.014444,0,0
3,PID IGF1 PATHWAY,0.91293,0.00093089,-0.0084125,0,0
3,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.88523,0.00090348,-0.010151,0,0
3,MONOOXYGENASE ACTIVITY,0.74288,0.00070036,-0.01302,0,0
3,REGULATION OF MOLECULAR FUNCTION,0.62113,0.00066665,-0.017374,0,0
3,REACTOME DAG AND IP3 SIGNALING,0.98953,0.00046067,2.5578e-05,0,0
3,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.53742,0.00017729,-0.082607,0,0
3,MEMBRANE PART,0.91987,0.00014865,-0.0069494,0,0
3,KEGG FOCAL ADHESION,0.80312,-8.7278e-05,-0.055404,0,0
3,ORGANELLE ORGANIZATION AND BIOGENESIS,0.81668,-8.7902e-05,0.0025105,0,0
3,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.67776,-0.00010442,-0.022201,0,0
3,DEFENSE RESPONSE TO BACTERIUM,0.94769,-0.00022475,-0.021846,0,0
3,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.56075,-0.00024797,-0.041295,0,0
3,REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE,0.8303,-0.00025481,0.012116,0,0
3,REACTOME CELL CYCLE,0.69707,-0.00066587,0.0132,0,0
3,REACTOME UNWINDING OF DNA,0.21256,-0.00091614,0.14819,0,0
3,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.94073,-0.00099175,0.0079822,0,0
3,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.66501,-0.0010287,-0.019205,0,0
3,ATP BINDING,0.69061,-0.0011075,-0.012954,0,0
3,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.72313,-0.0012047,-0.021516,0,0
3,BIOCARTA GLEEVEC PATHWAY,0.78289,-0.001527,0.019231,0,0
3,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.98255,-0.0016911,-0.0021841,0,0
3,VIRAL INFECTIOUS CYCLE,0.76948,-0.0020821,-0.039145,0,0
3,PROTEIN AMINO ACID LIPIDATION,0.39858,-0.0023768,-0.088091,0,0
3,KEGG CELL CYCLE,0.92682,-0.0023973,-0.0027541,0,0
3,ESTABLISHMENT OF LOCALIZATION,0.92682,-0.0024164,-0.0039304,0,0
3,POLYSACCHARIDE METABOLIC PROCESS,0.82348,-0.0028376,-0.027039,0,0
3,HOMEOSTASIS OF NUMBER OF CELLS,0.3746,-0.0029026,-0.092469,0,0
3,REACTOME DOUBLE STRAND BREAK REPAIR,0.89215,-0.0033228,-0.0055547,0,0
3,VESICLE MEDIATED TRANSPORT,0.82348,-0.0033574,-0.011281,0,0
3,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.89907,-0.0033685,-0.031245,0,0
3,REACTOME PI 3K CASCADE,0.71658,-0.0037255,0.023555,0,0
3,N ACYLTRANSFERASE ACTIVITY,1,-0.0037944,0.0051136,0,0
3,PID ERBB2ERBB3PATHWAY,0.91293,-0.0038358,-0.0033229,0,0
3,VITAMIN METABOLIC PROCESS,0.8303,-0.0039325,0.011311,0,0
3,BIOCARTA CFTR PATHWAY,0.97557,-0.0040902,0.0066581,0,0
3,RNA DEPENDENT ATPASE ACTIVITY,0.27611,-0.0041047,0.1056,0,0
3,PROTEIN KINASE BINDING,0.67137,-0.0041126,-0.020127,0,0
3,PID ERBB4 PATHWAY,0.53167,-0.0041887,0.029758,0,0
3,PHOSPHOLIPASE C ACTIVITY,0.97557,-0.0042562,-0.011848,0,0
3,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.50896,-0.004279,-0.027625,0,0
3,MICROTUBULE BASED PROCESS,0.46512,-0.0046683,-0.036685,0,0
3,KEGG PEROXISOME,0.90599,-0.0048604,-0.0025998,0,0
3,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.64605,-0.0048761,-0.02718,0,0
3,PID DNAPK PATHWAY,0.84397,-0.0049353,-0.011404,0,0
3,PROTEIN DOMAIN SPECIFIC BINDING,0.55487,-0.0051768,-0.019771,0,0
3,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.36064,-0.0054161,-0.046077,0,0
3,STRUCTURE SPECIFIC DNA BINDING,0.4598,-0.0054505,-0.030248,0,0
3,POSITIVE REGULATION OF METABOLIC PROCESS,0.62113,-0.0055504,-0.025815,0,0
3,MESODERM DEVELOPMENT,0.40349,-0.0059786,-0.15646,0,0
3,RESPONSE TO ENDOGENOUS STIMULUS,0.85082,-0.0060286,-0.0066029,0,0
3,HORMONE METABOLIC PROCESS,0.94073,-0.0063012,-0.028704,0,0
3,REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1,0.84397,-0.0063356,0.020171,0,0
3,PID TRKRPATHWAY,0.87144,-0.006364,-0.00032586,0,0
3,PID IL8CXCR2 PATHWAY,0.95466,-0.00644,-0.019041,0,0
3,TRANSCRIPTION INITIATION,0.87833,-0.0064431,0.0090921,0,0
3,RNA CATABOLIC PROCESS,0.71658,-0.006466,-0.032559,0,0
3,MEIOTIC CELL CYCLE,0.46512,-0.0065352,-0.050491,0,0
3,CYTOKINE BINDING,0.33812,-0.0068406,-0.082931,0,0
3,PROTEIN STABILIZATION,0.95466,-0.006948,-0.013151,0,0
3,PID HDAC CLASSI PATHWAY,0.85768,-0.0073844,0.0036223,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.60272,-0.0075236,0.039845,0,0
3,MEMBRANE,0.56075,-0.0078083,-0.016901,0,0
3,TRANSCRIPTION COFACTOR ACTIVITY,0.99651,-0.0079164,0.0071005,0,0
3,CHROMOSOME SEGREGATION,0.59664,-0.0079269,-0.024318,0,0
3,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.38408,-0.0082132,0.20953,0,0
3,REACTOME SEROTONIN RECEPTORS,0.8303,-0.0084944,-0.0010666,0,0
3,KEGG GLIOMA,0.84397,-0.0086187,-0.0052979,0,0
3,WOUND HEALING,0.73628,-0.0086456,-0.055346,0,0
3,REACTOME HEMOSTASIS,0.76948,-0.0086682,-0.01225,0,0
3,KEGG HEDGEHOG SIGNALING PATHWAY,0.91987,-0.0086905,0.016413,0,0
3,PID TOLL ENDOGENOUS PATHWAY,0.14285,-0.0086952,-0.16062,0,0
3,REACTOME SIGNALING BY FGFR,0.65234,-0.0090785,-0.016333,0,0
3,TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27227,-0.009127,-0.10669,0,0
3,REGULATION OF CELL GROWTH,0.65234,-0.0092576,-0.051213,0,0
3,PID INTEGRIN1 PATHWAY,0.98255,-0.0094529,-0.09873,0,0
3,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.52025,-0.0095199,-0.029186,0,0
3,CHROMATIN MODIFICATION,0.91987,-0.0095811,0.0017882,0,0
3,ANDROGEN RECEPTOR SIGNALING PATHWAY,0.86455,-0.0096069,0.019795,0,0
3,REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER,0.85082,-0.0097362,0.023289,0,0
3,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.59664,-0.0097835,-0.018742,0,0
3,REACTOME SIGNALING BY INSULIN RECEPTOR,0.93377,-0.010071,-0.00082151,0,0
3,PID EPHA2 FWDPATHWAY,0.38408,-0.010131,-0.073447,0,0
3,NUCLEAR MEMBRANE,0.79636,-0.010167,-0.015008,0,0
3,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.78962,-0.010186,0.0088917,0,0
3,SPINDLE MICROTUBULE,0.84397,-0.01019,0.015472,0,0
3,POLYSACCHARIDE BINDING,0.94073,-0.010268,0.015811,0,0
3,MEMBRANE LIPID METABOLIC PROCESS,0.60883,-0.010293,-0.026094,0,0
3,INTEGRATOR COMPLEX,0.94073,-0.010392,-0.0035348,0,0
3,CYTOPLASMIC PART,0.4545,-0.010471,-0.026834,0,0
3,ENZYME BINDING,0.4978,-0.010695,-0.019797,0,0
3,LIPOPROTEIN METABOLIC PROCESS,0.18219,-0.010697,-0.096221,0,0
3,SPECIFIC TRANSCRIPTIONAL REPRESSOR ACTIVITY,0.88523,-0.011072,-0.014051,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.8303,-0.011231,-0.024994,0,0
3,RESPONSE TO DNA DAMAGE STIMULUS,0.85768,-0.011273,-0.001985,0,0
3,REGULATION OF PROTEIN STABILITY,0.86455,-0.011486,-0.013657,0,0
3,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.81668,-0.011825,-0.023149,0,0
3,MEMBRANE BOUND VESICLE,0.29992,-0.011867,-0.047745,0,0
3,NUCLEAR EXPORT,0.94769,-0.012165,0.0071881,0,0
3,REACTOME SIGNALING BY NOTCH,0.63354,-0.012451,-0.01984,0,0
3,INTRACELLULAR PROTEIN TRANSPORT,0.48131,-0.012494,-0.041205,0,0
3,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.75615,-0.012501,0.043912,0,0
3,REGULATION OF IMMUNE RESPONSE,0.73628,-0.012778,-0.027643,0,0
3,REACTOME STEROID HORMONES,0.80989,-0.012905,-0.018456,0,0
3,KEGG PPAR SIGNALING PATHWAY,0.98953,-0.012982,0.0072708,0,0
3,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.99651,-0.012984,0.016543,0,0
3,REGULATION OF CELL PROLIFERATION,0.48131,-0.012994,-0.040646,0,0
3,POSITIVE REGULATION OF IMMUNE RESPONSE,0.75615,-0.013135,-0.02046,0,0
3,PID RHOA PATHWAY,0.41842,-0.013142,-0.068519,0,0
3,CELLULAR PROTEIN CATABOLIC PROCESS,0.092194,-0.013527,-0.064104,0,0
3,PID BETACATENIN DEG PATHWAY,0.8303,-0.013527,0.016168,0,0
3,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.71006,-0.013594,-0.016731,0,0
3,MICROTUBULE CYTOSKELETON,0.85082,-0.013669,0.020417,0,0
3,ANATOMICAL STRUCTURE DEVELOPMENT,0.93377,-0.013825,0.0028699,0,0
3,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.55487,-0.013862,-0.048015,0,0
3,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.34256,-0.014055,-0.025715,0,0
3,KEGG REGULATION OF ACTIN CYTOSKELETON,0.41341,-0.014191,-0.05048,0,0
3,MITOTIC CELL CYCLE,0.69061,-0.01422,-0.014303,0,0
3,BASE EXCISION REPAIR,0.72969,-0.014415,-0.011739,0,0
3,REACTOME PHOSPHORYLATION OF THE APC C,0.47588,-0.014451,-0.027867,0,0
3,NUCLEOPLASM,0.42855,-0.014491,-0.013132,0,0
3,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.62113,-0.014667,-0.02426,0,0
3,POSITIVE REGULATION OF CELL PROLIFERATION,0.46512,-0.014695,-0.05464,0,0
3,TRANSCRIPTION REPRESSOR ACTIVITY,0.76281,-0.014778,-0.014572,0,0
3,CELL PROLIFERATION GO 0008283,0.48131,-0.014839,-0.035707,0,0
3,NUCLEAR REPLICATION FORK,0.40843,-0.014849,-0.046024,0,0
3,KEGG NITROGEN METABOLISM,0.75615,-0.015255,-0.034377,0,0
3,REACTOME TRANSCRIPTION,0.78289,-0.015321,0.017073,0,0
3,ST G ALPHA S PATHWAY,0.51459,-0.015411,-0.03923,0,0
3,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.80312,-0.015529,0.025317,0,0
3,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.55487,-0.016298,0.061411,0,0
3,KEGG LONG TERM POTENTIATION,0.63354,-0.016422,-0.016936,0,0
3,PML BODY,0.5726,-0.016631,-0.050367,0,0
3,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.71658,-0.016636,-0.01005,0,0
3,PID P38 MKK3 6PATHWAY,0.4978,-0.016893,-0.046022,0,0
3,CALCIUM ION BINDING,0.59664,-0.017076,-0.026684,0,0
3,TRANSCRIPTION FACTOR BINDING,0.33812,-0.017561,-0.021213,0,0
3,BIOCARTA LONGEVITY PATHWAY,0.62113,-0.017821,-0.050535,0,0
3,ENERGY RESERVE METABOLIC PROCESS,0.7495,-0.017907,-0.023188,0,0
3,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.86455,-0.017928,-0.026413,0,0
3,BIOCARTA AGPCR PATHWAY,0.87144,-0.017977,0.010675,0,0
3,RESPONSE TO HORMONE STIMULUS,0.98255,-0.018064,-0.0074835,0,0
3,ACTIN FILAMENT BUNDLE FORMATION,0.84397,-0.018234,-0.014646,0,0
3,CELL CYCLE GO 0007049,0.38888,-0.018249,-0.022296,0,0
3,PID WNT SIGNALING PATHWAY,0.53742,-0.018268,-0.075663,0,0
3,KEGG RENAL CELL CARCINOMA,0.77618,-0.018298,-0.014664,0,0
3,CELL CYCLE PROCESS,0.67137,-0.018305,-0.011476,0,0
3,MICROTUBULE ORGANIZING CENTER,0.55487,-0.01832,-0.014071,0,0
3,TRANSCRIPTION,0.36991,-0.018366,-0.021612,0,0
3,KEGG SMALL CELL LUNG CANCER,0.87833,-0.018429,-0.014868,0,0
3,INTERPHASE,0.23245,-0.018516,-0.044256,0,0
3,REACTOME ACTIVATION OF RAC,0.80989,-0.018698,-0.015638,0,0
3,PROTEIN EXPORT FROM NUCLEUS,0.65234,-0.018802,0.0449,0,0
3,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.8303,-0.018836,-0.027796,0,0
3,JAK STAT CASCADE,0.67137,-0.018889,-0.0642,0,0
3,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.82348,-0.018978,0.0095833,0,0
3,ST STAT3 PATHWAY,0.71658,-0.019119,-0.035017,0,0
3,PROTEIN N TERMINUS BINDING,0.39858,-0.019304,-0.04024,0,0
3,REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA,0.8303,-0.019372,0.012187,0,0
3,REGULATION OF HOMEOSTATIC PROCESS,0.43883,-0.019668,-0.11849,0,0
3,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.80312,-0.019814,-0.007488,0,0
3,COAGULATION,0.54903,-0.019866,-0.075194,0,0
3,ATP DEPENDENT RNA HELICASE ACTIVITY,0.22235,-0.019934,0.11057,0,0
3,NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.87833,-0.020017,-0.011866,0,0
3,CELLULAR LOCALIZATION,0.17934,-0.020232,-0.037233,0,0
3,ELECTRON CARRIER ACTIVITY,0.71658,-0.020399,-0.044248,0,0
3,INTERLEUKIN RECEPTOR ACTIVITY,0.3746,-0.020778,-0.12177,0,0
3,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.16294,-0.020781,-0.040789,0,0
3,INTRACELLULAR ORGANELLE PART,0.44924,-0.020897,-0.014589,0,0
3,CELL CYCLE PHASE,0.29184,-0.021092,-0.031016,0,0
3,REACTOME SMOOTH MUSCLE CONTRACTION,0.69707,-0.02112,-0.12708,0,0
3,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.99651,-0.021122,-0.0090942,0,0
3,PROTEIN TRANSPORT,0.36526,-0.021309,-0.044754,0,0
3,STEROL BINDING,0.76281,-0.021496,-0.03441,0,0
3,POSITIVE REGULATION OF CELL CYCLE,0.3746,-0.02152,-0.11406,0,0
3,REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.98953,-0.021767,0.0068285,0,0
3,PID HEDGEHOG GLIPATHWAY,0.60883,-0.021806,-0.0078179,0,0
3,ORGANELLE OUTER MEMBRANE,0.35607,-0.021889,-0.066144,0,0
3,REACTOME G PROTEIN ACTIVATION,0.43367,-0.021926,0.077802,0,0
3,PID PDGFRBPATHWAY,0.36064,-0.022064,-0.041967,0,0
3,LIPID BIOSYNTHETIC PROCESS,0.53167,-0.02228,-0.045596,0,0
3,INTRACELLULAR TRANSPORT,0.085627,-0.022519,-0.060164,0,0
3,REGULATION OF CELLULAR METABOLIC PROCESS,0.34256,-0.022609,-0.026553,0,0
3,PID ERA GENOMIC PATHWAY,0.84397,-0.022642,0.00044689,0,0
3,RECEPTOR MEDIATED ENDOCYTOSIS,0.63354,-0.02282,-0.030887,0,0
3,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.29992,-0.022971,-0.089617,0,0
3,PID RET PATHWAY,0.66501,-0.023073,-0.037395,0,0
3,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.47049,-0.023286,-0.022006,0,0
3,DOUBLE STRANDED DNA BINDING,0.35607,-0.023828,-0.049712,0,0
3,LEUKOCYTE ACTIVATION,0.2,-0.023945,-0.05867,0,0
3,BIOPOLYMER METABOLIC PROCESS,0.32938,-0.024043,-0.018282,0,0
3,REGULATION OF METABOLIC PROCESS,0.32077,-0.024118,-0.027493,0,0
3,POSITIVE REGULATION OF T CELL ACTIVATION,0.36526,-0.024163,-0.081066,0,0
3,BIOCARTA ATRBRCA PATHWAY,0.52025,-0.024196,-0.049854,0,0
3,STRIATED MUSCLE DEVELOPMENT,0.84397,-0.024199,-0.022912,0,0
3,REGULATION OF PROTEIN METABOLIC PROCESS,0.67137,-0.024349,-0.037183,0,0
3,REGULATION OF CELL SHAPE,0.63978,-0.024363,-0.056783,0,0
3,ENDOSOME TRANSPORT,0.12049,-0.024902,-0.12018,0,0
3,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.64605,-0.025033,-0.043701,0,0
3,KEGG OOCYTE MEIOSIS,0.80989,-0.025045,-0.005142,0,0
3,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.98953,-0.025162,0.013321,0,0
3,PID FAK PATHWAY,0.36991,-0.025203,-0.079198,0,0
3,BIOCARTA G1 PATHWAY,0.98255,-0.025376,-0.0024693,0,0
3,ORGANELLE PART,0.35153,-0.025431,-0.017194,0,0
3,BIOCARTA TALL1 PATHWAY,0.43883,-0.025521,-0.048884,0,0
3,REACTOME LAGGING STRAND SYNTHESIS,0.87833,-0.025578,0.034881,0,0
3,CATION TRANSPORT,0.98953,-0.025593,0.0025996,0,0
3,NON MEMBRANE BOUND ORGANELLE,0.26471,-0.025695,-0.023756,0,0
3,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.26471,-0.025695,-0.023756,0,0
3,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.98255,-0.026331,0.0084472,0,0
3,PROTEIN HOMOOLIGOMERIZATION,0.42347,-0.026334,-0.08812,0,0
3,DETECTION OF EXTERNAL STIMULUS,0.24643,-0.026414,-0.079872,0,0
3,DAMAGED DNA BINDING,0.4545,-0.026487,-0.022036,0,0
3,PID INSULIN PATHWAY,0.51459,-0.026502,-0.044914,0,0
3,ACTIVATION OF MAPK ACTIVITY,0.4978,-0.026603,-0.04544,0,0
3,PID RETINOIC ACID PATHWAY,0.85768,-0.02666,-0.0089174,0,0
3,REACTOME IL 7 SIGNALING,0.78962,-0.026764,0.077638,0,0
3,REACTOME SIGNALING BY ERBB2,0.1313,-0.026786,-0.042688,0,0
3,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.94073,-0.026849,-0.010799,0,0
3,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.87833,-0.026942,0.0071119,0,0
3,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.95466,-0.026952,0.0073146,0,0
3,REGULATION OF CELL MORPHOGENESIS,0.49227,-0.02852,-0.064652,0,0
3,PHOSPHOINOSITIDE METABOLIC PROCESS,0.12049,-0.028672,-0.084659,0,0
3,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.52594,-0.028689,-0.018525,0,0
3,MONOVALENT INORGANIC CATION HOMEOSTASIS,0.71658,-0.028698,-0.042933,0,0
3,OXIDOREDUCTASE ACTIVITY GO 0016706,0.56666,-0.029244,-0.096588,0,0
3,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.59664,-0.029264,-0.022172,0,0
3,MEMBRANE ORGANIZATION AND BIOGENESIS,0.24288,-0.029403,-0.036562,0,0
3,REGULATION OF RHO GTPASE ACTIVITY,0.38408,-0.029517,-0.061011,0,0
3,KINASE ACTIVITY,0.16294,-0.029523,-0.03892,0,0
3,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.4978,-0.029667,-0.025852,0,0
3,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.22905,-0.029918,-0.056614,0,0
3,REACTOME AMINE LIGAND BINDING RECEPTORS,0.57857,-0.030362,-0.019271,0,0
3,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.82348,-0.030435,-0.015876,0,0
3,REACTOME NUCLEAR SIGNALING BY ERBB4,0.80989,-0.030442,-0.031135,0,0
3,REACTOME ERK MAPK TARGETS,0.53167,-0.030547,-0.035127,0,0
3,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.59059,-0.030673,-0.018707,0,0
3,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.63978,-0.030675,-0.034705,0,0
3,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.59059,-0.030911,-0.035122,0,0
3,CYTOSOL,0.56666,-0.030947,-0.027979,0,0
3,KEGG COMPLEMENT AND COAGULATION CASCADES,0.16294,-0.031232,-0.16632,0,0
3,REGULATION OF RNA METABOLIC PROCESS,0.54903,-0.031666,-0.019496,0,0
3,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.2839,-0.03172,-0.04515,0,0
3,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.69061,-0.03192,-0.040231,0,0
3,M PHASE,0.43883,-0.032088,-0.025604,0,0
3,CYTOPLASM,0.25363,-0.032142,-0.035703,0,0
3,KEGG GLUTATHIONE METABOLISM,0.53742,-0.03228,-0.076496,0,0
3,BIOCARTA PITX2 PATHWAY,0.36991,-0.032301,-0.087085,0,0
3,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.84397,-0.032499,0.031386,0,0
3,PID IL12 STAT4PATHWAY,0.24288,-0.03256,-0.10167,0,0
3,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.67137,-0.032686,-0.04956,0,0
3,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.70355,-0.033,-0.022328,0,0
3,STEROID BIOSYNTHETIC PROCESS,0.30402,-0.033076,-0.10628,0,0
3,TISSUE DEVELOPMENT,0.39858,-0.033184,-0.06973,0,0
3,CHANNEL REGULATOR ACTIVITY,0.89215,-0.033214,0.0023415,0,0
3,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.26471,-0.033215,-0.082631,0,0
3,BIOCARTA AKAP13 PATHWAY,0.94073,-0.033252,0.00035681,0,0
3,BIOCARTA INSULIN PATHWAY,0.53167,-0.033663,-0.040686,0,0
3,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.73628,-0.033801,-0.0091878,0,0
3,BIOCARTA PPARA PATHWAY,0.30815,-0.033906,-0.042053,0,0
3,REACTOME ER PHAGOSOME PATHWAY,0.17934,-0.033944,-0.16553,0,0
3,REACTOME SIGNALING BY ERBB4,0.16294,-0.034358,-0.046872,0,0
3,NUCLEOPLASM PART,0.15264,-0.034363,-0.031257,0,0
3,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.51459,-0.034445,-0.067859,0,0
3,REGULATION OF PROTEIN KINASE ACTIVITY,0.50896,-0.034546,-0.019221,0,0
3,REGULATION OF KINASE ACTIVITY,0.47588,-0.034557,-0.022068,0,0
3,ION BINDING,0.67137,-0.034598,-0.010737,0,0
3,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.14285,-0.034967,-0.083044,0,0
3,ST GAQ PATHWAY,0.83713,-0.034993,-0.030303,0,0
3,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.17374,-0.035169,-0.03729,0,0
3,NUCLEAR BODY,0.0695,-0.03518,-0.060795,0,0
3,ENDOPLASMIC RETICULUM,0.24288,-0.035218,-0.064562,0,0
3,KEGG THYROID CANCER,0.74288,-0.03527,-0.024521,0,0
3,CELL CELL SIGNALING,0.76281,-0.0354,-0.0086278,0,0
3,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.14285,-0.035471,-0.11472,0,0
3,ALCOHOL METABOLIC PROCESS,0.50896,-0.035556,-0.051835,0,0
3,REGULATION OF GENE EXPRESSION,0.11039,-0.035672,-0.037683,0,0
3,FEMALE PREGNANCY,0.12473,-0.035733,-0.10121,0,0
3,BIOCARTA FIBRINOLYSIS PATHWAY,0.71658,-0.035738,-0.11832,0,0
3,REGULATION OF RAS GTPASE ACTIVITY,0.67137,-0.035749,-0.040604,0,0
3,REGULATION OF TRANSCRIPTION,0.21256,-0.035806,-0.033835,0,0
3,REGULATION OF CELL CYCLE,0.26098,-0.035942,-0.035562,0,0
3,BIOCARTA IL4 PATHWAY,0.31232,-0.036078,-0.17672,0,0
3,TRANSCRIPTION COACTIVATOR ACTIVITY,0.24288,-0.036367,-0.019722,0,0
3,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.16828,-0.036475,-0.033312,0,0
3,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.35607,-0.036652,-0.036156,0,0
3,REACTOME SHC MEDIATED CASCADE,0.68418,-0.036742,-0.025278,0,0
3,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.80312,-0.036869,0.0063506,0,0
3,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.85768,-0.037079,0.0025783,0,0
3,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.88523,-0.037139,-0.004125,0,0
3,ACTIVATION OF JNK ACTIVITY,0.60272,-0.037223,-0.038948,0,0
3,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.26847,-0.037436,-0.065128,0,0
3,NUCLEAR UBIQUITIN LIGASE COMPLEX,0.35607,-0.037563,-0.051096,0,0
3,BIOCARTA CCR5 PATHWAY,0.63354,-0.037869,-0.03501,0,0
3,NITROGEN COMPOUND CATABOLIC PROCESS,0.74288,-0.038135,-0.015675,0,0
3,CELLULAR HOMEOSTASIS,0.44924,-0.038157,-0.032787,0,0
3,PROTEIN CATABOLIC PROCESS,0.070855,-0.038206,-0.054346,0,0
3,DOUBLE STRAND BREAK REPAIR,0.36064,-0.038434,-0.053705,0,0
3,BIOCARTA RACCYCD PATHWAY,0.93377,-0.038488,-0.0064092,0,0
3,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.23589,-0.038581,-0.080861,0,0
3,PID INTEGRIN5 PATHWAY,0.82348,-0.038615,0.034145,0,0
3,REGULATION OF TRANSFERASE ACTIVITY,0.56075,-0.039031,-0.019899,0,0
3,PID LPA4 PATHWAY,0.91293,-0.039111,0.0020617,0,0
3,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.91987,-0.039191,0.016767,0,0
3,KEGG BUTANOATE METABOLISM,0.40843,-0.039303,-0.047191,0,0
3,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.32506,-0.039381,-0.036209,0,0
3,ADENYL RIBONUCLEOTIDE BINDING,0.16294,-0.039566,-0.037783,0,0
3,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.14526,-0.039681,-0.14127,0,0
3,REACTOME CD28 CO STIMULATION,0.18219,-0.039688,-0.085056,0,0
3,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.90599,-0.039727,0.0013282,0,0
3,PID SYNDECAN 3 PATHWAY,0.48678,-0.039955,-0.088038,0,0
3,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.32506,-0.040504,-0.024643,0,0
3,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.19393,-0.040684,-0.059478,0,0
3,VIRAL REPRODUCTIVE PROCESS,0.34256,-0.040737,-0.07344,0,0
3,PYROPHOSPHATASE ACTIVITY,0.16294,-0.040851,-0.032735,0,0
3,REACTOME SIGNAL TRANSDUCTION BY L1,0.36064,-0.040851,-0.042756,0,0
3,PID MYC REPRESSPATHWAY,0.22568,-0.040893,-0.11147,0,0
3,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.34702,-0.040997,-0.078665,0,0
3,BIOCARTA BARRESTIN SRC PATHWAY,0.65866,-0.041182,0.035325,0,0
3,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.67776,-0.041297,-0.034337,0,0
3,REACTOME IRON UPTAKE AND TRANSPORT,0.21256,-0.041317,-0.074694,0,0
3,SEQUENCE SPECIFIC DNA BINDING,0.12473,-0.041641,-0.062761,0,0
3,AMINE RECEPTOR ACTIVITY,0.63978,-0.04171,-0.02204,0,0
3,SIGNAL TRANSDUCTION,0.13814,-0.041796,-0.046624,0,0
3,LIPID TRANSPORT,0.36991,-0.041854,-0.099303,0,0
3,M PHASE OF MITOTIC CELL CYCLE,0.22568,-0.041971,-0.042018,0,0
3,KEGG TYPE II DIABETES MELLITUS,0.78289,-0.042022,0.031661,0,0
3,PID P38 MK2PATHWAY,0.18508,-0.042237,-0.097548,0,0
3,CHEMICAL HOMEOSTASIS,0.19393,-0.04234,-0.059047,0,0
3,BIOCARTA IL6 PATHWAY,0.59664,-0.042496,-0.048881,0,0
3,ATPASE ACTIVITY,0.43883,-0.042721,-0.017128,0,0
3,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.83713,-0.04279,-0.035456,0,0
3,BIOCARTA PTEN PATHWAY,0.35153,-0.042867,-0.088124,0,0
3,ORGAN DEVELOPMENT,0.29184,-0.042988,-0.04031,0,0
3,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.27611,-0.043063,-0.067488,0,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.55487,-0.043113,-0.044341,0,0
3,NEGATIVE REGULATION OF CELL MIGRATION,0.94769,-0.043213,0.019163,0,0
3,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.42347,-0.043319,-0.041676,0,0
3,HOMOPHILIC CELL ADHESION,1,-0.043527,0.027528,0,0
3,EXOPEPTIDASE ACTIVITY,0.64605,-0.043559,-0.045523,0,0
3,BIOCARTA AKAP95 PATHWAY,0.97557,-0.043697,0.0034269,0,0
3,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.39858,-0.043802,-0.068091,0,0
3,REGULATION OF GENE EXPRESSION EPIGENETIC,0.23589,-0.043848,-0.0548,0,0
3,PATTERN BINDING,0.78962,-0.043895,-0.0051208,0,0
3,BIOCARTA TOLL PATHWAY,0.13814,-0.043953,-0.10051,0,0
3,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.082489,-0.044024,-0.046552,0,0
3,PID ERBB NETWORK PATHWAY,0.42347,-0.04426,-0.13307,0,0
3,KEGG PROTEIN EXPORT,0.18219,-0.044412,-0.083069,0,0
3,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GLOBO SERIES,0.76281,-0.04451,0.01688,0,0
3,PID P53DOWNSTREAMPATHWAY,0.12049,-0.044683,-0.1014,0,0
3,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.16559,-0.044721,-0.032395,0,0
3,BIOCARTA MEF2D PATHWAY,0.22568,-0.044759,-0.085191,0,0
3,ADENYL NUCLEOTIDE BINDING,0.13583,-0.044923,-0.043092,0,0
3,BLOOD COAGULATION,0.14769,-0.044953,-0.1186,0,0
3,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.17374,-0.045307,-0.070265,0,0
3,PID ENDOTHELINPATHWAY,0.62113,-0.045377,-0.024432,0,0
3,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.072231,-0.045423,-0.075301,0,0
3,EMBRYONIC MORPHOGENESIS,0.9686,-0.045568,-0.035034,0,0
3,BIOCARTA PTC1 PATHWAY,0.58456,-0.045655,-0.038321,0,0
3,ST T CELL SIGNAL TRANSDUCTION,0.63978,-0.045718,-0.024398,0,0
3,PROTEIN C TERMINUS BINDING,0.15015,-0.045736,-0.043918,0,0
3,ANION TRANSPORT,0.36991,-0.045749,-0.046246,0,0
3,NEGATIVE REGULATION OF CELL PROLIFERATION,0.095625,-0.045793,-0.064718,0,0
3,PERINUCLEAR REGION OF CYTOPLASM,0.27227,-0.045794,-0.048526,0,0
3,GLYCOSPHINGOLIPID METABOLIC PROCESS,0.38408,-0.046045,0.10971,0,0
3,BIOCARTA TNFR2 PATHWAY,0.20309,-0.046173,-0.12662,0,0
3,REGULATION OF BODY FLUID LEVELS,0.1313,-0.046652,-0.099154,0,0
3,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.48131,-0.046681,-0.046785,0,0
3,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.36991,-0.04677,-0.067582,0,0
3,ORGAN MORPHOGENESIS,0.20309,-0.04693,-0.056738,0,0
3,ANATOMICAL STRUCTURE MORPHOGENESIS,0.30815,-0.046955,-0.036058,0,0
3,REACTOME CIRCADIAN CLOCK,0.60883,-0.047029,-0.036814,0,0
3,TRANSCRIPTION ACTIVATOR ACTIVITY,0.16294,-0.047225,-0.031212,0,0
3,PID ALK1PATHWAY,0.94769,-0.047311,0.019482,0,0
3,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.56666,-0.047394,-0.043218,0,0
3,ACTIN FILAMENT BASED PROCESS,0.10845,-0.047656,-0.072604,0,0
3,COENZYME BINDING,0.27227,-0.047789,-0.1162,0,0
3,REACTOME TCR SIGNALING,0.10654,-0.047843,-0.077022,0,0
3,PID INSULIN GLUCOSE PATHWAY,0.15773,-0.047898,-0.082259,0,0
3,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.90599,-0.048027,-0.041756,0,0
3,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.3746,-0.048036,-0.036598,0,0
3,ST B CELL ANTIGEN RECEPTOR,0.23589,-0.048281,-0.057606,0,0
3,NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.48678,-0.04836,-0.06225,0,0
3,SEROTONIN RECEPTOR ACTIVITY,0.23937,-0.048528,-0.035981,0,0
3,REACTOME ADP SIGNALLING THROUGH P2RY12,0.91987,-0.048543,-0.0045733,0,0
3,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.35607,-0.048639,-0.07827,0,0
3,KEGG CHRONIC MYELOID LEUKEMIA,0.43367,-0.048842,-0.024104,0,0
3,KEGG TYROSINE METABOLISM,0.51459,-0.049205,-0.037219,0,0
3,ENZYME REGULATOR ACTIVITY,0.2839,-0.049246,-0.027449,0,0
3,CHROMOSOMAL PART,0.18219,-0.049409,-0.041103,0,0
3,MITOTIC CELL CYCLE CHECKPOINT,0.2839,-0.049612,-0.060595,0,0
3,PEPTIDYL AMINO ACID MODIFICATION,0.15015,-0.049954,-0.066718,0,0
3,CARBOHYDRATE BINDING,0.27227,-0.049982,-0.046978,0,0
3,CHROMOSOME,0.30815,-0.050105,-0.030213,0,0
3,BIOCARTA MAPK PATHWAY,0.50337,-0.050135,-0.023167,0,0
3,FATTY ACID BIOSYNTHETIC PROCESS,0.93377,-0.050267,-0.011543,0,0
3,REGULATION OF BLOOD PRESSURE,0.75615,-0.050352,-0.065145,0,0
3,KEGG ECM RECEPTOR INTERACTION,0.57857,-0.050608,-0.094776,0,0
3,SENSORY PERCEPTION,0.23245,-0.050638,-0.042161,0,0
3,ENDOPEPTIDASE ACTIVITY,0.53742,-0.050993,-0.037035,0,0
3,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.23937,-0.051176,-0.05905,0,0
3,BIOCARTA PYK2 PATHWAY,0.33812,-0.0512,-0.026237,0,0
3,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.24643,-0.05127,-0.049133,0,0
3,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.26471,-0.051321,-0.03343,0,0
3,ST JNK MAPK PATHWAY,0.23245,-0.051706,-0.057341,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.34256,-0.05176,-0.14999,0,0
3,REGULATION OF GROWTH,0.12689,-0.051998,-0.08317,0,0
3,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.1313,-0.052022,-0.086281,0,0
3,REACTOME FRS2 MEDIATED CASCADE,0.56075,-0.052078,-0.022218,0,0
3,ST ERK1 ERK2 MAPK PATHWAY,0.21256,-0.052096,-0.086397,0,0
3,ALDO KETO REDUCTASE ACTIVITY,0.39858,-0.052156,-0.23835,0,0
3,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.69707,-0.052265,-0.027868,0,0
3,BIOCARTA RAC1 PATHWAY,0.62113,-0.052299,-0.025618,0,0
3,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.26847,-0.052304,-0.045599,0,0
3,BASOLATERAL PLASMA MEMBRANE,0.15773,-0.052341,-0.13419,0,0
3,POSITIVE REGULATION OF TRANSLATION,0.28785,-0.05237,-0.088475,0,0
3,PID IL8CXCR1 PATHWAY,0.49227,-0.052408,-0.051404,0,0
3,LIPID CATABOLIC PROCESS,0.26847,-0.05246,-0.055063,0,0
3,REACTOME SIGNALING BY BMP,0.26098,-0.05249,-0.11483,0,0
3,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.042857,-0.052555,-0.072068,0,0
3,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.59059,-0.052878,-0.048226,0,0
3,MITOSIS,0.17099,-0.052895,-0.047179,0,0
3,SOLUBLE FRACTION,0.55487,-0.053018,-0.032452,0,0
3,RESPONSE TO STRESS,0.090515,-0.053276,-0.062541,0,0
3,PID REG GR PATHWAY,0.33373,-0.05358,-0.06307,0,0
3,CELLULAR PROTEIN METABOLIC PROCESS,0.26098,-0.053784,-0.03484,0,0
3,REACTOME SIGNALING BY FGFR IN DISEASE,0.092194,-0.053938,-0.06244,0,0
3,SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY,0.75615,-0.054012,-0.010159,0,0
3,CYTOSKELETAL PROTEIN BINDING,0.31232,-0.054057,-0.027542,0,0
3,BIOCARTA 41BB PATHWAY,0.67137,-0.054212,-0.03175,0,0
3,BIOCARTA P53 PATHWAY,0.2839,-0.054265,-0.10012,0,0
3,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.15264,-0.05484,-0.058731,0,0
3,REPLICATION FORK,0.52025,-0.054863,-0.016678,0,0
3,PROTEIN AMINO ACID PHOSPHORYLATION,0.23245,-0.054959,-0.033389,0,0
3,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.082489,-0.055188,-0.065692,0,0
3,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.26847,-0.055761,-0.04758,0,0
3,PROTEIN METABOLIC PROCESS,0.25001,-0.055792,-0.03701,0,0
3,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.43883,-0.055978,-0.031607,0,0
3,REACTOME SIGNALING BY PDGF,0.188,-0.05606,-0.064637,0,0
3,REACTOME REGULATION OF SIGNALING BY CBL,0.36064,-0.056438,-0.077873,0,0
3,RESPONSE TO HYPOXIA,0.39371,-0.056719,-0.063107,0,0
3,CELL DEVELOPMENT,0.085627,-0.057091,-0.055622,0,0
3,MAPKKK CASCADE GO 0000165,0.32938,-0.057311,-0.054058,0,0
3,MITOCHONDRIAL OUTER MEMBRANE,0.13583,-0.057459,-0.095257,0,0
3,VIRAL REPRODUCTION,0.18219,-0.057543,-0.089261,0,0
3,BIOPOLYMER BIOSYNTHETIC PROCESS,0.89907,-0.057615,-0.003169,0,0
3,ORGANELLE LOCALIZATION,0.19393,-0.057619,-0.064793,0,0
3,DEOXYRIBONUCLEASE ACTIVITY,0.32077,-0.057679,-0.044756,0,0
3,CELL FRACTION,0.19393,-0.057795,-0.052533,0,0
3,CELL ACTIVATION,0.29586,-0.058066,-0.045461,0,0
3,PID MTOR 4PATHWAY,0.12259,-0.05817,-0.054298,0,0
3,REACTOME CTLA4 INHIBITORY SIGNALING,0.15773,-0.058271,-0.074463,0,0
3,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.049546,-0.0584,-0.074968,0,0
3,REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,0.97557,-0.058508,0.0048934,0,0
3,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.39858,-0.058681,-0.053767,0,0
3,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11636,-0.05869,-0.066181,0,0
3,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.85082,-0.058735,0.02937,0,0
3,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.36526,-0.058851,-0.069454,0,0
3,POSITIVE REGULATION OF TRANSCRIPTION,0.15015,-0.058905,-0.053607,0,0
3,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.088862,-0.059314,-0.059577,0,0
3,PID P75NTRPATHWAY,0.10654,-0.059328,-0.093149,0,0
3,KEGG BETA ALANINE METABOLISM,0.39858,-0.059436,-0.062433,0,0
3,ADHERENS JUNCTION,0.2,-0.059621,-0.1195,0,0
3,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.33812,-0.059876,-0.058969,0,0
3,BIOCARTA CXCR4 PATHWAY,0.42855,-0.059917,-0.035911,0,0
3,CELL CORTEX,0.36991,-0.059966,-0.043243,0,0
3,PHOSPHORYLATION,0.17374,-0.060177,-0.036275,0,0
3,PID IL27PATHWAY,0.3746,-0.060237,-0.092926,0,0
3,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.21579,-0.06034,-0.052718,0,0
3,VIRAL GENOME REPLICATION,0.41341,-0.060483,-0.062916,0,0
3,POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.188,-0.06061,-0.14886,0,0
3,BIOCARTA MYOSIN PATHWAY,0.32938,-0.060847,-0.059231,0,0
3,BIOCARTA G2 PATHWAY,0.50337,-0.060872,-0.023134,0,0
3,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.016734,-0.061187,-0.15874,0,0
3,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.05824,-0.061571,-0.059039,0,0
3,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.12689,-0.061601,-0.11135,0,0
3,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.80312,-0.061609,-0.021922,0,0
3,REGULATION OF BIOLOGICAL QUALITY,0.04854,-0.061647,-0.070982,0,0
3,AMINOPEPTIDASE ACTIVITY,0.090515,-0.06219,-0.15173,0,0
3,PID AR NONGENOMIC PATHWAY,0.74288,-0.06236,-0.011578,0,0
3,CENTROSOME,0.22905,-0.062406,-0.0391,0,0
3,CELLULAR LIPID CATABOLIC PROCESS,0.26098,-0.062452,-0.060811,0,0
3,ION HOMEOSTASIS,0.31653,-0.062467,-0.0415,0,0
3,BIOCARTA PS1 PATHWAY,0.0695,-0.062711,-0.12198,0,0
3,REGULATION OF JNK ACTIVITY,0.47588,-0.062903,-0.056255,0,0
3,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.16559,-0.06342,-0.060839,0,0
3,CHROMATIN BINDING,0.31232,-0.06347,-0.036912,0,0
3,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.063042,-0.063544,-0.10057,0,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.16032,-0.063631,-0.067795,0,0
3,VITAMIN TRANSPORT,0.67776,-0.063769,-0.027502,0,0
3,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.075049,-0.063923,-0.094767,0,0
3,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.23245,-0.06408,-0.061223,0,0
3,SMAD BINDING,0.14526,-0.064205,-0.092034,0,0
3,PID WNT NONCANONICAL PATHWAY,0.084046,-0.064353,-0.08772,0,0
3,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.188,-0.064538,-0.099094,0,0
3,NEURON APOPTOSIS,0.52594,-0.064565,-0.01285,0,0
3,INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.36526,-0.064595,-0.058946,0,0
3,BIOCARTA EPONFKB PATHWAY,0.69061,-0.065055,-0.044647,0,0
3,PID CERAMIDE PATHWAY,0.17374,-0.065148,-0.077904,0,0
3,SPHINGOLIPID METABOLIC PROCESS,0.54903,-0.065187,-0.014471,0,0
3,SECRETION BY CELL,0.11841,-0.065461,-0.074506,0,0
3,REGULATION OF TRANSLATION,0.085627,-0.065539,-0.088279,0,0
3,NF KAPPAB BINDING,0.15015,-0.065592,-0.10795,0,0
3,LEADING EDGE,0.10096,-0.065643,-0.11831,0,0
3,ORGANELLE MEMBRANE,0.084046,-0.065703,-0.062973,0,0
3,REGULATION OF INTRACELLULAR TRANSPORT,0.099158,-0.065803,-0.13356,0,0
3,NEGATIVE REGULATION OF GROWTH,0.21579,-0.065836,-0.069153,0,0
3,REACTOME SHC MEDIATED SIGNALLING,0.13583,-0.065886,-0.088502,0,0
3,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.29586,-0.065906,-0.073328,0,0
3,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.035393,-0.065982,-0.078908,0,0
3,PHOSPHOLIPID METABOLIC PROCESS,0.19393,-0.066051,-0.053929,0,0
3,REGULATION OF MITOSIS,0.073629,-0.066261,-0.079795,0,0
3,MYOBLAST DIFFERENTIATION,0.11841,-0.066286,-0.16504,0,0
3,POSITIVE REGULATION OF JNK ACTIVITY,0.60272,-0.066297,-0.033905,0,0
3,LEARNING AND OR MEMORY,0.65234,-0.066462,-0.012455,0,0
3,LYMPHOCYTE ACTIVATION,0.029068,-0.066471,-0.10425,0,0
3,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.085627,-0.066584,-0.10592,0,0
3,BASEMENT MEMBRANE,0.73628,-0.066598,0.021751,0,0
3,N ACETYLTRANSFERASE ACTIVITY,0.17374,-0.067037,-0.056098,0,0
3,PHOSPHATASE REGULATOR ACTIVITY,0.30402,-0.067384,-0.062657,0,0
3,CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.43367,-0.067495,-0.087311,0,0
3,THYROID HORMONE RECEPTOR BINDING,0.55487,-0.067652,-0.0099636,0,0
3,HOMEOSTATIC PROCESS,0.18508,-0.067713,-0.055596,0,0
3,MUSCLE CELL DIFFERENTIATION,0.065563,-0.067913,-0.16213,0,0
3,PID INTEGRIN A4B1 PATHWAY,0.093897,-0.068226,-0.11947,0,0
3,REACTOME CHROMOSOME MAINTENANCE,0.52594,-0.068445,-0.041463,0,0
3,REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA,0.21579,-0.068468,-0.1094,0,0
3,CALMODULIN BINDING,0.50337,-0.068899,-0.054769,0,0
3,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.10845,-0.06896,-0.072067,0,0
3,CATION HOMEOSTASIS,0.2839,-0.069053,-0.03791,0,0
3,HEMOSTASIS,0.075049,-0.069555,-0.11519,0,0
3,CELLULAR LIPID METABOLIC PROCESS,0.12259,-0.069704,-0.078497,0,0
3,KEGG ACUTE MYELOID LEUKEMIA,0.044685,-0.070147,-0.074858,0,0
3,REACTOME ACYL CHAIN REMODELLING OF PG,0.16559,-0.070165,-0.123,0,0
3,KEGG TGF BETA SIGNALING PATHWAY,0.27611,-0.07041,-0.059768,0,0
3,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.14769,-0.070737,-0.09261,0,0
3,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.91293,-0.070779,0.086731,0,0
3,INTRINSIC TO GOLGI MEMBRANE,0.25729,-0.070785,-0.096097,0,0
3,INTRACELLULAR SIGNALING CASCADE,0.061812,-0.071237,-0.060386,0,0
3,REGULATION OF MITOTIC CELL CYCLE,0.24643,-0.071762,-0.088004,0,0
3,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.23937,-0.071861,-0.098561,0,0
3,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.12689,-0.071965,-0.12356,0,0
3,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.087232,-0.072137,-0.10294,0,0
3,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.073629,-0.072254,-0.083382,0,0
3,PID IFNGPATHWAY,0.21579,-0.072535,-0.066669,0,0
3,KEGG N GLYCAN BIOSYNTHESIS,0.16294,-0.072695,-0.098169,0,0
3,CELLULAR CATION HOMEOSTASIS,0.29586,-0.072899,-0.043167,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.13355,-0.073608,-0.089282,0,0
3,REACTOME ENDOGENOUS STEROLS,0.25729,-0.073769,-0.12009,0,0
3,REACTOME PLATELET SENSITIZATION BY LDL,0.25363,-0.0739,-0.07869,0,0
3,AMINO ACID CATABOLIC PROCESS,0.4978,-0.073923,-0.045672,0,0
3,KEGG JAK STAT SIGNALING PATHWAY,0.10845,-0.073977,-0.092688,0,0
3,KEGG TRYPTOPHAN METABOLISM,0.60883,-0.074016,-0.03687,0,0
3,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.093897,-0.074247,-0.14809,0,0
3,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.072231,-0.074881,-0.063188,0,0
3,PID VEGFR1 PATHWAY,0.40349,-0.074886,-0.042773,0,0
3,REGULATED SECRETORY PATHWAY,0.73628,-0.075017,0.13217,0,0
3,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.54903,-0.075107,-0.04519,0,0
3,REACTOME P2Y RECEPTORS,0.21905,-0.075636,-0.062931,0,0
3,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.59664,-0.075792,-0.031604,0,0
3,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.12473,-0.076089,-0.19977,0,0
3,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.16294,-0.076326,-0.09267,0,0
3,CARBON CARBON LYASE ACTIVITY,0.59664,-0.076483,-0.070417,0,0
3,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,0.15517,-0.076619,-0.08932,0,0
3,METALLOPEPTIDASE ACTIVITY,0.32938,-0.076624,-0.050135,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.011904,-0.077303,-0.11197,0,0
3,AMINE CATABOLIC PROCESS,0.53167,-0.077341,-0.037041,0,0
3,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.1313,-0.077403,-0.08112,0,0
3,ATPASE ACTIVITY COUPLED,0.14769,-0.077489,-0.036433,0,0
3,REGULATION OF CYTOKINE PRODUCTION,0.093897,-0.077734,-0.11576,0,0
3,REACTOME SIGNALING BY NODAL,0.15517,-0.077886,-0.073459,0,0
3,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.052669,-0.07804,-0.081984,0,0
3,PID INTEGRIN CS PATHWAY,0.3746,-0.078214,-0.11102,0,0
3,SERINE HYDROLASE ACTIVITY,0.05161,-0.078238,-0.11731,0,0
3,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.16032,-0.078259,-0.10001,0,0
3,REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE,0.35153,-0.078514,-0.043083,0,0
3,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.21905,-0.078733,-0.13959,0,0
3,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.030383,-0.078736,-0.099984,0,0
3,LOW DENSITY LIPOPROTEIN BINDING,0.29992,-0.079187,-0.092703,0,0
3,INTERACTION WITH HOST,0.19393,-0.079646,-0.086416,0,0
3,PATTERN SPECIFICATION PROCESS,0.20621,-0.079934,-0.12746,0,0
3,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.11434,-0.080081,-0.10374,0,0
3,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.11434,-0.080081,-0.10374,0,0
3,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.31653,-0.080103,-0.12192,0,0
3,PID SYNDECAN 2 PATHWAY,0.17934,-0.080398,-0.11744,0,0
3,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.05824,-0.080758,-0.078582,0,0
3,MEMBRANE FUSION,0.19695,-0.080832,-0.080174,0,0
3,PID HIF1 TFPATHWAY,0.87144,-0.081039,-0.033506,0,0
3,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.39371,-0.081287,-0.038747,0,0
3,REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY,0.38408,-0.081318,-0.11607,0,0
3,PID UPA UPAR PATHWAY,0.3746,-0.081549,-0.13265,0,0
3,REACTOME GLYCOSPHINGOLIPID METABOLISM,0.32938,-0.081633,-0.11442,0,0
3,CYTOSKELETON,0.0042883,-0.081696,-0.087158,0,0
3,BIOCARTA MET PATHWAY,0.14285,-0.081812,-0.11254,0,0
3,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.23245,-0.081853,-0.074226,0,0
3,MEMBRANE FRACTION,0.14048,-0.082079,-0.057171,0,0
3,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.057089,-0.082308,-0.11563,0,0
3,PID AVB3 OPN PATHWAY,0.26471,-0.082536,-0.13357,0,0
3,KEGG PROSTATE CANCER,0.10654,-0.082802,-0.09104,0,0
3,SA B CELL RECEPTOR COMPLEXES,0.085627,-0.083224,-0.13946,0,0
3,REACTOME G ALPHA Z SIGNALLING EVENTS,0.25729,-0.083999,-0.064474,0,0
3,RESPONSE TO EXTRACELLULAR STIMULUS,0.57857,-0.084158,-0.011563,0,0
3,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.26847,-0.084246,-0.15167,0,0
3,REACTOME INFLAMMASOMES,0.29992,-0.084407,-0.045993,0,0
3,UBIQUITIN LIGASE COMPLEX,0.11636,-0.084594,-0.053132,0,0
3,DETECTION OF ABIOTIC STIMULUS,0.10465,-0.084634,-0.12996,0,0
3,REACTOME MEIOSIS,0.27227,-0.084832,-0.10589,0,0
3,ANTIPORTER ACTIVITY,0.95466,-0.084935,0.010419,0,0
3,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.22905,-0.085024,-0.092622,0,0
3,RAS GTPASE ACTIVATOR ACTIVITY,0.31232,-0.085329,-0.088592,0,0
3,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.1313,-0.086255,-0.14197,0,0
3,PHOSPHOLIPID BINDING,0.052669,-0.086366,-0.10239,0,0
3,PID NOTCH PATHWAY,0.17374,-0.086467,-0.068678,0,0
3,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.15773,-0.086569,-0.072654,0,0
3,METALLOEXOPEPTIDASE ACTIVITY,0.15517,-0.086641,-0.099638,0,0
3,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.14048,-0.087149,-0.083387,0,0
3,PID IL2 PI3KPATHWAY,0.080955,-0.087607,-0.11872,0,0
3,TISSUE REMODELING,0.80989,-0.088107,-0.0044958,0,0
3,SERINE TYPE PEPTIDASE ACTIVITY,0.043763,-0.08834,-0.12588,0,0
3,G1 PHASE OF MITOTIC CELL CYCLE,0.73628,-0.0884,-0.024274,0,0
3,MONOSACCHARIDE BINDING,0.21256,-0.088596,-0.080997,0,0
3,REACTOME TELOMERE MAINTENANCE,0.50337,-0.089375,-0.064443,0,0
3,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.036948,-0.089486,-0.1016,0,0
3,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.16032,-0.08952,-0.085178,0,0
3,PROTEIN AUTOPROCESSING,0.040234,-0.089541,-0.09727,0,0
3,PID PLK1 PATHWAY,0.37932,-0.089818,-0.045696,0,0
3,KEGG INOSITOL PHOSPHATE METABOLISM,0.057089,-0.089901,-0.077472,0,0
3,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.30815,-0.09026,-0.10546,0,0
3,REACTOME BILE ACID AND BILE SALT METABOLISM,0.024288,-0.09054,-0.19063,0,0
3,BIOCARTA EXTRINSIC PATHWAY,0.11636,-0.090633,-0.2526,0,0
3,CHROMATIN REMODELING,0.34702,-0.091274,-0.043243,0,0
3,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.088862,-0.091679,-0.11415,0,0
3,REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,0.24288,-0.091749,-0.11305,0,0
3,BIOCARTA CCR3 PATHWAY,0.057089,-0.092211,-0.10499,0,0
3,PROTEIN TYROSINE KINASE ACTIVITY,0.068167,-0.092815,-0.1482,0,0
3,REGULATION OF LIPID METABOLIC PROCESS,0.1313,-0.092945,-0.12536,0,0
3,BIOCARTA AT1R PATHWAY,0.088862,-0.092974,-0.11027,0,0
3,ACTIN BINDING,0.073629,-0.093222,-0.084609,0,0
3,ST P38 MAPK PATHWAY,0.34702,-0.093456,-0.046179,0,0
3,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.21256,-0.093619,-0.10933,0,0
3,KEGG TASTE TRANSDUCTION,0.14526,-0.094101,-0.066586,0,0
3,EXONUCLEASE ACTIVITY,0.088862,-0.094116,-0.10212,0,0
3,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.25001,-0.094168,-0.038816,0,0
3,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.27227,-0.094637,-0.079255,0,0
3,REACTOME SEMAPHORIN INTERACTIONS,0.017549,-0.094715,-0.13337,0,0
3,KEGG NON HOMOLOGOUS END JOINING,0.31653,-0.095042,-0.066947,0,0
3,PID CDC42 PATHWAY,0.17099,-0.095298,-0.079919,0,0
3,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.15517,-0.095412,-0.07059,0,0
3,PID AP1 PATHWAY,0.085627,-0.095675,-0.15883,0,0
3,BIOCARTA CALCINEURIN PATHWAY,0.32938,-0.095782,-0.070512,0,0
3,REACTOME SIGNALING BY FGFR3 MUTANTS,0.27227,-0.095902,-0.086165,0,0
3,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.063042,-0.095975,-0.094212,0,0
3,PID LYMPHANGIOGENESIS PATHWAY,0.59664,-0.096021,-0.05176,0,0
3,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.31232,-0.096191,-0.058764,0,0
3,EXTRACELLULAR REGION PART,0.10465,-0.096325,-0.096005,0,0
3,PID IL2 STAT5PATHWAY,0.11039,-0.096404,-0.1225,0,0
3,SMALL CONJUGATING PROTEIN BINDING,0.26098,-0.09669,-0.050938,0,0
3,REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES,0.066855,-0.096998,-0.082246,0,0
3,KEGG STEROID BIOSYNTHESIS,0.9686,-0.097262,0.019029,0,0
3,OLIGOSACCHARIDE METABOLIC PROCESS,0.66501,-0.097809,-0.065131,0,0
3,LIPID METABOLIC PROCESS,0.099158,-0.098287,-0.078229,0,0
3,REGULATION OF MAP KINASE ACTIVITY,0.04854,-0.098806,-0.096303,0,0
3,UBIQUITIN BINDING,0.075049,-0.099177,-0.10006,0,0
3,BIOCARTA PLCE PATHWAY,0.075049,-0.099195,-0.15098,0,0
3,SIG CD40PATHWAYMAP,0.068167,-0.099206,-0.09666,0,0
3,REACTOME UNFOLDED PROTEIN RESPONSE,0.11841,-0.09969,-0.098455,0,0
3,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.013798,-0.10035,-0.090937,0,0
3,ANION CHANNEL ACTIVITY,0.13583,-0.10038,-0.092495,0,0
3,CHLORIDE CHANNEL ACTIVITY,0.13583,-0.10038,-0.092495,0,0
3,REACTOME DSCAM INTERACTIONS,0.59664,-0.1008,-0.07047,0,0
3,RAS PROTEIN SIGNAL TRANSDUCTION,0.15773,-0.10107,-0.070691,0,0
3,PROTEIN OLIGOMERIZATION,0.052669,-0.10202,-0.10768,0,0
3,PID P38ALPHABETAPATHWAY,0.097379,-0.10206,-0.10032,0,0
3,DNA DIRECTED RNA POLYMERASE COMPLEX,0.43367,-0.10209,-0.034415,0,0
3,RNA POLYMERASE COMPLEX,0.43367,-0.10209,-0.034415,0,0
3,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.43367,-0.10209,-0.034415,0,0
3,GTPASE ACTIVATOR ACTIVITY,0.36991,-0.10226,-0.047539,0,0
3,PID IL5 PATHWAY,0.21905,-0.10229,-0.10714,0,0
3,KEGG ENDOCYTOSIS,0.049546,-0.10328,-0.09719,0,0
3,PID AVB3 INTEGRIN PATHWAY,0.188,-0.1033,-0.12876,0,0
3,KEGG MELANOGENESIS,0.0073363,-0.10401,-0.099349,0,0
3,BIOCARTA ERYTH PATHWAY,0.16294,-0.10408,-0.14668,0,0
3,RHO PROTEIN SIGNAL TRANSDUCTION,0.14285,-0.10423,-0.079194,0,0
3,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.02843,-0.10428,-0.10731,0,0
3,NUCLEAR CHROMOSOME,0.024846,-0.1064,-0.099819,0,0
3,REACTOME PEROXISOMAL LIPID METABOLISM,0.32938,-0.10656,-0.10793,0,0
3,RUFFLE,0.21579,-0.10669,-0.12568,0,0
3,PID AMB2 NEUTROPHILS PATHWAY,0.079444,-0.10686,-0.12131,0,0
3,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.10465,-0.10702,-0.085421,0,0
3,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.012508,-0.10749,-0.094256,0,0
3,PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.17934,-0.10835,-0.16655,0,0
3,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.29586,-0.10882,-0.073514,0,0
3,SH3 DOMAIN BINDING,0.097379,-0.10889,-0.087597,0,0
3,SA PTEN PATHWAY,0.064293,-0.10902,-0.12142,0,0
3,REACTOME ADP SIGNALLING THROUGH P2RY1,0.29184,-0.11002,-0.085456,0,0
3,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.054842,-0.11066,-0.11495,0,0
3,BIOCARTA PARKIN PATHWAY,0.87144,-0.11099,0.00085404,0,0
3,PID NCADHERINPATHWAY,0.17099,-0.11224,-0.066491,0,0
3,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.055956,-0.11245,-0.13194,0,0
3,REACTOME SIGNALLING TO ERKS,0.0066042,-0.11267,-0.11084,0,0
3,REACTOME SHC RELATED EVENTS,0.042857,-0.11298,-0.11018,0,0
3,CALCIUM ION TRANSPORT,0.0695,-0.11313,-0.14295,0,0
3,REACTOME G0 AND EARLY G1,0.087232,-0.11361,-0.1038,0,0
3,REACTOME SIGNAL AMPLIFICATION,0.18219,-0.11365,-0.082624,0,0
3,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.0075304,-0.11384,-0.15793,0,0
3,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.35153,-0.11389,-0.096302,0,0
3,SIG IL4RECEPTOR IN B LYPHOCYTES,0.13355,-0.11451,-0.07815,0,0
3,INTERCELLULAR JUNCTION ASSEMBLY AND MAINTENANCE,0.20621,-0.11526,-0.16833,0,0
3,PROTEIN PROCESSING,0.001872,-0.11552,-0.13312,0,0
3,PID PRLSIGNALINGEVENTSPATHWAY,0.036164,-0.11571,-0.18445,0,0
3,PHOTOTRANSDUCTION,0.076492,-0.11576,-0.18417,0,0
3,REACTOME INTEGRATION OF ENERGY METABOLISM,0.17934,-0.11681,-0.055512,0,0
3,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.046579,-0.11688,-0.10209,0,0
3,DNA DIRECTED RNA POLYMERASEII CORE COMPLEX,0.044685,-0.11709,-0.11386,0,0
3,KEGG OTHER GLYCAN DEGRADATION,0.14048,-0.11716,-0.22476,0,0
3,REACTOME HYALURONAN METABOLISM,0.12473,-0.11727,-0.13685,0,0
3,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.32506,-0.1183,-0.11753,0,0
3,PID RHODOPSIN PATHWAY,0.085627,-0.11905,-0.1139,0,0
3,PID INTEGRIN3 PATHWAY,0.53742,-0.11908,-0.1143,0,0
3,KEGG MELANOMA,0.034637,-0.11958,-0.092538,0,0
3,PID GLYPICAN 1PATHWAY,0.12049,-0.11991,-0.095262,0,0
3,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.4978,-0.12088,-0.060225,0,0
3,REACTOME MEIOTIC SYNAPSIS,0.25729,-0.12096,-0.13326,0,0
3,3 5 EXONUCLEASE ACTIVITY,0.057089,-0.12161,-0.12467,0,0
3,REACTOME CHOLESTEROL BIOSYNTHESIS,0.71658,-0.12199,0.083042,0,0
3,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.012203,-0.12213,-0.23301,0,0
3,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.088862,-0.12264,-0.11811,0,0
3,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0006154,-0.12268,-0.23225,0,0
3,ER NUCLEAR SIGNALING PATHWAY,0.057089,-0.12277,-0.11557,0,0
3,REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION,0.4978,-0.12284,-0.060947,0,0
3,BIOCARTA P53HYPOXIA PATHWAY,0.29992,-0.12288,-0.11325,0,0
3,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.0066042,-0.12318,-0.14052,0,0
3,REACTOME AMYLOIDS,0.19695,-0.1239,-0.14693,0,0
3,REACTOME SOS MEDIATED SIGNALLING,0.054842,-0.12455,-0.083959,0,0
3,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.050569,-0.12535,-0.11458,0,0
3,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.62732,-0.12568,-0.042412,0,0
3,BIOCARTA DNAFRAGMENT PATHWAY,0.092194,-0.12684,-0.11444,0,0
3,CHEMOKINE ACTIVITY,0.034637,-0.12707,-0.14536,0,0
3,CHEMOKINE RECEPTOR BINDING,0.034637,-0.12707,-0.14536,0,0
3,REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,0.2,-0.12755,-0.11785,0,0
3,SARCOMERE,0.17934,-0.12764,-0.14741,0,0
3,BIOCARTA STRESS PATHWAY,0.05161,-0.12792,-0.14895,0,0
3,KEGG REGULATION OF AUTOPHAGY,0.042857,-0.12805,-0.083044,0,0
3,PID SMAD2 3PATHWAY,0.055956,-0.12825,-0.10362,0,0
3,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.017549,-0.1286,-0.14418,0,0
3,KEGG HISTIDINE METABOLISM,0.055956,-0.12994,-0.11075,0,0
3,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.018836,-0.13042,-0.15862,0,0
3,BIOCARTA ETS PATHWAY,0.065563,-0.13161,-0.11184,0,0
3,RESPONSE TO NUTRIENT LEVELS,0.21579,-0.13194,-0.059391,0,0
3,KEGG LEISHMANIA INFECTION,0.061812,-0.13212,-0.12662,0,0
3,REACTOME RNA POL I TRANSCRIPTION,0.25729,-0.13263,-0.1215,0,0
3,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.033894,-0.13499,-0.095496,0,0
3,REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES,0.073629,-0.13543,-0.13337,0,0
3,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.60883,-0.13556,0.1563,0,0
3,PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.02068,-0.1357,-0.1803,0,0
3,CASPASE REGULATOR ACTIVITY,0.18508,-0.13578,-0.10691,0,0
3,CARBOXY LYASE ACTIVITY,0.11841,-0.13587,-0.16696,0,0
3,INTERCELLULAR JUNCTION ASSEMBLY,0.2,-0.13648,-0.20049,0,0
3,SA REG CASCADE OF CYCLIN EXPR,0.41341,-0.1369,-0.051995,0,0
3,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.090515,-0.13692,-0.13226,0,0
3,REGULATION OF RESPONSE TO STIMULUS,0.040234,-0.13758,-0.099595,0,0
3,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.082489,-0.13942,-0.1393,0,0
3,REACTOME MEIOTIC RECOMBINATION,0.26098,-0.14007,-0.13402,0,0
3,CONDENSED NUCLEAR CHROMOSOME,0.14285,-0.14167,-0.08724,0,0
3,NEGATIVE REGULATION OF SECRETION,0.055956,-0.14172,-0.15588,0,0
3,PID EPHRINBREVPATHWAY,0.12473,-0.1418,-0.089875,0,0
3,CONDENSED CHROMOSOME,0.035393,-0.14206,-0.11332,0,0
3,BIOCARTA IL17 PATHWAY,0.034637,-0.14215,-0.12039,0,0
3,PID SYNDECAN 4 PATHWAY,0.049546,-0.14231,-0.23365,0,0
3,NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.17653,-0.14273,-0.122,0,0
3,ENDOCYTIC VESICLE,0.053746,-0.14377,-0.1742,0,0
3,REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS,0.87144,-0.14474,0.049572,0,0
3,REGULATION OF MEMBRANE POTENTIAL,0.05824,-0.14508,-0.18299,0,0
3,NEUROTRANSMITTER SECRETION,0.79636,-0.146,0.17227,0,0
3,KINASE ACTIVATOR ACTIVITY,0.11636,-0.14732,-0.11472,0,0
3,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,0.1028,-0.14738,-0.12897,0,0
3,NEGATIVE REGULATION OF BINDING,0.27999,-0.14892,-0.068434,0,0
3,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.10845,-0.14903,-0.12581,0,0
3,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.10096,-0.14918,-0.14254,0,0
3,INNATE IMMUNE RESPONSE,0.10654,-0.15049,-0.10977,0,0
3,RECEPTOR SIGNALING PROTEIN ACTIVITY,8.7323e-05,-0.15097,-0.15827,0,0
3,KEGG ARACHIDONIC ACID METABOLISM,0.15264,-0.151,-0.11177,0,0
3,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.070855,-0.15102,-0.10417,0,0
3,CLATHRIN COATED VESICLE,0.0019282,-0.15206,-0.13735,0,0
3,REGULATION OF IMMUNE SYSTEM PROCESS,0.0011199,-0.15298,-0.14934,0,0
3,DEPHOSPHORYLATION,0.0010859,-0.1532,-0.14924,0,0
3,REGULATION OF GENE SPECIFIC TRANSCRIPTION,0.13583,-0.1541,-0.10755,0,0
3,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.0015189,-0.1561,-0.15842,0,0
3,SINGLE STRANDED RNA BINDING,0.26098,-0.15715,-0.070539,0,0
3,REACTOME INSULIN RECEPTOR RECYCLING,0.031059,-0.15728,-0.16242,0,0
3,KEGG ASTHMA,0.16559,-0.1575,-0.18766,0,0
3,BIOCARTA IGF1R PATHWAY,0.0085714,-0.15771,-0.1367,0,0
3,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.00079435,-0.15989,-0.17884,0,0
3,SISTER CHROMATID SEGREGATION,0.015203,-0.1604,-0.13483,0,0
3,BIOCARTA INTRINSIC PATHWAY,0.12689,-0.16124,-0.2228,0,0
3,LIPOPROTEIN BINDING,0.10096,-0.1622,-0.10789,0,0
3,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.0013872,-0.1622,-0.14378,0,0
3,PID ATF2 PATHWAY,0.090515,-0.16363,-0.12338,0,0
3,FATTY ACID BETA OXIDATION,0.059411,-0.16524,-0.22658,0,0
3,BIOCARTA CREB PATHWAY,0.085627,-0.16587,-0.11024,0,0
3,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.04854,-0.16621,-0.15663,0,0
3,BIOCARTA TRKA PATHWAY,0.093897,-0.1665,-0.15377,0,0
3,PID TCRCALCIUMPATHWAY,0.063042,-0.16695,-0.14957,0,0
3,PID HIF2PATHWAY,0.050569,-0.16759,-0.17138,0,0
3,BIOCARTA IL10 PATHWAY,0.22568,-0.16814,-0.14956,0,0
3,NEGATIVE REGULATION OF PHOSPHORYLATION,0.29184,-0.16995,-0.086185,0,0
3,NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.29184,-0.16995,-0.086185,0,0
3,NUCLEOTIDE SUGAR METABOLIC PROCESS,0.065563,-0.1704,-0.18751,0,0
3,EMBRYONIC DEVELOPMENT,0.007729,-0.17042,-0.15759,0,0
3,BETA TUBULIN BINDING,0.0695,-0.17428,-0.11105,0,0
3,BIOCARTA GPCR PATHWAY,0.13814,-0.17432,-0.090424,0,0
3,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.10465,-0.17503,-0.088439,0,0
3,PID NFAT 3PATHWAY,0.0010859,-0.17589,-0.16345,0,0
3,REACTOME PHASE II CONJUGATION,0.0062634,-0.17772,-0.18508,0,0
3,MITOTIC SISTER CHROMATID SEGREGATION,0.023741,-0.17816,-0.13512,0,0
3,REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION,0.093897,-0.17901,-0.13183,0,0
3,PID RANBP2PATHWAY,0.11434,-0.17929,-0.073723,0,0
3,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.13814,-0.17983,-0.20156,0,0
3,ACTIN CYTOSKELETON,0.00030804,-0.18009,-0.17809,0,0
3,AGING,0.080955,-0.18057,-0.159,0,0
3,PHOSPHOLIPASE C ACTIVATION,0.015953,-0.18062,-0.15255,0,0
3,FATTY ACID OXIDATION,0.04854,-0.18086,-0.20059,0,0
3,BIOCARTA VITCB PATHWAY,0.064293,-0.18139,-0.30874,0,0
3,REACTOME ALPHA LINOLENIC ACID ALA METABOLISM,0.017969,-0.18218,-0.1634,0,0
3,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.023741,-0.18239,-0.16432,0,0
3,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.046579,-0.18663,-0.17623,0,0
3,REGULATION OF NEUROTRANSMITTER LEVELS,0.29586,-0.18668,-0.066612,0,0
3,RESPONSE TO NUTRIENT,0.16032,-0.18712,-0.099464,0,0
3,BIOCARTA RAB PATHWAY,0.0079323,-0.18727,-0.21411,0,0
3,PROTEIN KINASE REGULATOR ACTIVITY,0.061812,-0.18976,-0.11968,0,0
3,REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE,0.011326,-0.19035,-0.21979,0,0
3,REACTOME SULFUR AMINO ACID METABOLISM,0.099158,-0.19095,-0.11427,0,0
3,PID CIRCADIANPATHWAY,0.099158,-0.19185,-0.1313,0,0
3,KEGG TAURINE AND HYPOTAURINE METABOLISM,0.1028,-0.19323,-0.13322,0,0
3,CYTOKINE SECRETION,0.015953,-0.1955,-0.16836,0,0
3,BIOGENIC AMINE METABOLIC PROCESS,0.023205,-0.19814,-0.15761,0,0
3,CELLULAR RESPONSE TO STRESS,0.05824,-0.19852,-0.12994,0,0
3,PID CMYB PATHWAY,0.00021167,-0.19852,-0.18664,0,0
3,REACTOME CRMPS IN SEMA3A SIGNALING,0.39858,-0.20001,-0.024844,0,0
3,KINASE REGULATOR ACTIVITY,0.025994,-0.20266,-0.13107,0,0
3,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.017969,-0.20343,-0.2024,0,0
3,REGULATION OF ACTION POTENTIAL,0.014486,-0.20466,-0.16597,0,0
3,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.00098941,-0.20486,-0.16172,0,0
3,NEGATIVE REGULATION OF DNA BINDING,0.13355,-0.20498,-0.10202,0,0
3,REACTOME SIGNALING BY SCF KIT,3.4421e-05,-0.2065,-0.20621,0,0
3,REGULATION OF IMMUNE EFFECTOR PROCESS,0.016734,-0.20882,-0.16331,0,0
3,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.00090094,-0.21134,-0.2307,0,0
3,REACTOME PACKAGING OF TELOMERE ENDS,0.26471,-0.21164,-0.17296,0,0
3,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.27611,-0.21299,-0.062361,0,0
3,PID IL6 7PATHWAY,0.05161,-0.21667,-0.15637,0,0
3,ENDOPLASMIC RETICULUM LUMEN,0.12473,-0.21683,-0.18779,0,0
3,APOPTOTIC MITOCHONDRIAL CHANGES,0.066855,-0.21722,-0.18826,0,0
3,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.00013917,-0.21752,-0.24075,0,0
3,PROTEIN KINASE INHIBITOR ACTIVITY,0.052669,-0.21784,-0.17754,0,0
3,BIOCARTA PML PATHWAY,0.04854,-0.21803,-0.20311,0,0
3,INACTIVATION OF MAPK ACTIVITY,0.015953,-0.22109,-0.24967,0,0
3,PID BMPPATHWAY,0.0014738,-0.22181,-0.23613,0,0
3,REACTOME RNA POL I PROMOTER OPENING,0.16559,-0.22298,-0.20318,0,0
3,BIOCARTA RB PATHWAY,0.087232,-0.22356,-0.11768,0,0
3,REGULATION OF CYTOKINE SECRETION,0.0099891,-0.22441,-0.19051,0,0
3,BIOCARTA SRCRPTP PATHWAY,0.082489,-0.22744,-0.1641,0,0
3,BIOCARTA CELL2CELL PATHWAY,0.14769,-0.23011,-0.14709,0,0
3,G2 M TRANSITION OF MITOTIC CELL CYCLE,0.02068,-0.23285,-0.17803,0,0
3,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.004408,-0.23297,-0.24875,0,0
3,BIOCARTA STATHMIN PATHWAY,0.052669,-0.23361,-0.11293,0,0
3,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.084046,-0.23442,-0.1796,0,0
3,CATION TRANSPORTING ATPASE ACTIVITY,0.0097392,-0.23479,-0.24534,0,0
3,BIOCARTA RANKL PATHWAY,0.17374,-0.23777,-0.14739,0,0
3,POSITIVE REGULATION OF PROTEIN SECRETION,0.02843,-0.23946,-0.19374,0,0
3,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.02068,-0.24225,-0.17585,0,0
3,PID ALK2PATHWAY,0.041093,-0.24231,-0.20995,0,0
3,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,1.0604e-05,-0.24245,-0.24975,0,0
3,REACTOME TIE2 SIGNALING,0.00024286,-0.24372,-0.27742,0,0
3,PROTEIN TETRAMERIZATION,0.018836,-0.2478,-0.17436,0,0
3,BIOCARTA MPR PATHWAY,0.00047456,-0.24854,-0.19641,0,0
3,KEGG PHENYLALANINE METABOLISM,0.012508,-0.24978,-0.25407,0,0
3,REACTOME IL 3 5 AND GM CSF SIGNALING,0.00010092,-0.25513,-0.26257,0,0
3,PHOSPHATASE INHIBITOR ACTIVITY,0.15773,-0.26397,-0.15312,0,0
3,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.014138,-0.26959,-0.22062,0,0
3,REACTOME SIGNALING BY FGFR1 MUTANTS,2.2658e-06,-0.26973,-0.2868,0,0
3,VITAMIN BINDING,0.025414,-0.27222,-0.24773,0,0
3,INTERMEDIATE FILAMENT CYTOSKELETON,0.031059,-0.27371,-0.21885,0,0
3,INTERMEDIATE FILAMENT,0.031059,-0.27371,-0.21885,0,0
3,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.0028141,-0.27632,-0.24567,0,0
3,TISSUE MORPHOGENESIS,9.0551e-05,-0.28237,-0.38623,0,0
3,REACTOME P38MAPK EVENTS,3.8583e-05,-0.28249,-0.31211,0,0
3,PID THROMBIN PAR4 PATHWAY,0.011612,-0.28802,-0.20258,0,0
3,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL,0.0018173,-0.28831,-0.31025,0,0
3,DETECTION OF STIMULUS,0.00040247,-0.29506,-0.22838,0,0
3,REACTOME IL RECEPTOR SHC SIGNALING,0.00017796,-0.30261,-0.30141,0,0
3,ACTIN FILAMENT,0.0036303,-0.32185,-0.2494,0,0
3,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,4.8379e-05,-0.32296,-0.31666,0,0
3,REACTOME PEPTIDE HORMONE BIOSYNTHESIS,0.0046564,-0.32737,-0.40281,0,0
3,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,7.6603e-06,-0.33597,-0.32383,0,0
3,POSITIVE REGULATION OF TRANSPORT,6.0504e-05,-0.3361,-0.33514,0,0
3,POSITIVE REGULATION OF SECRETION,0.00012512,-0.35461,-0.3663,0,0
3,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0040578,-0.36406,-0.32738,0,0
3,CELL RECOGNITION,0.007729,-0.3766,-0.28493,0,0
3,CELL PROJECTION PART,0.00032948,-0.38032,-0.29919,0,0
3,ENDOTHELIAL CELL MIGRATION,0.070855,-0.39423,-0.34705,0,0
3,REGULATION OF HORMONE SECRETION,0.025414,-0.39553,-0.21681,0,0
3,REGULATION OF SECRETION,9.7346e-05,-0.41369,-0.31059,0,0
3,MAP KINASE ACTIVITY,6.7596e-05,-0.44179,-0.41276,0,0
3,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.0030654,-0.46414,-0.25904,0,0
3,BIOCARTA ACE2 PATHWAY,0.0050528,-0.47537,-0.44116,0,0
3,DETECTION OF CHEMICAL STIMULUS,0.0024367,-0.48865,-0.35483,0,0
3,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,8.1192e-05,-0.52347,-0.47743,0,0
3,HORMONE SECRETION,0.00050664,-0.6606,-0.50288,0,0
3,NEUROPEPTIDE SIGNALING PATHWAY,2.9532e-05,-0.6834,-0.50004,0,0
3,LEUKOCYTE CHEMOTAXIS,0.00014935,-0.71278,-0.54144,0,0
4,ENDOTHELIAL CELL MIGRATION,3.4421e-05,1.1556,0.87186,1,1
4,REACTOME INTERFERON ALPHA BETA SIGNALING,7.6603e-06,0.91347,0.80993,1,1
4,ENDOTHELIAL CELL PROLIFERATION,4.1112e-06,0.89187,0.84176,1,1
4,BIOCARTA NKCELLS PATHWAY,9.0221e-07,0.70983,0.71846,1,1
4,ICOSANOID METABOLIC PROCESS,0.00016595,0.69921,0.69437,1,1
4,MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.6959,0.5384,1,1
4,REGULATION OF BLOOD PRESSURE,1.7474e-06,0.69276,0.59012,1,1
4,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,2.1663e-05,0.67203,0.645,1,1
4,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,8.1192e-05,0.67029,0.55708,1,1
4,REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS,0.00030804,0.6534,0.72113,1,1
4,POSITIVE REGULATION OF CELL DIFFERENTIATION,2.8077e-06,0.63466,0.59181,1,1
4,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,9.8628e-07,0.62927,0.72256,1,1
4,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,5.4977e-07,0.62878,0.5708,1,1
4,CALCIUM INDEPENDENT CELL CELL ADHESION,1.6455e-05,0.62573,0.62633,1,1
4,NEUROPEPTIDE HORMONE ACTIVITY,0.0007696,0.62079,0.64384,1,1
4,KEGG STEROID BIOSYNTHESIS,9.7346e-05,0.61737,0.53997,1,1
4,ALDO KETO REDUCTASE ACTIVITY,0.0013872,0.60421,0.80192,1,1
4,REGULATION OF MYELOID CELL DIFFERENTIATION,1.349e-05,0.59451,0.58207,1,1
4,REACTOME INTERFERON GAMMA SIGNALING,2.1663e-05,0.58904,0.53323,1,1
4,REACTOME TIGHT JUNCTION INTERACTIONS,4.6597e-05,0.5812,0.5406,1,1
4,POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.1617e-05,0.57676,0.42831,1,1
4,REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN,5.2837e-06,0.57478,0.69524,1,1
4,UDP GLYCOSYLTRANSFERASE ACTIVITY,2.8077e-06,0.5731,0.55917,1,1
4,REACTOME SIGNALING BY NOTCH2,1.0779e-06,0.55838,0.5487,1,1
4,BIOCARTA ARENRF2 PATHWAY,5.2837e-06,0.55298,0.58052,1,1
4,REGULATION OF HOMEOSTATIC PROCESS,0.00059588,0.54447,0.45559,1,1
4,REACTOME LYSOSOME VESICLE BIOGENESIS,3.9418e-06,0.53507,0.45371,1,1
4,BIOCARTA DEATH PATHWAY,7.547e-05,0.52196,0.41839,1,1
4,DEAMINASE ACTIVITY,2.8077e-06,0.52078,0.53105,1,1
4,REACTOME AMINE DERIVED HORMONES,0.00019079,0.513,0.5597,1,1
4,SECRETORY GRANULE,1.4674e-06,0.51024,0.51789,1,1
4,REACTOME SIGNALING BY NOTCH4,3.6414e-07,0.50283,0.52451,1,1
4,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0021689,0.50097,0.48235,1,1
4,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.00016595,0.50095,0.41541,1,1
4,HORMONE BINDING,0.00013433,0.5002,0.44911,1,1
4,REACTOME SIGNALING BY NOTCH3,7.5427e-07,0.49614,0.48924,1,1
4,BIOCARTA IL22BP PATHWAY,0.00017796,0.48693,0.43217,1,1
4,REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,8.1192e-05,0.48683,0.46591,1,1
4,KEGG TYPE I DIABETES MELLITUS,0.00067758,0.48341,0.41519,1,1
4,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.0018173,0.48038,0.39886,1,1
4,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,7.3528e-06,0.47889,0.46641,1,1
4,GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.9301e-06,0.4787,0.43832,1,1
4,BIOCARTA D4GDI PATHWAY,2.9532e-05,0.47404,0.35499,1,1
4,REACTOME REGULATION OF IFNA SIGNALING,9.8628e-07,0.4733,0.51243,1,1
4,ADENYLATE CYCLASE ACTIVATION,0.0032441,0.4717,0.31997,1,1
4,LIPID TRANSPORTER ACTIVITY,1.0604e-05,0.47076,0.38077,1,1
4,REACTOME O LINKED GLYCOSYLATION OF MUCINS,3.6228e-06,0.47,0.40776,1,1
4,KEGG MATURITY ONSET DIABETES OF THE YOUNG,3.8583e-05,0.46938,0.48005,1,1
4,GALACTOSYLTRANSFERASE ACTIVITY,2.0033e-05,0.46686,0.4611,1,1
4,TUBE MORPHOGENESIS,2.0833e-05,0.46644,0.47658,1,1
4,DIGESTION,1.7118e-05,0.46578,0.51462,1,1
4,VACUOLAR MEMBRANE,2.3418e-05,0.46447,0.43816,1,1
4,GLYCOPROTEIN METABOLIC PROCESS,1.3441e-06,0.46432,0.41883,1,1
4,STEROID BIOSYNTHETIC PROCESS,2.0784e-06,0.46278,0.50974,1,1
4,REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE,0.0051916,0.46219,0.31515,1,1
4,BIOCARTA RANKL PATHWAY,3.8583e-05,0.45994,0.46934,1,1
4,APICAL JUNCTION COMPLEX,1.2454e-05,0.45661,0.43781,1,1
4,APICOLATERAL PLASMA MEMBRANE,1.2454e-05,0.45661,0.43781,1,1
4,BIOCARTA SODD PATHWAY,0.00028792,0.45633,0.40511,1,1
4,SH2 DOMAIN BINDING,2.7343e-05,0.45601,0.41729,1,1
4,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,5.0683e-06,0.45427,0.46374,1,1
4,BIOCARTA MITOCHONDRIA PATHWAY,5.9841e-06,0.45401,0.46277,1,1
4,BIOCARTA IL2 PATHWAY,6.7728e-06,0.45016,0.42165,1,1
4,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,8.7323e-05,0.44491,0.43006,1,1
4,TIGHT JUNCTION,5.6174e-05,0.43931,0.42966,1,1
4,MYELOID CELL DIFFERENTIATION,3.3132e-05,0.43897,0.3877,1,1
4,SA B CELL RECEPTOR COMPLEXES,1.6452e-07,0.43822,0.50184,1,1
4,APICAL PART OF CELL,1.0184e-05,0.43784,0.44914,1,1
4,APICAL PLASMA MEMBRANE,1.1493e-05,0.43738,0.44245,1,1
4,AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,4.6597e-05,0.43664,0.43243,1,1
4,LYSOSOMAL MEMBRANE,2.0033e-05,0.43554,0.42333,1,1
4,REACTOME CELL CELL JUNCTION ORGANIZATION,0.00026903,0.43542,0.37026,1,1
4,PROTEIN HOMOOLIGOMERIZATION,1.7118e-05,0.43236,0.4175,1,1
4,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.0017123,0.43224,0.44412,1,1
4,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.00047456,0.42978,0.30993,1,1
4,REACTOME METABOLISM OF POLYAMINES,6.7728e-06,0.42907,0.39127,1,1
4,SODIUM ION TRANSPORT,3.0689e-05,0.42842,0.4261,1,1
4,COENZYME BIOSYNTHETIC PROCESS,0.00065623,0.42554,0.4638,1,1
4,VACUOLAR PART,2.2524e-05,0.42019,0.40239,1,1
4,BIOCARTA CASPASE PATHWAY,0.00016023,0.41734,0.37375,1,1
4,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.0001547,0.41558,0.43395,1,1
4,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.001228,0.41505,0.39485,1,1
4,BIOCARTA TOLL PATHWAY,1.2308e-06,0.41491,0.37237,1,1
4,TUBE DEVELOPMENT,4.8379e-05,0.40795,0.41304,1,1
4,REACTOME INTERFERON SIGNALING,4.6597e-05,0.40456,0.35134,1,1
4,BIOCARTA IL3 PATHWAY,4.6597e-05,0.40253,0.37102,1,1
4,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.0001165,0.40086,0.28343,1,1
4,STEROID METABOLIC PROCESS,1.4674e-06,0.3973,0.47736,1,1
4,PID A6B1 A6B4 INTEGRIN PATHWAY,0.015203,0.39666,0.23148,1,1
4,BIOCARTA CTL PATHWAY,0.0034322,0.39632,0.29759,1,1
4,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.013139,0.39625,0.31576,1,1
4,MORPHOGENESIS OF AN EPITHELIUM,0.0054795,0.38743,0.31245,1,1
4,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,1.0604e-05,0.38388,0.42065,1,1
4,VACUOLE,5.508e-06,0.38162,0.35315,1,1
4,KEGG O GLYCAN BIOSYNTHESIS,2.0033e-05,0.38143,0.41429,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,5.7413e-06,0.37963,0.38749,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,2.0833e-05,0.37868,0.3431,1,1
4,BIOCARTA EPO PATHWAY,2.7343e-05,0.37863,0.31979,1,1
4,BIOCARTA NUCLEARRS PATHWAY,2.7343e-05,0.37817,0.47942,1,1
4,REACTOME NOD1 2 SIGNALING PATHWAY,1.7118e-05,0.37703,0.33425,1,1
4,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.014841,0.37655,0.37181,1,1
4,BIOCARTA NFKB PATHWAY,0.00016023,0.37608,0.29269,1,1
4,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.00036427,0.37444,0.40324,1,1
4,GLAND DEVELOPMENT,0.014841,0.37409,0.33976,1,1
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.0081404,0.36953,0.37028,1,1
4,GLYCOPROTEIN CATABOLIC PROCESS,2.4346e-05,0.36893,0.3577,1,1
4,ST INTERLEUKIN 4 PATHWAY,6.5149e-05,0.36842,0.31361,1,1
4,I KAPPAB KINASE NF KAPPAB CASCADE,1.9263e-05,0.36493,0.33529,1,1
4,PROTEIN SECRETION,0.00025131,0.36469,0.3106,1,1
4,SA PROGRAMMED CELL DEATH,5.8301e-05,0.36414,0.38779,1,1
4,BIOCARTA IL7 PATHWAY,0.00012512,0.36153,0.42972,1,1
4,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GLOBO SERIES,0.0099891,0.35971,0.25429,1,1
4,NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0021689,0.35725,0.27277,1,1
4,REACTOME KERATAN SULFATE DEGRADATION,0.0029794,0.35593,0.28918,1,1
4,PROTEASE INHIBITOR ACTIVITY,0.0059384,0.35534,0.25917,1,1
4,BIOCARTA EPONFKB PATHWAY,0.0013054,0.35318,0.33936,1,1
4,LYTIC VACUOLE,6.7728e-06,0.35298,0.33958,1,1
4,LYSOSOME,6.7728e-06,0.35298,0.33958,1,1
4,REGULATION OF LIPID METABOLIC PROCESS,0.00041602,0.35114,0.31135,1,1
4,COENZYME BINDING,0.00026903,0.35075,0.34901,1,1
4,REACTOME REGULATION OF COMPLEMENT CASCADE,0.0011199,0.35061,0.37865,1,1
4,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.00049035,0.35055,0.37025,1,1
4,OLIGOSACCHARYL TRANSFERASE COMPLEX,1.5201e-05,0.3504,0.41031,1,1
4,BIOCARTA BCELLSURVIVAL PATHWAY,0.00040247,0.34874,0.26059,1,1
4,REACTOME ACYL CHAIN REMODELLING OF PE,1.5816e-05,0.34768,0.35486,1,1
4,PID TOLL ENDOGENOUS PATHWAY,0.0001547,0.34724,0.29903,1,1
4,CELLULAR DEFENSE RESPONSE,0.00014935,0.34489,0.30641,1,1
4,COFACTOR BINDING,0.00014935,0.34435,0.32045,1,1
4,KEGG SPHINGOLIPID METABOLISM,5.7413e-06,0.34384,0.31611,1,1
4,REACTOME SYNTHESIS OF PC,0.00040247,0.34279,0.30591,1,1
4,KEGG RIBOFLAVIN METABOLISM,0.00049035,0.34251,0.38284,1,1
4,REACTOME N GLYCAN ANTENNAE ELONGATION,0.0038387,0.34214,0.33399,1,1
4,LIPID RAFT,6.2786e-05,0.34117,0.36591,1,1
4,NEGATIVE REGULATION OF PHOSPHORYLATION,0.015953,0.33886,0.30571,1,1
4,NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.015953,0.33886,0.30571,1,1
4,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,0.33885,0.32533,1,1
4,REACTOME CHOLESTEROL BIOSYNTHESIS,0.0097392,0.3388,0.29774,1,1
4,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,3.8583e-05,0.33802,0.35365,1,1
4,NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00013433,0.33786,0.35758,1,1
4,SODIUM CHANNEL ACTIVITY,0.00059588,0.33748,0.3175,1,1
4,REACTOME REGULATION OF KIT SIGNALING,0.030383,0.33744,0.2851,1,1
4,REACTOME INNATE IMMUNE SYSTEM,1.4039e-05,0.33677,0.27486,1,1
4,REGULATION OF CYTOKINE PRODUCTION,0.00054072,0.33631,0.23221,1,1
4,OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR,0.0040578,0.33584,0.36717,1,1
4,REACTOME PEROXISOMAL LIPID METABOLISM,0.0033369,0.3354,0.28596,1,1
4,GOLGI STACK,0.00012964,0.33514,0.27648,1,1
4,PID ERB GENOMIC PATHWAY,5.2837e-06,0.33512,0.35701,1,1
4,CYTOKINE METABOLIC PROCESS,1.4609e-05,0.33504,0.28187,1,1
4,PID ALPHASYNUCLEIN PATHWAY,3.4421e-05,0.33399,0.31451,1,1
4,TISSUE REMODELING,0.0015653,0.33288,0.27679,1,1
4,PID HNF3APATHWAY,1.6455e-05,0.3327,0.37812,1,1
4,KINASE INHIBITOR ACTIVITY,0.0030654,0.33035,0.36921,1,1
4,INTERCELLULAR JUNCTION,6.7596e-05,0.3302,0.30856,1,1
4,LEUKOCYTE MIGRATION,0.00016595,0.32989,0.36847,1,1
4,STEROID BINDING,0.001986,0.32942,0.33407,1,1
4,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,1.9263e-05,0.32838,0.30666,1,1
4,SIG PIP3 SIGNALING IN B LYMPHOCYTES,2.3654e-06,0.32435,0.34836,1,1
4,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.0017123,0.32263,0.26529,1,1
4,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0036303,0.3221,0.27747,1,1
4,PID CASPASE PATHWAY,0.001872,0.32207,0.21324,1,1
4,BIOCARTA KERATINOCYTE PATHWAY,0.00010462,0.322,0.30745,1,1
4,REACTOME TOLL RECEPTOR CASCADES,3.7791e-06,0.32177,0.2919,1,1
4,KEGG NOTCH SIGNALING PATHWAY,0.0013457,0.32151,0.22186,1,1
4,EXCRETION,1.5816e-05,0.31891,0.30358,1,1
4,PID EPOPATHWAY,5.6174e-05,0.31846,0.33365,1,1
4,CALCIUM MEDIATED SIGNALING,0.0016129,0.31425,0.23778,1,1
4,INTEGRIN COMPLEX,0.00032948,0.31272,0.26475,1,1
4,PID HNF3BPATHWAY,1.906e-06,0.31241,0.43543,1,1
4,PML BODY,6.0504e-05,0.31208,0.2905,1,1
4,REACTOME GLUTATHIONE CONJUGATION,0.013798,0.31155,0.41843,1,1
4,PID IL1PATHWAY,4.1617e-05,0.31152,0.23937,1,1
4,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,4.4878e-05,0.31005,0.27438,1,1
4,FATTY ACID OXIDATION,0.0022992,0.30935,0.30064,1,1
4,BIOCARTA CERAMIDE PATHWAY,1.4039e-05,0.30875,0.32024,1,1
4,CYTOKINE BIOSYNTHETIC PROCESS,2.5308e-05,0.30847,0.2732,1,1
4,REACTOME CELL JUNCTION ORGANIZATION,0.00013917,0.30775,0.29809,1,1
4,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,2.0033e-05,0.30749,0.33843,1,1
4,PID AVB3 OPN PATHWAY,0.0022992,0.30736,0.26468,1,1
4,NEGATIVE REGULATION OF ANGIOGENESIS,0.0046564,0.30734,0.2077,1,1
4,REACTOME ACYL CHAIN REMODELLING OF PS,0.00013917,0.30633,0.35193,1,1
4,REACTOME SPHINGOLIPID METABOLISM,1.6455e-05,0.30606,0.29048,1,1
4,REACTOME HS GAG BIOSYNTHESIS,0.004408,0.30567,0.32009,1,1
4,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,1.0604e-05,0.30496,0.31228,1,1
4,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.3654e-06,0.304,0.29697,1,1
4,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,6.2786e-05,0.30394,0.26471,1,1
4,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.00059588,0.30279,0.26925,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,1.1493e-05,0.30215,0.2787,1,1
4,PROTEIN OLIGOMERIZATION,6.0504e-05,0.30176,0.28966,1,1
4,REACTOME P75NTR SIGNALS VIA NFKB,0.0015653,0.30131,0.21471,1,1
4,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.00014935,0.30129,0.24964,1,1
4,REGULATION OF MEMBRANE POTENTIAL,0.0021062,0.30114,0.28104,1,1
4,PID NECTIN PATHWAY,0.00087311,0.30048,0.30636,1,1
4,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.0071468,0.3002,0.2555,1,1
4,BIOCARTA ETS PATHWAY,0.00024286,0.30009,0.28147,1,1
4,ALCOHOL METABOLIC PROCESS,3.0264e-07,0.29867,0.32828,1,1
4,PROTEIN BINDING BRIDGING,0.00067758,0.29833,0.21439,1,1
4,TRANSPORT VESICLE,0.00010462,0.29595,0.26332,1,1
4,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.0021689,0.29512,0.27663,1,1
4,REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL,0.00081984,0.29461,0.27359,1,1
4,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.012508,0.29373,0.19677,1,1
4,PID IL5 PATHWAY,0.0069616,0.29365,0.26886,1,1
4,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.00090094,0.29309,0.23078,1,1
4,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,5.4121e-05,0.29149,0.25186,1,1
4,SH3 SH2 ADAPTOR ACTIVITY,0.00092958,0.29098,0.23232,1,1
4,PROTEIN KINASE INHIBITOR ACTIVITY,0.0087944,0.29089,0.34762,1,1
4,PID TAP63PATHWAY,0.0071468,0.29031,0.23009,1,1
4,NEGATIVE REGULATION OF TRANSLATION,0.00012512,0.29008,0.24444,1,1
4,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.0067808,0.29005,0.21406,1,1
4,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.02268,0.28923,0.22059,1,1
4,SEXUAL REPRODUCTION,3.6228e-06,0.28888,0.26292,1,1
4,BIOCARTA IL2RB PATHWAY,4.6597e-05,0.28849,0.2806,1,1
4,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,5.4121e-05,0.28842,0.31544,1,1
4,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,1.349e-05,0.28729,0.30313,1,1
4,INFLAMMATORY RESPONSE,9.389e-05,0.28667,0.2269,1,1
4,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,0.00057693,0.28562,0.29697,1,1
4,BIOCARTA STRESS PATHWAY,0.0001547,0.28459,0.25877,1,1
4,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00016595,0.2833,0.25192,1,1
4,INTRINSIC TO GOLGI MEMBRANE,0.0060989,0.28306,0.19511,1,1
4,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,1.1493e-05,0.28289,0.27744,1,1
4,SIG BCR SIGNALING PATHWAY,2.9301e-06,0.28203,0.31814,1,1
4,PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY,0.00067758,0.28164,0.26047,1,1
4,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.0094949,0.28075,0.2118,1,1
4,CARBOXYLESTERASE ACTIVITY,0.00049035,0.28059,0.2495,1,1
4,EARLY ENDOSOME,0.022165,0.28057,0.16971,1,1
4,CELLULAR LIPID METABOLIC PROCESS,2.5774e-06,0.27992,0.30259,1,1
4,REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA,0.00059588,0.27962,0.28305,1,1
4,REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION,0.00044439,0.27862,0.32688,1,1
4,REACTOME ACTIVATED TLR4 SIGNALLING,1.8251e-06,0.27762,0.27614,1,1
4,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.00030804,0.27684,0.23877,1,1
4,REACTOME KERATAN SULFATE KERATIN METABOLISM,0.00024286,0.27677,0.23686,1,1
4,PID IL6 7PATHWAY,0.00067758,0.2763,0.26572,1,1
4,BIOCARTA TNFR2 PATHWAY,0.0028141,0.27585,0.19479,1,1
4,ENDOSOME,0.00012512,0.27565,0.21053,1,1
4,BIOCARTA IL6 PATHWAY,0.00032948,0.27516,0.24475,1,1
4,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.030383,0.27395,0.25592,1,1
4,HORMONE ACTIVITY,0.0010859,0.27369,0.31364,1,1
4,DEFENSE RESPONSE,4.4878e-05,0.27272,0.23524,1,1
4,PID IL2 PI3KPATHWAY,0.011904,0.27234,0.18334,1,1
4,CELL MATURATION,0.0039469,0.27197,0.27664,1,1
4,ST WNT CA2 CYCLIC GMP PATHWAY,0.0021689,0.27187,0.20514,1,1
4,MOLECULAR ADAPTOR ACTIVITY,0.00054072,0.27186,0.23815,1,1
4,PID AP1 PATHWAY,0.011904,0.27054,0.19924,1,1
4,CARBON CARBON LYASE ACTIVITY,0.00013433,0.26919,0.29394,1,1
4,GLUCOSE METABOLIC PROCESS,2.5308e-05,0.26858,0.32522,1,1
4,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.0054795,0.2681,0.19939,1,1
4,BILE ACID METABOLIC PROCESS,0.0021062,0.26758,0.36833,1,1
4,PROTEIN TYROSINE KINASE ACTIVITY,0.0057817,0.26716,0.20809,1,1
4,FATTY ACID METABOLIC PROCESS,0.00010845,0.26712,0.32201,1,1
4,CYTOKINE PRODUCTION,8.6584e-06,0.26656,0.25073,1,1
4,BIOCARTA IL1R PATHWAY,8.1192e-05,0.26647,0.21747,1,1
4,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.00026903,0.26621,0.24937,1,1
4,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.8583e-05,0.26561,0.26235,1,1
4,BIOCARTA DC PATHWAY,0.0073363,0.26555,0.16543,1,1
4,CELLULAR LIPID CATABOLIC PROCESS,8.3127e-06,0.26501,0.30305,1,1
4,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.0017641,0.26501,0.26435,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.00011241,0.26443,0.25683,1,1
4,LIPID METABOLIC PROCESS,8.6584e-06,0.26441,0.2604,1,1
4,EXOCYTOSIS,0.02068,0.26304,0.26402,1,1
4,PID HIVNEFPATHWAY,0.00016595,0.26256,0.29549,1,1
4,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.016339,0.26212,0.30361,1,1
4,PID TCRJNKPATHWAY,0.0024367,0.26181,0.22882,1,1
4,LEUKOCYTE DIFFERENTIATION,0.001191,0.26136,0.23117,1,1
4,SINGLE STRANDED RNA BINDING,0.0046564,0.26116,0.24829,1,1
4,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.046579,0.26106,0.18293,1,1
4,ENDOSOME TRANSPORT,0.00017186,0.26082,0.24389,1,1
4,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0001547,0.26077,0.19144,1,1
4,LIPID BIOSYNTHETIC PROCESS,1.8521e-05,0.26055,0.25507,1,1
4,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.0571e-06,0.25995,0.24481,1,1
4,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,1.5331e-06,0.25934,0.26831,1,1
4,KEGG SULFUR METABOLISM,0.031059,0.25898,0.19384,1,1
4,LATE ENDOSOME,0.00059588,0.25882,0.26952,1,1
4,REACTOME CD28 CO STIMULATION,0.0010528,0.25846,0.24622,1,1
4,CYTOKINE ACTIVITY,4.6597e-05,0.25756,0.23,1,1
4,BIOCARTA 41BB PATHWAY,0.00021909,0.25734,0.25879,1,1
4,KEGG N GLYCAN BIOSYNTHESIS,4.1617e-05,0.25699,0.28712,1,1
4,BIOCARTA MTA3 PATHWAY,0.012203,0.25664,0.25407,1,1
4,KEGG CYTOSOLIC DNA SENSING PATHWAY,2.3418e-05,0.25583,0.22775,1,1
4,RESPONSE TO WOUNDING,0.00023468,0.2523,0.19184,1,1
4,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,4.6597e-05,0.25218,0.24832,1,1
4,GAMETE GENERATION,0.00028792,0.25194,0.22825,1,1
4,REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA,0.010245,0.25194,0.2306,1,1
4,REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS,0.0001165,0.25169,0.26645,1,1
4,NEGATIVE REGULATION OF SECRETION,0.00014935,0.25115,0.30711,1,1
4,BIOCARTA HIVNEF PATHWAY,0.0010206,0.25081,0.23064,1,1
4,BIOCARTA GRANULOCYTES PATHWAY,0.0012662,0.25042,0.17255,1,1
4,KEGG STEROID HORMONE BIOSYNTHESIS,0.00095906,0.24931,0.40084,1,1
4,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.00029782,0.24904,0.21118,1,1
4,SECRETION,6.4994e-06,0.24736,0.23799,1,1
4,KEGG RENIN ANGIOTENSIN SYSTEM,0.014138,0.2467,0.26179,1,1
4,MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00018427,0.24536,0.28795,1,1
4,MONOVALENT INORGANIC CATION TRANSPORT,0.00020448,0.24423,0.283,1,1
4,CYTOPLASMIC VESICLE MEMBRANE,0.00055855,0.24413,0.20716,1,1
4,CYTOPLASMIC VESICLE PART,0.00055855,0.24413,0.20716,1,1
4,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.001228,0.2435,0.16756,1,1
4,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0031536,0.24313,0.31892,1,1
4,REACTOME REGULATION OF IFNG SIGNALING,0.00028792,0.24256,0.2863,1,1
4,BIOCARTA CTLA4 PATHWAY,0.0046564,0.2419,0.19486,1,1
4,KEGG CELL ADHESION MOLECULES CAMS,0.0029794,0.24079,0.21543,1,1
4,REACTOME CELL CELL COMMUNICATION,0.0028957,0.2406,0.18486,1,1
4,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00022676,0.2404,0.22943,1,1
4,LIPID CATABOLIC PROCESS,1.0184e-05,0.23978,0.27819,1,1
4,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,3.4421e-05,0.23909,0.22636,1,1
4,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,0.00084609,0.23893,0.24442,1,1
4,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.00074557,0.23813,0.18618,1,1
4,CELLULAR HOMEOSTASIS,0.00069957,0.23806,0.16515,1,1
4,IMMUNE RESPONSE,7.8282e-05,0.23786,0.19008,1,1
4,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.00020448,0.23691,0.26084,1,1
4,ION HOMEOSTASIS,0.00036427,0.23634,0.17635,1,1
4,INSOLUBLE FRACTION,0.00025131,0.23609,0.28534,1,1
4,BIOCARTA BIOPEPTIDES PATHWAY,0.0094949,0.23605,0.156,1,1
4,PHOSPHOLIPID METABOLIC PROCESS,6.0198e-07,0.23579,0.23989,1,1
4,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.00019753,0.23472,0.29668,1,1
4,KEGG PROTEIN EXPORT,0.00016023,0.23451,0.22892,1,1
4,BIOCARTA GSK3 PATHWAY,0.004408,0.23412,0.17504,1,1
4,CELLULAR CATION HOMEOSTASIS,0.00030804,0.23399,0.18599,1,1
4,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012512,0.23278,0.26402,1,1
4,KEGG TRYPTOPHAN METABOLISM,0.0013054,0.23243,0.22968,1,1
4,ACTIN FILAMENT BINDING,0.0034322,0.23201,0.20946,1,1
4,REACTOME IRON UPTAKE AND TRANSPORT,0.00010462,0.23192,0.2474,1,1
4,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.013139,0.2318,0.27393,1,1
4,BIOCARTA EGF PATHWAY,0.00032948,0.23049,0.24339,1,1
4,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,6.7596e-05,0.23009,0.25167,1,1
4,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.007729,0.22959,0.27207,1,1
4,CATION HOMEOSTASIS,0.00021167,0.22865,0.18408,1,1
4,KEGG DRUG METABOLISM CYTOCHROME P450,0.024846,0.22845,0.20535,1,1
4,REACTOME BIOLOGICAL OXIDATIONS,0.00049035,0.22791,0.26039,1,1
4,PID P38 MKK3 6PATHWAY,0.00065623,0.22776,0.21116,1,1
4,PID CD40 PATHWAY,0.001191,0.22732,0.19747,1,1
4,ENDOCYTIC VESICLE,0.029068,0.22671,0.18114,1,1
4,KEGG ABC TRANSPORTERS,0.00035231,0.22644,0.26904,1,1
4,PID IL4 2PATHWAY,0.00072223,0.22636,0.23483,1,1
4,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.00031859,0.22633,0.25372,1,1
4,REACTOME TRIF MEDIATED TLR3 SIGNALING,6.7596e-05,0.22543,0.22093,1,1
4,APOPTOTIC PROGRAM,0.00021909,0.22531,0.20174,1,1
4,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.00045924,0.22525,0.1683,1,1
4,BONE REMODELING,0.045624,0.22488,0.14234,1,1
4,KEGG RETINOL METABOLISM,0.0014299,0.22381,0.24201,1,1
4,REACTOME APOPTOSIS,0.00036427,0.2233,0.16469,1,1
4,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,1.349e-05,0.22317,0.23453,1,1
4,PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.1192e-05,0.22308,0.21983,1,1
4,PID PTP1BPATHWAY,0.0085714,0.22204,0.16619,1,1
4,REACTOME SYNTHESIS OF PE,0.0026572,0.22191,0.20163,1,1
4,CATION TRANSPORT,9.7346e-05,0.22082,0.23198,1,1
4,KEGG HISTIDINE METABOLISM,0.00081984,0.22072,0.22853,1,1
4,REACTOME PURINE CATABOLISM,0.0081404,0.21977,0.16605,1,1
4,PID IL2 STAT5PATHWAY,0.046579,0.21971,0.15688,1,1
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.024846,0.21959,0.1547,1,1
4,PROTEIN TRANSPORTER ACTIVITY,0.0051916,0.2195,0.219,1,1
4,DEVELOPMENTAL MATURATION,0.0021689,0.21845,0.26232,1,1
4,KEGG APOPTOSIS,0.00057693,0.21771,0.18724,1,1
4,PID AJDISS 2PATHWAY,0.0028957,0.21738,0.19761,1,1
4,BIOCARTA HSP27 PATHWAY,0.0062634,0.21728,0.16718,1,1
4,CELL CELL ADHESION,0.00029782,0.21663,0.21976,1,1
4,LOW DENSITY LIPOPROTEIN BINDING,0.0081404,0.21618,0.22742,1,1
4,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.00028792,0.21601,0.16665,1,1
4,SERINE HYDROLASE ACTIVITY,0.0071468,0.21566,0.27341,1,1
4,RESPONSE TO VIRUS,0.0011199,0.21554,0.20055,1,1
4,PHOSPHOINOSITIDE BINDING,0.0012662,0.21501,0.20431,1,1
4,BIOCARTA P53HYPOXIA PATHWAY,0.0090226,0.21472,0.20112,1,1
4,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.044685,0.21461,0.16768,1,1
4,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.0025817,0.21403,0.18868,1,1
4,MEMBRANE BOUND VESICLE,0.00047456,0.214,0.15957,1,1
4,KEGG ARACHIDONIC ACID METABOLISM,0.00017796,0.21395,0.27795,1,1
4,CHEMICAL HOMEOSTASIS,7.2754e-05,0.21288,0.18904,1,1
4,POLYSACCHARIDE METABOLIC PROCESS,0.0028957,0.21285,0.21523,1,1
4,PID IL3 PATHWAY,0.010245,0.21215,0.18613,1,1
4,VESICLE MEMBRANE,0.0025083,0.21186,0.17671,1,1
4,KEGG DORSO VENTRAL AXIS FORMATION,0.0090226,0.2115,0.21539,1,1
4,RESPONSE TO OTHER ORGANISM,0.00040247,0.21141,0.16597,1,1
4,KEGG LINOLEIC ACID METABOLISM,5.8301e-05,0.21055,0.27707,1,1
4,NUCLEAR SPECK,0.042857,0.21025,0.15323,1,1
4,REACTOME IL1 SIGNALING,6.7596e-05,0.20987,0.2058,1,1
4,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.013798,0.20974,0.15559,1,1
4,EXONUCLEASE ACTIVITY,0.0029794,0.2092,0.17084,1,1
4,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031748,0.20918,0.14694,1,1
4,PID HIF2PATHWAY,0.018836,0.20895,0.1943,1,1
4,PID CERAMIDE PATHWAY,0.00069957,0.20862,0.16225,1,1
4,REACTOME SIGNALING BY ILS,0.00017186,0.20807,0.20442,1,1
4,REACTOME APOPTOTIC EXECUTION PHASE,0.012508,0.20798,0.15161,1,1
4,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.014486,0.20748,0.2029,1,1
4,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.00087311,0.20701,0.21065,1,1
4,REACTOME OLFACTORY SIGNALING PATHWAY,4.6597e-05,0.20623,0.23217,1,1
4,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.001662,0.20571,0.14063,1,1
4,PID NFKAPPABATYPICALPATHWAY,0.0075304,0.20564,0.2581,1,1
4,MONOOXYGENASE ACTIVITY,0.0039469,0.20544,0.32292,1,1
4,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00079435,0.20483,0.19438,1,1
4,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0015653,0.20436,0.153,1,1
4,PHOSPHOLIPASE ACTIVITY,0.0007696,0.20418,0.19717,1,1
4,BIOCARTA INSULIN PATHWAY,0.0007696,0.20387,0.19167,1,1
4,G PROTEIN COUPLED RECEPTOR BINDING,0.015203,0.20385,0.13129,1,1
4,PID IFNGPATHWAY,0.00019753,0.20332,0.22926,1,1
4,ANATOMICAL STRUCTURE FORMATION,0.0057817,0.20314,0.13882,1,1
4,REACTOME IL 2 SIGNALING,0.0018173,0.20171,0.23829,1,1
4,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.00055855,0.20163,0.20596,1,1
4,METAL ION TRANSPORT,0.00049035,0.20148,0.22334,1,1
4,IMMUNE SYSTEM PROCESS,3.3132e-05,0.20101,0.19291,1,1
4,PID RAC1 PATHWAY,0.00047456,0.2009,0.20692,1,1
4,ANGIOGENESIS,0.011904,0.20085,0.14395,1,1
4,SIG IL4RECEPTOR IN B LYPHOCYTES,0.0024367,0.20053,0.1731,1,1
4,RESPONSE TO ORGANIC SUBSTANCE,0.0073363,0.20004,0.15335,1,1
4,PROTEIN KINASE CASCADE,9.0551e-05,0.2,0.19755,1,1
4,EXTRACELLULAR SPACE,0.00072223,0.19967,0.17648,1,1
4,ION TRANSPORT,9.389e-05,0.19962,0.19948,1,1
4,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,0.00012964,0.19942,0.20849,1,1
4,BIOCARTA IGF1 PATHWAY,0.0094949,0.19936,0.14287,1,1
4,CARBOXYLIC ACID METABOLIC PROCESS,0.0032441,0.19934,0.19861,1,1
4,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,4.6597e-05,0.19928,0.20009,1,1
4,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.009256,0.19916,0.12625,1,1
4,BIOCARTA SPPA PATHWAY,0.025994,0.19846,0.14898,1,1
4,HOMEOSTATIC PROCESS,9.389e-05,0.19811,0.17065,1,1
4,RNA CATABOLIC PROCESS,0.0010206,0.19795,0.18241,1,1
4,BIOCARTA TALL1 PATHWAY,0.001986,0.1974,0.16272,1,1
4,TRANS GOLGI NETWORK TRANSPORT VESICLE,0.0069616,0.19731,0.1813,1,1
4,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.0011549,0.19723,0.1896,1,1
4,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.0027346,0.19682,0.10715,1,1
4,MEMBRANE LIPID METABOLIC PROCESS,9.3916e-06,0.19552,0.20075,1,1
4,REACTOME KERATAN SULFATE BIOSYNTHESIS,0.0094949,0.19526,0.14237,1,1
4,PID GMCSF PATHWAY,0.00095906,0.19512,0.21351,1,1
4,CYTOPLASMIC VESICLE,0.00049035,0.19502,0.15267,1,1
4,REACTOME REGULATION OF INSULIN SECRETION,0.013465,0.19454,0.1815,1,1
4,PID IL2 1PATHWAY,0.0012662,0.19433,0.22601,1,1
4,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,0.0021689,0.19378,0.16057,1,1
4,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.00069957,0.19328,0.25862,1,1
4,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR BINDING,0.0069616,0.1929,0.14777,1,1
4,PID P53DOWNSTREAMPATHWAY,0.0014299,0.19273,0.16936,1,1
4,CELL JUNCTION,0.0047853,0.19257,0.17513,1,1
4,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.0023671,0.19221,0.15973,1,1
4,CELLULAR RESPIRATION,0.00081984,0.19215,0.22404,1,1
4,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.0013457,0.19214,0.1791,1,1
4,PID BCR 5PATHWAY,0.00010845,0.19213,0.19321,1,1
4,REACTOME ACYL CHAIN REMODELLING OF PG,0.00081984,0.19192,0.26114,1,1
4,SOLUBLE FRACTION,1.1493e-05,0.19147,0.22353,1,1
4,CYTOKINE BINDING,0.0051916,0.19127,0.13583,1,1
4,REACTOME ION CHANNEL TRANSPORT,0.021165,0.19095,0.13686,1,1
4,GOLGI APPARATUS PART,0.00027832,0.19072,0.15984,1,1
4,HUMORAL IMMUNE RESPONSE,0.009256,0.1904,0.19334,1,1
4,PROTEOLYSIS,0.00010462,0.18994,0.17833,1,1
4,PID FASPATHWAY,0.0049174,0.18963,0.16152,1,1
4,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.014841,0.18925,0.17425,1,1
4,HEMOPOIESIS,0.00034072,0.1892,0.21071,1,1
4,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.0067808,0.18813,0.17091,1,1
4,REGULATION OF PH,0.0073363,0.188,0.1772,1,1
4,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,8.4205e-05,0.18799,0.17715,1,1
4,PEROXISOMAL PART,0.016339,0.18779,0.14746,1,1
4,MICROBODY PART,0.016339,0.18779,0.14746,1,1
4,REACTOME DIABETES PATHWAYS,0.00081984,0.18769,0.19006,1,1
4,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.027188,0.18743,0.19833,1,1
4,VESICLE,0.00084609,0.18727,0.14116,1,1
4,AEROBIC RESPIRATION,0.0017123,0.18689,0.19923,1,1
4,PID CD8TCRPATHWAY,0.0057817,0.18676,0.15445,1,1
4,PID IL12 2PATHWAY,0.001228,0.18635,0.18238,1,1
4,KEGG ALZHEIMERS DISEASE,0.00040247,0.18615,0.14232,1,1
4,REACTOME IMMUNE SYSTEM,0.00013917,0.18612,0.16685,1,1
4,REPRODUCTION,9.3916e-06,0.18608,0.17894,1,1
4,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.031059,0.18594,0.1655,1,1
4,REGULATION OF BODY FLUID LEVELS,0.001191,0.18583,0.22796,1,1
4,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.001662,0.18471,0.18077,1,1
4,BIOCARTA PDGF PATHWAY,0.00021909,0.18368,0.20746,1,1
4,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0053338,0.18337,0.19299,1,1
4,KEGG TYPE II DIABETES MELLITUS,0.0090226,0.18307,0.17921,1,1
4,MULTI ORGANISM PROCESS,0.00027832,0.1826,0.16607,1,1
4,SIG CD40PATHWAYMAP,0.0015653,0.18239,0.16538,1,1
4,MEMBRANE FRACTION,0.00036427,0.18225,0.17674,1,1
4,FEMALE GAMETE GENERATION,0.0073363,0.18196,0.17,1,1
4,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.025414,0.18169,0.151,1,1
4,CASPASE ACTIVATION,0.011904,0.18156,0.13542,1,1
4,ANION TRANSPORT,0.0034322,0.18072,0.20624,1,1
4,PID HIF1 TFPATHWAY,0.0047853,0.18059,0.26673,1,1
4,EXTRACELLULAR REGION,0.0062634,0.18032,0.11636,1,1
4,PHOSPHOINOSITIDE METABOLIC PROCESS,0.00049035,0.17998,0.15392,1,1
4,KEGG PEROXISOME,0.0036303,0.17916,0.17532,1,1
4,GTPASE ACTIVATOR ACTIVITY,0.046579,0.17903,0.11604,1,1
4,PROTEIN TARGETING TO MEMBRANE,0.0027346,0.17872,0.21116,1,1
4,T CELL PROLIFERATION,0.0021062,0.17871,0.1828,1,1
4,ENDOPLASMIC RETICULUM PART,0.00023468,0.17837,0.22369,1,1
4,ST B CELL ANTIGEN RECEPTOR,0.0017123,0.1776,0.15058,1,1
4,LYASE ACTIVITY,0.0010859,0.17742,0.16836,1,1
4,ORGANIC ACID METABOLIC PROCESS,0.0027346,0.17741,0.19756,1,1
4,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.00025131,0.17725,0.17753,1,1
4,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,8.7323e-05,0.1772,0.20844,1,1
4,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.0079323,0.17708,0.17656,1,1
4,PID IL23PATHWAY,0.00353,0.17708,0.13102,1,1
4,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.0011199,0.17692,0.24496,1,1
4,CHLORIDE CHANNEL ACTIVITY,0.024846,0.1758,0.1356,1,1
4,ANION CHANNEL ACTIVITY,0.024846,0.1758,0.1356,1,1
4,IMMUNE SYSTEM DEVELOPMENT,0.0015189,0.17579,0.17545,1,1
4,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.007729,0.17535,0.24181,1,1
4,UBIQUITIN BINDING,0.0045306,0.17499,0.19028,1,1
4,KEGG LEISHMANIA INFECTION,0.0011199,0.17456,0.18493,1,1
4,HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS,0.001872,0.17425,0.17163,1,1
4,REACTOME PD1 SIGNALING,0.042857,0.17406,0.23456,1,1
4,MICROSOME,0.00021909,0.1734,0.19525,1,1
4,REGULATION OF CELLULAR PH,0.0085714,0.17296,0.19227,1,1
4,CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.0226e-05,0.17267,0.18225,1,1
4,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,0.00018427,0.17264,0.16421,1,1
4,PID P38ALPHABETADOWNSTREAMPATHWAY,0.0033369,0.17249,0.16304,1,1
4,PID NFAT TFPATHWAY,0.035393,0.17223,0.15206,1,1
4,REGULATION OF PROTEIN SECRETION,0.02068,0.17216,0.14704,1,1
4,BIOCARTA TPO PATHWAY,0.0024367,0.17211,0.21265,1,1
4,ENDOPLASMIC RETICULUM MEMBRANE,0.00020448,0.17193,0.21696,1,1
4,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.011326,0.17187,0.15703,1,1
4,REGULATION OF BIOLOGICAL QUALITY,4.4878e-05,0.17114,0.16542,1,1
4,SMALL CONJUGATING PROTEIN BINDING,0.0028141,0.17098,0.18099,1,1
4,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.0064317,0.1709,0.18508,1,1
4,REACTOME PHOSPHOLIPID METABOLISM,5.508e-06,0.17036,0.21354,1,1
4,REACTOME SIGNAL ATTENUATION,0.0069616,0.17005,0.19,1,1
4,MAGNESIUM ION BINDING,0.0028957,0.16984,0.13799,1,1
4,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.027803,0.16982,0.12328,1,1
4,REPRODUCTIVE PROCESS,0.00020448,0.16974,0.14796,1,1
4,MONOSACCHARIDE BINDING,0.011904,0.16955,0.17646,1,1
4,PID DELTANP63PATHWAY,0.016339,0.16907,0.19174,1,1
4,RESPONSE TO EXTERNAL STIMULUS,0.0015653,0.16883,0.12548,1,1
4,METALLOEXOPEPTIDASE ACTIVITY,0.034637,0.16857,0.14809,1,1
4,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0007696,0.16819,0.17985,1,1
4,PID INTEGRIN A4B1 PATHWAY,0.0062634,0.16799,0.19882,1,1
4,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0075304,0.16684,0.1237,1,1
4,BIOCARTA GLEEVEC PATHWAY,0.0071468,0.16669,0.16291,1,1
4,LIPOPROTEIN METABOLIC PROCESS,0.0001547,0.16654,0.21186,1,1
4,LIPASE ACTIVITY,0.0014299,0.16644,0.16676,1,1
4,IMMUNE EFFECTOR PROCESS,0.022165,0.16507,0.12022,1,1
4,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.0017123,0.16485,0.1718,1,1
4,PID TXA2PATHWAY,0.025994,0.1647,0.17519,1,1
4,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.024288,0.16461,0.16411,1,1
4,BIOCARTA BCR PATHWAY,0.0013872,0.16431,0.2116,1,1
4,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.0014738,0.16385,0.22729,1,1
4,REGULATION OF CELL DIFFERENTIATION,0.0020453,0.16368,0.17747,1,1
4,BIOCARTA MAL PATHWAY,0.0090226,0.16356,0.12829,1,1
4,DOUBLE STRANDED RNA BINDING,0.014841,0.16211,0.14024,1,1
4,SUGAR BINDING,0.00092958,0.16176,0.14397,1,1
4,PID ATF2 PATHWAY,0.0081404,0.16165,0.17636,1,1
4,VESICULAR FRACTION,0.0010859,0.16133,0.1672,1,1
4,PID PI3KCIPATHWAY,0.0029794,0.16132,0.18992,1,1
4,KEGG FC EPSILON RI SIGNALING PATHWAY,0.00049035,0.15967,0.16068,1,1
4,CELL FRACTION,0.00010462,0.15927,0.17997,1,1
4,LIPID BINDING,0.0031536,0.15902,0.13298,1,1
4,ACID AMINO ACID LIGASE ACTIVITY,0.02268,0.15877,0.086607,1,1
4,FEMALE PREGNANCY,0.0067808,0.15785,0.13467,1,1
4,PID REG GR PATHWAY,0.014486,0.15781,0.13912,1,1
4,REGULATION OF PROGRAMMED CELL DEATH,0.00069957,0.15671,0.1414,1,1
4,PID S1P S1P2 PATHWAY,0.030383,0.15635,0.18535,1,1
4,MAPKKK CASCADE GO 0000165,0.041093,0.15604,0.10315,1,1
4,PEROXISOME,0.004408,0.15601,0.16599,1,1
4,MICROBODY,0.004408,0.15601,0.16599,1,1
4,INTEGRAL TO ORGANELLE MEMBRANE,0.00072223,0.15578,0.18248,1,1
4,PEPTIDE RECEPTOR ACTIVITY,0.013465,0.15575,0.11175,1,1
4,PID CD8TCRDOWNSTREAMPATHWAY,0.0054795,0.15486,0.14301,1,1
4,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.0025817,0.15458,0.12903,1,1
4,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.00055855,0.15429,0.18186,1,1
4,REACTOME STEROID HORMONES,0.0053338,0.15424,0.17818,1,1
4,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.012508,0.154,0.090167,1,1
4,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.0025817,0.15384,0.13637,1,1
4,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.00069957,0.15362,0.16743,1,1
4,PEROXISOME ORGANIZATION AND BIOGENESIS,0.0037331,0.15349,0.19554,1,1
4,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.0012662,0.15327,0.15703,1,1
4,PID FCER1PATHWAY,0.00022676,0.15218,0.16868,1,1
4,BIOCARTA FCER1 PATHWAY,0.0016129,0.15194,0.17897,1,1
4,INTRINSIC TO ORGANELLE MEMBRANE,0.0010859,0.15092,0.17482,1,1
4,ENZYME INHIBITOR ACTIVITY,0.011904,0.15089,0.11326,1,1
4,PID IL12 STAT4PATHWAY,0.030383,0.15018,0.11587,1,1
4,BIOCARTA MET PATHWAY,0.029068,0.1501,0.11628,1,1
4,EXTRACELLULAR REGION PART,0.033166,0.15008,0.07814,1,1
4,REGULATION OF APOPTOSIS,0.001228,0.1497,0.13327,1,1
4,RECEPTOR BINDING,0.0081404,0.14916,0.096094,1,1
4,ADAPTIVE IMMUNE RESPONSE,0.041967,0.14861,0.066993,1,1
4,PID ERBB1 DOWNSTREAM PATHWAY,0.0075304,0.14831,0.13249,1,1
4,DEFENSE RESPONSE TO BACTERIUM,0.0087944,0.14807,0.095422,1,1
4,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.00084609,0.1478,0.2047,1,1
4,BIOSYNTHETIC PROCESS,0.00079435,0.14779,0.1511,1,1
4,RESPONSE TO CHEMICAL STIMULUS,0.00013433,0.14745,0.13748,1,1
4,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.0090226,0.1474,0.14328,1,1
4,PID FGF PATHWAY,0.0097392,0.14689,0.13636,1,1
4,PROGRAMMED CELL DEATH,0.00092958,0.14663,0.12838,1,1
4,PID MAPKTRKPATHWAY,0.0081404,0.14562,0.1473,1,1
4,POST GOLGI VESICLE MEDIATED TRANSPORT,0.017549,0.14523,0.21783,1,1
4,REACTOME SIGNALING BY NOTCH,0.0069616,0.14363,0.13001,1,1
4,UBIQUITIN LIGASE COMPLEX,0.021165,0.14342,0.076308,1,1
4,REACTOME METAL ION SLC TRANSPORTERS,0.0049174,0.14341,0.20847,1,1
4,KEGG JAK STAT SIGNALING PATHWAY,0.004408,0.14319,0.13219,1,1
4,PID HES HEYPATHWAY,0.034637,0.14218,0.12818,1,1
4,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.015953,0.14169,0.10767,1,1
4,CARBOHYDRATE METABOLIC PROCESS,0.00084609,0.14026,0.14537,1,1
4,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.013139,0.14019,0.15506,1,1
4,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.02843,0.14002,0.12165,1,1
4,PID MET PATHWAY,0.0060989,0.13987,0.12074,1,1
4,REACTOME ERK MAPK TARGETS,0.018836,0.13957,0.14777,1,1
4,APOPTOSIS GO,0.0013457,0.13955,0.1219,1,1
4,RECEPTOR COMPLEX,0.017549,0.13918,0.11817,1,1
4,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.02068,0.13754,0.10529,1,1
4,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.0010528,0.13733,0.11328,1,1
4,PHOSPHOLIPID BINDING,0.0033369,0.13721,0.13404,1,1
4,BIOCARTA GH PATHWAY,0.007729,0.13698,0.15223,1,1
4,PID RHOA PATHWAY,0.011612,0.13672,0.14606,1,1
4,BIOCARTA ECM PATHWAY,0.042857,0.13633,0.12812,1,1
4,INTEGRAL TO PLASMA MEMBRANE,0.0015189,0.13583,0.12297,1,1
4,RESPONSE TO HYPOXIA,0.040234,0.13572,0.1548,1,1
4,KEGG ALPHA LINOLENIC ACID METABOLISM,0.0057817,0.13552,0.1732,1,1
4,BIOCARTA LECTIN PATHWAY,0.044685,0.13519,0.052751,1,1
4,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.00027832,0.13495,0.14883,1,1
4,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.022165,0.13481,0.14167,1,1
4,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.00081984,0.13452,0.18605,1,1
4,PEPTIDE BINDING,0.001872,0.1339,0.1444,1,1
4,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.0037331,0.13326,0.14953,1,1
4,KEGG OXIDATIVE PHOSPHORYLATION,0.012508,0.13298,0.12788,1,1
4,INTRINSIC TO PLASMA MEMBRANE,0.0028141,0.13262,0.11601,1,1
4,CALCIUM ION BINDING,0.013465,0.13222,0.10816,1,1
4,PLASMA MEMBRANE,0.00063551,0.13186,0.12799,1,1
4,COATED VESICLE,0.014841,0.1303,0.10404,1,1
4,POSITIVE REGULATION OF CELLULAR PROCESS,0.0012662,0.1296,0.11039,1,1
4,PLASMA MEMBRANE PART,0.001191,0.12954,0.12195,1,1
4,ACTIN BINDING,0.0030654,0.12921,0.14998,1,1
4,CHROMOSOME CONDENSATION,0.013465,0.12803,0.1842,1,1
4,BIOCARTA AT1R PATHWAY,0.037747,0.12792,0.14263,1,1
4,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00031859,0.12792,0.18248,1,1
4,REGULATION OF DEVELOPMENTAL PROCESS,0.0021689,0.12681,0.11587,1,1
4,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.02068,0.12664,0.070523,1,1
4,EXOPEPTIDASE ACTIVITY,0.031059,0.12592,0.16959,1,1
4,INTEGRAL TO MEMBRANE,0.0011549,0.1258,0.12435,1,1
4,TRANSMEMBRANE RECEPTOR ACTIVITY,0.024846,0.12512,0.081877,1,1
4,RESPONSE TO BACTERIUM,0.0050528,0.12489,0.094704,1,1
4,INTRACELLULAR SIGNALING CASCADE,0.00084609,0.12471,0.11806,1,1
4,PID ANGIOPOIETINRECEPTOR PATHWAY,0.015203,0.12432,0.13821,1,1
4,BIOPOLYMER MODIFICATION,0.0015653,0.12431,0.10623,1,1
4,REACTOME SIGNALLING TO RAS,0.012203,0.12391,0.11151,1,1
4,REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.0062634,0.12337,0.14427,1,1
4,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.0020453,0.12316,0.12805,1,1
4,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.044685,0.12303,0.067569,1,1
4,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.035393,0.1229,0.069123,1,1
4,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0018173,0.12212,0.1283,1,1
4,BIOCARTA TNFR1 PATHWAY,0.024288,0.12199,0.10991,1,1
4,PID FOXOPATHWAY,0.03245,0.12119,0.10698,1,1
4,BIOCARTA NGF PATHWAY,0.0057817,0.12114,0.14517,1,1
4,MEMBRANE,0.00095906,0.12034,0.11981,1,1
4,INTRINSIC TO MEMBRANE,0.0015189,0.11988,0.1182,1,1
4,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0071468,0.11987,0.091425,1,1
4,PROTEIN MODIFICATION PROCESS,0.001872,0.11872,0.10503,1,1
4,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0031536,0.11809,0.10021,1,1
4,ENZYME ACTIVATOR ACTIVITY,0.017137,0.11809,0.11724,1,1
4,NEGATIVE REGULATION OF CELL PROLIFERATION,0.011047,0.11779,0.099349,1,1
4,HEMOSTASIS,0.0067808,0.11674,0.21115,1,1
4,KEGG INOSITOL PHOSPHATE METABOLISM,0.027188,0.11667,0.099984,1,1
4,BIOCARTA CXCR4 PATHWAY,0.025414,0.11657,0.13533,1,1
4,KEGG GNRH SIGNALING PATHWAY,0.0025817,0.11653,0.13596,1,1
4,KEGG VIBRIO CHOLERAE INFECTION,0.014486,0.11609,0.10206,1,1
4,PROTEIN KINASE ACTIVITY,0.0023671,0.11597,0.11339,1,1
4,LOCOMOTORY BEHAVIOR,0.001228,0.11562,0.10836,1,1
4,RESPONSE TO BIOTIC STIMULUS,0.0012662,0.11556,0.12099,1,1
4,PROTEIN HOMODIMERIZATION ACTIVITY,0.0071468,0.11513,0.10578,1,1
4,DEOXYRIBONUCLEASE ACTIVITY,0.0038387,0.11444,0.12655,1,1
4,RESPONSE TO STRESS,0.0029794,0.1136,0.096383,1,1
4,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.0010859,0.11355,0.10865,1,1
4,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.02843,0.11337,0.11021,1,1
4,KEGG OLFACTORY TRANSDUCTION,0.0099891,0.11314,0.10439,1,1
4,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.013798,0.11084,0.21392,1,1
4,REACTOME GPCR LIGAND BINDING,0.024846,0.11034,0.068945,1,1
4,PID SMAD2 3PATHWAY,0.012203,0.11027,0.15233,1,1
4,IDENTICAL PROTEIN BINDING,0.0011199,0.11012,0.11121,1,1
4,MEMBRANE PART,0.00063551,0.10957,0.12108,1,1
4,ENDOPEPTIDASE ACTIVITY,0.0073363,0.10929,0.12844,1,1
4,PID P73PATHWAY,0.043763,0.10913,0.10599,1,1
4,BIOCARTA TCR PATHWAY,0.0079323,0.10887,0.15574,1,1
4,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.014138,0.10863,0.096672,1,1
4,REGULATION OF HYDROLASE ACTIVITY,0.011904,0.10852,0.10472,1,1
4,CYTOPLASM,0.0013054,0.10788,0.094537,1,1
4,REACTOME GPCR DOWNSTREAM SIGNALING,0.035393,0.107,0.062799,1,1
4,PEPTIDASE ACTIVITY,0.0099891,0.10674,0.13218,1,1
4,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.016339,0.10596,0.10111,1,1
4,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.027803,0.10503,0.07391,1,1
4,REACTOME G ALPHA S SIGNALLING EVENTS,0.033894,0.10469,0.096923,1,1
4,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.018836,0.10436,0.1104,1,1
4,BIOCARTA ATM PATHWAY,0.011904,0.10389,0.17025,1,1
4,KEGG GLYCEROLIPID METABOLISM,0.031059,0.10381,0.17474,1,1
4,HISTONE DEACETYLASE BINDING,0.015953,0.10363,0.12921,1,1
4,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.007729,0.10354,0.11891,1,1
4,LIPOPROTEIN BINDING,0.047551,0.10276,0.14451,1,1
4,ADENYL NUCLEOTIDE BINDING,0.025994,0.10183,0.079164,1,1
4,SIGNAL TRANSDUCTION,0.0039469,0.10178,0.096174,1,1
4,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,0.0014738,0.10161,0.11623,1,1
4,CELL PROJECTION,0.025414,0.10114,0.080577,1,1
4,NUCLEAR BODY,0.001662,0.098447,0.10489,1,1
4,CELL DEVELOPMENT,0.02268,0.096732,0.074917,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,0.011904,0.094772,0.078065,1,1
4,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.023205,0.093582,0.11611,1,1
4,PID ENDOTHELINPATHWAY,0.029719,0.093265,0.10595,1,1
4,PURINE NUCLEOTIDE BINDING,0.022165,0.092893,0.074657,1,1
4,PURINE RIBONUCLEOTIDE BINDING,0.031059,0.092783,0.065468,1,1
4,RECEPTOR ACTIVITY,0.038561,0.092187,0.074225,1,1
4,ESTABLISHMENT OF LOCALIZATION,0.00047456,0.092071,0.10794,1,1
4,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.043763,0.089436,0.11718,1,1
4,NEGATIVE REGULATION OF METABOLIC PROCESS,0.033894,0.088397,0.066553,1,1
4,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.0059384,0.088074,0.094963,1,1
4,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.03245,0.08758,0.067318,1,1
4,BIOCARTA MAPK PATHWAY,0.018398,0.087479,0.1035,1,1
4,KEGG PPAR SIGNALING PATHWAY,0.02843,0.08734,0.10773,1,1
4,KINASE ACTIVITY,0.0085714,0.08617,0.085103,1,1
4,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015203,0.085281,0.10427,1,1
4,ESTABLISHMENT OF CELLULAR LOCALIZATION,0.010773,0.084643,0.078677,1,1
4,NUCLEOTIDE BINDING,0.025414,0.084125,0.071787,1,1
4,GOLGI ASSOCIATED VESICLE,0.0066042,0.083658,0.11667,1,1
4,ADENYL RIBONUCLEOTIDE BINDING,0.037747,0.080766,0.067809,1,1
4,CELLULAR LOCALIZATION,0.018836,0.080335,0.072715,1,1
4,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.021165,0.077095,0.098046,1,1
4,PROTEIN DIMERIZATION ACTIVITY,0.041967,0.070603,0.068942,1,1
4,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.015953,0.063395,0.077343,1,1
4,REACTOME SIGNALING BY INSULIN RECEPTOR,0.0099891,0.061841,0.084884,1,1
4,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.00074557,0.81664,0.67463,1,0
4,KEGG ALLOGRAFT REJECTION,0.0037331,0.542,0.40922,1,0
4,KEGG AUTOIMMUNE THYROID DISEASE,0.0013054,0.4998,0.40981,1,0
4,BIOCARTA IL10 PATHWAY,0.00036427,0.49258,0.41994,1,0
4,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.00028792,0.46918,0.37671,1,0
4,KEGG GRAFT VERSUS HOST DISEASE,0.0046564,0.45511,0.33789,1,0
4,REACTOME ER PHAGOSOME PATHWAY,0.00037661,0.4489,0.36264,1,0
4,KEGG LYSOSOME,4.0073e-05,0.44764,0.40272,1,0
4,LIPID HOMEOSTASIS,0.0081404,0.42929,0.36431,1,0
4,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.00012074,0.4204,0.41024,1,0
4,REACTOME CALNEXIN CALRETICULIN CYCLE,0.00024286,0.40802,0.41771,1,0
4,KEGG OTHER GLYCAN DEGRADATION,0.0013457,0.40258,0.45854,1,0
4,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,2.8418e-05,0.39545,0.35733,1,0
4,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,2.6307e-05,0.391,0.34415,1,0
4,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.00041602,0.37042,0.26432,1,0
4,LIPID TRANSPORT,0.0014299,0.36848,0.28799,1,0
4,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.00055855,0.36488,0.3973,1,0
4,PID TRAIL PATHWAY,9.389e-05,0.35641,0.31945,1,0
4,REACTOME IL 6 SIGNALING,0.0085714,0.3463,0.25583,1,0
4,REACTOME GLYCOSPHINGOLIPID METABOLISM,2.9532e-05,0.34034,0.37359,1,0
4,ER GOLGI INTERMEDIATE COMPARTMENT,0.0010528,0.3342,0.31061,1,0
4,REACTOME ACYL CHAIN REMODELLING OF PI,0.0060989,0.32892,0.25141,1,0
4,ENDOPLASMIC RETICULUM LUMEN,0.0040578,0.32217,0.29534,1,0
4,BIOCARTA IL4 PATHWAY,0.0037331,0.3069,0.25602,1,0
4,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.0014299,0.3039,0.31142,1,0
4,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.00090094,0.30005,0.32463,1,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON SULFUR GROUP OF DONORS,0.02166,0.29451,0.2295,1,0
4,REACTOME HS GAG DEGRADATION,0.0028957,0.29226,0.39253,1,0
4,IMMUNOLOGICAL SYNAPSE,0.0012662,0.2903,0.29737,1,0
4,KEGG VIRAL MYOCARDITIS,0.025414,0.27836,0.16913,1,0
4,SA CASPASE CASCADE,0.0010859,0.27603,0.30518,1,0
4,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.045624,0.26502,0.1363,1,0
4,BIOCARTA RELA PATHWAY,0.0026572,0.26339,0.2145,1,0
4,REACTOME ACYL CHAIN REMODELLING OF PC,4.1617e-05,0.26262,0.30721,1,0
4,BIOCARTA CD40 PATHWAY,0.0014299,0.25869,0.26263,1,0
4,RESPONSE TO DRUG,0.0021689,0.25741,0.33412,1,0
4,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.0001547,0.25692,0.21929,1,0
4,PID TNFPATHWAY,0.001986,0.25647,0.19083,1,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.036948,0.25299,0.25566,1,0
4,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.0073363,0.25226,0.20484,1,0
4,MANNOSYLTRANSFERASE ACTIVITY,0.013139,0.25186,0.21666,1,0
4,REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS,0.037747,0.25031,0.22914,1,0
4,REACTOME HYALURONAN METABOLISM,0.0099891,0.2475,0.17932,1,0
4,KEGG PROTEASOME,0.010245,0.24612,0.19118,1,0
4,TRANSITION METAL ION TRANSPORT,0.0010528,0.23883,0.25605,1,0
4,ST TUMOR NECROSIS FACTOR PATHWAY,0.00032948,0.23877,0.21449,1,0
4,KEGG PRIMARY IMMUNODEFICIENCY,0.0010859,0.23858,0.20717,1,0
4,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.0039469,0.23788,0.17379,1,0
4,STEROL BINDING,0.0047853,0.23639,0.25362,1,0
4,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.0099891,0.23489,0.17163,1,0
4,REGULATION OF ANGIOGENESIS,0.02166,0.23218,0.15728,1,0
4,REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES,0.012203,0.23209,0.1845,1,0
4,REACTOME PURINE SALVAGE,0.017137,0.23106,0.22452,1,0
4,LYSOSOME ORGANIZATION AND BIOGENESIS,0.011047,0.22965,0.23583,1,0
4,PID WNT SIGNALING PATHWAY,0.046579,0.22703,0.17412,1,0
4,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.020205,0.22692,0.15706,1,0
4,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.011047,0.22444,0.17259,1,0
4,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.016734,0.22192,0.1698,1,0
4,CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.014486,0.22093,0.22079,1,0
4,ANTIOXIDANT ACTIVITY,0.015953,0.21669,0.28559,1,0
4,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.0059384,0.21643,0.15942,1,0
4,PID INTEGRIN A9B1 PATHWAY,0.010506,0.21328,0.23171,1,0
4,GOLGI MEMBRANE,0.0019282,0.21099,0.18579,1,0
4,BIOCARTA RHO PATHWAY,0.02268,0.2105,0.15606,1,0
4,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,0.026586,0.21046,0.15903,1,0
4,RESPONSE TO TEMPERATURE STIMULUS,0.017969,0.21015,0.17259,1,0
4,MICROTUBULE MOTOR ACTIVITY,0.014841,0.20992,0.20921,1,0
4,REACTOME COMPLEMENT CASCADE,0.0032441,0.20957,0.23304,1,0
4,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.012508,0.20519,0.16191,1,0
4,VACUOLE ORGANIZATION AND BIOGENESIS,0.014138,0.20449,0.20237,1,0
4,KEGG COMPLEMENT AND COAGULATION CASCADES,0.0020453,0.20308,0.24066,1,0
4,REGULATION OF SIGNAL TRANSDUCTION,0.00036427,0.20064,0.18758,1,0
4,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,0.0090226,0.19932,0.23039,1,0
4,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.011612,0.19796,0.16634,1,0
4,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.021165,0.19734,0.15049,1,0
4,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.038561,0.19696,0.18165,1,0
4,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.009256,0.19681,0.14853,1,0
4,FATTY ACID BETA OXIDATION,0.031059,0.19548,0.26148,1,0
4,KERATINOCYTE DIFFERENTIATION,0.020205,0.19531,0.21275,1,0
4,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.0016129,0.19489,0.2037,1,0
4,REACTOME MEMBRANE TRAFFICKING,0.00065623,0.1916,0.18746,1,0
4,COENZYME METABOLIC PROCESS,0.023205,0.1892,0.22453,1,0
4,VASCULATURE DEVELOPMENT,0.019283,0.18915,0.12551,1,0
4,PID TCPTP PATHWAY,0.010773,0.18741,0.1974,1,0
4,NEGATIVE REGULATION OF APOPTOSIS,0.0050528,0.18611,0.14223,1,0
4,COFACTOR BIOSYNTHETIC PROCESS,0.011904,0.18541,0.25625,1,0
4,OXIDOREDUCTASE ACTIVITY,0.001872,0.18514,0.23094,1,0
4,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.0039469,0.18201,0.1422,1,0
4,JAK STAT CASCADE,0.010506,0.17977,0.13618,1,0
4,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,0.0090226,0.17816,0.17139,1,0
4,PID NFKAPPABCANONICALPATHWAY,0.042857,0.17543,0.08351,1,0
4,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.018398,0.17523,0.12243,1,0
4,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0012662,0.17426,0.18045,1,0
4,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.014138,0.17368,0.15369,1,0
4,INTERLEUKIN RECEPTOR ACTIVITY,0.023741,0.16959,0.13953,1,0
4,RAS PROTEIN SIGNAL TRANSDUCTION,0.0083534,0.16759,0.13494,1,0
4,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.00098941,0.16567,0.24514,1,0
4,REACTOME METABOLISM OF VITAMINS AND COFACTORS,0.041967,0.16564,0.17608,1,0
4,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.034637,0.16534,0.10218,1,0
4,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.0099891,0.16524,0.16121,1,0
4,MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0071468,0.16487,0.20069,1,0
4,RHO PROTEIN SIGNAL TRANSDUCTION,0.0067808,0.16132,0.15333,1,0
4,KEGG ARGININE AND PROLINE METABOLISM,0.036948,0.16058,0.15681,1,0
4,KEGG P53 SIGNALING PATHWAY,0.0045306,0.15843,0.1635,1,0
4,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.044685,0.15741,0.10021,1,0
4,REACTOME SULFUR AMINO ACID METABOLISM,0.036948,0.15736,0.14051,1,0
4,ST ERK1 ERK2 MAPK PATHWAY,0.0073363,0.15468,0.18679,1,0
4,ELECTRON CARRIER ACTIVITY,0.0066042,0.15438,0.24943,1,0
4,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.01282,0.15404,0.14291,1,0
4,COFACTOR METABOLIC PROCESS,0.019739,0.1539,0.213,1,0
4,REGULATION OF TRANSLATION,0.0028141,0.15389,0.12843,1,0
4,KEGG ETHER LIPID METABOLISM,0.0027346,0.15182,0.14309,1,0
4,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.017969,0.15116,0.098575,1,0
4,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.0013872,0.1504,0.13657,1,0
4,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,0.0085714,0.1498,0.24683,1,0
4,POSITIVE REGULATION OF TRANSLATION,0.0071468,0.14835,0.11688,1,0
4,REGULATION OF PHOSPHORYLATION,0.024846,0.1483,0.11831,1,0
4,PROTEIN MATURATION,0.029719,0.14448,0.1118,1,0
4,PROTEIN COMPLEX ASSEMBLY,0.0020453,0.14199,0.13151,1,0
4,ELECTRON TRANSPORT GO 0006118,0.015203,0.14098,0.20065,1,0
4,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.016734,0.13894,0.08991,1,0
4,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.030383,0.1385,0.099431,1,0
4,NITROGEN COMPOUND METABOLIC PROCESS,0.0060989,0.13663,0.13195,1,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.036948,0.13486,0.22841,1,0
4,REACTOME REGULATION OF APOPTOSIS,0.02166,0.13457,0.11486,1,0
4,MACROMOLECULE BIOSYNTHETIC PROCESS,0.0012662,0.13436,0.14628,1,0
4,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.007729,0.13405,0.11703,1,0
4,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0060989,0.1311,0.099172,1,0
4,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.014138,0.12989,0.14583,1,0
4,GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.015203,0.12971,0.15503,1,0
4,REACTOME METABOLISM OF PROTEINS,0.034637,0.12826,0.091878,1,0
4,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,0.0042883,0.12815,0.11811,1,0
4,ENDOPLASMIC RETICULUM,0.0016129,0.12703,0.14139,1,0
4,REACTOME SIGNALING BY WNT,0.02843,0.12551,0.1023,1,0
4,REGULATION OF PROTEIN METABOLIC PROCESS,0.0069616,0.12462,0.097781,1,0
4,ORGANELLE MEMBRANE,0.0094949,0.12316,0.0958,1,0
4,PROTEIN METABOLIC PROCESS,0.0023671,0.12225,0.090609,1,0
4,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.033166,0.1215,0.16172,1,0
4,PROTEIN LOCALIZATION,0.019283,0.12076,0.075963,1,0
4,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0021062,0.12059,0.11993,1,0
4,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.024846,0.12047,0.12944,1,0
4,ENDOMEMBRANE SYSTEM,0.027188,0.11961,0.094431,1,0
4,REACTOME UNFOLDED PROTEIN RESPONSE,0.0085714,0.11957,0.13408,1,0
4,VESICLE COAT,0.015203,0.11949,0.15585,1,0
4,BIOCARTA NTHI PATHWAY,0.038561,0.11546,0.1021,1,0
4,PID MYC REPRESSPATHWAY,0.033894,0.11506,0.10084,1,0
4,GOLGI APPARATUS,0.00079435,0.11443,0.11607,1,0
4,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.017137,0.11416,0.10279,1,0
4,MEMBRANE FUSION,0.036948,0.11397,0.13107,1,0
4,CELLULAR MACROMOLECULE METABOLIC PROCESS,0.0025817,0.1134,0.086943,1,0
4,CELLULAR PROTEIN METABOLIC PROCESS,0.0032441,0.11309,0.087852,1,0
4,COATED VESICLE MEMBRANE,0.02843,0.11238,0.13192,1,0
4,ST P38 MAPK PATHWAY,0.03245,0.11219,0.12665,1,0
4,BLOOD COAGULATION,0.022165,0.11218,0.22192,1,0
4,GROWTH FACTOR BINDING,0.037747,0.11153,0.10845,1,0
4,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.01282,0.11007,0.086686,1,0
4,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.026586,0.10942,0.1132,1,0
4,PID IGF1 PATHWAY,0.011326,0.10869,0.11696,1,0
4,REACTOME ENOS ACTIVATION AND REGULATION,0.012203,0.10813,0.18101,1,0
4,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.026586,0.10572,0.064111,1,0
4,MACROMOLECULE LOCALIZATION,0.02268,0.10517,0.068265,1,0
4,REACTOME XENOBIOTICS,0.026586,0.10431,0.26588,1,0
4,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019739,0.10156,0.10414,1,0
4,AMINO ACID METABOLIC PROCESS,0.030383,0.1001,0.13829,1,0
4,NEGATIVE REGULATION OF CELLULAR PROCESS,0.026586,0.099576,0.062286,1,0
4,REACTOME COMMON PATHWAY,0.031748,0.099234,0.41328,1,0
4,CYTOPLASMIC PART,0.0014299,0.098572,0.10223,1,0
4,PID ARF6 PATHWAY,0.017549,0.097375,0.18713,1,0
4,RESPONSE TO HORMONE STIMULUS,0.033894,0.096944,0.16593,1,0
4,MEMBRANE COAT,0.03939,0.095684,0.12454,1,0
4,COATED MEMBRANE,0.03939,0.095684,0.12454,1,0
4,BIOCARTA PTDINS PATHWAY,0.024288,0.092925,0.12136,1,0
4,COAGULATION,0.047551,0.092688,0.2052,1,0
4,PID KITPATHWAY,0.025994,0.092534,0.16679,1,0
4,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.02268,0.090904,0.079466,1,0
4,CELL PROLIFERATION GO 0008283,0.024288,0.089726,0.072188,1,0
4,PROTEIN TRANSPORT,0.045624,0.084569,0.05726,1,0
4,GOLGI VESICLE TRANSPORT,0.0085714,0.083887,0.12632,1,0
4,BIOCARTA CYTOKINE PATHWAY,0.040234,0.070318,0.029154,1,0
4,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.03245,0.068024,0.062022,1,0
4,OXIDOREDUCTASE ACTIVITY GO 0016616,0.047551,0.067073,0.25642,1,0
4,ST FAS SIGNALING PATHWAY,0.030383,0.062174,0.07739,1,0
4,PROTEIN HETERODIMERIZATION ACTIVITY,0.011904,0.061649,0.085241,1,0
4,REGULATION OF CELL PROLIFERATION,0.042857,0.060585,0.063988,1,0
4,ION BINDING,0.036164,0.058206,0.064639,1,0
4,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.046579,0.051351,0.24859,1,0
4,CYTOSOL,0.047551,0.051162,0.07014,1,0
4,MACROMOLECULE CATABOLIC PROCESS,0.037747,0.038237,0.067884,1,0
4,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.025994,-0.046697,-0.07692,1,0
4,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.035393,-0.052892,-0.082577,1,0
4,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.037747,-0.053345,-0.084879,1,0
4,REACTOME ELONGATION ARREST AND RECOVERY,0.036948,-0.066711,-0.086614,1,0
4,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.031748,-0.068867,-0.087116,1,0
4,REACTOME HIV LIFE CYCLE,0.015953,-0.069624,-0.093349,1,0
4,ST INTEGRIN SIGNALING PATHWAY,0.041093,-0.069743,-0.10725,1,0
4,KEGG RNA DEGRADATION,0.016339,-0.07536,-0.08926,1,0
4,REACTOME MRNA 3 END PROCESSING,0.046579,-0.077271,-0.10451,1,0
4,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.016339,-0.079579,-0.093645,1,0
4,REACTOME RNA POL II TRANSCRIPTION,0.0067808,-0.081053,-0.096906,1,0
4,RESPONSE TO RADIATION,0.023205,-0.084551,-0.086556,1,0
4,KEGG HOMOLOGOUS RECOMBINATION,0.038561,-0.086815,-0.12874,1,0
4,REACTOME MRNA PROCESSING,0.0069616,-0.088622,-0.10975,1,0
4,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.011612,-0.090196,-0.10931,1,0
4,MAINTENANCE OF LOCALIZATION,0.027188,-0.092625,-0.16582,1,0
4,METHYLTRANSFERASE ACTIVITY,0.009256,-0.092991,-0.12607,1,0
4,TUBULIN BINDING,0.017137,-0.093883,-0.13128,1,0
4,OVULATION CYCLE,0.024846,-0.094574,-0.11388,1,0
4,NUCLEAR MEMBRANE PART,0.042857,-0.094753,-0.098781,1,0
4,REACTOME REGULATORY RNA PATHWAYS,0.024288,-0.10186,-0.1034,1,0
4,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.0087944,-0.10217,-0.14022,1,0
4,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.02166,-0.1034,-0.10265,1,0
4,RNA PROCESSING,0.0028957,-0.10343,-0.10632,1,0
4,MICROTUBULE ASSOCIATED COMPLEX,0.029719,-0.10343,-0.1259,1,0
4,HEPARIN BINDING,0.037747,-0.10382,-0.15338,1,0
4,REACTOME CELL CYCLE MITOTIC,0.042857,-0.10516,-0.065753,1,0
4,KEGG RNA POLYMERASE,0.033894,-0.10768,-0.10059,1,0
4,MRNA METABOLIC PROCESS,0.0046564,-0.10832,-0.093079,1,0
4,ATP DEPENDENT HELICASE ACTIVITY,0.045624,-0.10892,-0.1113,1,0
4,PROTEIN RNA COMPLEX ASSEMBLY,0.014841,-0.10919,-0.13736,1,0
4,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.030383,-0.10955,-0.093386,1,0
4,SPLICEOSOME,0.013465,-0.11083,-0.10859,1,0
4,MICROTUBULE CYTOSKELETON,0.041093,-0.11099,-0.091894,1,0
4,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.040234,-0.11241,-0.099515,1,0
4,REACTOME G1 PHASE,0.009256,-0.11265,-0.12451,1,0
4,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.014486,-0.11275,-0.11969,1,0
4,KEGG SPLICEOSOME,0.0067808,-0.11305,-0.11012,1,0
4,REACTOME MRNA SPLICING,0.0081404,-0.11436,-0.11532,1,0
4,RESPONSE TO UV,0.02166,-0.11449,-0.090272,1,0
4,PID BETACATENIN NUC PATHWAY,0.023741,-0.11507,-0.12606,1,0
4,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.004408,-0.11539,-0.11697,1,0
4,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.02166,-0.11544,-0.28068,1,0
4,NUCLEAR HORMONE RECEPTOR BINDING,0.001228,-0.11877,-0.14376,1,0
4,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.0097392,-0.11905,-0.14444,1,0
4,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.010245,-0.12096,-0.13346,1,0
4,REACTOME MITOTIC PROMETAPHASE,0.025994,-0.12135,-0.099245,1,0
4,ENDONUCLEASE ACTIVITY GO 0016893,0.037747,-0.12165,-0.11857,1,0
4,ATP DEPENDENT DNA HELICASE ACTIVITY,0.015574,-0.12169,-0.16523,1,0
4,ENDORIBONUCLEASE ACTIVITY,0.034637,-0.12535,-0.12197,1,0
4,HORMONE RECEPTOR BINDING,0.001872,-0.12551,-0.14079,1,0
4,NUCLEAR MEMBRANE,0.03245,-0.12649,-0.11238,1,0
4,NEUROGENESIS,0.0054795,-0.12693,-0.1953,1,0
4,EXTRACELLULAR MATRIX PART,0.025994,-0.12867,-0.24374,1,0
4,DNA DEPENDENT ATPASE ACTIVITY,0.011904,-0.13115,-0.15409,1,0
4,GENERATION OF NEURONS,0.010506,-0.13201,-0.20542,1,0
4,PORE COMPLEX,0.020205,-0.13202,-0.12778,1,0
4,HELICASE ACTIVITY,0.0022992,-0.13226,-0.14496,1,0
4,CELL DIVISION,0.016734,-0.13297,-0.17371,1,0
4,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.016734,-0.13307,-0.13853,1,0
4,REACTOME G2 M CHECKPOINTS,0.031748,-0.13364,-0.10929,1,0
4,KINETOCHORE,0.033166,-0.13463,-0.10222,1,0
4,GLUTAMATE SIGNALING PATHWAY,0.042857,-0.13588,-0.21167,1,0
4,CHROMOSOMEPERICENTRIC REGION,0.029719,-0.1366,-0.10227,1,0
4,REACTOME MRNA SPLICING MINOR PATHWAY,0.010506,-0.13807,-0.12453,1,0
4,RNA SPLICING,0.0013872,-0.13822,-0.12461,1,0
4,PID RETINOIC ACID PATHWAY,0.025414,-0.13836,-0.14897,1,0
4,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.0062634,-0.13881,-0.13102,1,0
4,CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.015574,-0.13945,-0.16401,1,0
4,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.0011199,-0.14001,-0.14294,1,0
4,DNA HELICASE ACTIVITY,0.0024367,-0.14166,-0.1644,1,0
4,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.018398,-0.14448,-0.10426,1,0
4,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.0016129,-0.14574,-0.15485,1,0
4,NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.014138,-0.14619,-0.19679,1,0
4,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.041093,-0.14685,-0.10315,1,0
4,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,5.2139e-05,-0.14813,-0.16763,1,0
4,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.03939,-0.14934,-0.11649,1,0
4,MRNA SPLICE SITE SELECTION,0.012203,-0.14973,-0.15131,1,0
4,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.020205,-0.15459,-0.16238,1,0
4,REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.031059,-0.15619,-0.30126,1,0
4,SPINDLE,0.010506,-0.15632,-0.17152,1,0
4,STEROID HORMONE RECEPTOR BINDING,0.029068,-0.15922,-0.15732,1,0
4,REACTOME TRANSCRIPTION,0.0042883,-0.16209,-0.12591,1,0
4,BIOCARTA P27 PATHWAY,0.034637,-0.16352,-0.16034,1,0
4,G1 PHASE OF MITOTIC CELL CYCLE,0.017969,-0.16513,-0.18926,1,0
4,COLLAGEN,0.014486,-0.16737,-0.28976,1,0
4,BIOCARTA CHREBP2 PATHWAY,0.0013457,-0.17192,-0.16584,1,0
4,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.0013872,-0.17324,-0.18356,1,0
4,KEGG BASAL TRANSCRIPTION FACTORS,0.0013457,-0.17591,-0.14516,1,0
4,REACTOME MITOTIC G2 G2 M PHASES,0.0023671,-0.17684,-0.13027,1,0
4,POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.0031536,-0.1771,-0.23994,1,0
4,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.042857,-0.17976,-0.15995,1,0
4,SPINDLE POLE,0.041093,-0.18123,-0.13257,1,0
4,DNA INTEGRITY CHECKPOINT,0.00049035,-0.18304,-0.1974,1,0
4,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0022332,-0.18382,-0.19912,1,0
4,S PHASE,0.0057817,-0.18581,-0.14886,1,0
4,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.0021689,-0.1887,-0.21353,1,0
4,BIOCARTA MCM PATHWAY,0.012508,-0.19024,-0.1775,1,0
4,NUCLEAR PORE,0.0062634,-0.19294,-0.16507,1,0
4,ACTIN FILAMENT POLYMERIZATION,0.023741,-0.19645,-0.18512,1,0
4,MITOTIC CELL CYCLE CHECKPOINT,0.0010206,-0.19892,-0.21162,1,0
4,REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS,0.036164,-0.19948,-0.20573,1,0
4,BIOCARTA ARF PATHWAY,0.00353,-0.19977,-0.23504,1,0
4,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.0011199,-0.20065,-0.22821,1,0
4,BIOCARTA AKAP13 PATHWAY,0.0085714,-0.20205,-0.24157,1,0
4,RRNA METABOLIC PROCESS,0.045624,-0.20366,-0.16666,1,0
4,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.00072223,-0.21007,-0.20457,1,0
4,MAINTENANCE OF CELLULAR LOCALIZATION,0.0060989,-0.21675,-0.19571,1,0
4,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.0049174,-0.2265,-0.20441,1,0
4,RRNA PROCESSING,0.038561,-0.22719,-0.18647,1,0
4,SPINDLE MICROTUBULE,0.001872,-0.22852,-0.20118,1,0
4,MICROTUBULE BINDING,0.00019079,-0.22998,-0.24543,1,0
4,REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1,0.0017641,-0.23103,-0.23316,1,0
4,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.0046564,-0.23137,-0.24504,1,0
4,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.0067808,-0.23222,-0.16073,1,0
4,CYTOKINESIS,0.0030654,-0.23262,-0.22475,1,0
4,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.009256,-0.23303,-0.26908,1,0
4,REACTOME SIGNALING BY BMP,0.0090226,-0.23471,-0.23685,1,0
4,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.010245,-0.23609,-0.21481,1,0
4,BIOCARTA SARS PATHWAY,0.030383,-0.23703,-0.18319,1,0
4,GLIOGENESIS,0.025414,-0.24135,-0.20331,1,0
4,DEVELOPMENTAL GROWTH,0.018836,-0.24268,-0.22358,1,0
4,PROTEIN POLYMERIZATION,0.0071468,-0.24409,-0.20341,1,0
4,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,5.0226e-05,-0.24451,-0.27359,1,0
4,MAINTENANCE OF CELLULAR PROTEIN LOCALIZATION,0.0034322,-0.2461,-0.22386,1,0
4,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.0014299,-0.25025,-0.23947,1,0
4,SYNAPSE PART,0.0030654,-0.25109,-0.2575,1,0
4,ANCHORED TO MEMBRANE,0.0054795,-0.25453,-0.32387,1,0
4,ANCHORED TO PLASMA MEMBRANE,0.0054795,-0.25453,-0.32387,1,0
4,COFACTOR TRANSPORTER ACTIVITY,0.0029794,-0.26046,-0.31117,1,0
4,S PHASE OF MITOTIC CELL CYCLE,0.0047853,-0.26157,-0.21016,1,0
4,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.0062634,-0.26294,-0.25393,1,0
4,NICOTINIC ACETYLCHOLINE GATED RECEPTOR CHANNEL COMPLEX,0.012203,-0.26709,-0.31566,1,0
4,NICOTINIC ACETYLCHOLINE ACTIVATED CATION SELECTIVE CHANNEL ACTIVITY,0.012203,-0.26709,-0.31566,1,0
4,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00353,-0.27093,-0.19036,1,0
4,MAINTENANCE OF PROTEIN LOCALIZATION,0.0013872,-0.27712,-0.24294,1,0
4,REGULATION OF CELL MIGRATION,0.00029782,-0.27866,-0.36772,1,0
4,GABA RECEPTOR ACTIVITY,0.0026572,-0.27905,-0.31765,1,0
4,NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0023671,-0.28837,-0.24501,1,0
4,REACTOME SIGNALING BY FGFR3 MUTANTS,0.00012074,-0.29596,-0.28839,1,0
4,BIOCARTA SKP2E2F PATHWAY,0.0075304,-0.33322,-0.2792,1,0
4,BIOCARTA THELPER PATHWAY,0.013798,-0.33436,-0.22182,1,0
4,BIOCARTA CARM1 PATHWAY,0.0047853,-0.34099,-0.24495,1,0
4,MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0025817,-0.35065,-0.32094,1,0
4,REACTOME CRMPS IN SEMA3A SIGNALING,0.041967,-0.35248,-0.26179,1,0
4,CELL MATRIX JUNCTION,3.4421e-05,-0.44137,-0.43195,1,0
4,CELL SUBSTRATE ADHERENS JUNCTION,0.00021909,-0.45086,-0.39033,1,0
4,NEGATIVE REGULATION OF CELL MIGRATION,0.00023468,-0.46312,-0.38625,1,0
4,FOCAL ADHESION,7.8282e-05,-0.56859,-0.48143,1,0
4,PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.088862,0.52484,0.26387,0,1
4,VESICLE LOCALIZATION,0.11039,0.30676,0.1504,0,1
4,REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY,0.065563,0.27147,0.20977,0,1
4,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.097379,0.26631,0.1851,0,1
4,BIOCARTA BARRESTIN PATHWAY,0.082489,0.23861,0.18213,0,1
4,T CELL DIFFERENTIATION,0.11636,0.21524,0.10425,0,1
4,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.054842,0.20795,0.19117,0,1
4,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.0695,0.1998,0.27505,0,1
4,BIOCARTA PS1 PATHWAY,0.075049,0.19724,0.12325,0,1
4,MYOBLAST DIFFERENTIATION,0.059411,0.1936,0.16378,0,1
4,REACTOME TIE2 SIGNALING,0.20621,0.19128,0.10151,0,1
4,NUCLEAR UBIQUITIN LIGASE COMPLEX,0.12259,0.19063,0.083463,0,1
4,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.15015,0.18614,0.15619,0,1
4,REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX,0.052669,0.18506,0.16991,0,1
4,OXIDOREDUCTASE ACTIVITY GO 0016705,0.059411,0.18355,0.19282,0,1
4,OXYGEN BINDING,0.21579,0.18335,0.10825,0,1
4,REACTOME IL 7 SIGNALING,0.18508,0.17946,0.10193,0,1
4,BIOCARTA CCR5 PATHWAY,0.057089,0.17929,0.20331,0,1
4,PEROXISOMAL MEMBRANE,0.070855,0.17469,0.11856,0,1
4,MICROBODY MEMBRANE,0.070855,0.17469,0.11856,0,1
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.11434,0.16467,0.10649,0,1
4,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.077957,0.16102,0.12021,0,1
4,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.063042,0.15706,0.13342,0,1
4,REACTOME ALPHA LINOLENIC ACID ALA METABOLISM,0.18219,0.14762,0.085131,0,1
4,VOLTAGE GATED SODIUM CHANNEL ACTIVITY,0.070855,0.14208,0.12935,0,1
4,BIOCARTA SPRY PATHWAY,0.11434,0.14167,0.13612,0,1
4,INTERMEDIATE FILAMENT CYTOSKELETON,0.065563,0.1391,0.1094,0,1
4,INTERMEDIATE FILAMENT,0.065563,0.1391,0.1094,0,1
4,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.10096,0.13551,0.11464,0,1
4,BIOCARTA BARR MAPK PATHWAY,0.26847,0.13357,0.092761,0,1
4,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.2839,0.13291,0.095013,0,1
4,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.12689,0.13171,0.06335,0,1
4,PID NOTCH PATHWAY,0.2839,0.1295,0.049065,0,1
4,DNA MODIFICATION,0.070855,0.12859,0.16364,0,1
4,STRIATED MUSCLE DEVELOPMENT,0.41842,0.12762,0.045357,0,1
4,PID TCRCALCIUMPATHWAY,0.14769,0.12699,0.1192,0,1
4,REGULATION OF IMMUNE SYSTEM PROCESS,0.061812,0.12639,0.072395,0,1
4,BIOCARTA HER2 PATHWAY,0.073629,0.12463,0.11784,0,1
4,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.061812,0.12443,0.12323,0,1
4,SEROTONIN RECEPTOR ACTIVITY,0.04854,0.12378,0.082805,0,1
4,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.099158,0.12251,0.049948,0,1
4,CYTOCHROME C OXIDASE ACTIVITY,0.055956,0.12166,0.11726,0,1
4,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.15264,0.12157,0.12284,0,1
4,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.10096,0.12013,0.10875,0,1
4,KEGG THYROID CANCER,0.19095,0.11828,0.086119,0,1
4,BIOCARTA TGFB PATHWAY,0.23245,0.11767,0.054925,0,1
4,ER NUCLEAR SIGNALING PATHWAY,0.46512,0.11757,0.040266,0,1
4,NF KAPPAB BINDING,0.066855,0.1154,0.12774,0,1
4,MITOCHONDRIAL OUTER MEMBRANE,0.066855,0.11391,0.10489,0,1
4,BIOCARTA PPARA PATHWAY,0.0695,0.10875,0.086487,0,1
4,HORMONE METABOLIC PROCESS,0.11434,0.10868,0.13048,0,1
4,SULFOTRANSFERASE ACTIVITY,0.076492,0.10691,0.10816,0,1
4,UBIQUITIN CYCLE,0.050569,0.10632,0.091459,0,1
4,LEUKOCYTE ACTIVATION,0.20621,0.1046,0.044921,0,1
4,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.11235,0.1045,0.062719,0,1
4,PID RET PATHWAY,0.088862,0.10443,0.10516,0,1
4,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.061812,0.10434,0.14555,0,1
4,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.19393,0.10378,0.064348,0,1
4,PHOSPHATASE BINDING,0.85082,0.1035,0.009525,0,1
4,CELL ACTIVATION,0.084046,0.10313,0.05558,0,1
4,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.068167,0.10228,0.072565,0,1
4,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.093897,0.10173,0.1339,0,1
4,BIOCARTA BARRESTIN SRC PATHWAY,0.56075,0.1009,0.03861,0,1
4,VESICLE MEDIATED TRANSPORT,0.063042,0.10063,0.071662,0,1
4,REACTOME SIGNALING BY GPCR,0.077957,0.10027,0.052049,0,1
4,PID LYSOPHOSPHOLIPID PATHWAY,0.097379,0.099303,0.086958,0,1
4,KINASE BINDING,0.41341,0.098708,0.049646,0,1
4,REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,0.23245,0.098696,0.090081,0,1
4,BASE EXCISION REPAIR,0.188,0.098691,0.063627,0,1
4,PID ECADHERIN NASCENTAJ PATHWAY,0.22905,0.098632,0.058173,0,1
4,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.12689,0.098241,0.044666,0,1
4,CELLULAR PROTEIN CATABOLIC PROCESS,0.15517,0.097672,0.04476,0,1
4,BIOCARTA LONGEVITY PATHWAY,0.29992,0.096885,0.040179,0,1
4,ACTIN CYTOSKELETON,0.055956,0.095746,0.074648,0,1
4,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.2,0.094254,0.042336,0,1
4,PROTEIN STABILIZATION,0.12689,0.093926,0.17093,0,1
4,REACTOME AMINE LIGAND BINDING RECEPTORS,0.076492,0.093693,0.092465,0,1
4,REGULATION OF PROTEIN STABILITY,0.092194,0.093504,0.15223,0,1
4,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.097379,0.093467,0.047974,0,1
4,PID ERBB2ERBB3PATHWAY,0.090515,0.090787,0.061351,0,1
4,PID WNT NONCANONICAL PATHWAY,0.19393,0.089738,0.095073,0,1
4,REGULATION OF IMMUNE EFFECTOR PROCESS,0.16559,0.089584,0.077847,0,1
4,ATP BINDING,0.061812,0.087588,0.055512,0,1
4,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.16828,0.086872,0.062689,0,1
4,KEGG CALCIUM SIGNALING PATHWAY,0.25729,0.08584,0.035712,0,1
4,PROTEIN KINASE BINDING,0.2,0.083095,0.073523,0,1
4,PID SMAD2 3NUCLEARPATHWAY,0.39858,0.081006,0.015006,0,1
4,REACTOME BASE EXCISION REPAIR,0.04854,0.080857,0.072852,0,1
4,STRUCTURE SPECIFIC DNA BINDING,0.188,0.080413,0.0551,0,1
4,ENZYME BINDING,0.13814,0.077325,0.050016,0,1
4,REACTOME SIGNALING BY NOTCH1,0.084046,0.074454,0.10008,0,1
4,ANATOMICAL STRUCTURE MORPHOGENESIS,0.23937,0.071434,0.038861,0,1
4,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.072231,0.071394,0.085379,0,1
4,REACTOME PI METABOLISM,0.077957,0.067989,0.078377,0,1
4,REGULATION OF LYMPHOCYTE ACTIVATION,0.69061,0.067844,-0.0067068,0,1
4,VITAMIN METABOLIC PROCESS,0.20621,0.067764,0.1559,0,1
4,PID CDC42 PATHWAY,0.25001,0.066953,0.059097,0,1
4,OUTER MEMBRANE,0.19095,0.066696,0.070209,0,1
4,TRANSCRIPTION ACTIVATOR ACTIVITY,0.16828,0.066104,0.0282,0,1
4,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.17653,0.064288,0.05438,0,1
4,BIOCARTA FMLP PATHWAY,0.072231,0.062373,0.088435,0,1
4,PROTEIN AMINO ACID PHOSPHORYLATION,0.1028,0.061379,0.051345,0,1
4,PHOSPHORYLATION,0.050569,0.060663,0.059987,0,1
4,POST TRANSLATIONAL PROTEIN MODIFICATION,0.066855,0.055974,0.057622,0,1
4,N ACETYLTRANSFERASE ACTIVITY,0.12049,0.055611,0.078249,0,1
4,BIOPOLYMER METABOLIC PROCESS,0.068167,0.054273,0.039677,0,1
4,BEHAVIOR,0.080955,0.054062,0.045255,0,1
4,RESPONSE TO ENDOGENOUS STIMULUS,0.095625,0.046498,0.035818,0,1
4,KEGG INSULIN SIGNALING PATHWAY,0.12259,0.045562,0.044145,0,1
4,BIOCARTA ERK5 PATHWAY,0.93377,0.043736,-0.026353,0,1
4,KEGG PHENYLALANINE METABOLISM,1.4039e-05,0.44889,0.45141,0,0
4,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.00074557,0.44032,0.46241,0,0
4,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL,0.00034072,0.40759,0.434,0,0
4,REACTOME THE ACTIVATION OF ARYLSULFATASES,0.0021062,0.40294,0.32693,0,0
4,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00067758,0.39308,0.45857,0,0
4,REACTOME PEPTIDE HORMONE BIOSYNTHESIS,0.00057693,0.38272,0.5039,0,0
4,LEUKOCYTE CHEMOTAXIS,0.00017796,0.36902,0.46189,0,0
4,HOMOPHILIC CELL ADHESION,0.024846,0.36659,0.29228,0,0
4,REACTOME INSULIN RECEPTOR RECYCLING,2.0033e-05,0.33006,0.32771,0,0
4,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,1.5201e-05,0.31599,0.31721,0,0
4,NEUROPEPTIDE SIGNALING PATHWAY,0.021165,0.30656,0.33723,0,0
4,BIOCARTA ACE2 PATHWAY,0.014486,0.28226,0.4076,0,0
4,INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.11039,0.27476,0.10214,0,0
4,BIOCARTA CDMAC PATHWAY,0.0062634,0.26079,0.2292,0,0
4,APOPTOTIC MITOCHONDRIAL CHANGES,0.033894,0.2502,0.23664,0,0
4,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00018427,0.24995,0.24496,0,0
4,CARBOXY LYASE ACTIVITY,0.00052342,0.24655,0.26507,0,0
4,DETECTION OF CHEMICAL STIMULUS,0.03245,0.24213,0.24646,0,0
4,CALCIUM ION TRANSPORT,0.053746,0.24148,0.15387,0,0
4,HORMONE SECRETION,0.011326,0.23933,0.32431,0,0
4,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,9.389e-05,0.23772,0.286,0,0
4,SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY,0.05161,0.22213,0.19614,0,0
4,CELL PROJECTION PART,0.0026572,0.2195,0.24176,0,0
4,REACTOME REGULATION OF SIGNALING BY CBL,0.02166,0.21921,0.17389,0,0
4,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00063551,0.20845,0.20105,0,0
4,BIOCARTA PARKIN PATHWAY,0.042857,0.20621,0.17884,0,0
4,REGULATION OF ACTION POTENTIAL,0.011326,0.20152,0.1829,0,0
4,REACTOME REGULATED PROTEOLYSIS OF P75NTR,0.11039,0.1977,0.12401,0,0
4,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.037747,0.19589,0.22128,0,0
4,MUSCLE CELL DIFFERENTIATION,0.037747,0.19561,0.14909,0,0
4,SERINE TYPE PEPTIDASE ACTIVITY,0.0073363,0.19256,0.27896,0,0
4,KEGG CIRCADIAN RHYTHM MAMMAL,0.054842,0.19109,0.24287,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.14285,0.19077,0.10348,0,0
4,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.0017641,0.18935,0.30069,0,0
4,RESPONSE TO CARBOHYDRATE STIMULUS,0.049546,0.18918,0.17473,0,0
4,BIOCARTA VITCB PATHWAY,0.24288,0.18432,0.22368,0,0
4,SULFURIC ESTER HYDROLASE ACTIVITY,0.022165,0.18392,0.25182,0,0
4,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.079444,0.1834,0.081604,0,0
4,BIOCARTA PLATELETAPP PATHWAY,0.14769,0.18251,0.2186,0,0
4,REACTOME BILE ACID AND BILE SALT METABOLISM,0.0013054,0.18052,0.30527,0,0
4,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.077957,0.17991,0.17064,0,0
4,REACTOME IL 3 5 AND GM CSF SIGNALING,0.0085714,0.17988,0.18502,0,0
4,REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS,0.31232,0.17978,0.086188,0,0
4,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.015953,0.17827,0.23119,0,0
4,KEGG ASTHMA,0.065563,0.17716,0.13142,0,0
4,G2 M TRANSITION OF MITOTIC CELL CYCLE,0.045624,0.17566,0.15759,0,0
4,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.11235,0.17554,0.070864,0,0
4,B CELL ACTIVATION,0.073629,0.17414,0.09146,0,0
4,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.061812,0.17334,0.13406,0,0
4,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.092194,0.17329,0.094841,0,0
4,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.0026572,0.17317,0.30705,0,0
4,FATTY ACID BIOSYNTHETIC PROCESS,0.15517,0.17291,0.12736,0,0
4,KEGG GLUTATHIONE METABOLISM,0.088862,0.17286,0.2332,0,0
4,SECRETION BY CELL,0.00017186,0.1728,0.18529,0,0
4,OXIDOREDUCTASE ACTIVITY GO 0016706,0.14048,0.17279,0.17533,0,0
4,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22235,0.17024,0.085064,0,0
4,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.060602,0.16936,0.21385,0,0
4,CHEMOKINE ACTIVITY,0.016339,0.16914,0.11584,0,0
4,CHEMOKINE RECEPTOR BINDING,0.016339,0.16914,0.11584,0,0
4,REACTOME PHASE II CONJUGATION,0.016734,0.16823,0.22171,0,0
4,PID INTEGRIN5 PATHWAY,0.26098,0.16822,0.047128,0,0
4,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0062634,0.16817,0.16927,0,0
4,PID ERA GENOMIC PATHWAY,0.00042998,0.16667,0.18677,0,0
4,GLYCOSPHINGOLIPID METABOLIC PROCESS,0.31653,0.16599,0.104,0,0
4,PHOSPHOLIPASE A2 ACTIVITY,0.0071468,0.16571,0.16245,0,0
4,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.054842,0.16474,0.11879,0,0
4,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.020205,0.16352,0.1636,0,0
4,PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.20937,0.16344,0.085608,0,0
4,SECRETORY PATHWAY,0.0028141,0.16261,0.14031,0,0
4,REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,0.16559,0.16086,0.078785,0,0
4,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.084046,0.16007,0.074042,0,0
4,NEGATIVE REGULATION OF DNA REPLICATION,0.34256,0.15934,0.070726,0,0
4,REACTOME CS DS DEGRADATION,0.41341,0.15681,0.045014,0,0
4,REGULATION OF NEUROTRANSMITTER LEVELS,0.40349,0.15651,0.13325,0,0
4,SA MMP CYTOKINE CONNECTION,0.12259,0.1548,0.054093,0,0
4,CASPASE REGULATOR ACTIVITY,0.085627,0.15448,0.10608,0,0
4,KEGG GALACTOSE METABOLISM,0.93377,0.15329,0.0044696,0,0
4,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.015203,0.15313,0.21559,0,0
4,PID SYNDECAN 4 PATHWAY,0.23589,0.1522,0.069297,0,0
4,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.076492,0.15156,0.11651,0,0
4,VITAMIN BINDING,0.17653,0.15099,0.1238,0,0
4,KEGG TYROSINE METABOLISM,0.00050664,0.15075,0.2004,0,0
4,CARBON OXYGEN LYASE ACTIVITY,0.021165,0.14773,0.13513,0,0
4,PID INTEGRIN CS PATHWAY,0.11841,0.14751,0.10497,0,0
4,PID ERBB NETWORK PATHWAY,0.39371,0.1471,0.069856,0,0
4,ANTI APOPTOSIS,0.075049,0.14678,0.07515,0,0
4,BIOCARTA PML PATHWAY,0.090515,0.14649,0.087837,0,0
4,PID ECADHERIN STABILIZATION PATHWAY,0.12049,0.14558,0.10267,0,0
4,RESPIRATORY GASEOUS EXCHANGE,0.14048,0.14427,0.10335,0,0
4,BIOCARTA INTEGRIN PATHWAY,0.12259,0.14345,0.049898,0,0
4,REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE,0.47049,0.14318,0.1685,0,0
4,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.090515,0.14296,0.13094,0,0
4,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.090515,0.14288,0.097841,0,0
4,REACTOME INTEGRATION OF ENERGY METABOLISM,0.043763,0.14276,0.11707,0,0
4,GLYCOLIPID METABOLIC PROCESS,0.05824,0.14251,0.23429,0,0
4,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.099158,0.14213,0.09043,0,0
4,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0085714,0.13988,0.16362,0,0
4,CARBOHYDRATE CATABOLIC PROCESS,0.0085714,0.13988,0.16362,0,0
4,PID UPA UPAR PATHWAY,0.38408,0.13931,-0.0012421,0,0
4,REACTOME LIPOPROTEIN METABOLISM,0.079444,0.13891,0.12975,0,0
4,ST GAQ PATHWAY,0.092194,0.1385,0.090683,0,0
4,BIOCARTA DREAM PATHWAY,0.17653,0.1384,0.11288,0,0
4,GROWTH FACTOR ACTIVITY,0.097379,0.13836,0.077188,0,0
4,PID IL8CXCR1 PATHWAY,0.40349,0.13812,0.064953,0,0
4,ISOPRENOID METABOLIC PROCESS,0.16294,0.13787,0.21745,0,0
4,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.12908,0.13758,0.085474,0,0
4,REACTOME P38MAPK EVENTS,0.02268,0.13626,0.16562,0,0
4,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.10465,0.13624,0.17034,0,0
4,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.33812,0.13577,0.010824,0,0
4,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.041093,0.13548,0.17882,0,0
4,POTASSIUM CHANNEL ACTIVITY,0.11841,0.13426,0.18769,0,0
4,AXON,0.46512,0.13422,0.088153,0,0
4,ORGANELLAR SMALL RIBOSOMAL SUBUNIT,0.05824,0.13397,0.13526,0,0
4,MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT,0.05824,0.13397,0.13526,0,0
4,SMALL RIBOSOMAL SUBUNIT,0.05824,0.13397,0.13526,0,0
4,T CELL ACTIVATION,0.12259,0.1335,0.070744,0,0
4,DETECTION OF STIMULUS,0.080955,0.13326,0.11217,0,0
4,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.065563,0.13313,0.14757,0,0
4,KEGG ENDOCYTOSIS,0.11039,0.13243,0.085177,0,0
4,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.097379,0.13141,0.118,0,0
4,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.097379,0.13141,0.118,0,0
4,REGULATION OF CELLULAR COMPONENT SIZE,0.20937,0.13102,0.11935,0,0
4,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.097379,0.13063,0.11437,0,0
4,PID TCRRASPATHWAY,0.11235,0.1302,0.12977,0,0
4,RUFFLE,0.62113,0.12971,0.02198,0,0
4,BIOCARTA FAS PATHWAY,0.14048,0.12955,0.076341,0,0
4,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.021165,0.12925,0.19094,0,0
4,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.021165,0.12925,0.19094,0,0
4,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.064293,0.12869,0.18763,0,0
4,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.29586,0.12826,0.086658,0,0
4,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.0071468,0.12789,0.10568,0,0
4,BIOCARTA CHEMICAL PATHWAY,0.04854,0.12748,0.1528,0,0
4,3 5 EXONUCLEASE ACTIVITY,0.0037331,0.12712,0.2061,0,0
4,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.013139,0.1271,0.12615,0,0
4,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,0.15517,0.12705,0.095751,0,0
4,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.052669,0.12649,0.12186,0,0
4,ACTIN FILAMENT,0.92682,0.1262,-0.0077851,0,0
4,INTERLEUKIN BINDING,0.063042,0.12527,0.08761,0,0
4,CARBOHYDRATE TRANSPORT,0.082489,0.12526,0.11858,0,0
4,INORGANIC ANION TRANSPORT,0.016339,0.12524,0.23295,0,0
4,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.055956,0.1238,0.15298,0,0
4,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.065563,0.12366,0.10665,0,0
4,LYMPHOCYTE ACTIVATION,0.11636,0.12353,0.062378,0,0
4,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.007729,0.12302,0.15633,0,0
4,TISSUE MORPHOGENESIS,0.80989,0.12297,-0.063462,0,0
4,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.15015,0.12232,0.11347,0,0
4,POSITIVE REGULATION OF SECRETION,0.041093,0.12204,0.17209,0,0
4,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.010506,0.12143,0.14425,0,0
4,BIOCARTA PAR1 PATHWAY,0.36991,0.12118,0.080863,0,0
4,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.11434,0.12102,0.099152,0,0
4,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.063042,0.12096,0.11974,0,0
4,ST STAT3 PATHWAY,0.10845,0.12064,0.13115,0,0
4,PID INSULIN GLUCOSE PATHWAY,0.25001,0.12039,0.063933,0,0
4,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.23245,0.11914,0.035201,0,0
4,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.22905,0.11911,0.061493,0,0
4,MEIOTIC RECOMBINATION,0.31653,0.11885,0.066141,0,0
4,BIOCARTA FIBRINOLYSIS PATHWAY,0.56666,0.11863,0.085202,0,0
4,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.0016129,0.1185,0.14761,0,0
4,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.010245,0.11845,0.15183,0,0
4,PHOSPHOLIPASE C ACTIVATION,0.041093,0.11744,0.14071,0,0
4,MITOCHONDRIAL TRANSPORT,0.11841,0.11695,0.069171,0,0
4,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.188,0.11651,0.065372,0,0
4,REACTOME ZINC TRANSPORTERS,0.02843,0.11599,0.19203,0,0
4,REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN,0.40843,0.11569,0.053645,0,0
4,BIOCARTA HIF PATHWAY,0.1313,0.1155,0.14846,0,0
4,POSITIVE REGULATION OF PHOSPHORYLATION,0.17099,0.11369,0.053328,0,0
4,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.72313,0.11345,0.029395,0,0
4,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.42347,0.11312,0.054833,0,0
4,BIOCARTA SALMONELLA PATHWAY,0.2839,0.11304,0.068984,0,0
4,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.22235,0.11246,0.082821,0,0
4,REGULATION OF PROTEIN MODIFICATION PROCESS,0.090515,0.11202,0.077208,0,0
4,PHOSPHOLIPASE C ACTIVITY,0.090515,0.11197,0.11343,0,0
4,PID RHOA REG PATHWAY,0.076492,0.11191,0.091755,0,0
4,REGULATION OF ACTIN FILAMENT LENGTH,0.21905,0.1115,0.13537,0,0
4,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0059384,0.11068,0.13465,0,0
4,RESPONSE TO OXIDATIVE STRESS,0.29184,0.11022,0.07355,0,0
4,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.097379,0.1091,0.08711,0,0
4,REACTOME ENDOGENOUS STEROLS,0.38408,0.10896,0.078841,0,0
4,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,0.059411,0.10887,0.095959,0,0
4,KEGG PARKINSONS DISEASE,0.076492,0.10867,0.095562,0,0
4,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.22905,0.10865,0.079483,0,0
4,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.016734,0.10844,0.16216,0,0
4,CLATHRIN COATED VESICLE,0.054842,0.10735,0.096019,0,0
4,ENERGY RESERVE METABOLIC PROCESS,0.40843,0.10727,0.051274,0,0
4,PROTEASOME COMPLEX,0.188,0.10714,0.088135,0,0
4,KINASE REGULATOR ACTIVITY,0.079444,0.10571,0.17113,0,0
4,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.079444,0.10543,0.087717,0,0
4,REACTOME SIGNALING BY SCF KIT,0.012203,0.10519,0.16996,0,0
4,MEIOSIS I,0.39371,0.10515,0.053212,0,0
4,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.10845,0.1051,0.073229,0,0
4,KEGG TIGHT JUNCTION,0.082489,0.10497,0.084577,0,0
4,UNFOLDED PROTEIN BINDING,0.064293,0.10491,0.10279,0,0
4,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,0.35607,0.10485,0.053471,0,0
4,PROTEIN COMPLEX DISASSEMBLY,0.37932,0.10479,0.019793,0,0
4,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.21579,0.10465,0.11684,0,0
4,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.24643,0.1045,0.15778,0,0
4,PROTEIN TETRAMERIZATION,0.36526,0.10334,0.091158,0,0
4,MONOCARBOXYLIC ACID TRANSPORT,0.21905,0.10299,0.17147,0,0
4,INACTIVATION OF MAPK ACTIVITY,0.15517,0.10278,0.16543,0,0
4,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.43367,0.10238,0.0052153,0,0
4,AMINE METABOLIC PROCESS,0.016734,0.1022,0.10423,0,0
4,CATION TRANSPORTING ATPASE ACTIVITY,0.17374,0.10208,0.10173,0,0
4,RIBOSOME,0.041967,0.10198,0.13997,0,0
4,DOUBLE STRANDED DNA BINDING,0.60272,0.10135,0.013246,0,0
4,BIOCARTA EGFR SMRTE PATHWAY,0.22905,0.1012,0.10829,0,0
4,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.085627,0.10113,0.081526,0,0
4,REGULATION OF SECRETION,0.01282,0.10104,0.18745,0,0
4,EPIDERMIS DEVELOPMENT,0.050569,0.10044,0.052353,0,0
4,BIOCARTA TID PATHWAY,0.25363,0.10043,0.059578,0,0
4,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.24643,0.10038,0.1072,0,0
4,BIOCARTA BAD PATHWAY,0.43883,0.10026,0.082855,0,0
4,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.013139,0.10023,0.15589,0,0
4,CELLULAR CATABOLIC PROCESS,0.0031536,0.1,0.11791,0,0
4,POTASSIUM ION TRANSPORT,0.11434,0.099958,0.16246,0,0
4,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.15264,0.09972,0.076682,0,0
4,PID P38ALPHABETAPATHWAY,0.076492,0.099447,0.11081,0,0
4,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.040234,0.098585,0.099928,0,0
4,PID PDGFRAPATHWAY,0.3746,0.098539,0.017921,0,0
4,MEMBRANE ORGANIZATION AND BIOGENESIS,0.12908,0.098516,0.057447,0,0
4,STRUCTURAL CONSTITUENT OF MUSCLE,0.082489,0.098475,0.11604,0,0
4,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.099158,0.098059,0.1185,0,0
4,BIOCARTA TFF PATHWAY,0.42855,0.09754,0.045376,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.37932,0.097177,0.06649,0,0
4,BIOCARTA ARAP PATHWAY,0.96163,0.097133,-0.022574,0,0
4,REACTOME CIRCADIAN CLOCK,0.16559,0.097097,0.078722,0,0
4,PEPTIDYL TYROSINE MODIFICATION,0.11235,0.096967,0.061308,0,0
4,REACTOME GAP JUNCTION ASSEMBLY,0.20937,0.09671,0.043688,0,0
4,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.19393,0.096356,0.1969,0,0
4,BIOCARTA LAIR PATHWAY,0.24643,0.096302,0.022805,0,0
4,PID THROMBIN PAR4 PATHWAY,0.038561,0.096153,0.19315,0,0
4,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,0.15773,0.096076,0.10012,0,0
4,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.013798,0.095774,0.14376,0,0
4,SKELETAL MUSCLE DEVELOPMENT,0.12259,0.095616,0.10558,0,0
4,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.33373,0.095562,0.030478,0,0
4,WOUND HEALING,0.11434,0.095003,0.13051,0,0
4,CELLULAR BIOSYNTHETIC PROCESS,0.20621,0.094972,0.067916,0,0
4,INTERACTION WITH HOST,0.56666,0.094938,0.019113,0,0
4,ADP BINDING,0.085627,0.094843,0.17342,0,0
4,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.16559,0.094589,0.21703,0,0
4,NUCLEOTIDE METABOLIC PROCESS,0.22905,0.094138,0.065659,0,0
4,ANTIPORTER ACTIVITY,0.40349,0.094036,0.069146,0,0
4,AROMATIC COMPOUND METABOLIC PROCESS,0.13355,0.093784,0.085247,0,0
4,ST GRANULE CELL SURVIVAL PATHWAY,0.30402,0.093491,0.11181,0,0
4,PID HDAC CLASSIII PATHWAY,0.11039,0.093447,0.13222,0,0
4,SYNAPTIC VESICLE,0.97557,0.092751,0.0050603,0,0
4,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.085627,0.092541,0.13337,0,0
4,CHANNEL REGULATOR ACTIVITY,0.097379,0.092501,0.12058,0,0
4,PID AR TF PATHWAY,0.038561,0.092309,0.086623,0,0
4,AMINOPEPTIDASE ACTIVITY,0.22235,0.092122,0.08275,0,0
4,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.099158,0.092005,0.15565,0,0
4,PID AR NONGENOMIC PATHWAY,0.35607,0.091882,0.045091,0,0
4,REACTOME ACTIVATION OF RAC,0.56666,0.091842,0.022976,0,0
4,KEGG STARCH AND SUCROSE METABOLISM,0.24643,0.09164,0.056799,0,0
4,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,0.049546,0.091429,0.098849,0,0
4,HYDRO LYASE ACTIVITY,0.077957,0.0908,0.11316,0,0
4,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.10465,0.090766,0.059883,0,0
4,PEPTIDYL AMINO ACID MODIFICATION,0.082489,0.090647,0.04989,0,0
4,NUCLEOTIDE KINASE ACTIVITY,0.21905,0.090256,0.13528,0,0
4,CATABOLIC PROCESS,0.0051916,0.089981,0.10635,0,0
4,PID PRLSIGNALINGEVENTSPATHWAY,0.087232,0.089421,0.15238,0,0
4,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.28785,0.089293,0.077069,0,0
4,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,0.24643,0.088529,0.069886,0,0
4,KEGG PENTOSE PHOSPHATE PATHWAY,0.063042,0.088463,0.16843,0,0
4,BIOCARTA DNAFRAGMENT PATHWAY,0.32938,0.088388,0.078362,0,0
4,BIOCARTA PROTEASOME PATHWAY,0.57857,0.088178,0.02254,0,0
4,KEGG PATHWAYS IN CANCER,0.14769,0.088043,0.052269,0,0
4,BASOLATERAL PLASMA MEMBRANE,0.57857,0.087966,0.0095936,0,0
4,CELLULAR RESPONSE TO STRESS,0.2,0.087863,0.091418,0,0
4,BIOCARTA CARDIACEGF PATHWAY,0.37932,0.087835,0.11413,0,0
4,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.17374,0.087403,0.082291,0,0
4,BIOCARTA MCALPAIN PATHWAY,0.2,0.087332,0.072431,0,0
4,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.188,0.08688,0.066012,0,0
4,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.15264,0.086778,0.11268,0,0
4,PID CMYB PATHWAY,0.14526,0.086628,0.086297,0,0
4,MAP KINASE ACTIVITY,0.16559,0.086507,0.14461,0,0
4,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.63978,0.086315,0.00056034,0,0
4,REGULATION OF NEURON APOPTOSIS,0.91293,0.086135,0.010736,0,0
4,INTRACELLULAR PROTEIN TRANSPORT,0.1028,0.086041,0.056127,0,0
4,BIOCARTA G2 PATHWAY,0.14526,0.085946,0.10339,0,0
4,BIOCARTA CLASSIC PATHWAY,0.29992,0.08594,0.0016562,0,0
4,KEGG BUTANOATE METABOLISM,0.03939,0.085144,0.22246,0,0
4,PID S1P S1P3 PATHWAY,0.25729,0.08512,0.11508,0,0
4,MACROMOLECULAR COMPLEX DISASSEMBLY,0.31653,0.084914,0.040879,0,0
4,PROTEIN AMINO ACID LIPIDATION,0.017549,0.084695,0.12903,0,0
4,RIBOSOMAL SUBUNIT,0.188,0.084593,0.082817,0,0
4,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.1028,0.084542,0.057323,0,0
4,PID ECADHERIN KERATINOCYTE PATHWAY,0.40349,0.084465,0.061003,0,0
4,ORGANIC ACID TRANSPORT,0.36991,0.084384,0.10568,0,0
4,CARBOXYLIC ACID TRANSPORT,0.36991,0.084384,0.10568,0,0
4,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.027188,0.084287,0.13234,0,0
4,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.049546,0.084261,0.096591,0,0
4,CARBOXYPEPTIDASE ACTIVITY,0.68418,0.083768,0.016029,0,0
4,KEGG PANTOTHENATE AND COA BIOSYNTHESIS,0.37932,0.08375,0.055515,0,0
4,BIOCARTA IL12 PATHWAY,0.65866,0.083615,0.030435,0,0
4,TRANSPORT,0.0023671,0.083586,0.097771,0,0
4,KEGG VEGF SIGNALING PATHWAY,0.088862,0.083444,0.067665,0,0
4,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.099158,0.083408,0.058506,0,0
4,MEIOTIC CELL CYCLE,0.27227,0.083272,0.06452,0,0
4,PID LPA4 PATHWAY,0.0695,0.083154,0.135,0,0
4,LYMPHOCYTE DIFFERENTIATION,0.43883,0.082796,0.023491,0,0
4,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP,0.077957,0.082413,0.2569,0,0
4,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.1028,0.082364,0.053737,0,0
4,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.12259,0.081922,0.086119,0,0
4,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.14526,0.081786,0.11604,0,0
4,BIOCARTA INFLAM PATHWAY,0.25363,0.081541,-0.022968,0,0
4,BIOCARTA PGC1A PATHWAY,0.56075,0.08154,0.0334,0,0
4,REGULATION OF T CELL PROLIFERATION,0.12049,0.081413,0.069766,0,0
4,ECTODERM DEVELOPMENT,0.061812,0.081147,0.046303,0,0
4,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.085627,0.080969,0.084227,0,0
4,REACTOME SIGNALING BY FGFR1 MUTANTS,0.4978,0.080769,0.039597,0,0
4,SPHINGOLIPID METABOLIC PROCESS,0.061812,0.080523,0.10822,0,0
4,CELL CELL SIGNALING,0.014138,0.080187,0.098567,0,0
4,CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.22905,0.080175,0.081974,0,0
4,BIOCARTA EXTRINSIC PATHWAY,0.15015,0.080124,0.38174,0,0
4,SYSTEM PROCESS,0.031748,0.079982,0.074069,0,0
4,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.188,0.079793,0.074085,0,0
4,PID AMB2 NEUTROPHILS PATHWAY,0.46512,0.07975,0.042635,0,0
4,PID HIF1APATHWAY,0.14048,0.079397,0.10635,0,0
4,ANTIGEN BINDING,0.16294,0.079006,0.098363,0,0
4,BIOCARTA ALK PATHWAY,0.41842,0.078425,0.037983,0,0
4,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.17374,0.078136,0.047598,0,0
4,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.29586,0.078115,0.094767,0,0
4,ORGANELLE OUTER MEMBRANE,0.32506,0.077679,0.056072,0,0
4,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.11841,0.077646,0.063494,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.40349,0.077299,0.055465,0,0
4,KINASE ACTIVATOR ACTIVITY,0.47588,0.077288,0.070197,0,0
4,MITOCHONDRIAL MEMBRANE,0.20937,0.077221,0.043391,0,0
4,CATION CHANNEL ACTIVITY,0.12908,0.077109,0.12068,0,0
4,SECOND MESSENGER MEDIATED SIGNALING,0.17653,0.076983,0.044001,0,0
4,REACTOME SYNTHESIS OF PA,0.28785,0.076958,0.043934,0,0
4,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.16032,0.076783,0.067605,0,0
4,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,0.0040578,0.076458,0.11546,0,0
4,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.22235,0.076369,0.11138,0,0
4,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.14769,0.076086,0.050948,0,0
4,REACTOME PURINE METABOLISM,0.22905,0.075971,0.072922,0,0
4,ORGAN MORPHOGENESIS,0.18508,0.075392,0.045389,0,0
4,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.31232,0.075297,0.092156,0,0
4,BIOCARTA ERYTH PATHWAY,0.9686,0.075067,-0.083094,0,0
4,REACTOME EGFR DOWNREGULATION,0.59664,0.074964,0.018538,0,0
4,BIOCARTA UCALPAIN PATHWAY,0.4598,0.074319,0.013718,0,0
4,KEGG MELANOGENESIS,0.073629,0.074184,0.068118,0,0
4,PID INSULIN PATHWAY,0.84397,0.073888,0.0046319,0,0
4,BIOCARTA GATA3 PATHWAY,0.66501,0.07336,0.019591,0,0
4,REGULATION OF T CELL ACTIVATION,0.56075,0.073015,0.0055058,0,0
4,NEURON APOPTOSIS,0.85768,0.072913,-0.01863,0,0
4,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.66501,0.072498,0.0048008,0,0
4,AMINO ACID TRANSPORT,0.48131,0.072058,0.091401,0,0
4,BIOPOLYMER BIOSYNTHETIC PROCESS,0.02268,0.071717,0.1888,0,0
4,REACTOME SIGNAL TRANSDUCTION BY L1,0.56666,0.07142,0.035404,0,0
4,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.25001,0.07141,0.055635,0,0
4,KEGG NITROGEN METABOLISM,0.05161,0.071399,0.146,0,0
4,BIOCARTA MEF2D PATHWAY,0.40843,0.071348,0.091441,0,0
4,REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,0.7495,0.071044,0.09023,0,0
4,PID VEGFR1 2 PATHWAY,0.15517,0.070661,0.078063,0,0
4,PID INTEGRIN1 PATHWAY,0.8303,0.070529,-0.035833,0,0
4,POSITIVE REGULATION OF CASPASE ACTIVITY,0.32077,0.070431,0.057136,0,0
4,PID TCR PATHWAY,0.10654,0.070214,0.068926,0,0
4,ST JNK MAPK PATHWAY,0.12259,0.070132,0.10102,0,0
4,INSULIN RECEPTOR SIGNALING PATHWAY,0.36526,0.070107,0.056443,0,0
4,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.57857,0.069635,-0.032547,0,0
4,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.063042,0.069623,0.10243,0,0
4,REACTOME PKB MEDIATED EVENTS,0.12259,0.069101,0.083037,0,0
4,POSITIVE REGULATION OF MAPKKK CASCADE,0.69707,0.068958,0.028521,0,0
4,REACTOME INFLAMMASOMES,0.48678,0.068423,0.067672,0,0
4,PID CXCR3PATHWAY,0.50896,0.068309,0.02178,0,0
4,POSITIVE REGULATION OF CELL PROLIFERATION,0.049546,0.068071,0.07352,0,0
4,REGULATION OF RHO GTPASE ACTIVITY,0.18508,0.067789,0.084361,0,0
4,PID SHP2 PATHWAY,0.21905,0.067787,0.065087,0,0
4,REACTOME CELL CYCLE CHECKPOINTS,0.19095,0.067657,0.055224,0,0
4,PID S1P S1P1 PATHWAY,0.56075,0.067541,0.016552,0,0
4,PROTEIN UBIQUITINATION,0.27999,0.067508,0.050501,0,0
4,PROTEIN TARGETING TO MITOCHONDRION,0.54321,0.067397,0.017542,0,0
4,REGULATION OF HORMONE SECRETION,0.80312,0.067188,0.10697,0,0
4,BIOCARTA PTEN PATHWAY,0.42855,0.066858,0.037679,0,0
4,MOTOR ACTIVITY,0.14285,0.066603,0.12861,0,0
4,PID P75NTRPATHWAY,0.20937,0.066564,0.052577,0,0
4,PROTEIN PROCESSING,0.085627,0.066468,0.079328,0,0
4,KEGG ECM RECEPTOR INTERACTION,0.3746,0.066363,0.017499,0,0
4,PID CXCR4 PATHWAY,0.19393,0.066313,0.075557,0,0
4,REGULATION OF MAPKKK CASCADE,0.14769,0.066056,0.11434,0,0
4,CELL CORTEX,0.76281,0.065879,0.014155,0,0
4,BIOCARTA CK1 PATHWAY,0.66501,0.065647,-0.070895,0,0
4,BIOCARTA EDG1 PATHWAY,0.23589,0.065533,0.081101,0,0
4,REACTOME CD28 DEPENDENT VAV1 PATHWAY,0.072231,0.065277,0.23337,0,0
4,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.18508,0.064881,0.043114,0,0
4,PEPTIDYL TYROSINE PHOSPHORYLATION,0.16032,0.064859,0.063991,0,0
4,DNA CATABOLIC PROCESS,0.11434,0.064647,0.070818,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.21256,0.064248,0.071418,0,0
4,KEGG RENAL CELL CARCINOMA,0.15773,0.063319,0.063746,0,0
4,DRUG BINDING,0.48131,0.063294,0.057259,0,0
4,NUCLEASE ACTIVITY,0.15015,0.06323,0.043134,0,0
4,BIOCARTA ATRBRCA PATHWAY,0.29992,0.063211,0.042647,0,0
4,REACTOME SEROTONIN RECEPTORS,0.21579,0.063166,0.053271,0,0
4,REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE,0.30402,0.06298,0.08064,0,0
4,BIOCARTA TH1TH2 PATHWAY,0.34256,0.062855,0.010732,0,0
4,APOPTOTIC NUCLEAR CHANGES,0.27999,0.062216,0.05035,0,0
4,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.97557,0.062214,0.021749,0,0
4,REGULATION OF RAS GTPASE ACTIVITY,0.34702,0.062165,0.061642,0,0
4,REACTOME SHC RELATED EVENTS,0.17099,0.062067,0.08783,0,0
4,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.27611,0.06162,0.046933,0,0
4,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE ACTIVITY,0.16828,0.060769,0.096676,0,0
4,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.32938,0.060597,0.048736,0,0
4,INTRACELLULAR TRANSPORT,0.076492,0.060516,0.056975,0,0
4,REACTOME P2Y RECEPTORS,0.4978,0.060438,0.050783,0,0
4,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.1028,0.060279,0.085962,0,0
4,NADH DEHYDROGENASE COMPLEX,0.83713,0.060242,-0.013134,0,0
4,MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I,0.83713,0.060242,-0.013134,0,0
4,RESPIRATORY CHAIN COMPLEX I,0.83713,0.060242,-0.013134,0,0
4,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.41341,0.060203,0.035556,0,0
4,KEGG PROSTATE CANCER,0.26847,0.059991,0.04557,0,0
4,KEGG HEMATOPOIETIC CELL LINEAGE,0.11636,0.059947,0.031366,0,0
4,MITOCHONDRIAL RESPIRATORY CHAIN,0.22905,0.059567,0.076119,0,0
4,HEME METABOLIC PROCESS,0.41341,0.059431,0.087888,0,0
4,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.1313,0.059005,0.049307,0,0
4,REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES,0.11235,0.058334,0.14274,0,0
4,ENZYME REGULATOR ACTIVITY,0.13814,0.057956,0.044689,0,0
4,NUCLEAR REPLICATION FORK,0.83713,0.05767,-0.0056884,0,0
4,CYTOSOLIC PART,0.71006,0.057531,0.012432,0,0
4,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.4978,0.05725,0.040252,0,0
4,REGULATION OF MOLECULAR FUNCTION,0.15517,0.057104,0.045672,0,0
4,BIOCARTA ACH PATHWAY,0.31653,0.056474,0.060511,0,0
4,REACTOME SOS MEDIATED SIGNALLING,0.095625,0.056447,0.093168,0,0
4,ST ADRENERGIC,0.31232,0.05636,0.035239,0,0
4,KEGG GLYCINE SERINE AND THREONINE METABOLISM,0.8303,0.056335,0.026936,0,0
4,PID CIRCADIANPATHWAY,0.2839,0.056246,0.10171,0,0
4,KEGG ADHERENS JUNCTION,0.41341,0.056202,0.039712,0,0
4,PID INTEGRIN2 PATHWAY,0.12259,0.056065,0.14828,0,0
4,INNATE IMMUNE RESPONSE,0.43883,0.0557,0.031954,0,0
4,BIOCARTA VEGF PATHWAY,0.53167,0.055584,0.021712,0,0
4,THIOLESTER HYDROLASE ACTIVITY,0.15015,0.055373,0.065387,0,0
4,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.15015,0.055334,0.094806,0,0
4,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.64605,0.055274,0.015269,0,0
4,CORTICAL ACTIN CYTOSKELETON,0.98255,0.055246,-0.0057888,0,0
4,KEGG REGULATION OF AUTOPHAGY,0.054842,0.054863,0.1227,0,0
4,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.52025,0.05482,0.0087789,0,0
4,GTPASE REGULATOR ACTIVITY,0.62732,0.05481,0.0181,0,0
4,TRNA PROCESSING,0.51459,0.054758,0.026579,0,0
4,PROTEIN KINASE REGULATOR ACTIVITY,0.19695,0.054479,0.16298,0,0
4,KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS,0.49227,0.054383,0.040009,0,0
4,NUCLEAR CHROMATIN,0.70355,0.054049,0.043348,0,0
4,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.74288,0.053733,0.01608,0,0
4,MITOCHONDRIAL MATRIX,0.17653,0.053718,0.077817,0,0
4,MITOCHONDRIAL LUMEN,0.17653,0.053718,0.077817,0,0
4,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.14769,0.05329,0.13463,0,0
4,PID ER NONGENOMIC PATHWAY,0.43367,0.053274,0.035869,0,0
4,MITOCHONDRIAL PART,0.13355,0.05326,0.058104,0,0
4,BIOCARTA AHSP PATHWAY,0.83713,0.053259,-0.06542,0,0
4,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.41341,0.05317,0.090752,0,0
4,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.96163,0.053069,-0.0067272,0,0
4,KEGG HUNTINGTONS DISEASE,0.13583,0.052979,0.044947,0,0
4,KEGG PROPANOATE METABOLISM,0.44924,0.052955,0.083883,0,0
4,NUCLEAR ORGANIZATION AND BIOGENESIS,0.22235,0.052942,0.044138,0,0
4,RECEPTOR MEDIATED ENDOCYTOSIS,0.3746,0.052905,0.031711,0,0
4,REACTOME HEMOSTASIS,0.14048,0.052737,0.048559,0,0
4,BIOCARTA INTRINSIC PATHWAY,0.19095,0.052485,0.25225,0,0
4,PID IL27PATHWAY,0.43367,0.052431,0.008615,0,0
4,KEGG BETA ALANINE METABOLISM,0.16559,0.052,0.10778,0,0
4,PID WNT CANONICAL PATHWAY,0.41842,0.051748,0.030883,0,0
4,RESPONSE TO EXTRACELLULAR STIMULUS,0.31232,0.051748,0.059303,0,0
4,PID P38 MK2PATHWAY,0.27227,0.051653,0.061573,0,0
4,TRANS GOLGI NETWORK,0.91293,0.051435,-0.012601,0,0
4,CAMP MEDIATED SIGNALING,0.48131,0.051386,0.037746,0,0
4,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.41842,0.051054,0.024564,0,0
4,MITOCHONDRION,0.054842,0.050659,0.07977,0,0
4,PID PS1PATHWAY,0.36526,0.050461,0.033196,0,0
4,PID EPHA2 FWDPATHWAY,0.27999,0.050452,0.054218,0,0
4,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.48678,0.050185,0.039021,0,0
4,CONTRACTILE FIBER PART,0.59664,0.050028,0.022719,0,0
4,SMALL GTPASE REGULATOR ACTIVITY,0.36991,0.049961,0.047172,0,0
4,SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.54903,0.049866,0.019562,0,0
4,VIRAL GENOME REPLICATION,0.75615,0.04964,-0.0080522,0,0
4,NEUROTRANSMITTER BINDING,0.76948,0.049282,0.012586,0,0
4,KEGG DRUG METABOLISM OTHER ENZYMES,0.17653,0.048551,0.078737,0,0
4,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.9686,0.048547,0.036112,0,0
4,REGULATION OF METABOLIC PROCESS,0.12908,0.048507,0.029952,0,0
4,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.28785,0.048191,0.073463,0,0
4,RESPONSE TO NUTRIENT LEVELS,0.35153,0.048183,0.062659,0,0
4,ION CHANNEL ACTIVITY,0.15264,0.048155,0.099114,0,0
4,RESPONSE TO NUTRIENT,0.29992,0.048093,0.084305,0,0
4,ST T CELL SIGNAL TRANSDUCTION,0.48678,0.047532,0.039624,0,0
4,KEGG GLIOMA,0.96163,0.047146,0.0036508,0,0
4,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.85082,0.047005,0.0037184,0,0
4,VOLTAGE GATED CHANNEL ACTIVITY,0.24643,0.046888,0.10617,0,0
4,ORGAN DEVELOPMENT,0.32938,0.046844,0.025129,0,0
4,GTP BINDING,0.42855,0.046838,0.021634,0,0
4,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.11636,0.04674,0.077431,0,0
4,REGULATION OF CELLULAR METABOLIC PROCESS,0.15517,0.046577,0.0282,0,0
4,REACTOME METABOLISM OF CARBOHYDRATES,0.085627,0.046516,0.073406,0,0
4,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.30815,0.04649,0.060381,0,0
4,REACTOME ERKS ARE INACTIVATED,0.35607,0.046407,0.081049,0,0
4,PID ILK PATHWAY,0.33373,0.046395,0.0066908,0,0
4,RNA POLYMERASE II TRANSCRIPTION MEDIATOR ACTIVITY,0.22905,0.046277,0.052395,0,0
4,KEGG TGF BETA SIGNALING PATHWAY,0.81668,0.046107,-0.024443,0,0
4,CONDENSED NUCLEAR CHROMOSOME,0.47588,0.045948,0.05546,0,0
4,ACTIN FILAMENT BASED PROCESS,0.95466,0.045873,-0.009205,0,0
4,STEROID HORMONE RECEPTOR ACTIVITY,0.62113,0.045569,0.02509,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION,0.17653,0.045482,0.043039,0,0
4,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.39858,0.045482,0.10811,0,0
4,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.48131,0.045481,0.035193,0,0
4,PID S1P META PATHWAY,0.63354,0.04538,0.063876,0,0
4,REACTOME METABOLISM OF PORPHYRINS,0.36064,0.045133,0.07893,0,0
4,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,0.25363,0.044576,0.047733,0,0
4,PID MTOR 4PATHWAY,0.065563,0.044505,0.08252,0,0
4,REACTOME G ALPHA Q SIGNALLING EVENTS,0.29992,0.044361,0.038732,0,0
4,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.85082,0.044058,-0.045303,0,0
4,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.4598,0.043902,0.078999,0,0
4,ANION CATION SYMPORTER ACTIVITY,0.31232,0.043838,0.044259,0,0
4,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.082489,0.043809,0.076347,0,0
4,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.87144,0.043736,0.0098497,0,0
4,PID PDGFRBPATHWAY,0.10845,0.043619,0.080785,0,0
4,REACTOME BASIGIN INTERACTIONS,0.25729,0.043601,0.09667,0,0
4,POSITIVE REGULATION OF PROTEIN SECRETION,0.65234,0.043425,0.038404,0,0
4,RESPONSE TO HEAT,0.29992,0.042829,0.074904,0,0
4,REACTOME SIGNALING BY ERBB4,0.36991,0.042775,0.035488,0,0
4,PROTEIN AMINO ACID ADP RIBOSYLATION,0.56666,0.042746,0.0234,0,0
4,NEUROPEPTIDE BINDING,0.55487,0.042372,0.029553,0,0
4,NEUROPEPTIDE RECEPTOR ACTIVITY,0.55487,0.042372,0.029553,0,0
4,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.30815,0.04236,0.1089,0,0
4,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.39371,0.042085,0.0092473,0,0
4,BIOCARTA GPCR PATHWAY,0.37932,0.041918,0.067825,0,0
4,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.46512,0.041874,0.036121,0,0
4,REACTOME IL RECEPTOR SHC SIGNALING,0.31232,0.04156,0.093048,0,0
4,GTPASE ACTIVITY,0.52594,0.0415,0.020739,0,0
4,PID THROMBIN PAR1 PATHWAY,0.62732,0.041074,0.022503,0,0
4,BIOCARTA RAS PATHWAY,0.22235,0.041018,0.054524,0,0
4,MYOFIBRIL,0.50896,0.040803,0.045305,0,0
4,REGULATION OF CATALYTIC ACTIVITY,0.14048,0.040696,0.047583,0,0
4,REACTOME INTRINSIC PATHWAY,0.43367,0.040623,0.066099,0,0
4,PROTEIN CATABOLIC PROCESS,0.36526,0.039957,0.021864,0,0
4,PID BMPPATHWAY,0.62113,0.039849,0.032975,0,0
4,NUCLEAR CHROMOSOME,0.35607,0.039706,0.050306,0,0
4,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.58456,0.039681,0.0066722,0,0
4,PROTEIN DOMAIN SPECIFIC BINDING,0.60272,0.039329,0.015282,0,0
4,SISTER CHROMATID SEGREGATION,0.76281,0.039262,0.015071,0,0
4,SPHINGOID METABOLIC PROCESS,0.84397,0.038986,-0.05307,0,0
4,REGULATION OF GENE EXPRESSION,0.25001,0.038924,0.019637,0,0
4,KEGG ACUTE MYELOID LEUKEMIA,0.73628,0.038921,0.010926,0,0
4,AMINE RECEPTOR ACTIVITY,0.14769,0.03892,0.067745,0,0
4,BIOPOLYMER CATABOLIC PROCESS,0.072231,0.038914,0.051709,0,0
4,PID PI3KCIAKTPATHWAY,0.22568,0.038807,0.064308,0,0
4,PID RHODOPSIN PATHWAY,0.2839,0.038704,0.052004,0,0
4,LIGAND GATED CHANNEL ACTIVITY,0.51459,0.038669,0.026822,0,0
4,LIGASE ACTIVITY,0.71658,0.038599,0.0051689,0,0
4,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.39858,0.038494,0.045501,0,0
4,CELLULAR COMPONENT ASSEMBLY,0.24288,0.038175,0.021119,0,0
4,PID PLK1 PATHWAY,0.86455,0.038137,-0.022202,0,0
4,REACTOME M G1 TRANSITION,0.49227,0.038051,0.02488,0,0
4,DNA FRAGMENTATION DURING APOPTOSIS,0.59664,0.037837,0.029431,0,0
4,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.31232,0.037788,0.022072,0,0
4,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.65234,0.037777,-0.080773,0,0
4,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.11636,0.037162,0.063034,0,0
4,TRANSCRIPTION COACTIVATOR ACTIVITY,0.34256,0.036915,0.01566,0,0
4,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.52025,0.036904,-0.055925,0,0
4,MITOCHONDRIAL ENVELOPE,0.15773,0.036874,0.048272,0,0
4,AMINO ACID CATABOLIC PROCESS,0.16294,0.036443,0.095434,0,0
4,ST GA12 PATHWAY,0.21256,0.036342,0.076396,0,0
4,REACTOME TRANSLATION,0.90599,0.036311,-0.032565,0,0
4,LYSOSOMAL TRANSPORT,0.4598,0.036272,0.036652,0,0
4,PROTEIN TARGETING,0.40843,0.036215,0.017434,0,0
4,KEGG LONG TERM DEPRESSION,0.084046,0.036013,0.075524,0,0
4,POSITIVE REGULATION OF T CELL ACTIVATION,0.89215,0.035843,-0.043888,0,0
4,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.23589,0.035744,0.064417,0,0
4,VACUOLAR TRANSPORT,0.26847,0.035334,0.064341,0,0
4,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.19695,0.035326,0.069404,0,0
4,INTERCELLULAR JUNCTION ASSEMBLY AND MAINTENANCE,0.78289,0.035235,-0.041421,0,0
4,REACTOME GAP JUNCTION TRAFFICKING,0.98953,0.035095,-0.0085023,0,0
4,REGULATION OF RESPONSE TO STIMULUS,0.72313,0.035006,0.014035,0,0
4,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.33373,0.034607,0.044793,0,0
4,PID AVB3 INTEGRIN PATHWAY,0.65866,0.034566,-0.08262,0,0
4,POSITIVE REGULATION OF METABOLIC PROCESS,0.39858,0.034555,0.0093996,0,0
4,SYMPORTER ACTIVITY,0.25001,0.034261,0.063973,0,0
4,PID FAK PATHWAY,0.79636,0.034211,-0.00089821,0,0
4,REACTOME RETROGRADE NEUROTROPHIN SIGNALLING,0.80312,0.033972,0.025062,0,0
4,REACTOME METABOLISM OF MRNA,0.98255,0.033856,-0.011481,0,0
4,CELLULAR COMPONENT DISASSEMBLY,0.56666,0.033777,0.025867,0,0
4,KEGG PANCREATIC CANCER,0.94769,0.03375,-0.013245,0,0
4,REACTOME SIGNALLING TO ERKS,0.26471,0.033741,0.046986,0,0
4,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.23245,0.03373,0.041665,0,0
4,INTRACELLULAR ORGANELLE PART,0.17099,0.03356,0.019508,0,0
4,REACTOME SYNTHESIS OF DNA,0.42347,0.033343,0.028476,0,0
4,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.99651,0.032914,-0.0092827,0,0
4,REACTOME PI3K AKT ACTIVATION,0.34256,0.032797,0.041386,0,0
4,CYTOKINE SECRETION,0.39858,0.032618,0.057119,0,0
4,REACTOME SPRY REGULATION OF FGF SIGNALING,0.60883,0.032611,0.024894,0,0
4,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.18219,0.032036,0.12933,0,0
4,BIOCARTA HDAC PATHWAY,0.87144,0.032025,0.010935,0,0
4,EXTRINSIC TO PLASMA MEMBRANE,0.38408,0.031922,0.10385,0,0
4,PID FOXM1PATHWAY,0.88523,0.031908,-0.0098029,0,0
4,KEGG LYSINE DEGRADATION,0.85768,0.03183,0.018274,0,0
4,ORGANELLE PART,0.18508,0.031781,0.019135,0,0
4,BIOCARTA ACTINY PATHWAY,0.53742,0.031478,0.03518,0,0
4,KEGG ERBB SIGNALING PATHWAY,0.50896,0.03116,0.016381,0,0
4,PID LYMPHANGIOGENESIS PATHWAY,0.99651,0.031011,-0.024198,0,0
4,HOMEOSTASIS OF NUMBER OF CELLS,0.24643,0.031001,0.0768,0,0
4,NITROGEN COMPOUND CATABOLIC PROCESS,0.33373,0.030983,0.072952,0,0
4,REACTOME VITAMIN B5 PANTOTHENATE METABOLISM,0.10096,0.030954,0.11168,0,0
4,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.37932,0.030909,0.011231,0,0
4,KEGG CHEMOKINE SIGNALING PATHWAY,0.53742,0.030709,0.015489,0,0
4,MACROMOLECULAR COMPLEX ASSEMBLY,0.17934,0.030589,0.021959,0,0
4,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.69061,0.030584,0.012056,0,0
4,NUCLEOTIDYLTRANSFERASE ACTIVITY,0.78289,0.030532,-0.0082196,0,0
4,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.99651,0.030317,0.055608,0,0
4,REACTOME PYRUVATE METABOLISM,0.60883,0.030275,0.033552,0,0
4,CATION BINDING,0.16828,0.030169,0.046831,0,0
4,ORGANELLAR RIBOSOME,0.24643,0.030113,0.083246,0,0
4,MITOCHONDRIAL RIBOSOME,0.24643,0.030113,0.083246,0,0
4,DENDRITE,0.90599,0.03011,-0.033055,0,0
4,AMINE CATABOLIC PROCESS,0.27999,0.029917,0.070091,0,0
4,AMINE TRANSPORT,0.12473,0.029898,0.12805,0,0
4,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.188,0.029754,0.058566,0,0
4,REPLICATION FORK,0.80312,0.029686,0.00051928,0,0
4,PID ERBB1 INTERNALIZATION PATHWAY,0.36991,0.029578,0.054456,0,0
4,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.23245,0.029133,0.032979,0,0
4,REACTOME BOTULINUM NEUROTOXICITY,0.50896,0.028755,0.054167,0,0
4,POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.69707,0.028734,-0.052667,0,0
4,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.41341,0.028708,0.035498,0,0
4,REGULATION OF DEFENSE RESPONSE,0.39858,0.028336,0.031575,0,0
4,CARBONATE DEHYDRATASE ACTIVITY,0.21905,0.028255,0.133,0,0
4,RAS GTPASE ACTIVATOR ACTIVITY,0.41842,0.028226,0.068246,0,0
4,REACTOME GAB1 SIGNALOSOME,0.7495,0.028192,0.023278,0,0
4,BIOCARTA IGF1R PATHWAY,0.88523,0.028162,0.0061515,0,0
4,REACTOME SIGNALLING BY NGF,0.39858,0.028083,0.031015,0,0
4,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.29586,0.027896,0.029605,0,0
4,ORGANELLE LUMEN,0.65234,0.027881,0.0043411,0,0
4,MEMBRANE ENCLOSED LUMEN,0.65234,0.027881,0.0043411,0,0
4,KEGG MELANOMA,0.76948,0.027622,-0.020025,0,0
4,GUANYL NUCLEOTIDE BINDING,0.41842,0.027621,0.021446,0,0
4,BIOCARTA RAC1 PATHWAY,0.85768,0.027619,-0.021187,0,0
4,CALCIUM CHANNEL ACTIVITY,0.47588,0.027443,0.066014,0,0
4,INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.40843,0.027379,0.065084,0,0
4,METALLOPEPTIDASE ACTIVITY,0.32938,0.027263,0.041457,0,0
4,INTERPHASE,0.66501,0.027247,0.01176,0,0
4,REGULATION OF RNA METABOLIC PROCESS,0.86455,0.02704,-0.002457,0,0
4,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.83713,0.027036,-0.0018423,0,0
4,KEGG SMALL CELL LUNG CANCER,0.72313,0.027007,0.0088928,0,0
4,PROTEOGLYCAN METABOLIC PROCESS,0.77618,0.026954,0.020356,0,0
4,BIOCARTA CDC42RAC PATHWAY,0.22568,0.02694,0.072995,0,0
4,BIOCARTA AGR PATHWAY,0.5726,0.026856,0.049126,0,0
4,REGULATION OF CYTOKINE SECRETION,0.47588,0.026615,0.046847,0,0
4,REGULATION OF HEART CONTRACTION,0.29992,0.0264,0.082495,0,0
4,SULFUR METABOLIC PROCESS,0.26098,0.026312,0.079951,0,0
4,TRNA METABOLIC PROCESS,0.98255,0.026174,-0.022598,0,0
4,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.29184,0.025414,0.10667,0,0
4,PID IL8CXCR2 PATHWAY,0.80312,0.025306,-0.026522,0,0
4,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.72313,0.025286,0.0046852,0,0
4,NON MEMBRANE BOUND ORGANELLE,0.72313,0.025286,0.0046852,0,0
4,KEGG PURINE METABOLISM,0.59059,0.025183,0.012336,0,0
4,KEGG OOCYTE MEIOSIS,0.85082,0.025078,0.0038448,0,0
4,ST GA13 PATHWAY,0.71658,0.025024,0.0074855,0,0
4,CYTOSKELETON,0.91987,0.024901,-0.0019943,0,0
4,ORGANELLE ORGANIZATION AND BIOGENESIS,0.70355,0.024715,-0.013204,0,0
4,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.83713,0.024655,0.0098307,0,0
4,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.53167,0.024507,0.046844,0,0
4,MITOTIC SISTER CHROMATID SEGREGATION,0.75615,0.024375,0.024394,0,0
4,VIRAL REPRODUCTION,0.35607,0.024306,0.038844,0,0
4,REACTOME SIGNALING BY PDGF,0.65234,0.024295,0.016295,0,0
4,REGULATION OF INTRACELLULAR TRANSPORT,0.50337,0.024031,0.0090539,0,0
4,BIOCARTA GCR PATHWAY,0.65866,0.024003,0.03966,0,0
4,BIOCARTA CBL PATHWAY,0.92682,0.023959,-0.0115,0,0
4,MYOSIN COMPLEX,0.20937,0.023849,0.080152,0,0
4,ISOMERASE ACTIVITY,0.30402,0.02375,0.055539,0,0
4,BETA TUBULIN BINDING,0.56666,0.023611,0.044261,0,0
4,REACTOME GLUCONEOGENESIS,0.43367,0.023476,0.060478,0,0
4,KEGG FATTY ACID METABOLISM,0.37932,0.023443,0.057094,0,0
4,PID ARF6 TRAFFICKINGPATHWAY,0.39371,0.022853,0.04464,0,0
4,KEGG FOCAL ADHESION,0.48678,0.022798,-0.00089623,0,0
4,PYROPHOSPHATASE ACTIVITY,0.57857,0.02213,0.015494,0,0
4,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.91293,0.022126,0.015314,0,0
4,CALMODULIN BINDING,0.87833,0.022042,0.0060796,0,0
4,PID SYNDECAN 2 PATHWAY,0.32506,0.022033,-0.10514,0,0
4,TRANSCRIPTION DNA DEPENDENT,0.59059,0.021661,0.011746,0,0
4,DNA POLYMERASE ACTIVITY,0.47049,0.02165,0.033195,0,0
4,CHROMATIN BINDING,0.93377,0.021599,-0.0043102,0,0
4,HISTONE DEACETYLASE COMPLEX,0.8303,0.021561,-0.0070678,0,0
4,REGULATION OF JNK CASCADE,0.24288,0.021535,0.14488,0,0
4,STRIATED MUSCLE CONTRACTION GO 0006941,0.72969,0.021371,0.023408,0,0
4,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.51459,0.021329,0.014907,0,0
4,PID AR PATHWAY,0.81668,0.021317,0.0020512,0,0
4,KEGG LONG TERM POTENTIATION,0.66501,0.02112,0.018144,0,0
4,ST G ALPHA S PATHWAY,0.78289,0.020927,0.010655,0,0
4,ENVELOPE,0.73628,0.020908,-0.02198,0,0
4,ORGANELLE ENVELOPE,0.73628,0.020908,-0.02198,0,0
4,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.69707,0.020743,0.022126,0,0
4,REACTOME POTASSIUM CHANNELS,0.51459,0.020655,0.086501,0,0
4,REACTOME HIV INFECTION,0.60272,0.020545,0.0059222,0,0
4,REGULATION OF JNK ACTIVITY,1,0.02051,-0.0082657,0,0
4,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.52594,0.020468,0.022581,0,0
4,RNA BIOSYNTHETIC PROCESS,0.58456,0.02034,0.01125,0,0
4,REACTOME G ALPHA I SIGNALLING EVENTS,0.98953,0.020291,-0.016808,0,0
4,DETECTION OF EXTERNAL STIMULUS,0.67776,0.020044,-0.063824,0,0
4,DNA METABOLIC PROCESS,0.54903,0.019922,0.0084489,0,0
4,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.85082,0.019886,0.019111,0,0
4,NUCLEUS,0.62732,0.019856,0.0058473,0,0
4,INTERCELLULAR JUNCTION ASSEMBLY,0.90599,0.019831,-0.051598,0,0
4,REACTOME THE NLRP3 INFLAMMASOME,0.32938,0.019758,0.077486,0,0
4,REACTOME PERK REGULATED GENE EXPRESSION,0.66501,0.019349,-0.04277,0,0
4,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.73628,0.019221,0.0037787,0,0
4,ACETYLTRANSFERASE ACTIVITY,0.25729,0.019123,0.0529,0,0
4,BIOCARTA TCRA PATHWAY,0.58456,0.018778,0.060366,0,0
4,CIRCADIAN RHYTHM,0.89215,0.018734,-0.010763,0,0
4,RIBONUCLEASE ACTIVITY,0.60883,0.018605,0.0035523,0,0
4,PID HDAC CLASSI PATHWAY,0.99651,0.018489,-0.012812,0,0
4,REACTOME PLC BETA MEDIATED EVENTS,0.71006,0.018287,-0.01402,0,0
4,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.61497,0.018226,-0.053413,0,0
4,REACTOME DOWNSTREAM TCR SIGNALING,0.43367,0.018194,0.046023,0,0
4,ENDONUCLEASE ACTIVITY,0.77618,0.017984,-0.022071,0,0
4,NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.87833,0.017914,-0.046909,0,0
4,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.53167,0.017888,0.015007,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.55487,0.017851,0.0090008,0,0
4,KEGG MTOR SIGNALING PATHWAY,0.97557,0.017807,-0.013301,0,0
4,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.50896,0.017636,0.014195,0,0
4,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.54903,0.017396,0.04052,0,0
4,REGULATION OF CELL SHAPE,0.91987,0.017216,-0.048593,0,0
4,REACTOME S PHASE,0.9686,0.017172,-0.0064764,0,0
4,SMALL GTPASE BINDING,0.97557,0.016602,-0.014262,0,0
4,SMAD BINDING,0.79636,0.016368,0.014156,0,0
4,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.47049,0.016302,0.054957,0,0
4,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.29992,0.016144,0.054447,0,0
4,SA PTEN PATHWAY,0.65234,0.015798,0.025911,0,0
4,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.88523,0.015696,-0.011727,0,0
4,PID CDC42 REG PATHWAY,0.98255,0.015243,0.0098524,0,0
4,KEGG MAPK SIGNALING PATHWAY,0.59059,0.015057,0.015678,0,0
4,REACTOME SIGNALING BY FGFR MUTANTS,0.78289,0.014628,-0.026652,0,0
4,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.88523,0.014568,-0.023191,0,0
4,PID INTEGRIN4 PATHWAY,0.80312,0.014523,-0.068983,0,0
4,REGULATION OF BINDING,0.67137,0.014294,0.0065162,0,0
4,TRANSCRIPTION FACTOR TFIID COMPLEX,0.78962,0.014199,-0.024868,0,0
4,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.33812,0.013953,0.07038,0,0
4,REGULATION OF CELL ADHESION,0.94769,0.013952,-0.024438,0,0
4,KEGG GLYCOLYSIS GLUCONEOGENESIS,0.57857,0.013556,0.03615,0,0
4,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,0.31653,0.013422,0.03616,0,0
4,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.75615,0.013392,-0.039929,0,0
4,REGULATION OF DNA REPLICATION,0.80312,0.013292,-0.0051558,0,0
4,REGULATION OF TRANSCRIPTION,0.53742,0.013288,0.010473,0,0
4,REACTOME PI3K CASCADE,0.38888,0.013216,0.038984,0,0
4,BIOCARTA NKT PATHWAY,0.74288,0.013118,-0.066154,0,0
4,PROTEIN FOLDING,0.48131,0.01311,0.03399,0,0
4,CONDENSED CHROMOSOME,0.52025,0.012982,0.052979,0,0
4,ORGANELLE INNER MEMBRANE,0.58456,0.012925,0.011002,0,0
4,AMINE BIOSYNTHETIC PROCESS,0.73628,0.012815,-0.048563,0,0
4,REACTOME CTLA4 INHIBITORY SIGNALING,0.56075,0.012262,0.052777,0,0
4,KEGG TASTE TRANSDUCTION,0.39371,0.011866,0.072887,0,0
4,BIOCARTA CARM ER PATHWAY,0.75615,0.011406,-0.02936,0,0
4,KEGG CHRONIC MYELOID LEUKEMIA,0.52594,0.011317,0.020841,0,0
4,TRANSCRIPTION COFACTOR ACTIVITY,0.32506,0.011188,0.024136,0,0
4,KEGG GLYOXYLATE AND DICARBOXYLATE METABOLISM,0.54903,0.011159,0.046064,0,0
4,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.78962,0.010927,0.015559,0,0
4,WNT SIGNALING,0.71658,0.010864,0.0182,0,0
4,N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.98953,0.010524,-0.010721,0,0
4,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.59664,0.01041,0.0093515,0,0
4,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.65234,0.010374,-0.073005,0,0
4,TRANSLATION,0.50896,0.010332,0.031583,0,0
4,REGULATION OF VIRAL REPRODUCTION,0.84397,0.010117,0.0084198,0,0
4,SINGLE STRANDED DNA BINDING,0.8303,0.0099978,-0.02168,0,0
4,REACTOME RAF MAP KINASE CASCADE,0.42347,0.0098582,0.052483,0,0
4,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.86455,0.0097481,-0.0064191,0,0
4,BIOCARTA P38MAPK PATHWAY,0.73628,0.009733,0.033387,0,0
4,TRANSCRIPTION,0.37932,0.0095501,0.020209,0,0
4,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.76948,0.0094397,0.033854,0,0
4,CYTOSKELETAL PROTEIN BINDING,0.62113,0.0091524,0.023776,0,0
4,PROTEIN COMPLEX,0.67776,0.0090044,0.0063373,0,0
4,ATPASE ACTIVITY,0.48131,0.0089105,0.022699,0,0
4,PID ALK2PATHWAY,0.53167,0.0083376,-0.11972,0,0
4,CELL SOMA,0.84397,0.0080376,0.018342,0,0
4,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.80312,0.0078381,-0.010637,0,0
4,SENSORY PERCEPTION,0.38888,0.0077521,0.018426,0,0
4,KEGG CARDIAC MUSCLE CONTRACTION,0.8303,0.0077428,0.0019403,0,0
4,ATPASE ACTIVITY COUPLED,0.19695,0.0075963,0.042079,0,0
4,PID CONE PATHWAY,0.22905,0.0074367,-0.10166,0,0
4,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.57857,0.0072695,0.013692,0,0
4,TRANSCRIPTION ELONGATION REGULATOR ACTIVITY,0.52025,0.0072539,-0.053415,0,0
4,GATED CHANNEL ACTIVITY,0.35153,0.0072385,0.071529,0,0
4,GTPASE BINDING,0.87144,0.0070627,-0.023412,0,0
4,REACTOME SIGNALING BY EGFR IN CANCER,0.62732,0.0067198,0.023786,0,0
4,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.78962,0.0064127,-0.010331,0,0
4,PIGMENT METABOLIC PROCESS,0.78962,0.0063839,0.012065,0,0
4,BIOCARTA IGF1MTOR PATHWAY,0.48131,0.006231,-0.066621,0,0
4,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.63978,0.0062167,-0.085668,0,0
4,KEGG ASCORBATE AND ALDARATE METABOLISM,0.64605,0.0060378,0.10463,0,0
4,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.54321,0.0059958,-0.043626,0,0
4,PID EPHRINBREVPATHWAY,0.99651,0.0059287,-0.0044928,0,0
4,REGULATION OF CELL GROWTH,0.63354,0.005794,0.0041176,0,0
4,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.89215,0.0057638,0.00040045,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.62113,0.0055859,0.013744,0,0
4,MITOCHONDRIAL INNER MEMBRANE,0.82348,0.0055842,-0.0050306,0,0
4,CHROMATIN,0.63978,0.0055519,-0.027055,0,0
4,KEGG REGULATION OF ACTIN CYTOSKELETON,0.74288,0.0051032,0.013906,0,0
4,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.57857,0.005103,0.072565,0,0
4,CELL CYCLE PHASE,0.98255,0.005098,-0.0056573,0,0
4,KEGG GAP JUNCTION,0.75615,0.0049745,-0.026827,0,0
4,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.71658,0.0049411,0.014299,0,0
4,REACTOME SIGNALING BY NODAL,0.73628,0.0048881,0.035127,0,0
4,TRANSCRIPTION FACTOR BINDING,0.56075,0.0047093,0.013236,0,0
4,REACTOME ACTIVATION OF GENES BY ATF4,0.52025,0.0045935,-0.0613,0,0
4,CARBOHYDRATE BINDING,0.63354,0.0045249,0.013799,0,0
4,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.76281,0.0045068,-0.021641,0,0
4,HISTONE MODIFICATION,0.38408,0.0041368,0.048083,0,0
4,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.91293,0.0039823,-0.012044,0,0
4,BIOCARTA MPR PATHWAY,0.84397,0.0039313,0.015016,0,0
4,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.9686,0.0038382,-0.0070685,0,0
4,DOUBLE STRAND BREAK REPAIR,0.98255,0.0036938,0.0029211,0,0
4,GROWTH,0.8303,0.0036807,-0.019931,0,0
4,NOTCH SIGNALING PATHWAY,0.81668,0.0036564,0.017075,0,0
4,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.54903,0.0036059,-0.081951,0,0
4,COVALENT CHROMATIN MODIFICATION,0.54321,0.0035447,0.035371,0,0
4,DNA BINDING,0.79636,0.0034714,-0.0081543,0,0
4,RNA METABOLIC PROCESS,0.83713,0.0033238,-0.0097007,0,0
4,RAS GTPASE BINDING,0.94769,0.0032267,-0.010394,0,0
4,POSITIVE REGULATION OF ANGIOGENESIS,0.8303,0.0029626,-0.047478,0,0
4,ONE CARBON COMPOUND METABOLIC PROCESS,0.58456,0.0028842,0.03552,0,0
4,TISSUE DEVELOPMENT,0.66501,0.0028483,-0.023315,0,0
4,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.59664,0.0027697,-0.052366,0,0
4,ZINC ION BINDING,0.93377,0.0026954,-0.016434,0,0
4,RESPONSE TO DNA DAMAGE STIMULUS,1,0.0026279,-0.00078491,0,0
4,REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND,0.91293,0.0025936,-0.0053543,0,0
4,REGULATION OF CATABOLIC PROCESS,0.77618,0.0024496,0.018759,0,0
4,RIBONUCLEOPROTEIN COMPLEX,0.92682,0.0024093,-0.0024925,0,0
4,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.4598,0.0022732,-0.057989,0,0
4,REACTOME RECYCLING PATHWAY OF L1,0.74288,0.002256,-0.023433,0,0
4,BIOCARTA RAB PATHWAY,0.74288,0.0021637,0.032819,0,0
4,MUSCLE DEVELOPMENT,0.65866,0.0018522,-0.045233,0,0
4,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.91293,0.0018228,0.0029441,0,0
4,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.98953,0.0018142,-0.006826,0,0
4,DNA REPLICATION,0.46512,0.0017405,-0.029905,0,0
4,NEUROLOGICAL SYSTEM PROCESS,0.80312,0.0015208,0.014904,0,0
4,LEADING EDGE,0.93377,0.0013863,-0.029517,0,0
4,DNA DIRECTED RNA POLYMERASEII CORE COMPLEX,0.44402,0.0011414,0.05061,0,0
4,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.73628,0.00068411,0.066203,0,0
4,HETEROCYCLE METABOLIC PROCESS,0.74288,0.00065305,-0.041833,0,0
4,REACTOME PLATELET SENSITIZATION BY LDL,0.80312,5.0691e-05,-0.029448,0,0
4,RNA EXPORT FROM NUCLEUS,0.59664,-0.00012175,-0.031512,0,0
4,REGULATION OF CELL MORPHOGENESIS,0.8303,-0.00072736,-0.04722,0,0
4,REACTOME MTORC1 MEDIATED SIGNALLING,0.60883,-0.00099614,0.038303,0,0
4,CENTROSOME,0.61497,-0.0010399,-0.036285,0,0
4,INTEGRATOR COMPLEX,0.38408,-0.00114,-0.071352,0,0
4,MEDIATOR COMPLEX,0.62113,-0.0013316,-0.039217,0,0
4,PROTEIN EXPORT FROM NUCLEUS,0.50337,-0.0015926,-0.062394,0,0
4,REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS,0.99651,-0.0017117,-0.014551,0,0
4,THYROID HORMONE RECEPTOR BINDING,0.53167,-0.0017171,-0.044166,0,0
4,TELOMERIC DNA BINDING,0.67776,-0.0018094,-0.041016,0,0
4,NUCLEOTIDE BIOSYNTHETIC PROCESS,0.78962,-0.0018954,0.0047564,0,0
4,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.71006,-0.0024023,-0.022599,0,0
4,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.71658,-0.0024221,0.01198,0,0
4,REACTOME ARMS MEDIATED ACTIVATION,0.84397,-0.0024532,-0.0094935,0,0
4,POSITIVE REGULATION OF TRANSCRIPTION,0.72969,-0.0025092,-0.024319,0,0
4,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.53742,-0.0027248,0.015274,0,0
4,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.9686,-0.0027638,-0.006838,0,0
4,VIRAL REPRODUCTIVE PROCESS,0.96163,-0.0031043,-0.0095252,0,0
4,REACTOME PI 3K CASCADE,0.83713,-0.0034277,-0.01457,0,0
4,DAMAGED DNA BINDING,0.50896,-0.0036518,-0.025512,0,0
4,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.34702,-0.0037367,-0.086808,0,0
4,ANATOMICAL STRUCTURE DEVELOPMENT,0.95466,-0.0038794,-0.0050487,0,0
4,BIOCARTA COMP PATHWAY,0.32938,-0.0039769,0.0091202,0,0
4,BIOCARTA AMI PATHWAY,0.30402,-0.0042529,0.21731,0,0
4,TRANSITION METAL ION BINDING,0.99651,-0.0043347,-0.0094939,0,0
4,REACTOME PHOSPHORYLATION OF THE APC C,0.40349,-0.004412,0.068389,0,0
4,STRUCTURAL MOLECULE ACTIVITY,0.71658,-0.0046118,-0.038358,0,0
4,REACTOME GLUCOSE METABOLISM,0.81668,-0.004652,0.0073858,0,0
4,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.43367,-0.0048785,-0.05375,0,0
4,MACROMOLECULAR COMPLEX,0.7495,-0.0054915,0.0039455,0,0
4,REACTOME METABOLISM OF NUCLEOTIDES,0.99651,-0.0055081,-0.0029449,0,0
4,PID RXR VDR PATHWAY,0.76281,-0.0056035,-0.033,0,0
4,BIOCARTA MYOSIN PATHWAY,0.61497,-0.005698,0.067221,0,0
4,MRNA BINDING,0.47588,-0.00646,0.042897,0,0
4,REACTOME SMOOTH MUSCLE CONTRACTION,0.74288,-0.006538,-0.14671,0,0
4,TRANSCRIPTION FACTOR COMPLEX,0.74288,-0.0066848,-0.019496,0,0
4,REACTOME NUCLEAR SIGNALING BY ERBB4,0.76281,-0.007061,-0.022409,0,0
4,RESPONSE TO ABIOTIC STIMULUS,0.67776,-0.0071682,-0.019791,0,0
4,REACTOME POL SWITCHING,0.58456,-0.0072665,-0.036666,0,0
4,PROTEIN C TERMINUS BINDING,0.86455,-0.0073112,0.00044995,0,0
4,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.82348,-0.0073685,-0.011667,0,0
4,REACTOME MITOCHONDRIAL PROTEIN IMPORT,1,-0.0074193,0.01072,0,0
4,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.94769,-0.0079147,-0.0087332,0,0
4,REACTOME SIGNALING BY ERBB2,0.85082,-0.0083731,0.012831,0,0
4,REACTOME GLOBAL GENOMIC NER GG NER,0.47588,-0.0086291,-0.03408,0,0
4,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.82348,-0.009104,0.0062048,0,0
4,TRANSMISSION OF NERVE IMPULSE,0.73628,-0.0091301,-0.014768,0,0
4,REACTOME METABOLISM OF RNA,0.69061,-0.0094238,-0.031053,0,0
4,SH3 DOMAIN BINDING,0.62113,-0.0095486,-0.033425,0,0
4,NUCLEOPLASM,0.39371,-0.0096902,-0.020974,0,0
4,CONTRACTILE FIBER,0.94073,-0.010129,-0.0014113,0,0
4,N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.51459,-0.010701,-0.050089,0,0
4,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.4545,-0.010871,0.070468,0,0
4,BIOGENIC AMINE METABOLIC PROCESS,0.82348,-0.010878,-0.020303,0,0
4,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.44924,-0.010882,-0.059524,0,0
4,ST G ALPHA I PATHWAY,0.94769,-0.010901,0.016467,0,0
4,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.80312,-0.010917,-0.033782,0,0
4,BIOCARTA TOB1 PATHWAY,0.59059,-0.011433,0.0088768,0,0
4,NUCLEOPLASM PART,0.32077,-0.011486,-0.026795,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.72313,-0.011712,-0.017555,0,0
4,RIBONUCLEOTIDE METABOLIC PROCESS,0.94073,-0.011918,-0.012379,0,0
4,POSITIVE REGULATION OF CELL CYCLE,0.67137,-0.011981,-0.096835,0,0
4,NUCLEOLUS,0.83713,-0.012448,-0.020558,0,0
4,PID NEPHRIN NEPH1 PATHWAY,0.76281,-0.012732,-0.0079093,0,0
4,BIOCARTA NFAT PATHWAY,0.63978,-0.012817,-0.018396,0,0
4,PID RB 1PATHWAY,0.89907,-0.012993,0.0050325,0,0
4,REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE,0.67137,-0.013078,0.021282,0,0
4,BIOCARTA PYK2 PATHWAY,0.58456,-0.013247,0.025732,0,0
4,DNA REPAIR,0.32077,-0.013359,-0.02504,0,0
4,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.50896,-0.013406,-0.035465,0,0
4,CERAMIDE METABOLIC PROCESS,0.85082,-0.013478,-0.027322,0,0
4,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.87144,-0.013556,0.026944,0,0
4,PROTEIN N TERMINUS BINDING,0.27999,-0.013658,-0.039434,0,0
4,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.43883,-0.013745,-0.039294,0,0
4,PROTEIN DEACETYLASE ACTIVITY,0.95466,-0.013876,0.0096216,0,0
4,BIOCARTA P53 PATHWAY,0.82348,-0.014021,0.019134,0,0
4,POSITIVE REGULATION OF IMMUNE RESPONSE,0.80312,-0.014063,-0.00049917,0,0
4,PROTEIN COMPLEX BINDING,0.83713,-0.014267,0.020446,0,0
4,REACTOME SIGNALING BY FGFR IN DISEASE,0.4978,-0.014618,0.027875,0,0
4,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.75615,-0.014841,0.023327,0,0
4,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.80989,-0.014865,0.025474,0,0
4,DEACETYLASE ACTIVITY,0.96163,-0.01491,0.0069231,0,0
4,CHROMOSOME SEGREGATION,0.9686,-0.014912,-0.0019806,0,0
4,SYSTEM DEVELOPMENT,0.70355,-0.014953,-0.017678,0,0
4,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,0.64605,-0.015165,-0.023405,0,0
4,REGULATION OF TRANSFERASE ACTIVITY,0.71006,-0.015179,0.018865,0,0
4,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.57857,-0.015215,-0.051219,0,0
4,KEGG PYRUVATE METABOLISM,0.8303,-0.015244,-0.031787,0,0
4,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.46512,-0.015246,-0.046016,0,0
4,REACTOME DEFENSINS,0.75615,-0.015292,-0.023061,0,0
4,PID P53REGULATIONPATHWAY,0.63978,-0.015644,-0.033473,0,0
4,REACTOME SIGNALING BY FGFR,0.89907,-0.015728,-0.00059922,0,0
4,BIOCARTA NO1 PATHWAY,0.56666,-0.015827,-0.063041,0,0
4,REGULATION OF DNA BINDING,0.66501,-0.015842,-0.023905,0,0
4,CHROMATIN MODIFICATION,0.69707,-0.015859,-0.0083176,0,0
4,NEGATIVE REGULATION OF BINDING,0.84397,-0.015916,-0.023516,0,0
4,KEGG RIBOSOME,0.65234,-0.016073,-0.075833,0,0
4,REACTOME PEPTIDE CHAIN ELONGATION,0.73628,-0.016419,-0.074869,0,0
4,PID TGFBRPATHWAY,0.93377,-0.016438,-0.02434,0,0
4,DNA DIRECTED RNA POLYMERASE COMPLEX,0.91293,-0.016524,0.017742,0,0
4,RNA POLYMERASE COMPLEX,0.91293,-0.016524,0.017742,0,0
4,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.91293,-0.016524,0.017742,0,0
4,PID E2F PATHWAY,0.59059,-0.016693,-0.033446,0,0
4,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.43367,-0.017084,-0.048023,0,0
4,PERINUCLEAR REGION OF CYTOPLASM,0.91293,-0.017115,0.0025664,0,0
4,NUCLEAR LUMEN,0.52025,-0.017141,-0.016862,0,0
4,PID EPHA FWDPATHWAY,0.72313,-0.017368,-0.02615,0,0
4,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.63978,-0.017395,0.075793,0,0
4,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.95466,-0.017425,-0.031752,0,0
4,CELL CYCLE PROCESS,0.29992,-0.017445,-0.025217,0,0
4,REGULATION OF TRANSPORT,0.9686,-0.017538,-0.010605,0,0
4,KEGG CITRATE CYCLE TCA CYCLE,0.21905,-0.017553,0.088249,0,0
4,KEGG PYRIMIDINE METABOLISM,0.91293,-0.017925,-0.010995,0,0
4,BIOCARTA CDK5 PATHWAY,0.88523,-0.018101,0.017915,0,0
4,REACTOME FANCONI ANEMIA PATHWAY,0.54903,-0.018614,-0.037494,0,0
4,PID GLYPICAN 1PATHWAY,0.67137,-0.018836,0.028674,0,0
4,MICROTUBULE ORGANIZING CENTER,0.40843,-0.018959,-0.041646,0,0
4,PID P38GAMMADELTAPATHWAY,0.98255,-0.019033,-0.0018573,0,0
4,GLUCOSAMINE METABOLIC PROCESS,0.94769,-0.019144,-0.0077429,0,0
4,TRANSCRIPTION FACTOR ACTIVITY,0.50337,-0.019448,-0.024464,0,0
4,PID BARD1PATHWAY,0.34256,-0.019556,-0.068282,0,0
4,PID FRA PATHWAY,0.40349,-0.019726,-0.12189,0,0
4,KEGG NUCLEOTIDE EXCISION REPAIR,0.67776,-0.019782,-0.016254,0,0
4,DNA PACKAGING,0.58456,-0.019924,-0.025976,0,0
4,MITOCHONDRIAL MEMBRANE PART,0.94769,-0.020155,0.0017717,0,0
4,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.27611,-0.0202,-0.050741,0,0
4,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.41842,-0.020421,-0.060728,0,0
4,REACTOME G1 S TRANSITION,0.56666,-0.020784,-0.026303,0,0
4,POSITIVE REGULATION OF TRANSPORT,0.80989,-0.02109,0.034805,0,0
4,SIGNAL SEQUENCE BINDING,0.33373,-0.021109,-0.056245,0,0
4,REACTOME LAGGING STRAND SYNTHESIS,0.15264,-0.021281,-0.067658,0,0
4,TRANSCRIPTION REPRESSOR ACTIVITY,0.98255,-0.021368,0.00763,0,0
4,PID VEGFR1 PATHWAY,0.32506,-0.021371,-0.076912,0,0
4,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.36064,-0.021596,-0.056135,0,0
4,SYNAPTIC TRANSMISSION,0.4545,-0.022101,-0.033477,0,0
4,STRUCTURAL CONSTITUENT OF RIBOSOME,0.71658,-0.022505,-0.066101,0,0
4,CELL CYCLE GO 0007049,0.41842,-0.022572,-0.020445,0,0
4,REACTOME INFLUENZA LIFE CYCLE,0.56075,-0.022617,-0.071626,0,0
4,BIOCARTA TEL PATHWAY,0.25001,-0.022692,-0.093606,0,0
4,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.59664,-0.023008,-0.036748,0,0
4,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.67776,-0.02323,0.030036,0,0
4,REGULATION OF MAP KINASE ACTIVITY,0.91987,-0.023412,0.006016,0,0
4,INTERPHASE OF MITOTIC CELL CYCLE,0.24643,-0.023542,-0.057405,0,0
4,REGULATION OF SYNAPSE STRUCTURE AND ACTIVITY,0.91293,-0.024664,0.023711,0,0
4,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.90599,-0.024817,-0.0052042,0,0
4,PHAGOCYTOSIS,0.60272,-0.025002,0.036545,0,0
4,BIOCARTA ERK PATHWAY,0.89907,-0.025136,0.0049503,0,0
4,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.39858,-0.025149,-0.078179,0,0
4,SA TRKA RECEPTOR,0.54903,-0.025256,-0.058211,0,0
4,TRANSCRIPTION COREPRESSOR ACTIVITY,0.91293,-0.025265,-0.0063042,0,0
4,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.21256,-0.025428,-0.12134,0,0
4,REACTOME DEVELOPMENTAL BIOLOGY,0.27227,-0.025849,-0.045532,0,0
4,PID ARF 3PATHWAY,0.98255,-0.026733,-0.0015161,0,0
4,REGULATION OF PROTEIN KINASE ACTIVITY,0.98255,-0.026785,0.0083795,0,0
4,KEGG BASE EXCISION REPAIR,0.83713,-0.02729,-0.0020849,0,0
4,REGULATION OF IMMUNE RESPONSE,0.64605,-0.027387,-0.011886,0,0
4,KEGG SELENOAMINO ACID METABOLISM,0.54321,-0.027388,-0.051414,0,0
4,BIOCARTA IL17 PATHWAY,0.72969,-0.027584,-0.037297,0,0
4,BIOCARTA EIF4 PATHWAY,0.42347,-0.027663,-0.066111,0,0
4,KEGG DILATED CARDIOMYOPATHY,0.41842,-0.027702,-0.059301,0,0
4,REGULATION OF GTPASE ACTIVITY,0.58456,-0.027734,-0.059994,0,0
4,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.94769,-0.027748,0.0091691,0,0
4,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.60883,-0.02793,-0.023319,0,0
4,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.30815,-0.027986,-0.023452,0,0
4,POSITIVE REGULATION OF JNK ACTIVITY,0.41341,-0.028356,-0.058727,0,0
4,BIOCARTA VDR PATHWAY,0.66501,-0.02858,-0.037464,0,0
4,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.5726,-0.028658,-0.081324,0,0
4,REACTOME DNA REPAIR,0.17099,-0.029186,-0.03908,0,0
4,REACTOME DEADENYLATION OF MRNA,0.25001,-0.029365,-0.055556,0,0
4,REACTOME TCR SIGNALING,0.78289,-0.029473,-0.008618,0,0
4,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.20937,-0.029543,-0.081353,0,0
4,BIOCARTA CSK PATHWAY,0.64605,-0.0298,-0.02915,0,0
4,REGULATION OF KINASE ACTIVITY,0.98953,-0.029887,0.0061682,0,0
4,CELL PROJECTION BIOGENESIS,0.25729,-0.030147,-0.080491,0,0
4,PID TRKRPATHWAY,0.21905,-0.030588,-0.066392,0,0
4,NUCLEAR PART,0.40843,-0.030688,-0.022893,0,0
4,MITOTIC CELL CYCLE,0.18219,-0.030804,-0.04775,0,0
4,BIOCARTA MTOR PATHWAY,0.77618,-0.030848,-0.030744,0,0
4,PID FANCONI PATHWAY,0.2839,-0.03089,-0.052864,0,0
4,CORNIFIED ENVELOPE,0.71006,-0.030951,0.024124,0,0
4,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.53742,-0.031032,-0.047392,0,0
4,CELL SURFACE,0.43367,-0.031081,-0.047058,0,0
4,REGULATION OF DNA METABOLIC PROCESS,0.25729,-0.03111,-0.061304,0,0
4,SMOOTH MUSCLE CONTRACTION GO 0006939,0.71658,-0.03159,-0.041634,0,0
4,VIRAL INFECTIOUS CYCLE,0.9686,-0.031822,0.0056951,0,0
4,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.28785,-0.032203,-0.069018,0,0
4,CELLULAR RESPONSE TO STIMULUS,0.53742,-0.032217,0.043342,0,0
4,SIG CHEMOTAXIS,0.37932,-0.032257,-0.042393,0,0
4,REACTOME DAG AND IP3 SIGNALING,0.68418,-0.032316,-0.025763,0,0
4,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.12689,-0.032559,-0.051094,0,0
4,REACTOME PYRIMIDINE METABOLISM,0.94769,-0.03262,-0.0066782,0,0
4,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.23589,-0.032743,-0.039416,0,0
4,REACTOME SHC MEDIATED SIGNALLING,0.69707,-0.032893,0.024118,0,0
4,DNA REPLICATION INITIATION,0.14769,-0.033249,-0.095972,0,0
4,PID LKB1 PATHWAY,0.14769,-0.033616,-0.063071,0,0
4,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.31232,-0.033899,-0.13134,0,0
4,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.60272,-0.034378,-0.031752,0,0
4,REACTOME G ALPHA Z SIGNALLING EVENTS,0.70355,-0.034843,-0.0316,0,0
4,BIOCARTA AKT PATHWAY,0.48131,-0.034908,0.033593,0,0
4,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.12049,-0.035038,-0.087894,0,0
4,RNA BINDING,0.47588,-0.035235,-0.025916,0,0
4,CELL MIGRATION,0.36526,-0.035427,-0.052074,0,0
4,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.48131,-0.035599,-0.075524,0,0
4,POSITIVE REGULATION OF DNA BINDING,0.22568,-0.0357,-0.064304,0,0
4,KEGG CELL CYCLE,0.43883,-0.035926,-0.031681,0,0
4,POSITIVE REGULATION OF BINDING,0.22905,-0.036123,-0.053666,0,0
4,PID RANBP2PATHWAY,0.78289,-0.036312,0.022387,0,0
4,TRANSLATION REGULATOR ACTIVITY,0.39858,-0.036421,-0.090272,0,0
4,BIOCARTA EIF2 PATHWAY,0.25729,-0.036538,-0.098084,0,0
4,HISTONE ACETYLTRANSFERASE ACTIVITY,0.30815,-0.036545,-0.059519,0,0
4,KEGG ONE CARBON POOL BY FOLATE,0.29992,-0.037035,-0.1033,0,0
4,REGULATION OF GROWTH,0.56666,-0.037182,-0.029053,0,0
4,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.26098,-0.037211,-0.086803,0,0
4,KEGG BLADDER CANCER,0.75615,-0.037365,-0.023772,0,0
4,BIOCARTA NDKDYNAMIN PATHWAY,0.70355,-0.037473,-0.044431,0,0
4,NEGATIVE REGULATION OF DNA BINDING,0.76281,-0.037544,-0.0067834,0,0
4,MICROTUBULE ORGANIZING CENTER PART,0.26847,-0.037584,-0.060974,0,0
4,NUCLEAR IMPORT,0.66501,-0.037998,-0.042623,0,0
4,BIOCARTA RARRXR PATHWAY,0.34256,-0.038006,-0.069944,0,0
4,REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND,0.23589,-0.038085,-0.063285,0,0
4,JNK CASCADE,0.99651,-0.03814,0.0051903,0,0
4,MITOSIS,0.34256,-0.039044,-0.038226,0,0
4,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.67776,-0.039064,-0.0072819,0,0
4,PID TELOMERASEPATHWAY,0.40843,-0.039123,-0.055613,0,0
4,KEGG NON SMALL CELL LUNG CANCER,0.42347,-0.03919,-0.04378,0,0
4,DEPHOSPHORYLATION,0.52594,-0.039191,-0.043159,0,0
4,KEGG CYSTEINE AND METHIONINE METABOLISM,0.38888,-0.039227,-0.070452,0,0
4,REACTOME PLATELET HOMEOSTASIS,0.46512,-0.039625,-0.031818,0,0
4,REACTOME AMYLOIDS,1,-0.039774,0.0067232,0,0
4,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.25729,-0.03984,-0.11905,0,0
4,INTERFERON GAMMA PRODUCTION,0.16294,-0.040199,-0.099903,0,0
4,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.46512,-0.040439,0.011572,0,0
4,ARYLSULFATASE ACTIVITY,0.36064,-0.040496,0.12352,0,0
4,ST MYOCYTE AD PATHWAY,0.73628,-0.040612,-0.013872,0,0
4,TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.57857,-0.040731,0.023883,0,0
4,REACTOME NUCLEOTIDE EXCISION REPAIR,0.15517,-0.041461,-0.047714,0,0
4,BIOCARTA AGPCR PATHWAY,0.19095,-0.041718,-0.16771,0,0
4,NUCLEAR CHROMOSOME PART,0.91987,-0.041764,0.0015112,0,0
4,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.99651,-0.042167,-0.028625,0,0
4,COFACTOR TRANSPORT,0.48131,-0.042439,-0.080691,0,0
4,N ACYLTRANSFERASE ACTIVITY,0.51459,-0.042513,-0.016439,0,0
4,REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES,0.5726,-0.042655,-0.025481,0,0
4,KEGG ENDOMETRIAL CANCER,0.16032,-0.042692,-0.084298,0,0
4,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.71658,-0.042719,-0.038742,0,0
4,BIOCARTA CREB PATHWAY,0.76948,-0.042832,-0.028074,0,0
4,ORGANELLE LOCALIZATION,0.82348,-0.042844,-0.010794,0,0
4,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.73628,-0.042861,-0.04849,0,0
4,PID INTEGRIN3 PATHWAY,0.72969,-0.042907,-0.0044352,0,0
4,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,0.96163,-0.04304,-0.0043369,0,0
4,PURINE NUCLEOTIDE METABOLIC PROCESS,0.5726,-0.043206,-0.040218,0,0
4,LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS,0.50896,-0.043416,-0.096405,0,0
4,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.86455,-0.043445,-0.021211,0,0
4,AGING,0.96163,-0.043703,0.022268,0,0
4,CHROMOSOME,0.29992,-0.044054,-0.025428,0,0
4,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.76281,-0.04422,-0.034679,0,0
4,M PHASE,0.57857,-0.044378,-0.019112,0,0
4,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.20309,-0.044473,-0.030289,0,0
4,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.4545,-0.044486,-0.10667,0,0
4,BASAL LAMINA,0.17099,-0.044601,-0.17065,0,0
4,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.52594,-0.044979,-0.097373,0,0
4,REGULATION OF GENE EXPRESSION EPIGENETIC,0.56666,-0.045363,-0.037556,0,0
4,VITAMIN TRANSPORT,0.76948,-0.045854,-0.017433,0,0
4,M PHASE OF MITOTIC CELL CYCLE,0.30815,-0.046039,-0.039067,0,0
4,BIOCARTA HCMV PATHWAY,0.78289,-0.046062,0.032528,0,0
4,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.12689,-0.04609,-0.056783,0,0
4,REACTOME L1CAM INTERACTIONS,0.44924,-0.046287,-0.053268,0,0
4,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.1028,-0.046459,-0.081439,0,0
4,REACTOME DSCAM INTERACTIONS,0.35153,-0.046934,-0.084642,0,0
4,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.15517,-0.047049,-0.059729,0,0
4,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.18219,-0.047052,-0.080918,0,0
4,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.71658,-0.04718,-0.04235,0,0
4,BIOCARTA RB PATHWAY,0.40349,-0.047294,-0.058506,0,0
4,PROTEIN AUTOPROCESSING,0.85082,-0.04738,-0.0093847,0,0
4,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.31653,-0.047574,-0.041132,0,0
4,ACTIVATION OF MAPK ACTIVITY,0.13814,-0.047742,-0.08585,0,0
4,CHROMOSOMAL PART,0.17374,-0.047977,-0.04315,0,0
4,BIOCARTA CCR3 PATHWAY,0.75615,-0.04815,0.032441,0,0
4,REACTOME PROTEIN FOLDING,0.05161,-0.04841,-0.10546,0,0
4,REACTOME MITOTIC G1 G1 S PHASES,0.26847,-0.048659,-0.041876,0,0
4,REACTOME SIGNALING BY HIPPO,0.27611,-0.048711,-0.15418,0,0
4,ATP DEPENDENT RNA HELICASE ACTIVITY,0.37932,-0.048981,-0.070222,0,0
4,ENDODEOXYRIBONUCLEASE ACTIVITY,0.62732,-0.049188,-0.012142,0,0
4,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.4598,-0.049307,-0.10978,0,0
4,ACTIN FILAMENT BUNDLE FORMATION,0.68418,-0.049349,-5.3015e-05,0,0
4,REACTOME MICRORNA MIRNA BIOGENESIS,0.11841,-0.049513,-0.081498,0,0
4,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.188,-0.049828,-0.05988,0,0
4,NEGATIVE REGULATION OF CELL ADHESION,0.4978,-0.05083,-0.07727,0,0
4,PID ALK1PATHWAY,0.12689,-0.051076,-0.14952,0,0
4,OLIGOSACCHARIDE METABOLIC PROCESS,0.92682,-0.051155,0.010385,0,0
4,REGULATION OF MITOSIS,0.21579,-0.051165,-0.057437,0,0
4,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.11636,-0.05151,-0.067086,0,0
4,PID MYC PATHWAY,0.10654,-0.05164,-0.11879,0,0
4,PID PI3KPLCTRKPATHWAY,0.20309,-0.051643,-0.069812,0,0
4,PDZ DOMAIN BINDING,0.58456,-0.051966,-0.018967,0,0
4,CYTOSKELETAL PART,0.14285,-0.052348,-0.054356,0,0
4,ACTIVATION OF IMMUNE RESPONSE,0.42855,-0.05271,-0.049022,0,0
4,REACTOME MITOTIC M M G1 PHASES,0.29992,-0.052845,-0.036918,0,0
4,REACTOME GLUCOSE TRANSPORT,0.19695,-0.052857,-0.07437,0,0
4,PATTERN BINDING,0.5726,-0.052954,-0.033092,0,0
4,NEGATIVE REGULATION OF GROWTH,0.73628,-0.053057,-0.0010794,0,0
4,RNA 3END PROCESSING,0.60272,-0.053135,-0.050564,0,0
4,TRANSCRIPTION INITIATION,0.072231,-0.053743,-0.081093,0,0
4,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.21579,-0.053934,-0.10805,0,0
4,PID NCADHERINPATHWAY,0.83713,-0.054009,-0.026308,0,0
4,NUCLEOLAR PART,0.8303,-0.054363,-0.027496,0,0
4,REACTOME CGMP EFFECTS,0.89907,-0.054422,0.012999,0,0
4,REACTOME NEURONAL SYSTEM,0.78289,-0.054529,0.005907,0,0
4,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.061812,-0.054657,-0.095179,0,0
4,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.34256,-0.05472,-0.042792,0,0
4,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.29992,-0.055305,-0.044378,0,0
4,REACTOME HDL MEDIATED LIPID TRANSPORT,0.87833,-0.055619,-0.013709,0,0
4,PID DNAPK PATHWAY,0.057089,-0.055794,-0.098844,0,0
4,BIOCARTA PTC1 PATHWAY,0.78289,-0.056306,-0.033302,0,0
4,PROTEIN IMPORT,0.36064,-0.056513,-0.060242,0,0
4,NUCLEAR TRANSPORT,0.26847,-0.056589,-0.053114,0,0
4,BIOCARTA RANMS PATHWAY,0.30402,-0.056796,-0.087713,0,0
4,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.34256,-0.056895,-0.081661,0,0
4,RNA HELICASE ACTIVITY,0.073629,-0.056978,-0.11054,0,0
4,KEGG DNA REPLICATION,0.036948,-0.057991,-0.1002,0,0
4,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.36064,-0.057995,-0.052069,0,0
4,PID ANTHRAXPATHWAY,0.27611,-0.05836,-0.07466,0,0
4,NEURON PROJECTION,0.55487,-0.058365,-0.040778,0,0
4,NUCLEOTIDE EXCISION REPAIR,0.10654,-0.058673,-0.068628,0,0
4,SEQUENCE SPECIFIC DNA BINDING,0.16032,-0.058729,-0.06399,0,0
4,KEGG COLORECTAL CANCER,0.18219,-0.058987,-0.055947,0,0
4,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27227,-0.059449,-0.054032,0,0
4,EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX,0.57857,-0.059538,-0.10417,0,0
4,KEGG WNT SIGNALING PATHWAY,0.23589,-0.05964,-0.051498,0,0
4,ANDROGEN RECEPTOR SIGNALING PATHWAY,0.072231,-0.060135,-0.11725,0,0
4,DNA DEPENDENT DNA REPLICATION,0.1028,-0.060318,-0.083739,0,0
4,NUCLEOCYTOPLASMIC TRANSPORT,0.27227,-0.061261,-0.05483,0,0
4,SYNAPSE ORGANIZATION AND BIOGENESIS,0.93377,-0.061612,0.018093,0,0
4,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.11039,-0.061658,-0.070802,0,0
4,PHOSPHATASE REGULATOR ACTIVITY,0.15517,-0.062207,-0.11552,0,0
4,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.46512,-0.0623,-0.045464,0,0
4,COLLAGEN BINDING,0.28785,-0.062463,-0.15237,0,0
4,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.13814,-0.062753,-0.090787,0,0
4,KEGG PRION DISEASES,0.46512,-0.063125,-0.048238,0,0
4,MICROTUBULE BASED PROCESS,0.16828,-0.063412,-0.062008,0,0
4,PID HEDGEHOG GLIPATHWAY,0.69707,-0.063689,-0.029001,0,0
4,RHYTHMIC PROCESS,0.17653,-0.063887,-0.064027,0,0
4,PROTEIN IMPORT INTO NUCLEUS,0.23589,-0.064214,-0.082799,0,0
4,REACTOME TRNA AMINOACYLATION,0.87833,-0.0647,-0.021224,0,0
4,BIOCARTA STATHMIN PATHWAY,0.20309,-0.065252,-0.057662,0,0
4,REGULATION OF CELL CYCLE,0.1313,-0.065856,-0.049757,0,0
4,REACTOME SIGNALING BY RHO GTPASES,0.19095,-0.066195,-0.061771,0,0
4,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.16294,-0.066404,-0.15955,0,0
4,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.99651,-0.066737,0.042559,0,0
4,NUCLEAR EXPORT,0.48131,-0.067111,-0.042533,0,0
4,RNA DEPENDENT ATPASE ACTIVITY,0.27227,-0.067161,-0.074224,0,0
4,REACTOME STRIATED MUSCLE CONTRACTION,0.05824,-0.067257,-0.1958,0,0
4,NUCLEAR ENVELOPE,0.063042,-0.067587,-0.082069,0,0
4,REACTOME GABA B RECEPTOR ACTIVATION,0.31653,-0.067865,-0.0814,0,0
4,SA G1 AND S PHASES,0.72313,-0.067866,-0.0074203,0,0
4,KEGG BASAL CELL CARCINOMA,0.16559,-0.067998,-0.092585,0,0
4,TRANSLATIONAL INITIATION,0.18508,-0.068335,-0.10684,0,0
4,AMINO SUGAR METABOLIC PROCESS,0.15264,-0.068749,-0.082801,0,0
4,REACTOME DNA REPLICATION,0.25001,-0.069297,-0.036824,0,0
4,PID NFAT 3PATHWAY,0.71658,-0.069624,0.035892,0,0
4,PID RAS PATHWAY,0.54321,-0.070085,-0.061735,0,0
4,PHOTOTRANSDUCTION,0.073629,-0.070389,-0.19587,0,0
4,REACTOME MRNA CAPPING,0.04854,-0.070417,-0.085296,0,0
4,PROTEIN POLYUBIQUITINATION,0.010773,-0.070732,-0.096956,0,0
4,CELL CYCLE ARREST GO 0007050,0.072231,-0.07126,-0.081608,0,0
4,REGULATION OF MUSCLE CONTRACTION,0.18508,-0.071532,-0.16813,0,0
4,EMBRYONIC DEVELOPMENT,0.37932,-0.07156,-0.054631,0,0
4,SKELETAL DEVELOPMENT,0.0695,-0.071818,-0.13737,0,0
4,SARCOMERE,0.26847,-0.072053,-0.14602,0,0
4,PROTEIN DNA COMPLEX ASSEMBLY,0.040234,-0.072656,-0.10381,0,0
4,PID BETACATENIN DEG PATHWAY,0.19393,-0.073044,-0.065239,0,0
4,REACTOME GABA A RECEPTOR ACTIVATION,0.65234,-0.073819,-0.11273,0,0
4,MESODERM DEVELOPMENT,0.33812,-0.073968,-0.10723,0,0
4,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.25001,-0.074016,-0.072121,0,0
4,REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER,0.43367,-0.074061,-0.035725,0,0
4,REACTOME FRS2 MEDIATED CASCADE,0.2839,-0.074553,-0.048405,0,0
4,BIOCARTA EIF PATHWAY,0.2,-0.074631,-0.1265,0,0
4,REGULATION OF MITOTIC CELL CYCLE,0.22905,-0.074869,-0.068922,0,0
4,LIPID KINASE ACTIVITY,0.11841,-0.075325,-0.13186,0,0
4,BIOCARTA AKAP95 PATHWAY,0.10845,-0.075864,-0.14612,0,0
4,GLUTATHIONE TRANSFERASE ACTIVITY,0.88523,-0.07612,0.083742,0,0
4,KEGG NON HOMOLOGOUS END JOINING,0.54321,-0.076236,-0.048169,0,0
4,AMINE BINDING,0.68418,-0.076415,-0.038854,0,0
4,DNA RECOMBINATION,0.080955,-0.076554,-0.08605,0,0
4,REACTOME DOUBLE STRAND BREAK REPAIR,0.15773,-0.076574,-0.089772,0,0
4,BASEMENT MEMBRANE,0.17374,-0.076925,-0.15948,0,0
4,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.17934,-0.077178,-0.086869,0,0
4,RNA POLYMERASE ACTIVITY,0.072231,-0.077953,-0.1239,0,0
4,KINESIN COMPLEX,0.12049,-0.078034,-0.1161,0,0
4,REACTOME AXON GUIDANCE,0.060602,-0.078055,-0.1037,0,0
4,PID RAC1 REG PATHWAY,0.35153,-0.079435,-0.056959,0,0
4,CHAPERONE BINDING,0.22905,-0.079849,-0.08936,0,0
4,PID SYNDECAN 3 PATHWAY,0.82348,-0.079922,-0.023193,0,0
4,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.025994,-0.080525,-0.11212,0,0
4,REACTOME NEPHRIN INTERACTIONS,0.35607,-0.080856,-0.054006,0,0
4,REACTOME PROCESSING OF INTRONLESS PRE MRNAS,0.05161,-0.081504,-0.13056,0,0
4,REACTOME SEMAPHORIN INTERACTIONS,0.44924,-0.081601,-0.032685,0,0
4,DETECTION OF ABIOTIC STIMULUS,0.28785,-0.081817,-0.082441,0,0
4,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.063042,-0.081831,-0.15095,0,0
4,REACTOME PROLACTIN RECEPTOR SIGNALING,0.5726,-0.081837,-0.04027,0,0
4,SECONDARY METABOLIC PROCESS,0.4978,-0.081912,-0.027332,0,0
4,PID HEDGEHOG 2PATHWAY,0.17934,-0.082104,-0.10268,0,0
4,PID EPHBFWDPATHWAY,0.16559,-0.082555,-0.10426,0,0
4,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.17374,-0.08304,-0.096629,0,0
4,HISTONE METHYLTRANSFERASE ACTIVITY,0.12259,-0.083166,-0.08834,0,0
4,NERVOUS SYSTEM DEVELOPMENT,0.047551,-0.083384,-0.12129,0,0
4,REACTOME SHC MEDIATED CASCADE,0.14769,-0.083421,-0.083603,0,0
4,BIOCARTA CALCINEURIN PATHWAY,0.87833,-0.083917,0.011885,0,0
4,PID ATM PATHWAY,0.17934,-0.08419,-0.054126,0,0
4,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.18508,-0.084499,-0.10195,0,0
4,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.54903,-0.084659,0.0024842,0,0
4,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.075049,-0.085535,-0.075736,0,0
4,REACTOME G0 AND EARLY G1,0.32077,-0.085558,-0.063509,0,0
4,BIOCARTA RACCYCD PATHWAY,0.60883,-0.085914,-0.040046,0,0
4,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.070855,-0.08604,-0.078613,0,0
4,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.15015,-0.086987,-0.11446,0,0
4,PIGMENT BIOSYNTHETIC PROCESS,0.56666,-0.087051,-0.030212,0,0
4,ACETYLCHOLINE BINDING,0.33812,-0.087514,-0.11112,0,0
4,KEGG AXON GUIDANCE,0.029068,-0.087636,-0.15324,0,0
4,HEART DEVELOPMENT,0.036948,-0.087718,-0.11119,0,0
4,NLS BEARING SUBSTRATE IMPORT INTO NUCLEUS,0.1028,-0.087827,-0.1709,0,0
4,POLYSACCHARIDE BINDING,0.26847,-0.087858,-0.075375,0,0
4,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.25363,-0.088041,-0.14181,0,0
4,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.4598,-0.088077,-0.047888,0,0
4,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.58456,-0.088484,-0.023743,0,0
4,FEEDING BEHAVIOR,0.59664,-0.088514,-0.0059076,0,0
4,U12 DEPENDENT SPLICEOSOME,0.12049,-0.088675,-0.086726,0,0
4,REACTOME CELL CYCLE,0.022165,-0.089135,-0.070544,0,0
4,BIOCARTA TRKA PATHWAY,0.26471,-0.089183,-0.078897,0,0
4,PID ERBB4 PATHWAY,0.27227,-0.089191,-0.061973,0,0
4,REGULATION OF CHROMOSOME ORGANIZATION AND BIOGENESIS,0.25001,-0.089252,-0.054668,0,0
4,REACTOME MUSCLE CONTRACTION,0.20937,-0.089456,-0.15068,0,0
4,CENTROSOME CYCLE,0.14526,-0.090349,-0.098848,0,0
4,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.53167,-0.09134,-0.063291,0,0
4,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.24643,-0.091789,-0.087741,0,0
4,SOLUTE SODIUM SYMPORTER ACTIVITY,0.48131,-0.091797,-0.052278,0,0
4,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.076492,-0.091854,-0.1385,0,0
4,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.18508,-0.091964,-0.16055,0,0
4,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.15773,-0.092704,-0.081468,0,0
4,REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION,0.12473,-0.093119,-0.13007,0,0
4,REACTOME DNA STRAND ELONGATION,0.010245,-0.093545,-0.11428,0,0
4,DNA DIRECTED DNA POLYMERASE ACTIVITY,0.054842,-0.093585,-0.077017,0,0
4,NEGATIVE REGULATION OF TRANSPORT,0.076492,-0.093613,-0.11377,0,0
4,PID ATR PATHWAY,0.10465,-0.094356,-0.07026,0,0
4,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.087232,-0.094669,-0.17214,0,0
4,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.36526,-0.094845,-0.078926,0,0
4,PID REELINPATHWAY,0.19095,-0.09495,-0.096595,0,0
4,REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE,0.21256,-0.095332,-0.075134,0,0
4,ACTIVATION OF JNK ACTIVITY,0.22235,-0.09604,-0.078096,0,0
4,EXTERNAL SIDE OF PLASMA MEMBRANE,0.12259,-0.09655,-0.086275,0,0
4,NEGATIVE REGULATION OF CELL CYCLE,0.10654,-0.097725,-0.069978,0,0
4,REACTOME CA DEPENDENT EVENTS,0.087232,-0.097922,-0.10288,0,0
4,CHROMATIN REMODELING,0.15773,-0.098092,-0.061646,0,0
4,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.61497,-0.098105,-0.03304,0,0
4,KEGG HEDGEHOG SIGNALING PATHWAY,0.25001,-0.098799,-0.052805,0,0
4,PID ARF6DOWNSTREAMPATHWAY,0.024288,-0.098946,-0.13897,0,0
4,REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS,0.34256,-0.098981,-0.15043,0,0
4,REACTOME GABA RECEPTOR ACTIVATION,0.29586,-0.099083,-0.078355,0,0
4,GLYCOSAMINOGLYCAN BINDING,0.16559,-0.099173,-0.095274,0,0
4,BIOCARTA PITX2 PATHWAY,0.47049,-0.099188,-0.042633,0,0
4,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.087232,-0.099301,-0.10479,0,0
4,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.077957,-0.099421,-0.10275,0,0
4,BIOCARTA VIP PATHWAY,0.20937,-0.099463,-0.082292,0,0
4,REACTOME MEIOTIC SYNAPSIS,0.24288,-0.099482,-0.10343,0,0
4,BIOCARTA PLCE PATHWAY,0.093897,-0.1001,-0.19813,0,0
4,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.052669,-0.10048,-0.16342,0,0
4,CARBOHYDRATE KINASE ACTIVITY,0.54903,-0.10086,-0.044561,0,0
4,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.4598,-0.10138,-0.061804,0,0
4,REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,0.10654,-0.10184,-0.1645,0,0
4,BIOCARTA CTCF PATHWAY,0.14769,-0.10186,-0.10022,0,0
4,REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY,0.097379,-0.10233,-0.10783,0,0
4,REGULATION OF TRANSLATIONAL INITIATION,0.13583,-0.10322,-0.12497,0,0
4,KEGG MISMATCH REPAIR,0.057089,-0.10333,-0.072314,0,0
4,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.11039,-0.1035,-0.091172,0,0
4,POSITIVE REGULATION OF CELL ADHESION,0.42855,-0.10355,-0.10737,0,0
4,RESPONSE TO IONIZING RADIATION,0.13814,-0.10383,-0.1208,0,0
4,REACTOME SIGNAL AMPLIFICATION,0.075049,-0.10473,-0.11811,0,0
4,METALLOENDOPEPTIDASE ACTIVITY,0.54321,-0.10478,-0.05198,0,0
4,REACTOME RNA POL III TRANSCRIPTION,0.012508,-0.10479,-0.10314,0,0
4,REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX,0.0695,-0.10616,-0.17174,0,0
4,REACTOME VIRAL MESSENGER RNA SYNTHESIS,0.093897,-0.10624,-0.092633,0,0
4,SPECIFIC TRANSCRIPTIONAL REPRESSOR ACTIVITY,0.12259,-0.10649,-0.10196,0,0
4,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.26847,-0.10659,-0.11993,0,0
4,RIBONUCLEOPROTEIN BINDING,0.13583,-0.10689,-0.12803,0,0
4,B CELL DIFFERENTIATION,0.26098,-0.10787,-0.07901,0,0
4,CELL CYCLE CHECKPOINT GO 0000075,0.0020453,-0.10806,-0.13654,0,0
4,REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS,0.072231,-0.10839,-0.089253,0,0
4,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.064293,-0.10976,-0.12336,0,0
4,PROTEIN METHYLTRANSFERASE ACTIVITY,0.009256,-0.1099,-0.13196,0,0
4,PID AURORA A PATHWAY,0.39858,-0.11022,-0.039837,0,0
4,PID AURORA B PATHWAY,0.059411,-0.11119,-0.13144,0,0
4,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.070855,-0.11134,-0.10898,0,0
4,TRANSLATION INITIATION FACTOR ACTIVITY,0.25729,-0.11156,-0.12431,0,0
4,EXTRACELLULAR MATRIX,0.05161,-0.1116,-0.19186,0,0
4,EMBRYO IMPLANTATION,0.04854,-0.112,-0.1263,0,0
4,KEGG VALINE LEUCINE AND ISOLEUCINE BIOSYNTHESIS,0.15015,-0.11292,-0.202,0,0
4,PROTEINACEOUS EXTRACELLULAR MATRIX,0.05161,-0.11319,-0.19544,0,0
4,BIOCARTA P35ALZHEIMERS PATHWAY,0.36064,-0.11335,-0.15583,0,0
4,REACTOME RAP1 SIGNALLING,0.40843,-0.11365,-0.072944,0,0
4,PID HDAC CLASSII PATHWAY,0.11235,-0.11415,-0.098685,0,0
4,PHOSPHATASE INHIBITOR ACTIVITY,0.29992,-0.11439,-0.1297,0,0
4,REACTOME INWARDLY RECTIFYING K CHANNELS,0.15264,-0.11458,-0.14422,0,0
4,PID SYNDECAN 1 PATHWAY,0.11434,-0.11489,-0.1902,0,0
4,BIOCARTA G1 PATHWAY,0.17374,-0.11523,-0.098651,0,0
4,CELL SUBSTRATE ADHESION,0.087232,-0.11543,-0.10298,0,0
4,CELL MATRIX ADHESION,0.087232,-0.11567,-0.10556,0,0
4,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.0062634,-0.11592,-0.13706,0,0
4,REACTOME OPIOID SIGNALLING,0.188,-0.1174,-0.06546,0,0
4,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.2839,-0.11787,-0.15838,0,0
4,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.11235,-0.11882,-0.12026,0,0
4,REACTOME ADP SIGNALLING THROUGH P2RY1,0.064293,-0.11964,-0.13638,0,0
4,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.11434,-0.11995,-0.096332,0,0
4,SPLICEOSOME ASSEMBLY,0.00029782,-0.1201,-0.15514,0,0
4,REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS,0.059411,-0.12045,-0.12,0,0
4,REGIONALIZATION,0.22235,-0.12159,-0.12142,0,0
4,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.188,-0.12201,-0.11647,0,0
4,REACTOME EARLY PHASE OF HIV LIFE CYCLE,0.0695,-0.1222,-0.14113,0,0
4,REACTOME KINESINS,0.042857,-0.12271,-0.16198,0,0
4,SIALYLTRANSFERASE ACTIVITY,0.26847,-0.12516,-0.16218,0,0
4,RESPONSE TO LIGHT STIMULUS,0.010245,-0.12553,-0.11445,0,0
4,REACTOME CHROMOSOME MAINTENANCE,0.092194,-0.12732,-0.10263,0,0
4,REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX,0.050569,-0.12821,-0.14586,0,0
4,REACTOME EXTENSION OF TELOMERES,0.027803,-0.12838,-0.1098,0,0
4,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.12259,-0.12971,-0.17456,0,0
4,REACTOME DARPP 32 EVENTS,0.03939,-0.12981,-0.1418,0,0
4,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.36526,-0.13033,-0.095543,0,0
4,REACTOME GLYCOLYSIS,0.23589,-0.1307,-0.10041,0,0
4,BIOCARTA CFTR PATHWAY,0.15015,-0.13108,-0.16618,0,0
4,REACTOME METABOLISM OF NON CODING RNA,0.053746,-0.13356,-0.11266,0,0
4,REACTOME MEIOSIS,0.23245,-0.13381,-0.088206,0,0
4,BIOCARTA CELLCYCLE PATHWAY,0.25363,-0.13448,-0.077816,0,0
4,REACTOME GAP JUNCTION DEGRADATION,0.090515,-0.13495,-0.18729,0,0
4,REGULATION OF ENDOCYTOSIS,0.079444,-0.13576,-0.13944,0,0
4,REACTOME RNA POL III CHAIN ELONGATION,0.11434,-0.1362,-0.093188,0,0
4,CENTROSOME ORGANIZATION AND BIOGENESIS,0.050569,-0.13625,-0.099003,0,0
4,N METHYLTRANSFERASE ACTIVITY,0.04854,-0.13678,-0.12034,0,0
4,MRNA PROCESSING GO 0006397,0.00038934,-0.13699,-0.12945,0,0
4,REACTOME G PROTEIN ACTIVATION,0.12689,-0.13821,-0.1291,0,0
4,RHO GTPASE ACTIVATOR ACTIVITY,0.24643,-0.13871,-0.089285,0,0
4,CELL FATE COMMITMENT,0.55487,-0.13903,-0.037371,0,0
4,REGULATION OF PROTEIN POLYMERIZATION,0.11841,-0.13962,-0.14139,0,0
4,REACTOME NETRIN1 SIGNALING,0.057089,-0.13987,-0.13132,0,0
4,CELL CORTEX PART,0.0695,-0.14079,-0.13071,0,0
4,EMBRYONIC MORPHOGENESIS,0.066855,-0.14169,-0.18863,0,0
4,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.11039,-0.14171,-0.15759,0,0
4,ST WNT BETA CATENIN PATHWAY,0.046579,-0.14207,-0.13775,0,0
4,CORTICAL CYTOSKELETON,0.05161,-0.14231,-0.15993,0,0
4,BIOCARTA AKAPCENTROSOME PATHWAY,0.036164,-0.14263,-0.15677,0,0
4,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.17653,-0.14301,-0.072012,0,0
4,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.0087944,-0.14407,-0.13803,0,0
4,G1 PHASE,0.19095,-0.14408,-0.089512,0,0
4,BIOCARTA CACAM PATHWAY,0.15264,-0.14448,-0.1117,0,0
4,INTEGRIN BINDING,0.11235,-0.14558,-0.13005,0,0
4,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.0083534,-0.14597,-0.19098,0,0
4,NUCLEAR MATRIX,0.054842,-0.14631,-0.11596,0,0
4,BIOCARTA CELL2CELL PATHWAY,0.15773,-0.14804,-0.1305,0,0
4,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.1313,-0.14863,-0.099258,0,0
4,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.44402,-0.14898,-0.073148,0,0
4,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.12049,-0.1502,-0.083926,0,0
4,REACTOME MYOGENESIS,0.011326,-0.15117,-0.19705,0,0
4,NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.044685,-0.1528,-0.15111,0,0
4,REGULATED SECRETORY PATHWAY,0.80312,-0.15411,0.0218,0,0
4,BIOCARTA NO2IL12 PATHWAY,0.0010859,-0.15477,-0.18129,0,0
4,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.22235,-0.15595,-0.061988,0,0
4,BRAIN DEVELOPMENT,0.04854,-0.15643,-0.13365,0,0
4,REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION,0.54321,-0.15709,-0.039555,0,0
4,REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.10465,-0.15748,-0.23258,0,0
4,REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE,0.48678,-0.15761,0.030992,0,0
4,BIOCARTA WNT PATHWAY,0.15773,-0.15821,-0.11014,0,0
4,REACTOME UNWINDING OF DNA,0.0047853,-0.16036,-0.1948,0,0
4,ACTIN FILAMENT BASED MOVEMENT,0.02068,-0.16045,-0.1621,0,0
4,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.054842,-0.16076,-0.20986,0,0
4,PID MYC ACTIVPATHWAY,0.077957,-0.16138,-0.14702,0,0
4,PATTERN SPECIFICATION PROCESS,0.090515,-0.16247,-0.11823,0,0
4,REGULATION OF GENE SPECIFIC TRANSCRIPTION,0.023741,-0.1666,-0.18828,0,0
4,PID NETRIN PATHWAY,0.0049174,-0.16907,-0.18777,0,0
4,REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE,0.20937,-0.16908,-0.063756,0,0
4,MICROTUBULE BASED MOVEMENT,0.03245,-0.17071,-0.13356,0,0
4,PID S1P S1P4 PATHWAY,0.2,-0.17094,-0.10455,0,0
4,ADHERENS JUNCTION,0.16559,-0.17097,-0.11516,0,0
4,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.097379,-0.17142,-0.16047,0,0
4,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36991,-0.17181,-0.10051,0,0
4,REACTOME MEIOTIC RECOMBINATION,0.16828,-0.17243,-0.13844,0,0
4,LAMELLIPODIUM,0.0028141,-0.17251,-0.18735,0,0
4,NEURON DIFFERENTIATION,0.00353,-0.17642,-0.26959,0,0
4,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.065563,-0.17882,-0.139,0,0
4,NEURON DEVELOPMENT,0.0060989,-0.17893,-0.23077,0,0
4,NUCLEOSOME ASSEMBLY,0.014486,-0.1798,-0.22433,0,0
4,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.05824,-0.18033,-0.26347,0,0
4,REACTOME ADP SIGNALLING THROUGH P2RY12,0.038561,-0.18169,-0.19366,0,0
4,DNA DAMAGE CHECKPOINT,0.00092958,-0.18328,-0.1855,0,0
4,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.02843,-0.18377,-0.13324,0,0
4,ACTIN FILAMENT ORGANIZATION,0.02166,-0.18382,-0.13488,0,0
4,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.024846,-0.18495,-0.22826,0,0
4,REACTOME COLLAGEN FORMATION,0.088862,-0.18928,-0.21314,0,0
4,REACTOME SIGNALING BY ROBO RECEPTOR,0.037747,-0.18962,-0.17588,0,0
4,CHROMATIN REMODELING COMPLEX,0.0066042,-0.18994,-0.19454,0,0
4,BIOCARTA SRCRPTP PATHWAY,0.47049,-0.19114,-0.048267,0,0
4,REACTOME TELOMERE MAINTENANCE,0.044685,-0.19245,-0.17194,0,0
4,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0073363,-0.19669,-0.14497,0,0
4,PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY,0.00020448,-0.19706,-0.27764,0,0
4,COPPER ION BINDING,0.17374,-0.19714,-0.12352,0,0
4,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.060602,-0.20207,-0.20542,0,0
4,KEGG TAURINE AND HYPOTAURINE METABOLISM,0.041967,-0.20532,-0.16919,0,0
4,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.025414,-0.20628,-0.18283,0,0
4,EXTRINSIC TO MEMBRANE,0.13583,-0.20775,-0.15142,0,0
4,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.17934,-0.20792,-0.10267,0,0
4,EPITHELIAL TO MESENCHYMAL TRANSITION,0.36991,-0.20854,-0.14833,0,0
4,NEUROTRANSMITTER SECRETION,0.78289,-0.20986,0.020767,0,0
4,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.10096,-0.21156,-0.10798,0,0
4,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.0031536,-0.21241,-0.29328,0,0
4,CHROMATIN ASSEMBLY,0.007729,-0.21289,-0.18286,0,0
4,RIBOSOME BIOGENESIS AND ASSEMBLY,0.049546,-0.21525,-0.18347,0,0
4,LEARNING AND OR MEMORY,0.02068,-0.2165,-0.18181,0,0
4,GLUTAMATE RECEPTOR ACTIVITY,0.075049,-0.21706,-0.23329,0,0
4,REACTOME RNA POL I TRANSCRIPTION,0.12259,-0.21832,-0.13731,0,0
4,IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY,0.41341,-0.21968,-0.1465,0,0
4,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.029068,-0.22024,-0.19257,0,0
4,SYNAPSE,0.019283,-0.22174,-0.15872,0,0
4,NEURITE DEVELOPMENT,0.0017123,-0.22539,-0.31599,0,0
4,AXONOGENESIS,0.0059384,-0.22609,-0.31211,0,0
4,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.15015,-0.23005,-0.12569,0,0
4,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.084046,-0.23754,-0.17736,0,0
4,AXON GUIDANCE,0.011904,-0.24264,-0.30931,0,0
4,SPINDLE ORGANIZATION AND BIOGENESIS,0.059411,-0.24437,-0.15104,0,0
4,MITOTIC SPINDLE ORGANIZATION AND BIOGENESIS,0.060602,-0.25048,-0.14583,0,0
4,CELL RECOGNITION,0.50896,-0.25076,-0.10171,0,0
4,SA REG CASCADE OF CYCLIN EXPR,0.11841,-0.25541,-0.12676,0,0
4,MICROTUBULE,2.0033e-05,-0.25911,-0.23675,0,0
4,PID LIS1PATHWAY,0.0011199,-0.26199,-0.21892,0,0
4,BIOCARTA NOS1 PATHWAY,0.030383,-0.26361,-0.18897,0,0
4,BIOCARTA SHH PATHWAY,4.1112e-06,-0.27121,-0.35721,0,0
4,REACTOME NCAM1 INTERACTIONS,0.012203,-0.28352,-0.28244,0,0
4,REACTOME RNA POL I PROMOTER OPENING,0.18219,-0.28564,-0.17258,0,0
4,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.00026003,-0.28952,-0.23711,0,0
4,SENSORY ORGAN DEVELOPMENT,0.0017641,-0.31272,-0.28539,0,0
4,REGULATION OF NEUROGENESIS,0.13814,-0.3156,-0.21083,0,0
4,BIOCARTA TCYTOTOXIC PATHWAY,0.0087944,-0.32623,-0.2407,0,0
4,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.00079435,-0.3281,-0.2575,0,0
4,REACTOME PACKAGING OF TELOMERE ENDS,0.12049,-0.33057,-0.20921,0,0
4,REGULATION OF AXONOGENESIS,0.01282,-0.53221,-0.46969,0,0
4,SITE OF POLARIZED GROWTH,0.00030804,-0.76321,-0.62079,0,0
4,GROWTH CONE,0.00044439,-0.83329,-0.66506,0,0
5,IMMUNOLOGICAL SYNAPSE,0.00041602,0.42472,0.35484,1,1
5,REACTOME CRMPS IN SEMA3A SIGNALING,0.00023468,0.39791,0.56123,1,1
5,REACTOME RNA POL I PROMOTER OPENING,0.024846,0.37103,0.33513,1,1
5,REACTOME CD28 DEPENDENT VAV1 PATHWAY,0.00020448,0.33257,0.29401,1,1
5,REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,0.025994,0.32897,0.21155,1,1
5,BIOCARTA SKP2E2F PATHWAY,0.00035231,0.32408,0.30442,1,1
5,SA REG CASCADE OF CYCLIN EXPR,0.0013457,0.31952,0.27295,1,1
5,PID SYNDECAN 3 PATHWAY,0.0059384,0.31839,0.33779,1,1
5,REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE,0.014841,0.29791,0.28209,1,1
5,REACTOME REGULATION OF KIT SIGNALING,0.014841,0.2963,0.30091,1,1
5,REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE,0.0028957,0.29433,0.25995,1,1
5,KINESIN COMPLEX,4.8379e-05,0.29169,0.3297,1,1
5,REACTOME FGFR1 LIGAND BINDING AND ACTIVATION,0.038561,0.27352,0.15955,1,1
5,REACTOME RNA POL I TRANSCRIPTION,0.041967,0.27026,0.20067,1,1
5,MICROTUBULE MOTOR ACTIVITY,0.0073363,0.27006,0.23128,1,1
5,BIOCARTA BAD PATHWAY,0.00057693,0.26464,0.29221,1,1
5,REACTOME MEIOTIC RECOMBINATION,0.030383,0.26283,0.23542,1,1
5,MICROTUBULE ASSOCIATED COMPLEX,0.00019079,0.25996,0.26886,1,1
5,REGULATION OF T CELL ACTIVATION,0.025414,0.24585,0.22427,1,1
5,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP,0.0067808,0.24372,0.32121,1,1
5,BIOCARTA CDK5 PATHWAY,0.0097392,0.24255,0.20066,1,1
5,BIOCARTA TCRA PATHWAY,0.0028957,0.22585,0.19403,1,1
5,PID NFKAPPABATYPICALPATHWAY,0.0069616,0.21413,0.1809,1,1
5,REACTOME MEIOSIS,0.025414,0.2035,0.18904,1,1
5,PHOTOTRANSDUCTION,0.014841,0.2033,0.15342,1,1
5,CENTROSOME,0.00013917,0.20016,0.16844,1,1
5,NUCLEAR CHROMATIN,0.022165,0.19918,0.21072,1,1
5,REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS,0.009256,0.18802,0.18602,1,1
5,REACTOME CD28 DEPENDENT PI3K AKT SIGNALING,0.0060989,0.18743,0.17527,1,1
5,REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION,0.017137,0.18641,0.18566,1,1
5,MOTOR ACTIVITY,0.011904,0.18349,0.18416,1,1
5,S PHASE,0.011612,0.17674,0.14185,1,1
5,REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1,0.0053338,0.17468,0.17313,1,1
5,MITOTIC SPINDLE ORGANIZATION AND BIOGENESIS,0.007729,0.17376,0.20496,1,1
5,BIOCARTA P27 PATHWAY,0.0064317,0.1737,0.16608,1,1
5,REGULATION OF CHROMOSOME ORGANIZATION AND BIOGENESIS,0.00353,0.1694,0.17458,1,1
5,REACTOME SIGNALING BY FGFR3 MUTANTS,0.025994,0.16565,0.15209,1,1
5,BIOCARTA IL7 PATHWAY,0.040234,0.16115,0.17653,1,1
5,BIOCARTA MCM PATHWAY,0.0025817,0.16108,0.19082,1,1
5,REACTOME INSULIN SYNTHESIS AND PROCESSING,0.0022332,0.16005,0.29217,1,1
5,MICROTUBULE CYTOSKELETON,5.0226e-05,0.15903,0.16092,1,1
5,T CELL ACTIVATION,0.024288,0.15786,0.15671,1,1
5,REACTOME CGMP EFFECTS,0.021165,0.15741,0.1729,1,1
5,REACTOME AQUAPORIN MEDIATED TRANSPORT,0.015203,0.15483,0.15869,1,1
5,BIOCARTA CSK PATHWAY,0.012203,0.15115,0.12918,1,1
5,CHROMATIN,0.0059384,0.14983,0.14125,1,1
5,REACTOME INFLAMMASOMES,0.029068,0.14969,0.15251,1,1
5,MICROTUBULE ORGANIZING CENTER PART,0.00098941,0.14801,0.173,1,1
5,MICROTUBULE ORGANIZING CENTER,0.00034072,0.14579,0.13875,1,1
5,REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION,0.009256,0.14567,0.14351,1,1
5,BIOCARTA RB PATHWAY,0.011326,0.14531,0.18774,1,1
5,SPINDLE MICROTUBULE,0.023205,0.13942,0.11547,1,1
5,TUBULIN BINDING,0.033166,0.13757,0.11548,1,1
5,NUCLEAR CHROMOSOME PART,0.0071468,0.1354,0.13362,1,1
5,S PHASE OF MITOTIC CELL CYCLE,0.03939,0.13485,0.13729,1,1
5,MICROTUBULE BINDING,0.0075304,0.13219,0.16379,1,1
5,REACTOME MITOTIC PROMETAPHASE,0.014486,0.13093,0.10861,1,1
5,NUCLEAR SPECK,0.033166,0.13079,0.10908,1,1
5,SPINDLE ORGANIZATION AND BIOGENESIS,0.012508,0.12852,0.17745,1,1
5,REACTOME EARLY PHASE OF HIV LIFE CYCLE,0.041093,0.12628,0.16243,1,1
5,REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,0.025994,0.12594,0.16472,1,1
5,REACTOME CTLA4 INHIBITORY SIGNALING,0.0097392,0.12557,0.13348,1,1
5,PID PI3KPLCTRKPATHWAY,0.02166,0.12451,0.10589,1,1
5,BIOCARTA ACH PATHWAY,0.018398,0.11995,0.09165,1,1
5,CENTROSOME CYCLE,0.020205,0.11834,0.14,1,1
5,MRNA SPLICE SITE SELECTION,0.041093,0.11728,0.12374,1,1
5,CHROMOSOMAL PART,0.0014299,0.11615,0.11518,1,1
5,KINETOCHORE,0.031059,0.11275,0.09756,1,1
5,REACTOME CD28 CO STIMULATION,0.03939,0.11202,0.072045,1,1
5,REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES,0.0056288,0.11093,0.10561,1,1
5,NUCLEAR REPLICATION FORK,0.02068,0.11015,0.12057,1,1
5,REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES,0.0057817,0.10849,0.099877,1,1
5,REACTOME TRANSCRIPTION,0.044685,0.10581,0.089665,1,1
5,PID FANCONI PATHWAY,0.020205,0.10481,0.10681,1,1
5,REACTOME INTRINSIC PATHWAY FOR APOPTOSIS,0.042857,0.10456,0.14866,1,1
5,PID FASPATHWAY,0.024288,0.10334,0.11854,1,1
5,REACTOME MITOTIC G2 G2 M PHASES,0.0062634,0.10051,0.10507,1,1
5,CENTROSOME ORGANIZATION AND BIOGENESIS,0.034637,0.088871,0.09718,1,1
5,CYTOSKELETAL PART,0.013465,0.087324,0.066648,1,1
5,REPLICATION FORK,0.047551,0.087157,0.1099,1,1
5,CHROMOSOME,0.0059384,0.083159,0.093483,1,1
5,MICROTUBULE ORGANIZING CENTER ORGANIZATION AND BIOGENESIS,0.043763,0.074553,0.10129,1,1
5,REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION ,0.044685,0.063922,0.087461,1,1
5,NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.019739,0.091263,0.11321,1,0
5,MICROTUBULE CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.044685,0.066629,0.12153,1,0
5,TRANSCRIPTION,0.021165,-0.035921,-0.053946,1,0
5,TRANSCRIPTION DNA DEPENDENT,0.023741,-0.040177,-0.0568,1,0
5,RNA BIOSYNTHETIC PROCESS,0.02268,-0.040849,-0.057015,1,0
5,REGULATION OF GENE EXPRESSION,0.012203,-0.043901,-0.065043,1,0
5,REACTOME PROTEIN FOLDING,0.043763,-0.046943,-0.10412,1,0
5,RNA METABOLIC PROCESS,0.011904,-0.04782,-0.054905,1,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.0017123,-0.048648,-0.059744,1,0
5,CYTOKINE METABOLIC PROCESS,0.02268,-0.052166,-0.17914,1,0
5,CYTOKINE BIOSYNTHETIC PROCESS,0.017969,-0.054305,-0.18443,1,0
5,MEMBRANE LIPID METABOLIC PROCESS,0.010773,-0.055532,-0.10479,1,0
5,CYTOPLASMIC MEMBRANE BOUND VESICLE,0.0053338,-0.055598,-0.10944,1,0
5,PROTEIN COMPLEX,0.0042883,-0.057601,-0.056702,1,0
5,REGULATION OF METABOLIC PROCESS,0.0013457,-0.058845,-0.077289,1,0
5,REGULATION OF CELLULAR METABOLIC PROCESS,0.0016129,-0.059037,-0.076804,1,0
5,LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS,0.018398,-0.059663,-0.08319,1,0
5,BIOPOLYMER METABOLIC PROCESS,0.00031859,-0.060944,-0.071576,1,0
5,REACTOME MHC CLASS II ANTIGEN PRESENTATION,0.009256,-0.061421,-0.10373,1,0
5,REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.015574,-0.062219,-0.17483,1,0
5,REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,0.030383,-0.062323,-0.096873,1,0
5,ENDOMEMBRANE SYSTEM,0.013139,-0.062946,-0.092022,1,0
5,KEGG ALANINE ASPARTATE AND GLUTAMATE METABOLISM,0.033166,-0.063062,-0.14591,1,0
5,ST B CELL ANTIGEN RECEPTOR,0.038561,-0.063985,-0.095718,1,0
5,PHOSPHORYLATION,0.011904,-0.064011,-0.085025,1,0
5,INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015574,-0.06427,-0.090562,1,0
5,CYTOPLASMIC VESICLE,0.0054795,-0.064441,-0.10643,1,0
5,KEGG OXIDATIVE PHOSPHORYLATION,0.029719,-0.064456,-0.12887,1,0
5,KEGG BASE EXCISION REPAIR,0.046579,-0.065383,-0.080857,1,0
5,REGULATION OF CELL ADHESION,0.0067808,-0.065613,-0.17845,1,0
5,RESPONSE TO BACTERIUM,0.0083534,-0.066515,-0.10406,1,0
5,REACTOME SIGNALING BY ERBB4,0.0099891,-0.066526,-0.079041,1,0
5,ORGANELLE LUMEN,0.0042883,-0.066706,-0.076895,1,0
5,MEMBRANE ENCLOSED LUMEN,0.0042883,-0.066706,-0.076895,1,0
5,REACTOME HEMOSTASIS,0.0047853,-0.067167,-0.095762,1,0
5,MEMBRANE BOUND VESICLE,0.0022992,-0.067418,-0.11249,1,0
5,PID SMAD2 3NUCLEARPATHWAY,0.047551,-0.067446,-0.094795,1,0
5,REACTOME HOST INTERACTIONS OF HIV FACTORS,0.033894,-0.069256,-0.10325,1,0
5,REGULATION OF MOLECULAR FUNCTION,0.0071468,-0.070105,-0.084014,1,0
5,PHOSPHOINOSITIDE METABOLIC PROCESS,0.0053338,-0.071225,-0.1223,1,0
5,VESICLE,0.0026572,-0.072052,-0.10955,1,0
5,PATTERN BINDING,0.043763,-0.073005,-0.11043,1,0
5,INTERFERON GAMMA PRODUCTION,0.014486,-0.073327,-0.1543,1,0
5,PID ERBB1 DOWNSTREAM PATHWAY,0.033894,-0.07336,-0.088472,1,0
5,KEGG SNARE INTERACTIONS IN VESICULAR TRANSPORT,0.016339,-0.074071,-0.096996,1,0
5,REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS,0.00095906,-0.074589,-0.10771,1,0
5,CELLULAR COMPONENT ASSEMBLY,0.00054072,-0.074628,-0.088837,1,0
5,PROTEIN HETERODIMERIZATION ACTIVITY,0.025414,-0.074697,-0.081182,1,0
5,ORGANELLE OUTER MEMBRANE,0.0037331,-0.07502,-0.14393,1,0
5,MULTI ORGANISM PROCESS,0.014138,-0.075278,-0.10761,1,0
5,RHODOPSIN LIKE RECEPTOR ACTIVITY,0.011047,-0.076565,-0.096688,1,0
5,MACROMOLECULAR COMPLEX,0.0028957,-0.077077,-0.062812,1,0
5,KEGG RENAL CELL CARCINOMA,0.040234,-0.077115,-0.078691,1,0
5,REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING,0.015953,-0.077252,-0.081068,1,0
5,CYTOKINE PRODUCTION,0.020205,-0.077427,-0.15386,1,0
5,IMMUNE RESPONSE,0.042857,-0.077487,-0.1033,1,0
5,NEGATIVE REGULATION OF CELL PROLIFERATION,0.0046564,-0.077652,-0.11993,1,0
5,BIOCARTA CYTOKINE PATHWAY,0.001228,-0.078766,-0.1455,1,0
5,GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.011326,-0.080205,-0.11903,1,0
5,REGULATION OF KINASE ACTIVITY,0.033894,-0.080353,-0.071641,1,0
5,RESPONSE TO STRESS,0.0011199,-0.080546,-0.10449,1,0
5,REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES,0.047551,-0.081189,-0.18042,1,0
5,KEGG HUNTINGTONS DISEASE,0.0038387,-0.081203,-0.10714,1,0
5,PID INTEGRIN A4B1 PATHWAY,0.044685,-0.081512,-0.14508,1,0
5,REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION,0.0049174,-0.081671,-0.099022,1,0
5,PID IL1PATHWAY,0.0054795,-0.081888,-0.149,1,0
5,KEGG CELL ADHESION MOLECULES CAMS,0.033166,-0.081985,-0.14976,1,0
5,REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,0.0007696,-0.082616,-0.17333,1,0
5,MACROMOLECULAR COMPLEX ASSEMBLY,0.00020448,-0.082674,-0.094602,1,0
5,PID AR PATHWAY,0.010773,-0.082931,-0.132,1,0
5,SIG PIP3 SIGNALING IN B LYMPHOCYTES,0.042857,-0.083233,-0.12284,1,0
5,PEPTIDASE ACTIVITY,0.0011549,-0.083557,-0.11933,1,0
5,REACTOME GPCR LIGAND BINDING,0.014138,-0.083637,-0.090684,1,0
5,OUTER MEMBRANE,0.00092958,-0.083722,-0.14621,1,0
5,GROWTH,0.018398,-0.08385,-0.11936,1,0
5,REACTOME COMPLEMENT CASCADE,0.036948,-0.083983,-0.21183,1,0
5,GOLGI STACK,0.047551,-0.084042,-0.12447,1,0
5,KEGG GLYCEROPHOSPHOLIPID METABOLISM,0.014486,-0.084066,-0.094837,1,0
5,STEROID METABOLIC PROCESS,0.014841,-0.084168,-0.16004,1,0
5,REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.084223,-0.068399,1,0
5,PHOSPHOLIPID METABOLIC PROCESS,0.0050528,-0.084223,-0.11213,1,0
5,NUCLEOTIDE BINDING,0.0011549,-0.08432,-0.094909,1,0
5,NEGATIVE REGULATION OF CELL ADHESION,0.031748,-0.084755,-0.15114,1,0
5,REGULATION OF RAS GTPASE ACTIVITY,0.02268,-0.085133,-0.1375,1,0
5,REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING,0.030383,-0.085556,-0.15245,1,0
5,PID IFNGPATHWAY,0.018836,-0.08566,-0.13573,1,0
5,NEGATIVE REGULATION OF CELLULAR PROCESS,0.0018173,-0.085881,-0.10571,1,0
5,REGULATION OF PROTEIN KINASE ACTIVITY,0.033166,-0.086135,-0.074818,1,0
5,REACTOME DEADENYLATION OF MRNA,0.001228,-0.086144,-0.15841,1,0
5,REACTOME SIGNALING BY PDGF,0.041093,-0.086421,-0.083245,1,0
5,SECOND MESSENGER MEDIATED SIGNALING,0.0056288,-0.086741,-0.10738,1,0
5,NEGATIVE REGULATION OF BIOLOGICAL PROCESS,0.0015653,-0.087074,-0.10695,1,0
5,KEGG OLFACTORY TRANSDUCTION,0.0013872,-0.087349,-0.091706,1,0
5,REACTOME OLFACTORY SIGNALING PATHWAY,0.0060989,-0.087533,-0.11736,1,0
5,CELL SURFACE RECEPTOR LINKED SIGNAL TRANSDUCTION GO 0007166,0.0030654,-0.087782,-0.09823,1,0
5,REACTOME DIABETES PATHWAYS,0.01282,-0.088232,-0.12348,1,0
5,POST TRANSLATIONAL PROTEIN MODIFICATION,0.001872,-0.088303,-0.090566,1,0
5,MACROMOLECULE LOCALIZATION,0.00074557,-0.089058,-0.101,1,0
5,PEPTIDYL AMINO ACID MODIFICATION,0.014486,-0.089098,-0.10664,1,0
5,NUCLEAR ENVELOPE ENDOPLASMIC RETICULUM NETWORK,0.011904,-0.089502,-0.11319,1,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDS,0.018836,-0.089787,-0.096502,1,0
5,KEGG MAPK SIGNALING PATHWAY,0.0075304,-0.089879,-0.09372,1,0
5,BIOPOLYMER CATABOLIC PROCESS,0.0024367,-0.089916,-0.088738,1,0
5,VESICULAR FRACTION,0.0081404,-0.089941,-0.11861,1,0
5,REGULATION OF CATALYTIC ACTIVITY,0.010506,-0.089949,-0.081417,1,0
5,BIOCARTA MTOR PATHWAY,0.016734,-0.089986,-0.13111,1,0
5,REGULATION OF DNA BINDING,0.025994,-0.090207,-0.09149,1,0
5,ENDOPLASMIC RETICULUM MEMBRANE,0.015953,-0.090636,-0.11878,1,0
5,MICROSOME,0.040234,-0.091006,-0.10316,1,0
5,PID INSULIN PATHWAY,0.02268,-0.091092,-0.10571,1,0
5,REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.0075304,-0.091244,-0.094636,1,0
5,PERINUCLEAR REGION OF CYTOPLASM,0.015574,-0.091382,-0.092366,1,0
5,HYDROLASE ACTIVITY ACTING ON ESTER BONDS,0.00022676,-0.092068,-0.12097,1,0
5,PROTEIN AMINO ACID PHOSPHORYLATION,0.0039469,-0.092574,-0.095873,1,0
5,BIOCARTA NFKB PATHWAY,0.043763,-0.092789,-0.18236,1,0
5,REACTOME GPCR DOWNSTREAM SIGNALING,0.0059384,-0.092952,-0.091477,1,0
5,NUCLEOTIDE EXCISION REPAIR,0.031748,-0.093748,-0.09381,1,0
5,GOLGI VESICLE TRANSPORT,0.03939,-0.093814,-0.11148,1,0
5,POSITIVE REGULATION OF METABOLIC PROCESS,0.00072223,-0.094221,-0.10187,1,0
5,PURINE NUCLEOTIDE BINDING,0.00035231,-0.094644,-0.10739,1,0
5,POSITIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.00084609,-0.095376,-0.10571,1,0
5,POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.021165,-0.095484,-0.1207,1,0
5,KEGG PANCREATIC CANCER,0.044685,-0.09563,-0.085722,1,0
5,METALLOPEPTIDASE ACTIVITY,0.011047,-0.095813,-0.1321,1,0
5,PID IL12 STAT4PATHWAY,0.019739,-0.095985,-0.16154,1,0
5,INDUCTION OF APOPTOSIS BY EXTRACELLULAR SIGNALS,0.0031536,-0.096293,-0.12022,1,0
5,PROTEIN AMINO ACID O LINKED GLYCOSYLATION,0.011904,-0.096352,-0.22444,1,0
5,KEGG PATHWAYS IN CANCER,0.0034322,-0.096413,-0.12913,1,0
5,CELL CYCLE ARREST GO 0007050,0.001662,-0.096499,-0.15235,1,0
5,REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,0.017137,-0.096577,-0.17134,1,0
5,CELLULAR LOCALIZATION,0.00019079,-0.096672,-0.098169,1,0
5,KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.03939,-0.096814,-0.09896,1,0
5,INTRACELLULAR SIGNALING CASCADE,0.0034322,-0.096991,-0.10415,1,0
5,KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.043763,-0.097091,-0.12685,1,0
5,PURINE RIBONUCLEOTIDE BINDING,0.00026903,-0.097592,-0.10732,1,0
5,INTRACELLULAR TRANSPORT,0.00014935,-0.097622,-0.11372,1,0
5,REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR,0.007729,-0.097691,-0.12551,1,0
5,PROTEIN MATURATION,0.02068,-0.097868,-0.14643,1,0
5,GTPASE BINDING,0.00065623,-0.098427,-0.15186,1,0
5,CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0064317,-0.09854,-0.12772,1,0
5,KEGG TGF BETA SIGNALING PATHWAY,0.019283,-0.098647,-0.11122,1,0
5,INTEGRAL TO ORGANELLE MEMBRANE,0.0041716,-0.098827,-0.13091,1,0
5,SIGNAL TRANSDUCTION,0.0011549,-0.099066,-0.10752,1,0
5,DEFENSE RESPONSE TO BACTERIUM,0.00057693,-0.09911,-0.14382,1,0
5,PID RAC1 PATHWAY,0.0073363,-0.099573,-0.14175,1,0
5,PID MYC PATHWAY,0.0071468,-0.099736,-0.18973,1,0
5,REACTOME INSULIN RECEPTOR SIGNALLING CASCADE,7.8282e-05,-0.099837,-0.11443,1,0
5,KEGG HEMATOPOIETIC CELL LINEAGE,0.023205,-0.099935,-0.14334,1,0
5,BIOCARTA EIF4 PATHWAY,0.043763,-0.099985,-0.09983,1,0
5,PROTEOLYSIS,0.0036303,-0.10009,-0.12377,1,0
5,IMMUNE SYSTEM DEVELOPMENT,0.024846,-0.10022,-0.11247,1,0
5,ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.029068,-0.1006,-0.13108,1,0
5,VIRAL REPRODUCTION,0.041967,-0.10074,-0.10618,1,0
5,KEGG ONE CARBON POOL BY FOLATE,0.030383,-0.10077,-0.18506,1,0
5,ADENYL RIBONUCLEOTIDE BINDING,0.00028792,-0.1008,-0.11349,1,0
5,BIOCARTA AT1R PATHWAY,0.033894,-0.10105,-0.092943,1,0
5,REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES,6.2786e-05,-0.10106,-0.12847,1,0
5,REACTOME ADAPTIVE IMMUNE SYSTEM,0.0018173,-0.10115,-0.10883,1,0
5,ATP BINDING,0.0010528,-0.10125,-0.1064,1,0
5,PROTEIN AMINO ACID ADP RIBOSYLATION,0.0020453,-0.1017,-0.13605,1,0
5,ST GA13 PATHWAY,0.0038387,-0.10175,-0.14425,1,0
5,CALCIUM ION BINDING,0.0042883,-0.10187,-0.12208,1,0
5,KEGG PENTOSE AND GLUCURONATE INTERCONVERSIONS,0.025994,-0.10193,-0.13905,1,0
5,OVULATION CYCLE,0.0075304,-0.10194,-0.14157,1,0
5,REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,0.031059,-0.10235,-0.16561,1,0
5,INTRINSIC TO ORGANELLE MEMBRANE,0.0053338,-0.10237,-0.1253,1,0
5,BIOCARTA MAL PATHWAY,0.030383,-0.10245,-0.090908,1,0
5,REACTOME SIGNALING BY INSULIN RECEPTOR,5.8301e-05,-0.10271,-0.10438,1,0
5,REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,0.013798,-0.10283,-0.15419,1,0
5,TRANSITION METAL ION BINDING,0.0023671,-0.10292,-0.11205,1,0
5,PROTEIN COMPLEX BINDING,0.00072223,-0.10298,-0.17621,1,0
5,GOLGI APPARATUS,0.00012964,-0.10304,-0.12347,1,0
5,BIOPOLYMER MODIFICATION,0.0006154,-0.10311,-0.1028,1,0
5,PROTEIN KINASE CASCADE,0.0081404,-0.10324,-0.13177,1,0
5,REACTOME MAP KINASE ACTIVATION IN TLR CASCADE,0.021165,-0.10328,-0.099489,1,0
5,ESTABLISHMENT OF CELLULAR LOCALIZATION,8.4205e-05,-0.1035,-0.10722,1,0
5,PROTEIN LOCALIZATION,0.00047456,-0.1038,-0.11384,1,0
5,LIPID BINDING,0.0020453,-0.10401,-0.13075,1,0
5,RESPONSE TO EXTERNAL STIMULUS,0.00067758,-0.10402,-0.13881,1,0
5,SECRETION,0.019739,-0.10402,-0.11059,1,0
5,MITOCHONDRIAL MEMBRANE PART,0.0018173,-0.1042,-0.1697,1,0
5,PHOSPHOINOSITIDE BIOSYNTHETIC PROCESS,0.0021689,-0.10431,-0.16009,1,0
5,REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES,0.0056288,-0.10442,-0.15121,1,0
5,CARBOHYDRATE METABOLIC PROCESS,0.0007696,-0.10446,-0.11808,1,0
5,ION BINDING,0.00055855,-0.10459,-0.096751,1,0
5,BIOCARTA SALMONELLA PATHWAY,0.02843,-0.10464,-0.13738,1,0
5,ADENYL NUCLEOTIDE BINDING,0.00029782,-0.10471,-0.11334,1,0
5,KEGG NOTCH SIGNALING PATHWAY,0.021165,-0.10475,-0.12342,1,0
5,PROTEIN MODIFICATION PROCESS,0.00067758,-0.105,-0.10336,1,0
5,METHYLTRANSFERASE ACTIVITY,0.011047,-0.10524,-0.11556,1,0
5,CELLULAR PROTEIN COMPLEX ASSEMBLY,0.00040247,-0.10526,-0.13457,1,0
5,CELL PROLIFERATION GO 0008283,0.00017796,-0.1056,-0.13095,1,0
5,TRANSMEMBRANE RECEPTOR ACTIVITY,0.00055855,-0.10566,-0.12504,1,0
5,BIOCARTA TOLL PATHWAY,0.0051916,-0.10571,-0.15992,1,0
5,PHOSPHOLIPID BINDING,0.044685,-0.10593,-0.093608,1,0
5,PROTEIN OLIGOMERIZATION,0.031748,-0.10598,-0.11709,1,0
5,REACTOME INNATE IMMUNE SYSTEM,0.010506,-0.10662,-0.13163,1,0
5,RIBONUCLEOPROTEIN COMPLEX,0.021165,-0.10667,-0.10106,1,0
5,RESPONSE TO CHEMICAL STIMULUS,0.00012964,-0.10668,-0.13063,1,0
5,ENZYME REGULATOR ACTIVITY,0.001228,-0.10669,-0.10679,1,0
5,REGULATION OF BODY FLUID LEVELS,0.00065623,-0.10673,-0.14641,1,0
5,BIOCARTA CHREBP2 PATHWAY,0.043763,-0.10679,-0.096665,1,0
5,ESTABLISHMENT OF LOCALIZATION,3.7791e-06,-0.10693,-0.12759,1,0
5,CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00054072,-0.10697,-0.11592,1,0
5,HEMOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT,0.024846,-0.10723,-0.11429,1,0
5,KEGG JAK STAT SIGNALING PATHWAY,0.0075304,-0.10725,-0.13774,1,0
5,LIGAND GATED CHANNEL ACTIVITY,0.036948,-0.10736,-0.1371,1,0
5,ORGAN MORPHOGENESIS,0.0083534,-0.10784,-0.10988,1,0
5,SIGNAL SEQUENCE BINDING,0.0025817,-0.10854,-0.17945,1,0
5,KEGG REGULATION OF ACTIN CYTOSKELETON,0.0081404,-0.10879,-0.12714,1,0
5,REGULATION OF CELL PROLIFERATION,0.00018427,-0.10889,-0.13343,1,0
5,REACTOME MEMBRANE TRAFFICKING,0.001986,-0.10955,-0.14969,1,0
5,PROTEIN DIMERIZATION ACTIVITY,0.00072223,-0.10984,-0.11617,1,0
5,REACTOME PEPTIDE LIGAND BINDING RECEPTORS,0.0025817,-0.10985,-0.12422,1,0
5,ENVELOPE,0.00044439,-0.10995,-0.12352,1,0
5,ORGANELLE ENVELOPE,0.00044439,-0.10995,-0.12352,1,0
5,IDENTICAL PROTEIN BINDING,0.00095906,-0.10996,-0.11282,1,0
5,REACTOME RNA POL I TRANSCRIPTION INITIATION,0.030383,-0.11003,-0.12207,1,0
5,REACTOME REGULATION OF MITOTIC CELL CYCLE,0.03245,-0.11016,-0.13372,1,0
5,CARBOHYDRATE BINDING,0.00044439,-0.11022,-0.14306,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING GLYCOSYL GROUPS,0.0010859,-0.11094,-0.16181,1,0
5,KEGG PYRIMIDINE METABOLISM,0.00090094,-0.11118,-0.12585,1,0
5,CELLULAR CATION HOMEOSTASIS,0.010506,-0.11197,-0.10829,1,0
5,ORGANELLE MEMBRANE,0.00054072,-0.11216,-0.12083,1,0
5,REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS,0.019739,-0.11219,-0.14792,1,0
5,PID RHOA REG PATHWAY,0.0020453,-0.11224,-0.21159,1,0
5,SA B CELL RECEPTOR COMPLEXES,0.041093,-0.11231,-0.14814,1,0
5,CHEMICAL HOMEOSTASIS,0.0037331,-0.11234,-0.1157,1,0
5,POSITIVE REGULATION OF CELLULAR PROCESS,0.0016129,-0.1125,-0.12022,1,0
5,POSITIVE REGULATION OF DNA BINDING,0.014841,-0.11287,-0.11414,1,0
5,ST TUMOR NECROSIS FACTOR PATHWAY,0.033166,-0.11293,-0.17209,1,0
5,PROTEIN COMPLEX ASSEMBLY,0.0017641,-0.11354,-0.11893,1,0
5,KEGG ETHER LIPID METABOLISM,0.0060989,-0.11368,-0.15047,1,0
5,GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.014486,-0.11394,-0.11538,1,0
5,PROTEIN RNA COMPLEX ASSEMBLY,0.0056288,-0.11397,-0.13935,1,0
5,REGULATION OF BINDING,0.02843,-0.11397,-0.087522,1,0
5,REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN,0.011904,-0.11412,-0.15494,1,0
5,ORGANELLE INNER MEMBRANE,0.00042998,-0.11414,-0.15743,1,0
5,NEGATIVE REGULATION OF CELL CYCLE,0.0021689,-0.11418,-0.14399,1,0
5,MITOCHONDRIAL OUTER MEMBRANE,0.0069616,-0.11487,-0.1631,1,0
5,REACTOME IMMUNE SYSTEM,0.0013054,-0.11491,-0.12671,1,0
5,PID AVB3 INTEGRIN PATHWAY,0.025994,-0.1152,-0.18764,1,0
5,TISSUE DEVELOPMENT,0.0013457,-0.11546,-0.18126,1,0
5,KEGG GLYCEROLIPID METABOLISM,0.045624,-0.11554,-0.10868,1,0
5,PROTEIN HOMODIMERIZATION ACTIVITY,0.00026903,-0.11557,-0.15104,1,0
5,CATION HOMEOSTASIS,0.0090226,-0.11595,-0.11372,1,0
5,CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024846,-0.11609,-0.1077,1,0
5,PID MET PATHWAY,0.011612,-0.11611,-0.092507,1,0
5,SMALL GTPASE BINDING,0.00034072,-0.1162,-0.15482,1,0
5,NUCLEOTIDYLTRANSFERASE ACTIVITY,5.6174e-05,-0.11623,-0.15373,1,0
5,PID CD8TCRDOWNSTREAMPATHWAY,0.043763,-0.11627,-0.088234,1,0
5,HEPARIN BINDING,0.0049174,-0.11673,-0.20848,1,0
5,KEGG NEUROACTIVE LIGAND RECEPTOR INTERACTION,0.0022992,-0.11703,-0.12747,1,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN CYCLIC AMIDINES,0.035393,-0.11722,-0.16017,1,0
5,MEMBRANE PART,3.1888e-05,-0.1173,-0.13798,1,0
5,REGULATION OF BIOLOGICAL QUALITY,0.00014935,-0.1174,-0.13055,1,0
5,REACTOME ACTIVATED TLR4 SIGNALLING,0.0025083,-0.11762,-0.14242,1,0
5,REACTOME SIGNALING BY THE B CELL RECEPTOR BCR,0.0028141,-0.11784,-0.12625,1,0
5,REGULATION OF DNA REPLICATION,0.027188,-0.11817,-0.16033,1,0
5,REACTOME RNA POL I TRANSCRIPTION TERMINATION,0.023741,-0.11818,-0.1465,1,0
5,MACROMOLECULE CATABOLIC PROCESS,0.00019753,-0.11834,-0.11186,1,0
5,KEGG CYSTEINE AND METHIONINE METABOLISM,0.0090226,-0.11857,-0.1624,1,0
5,MYELOID CELL DIFFERENTIATION,0.020205,-0.11868,-0.17842,1,0
5,HOMEOSTATIC PROCESS,0.00063551,-0.11878,-0.13101,1,0
5,ION HOMEOSTASIS,0.011612,-0.11909,-0.10237,1,0
5,PID PDGFRBPATHWAY,0.00098941,-0.11926,-0.15436,1,0
5,HEMOSTASIS,0.0050528,-0.11933,-0.14557,1,0
5,CELL SUBSTRATE ADHESION,0.011047,-0.11939,-0.16328,1,0
5,CYTOSOL,0.00013433,-0.11952,-0.12554,1,0
5,REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0019282,-0.11972,-0.19799,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS,8.1192e-05,-0.11975,-0.11601,1,0
5,REPRODUCTIVE PROCESS,0.015953,-0.11992,-0.10041,1,0
5,CELLULAR HOMEOSTASIS,0.0040578,-0.11992,-0.11555,1,0
5,PROTEIN KINASE ACTIVITY,0.0010206,-0.11996,-0.11354,1,0
5,POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0024367,-0.11998,-0.11527,1,0
5,NEGATIVE REGULATION OF TRANSPORT,0.041967,-0.12002,-0.13547,1,0
5,KEGG CYTOSOLIC DNA SENSING PATHWAY,0.0057817,-0.12005,-0.15212,1,0
5,POSITIVE REGULATION OF BINDING,0.013139,-0.1201,-0.10323,1,0
5,REACTOME TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7 8 OR 9 ACTIVATION,0.001662,-0.12032,-0.11611,1,0
5,SOLUTE SODIUM SYMPORTER ACTIVITY,0.036164,-0.12035,-0.16121,1,0
5,CAMP MEDIATED SIGNALING,0.03245,-0.12043,-0.11032,1,0
5,REACTOME SIGNALING BY NOTCH2,0.038561,-0.12086,-0.16669,1,0
5,HYDROGEN ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0038387,-0.1211,-0.13957,1,0
5,TRANSITION METAL ION TRANSPORT,0.03245,-0.12118,-0.1466,1,0
5,ION TRANSPORT,0.0022332,-0.12133,-0.1534,1,0
5,UNFOLDED PROTEIN BINDING,0.0066042,-0.12134,-0.17286,1,0
5,POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.024846,-0.12139,-0.1083,1,0
5,REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI,0.014486,-0.12146,-0.16244,1,0
5,POSITIVE REGULATION OF BIOLOGICAL PROCESS,0.0013872,-0.12161,-0.11852,1,0
5,REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.021165,-0.12169,-0.20924,1,0
5,REACTOME EGFR DOWNREGULATION,0.02068,-0.12183,-0.15289,1,0
5,REACTOME STEROID HORMONES,0.023205,-0.12185,-0.13261,1,0
5,RECEPTOR BINDING,0.0011549,-0.12196,-0.12274,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS,0.0014738,-0.1224,-0.148,1,0
5,EXONUCLEASE ACTIVITY,0.013798,-0.12264,-0.14215,1,0
5,KINASE ACTIVITY,0.00050664,-0.12271,-0.108,1,0
5,RECEPTOR ACTIVITY,3.7145e-05,-0.12317,-0.14722,1,0
5,MEMBRANE,2.6307e-05,-0.12349,-0.13594,1,0
5,RNA CATABOLIC PROCESS,0.013798,-0.1235,-0.14434,1,0
5,KEGG FC GAMMA R MEDIATED PHAGOCYTOSIS,0.0025817,-0.1235,-0.13238,1,0
5,POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.017549,-0.12422,-0.11113,1,0
5,BIOCARTA TALL1 PATHWAY,0.0034322,-0.12446,-0.14871,1,0
5,LATE ENDOSOME,0.023741,-0.12463,-0.13105,1,0
5,DNA DIRECTED DNA POLYMERASE ACTIVITY,0.02166,-0.12499,-0.089332,1,0
5,ACTIN BINDING,0.02166,-0.1252,-0.11288,1,0
5,REGULATION OF LIPID METABOLIC PROCESS,0.025414,-0.1252,-0.16427,1,0
5,G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0031536,-0.12579,-0.10792,1,0
5,LIGASE ACTIVITY,0.00025131,-0.12581,-0.14054,1,0
5,G PROTEIN SIGNALING COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.0046564,-0.12581,-0.13837,1,0
5,BIOCARTA PDGF PATHWAY,0.040234,-0.12586,-0.12307,1,0
5,NUCLEOLUS,0.0012662,-0.12586,-0.14224,1,0
5,REGULATION OF RHO GTPASE ACTIVITY,0.030383,-0.126,-0.13525,1,0
5,PHOSPHOTRANSFERASE ACTIVITY ALCOHOL GROUP AS ACCEPTOR,0.00047456,-0.12605,-0.11412,1,0
5,VESICLE MEMBRANE,0.019283,-0.12623,-0.12839,1,0
5,CELL MATRIX ADHESION,0.014138,-0.12643,-0.16674,1,0
5,ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00017796,-0.12664,-0.12976,1,0
5,PID RB 1PATHWAY,0.012203,-0.12707,-0.092746,1,0
5,CELL DEVELOPMENT,0.00016595,-0.12725,-0.13102,1,0
5,REACTOME SIGNALING BY RHO GTPASES,0.0042883,-0.12738,-0.1285,1,0
5,CYTOPLASMIC VESICLE MEMBRANE,0.030383,-0.12742,-0.11706,1,0
5,CYTOPLASMIC VESICLE PART,0.030383,-0.12742,-0.11706,1,0
5,CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0073363,-0.12798,-0.1339,1,0
5,GUANYL NUCLEOTIDE BINDING,0.035393,-0.12841,-0.092916,1,0
5,SERINE HYDROLASE ACTIVITY,0.00079435,-0.12851,-0.20686,1,0
5,BIOCARTA EIF2 PATHWAY,0.034637,-0.12861,-0.14943,1,0
5,GOLGI APPARATUS PART,0.00018427,-0.12874,-0.14326,1,0
5,CARBON CARBON LYASE ACTIVITY,0.043763,-0.12878,-0.14015,1,0
5,GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0054795,-0.12884,-0.15143,1,0
5,PEPTIDE RECEPTOR ACTIVITY,0.0057817,-0.129,-0.15896,1,0
5,ANGIOGENESIS,0.013465,-0.12909,-0.1728,1,0
5,KEGG DILATED CARDIOMYOPATHY,0.0083534,-0.12945,-0.15521,1,0
5,BIOCARTA CTCF PATHWAY,0.040234,-0.12946,-0.13795,1,0
5,REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS,0.0071468,-0.12993,-0.16739,1,0
5,APOPTOSIS GO,0.00037661,-0.13005,-0.14344,1,0
5,G PROTEIN SIGNALING COUPLED TO CAMP NUCLEOTIDE SECOND MESSENGER,0.029719,-0.13077,-0.11326,1,0
5,REGULATION OF APOPTOSIS,0.00040247,-0.13079,-0.15582,1,0
5,CYTOPLASMIC PART,3.3287e-06,-0.1308,-0.13941,1,0
5,REGULATION OF DEVELOPMENTAL PROCESS,0.00052342,-0.13105,-0.14368,1,0
5,KEGG PPAR SIGNALING PATHWAY,0.00069957,-0.13128,-0.16211,1,0
5,REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,0.046579,-0.13148,-0.20533,1,0
5,REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX,0.0031536,-0.13167,-0.14835,1,0
5,PID VEGFR1 2 PATHWAY,0.010245,-0.13195,-0.13258,1,0
5,CATION BINDING,0.00040247,-0.1321,-0.11586,1,0
5,REGULATION OF CATABOLIC PROCESS,0.0087944,-0.13236,-0.12154,1,0
5,REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE,0.0017123,-0.13236,-0.13836,1,0
5,RESPONSE TO ORGANIC SUBSTANCE,0.038561,-0.13252,-0.09953,1,0
5,CYTOPLASM,2.6902e-06,-0.13269,-0.12952,1,0
5,BIOCARTA NKT PATHWAY,0.018398,-0.13278,-0.1852,1,0
5,PLASMA MEMBRANE PART,0.00017186,-0.13287,-0.14063,1,0
5,PID MYC REPRESSPATHWAY,0.004408,-0.13288,-0.19949,1,0
5,REACTOME GLUCOSE TRANSPORT,0.0056288,-0.13291,-0.13793,1,0
5,REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE,0.037747,-0.13303,-0.14754,1,0
5,FEMALE PREGNANCY,0.0020453,-0.13314,-0.16375,1,0
5,ENDOPLASMIC RETICULUM PART,0.0097392,-0.13326,-0.13823,1,0
5,BIOCARTA STRESS PATHWAY,0.0094949,-0.13337,-0.16314,1,0
5,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.011047,-0.13357,-0.21472,1,0
5,VIRAL REPRODUCTIVE PROCESS,0.011612,-0.13364,-0.1472,1,0
5,INTRINSIC TO MEMBRANE,2.8418e-05,-0.13425,-0.14824,1,0
5,KEGG SPHINGOLIPID METABOLISM,0.0034322,-0.13453,-0.17017,1,0
5,POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.001986,-0.13456,-0.15217,1,0
5,PID NFKAPPABCANONICALPATHWAY,0.027803,-0.13457,-0.15747,1,0
5,PID TNFPATHWAY,0.024846,-0.13458,-0.17113,1,0
5,POSITIVE REGULATION OF TRANSLATION,7.2754e-05,-0.13464,-0.20534,1,0
5,REACTOME ASPARAGINE N LINKED GLYCOSYLATION,0.0011199,-0.13471,-0.18096,1,0
5,BIOCARTA CELL2CELL PATHWAY,0.045624,-0.13483,-0.17968,1,0
5,REACTOME ACTIVATION OF NF KAPPAB IN B CELLS,0.013465,-0.13494,-0.17395,1,0
5,RAS GTPASE BINDING,0.0013054,-0.13499,-0.15445,1,0
5,REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE,0.031059,-0.13536,-0.19421,1,0
5,REACTOME NOD1 2 SIGNALING PATHWAY,0.030383,-0.13539,-0.16048,1,0
5,PLASMA MEMBRANE,0.00010845,-0.13586,-0.14242,1,0
5,CELLULAR MACROMOLECULE METABOLIC PROCESS,1.1776e-06,-0.1359,-0.14398,1,0
5,PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0041716,-0.13615,-0.15607,1,0
5,REACTOME PHOSPHOLIPID METABOLISM,6.2786e-05,-0.13622,-0.15289,1,0
5,REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE,0.00092958,-0.13645,-0.14179,1,0
5,NUCLEAR TRANSPORT,0.0038387,-0.13656,-0.1214,1,0
5,REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM,0.041967,-0.13672,-0.18917,1,0
5,KEGG SELENOAMINO ACID METABOLISM,0.00067758,-0.13695,-0.23088,1,0
5,PROTEIN METABOLIC PROCESS,2.2658e-06,-0.13714,-0.14082,1,0
5,REACTOME PURINE CATABOLISM,0.0033369,-0.13716,-0.23226,1,0
5,REGULATION OF MAP KINASE ACTIVITY,0.02268,-0.13724,-0.11364,1,0
5,PID EPHA FWDPATHWAY,0.017137,-0.13753,-0.16071,1,0
5,VITAMIN METABOLIC PROCESS,0.018398,-0.13812,-0.16488,1,0
5,PROTEIN TRANSPORT,0.00012074,-0.13841,-0.13314,1,0
5,RIBONUCLEOPROTEIN COMPLEX BIOGENESIS AND ASSEMBLY,0.0022332,-0.1385,-0.16578,1,0
5,REGULATION OF PROGRAMMED CELL DEATH,0.00047456,-0.13874,-0.15877,1,0
5,COLLAGEN,0.037747,-0.13922,-0.25112,1,0
5,ECTODERM DEVELOPMENT,0.017969,-0.13943,-0.15601,1,0
5,INTEGRAL TO MEMBRANE,2.7343e-05,-0.13953,-0.14945,1,0
5,RNA 3END PROCESSING,0.014486,-0.13961,-0.16661,1,0
5,REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM,0.010773,-0.13965,-0.1645,1,0
5,CELLULAR PROTEIN METABOLIC PROCESS,1.3441e-06,-0.13977,-0.14392,1,0
5,BIOCARTA FIBRINOLYSIS PATHWAY,0.012508,-0.13991,-0.27059,1,0
5,REACTOME NUCLEAR SIGNALING BY ERBB4,0.0032441,-0.13997,-0.1466,1,0
5,KEGG RNA POLYMERASE,0.016339,-0.13997,-0.12572,1,0
5,BIOCARTA ARAP PATHWAY,0.0032441,-0.14005,-0.18418,1,0
5,BIOCARTA GCR PATHWAY,0.02268,-0.14017,-0.15628,1,0
5,L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0059384,-0.14019,-0.2066,1,0
5,PID IL12 2PATHWAY,0.016339,-0.1403,-0.13146,1,0
5,MITOCHONDRIAL RESPIRATORY CHAIN,0.00353,-0.1404,-0.19545,1,0
5,PROGRAMMED CELL DEATH,0.00036427,-0.14053,-0.14581,1,0
5,NUCLEOCYTOPLASMIC TRANSPORT,0.0038387,-0.14054,-0.12287,1,0
5,KEGG GLYCOSAMINOGLYCAN DEGRADATION,0.011047,-0.14055,-0.25948,1,0
5,MUSCLE DEVELOPMENT,0.0053338,-0.14071,-0.13398,1,0
5,REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,0.013139,-0.14084,-0.17279,1,0
5,REACTOME TRIF MEDIATED TLR3 SIGNALING,0.0015653,-0.14111,-0.13479,1,0
5,MITOCHONDRIAL MEMBRANE,0.00045924,-0.14131,-0.18879,1,0
5,REACTOME TOLL RECEPTOR CASCADES,0.00065623,-0.14168,-0.16357,1,0
5,REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION,0.00022676,-0.14177,-0.18167,1,0
5,GROWTH FACTOR BINDING,0.0031536,-0.14184,-0.14211,1,0
5,PID EPHA2 FWDPATHWAY,0.013139,-0.14186,-0.13404,1,0
5,INFLAMMATORY RESPONSE,0.0023671,-0.14209,-0.1712,1,0
5,PID P53DOWNSTREAMPATHWAY,0.009256,-0.14214,-0.15062,1,0
5,EXTRACELLULAR REGION,0.00047456,-0.14218,-0.16027,1,0
5,ENDOPLASMIC RETICULUM,0.00025131,-0.14219,-0.14893,1,0
5,PROTEIN FOLDING,0.0014299,-0.14236,-0.19562,1,0
5,REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES,0.00054072,-0.14242,-0.1614,1,0
5,CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.14301,-0.17636,1,0
5,LIPOPROTEIN METABOLIC PROCESS,0.00014935,-0.14331,-0.18442,1,0
5,COAGULATION,0.00031859,-0.14403,-0.20736,1,0
5,BIOCARTA P53HYPOXIA PATHWAY,0.031059,-0.1441,-0.20868,1,0
5,REGULATION OF MUSCLE CONTRACTION,0.037747,-0.14425,-0.13416,1,0
5,ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0046564,-0.14442,-0.12112,1,0
5,I KAPPAB KINASE NF KAPPAB CASCADE,0.044685,-0.14443,-0.18205,1,0
5,REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX,0.024288,-0.14449,-0.18032,1,0
5,BLOOD COAGULATION,0.00055855,-0.14465,-0.20208,1,0
5,EXTRACELLULAR REGION PART,0.0022992,-0.14468,-0.15257,1,0
5,REACTOME METABOLISM OF LIPIDS AND LIPOPROTEINS,2.2524e-05,-0.14479,-0.16038,1,0
5,DEFENSE RESPONSE,0.0041716,-0.14488,-0.14909,1,0
5,BIOCARTA MET PATHWAY,0.015953,-0.14512,-0.11692,1,0
5,ENDOPEPTIDASE ACTIVITY,0.00045924,-0.14551,-0.1371,1,0
5,REACTOME REGULATION OF COMPLEMENT CASCADE,0.0081404,-0.14565,-0.34462,1,0
5,REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION,0.00081984,-0.14584,-0.16634,1,0
5,ST P38 MAPK PATHWAY,0.0057817,-0.14749,-0.15528,1,0
5,RNA BINDING,0.00087311,-0.14769,-0.17422,1,0
5,METALLOENDOPEPTIDASE ACTIVITY,0.014138,-0.14775,-0.15222,1,0
5,INTRINSIC TO PLASMA MEMBRANE,7.8282e-05,-0.14803,-0.15567,1,0
5,REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS,0.001662,-0.14808,-0.17804,1,0
5,LIPID BIOSYNTHETIC PROCESS,0.00038934,-0.14809,-0.17919,1,0
5,REACTOME METAL ION SLC TRANSPORTERS,0.015203,-0.14818,-0.14503,1,0
5,PEROXISOME ORGANIZATION AND BIOGENESIS,0.0046564,-0.14819,-0.15897,1,0
5,PID RHOA PATHWAY,0.0090226,-0.14821,-0.13801,1,0
5,REGULATION OF INTRACELLULAR TRANSPORT,0.009256,-0.14851,-0.19938,1,0
5,NEGATIVE REGULATION OF TRANSLATION,0.022165,-0.14891,-0.14844,1,0
5,MITOCHONDRIAL INNER MEMBRANE,0.00049035,-0.14934,-0.19278,1,0
5,REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS,0.016339,-0.14947,-0.11875,1,0
5,EPIDERMIS DEVELOPMENT,0.014841,-0.14949,-0.16698,1,0
5,TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.02068,-0.14954,-0.15373,1,0
5,KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION,0.00072223,-0.14961,-0.19454,1,0
5,KEGG COMPLEMENT AND COAGULATION CASCADES,0.00069957,-0.14964,-0.24703,1,0
5,BIOCARTA CD40 PATHWAY,0.026586,-0.14985,-0.22532,1,0
5,SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY,0.00041602,-0.15004,-0.14094,1,0
5,REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS,0.035393,-0.1501,-0.12859,1,0
5,PID CERAMIDE PATHWAY,0.0028957,-0.15024,-0.14714,1,0
5,INTERACTION WITH HOST,0.0024367,-0.1505,-0.18302,1,0
5,DNA POLYMERASE ACTIVITY,0.0022992,-0.15079,-0.12799,1,0
5,AMINO SUGAR METABOLIC PROCESS,0.0059384,-0.15091,-0.16,1,0
5,AMINOPEPTIDASE ACTIVITY,0.013798,-0.15111,-0.22687,1,0
5,REACTOME IL1 SIGNALING,0.00057693,-0.15117,-0.18232,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING HEXOSYL GROUPS,0.0073363,-0.15126,-0.16416,1,0
5,SKELETAL DEVELOPMENT,0.004408,-0.15134,-0.18029,1,0
5,ALCOHOL METABOLIC PROCESS,0.00026903,-0.15146,-0.16392,1,0
5,NUCLEAR ORGANIZATION AND BIOGENESIS,0.00081984,-0.15154,-0.12855,1,0
5,INTEGRAL TO PLASMA MEMBRANE,6.5149e-05,-0.15159,-0.15669,1,0
5,KEGG PHOSPHATIDYLINOSITOL SIGNALING SYSTEM,0.0085714,-0.15175,-0.10774,1,0
5,REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,0.009256,-0.15277,-0.16478,1,0
5,CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,-0.15307,-0.16996,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING SULFUR CONTAINING GROUPS,0.017549,-0.15329,-0.1075,1,0
5,REACTOME CELL JUNCTION ORGANIZATION,0.041967,-0.15397,-0.13848,1,0
5,ST INTERLEUKIN 4 PATHWAY,0.023205,-0.15399,-0.16438,1,0
5,PROTEIN TARGETING,7.013e-05,-0.15431,-0.15747,1,0
5,MANNOSYLTRANSFERASE ACTIVITY,0.0062634,-0.1547,-0.16911,1,0
5,KEGG INOSITOL PHOSPHATE METABOLISM,8.7323e-05,-0.15503,-0.17164,1,0
5,TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00036427,-0.15535,-0.15383,1,0
5,CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0033369,-0.15559,-0.15313,1,0
5,ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00011241,-0.15574,-0.16253,1,0
5,KEGG BLADDER CANCER,0.041967,-0.15592,-0.13616,1,0
5,REACTOME COMMON PATHWAY,0.0051916,-0.15646,-0.24067,1,0
5,REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1,0.0071468,-0.15646,-0.18843,1,0
5,KEGG ADIPOCYTOKINE SIGNALING PATHWAY,0.00044439,-0.15646,-0.1532,1,0
5,RIBONUCLEOPROTEIN BINDING,0.019739,-0.15649,-0.15566,1,0
5,BIOCARTA INTEGRIN PATHWAY,0.0027346,-0.15687,-0.18117,1,0
5,INTRACELLULAR PROTEIN TRANSPORT,5.2139e-05,-0.1569,-0.14676,1,0
5,CELLULAR LIPID METABOLIC PROCESS,3.3132e-05,-0.15713,-0.19004,1,0
5,REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION,0.00034072,-0.15759,-0.17228,1,0
5,REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION,0.00074557,-0.15798,-0.24415,1,0
5,PID PDGFRAPATHWAY,0.013465,-0.1582,-0.17612,1,0
5,REGULATION OF SIGNAL TRANSDUCTION,0.0047853,-0.15842,-0.15593,1,0
5,POSITIVE REGULATION OF CELL PROLIFERATION,0.00035231,-0.15843,-0.17989,1,0
5,REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,0.0022992,-0.15854,-0.2672,1,0
5,PHOSPHOINOSITIDE MEDIATED SIGNALING,0.0025083,-0.15863,-0.13361,1,0
5,G PROTEIN SIGNALING COUPLED TO IP3 SECOND MESSENGERPHOSPHOLIPASE C ACTIVATING,0.0038387,-0.1588,-0.13742,1,0
5,KEGG LINOLEIC ACID METABOLISM,0.00026003,-0.15887,-0.19112,1,0
5,KEGG N GLYCAN BIOSYNTHESIS,0.0027346,-0.15888,-0.17455,1,0
5,REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING,0.017137,-0.15894,-0.19828,1,0
5,RECEPTOR COMPLEX,0.015574,-0.15909,-0.14896,1,0
5,KEGG HISTIDINE METABOLISM,0.0041716,-0.15925,-0.16796,1,0
5,PROTEIN IMPORT INTO NUCLEUS,0.010245,-0.1593,-0.14537,1,0
5,STRUCTURAL CONSTITUENT OF MUSCLE,0.007729,-0.1593,-0.1532,1,0
5,BIOCARTA MEF2D PATHWAY,0.020205,-0.15952,-0.18584,1,0
5,SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00055855,-0.15959,-0.14571,1,0
5,RESPONSE TO WOUNDING,0.00017796,-0.15963,-0.1831,1,0
5,PROTEOGLYCAN METABOLIC PROCESS,0.038561,-0.15967,-0.17113,1,0
5,TRANSLATION FACTOR ACTIVITY NUCLEIC ACID BINDING,0.0015189,-0.15977,-0.23427,1,0
5,STEROID BIOSYNTHETIC PROCESS,0.025994,-0.16029,-0.19117,1,0
5,ACTIVATION OF NF KAPPAB TRANSCRIPTION FACTOR,0.0037331,-0.16043,-0.15246,1,0
5,REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES,0.00023468,-0.16094,-0.17661,1,0
5,REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B,0.011047,-0.16105,-0.14886,1,0
5,KEGG LEUKOCYTE TRANSENDOTHELIAL MIGRATION,0.0030654,-0.1611,-0.17516,1,0
5,POSITIVE REGULATION OF PHOSPHORYLATION,0.0011549,-0.16119,-0.30594,1,0
5,BIOCARTA RARRXR PATHWAY,0.046579,-0.16138,-0.13562,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS,0.00055855,-0.16142,-0.16759,1,0
5,TRANS GOLGI NETWORK TRANSPORT VESICLE,0.0062634,-0.16145,-0.19645,1,0
5,PID CDC42 REG PATHWAY,0.0021689,-0.16156,-0.18852,1,0
5,PROTEIN HOMOOLIGOMERIZATION,0.017969,-0.16169,-0.18048,1,0
5,KEGG RENIN ANGIOTENSIN SYSTEM,0.019283,-0.16208,-0.21938,1,0
5,REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS,0.044685,-0.16208,-0.24197,1,0
5,POLYSACCHARIDE METABOLIC PROCESS,0.0085714,-0.16231,-0.17927,1,0
5,BIOCARTA NTHI PATHWAY,0.0064317,-0.16238,-0.18977,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING ACYL GROUPS,9.0551e-05,-0.16247,-0.18019,1,0
5,KEGG ENDOCYTOSIS,0.00021167,-0.16258,-0.17214,1,0
5,PHOSPHOLIPASE ACTIVITY,5.0226e-05,-0.16268,-0.20149,1,0
5,GLUCOSAMINE METABOLIC PROCESS,0.023741,-0.16271,-0.12554,1,0
5,POSITIVE REGULATION OF SIGNAL TRANSDUCTION,0.01282,-0.16278,-0.19297,1,0
5,TRANSLATION REGULATOR ACTIVITY,0.0014738,-0.1631,-0.23289,1,0
5,PID MTOR 4PATHWAY,4.6597e-05,-0.1632,-0.14436,1,0
5,SINGLE STRANDED RNA BINDING,0.0097392,-0.16339,-0.22312,1,0
5,KEGG DRUG METABOLISM OTHER ENZYMES,0.0010859,-0.16352,-0.18656,1,0
5,REACTOME IRON UPTAKE AND TRANSPORT,0.0028957,-0.16356,-0.15643,1,0
5,MOLECULAR ADAPTOR ACTIVITY,0.00090094,-0.16368,-0.19595,1,0
5,PID FRA PATHWAY,0.004408,-0.16403,-0.2498,1,0
5,KEGG HYPERTROPHIC CARDIOMYOPATHY HCM,0.0010206,-0.16457,-0.20649,1,0
5,PID ENDOTHELINPATHWAY,0.0050528,-0.16471,-0.14259,1,0
5,REGULATION OF PROTEIN METABOLIC PROCESS,1.8251e-06,-0.165,-0.19477,1,0
5,REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION,0.019739,-0.16506,-0.14688,1,0
5,REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION ,0.007729,-0.16524,-0.16915,1,0
5,LIPID METABOLIC PROCESS,1.4039e-05,-0.16532,-0.19475,1,0
5,REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C,0.0090226,-0.16535,-0.19385,1,0
5,REACTOME INTERFERON SIGNALING,0.014486,-0.16608,-0.19685,1,0
5,REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK,0.0027346,-0.16612,-0.16692,1,0
5,KEGG O GLYCAN BIOSYNTHESIS,0.011904,-0.16616,-0.21427,1,0
5,GROWTH FACTOR ACTIVITY,0.0019282,-0.16621,-0.20668,1,0
5,REACTOME XENOBIOTICS,0.033894,-0.16649,-0.16382,1,0
5,NEGATIVE REGULATION OF ANGIOGENESIS,0.0079323,-0.16667,-0.24057,1,0
5,LIPASE ACTIVITY,0.00017186,-0.16667,-0.16669,1,0
5,AMINO ACID TRANSPORT,0.0014738,-0.1667,-0.24626,1,0
5,SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0010859,-0.16678,-0.15104,1,0
5,PID SYNDECAN 4 PATHWAY,0.0047853,-0.16679,-0.28496,1,0
5,REACTOME REGULATION OF APOPTOSIS,0.0097392,-0.16695,-0.16799,1,0
5,RUFFLE,0.016339,-0.16703,-0.22203,1,0
5,VASCULATURE DEVELOPMENT,0.0030654,-0.1675,-0.19479,1,0
5,CARBOXYPEPTIDASE ACTIVITY,0.0087944,-0.16763,-0.23165,1,0
5,REACTOME SIGNALING BY WNT,0.0081404,-0.16768,-0.17038,1,0
5,REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER,0.0062634,-0.16808,-0.16675,1,0
5,KEGG ALZHEIMERS DISEASE,0.00040247,-0.16808,-0.1527,1,0
5,PID P73PATHWAY,0.00095906,-0.16809,-0.15106,1,0
5,KEGG SMALL CELL LUNG CANCER,0.00040247,-0.16843,-0.22683,1,0
5,MITOCHONDRIAL ENVELOPE,2.7343e-05,-0.16847,-0.21782,1,0
5,PID TCPTP PATHWAY,0.0071468,-0.16891,-0.18689,1,0
5,NEUROTRANSMITTER BINDING,0.033166,-0.16901,-0.14099,1,0
5,REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA,0.0033369,-0.16979,-0.21059,1,0
5,ISOMERASE ACTIVITY,0.00019079,-0.16996,-0.19881,1,0
5,ENDOSOME TRANSPORT,0.00057693,-0.1704,-0.19685,1,0
5,RAS GTPASE ACTIVATOR ACTIVITY,0.014486,-0.17063,-0.2094,1,0
5,REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM,5.7413e-06,-0.17135,-0.19466,1,0
5,PEPTIDE BINDING,1.2454e-05,-0.17135,-0.18502,1,0
5,REACTOME INTEGRIN CELL SURFACE INTERACTIONS,0.0030654,-0.17138,-0.23735,1,0
5,PID FAK PATHWAY,0.0011199,-0.1714,-0.20679,1,0
5,MICROBODY,0.00047456,-0.17166,-0.18155,1,0
5,PEROXISOME,0.00047456,-0.17166,-0.18155,1,0
5,NEUROTRANSMITTER RECEPTOR ACTIVITY,0.034637,-0.17261,-0.13908,1,0
5,REACTOME SPHINGOLIPID METABOLISM,0.00018427,-0.1728,-0.21498,1,0
5,WOUND HEALING,0.00055855,-0.17338,-0.19006,1,0
5,RAS PROTEIN SIGNAL TRANSDUCTION,0.0033369,-0.17343,-0.16798,1,0
5,VACUOLAR TRANSPORT,0.022165,-0.17363,-0.13403,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PC,0.035393,-0.17384,-0.12954,1,0
5,BIOCARTA MAPK PATHWAY,0.00054072,-0.17418,-0.15195,1,0
5,NUCLEAR IMPORT,0.0013457,-0.17423,-0.16577,1,0
5,KEGG ARGININE AND PROLINE METABOLISM,7.013e-05,-0.17446,-0.30706,1,0
5,PID SYNDECAN 1 PATHWAY,0.0036303,-0.17462,-0.27703,1,0
5,REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G,0.017549,-0.17469,-0.20569,1,0
5,BIOCARTA PTDINS PATHWAY,0.00012512,-0.17506,-0.19139,1,0
5,REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS,0.00050664,-0.17513,-0.21033,1,0
5,PID ANGIOPOIETINRECEPTOR PATHWAY,0.00054072,-0.1752,-0.19032,1,0
5,ANATOMICAL STRUCTURE FORMATION,0.0087944,-0.17535,-0.1724,1,0
5,CYTOKINE ACTIVITY,0.00092958,-0.17538,-0.18272,1,0
5,KEGG RETINOL METABOLISM,0.00049035,-0.17548,-0.2184,1,0
5,ORGANIC ACID TRANSPORT,0.0021062,-0.17588,-0.21147,1,0
5,CARBOXYLIC ACID TRANSPORT,0.0021062,-0.17588,-0.21147,1,0
5,BIOCARTA DC PATHWAY,0.00072223,-0.17615,-0.23006,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PE,0.036164,-0.1762,-0.15542,1,0
5,REACTOME MITOCHONDRIAL PROTEIN IMPORT,0.0025817,-0.1765,-0.21131,1,0
5,RRNA METABOLIC PROCESS,0.011904,-0.17654,-0.24881,1,0
5,PID HIF1APATHWAY,0.040234,-0.17658,-0.12066,1,0
5,REACTOME UNFOLDED PROTEIN RESPONSE,0.00016595,-0.17659,-0.1988,1,0
5,PID RXR VDR PATHWAY,0.0042883,-0.17689,-0.19715,1,0
5,PROTEIN IMPORT,0.00054072,-0.17722,-0.15571,1,0
5,ENZYME ACTIVATOR ACTIVITY,0.00010845,-0.1782,-0.17802,1,0
5,REGULATION OF CELL MORPHOGENESIS,0.0071468,-0.17877,-0.20831,1,0
5,REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,0.0021689,-0.17886,-0.16246,1,0
5,REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS,0.0066042,-0.17913,-0.31856,1,0
5,INTERLEUKIN BINDING,0.014841,-0.17919,-0.18082,1,0
5,RRNA PROCESSING,0.011612,-0.1799,-0.26221,1,0
5,MITOCHONDRION ORGANIZATION AND BIOGENESIS,0.00059588,-0.18056,-0.16874,1,0
5,PROTEIN SECRETION,0.011904,-0.18068,-0.22515,1,0
5,KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION,0.001191,-0.18087,-0.21576,1,0
5,MITOCHONDRION,3.0576e-06,-0.1809,-0.21896,1,0
5,GTPASE REGULATOR ACTIVITY,0.00065623,-0.18104,-0.15231,1,0
5,ANTI APOPTOSIS,1.5816e-05,-0.18169,-0.21097,1,0
5,CHAPERONE BINDING,0.0081404,-0.1823,-0.19435,1,0
5,REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,0.0097392,-0.1824,-0.21667,1,0
5,REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.011612,-0.18307,-0.19975,1,0
5,BIOCARTA 41BB PATHWAY,0.0031536,-0.18323,-0.18009,1,0
5,NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00010845,-0.18347,-0.1867,1,0
5,REGULATION OF PROTEIN MODIFICATION PROCESS,0.00019753,-0.18349,-0.26042,1,0
5,MONOOXYGENASE ACTIVITY,0.0059384,-0.18354,-0.18993,1,0
5,REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS,0.00010845,-0.1836,-0.18813,1,0
5,DEAMINASE ACTIVITY,0.037747,-0.1837,-0.21465,1,0
5,REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS,0.0012662,-0.18383,-0.18807,1,0
5,PROTEASOME COMPLEX,0.033166,-0.18407,-0.17746,1,0
5,SUGAR BINDING,0.00012074,-0.18422,-0.21655,1,0
5,GENERATION OF PRECURSOR METABOLITES AND ENERGY,4.1617e-05,-0.18467,-0.19161,1,0
5,ST G ALPHA I PATHWAY,0.0007696,-0.18472,-0.17577,1,0
5,REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE,0.00098941,-0.18495,-0.19123,1,0
5,CELL FRACTION,2.4692e-06,-0.18497,-0.19782,1,0
5,INTERCELLULAR JUNCTION ASSEMBLY AND MAINTENANCE,0.021165,-0.18535,-0.27684,1,0
5,REGULATION OF TRANSLATION,5.0683e-06,-0.18548,-0.22263,1,0
5,KEGG RIBOFLAVIN METABOLISM,0.015574,-0.18576,-0.17437,1,0
5,BIOCARTA EIF PATHWAY,0.00041602,-0.18591,-0.28068,1,0
5,PID UPA UPAR PATHWAY,0.0050528,-0.18644,-0.2888,1,0
5,REACTOME SMOOTH MUSCLE CONTRACTION,0.0054795,-0.18659,-0.33079,1,0
5,REACTOME PPARA ACTIVATES GENE EXPRESSION,0.00020448,-0.18692,-0.19341,1,0
5,REACTOME SYNTHESIS OF PA,0.00028792,-0.18715,-0.19476,1,0
5,REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX,9.7346e-05,-0.18729,-0.23457,1,0
5,RECEPTOR MEDIATED ENDOCYTOSIS,2.0033e-05,-0.18752,-0.1919,1,0
5,REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC,0.036164,-0.18781,-0.17896,1,0
5,COFACTOR BINDING,0.0051916,-0.18799,-0.2077,1,0
5,REACTOME LYSOSOME VESICLE BIOGENESIS,0.014486,-0.18803,-0.21607,1,0
5,GOLGI MEMBRANE,0.00038934,-0.18823,-0.20326,1,0
5,REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE,0.0050528,-0.18864,-0.18301,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PI,0.00353,-0.1891,-0.27315,1,0
5,REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT,0.00030804,-0.18915,-0.22617,1,0
5,BIOCARTA PPARA PATHWAY,0.0011199,-0.18928,-0.16479,1,0
5,AMINO ACID CATABOLIC PROCESS,8.7323e-05,-0.18967,-0.23091,1,0
5,PID ILK PATHWAY,8.1192e-05,-0.18976,-0.24123,1,0
5,BIOCARTA INFLAM PATHWAY,0.00044439,-0.1905,-0.29025,1,0
5,REACTOME EFFECTS OF PIP2 HYDROLYSIS,0.0073363,-0.19056,-0.17494,1,0
5,POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.3287e-06,-0.19075,-0.23719,1,0
5,KEGG VIRAL MYOCARDITIS,0.0030654,-0.19114,-0.25911,1,0
5,REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,2.5774e-06,-0.19129,-0.2099,1,0
5,BIOCARTA PML PATHWAY,0.02068,-0.19138,-0.18707,1,0
5,NITROGEN COMPOUND CATABOLIC PROCESS,0.00081984,-0.19191,-0.19514,1,0
5,NEGATIVE REGULATION OF APOPTOSIS,6.0504e-05,-0.19234,-0.20431,1,0
5,PID PS1PATHWAY,2.8418e-05,-0.19239,-0.18708,1,0
5,PID LYMPHANGIOGENESIS PATHWAY,0.031059,-0.19252,-0.21323,1,0
5,NITROGEN COMPOUND METABOLIC PROCESS,1.4044e-06,-0.19253,-0.22509,1,0
5,NEGATIVE REGULATION OF DNA REPLICATION,0.027803,-0.19258,-0.20668,1,0
5,REACTOME SIGNALING BY NOTCH,0.00065623,-0.19274,-0.16003,1,0
5,RHO PROTEIN SIGNAL TRANSDUCTION,0.00067758,-0.19328,-0.20984,1,0
5,REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,0.0067808,-0.19354,-0.22419,1,0
5,BIOCARTA LAIR PATHWAY,4.6597e-05,-0.19435,-0.25501,1,0
5,GLIOGENESIS,0.012508,-0.19443,-0.22215,1,0
5,PID ARF 3PATHWAY,0.00029782,-0.19453,-0.22008,1,0
5,KEGG FATTY ACID METABOLISM,0.00025131,-0.19468,-0.22907,1,0
5,REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT,0.00027832,-0.1947,-0.21157,1,0
5,INTERLEUKIN RECEPTOR ACTIVITY,0.043763,-0.19502,-0.18969,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS,0.042857,-0.19572,-0.24004,1,0
5,REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT,0.0079323,-0.19577,-0.21468,1,0
5,REACTOME NOTCH HLH TRANSCRIPTION PATHWAY,0.0050528,-0.19612,-0.25817,1,0
5,ST WNT CA2 CYCLIC GMP PATHWAY,0.00084609,-0.19632,-0.22201,1,0
5,PID IL8CXCR2 PATHWAY,0.0087944,-0.19632,-0.17858,1,0
5,SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.026586,-0.1966,-0.19061,1,0
5,REACTOME METABOLISM OF RNA,0.00035231,-0.19685,-0.24641,1,0
5,REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS,0.0022332,-0.19732,-0.20684,1,0
5,REGULATION OF CELL SHAPE,0.0039469,-0.19741,-0.22346,1,0
5,BIOCARTA ALK PATHWAY,0.00052342,-0.19747,-0.2311,1,0
5,RESPONSE TO HEAT,0.00074557,-0.19761,-0.23549,1,0
5,RIBOSOME BIOGENESIS AND ASSEMBLY,0.0054795,-0.19823,-0.27871,1,0
5,GLUCOSE METABOLIC PROCESS,0.010773,-0.19823,-0.16774,1,0
5,REACTOME CITRIC ACID CYCLE TCA CYCLE,0.00044439,-0.19826,-0.27843,1,0
5,REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,0.00037661,-0.19834,-0.22673,1,0
5,WNT SIGNALING,0.00018427,-0.19837,-0.17773,1,0
5,REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,0.00081984,-0.19888,-0.26606,1,0
5,LYASE ACTIVITY,2.1663e-05,-0.19922,-0.23368,1,0
5,REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE,2.3654e-06,-0.1994,-0.28562,1,0
5,PID CD40 PATHWAY,0.001191,-0.19945,-0.22777,1,0
5,KEGG TRYPTOPHAN METABOLISM,0.00020448,-0.19983,-0.22124,1,0
5,PID TOLL ENDOGENOUS PATHWAY,0.0015653,-0.2,-0.24083,1,0
5,PID ARF6 TRAFFICKINGPATHWAY,0.00042998,-0.20033,-0.19563,1,0
5,EXCRETION,2.8418e-05,-0.20092,-0.26028,1,0
5,MAINTENANCE OF PROTEIN LOCALIZATION,0.036164,-0.20111,-0.15354,1,0
5,JAK STAT CASCADE,0.0013457,-0.20134,-0.22238,1,0
5,REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL,0.012203,-0.20182,-0.21987,1,0
5,REACTOME GLYCOLYSIS,0.0099891,-0.20196,-0.25564,1,0
5,REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT,0.00025131,-0.20245,-0.23319,1,0
5,REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1,0.012203,-0.2026,-0.20732,1,0
5,REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION,0.0069616,-0.20313,-0.25447,1,0
5,REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR,0.030383,-0.20331,-0.21472,1,0
5,KEGG PURINE METABOLISM,5.508e-06,-0.20359,-0.20053,1,0
5,POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.0010528,-0.20404,-0.3366,1,0
5,HOMEOSTASIS OF NUMBER OF CELLS,0.0011549,-0.2041,-0.19788,1,0
5,ELECTRON CARRIER ACTIVITY,4.6597e-05,-0.2057,-0.23557,1,0
5,AGING,0.023205,-0.20572,-0.21204,1,0
5,SMOOTH MUSCLE CONTRACTION GO 0006939,0.0090226,-0.20591,-0.20999,1,0
5,PID P38ALPHABETADOWNSTREAMPATHWAY,0.0021062,-0.20593,-0.15643,1,0
5,SH3 SH2 ADAPTOR ACTIVITY,0.0013054,-0.20602,-0.1964,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS,0.0054795,-0.2066,-0.27511,1,0
5,REACTOME LIPOPROTEIN METABOLISM,0.00024286,-0.20685,-0.27939,1,0
5,BIOCARTA VEGF PATHWAY,0.00072223,-0.20698,-0.18106,1,0
5,ST MYOCYTE AD PATHWAY,0.0022332,-0.20748,-0.20225,1,0
5,CELLULAR DEFENSE RESPONSE,0.00020448,-0.20813,-0.26646,1,0
5,REGULATION OF JNK ACTIVITY,0.02166,-0.2085,-0.1361,1,0
5,AROMATIC COMPOUND METABOLIC PROCESS,0.0010859,-0.20872,-0.20689,1,0
5,BIOCARTA RHO PATHWAY,0.0032441,-0.20879,-0.22313,1,0
5,BIOCARTA ACTINY PATHWAY,0.0001165,-0.20905,-0.24058,1,0
5,KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION,0.0010859,-0.20907,-0.21687,1,0
5,POSITIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,2.6902e-06,-0.20946,-0.25085,1,0
5,PID AP1 PATHWAY,0.00047456,-0.20958,-0.28275,1,0
5,EXTRACELLULAR MATRIX PART,0.0021689,-0.20974,-0.25524,1,0
5,PID ECADHERIN STABILIZATION PATHWAY,0.0013872,-0.2098,-0.23707,1,0
5,BIOCARTA WNT PATHWAY,0.0030654,-0.2098,-0.2113,1,0
5,BIOCARTA RANKL PATHWAY,0.031748,-0.21005,-0.23652,1,0
5,KEGG LEISHMANIA INFECTION,0.00013917,-0.21033,-0.24021,1,0
5,REACTOME GROWTH HORMONE RECEPTOR SIGNALING,0.00063551,-0.21098,-0.25182,1,0
5,SULFUR METABOLIC PROCESS,0.00084609,-0.21132,-0.21312,1,0
5,BIOCARTA EXTRINSIC PATHWAY,0.013798,-0.21156,-0.32289,1,0
5,REACTOME REGULATED PROTEOLYSIS OF P75NTR,0.0018173,-0.21161,-0.2588,1,0
5,REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION,0.035393,-0.21187,-0.24012,1,0
5,REACTOME P75NTR SIGNALS VIA NFKB,0.0029794,-0.21209,-0.25178,1,0
5,REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES,0.0040578,-0.21246,-0.25667,1,0
5,REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS,2.1663e-05,-0.21253,-0.22046,1,0
5,CELL SURFACE,0.0013457,-0.21253,-0.18612,1,0
5,FATTY ACID BIOSYNTHETIC PROCESS,0.0071468,-0.21261,-0.23828,1,0
5,MONOSACCHARIDE BINDING,0.0011549,-0.21272,-0.21947,1,0
5,REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES,0.009256,-0.21309,-0.22316,1,0
5,EXOPEPTIDASE ACTIVITY,0.00081984,-0.21373,-0.19572,1,0
5,PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.019283,-0.21451,-0.22481,1,0
5,CELLULAR RESPIRATION,0.00090094,-0.21455,-0.20674,1,0
5,REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES,0.00063551,-0.21483,-0.21244,1,0
5,BIOCARTA NO1 PATHWAY,0.00019079,-0.21684,-0.25175,1,0
5,NEGATIVE REGULATION OF PROGRAMMED CELL DEATH,7.547e-05,-0.21744,-0.21064,1,0
5,LIPID CATABOLIC PROCESS,0.00014418,-0.21747,-0.22032,1,0
5,REACTOME PRE NOTCH EXPRESSION AND PROCESSING,0.00030804,-0.21814,-0.2026,1,0
5,REACTOME GLYCOSAMINOGLYCAN METABOLISM,0.00052342,-0.21828,-0.22417,1,0
5,REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0,0.001872,-0.21871,-0.25968,1,0
5,PROTEIN BINDING BRIDGING,0.00021167,-0.21877,-0.23546,1,0
5,REACTOME BASIGIN INTERACTIONS,0.0021689,-0.21881,-0.23796,1,0
5,REACTOME AMINE COMPOUND SLC TRANSPORTERS,0.0032441,-0.21934,-0.19695,1,0
5,BASOLATERAL PLASMA MEMBRANE,0.00016023,-0.21962,-0.26,1,0
5,REACTOME METABOLISM OF CARBOHYDRATES,1.4674e-06,-0.21976,-0.22484,1,0
5,REACTOME CIRCADIAN CLOCK,0.0046564,-0.21987,-0.15323,1,0
5,REACTOME PEROXISOMAL LIPID METABOLISM,0.001872,-0.21988,-0.24852,1,0
5,CONTRACTILE FIBER PART,0.020205,-0.2204,-0.18946,1,0
5,MACROMOLECULE BIOSYNTHETIC PROCESS,5.4977e-07,-0.22043,-0.23293,1,0
5,MYOFIBRIL,0.026586,-0.22045,-0.19915,1,0
5,MAINTENANCE OF CELLULAR LOCALIZATION,0.016339,-0.22046,-0.17035,1,0
5,REACTOME METABOLISM OF MRNA,0.00018427,-0.22049,-0.27993,1,0
5,PID RAS PATHWAY,0.0056288,-0.22052,-0.22769,1,0
5,OXIDOREDUCTASE ACTIVITY GO 0016616,0.00038934,-0.22099,-0.24271,1,0
5,REACTOME CHONDROITIN SULFATE BIOSYNTHESIS,0.0051916,-0.22147,-0.25522,1,0
5,PID P38GAMMADELTAPATHWAY,0.036164,-0.22167,-0.22086,1,0
5,KEGG PEROXISOME,4.4712e-06,-0.2217,-0.2481,1,0
5,INTRINSIC TO GOLGI MEMBRANE,0.00016023,-0.22191,-0.26682,1,0
5,BIOCARTA MTA3 PATHWAY,0.00079435,-0.22238,-0.2541,1,0
5,MEMBRANE FRACTION,2.0784e-06,-0.22268,-0.21224,1,0
5,ST STAT3 PATHWAY,0.0069616,-0.22286,-0.24068,1,0
5,MITOCHONDRIAL PART,1.1493e-05,-0.22292,-0.2547,1,0
5,EXTRACELLULAR MATRIX,0.00054072,-0.22315,-0.26559,1,0
5,REACTOME HYALURONAN METABOLISM,0.0001165,-0.22318,-0.32575,1,0
5,REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL,0.0049174,-0.22326,-0.23786,1,0
5,DEVELOPMENTAL GROWTH,0.027188,-0.22328,-0.219,1,0
5,PROTEINACEOUS EXTRACELLULAR MATRIX,0.00063551,-0.22338,-0.26564,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON SULFUR GROUP OF DONORS,0.0079323,-0.22359,-0.35037,1,0
5,GTPASE ACTIVATOR ACTIVITY,0.0010859,-0.22431,-0.20611,1,0
5,KEGG GLUTATHIONE METABOLISM,0.00353,-0.22445,-0.25136,1,0
5,REACTOME STRIATED MUSCLE CONTRACTION,0.0014738,-0.22542,-0.28603,1,0
5,KEGG NICOTINATE AND NICOTINAMIDE METABOLISM,0.0045306,-0.2259,-0.20874,1,0
5,MEMBRANE FUSION,5.8301e-05,-0.22602,-0.248,1,0
5,ANION CHANNEL ACTIVITY,0.0011199,-0.22624,-0.21401,1,0
5,CHLORIDE CHANNEL ACTIVITY,0.0011199,-0.22624,-0.21401,1,0
5,SOLUBLE FRACTION,3.7145e-05,-0.22707,-0.20391,1,0
5,REACTOME BIOLOGICAL OXIDATIONS,1.9263e-05,-0.22729,-0.26011,1,0
5,KEGG FOCAL ADHESION,9.0551e-05,-0.22732,-0.24748,1,0
5,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII,0.0007696,-0.22756,-0.24043,1,0
5,PID TAP63PATHWAY,0.0097392,-0.22795,-0.21736,1,0
5,KEGG LYSOSOME,4.6623e-06,-0.22815,-0.3111,1,0
5,BIOCARTA NUCLEARRS PATHWAY,0.00087311,-0.22853,-0.27866,1,0
5,BIOCARTA TH1TH2 PATHWAY,0.011904,-0.229,-0.25461,1,0
5,REACTOME INTERFERON GAMMA SIGNALING,0.0059384,-0.22986,-0.30232,1,0
5,BIOCARTA IL6 PATHWAY,0.00055855,-0.22989,-0.26246,1,0
5,RESPONSE TO OXIDATIVE STRESS,0.00052342,-0.22996,-0.22641,1,0
5,VACUOLE,0.00028792,-0.23073,-0.22452,1,0
5,KEGG ARACHIDONIC ACID METABOLISM,0.00063551,-0.23085,-0.22472,1,0
5,INTEGRIN BINDING,0.001872,-0.23125,-0.24245,1,0
5,KEGG CITRATE CYCLE TCA CYCLE,5.6174e-05,-0.23126,-0.30583,1,0
5,STEROID HORMONE RECEPTOR ACTIVITY,0.00092958,-0.23131,-0.23054,1,0
5,BIOCARTA TID PATHWAY,0.036164,-0.23133,-0.17338,1,0
5,TRANSLATIONAL INITIATION,0.00014935,-0.23208,-0.25257,1,0
5,REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S,0.00030804,-0.23234,-0.24556,1,0
5,MONOCARBOXYLIC ACID METABOLIC PROCESS,4.1617e-05,-0.23306,-0.25561,1,0
5,REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT,0.0083534,-0.23342,-0.26324,1,0
5,REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,7.2754e-05,-0.23351,-0.23055,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH,0.00098941,-0.23436,-0.21198,1,0
5,KEGG PYRUVATE METABOLISM,0.00074557,-0.23437,-0.28187,1,0
5,KEGG PROTEASOME,0.0083534,-0.23481,-0.24513,1,0
5,LIGAND DEPENDENT NUCLEAR RECEPTOR ACTIVITY,0.0087944,-0.23537,-0.21632,1,0
5,REACTOME MUSCLE CONTRACTION,0.00038934,-0.23542,-0.31328,1,0
5,LIPID TRANSPORT,0.00040247,-0.23581,-0.29029,1,0
5,ST GAQ PATHWAY,0.00012964,-0.23646,-0.25622,1,0
5,BIOCARTA IL1R PATHWAY,1.0604e-05,-0.23647,-0.27614,1,0
5,REACTOME TRANS GOLGI NETWORK VESICLE BUDDING,0.00020448,-0.23673,-0.23495,1,0
5,REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE,4.4712e-06,-0.23674,-0.31039,1,0
5,G PROTEIN SIGNALING ADENYLATE CYCLASE ACTIVATING PATHWAY,0.0045306,-0.23751,-0.23249,1,0
5,ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,2.8418e-05,-0.23761,-0.28291,1,0
5,CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,2.8418e-05,-0.23761,-0.28291,1,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS,0.00029782,-0.23794,-0.24408,1,0
5,PID IL27PATHWAY,0.00072223,-0.2382,-0.24758,1,0
5,PID A6B1 A6B4 INTEGRIN PATHWAY,0.00098941,-0.24022,-0.32991,1,0
5,PROTEIN TYROSINE KINASE ACTIVITY,7.013e-05,-0.24046,-0.26854,1,0
5,EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT,0.011326,-0.24059,-0.3244,1,0
5,CELLULAR LIPID CATABOLIC PROCESS,0.00013917,-0.24071,-0.24212,1,0
5,SECONDARY METABOLIC PROCESS,0.00013917,-0.24105,-0.24473,1,0
5,PID S1P S1P1 PATHWAY,0.00057693,-0.24133,-0.25042,1,0
5,REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR,0.0021062,-0.24185,-0.2325,1,0
5,BIOCARTA CTL PATHWAY,0.0059384,-0.24193,-0.24821,1,0
5,LYSOSOME,4.4878e-05,-0.24193,-0.23887,1,0
5,LYTIC VACUOLE,4.4878e-05,-0.24193,-0.23887,1,0
5,REACTOME INTRINSIC PATHWAY,2.0833e-05,-0.24194,-0.26319,1,0
5,REACTOME SULFUR AMINO ACID METABOLISM,0.00027832,-0.24196,-0.27751,1,0
5,BIOSYNTHETIC PROCESS,2.6322e-07,-0.24209,-0.23925,1,0
5,REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS,0.00012074,-0.24358,-0.25207,1,0
5,REACTOME ACYL CHAIN REMODELLING OF PS,0.015574,-0.24412,-0.21112,1,0
5,AMINE TRANSPORT,4.8379e-05,-0.24414,-0.24062,1,0
5,RIBOSOMAL SUBUNIT,0.0013872,-0.24475,-0.25522,1,0
5,OXYGEN BINDING,0.0081404,-0.24536,-0.17976,1,0
5,HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS,2.9532e-05,-0.2454,-0.24994,1,0
5,REGULATION OF TRANSLATIONAL INITIATION,0.00044439,-0.2457,-0.24642,1,0
5,MAINTENANCE OF CELLULAR PROTEIN LOCALIZATION,0.015953,-0.24632,-0.18466,1,0
5,OXIDOREDUCTASE ACTIVITY,3.3287e-06,-0.24668,-0.25775,1,0
5,NEGATIVE REGULATION OF SECRETION,0.017137,-0.24675,-0.19858,1,0
5,RHO GTPASE ACTIVATOR ACTIVITY,0.024846,-0.24686,-0.20058,1,0
5,HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN NOT PEPTIDEBONDSIN LINEAR AMIDES,0.00038934,-0.24688,-0.22146,1,0
5,KEGG METABOLISM OF XENOBIOTICS BY CYTOCHROME P450,0.0069616,-0.24699,-0.24718,1,0
5,BIOCARTA AMI PATHWAY,0.016734,-0.24704,-0.33838,1,0
5,INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY,0.00050664,-0.24733,-0.23423,1,0
5,KEGG AMINOACYL TRNA BIOSYNTHESIS,0.00021909,-0.24777,-0.28436,1,0
5,ER GOLGI INTERMEDIATE COMPARTMENT,0.00047456,-0.24847,-0.2979,1,0
5,SA MMP CYTOKINE CONNECTION,0.0025083,-0.24868,-0.34525,1,0
5,CARBOHYDRATE KINASE ACTIVITY,0.0062634,-0.25087,-0.22192,1,0
5,REACTOME METABOLISM OF PROTEINS,1.6729e-06,-0.25116,-0.25479,1,0
5,NUCLEOLAR PART,0.00050664,-0.2514,-0.25187,1,0
5,NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0016129,-0.25193,-0.30895,1,0
5,AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,3.4421e-05,-0.25196,-0.31161,1,0
5,BIOCARTA TOB1 PATHWAY,0.00095906,-0.25367,-0.29335,1,0
5,REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON,0.00013433,-0.25452,-0.33123,1,0
5,PID INTEGRIN A9B1 PATHWAY,0.0062634,-0.2546,-0.28233,1,0
5,REACTOME GLUCOSE METABOLISM,5.2837e-06,-0.25504,-0.28725,1,0
5,VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.010773,-0.25507,-0.24788,1,0
5,REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM,0.00014935,-0.25562,-0.33509,1,0
5,REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN,0.038561,-0.25853,-0.22043,1,0
5,REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE,0.00057693,-0.25865,-0.31753,1,0
5,REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS,0.03245,-0.25902,-0.19087,1,0
5,REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM,0.0066042,-0.25954,-0.21785,1,0
5,BIOCARTA INTRINSIC PATHWAY,0.0057817,-0.25989,-0.3434,1,0
5,REACTOME KERATAN SULFATE BIOSYNTHESIS,2.4346e-05,-0.26021,-0.26554,1,0
5,REACTOME EXTRACELLULAR MATRIX ORGANIZATION,0.00063551,-0.26297,-0.30114,1,0
5,AEROBIC RESPIRATION,0.00021909,-0.26474,-0.25193,1,0
5,ORGANELLAR RIBOSOME,0.0010206,-0.26596,-0.26298,1,0
5,MITOCHONDRIAL RIBOSOME,0.0010206,-0.26596,-0.26298,1,0
5,OXIDOREDUCTASE ACTIVITY GO 0016706,0.00026903,-0.26645,-0.40169,1,0
5,BIOCARTA CARDIACEGF PATHWAY,0.00090094,-0.26678,-0.3354,1,0
5,NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0069616,-0.26706,-0.2863,1,0
5,PHAGOCYTOSIS,0.0011199,-0.26745,-0.26538,1,0
5,REACTOME HS GAG BIOSYNTHESIS,0.0064317,-0.26825,-0.23434,1,0
5,REACTOME GLYCOSPHINGOLIPID METABOLISM,4.8379e-05,-0.26927,-0.30619,1,0
5,KEGG FRUCTOSE AND MANNOSE METABOLISM,0.00029782,-0.27016,-0.25664,1,0
5,EXTRINSIC TO PLASMA MEMBRANE,0.0019282,-0.2705,-0.29779,1,0
5,ORGANIC ACID METABOLIC PROCESS,6.5896e-07,-0.27062,-0.28291,1,0
5,CARBOXYLIC ACID METABOLIC PROCESS,6.5896e-07,-0.27074,-0.28643,1,0
5,TRANSLATION INITIATION FACTOR ACTIVITY,0.00067758,-0.2711,-0.29919,1,0
5,KEGG AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM,7.0571e-06,-0.2712,-0.30072,1,0
5,BIOCARTA P38MAPK PATHWAY,1.2962e-05,-0.2727,-0.2724,1,0
5,TRNA METABOLIC PROCESS,0.00022676,-0.27345,-0.27781,1,0
5,PID IL6 7PATHWAY,0.00024286,-0.27388,-0.2726,1,0
5,REACTOME METABOLISM OF VITAMINS AND COFACTORS,9.0551e-05,-0.27469,-0.24074,1,0
5,REACTOME FATTY ACYL COA BIOSYNTHESIS,0.0025817,-0.27476,-0.24348,1,0
5,PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY,8.7323e-05,-0.27499,-0.29264,1,0
5,FATTY ACID METABOLIC PROCESS,2.5308e-05,-0.27517,-0.31724,1,0
5,REACTOME HS GAG DEGRADATION,0.02843,-0.27518,-0.26403,1,0
5,KEGG PROPANOATE METABOLISM,0.00042998,-0.27549,-0.31156,1,0
5,DRUG BINDING,0.0045306,-0.27578,-0.22489,1,0
5,KEGG GLYOXYLATE AND DICARBOXYLATE METABOLISM,0.00019753,-0.27581,-0.27269,1,0
5,KEGG PORPHYRIN AND CHLOROPHYLL METABOLISM,4.8379e-05,-0.27596,-0.29851,1,0
5,REACTOME COLLAGEN FORMATION,0.00016023,-0.27597,-0.36484,1,0
5,REACTOME GLUCONEOGENESIS,3.5759e-05,-0.27636,-0.30539,1,0
5,ELECTRON TRANSPORT GO 0006118,0.00020448,-0.27641,-0.25045,1,0
5,AMINO ACID METABOLIC PROCESS,3.0264e-07,-0.27668,-0.3078,1,0
5,COENZYME BINDING,5.0226e-05,-0.27693,-0.34748,1,0
5,HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS,6.5149e-05,-0.27803,-0.2977,1,0
5,KEGG ABC TRANSPORTERS,9.7346e-05,-0.27826,-0.25879,1,0
5,PURINE NUCLEOTIDE METABOLIC PROCESS,0.018398,-0.2795,-0.22024,1,0
5,PID MYC ACTIVPATHWAY,0.0006154,-0.27981,-0.25284,1,0
5,MITOCHONDRIAL TRANSPORT,1.349e-05,-0.28034,-0.27144,1,0
5,INTERCELLULAR JUNCTION ASSEMBLY,0.0075304,-0.28236,-0.38294,1,0
5,REACTOME KERATAN SULFATE DEGRADATION,1.4039e-05,-0.28313,-0.37994,1,0
5,BASEMENT MEMBRANE,0.0012662,-0.28331,-0.27339,1,0
5,REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION,2.9301e-06,-0.28383,-0.36078,1,0
5,LYSOSOMAL TRANSPORT,0.0012662,-0.28385,-0.24811,1,0
5,POSITIVE REGULATION OF PROTEIN AMINO ACID PHOSPHORYLATION,2.0833e-05,-0.28516,-0.40862,1,0
5,RESPONSE TO TEMPERATURE STIMULUS,0.00010845,-0.28588,-0.27269,1,0
5,REACTOME PKB MEDIATED EVENTS,3.4728e-06,-0.28657,-0.26831,1,0
5,SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY,0.00087311,-0.28679,-0.3388,1,0
5,TRANSLATION,4.8612e-06,-0.28681,-0.33113,1,0
5,KEGG THYROID CANCER,9.0551e-05,-0.28814,-0.27981,1,0
5,TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0029794,-0.28848,-0.32579,1,0
5,RESPONSE TO HORMONE STIMULUS,3.1888e-05,-0.28861,-0.27085,1,0
5,REACTOME CALNEXIN CALRETICULIN CYCLE,0.00041602,-0.29051,-0.34199,1,0
5,PHOSPHOLIPASE C ACTIVITY,0.00031859,-0.29101,-0.25199,1,0
5,TRNA PROCESSING,0.00021167,-0.2911,-0.29143,1,0
5,PID INTEGRIN CS PATHWAY,0.0017123,-0.29126,-0.304,1,0
5,PROTEASE INHIBITOR ACTIVITY,7.8282e-05,-0.29161,-0.37879,1,0
5,GLYCOPROTEIN CATABOLIC PROCESS,0.00017186,-0.29216,-0.30007,1,0
5,CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0017641,-0.29237,-0.29869,1,0
5,INSOLUBLE FRACTION,0.0016129,-0.29414,-0.27096,1,0
5,GALACTOSYLTRANSFERASE ACTIVITY,0.0053338,-0.29459,-0.28076,1,0
5,REACTOME INFLUENZA LIFE CYCLE,0.00030804,-0.2955,-0.36638,1,0
5,TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY,0.00020448,-0.29614,-0.27912,1,0
5,POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,3.7145e-05,-0.29734,-0.33667,1,0
5,SARCOMERE,0.0040578,-0.29752,-0.29973,1,0
5,REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 ,1.5331e-06,-0.29843,-0.38154,1,0
5,REACTOME KERATAN SULFATE KERATIN METABOLISM,3.6228e-06,-0.3008,-0.32444,1,0
5,REACTOME TRANSLATION,0.00019079,-0.30119,-0.40712,1,0
5,BONE REMODELING,0.00052342,-0.30338,-0.31083,1,0
5,KEGG DRUG METABOLISM CYTOCHROME P450,8.7323e-05,-0.30374,-0.31234,1,0
5,REGULATION OF ANGIOGENESIS,0.00016023,-0.3048,-0.26897,1,0
5,STEROID BINDING,0.00042998,-0.30497,-0.32208,1,0
5,BIOCARTA IL4 PATHWAY,0.0012662,-0.30543,-0.38604,1,0
5,SODIUM CHANNEL ACTIVITY,0.03245,-0.3058,-0.19766,1,0
5,PID HIF2PATHWAY,8.3127e-06,-0.30747,-0.34689,1,0
5,KEGG TYPE I DIABETES MELLITUS,0.0094949,-0.3076,-0.29522,1,0
5,EXOCYTOSIS,0.043763,-0.30809,-0.19282,1,0
5,AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY,5.508e-06,-0.30866,-0.29825,1,0
5,STRUCTURAL MOLECULE ACTIVITY,4.1112e-06,-0.31044,-0.2948,1,0
5,PHOSPHORIC DIESTER HYDROLASE ACTIVITY,3.0576e-06,-0.31142,-0.3085,1,0
5,CASPASE REGULATOR ACTIVITY,6.7596e-05,-0.31147,-0.33856,1,0
5,REACTOME PRE NOTCH PROCESSING IN GOLGI,0.00024286,-0.31152,-0.34929,1,0
5,RESPONSE TO DRUG,0.00036427,-0.31231,-0.33252,1,0
5,TRANSFERASE ACTIVITY TRANSFERRING PENTOSYL GROUPS,5.0226e-05,-0.31407,-0.30096,1,0
5,BIOCARTA HIF PATHWAY,2.2524e-05,-0.31484,-0.32192,1,0
5,COENZYME BIOSYNTHETIC PROCESS,0.00047456,-0.31611,-0.40764,1,0
5,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00038934,-0.31627,-0.30717,1,0
5,PID INTEGRIN1 PATHWAY,0.00030804,-0.31651,-0.40446,1,0
5,REACTOME METABOLISM OF NUCLEOTIDES,0.00027832,-0.3226,-0.26097,1,0
5,PIGMENT BIOSYNTHETIC PROCESS,3.1888e-05,-0.32327,-0.32802,1,0
5,REACTOME HDL MEDIATED LIPID TRANSPORT,0.00045924,-0.325,-0.30829,1,0
5,REACTOME MITOCHONDRIAL TRNA AMINOACYLATION,5.6174e-05,-0.3252,-0.3112,1,0
5,KEGG GLYCOLYSIS GLUCONEOGENESIS,5.508e-06,-0.32591,-0.37171,1,0
5,NITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0011549,-0.32665,-0.28714,1,0
5,NUCLEOTIDE BIOSYNTHETIC PROCESS,7.547e-05,-0.32814,-0.32262,1,0
5,CYTOPLASM ORGANIZATION AND BIOGENESIS,0.011047,-0.3284,-0.32735,1,0
5,REACTOME CYTOSOLIC TRNA AMINOACYLATION,0.0020453,-0.32845,-0.34665,1,0
5,AMINE BIOSYNTHETIC PROCESS,0.00027832,-0.32877,-0.34282,1,0
5,PID WNT SIGNALING PATHWAY,0.00021909,-0.32895,-0.33972,1,0
5,MITOCHONDRIAL MATRIX,4.8379e-05,-0.33047,-0.31836,1,0
5,MITOCHONDRIAL LUMEN,4.8379e-05,-0.33047,-0.31836,1,0
5,CELLULAR BIOSYNTHETIC PROCESS,3.3202e-07,-0.33084,-0.30657,1,0
5,REACTOME TRNA AMINOACYLATION,0.00028792,-0.33454,-0.31115,1,0
5,COENZYME METABOLIC PROCESS,5.0194e-07,-0.33668,-0.39475,1,0
5,REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX,0.0007696,-0.33726,-0.40254,1,0
5,METALLOEXOPEPTIDASE ACTIVITY,0.0029794,-0.34257,-0.2303,1,0
5,RESPONSE TO CARBOHYDRATE STIMULUS,0.00021909,-0.34361,-0.33519,1,0
5,EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX,0.0030654,-0.34366,-0.38683,1,0
5,PID HIF1 TFPATHWAY,4.1617e-05,-0.34375,-0.36633,1,0
5,CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.00074557,-0.34431,-0.33931,1,0
5,REACTOME MTORC1 MEDIATED SIGNALLING,3.7145e-05,-0.34448,-0.38346,1,0
5,REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S,0.0001547,-0.34537,-0.47901,1,0
5,REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS,7.2111e-07,-0.34587,-0.37979,1,0
5,HETEROCYCLE METABOLIC PROCESS,2.5308e-05,-0.34637,-0.34565,1,0
5,KEGG ECM RECEPTOR INTERACTION,0.00012512,-0.34937,-0.35976,1,0
5,BIOCARTA SARS PATHWAY,0.0056288,-0.35121,-0.33787,1,0
5,COFACTOR BIOSYNTHETIC PROCESS,5.7413e-06,-0.35235,-0.4229,1,0
5,REACTOME ER PHAGOSOME PATHWAY,0.0020453,-0.35259,-0.32996,1,0
5,PID ARF6 PATHWAY,9.0179e-06,-0.35295,-0.34675,1,0
5,KEGG GRAFT VERSUS HOST DISEASE,0.00057693,-0.35382,-0.46207,1,0
5,NEUTRAL AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015574,-0.35404,-0.33982,1,0
5,BASAL LAMINA,0.00021909,-0.35465,-0.34391,1,0
5,REGULATION OF PROTEIN IMPORT INTO NUCLEUS,0.00042998,-0.35529,-0.33434,1,0
5,KEGG GALACTOSE METABOLISM,6.0504e-05,-0.35636,-0.31873,1,0
5,REACTOME CS DS DEGRADATION,0.0020453,-0.35776,-0.35992,1,0
5,FATTY ACID OXIDATION,0.0015653,-0.3581,-0.31289,1,0
5,REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX,0.00021167,-0.36022,-0.49915,1,0
5,INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00034072,-0.36039,-0.48068,1,0
5,REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00037661,-0.36085,-0.43116,1,0
5,PID INTEGRIN5 PATHWAY,0.0015653,-0.3632,-0.44536,1,0
5,ICOSANOID METABOLIC PROCESS,0.0049174,-0.36344,-0.3919,1,0
5,EPITHELIAL TO MESENCHYMAL TRANSITION,0.0021062,-0.36609,-0.40296,1,0
5,REACTOME ANTIGEN PROCESSING CROSS PRESENTATION,0.00057693,-0.36792,-0.37884,1,0
5,3 5 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY,0.00049035,-0.36823,-0.3664,1,0
5,PIGMENT METABOLIC PROCESS,1.5816e-05,-0.3685,-0.35835,1,0
5,COFACTOR METABOLIC PROCESS,5.753e-07,-0.37208,-0.41566,1,0
5,REACTOME PURINE METABOLISM,4.8612e-06,-0.37346,-0.37657,1,0
5,BIOCARTA VITCB PATHWAY,0.0057817,-0.3776,-0.43408,1,0
5,REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,0.00041602,-0.38574,-0.45247,1,0
5,PID INTEGRIN3 PATHWAY,0.00023468,-0.38773,-0.42507,1,0
5,REACTOME PURINE SALVAGE,6.5149e-05,-0.38915,-0.40221,1,0
5,REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS,0.0021062,-0.39504,-0.35153,1,0
5,STEROL BINDING,0.00022676,-0.39605,-0.36764,1,0
5,TISSUE REMODELING,0.00019753,-0.39801,-0.34216,1,0
5,REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION,0.00026003,-0.39842,-0.50588,1,0
5,REACTOME METABOLISM OF PORPHYRINS,8.1192e-05,-0.40476,-0.49002,1,0
5,REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS,0.00055855,-0.41899,-0.47816,1,0
5,STRUCTURAL CONSTITUENT OF RIBOSOME,0.00030804,-0.41983,-0.50983,1,0
5,LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS,0.00022676,-0.42408,-0.3869,1,0
5,KEGG ALLOGRAFT REJECTION,0.00049035,-0.42459,-0.52122,1,0
5,VACUOLE ORGANIZATION AND BIOGENESIS,3.5759e-05,-0.42551,-0.41446,1,0
5,KEGG AUTOIMMUNE THYROID DISEASE,0.00087311,-0.42676,-0.44596,1,0
5,BIOCARTA PLATELETAPP PATHWAY,0.0090226,-0.42925,-0.45656,1,0
5,BIOCARTA IL10 PATHWAY,0.0010206,-0.43421,-0.40242,1,0
5,KEGG ANTIGEN PROCESSING AND PRESENTATION,0.00025131,-0.43626,-0.41522,1,0
5,FATTY ACID BETA OXIDATION,0.001228,-0.4395,-0.38626,1,0
5,LYSOSOME ORGANIZATION AND BIOGENESIS,5.6174e-05,-0.44549,-0.44423,1,0
5,KEGG RIBOSOME,0.00050664,-0.44824,-0.51434,1,0
5,PROTEIN TARGETING TO MITOCHONDRION,2.6902e-06,-0.45838,-0.45158,1,0
5,REACTOME PEPTIDE CHAIN ELONGATION,0.00042998,-0.46481,-0.53845,1,0
5,KEGG OTHER GLYCAN DEGRADATION,1.9904e-06,-0.46956,-0.55849,1,0
5,KEGG VALINE LEUCINE AND ISOLEUCINE BIOSYNTHESIS,1.7806e-05,-0.47992,-0.55254,1,0
5,ANION TRANSPORT,3.9926e-07,-0.48362,-0.42241,1,0
5,ADENYLATE CYCLASE ACTIVATION,2.9532e-05,-0.5041,-0.44102,1,0
5,HEME METABOLIC PROCESS,4.6597e-05,-0.50867,-0.48239,1,0
5,REACTOME GLUTATHIONE CONJUGATION,0.00041602,-0.51192,-0.46569,1,0
5,REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC,0.0032441,-0.6276,-0.56746,1,0
5,PID INTEGRIN4 PATHWAY,0.00028792,-0.78271,-0.7171,1,0
5,GROWTH CONE,0.15015,0.35352,0.28641,0,1
5,SITE OF POLARIZED GROWTH,0.15264,0.33764,0.26043,0,1
5,INSULIN RECEPTOR SIGNALING PATHWAY,0.087232,0.21749,0.13126,0,1
5,POSITIVE REGULATION OF T CELL ACTIVATION,0.055956,0.21239,0.16497,0,1
5,REACTOME FGFR2C LIGAND BINDING AND ACTIVATION,0.055956,0.20929,0.12215,0,1
5,REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB,0.070855,0.20711,0.12576,0,1
5,BIOCARTA PLCE PATHWAY,0.070855,0.18557,0.1376,0,1
5,RESPONSE TO IONIZING RADIATION,0.090515,0.18221,0.11996,0,1
5,SH2 DOMAIN BINDING,0.097379,0.16921,0.1845,0,1
5,REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION,0.054842,0.15696,0.12757,0,1
5,NEGATIVE REGULATION OF DNA BINDING,0.17653,0.14852,0.10304,0,1
5,REACTOME UNWINDING OF DNA,0.04854,0.14606,0.12124,0,1
5,SA PROGRAMMED CELL DEATH,0.15773,0.14023,0.12426,0,1
5,PHOSPHATASE REGULATOR ACTIVITY,0.30402,0.13648,0.05849,0,1
5,REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,0.13583,0.13592,0.10075,0,1
5,SPLICEOSOME ASSEMBLY,0.075049,0.13356,0.085685,0,1
5,NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS,0.27611,0.13236,0.13402,0,1
5,NEGATIVE REGULATION OF PHOSPHORYLATION,0.27611,0.13236,0.13402,0,1
5,REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX,0.11434,0.12226,0.077891,0,1
5,T CELL DIFFERENTIATION,0.15015,0.12181,0.086967,0,1
5,PID ATM PATHWAY,0.052669,0.11643,0.076948,0,1
5,REACTOME MRNA 3 END PROCESSING,0.052669,0.11237,0.091272,0,1
5,RNA SPLICING FACTOR ACTIVITYTRANSESTERIFICATION MECHANISM,0.05161,0.11232,0.074047,0,1
5,PID LIS1PATHWAY,0.075049,0.10692,0.10852,0,1
5,CHROMOSOME CONDENSATION,0.073629,0.10642,0.096841,0,1
5,POSITIVE REGULATION OF IMMUNE RESPONSE,0.088862,0.10491,0.11394,0,1
5,REGULATION OF DEFENSE RESPONSE,0.27611,0.1045,0.060805,0,1
5,DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.11235,0.10107,0.059546,0,1
5,REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS,0.072231,0.10078,0.090888,0,1
5,ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.27227,0.10019,0.052992,0,1
5,REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,0.076492,0.09633,0.08663,0,1
5,REACTOME SIGNALLING TO P38 VIA RIT AND RIN,0.12473,0.09272,0.077212,0,1
5,MITOTIC CELL CYCLE CHECKPOINT,0.23245,0.091793,0.050826,0,1
5,POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.10096,0.091593,0.079998,0,1
5,PID AR NONGENOMIC PATHWAY,0.29992,0.09067,0.062463,0,1
5,REGULATION OF IMMUNE SYSTEM PROCESS,0.055956,0.089912,0.099426,0,1
5,PROTEIN KINASE BINDING,0.054842,0.086706,0.059199,0,1
5,REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX,0.15517,0.078138,0.11899,0,1
5,PID PI3KCIPATHWAY,0.16032,0.070371,0.052212,0,1
5,MICROTUBULE BASED PROCESS,0.18219,0.068992,0.055141,0,1
5,KINASE BINDING,0.052669,0.067631,0.05622,0,1
5,BIOCARTA TCR PATHWAY,0.11636,0.066872,0.074308,0,1
5,PROTEIN TARGETING TO MEMBRANE,0.25363,0.064458,0.039203,0,1
5,CHROMOSOME SEGREGATION,0.099158,0.063435,0.066769,0,1
5,REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA,0.18508,0.060898,0.059386,0,1
5,DAMAGED DNA BINDING,0.05161,0.060036,0.070856,0,1
5,KEGG T CELL RECEPTOR SIGNALING PATHWAY,0.16828,0.055561,0.045051,0,1
5,DEOXYRIBONUCLEASE ACTIVITY,0.21905,0.052189,0.047096,0,1
5,AMINE RECEPTOR ACTIVITY,0.35153,0.051338,0.032009,0,1
5,TRANSCRIPTION FROM RNA POLYMERASE III PROMOTER,0.78289,0.028301,0.0027062,0,1
5,REACTOME PACKAGING OF TELOMERE ENDS,0.017549,0.38053,0.34925,0,0
5,REACTOME MEIOTIC SYNAPSIS,0.024846,0.29147,0.23448,0,0
5,PHOSPHATASE INHIBITOR ACTIVITY,0.027188,0.27286,0.32103,0,0
5,OLIGOSACCHARIDE METABOLIC PROCESS,0.012508,0.25787,0.28857,0,0
5,VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.044685,0.24236,0.28337,0,0
5,REACTOME ACTIVATION OF BH3 ONLY PROTEINS,0.00353,0.2328,0.2318,0,0
5,REACTOME TELOMERE MAINTENANCE,0.022165,0.21778,0.20908,0,0
5,REACTOME G0 AND EARLY G1,0.00041602,0.21385,0.23177,0,0
5,REACTOME DSCAM INTERACTIONS,0.022165,0.207,0.17135,0,0
5,REACTOME G PROTEIN ACTIVATION,0.072231,0.20226,0.14531,0,0
5,MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.12908,0.20154,0.15926,0,0
5,CHROMATIN REMODELING COMPLEX,0.011047,0.18692,0.21683,0,0
5,REACTOME G1 S SPECIFIC TRANSCRIPTION,0.00353,0.18442,0.20208,0,0
5,REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS,0.036164,0.18422,0.31418,0,0
5,EMBRYONIC DEVELOPMENT,0.0060989,0.18182,0.15972,0,0
5,EMBRYONIC MORPHOGENESIS,0.097379,0.1817,0.16463,0,0
5,REACTOME AMYLOIDS,0.21579,0.18029,0.14919,0,0
5,REGULATION OF HORMONE SECRETION,0.18508,0.17623,0.18372,0,0
5,REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION,0.02843,0.1757,0.16719,0,0
5,PROTEIN KINASE INHIBITOR ACTIVITY,0.054842,0.16856,0.25595,0,0
5,REACTOME AMINE DERIVED HORMONES,0.13355,0.16389,0.21456,0,0
5,NEUROTRANSMITTER SECRETION,0.097379,0.16037,0.31742,0,0
5,KEGG TAURINE AND HYPOTAURINE METABOLISM,0.11235,0.15379,0.14611,0,0
5,MICROTUBULE BASED MOVEMENT,0.014486,0.15325,0.19121,0,0
5,REACTOME CHROMOSOME MAINTENANCE,0.017969,0.15221,0.15714,0,0
5,BIOCARTA CALCINEURIN PATHWAY,0.188,0.15055,0.097646,0,0
5,REACTOME REGULATION OF INSULIN SECRETION,0.11841,0.14894,0.12926,0,0
5,KEGG SYSTEMIC LUPUS ERYTHEMATOSUS,0.22568,0.1485,0.091534,0,0
5,APOPTOTIC MITOCHONDRIAL CHANGES,0.43883,0.14794,0.089898,0,0
5,CALCIUM MEDIATED SIGNALING,0.10096,0.14452,0.085914,0,0
5,REACTOME REGULATION OF SIGNALING BY CBL,0.046579,0.14377,0.12158,0,0
5,CALCIUM CHANNEL ACTIVITY,0.30402,0.14302,0.07261,0,0
5,DETECTION OF CHEMICAL STIMULUS,0.34256,0.14199,0.10961,0,0
5,REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR,0.12049,0.14149,0.14036,0,0
5,BIOCARTA BCELLSURVIVAL PATHWAY,0.10465,0.14083,0.10876,0,0
5,REACTOME ACTIVATED POINT MUTANTS OF FGFR2,0.1313,0.13946,0.073045,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.20621,0.13832,0.10667,0,0
5,REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR,0.077957,0.13754,0.18159,0,0
5,KINASE INHIBITOR ACTIVITY,0.077957,0.13719,0.23192,0,0
5,REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE,0.41842,0.13195,0.24939,0,0
5,REACTOME SIGNALING BY FGFR1 FUSION MUTANTS,0.088862,0.13137,0.095524,0,0
5,BRAIN DEVELOPMENT,0.11235,0.12996,0.13688,0,0
5,BIOCARTA AKAPCENTROSOME PATHWAY,0.15015,0.12646,0.064068,0,0
5,PID RANBP2PATHWAY,0.029068,0.12457,0.11251,0,0
5,SA G1 AND S PHASES,0.052669,0.11945,0.14654,0,0
5,INNATE IMMUNE RESPONSE,0.044685,0.11879,0.11414,0,0
5,REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY,0.92682,0.11819,-0.0037757,0,0
5,NUCLEOSOME ASSEMBLY,0.10654,0.11756,0.15891,0,0
5,BIOGENIC AMINE METABOLIC PROCESS,0.023205,0.11747,0.17754,0,0
5,AUXILIARY TRANSPORT PROTEIN ACTIVITY,0.047551,0.11704,0.15166,0,0
5,ACTIVATION OF IMMUNE RESPONSE,0.073629,0.11664,0.12045,0,0
5,CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.014138,0.1166,0.12507,0,0
5,REACTOME RECYCLING PATHWAY OF L1,0.47049,0.11571,0.044969,0,0
5,CELLULAR RESPONSE TO NUTRIENT LEVELS,0.47049,0.11307,0.060049,0,0
5,REACTOME GENERIC TRANSCRIPTION PATHWAY,0.12689,0.11087,0.066306,0,0
5,U12 DEPENDENT SPLICEOSOME,0.22235,0.11036,0.053401,0,0
5,PID ECADHERIN KERATINOCYTE PATHWAY,0.076492,0.10954,0.11366,0,0
5,NUCLEAR CHROMOSOME,0.023741,0.10923,0.099983,0,0
5,GENERATION OF A SIGNAL INVOLVED IN CELL CELL SIGNALING,0.13583,0.10809,0.24579,0,0
5,REACTOME PROCESSING OF INTRONLESS PRE MRNAS,0.37932,0.10706,0.05032,0,0
5,PATTERN SPECIFICATION PROCESS,0.17099,0.1067,0.079445,0,0
5,ACTIN FILAMENT ORGANIZATION,0.030383,0.10507,0.1132,0,0
5,DENDRITE,0.11235,0.10504,0.15621,0,0
5,DOUBLE STRAND BREAK REPAIR,0.32938,0.10493,0.045489,0,0
5,BIOCARTA MITOCHONDRIA PATHWAY,0.7495,0.10428,0.042381,0,0
5,REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS,0.18508,0.10372,0.08652,0,0
5,REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION,0.18508,0.10333,0.23359,0,0
5,BIOCARTA P53 PATHWAY,0.7495,0.10328,0.027882,0,0
5,REACTOME INTEGRATION OF ENERGY METABOLISM,0.41842,0.10287,0.061706,0,0
5,BIOCARTA CTLA4 PATHWAY,0.10465,0.10181,0.096223,0,0
5,REACTOME DOUBLE STRAND BREAK REPAIR,0.17099,0.1014,0.07723,0,0
5,REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION,0.16828,0.099947,0.17455,0,0
5,REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA,0.12473,0.099844,0.13086,0,0
5,BIOCARTA CELLCYCLE PATHWAY,0.1313,0.099259,0.091814,0,0
5,REACTOME GABA A RECEPTOR ACTIVATION,0.85768,0.098845,-0.06279,0,0
5,PID REELINPATHWAY,0.082489,0.098789,0.12703,0,0
5,DNA PACKAGING,0.025414,0.098683,0.096864,0,0
5,REACTOME RETROGRADE NEUROTROPHIN SIGNALLING,0.1313,0.098637,0.089011,0,0
5,REACTOME GENERATION OF SECOND MESSENGER MOLECULES,0.017969,0.098503,0.10507,0,0
5,NEGATIVE REGULATION OF BINDING,0.34256,0.097966,0.072886,0,0
5,PID ECADHERIN NASCENTAJ PATHWAY,0.11039,0.096938,0.060109,0,0
5,REACTOME NEPHRIN INTERACTIONS,0.32077,0.095283,0.061534,0,0
5,VOLTAGE GATED CALCIUM CHANNEL COMPLEX,0.20937,0.094708,0.13116,0,0
5,DETECTION OF STIMULUS,0.31232,0.094685,0.068369,0,0
5,BIOCARTA IL2 PATHWAY,0.42347,0.09468,0.045282,0,0
5,T CELL PROLIFERATION,0.43883,0.094294,0.023972,0,0
5,LIPID KINASE ACTIVITY,0.2839,0.094115,0.058447,0,0
5,REACTOME SIGNALING BY FGFR1 MUTANTS,0.014841,0.094061,0.13696,0,0
5,REACTOME P38MAPK EVENTS,0.36991,0.092222,0.057952,0,0
5,REACTOME ADP SIGNALLING THROUGH P2RY1,0.070855,0.091671,0.12832,0,0
5,ST DIFFERENTIATION PATHWAY IN PC12 CELLS,0.10096,0.091569,0.06941,0,0
5,BIOCARTA SHH PATHWAY,0.12259,0.090577,0.096041,0,0
5,REGULATION OF IMMUNE EFFECTOR PROCESS,0.031748,0.090402,0.12223,0,0
5,REACTOME CA DEPENDENT EVENTS,0.36526,0.090242,0.046202,0,0
5,KINASE REGULATOR ACTIVITY,0.079444,0.09021,0.16264,0,0
5,REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE,0.55487,0.08924,0.014132,0,0
5,REACTOME SIGNALING BY BMP,0.32077,0.088362,0.042036,0,0
5,CELL RECOGNITION,0.53167,0.087933,0.094227,0,0
5,SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.32077,0.087853,0.070972,0,0
5,KEGG TASTE TRANSDUCTION,0.05161,0.087796,0.14281,0,0
5,TELOMERIC DNA BINDING,0.12689,0.085694,0.085281,0,0
5,PID EPHRINBREVPATHWAY,0.054842,0.085682,0.1339,0,0
5,REACTOME CHOLESTEROL BIOSYNTHESIS,0.23937,0.084893,0.11287,0,0
5,DETECTION OF ABIOTIC STIMULUS,0.26847,0.084816,0.031789,0,0
5,REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE,0.23245,0.084393,0.070136,0,0
5,PROTEIN KINASE REGULATOR ACTIVITY,0.084046,0.084316,0.17501,0,0
5,CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.47588,0.083793,0.085249,0,0
5,CYTOKINESIS,0.10096,0.082496,0.084319,0,0
5,ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY,0.91987,0.081756,-0.052209,0,0
5,REGULATION OF MEMBRANE POTENTIAL,0.73628,0.081622,0.03046,0,0
5,MICROTUBULE,0.023741,0.081435,0.10042,0,0
5,BIOCARTA TRKA PATHWAY,0.17653,0.081098,0.13764,0,0
5,POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.3746,0.080775,0.048608,0,0
5,BIOCARTA SRCRPTP PATHWAY,0.16828,0.080632,0.11863,0,0
5,REACTOME ADP SIGNALLING THROUGH P2RY12,0.22905,0.080379,0.096948,0,0
5,REACTOME G2 M CHECKPOINTS,0.14048,0.079575,0.078759,0,0
5,REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA,0.48131,0.079455,0.061837,0,0
5,PID NEPHRIN NEPH1 PATHWAY,0.1313,0.078167,0.08333,0,0
5,LAMELLIPODIUM,0.48678,0.077282,0.031761,0,0
5,NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.56666,0.076895,0.0408,0,0
5,PID ALK2PATHWAY,0.34702,0.076362,0.10688,0,0
5,PID THROMBIN PAR4 PATHWAY,0.32077,0.076337,0.074414,0,0
5,CHANNEL REGULATOR ACTIVITY,0.23245,0.075981,0.097517,0,0
5,CELL DIVISION,0.17374,0.075879,0.073633,0,0
5,BIOCARTA P35ALZHEIMERS PATHWAY,0.25363,0.074977,0.12803,0,0
5,CELL SOMA,0.19695,0.074968,0.16379,0,0
5,NUCLEAR UBIQUITIN LIGASE COMPLEX,0.35153,0.074747,0.047778,0,0
5,REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.67776,0.074209,0.0067422,0,0
5,REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION,0.32077,0.074075,0.06926,0,0
5,REGULATION OF LYMPHOCYTE ACTIVATION,0.27227,0.073451,0.084169,0,0
5,REACTOME ALPHA LINOLENIC ACID ALA METABOLISM,0.16294,0.073317,0.084403,0,0
5,REACTOME TCR SIGNALING,0.22568,0.07328,0.04765,0,0
5,BIOCARTA IGF1R PATHWAY,0.14769,0.072224,0.093632,0,0
5,CATION TRANSPORTING ATPASE ACTIVITY,0.16828,0.071514,0.11984,0,0
5,REGULATION OF NEUROTRANSMITTER LEVELS,0.56666,0.071089,0.1144,0,0
5,RNA SPLICINGVIA TRANSESTERIFICATION REACTIONS,0.2,0.07102,0.046835,0,0
5,PID EPHBFWDPATHWAY,0.29184,0.070982,0.067363,0,0
5,REACTOME GLUCAGON TYPE LIGAND RECEPTORS,0.15773,0.070753,0.10259,0,0
5,REGULATION OF MITOSIS,0.31653,0.070341,0.031174,0,0
5,BIOCARTA TFF PATHWAY,0.42855,0.06977,0.015868,0,0
5,CHROMOSOMEPERICENTRIC REGION,0.10654,0.06932,0.077356,0,0
5,NEURON APOPTOSIS,0.38408,0.069106,0.082858,0,0
5,SIALYLTRANSFERASE ACTIVITY,0.39858,0.068736,0.12069,0,0
5,FEMALE GAMETE GENERATION,0.54903,0.068576,0.035638,0,0
5,PROTEIN DNA COMPLEX ASSEMBLY,0.10845,0.068033,0.065962,0,0
5,HISTONE METHYLTRANSFERASE ACTIVITY,0.14048,0.06797,0.076797,0,0
5,TRANSCRIPTION FACTOR TFIID COMPLEX,0.17099,0.067492,0.051933,0,0
5,HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN COMPLEX,0.12259,0.067272,0.07097,0,0
5,TISSUE MORPHOGENESIS,0.86455,0.066148,-0.012814,0,0
5,PID TCRJNKPATHWAY,0.19695,0.064924,0.083345,0,0
5,LYMPHOCYTE ACTIVATION,0.2839,0.064754,0.06986,0,0
5,KEGG DORSO VENTRAL AXIS FORMATION,0.59059,0.063922,0.029603,0,0
5,IMMUNE EFFECTOR PROCESS,0.85082,0.063803,-0.027377,0,0
5,PID HEDGEHOG 2PATHWAY,0.59664,0.063365,0.013472,0,0
5,BIOCARTA PTC1 PATHWAY,0.76948,0.063253,0.010229,0,0
5,PROTEIN METHYLTRANSFERASE ACTIVITY,0.16032,0.063092,0.069236,0,0
5,BIOCARTA NKCELLS PATHWAY,0.71658,0.062835,0.0060088,0,0
5,CELLULAR RESPONSE TO STRESS,0.16828,0.06274,0.09097,0,0
5,REGULATION OF IMMUNE RESPONSE,0.21579,0.062353,0.080069,0,0
5,PID TCRCALCIUMPATHWAY,0.38408,0.062175,0.041149,0,0
5,REACTOME SIGNALING BY SCF KIT,0.097379,0.061586,0.080748,0,0
5,MITOTIC SISTER CHROMATID SEGREGATION,0.16559,0.060301,0.081766,0,0
5,REACTOME SEMA3A PAK DEPENDENT AXON REPULSION,0.16559,0.060208,0.07871,0,0
5,ORGANELLE LOCALIZATION,0.25363,0.059241,0.027799,0,0
5,REACTOME PI3K AKT ACTIVATION,0.56666,0.059012,0.030191,0,0
5,CHROMOSOME ORGANIZATION AND BIOGENESIS,0.05161,0.058697,0.054416,0,0
5,REGULATED SECRETORY PATHWAY,0.32938,0.058126,0.18073,0,0
5,POTASSIUM CHANNEL REGULATOR ACTIVITY,0.21579,0.057776,0.14212,0,0
5,SPINDLE POLE,0.25363,0.057536,0.065787,0,0
5,REGULATION OF GENE EXPRESSION EPIGENETIC,0.13814,0.05726,0.08591,0,0
5,REACTOME SIGNAL AMPLIFICATION,0.24643,0.05709,0.062784,0,0
5,SPLICEOSOME,0.40843,0.057061,0.035345,0,0
5,REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY,0.90599,0.057028,-0.0088784,0,0
5,POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.64605,0.0569,0.020725,0,0
5,RNA SPLICING,0.19095,0.056878,0.045122,0,0
5,PID ARF6DOWNSTREAMPATHWAY,0.3746,0.056589,0.032276,0,0
5,DETECTION OF EXTERNAL STIMULUS,0.21256,0.055953,0.04868,0,0
5,MRNA PROCESSING GO 0006397,0.12259,0.055509,0.049599,0,0
5,SISTER CHROMATID SEGREGATION,0.12473,0.055357,0.089271,0,0
5,REACTOME DAG AND IP3 SIGNALING,0.53167,0.055137,0.035409,0,0
5,REGULATION OF GENE SPECIFIC TRANSCRIPTION,0.19393,0.054826,0.11992,0,0
5,KEGG PROGESTERONE MEDIATED OOCYTE MATURATION,0.33812,0.054685,0.01703,0,0
5,N ACYLTRANSFERASE ACTIVITY,0.73628,0.05438,0.0057822,0,0
5,FEEDING BEHAVIOR,0.43367,0.053876,0.020172,0,0
5,REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS,0.22905,0.053178,0.087503,0,0
5,NICOTINIC ACETYLCHOLINE GATED RECEPTOR CHANNEL COMPLEX,0.71658,0.053118,-0.11551,0,0
5,NICOTINIC ACETYLCHOLINE ACTIVATED CATION SELECTIVE CHANNEL ACTIVITY,0.71658,0.053118,-0.11551,0,0
5,BIOCARTA MPR PATHWAY,0.29184,0.052987,0.047177,0,0
5,CORTICAL CYTOSKELETON,0.79636,0.05293,0.010509,0,0
5,SPINDLE,0.15015,0.052838,0.06717,0,0
5,BIOCARTA CREB PATHWAY,0.37932,0.052779,0.070702,0,0
5,LYSOSOMAL MEMBRANE,0.89215,0.052241,-0.015143,0,0
5,CELL CORTEX PART,0.80312,0.052119,0.0034652,0,0
5,CHROMATIN BINDING,0.3746,0.052043,0.033064,0,0
5,BIOCARTA HER2 PATHWAY,0.59059,0.051975,0.025288,0,0
5,TUBE DEVELOPMENT,0.94073,0.051947,-0.030665,0,0
5,PID PLK1 PATHWAY,0.26847,0.051886,0.044512,0,0
5,CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.21579,0.05151,0.096573,0,0
5,PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY,0.61497,0.051469,0.019524,0,0
5,NERVOUS SYSTEM DEVELOPMENT,0.35153,0.051382,0.062474,0,0
5,TRANSCRIPTION INITIATION,0.11636,0.051037,0.060607,0,0
5,ACTIN FILAMENT BUNDLE FORMATION,0.44402,0.051026,0.049464,0,0
5,BIOCARTA GPCR PATHWAY,0.65234,0.050883,0.028919,0,0
5,PID CXCR3PATHWAY,0.24643,0.05087,0.045435,0,0
5,REACTOME CELL CYCLE,0.099158,0.050653,0.05821,0,0
5,REACTOME GABA B RECEPTOR ACTIVATION,0.8303,0.050634,0.0060439,0,0
5,NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.24643,0.050564,0.089596,0,0
5,NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.97557,0.050514,-0.026474,0,0
5,REACTOME IL 2 SIGNALING,0.27611,0.049766,0.082235,0,0
5,ENDODEOXYRIBONUCLEASE ACTIVITY,0.13355,0.049566,0.061053,0,0
5,BIOCARTA CHEMICAL PATHWAY,0.64605,0.049504,0.041993,0,0
5,PID S1P S1P4 PATHWAY,0.76948,0.049158,0.017494,0,0
5,HUMORAL IMMUNE RESPONSE,0.76948,0.049071,-0.0051786,0,0
5,REACTOME KINESINS,0.055956,0.048494,0.15681,0,0
5,PID PI3KCIAKTPATHWAY,0.049546,0.048487,0.081086,0,0
5,HISTONE ACETYLTRANSFERASE ACTIVITY,0.188,0.048377,0.065954,0,0
5,REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1,0.17374,0.047611,0.086251,0,0
5,REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES,0.46512,0.047378,0.020954,0,0
5,CASPASE ACTIVATION,0.59059,0.047294,0.048142,0,0
5,CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.83713,0.047149,0.0087843,0,0
5,REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION,0.56666,0.046559,0.054996,0,0
5,NUCLEAR BODY,0.58456,0.04613,0.011624,0,0
5,PID AURORA A PATHWAY,0.26098,0.045807,0.04969,0,0
5,BIOCARTA CFTR PATHWAY,0.21579,0.045573,0.099712,0,0
5,THYROID HORMONE RECEPTOR BINDING,0.4545,0.045376,0.031043,0,0
5,CHROMATIN REMODELING,0.26847,0.045064,0.058383,0,0
5,BIOCARTA SPRY PATHWAY,0.56075,0.044368,0.0075656,0,0
5,KEGG ALPHA LINOLENIC ACID METABOLISM,0.96163,0.044282,-0.0209,0,0
5,BIOCARTA RAS PATHWAY,0.27999,0.044021,0.049677,0,0
5,SYNAPSE,0.47049,0.043982,0.047774,0,0
5,PID NFAT 3PATHWAY,0.29586,0.043311,0.050821,0,0
5,PID HES HEYPATHWAY,0.34256,0.043002,0.03758,0,0
5,SIG IL4RECEPTOR IN B LYPHOCYTES,0.48678,0.042983,0.030864,0,0
5,MONOVALENT INORGANIC CATION HOMEOSTASIS,0.87833,0.04288,0.0076842,0,0
5,REACTOME DNA STRAND ELONGATION,0.16559,0.042632,0.071095,0,0
5,RESPONSE TO VIRUS,0.62732,0.04261,0.010073,0,0
5,BIOCARTA AKT PATHWAY,0.54321,0.042497,0.022431,0,0
5,REACTOME GPVI MEDIATED ACTIVATION CASCADE,0.22568,0.042193,0.067897,0,0
5,PID LPA4 PATHWAY,0.62113,0.042189,0.01806,0,0
5,VESICLE LOCALIZATION,0.73628,0.041837,-0.074928,0,0
5,CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY,0.56075,0.04149,-0.056851,0,0
5,REACTOME SIGNALLING TO ERKS,0.29184,0.041199,0.035697,0,0
5,GENERAL RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.72313,0.04094,0.0065964,0,0
5,REACTOME G ALPHA Z SIGNALLING EVENTS,0.7495,0.040381,0.033003,0,0
5,REACTOME DEFENSINS,0.69707,0.040351,-0.010421,0,0
5,PID ERBB1 INTERNALIZATION PATHWAY,0.56075,0.040302,0.03064,0,0
5,CONDENSED CHROMOSOME,0.093897,0.039938,0.082598,0,0
5,PID P38ALPHABETAPATHWAY,0.50896,0.039668,0.036772,0,0
5,CELL CYCLE CHECKPOINT GO 0000075,0.25001,0.039641,0.038383,0,0
5,SYNAPTIC VESICLE,0.40843,0.039261,0.11585,0,0
5,ONE CARBON COMPOUND METABOLIC PROCESS,0.78289,0.038734,0.0086058,0,0
5,PID ATR PATHWAY,0.29184,0.038647,0.043291,0,0
5,ST JNK MAPK PATHWAY,0.94073,0.038499,-0.024933,0,0
5,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS,0.74288,0.038026,0.021521,0,0
5,BIOCARTA RACCYCD PATHWAY,0.52025,0.037836,0.023999,0,0
5,M PHASE,0.50337,0.037535,0.020935,0,0
5,REACTOME SYNTHESIS OF PE,0.87833,0.037158,0.0047903,0,0
5,UBIQUITIN LIGASE COMPLEX,0.25363,0.037012,0.031713,0,0
5,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION,0.62732,0.036973,0.014139,0,0
5,REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE,0.12473,0.036517,0.072726,0,0
5,REACTOME SIGNALLING TO RAS,0.56075,0.036054,0.019008,0,0
5,BIOCARTA RAB PATHWAY,0.74288,0.036014,-0.0035568,0,0
5,PID RHODOPSIN PATHWAY,0.36991,0.035615,0.044637,0,0
5,MITOSIS,0.31653,0.035293,0.036585,0,0
5,KEGG BASAL TRANSCRIPTION FACTORS,0.24643,0.035225,0.044677,0,0
5,REACTOME CELL CYCLE MITOTIC,0.35153,0.034974,0.029967,0,0
5,REGIONALIZATION,0.36526,0.034853,0.076845,0,0
5,TUBE MORPHOGENESIS,0.69707,0.034764,0.016312,0,0
5,LYMPHOCYTE DIFFERENTIATION,0.4978,0.034563,0.025704,0,0
5,CHROMATIN ASSEMBLY OR DISASSEMBLY,0.19095,0.034446,0.083836,0,0
5,REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH,0.74288,0.033925,0.0079962,0,0
5,ST GRANULE CELL SURVIVAL PATHWAY,0.91293,0.033681,0.015683,0,0
5,BIOCARTA THELPER PATHWAY,0.75615,0.033115,-0.035358,0,0
5,REACTOME DNA REPLICATION,0.52025,0.03296,0.019395,0,0
5,REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.74288,0.032735,-0.11227,0,0
5,PID FOXOPATHWAY,0.74288,0.032033,0.010446,0,0
5,PID P38 MK2PATHWAY,0.67137,0.031966,0.010259,0,0
5,REACTOME PD1 SIGNALING,0.93377,0.031521,-0.019882,0,0
5,PROTEIN AMINO ACID AUTOPHOSPHORYLATION,0.37932,0.031449,0.051069,0,0
5,PID BETACATENIN DEG PATHWAY,0.4598,0.030622,0.032934,0,0
5,BASE EXCISION REPAIR,0.93377,0.030543,0.017575,0,0
5,BIOCARTA ECM PATHWAY,0.65234,0.029871,-0.0023008,0,0
5,REACTOME LAGGING STRAND SYNTHESIS,0.41842,0.029258,0.042061,0,0
5,BIOCARTA G1 PATHWAY,0.99651,0.02832,-0.029094,0,0
5,KEGG CELL CYCLE,0.33373,0.028211,0.031442,0,0
5,BIOCARTA CCR3 PATHWAY,0.60272,0.027946,-0.014207,0,0
5,MONOCARBOXYLIC ACID TRANSPORT,0.53167,0.027691,-0.10662,0,0
5,NEGATIVE REGULATION OF RNA METABOLIC PROCESS,0.41842,0.027355,0.021037,0,0
5,BIOCARTA DNAFRAGMENT PATHWAY,0.59059,0.027307,0.033207,0,0
5,PROTEIN AUTOPROCESSING,0.42855,0.027039,0.043489,0,0
5,REGULATION OF SECRETION,0.80312,0.02701,0.051018,0,0
5,KEGG UBIQUITIN MEDIATED PROTEOLYSIS,0.80989,0.026518,0.0033819,0,0
5,ESTABLISHMENT AND OR MAINTENANCE OF CHROMATIN ARCHITECTURE,0.43883,0.026264,0.027741,0,0
5,ATP DEPENDENT DNA HELICASE ACTIVITY,0.63354,0.026152,0.016722,0,0
5,BIOCARTA G2 PATHWAY,0.24643,0.026027,0.078483,0,0
5,PID ERBB2ERBB3PATHWAY,0.37932,0.025998,0.03049,0,0
5,REACTOME G PROTEIN BETA GAMMA SIGNALLING,0.54903,0.025671,0.043414,0,0
5,REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS,0.77618,0.02558,0.025835,0,0
5,MITOCHONDRIAL MEMBRANE ORGANIZATION AND BIOGENESIS,0.85768,0.025394,0.028781,0,0
5,PID HEDGEHOG GLIPATHWAY,0.59059,0.025199,0.0070778,0,0
5,KEGG ENDOMETRIAL CANCER,0.87833,0.025172,0.010952,0,0
5,M PHASE OF MITOTIC CELL CYCLE,0.29586,0.024814,0.040711,0,0
5,REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,0.39858,0.024259,0.02682,0,0
5,SENSORY ORGAN DEVELOPMENT,0.38888,0.024189,0.057851,0,0
5,REACTOME DNA REPAIR,0.4598,0.02403,0.020842,0,0
5,REGULATION OF RESPONSE TO STIMULUS,0.66501,0.023833,0.018991,0,0
5,SEQUENCE SPECIFIC DNA BINDING,0.33812,0.023256,0.025372,0,0
5,CYTOSKELETON,0.81668,0.023116,-0.004144,0,0
5,N ACETYLTRANSFERASE ACTIVITY,0.79636,0.022932,-0.0042099,0,0
5,DNA DIRECTED RNA POLYMERASEII CORE COMPLEX,0.94073,0.022436,-0.0053682,0,0
5,GAMETE GENERATION,0.36526,0.022325,0.034055,0,0
5,SEXUAL REPRODUCTION,0.8303,0.022323,0.0095365,0,0
5,KINASE ACTIVATOR ACTIVITY,0.75615,0.0222,-0.01123,0,0
5,BIOCARTA TCYTOTOXIC PATHWAY,0.97557,0.021854,-0.01965,0,0
5,MAGNESIUM ION BINDING,0.98255,0.021288,-0.0066879,0,0
5,LEUKOCYTE ACTIVATION,0.43367,0.021251,0.049313,0,0
5,TRANSCRIPTION ELONGATION REGULATOR ACTIVITY,0.53167,0.021208,0.036404,0,0
5,BIOCARTA PARKIN PATHWAY,0.8303,0.021131,0.0091147,0,0
5,PID BARD1PATHWAY,0.46512,0.021131,0.033236,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION DNA DEPENDENT,0.61497,0.021074,0.012294,0,0
5,CELL CYCLE PROCESS,0.42855,0.020951,0.01189,0,0
5,LEARNING AND OR MEMORY,0.61497,0.020743,0.043858,0,0
5,PROTEIN AMINO ACID N LINKED GLYCOSYLATION,0.32077,0.02043,0.071531,0,0
5,REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING,0.188,0.02028,0.15138,0,0
5,PID P75NTRPATHWAY,0.56075,0.020114,-0.034016,0,0
5,RESPONSE TO OTHER ORGANISM,0.78962,0.019969,-0.036854,0,0
5,PID TXA2PATHWAY,0.69061,0.019862,-0.041704,0,0
5,LEUKOCYTE MIGRATION,0.72969,0.019848,0.059356,0,0
5,POST GOLGI VESICLE MEDIATED TRANSPORT,0.92682,0.019575,0.027789,0,0
5,REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR,0.7495,0.019343,-0.038069,0,0
5,REGULATION OF ORGANELLE ORGANIZATION AND BIOGENESIS,0.68418,0.019209,0.012709,0,0
5,BIOCARTA ETS PATHWAY,0.76281,0.018914,0.018614,0,0
5,DNA REPLICATION INITIATION,0.88523,0.018437,-0.00014132,0,0
5,POSITIVE REGULATION OF TRANSPORT,0.65234,0.018418,0.041316,0,0
5,REACTOME DOWNSTREAM TCR SIGNALING,0.9686,0.018388,-0.0050844,0,0
5,DNA REPAIR,0.39858,0.018359,0.021521,0,0
5,PID IL2 1PATHWAY,0.74288,0.0181,-0.02023,0,0
5,AMINO ACID DERIVATIVE METABOLIC PROCESS,0.49227,0.017996,0.056237,0,0
5,UBIQUITIN BINDING,0.99651,0.017865,-0.008783,0,0
5,DNA DEPENDENT ATPASE ACTIVITY,0.48678,0.017834,0.035851,0,0
5,PID HDAC CLASSII PATHWAY,0.98255,0.017535,-0.00059452,0,0
5,REACTOME G1 PHASE,0.78962,0.01749,0.0074748,0,0
5,PID BMPPATHWAY,0.32938,0.017289,0.0429,0,0
5,NUCLEOPLASM,0.49227,0.01708,0.0094852,0,0
5,IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY,0.87833,0.016822,0.02637,0,0
5,REACTOME ARMS MEDIATED ACTIVATION,0.29992,0.016704,0.059145,0,0
5,SMALL CONJUGATING PROTEIN BINDING,0.87144,0.016642,-0.01162,0,0
5,DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.63354,0.01663,-0.032729,0,0
5,REACTOME ROLE OF DCC IN REGULATING APOPTOSIS,0.71006,0.016347,0.038619,0,0
5,REGULATION OF GROWTH,0.90599,0.016335,-0.02721,0,0
5,DNA REPLICATION,0.90599,0.016249,-0.016203,0,0
5,NUCLEOPLASM PART,0.57857,0.015984,0.010911,0,0
5,MITOTIC CELL CYCLE,0.82348,0.015983,0.0019092,0,0
5,GLAND DEVELOPMENT,0.91987,0.015663,-0.020253,0,0
5,KEGG HOMOLOGOUS RECOMBINATION,0.67776,0.015194,-0.021953,0,0
5,ATPASE ACTIVITY COUPLED TO TRANSMEMBRANE MOVEMENT OF IONS PHOSPHORYLATIVE MECHANISM,0.43883,0.015014,0.067092,0,0
5,HORMONE SECRETION,0.41842,0.014876,0.17113,0,0
5,REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES,0.91987,0.014723,-0.0024459,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE,0.38408,0.014704,0.10478,0,0
5,EXTERNAL SIDE OF PLASMA MEMBRANE,0.97557,0.014615,-0.011817,0,0
5,SINGLE STRANDED DNA BINDING,0.5726,0.014331,0.019903,0,0
5,REACTOME MRNA SPLICING,0.34256,0.014263,0.044371,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.50337,0.01425,0.02387,0,0
5,ANCHORED TO MEMBRANE,0.87833,0.014183,-0.052442,0,0
5,ANCHORED TO PLASMA MEMBRANE,0.87833,0.014183,-0.052442,0,0
5,PID CDC42 PATHWAY,0.96163,0.014042,-0.0030137,0,0
5,CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.56666,0.013955,0.04756,0,0
5,ANDROGEN RECEPTOR SIGNALING PATHWAY,0.41341,0.013813,0.055953,0,0
5,KEGG MISMATCH REPAIR,0.78962,0.013679,-0.0085663,0,0
5,CHROMATIN ASSEMBLY,0.26471,0.013644,0.092679,0,0
5,REACTOME MITOTIC M M G1 PHASES,0.69707,0.013436,0.0089131,0,0
5,REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES,0.85082,0.013381,-0.034129,0,0
5,REACTOME N GLYCAN ANTENNAE ELONGATION,0.92682,0.013009,-0.018924,0,0
5,REACTOME PROLONGED ERK ACTIVATION EVENTS,0.15773,0.013004,0.072362,0,0
5,PID REG GR PATHWAY,0.58456,0.012915,-0.034437,0,0
5,ACTIN FILAMENT,0.72969,0.012909,0.02911,0,0
5,BIOCARTA IL17 PATHWAY,0.62113,0.012676,0.0038701,0,0
5,PHOSPHOLIPASE A2 ACTIVITY,0.82348,0.012322,-0.034402,0,0
5,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITYENHANCER BINDING,0.85082,0.01213,-0.0087213,0,0
5,POSITIVE REGULATION OF SECRETION,0.80989,0.012086,-0.0092721,0,0
5,REACTOME AMINE LIGAND BINDING RECEPTORS,0.99651,0.0118,-0.0066223,0,0
5,COATED VESICLE,0.7495,0.01177,-0.010409,0,0
5,TRANSCRIPTION FACTOR ACTIVITY,0.78962,0.011608,-0.0092894,0,0
5,RNA EXPORT FROM NUCLEUS,0.78962,0.011489,-0.0049619,0,0
5,KEGG PRION DISEASES,0.76948,0.011362,-0.019198,0,0
5,INACTIVATION OF MAPK ACTIVITY,0.3746,0.011357,-0.11045,0,0
5,REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY,0.98953,0.011298,-0.012129,0,0
5,PID ALPHASYNUCLEIN PATHWAY,0.44402,0.011137,-0.06028,0,0
5,CELL ACTIVATION,0.47049,0.010958,0.04164,0,0
5,RESPONSE TO RADIATION,0.40843,0.010952,0.027189,0,0
5,PID MAPKTRKPATHWAY,0.80312,0.010662,-0.014705,0,0
5,CHROMATIN MODIFICATION,0.80989,0.010658,0.017411,0,0
5,PID ANTHRAXPATHWAY,0.42347,0.010545,0.026158,0,0
5,BIOCARTA NGF PATHWAY,0.76948,0.01043,0.011926,0,0
5,REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA,0.56666,0.010137,0.021619,0,0
5,SA TRKA RECEPTOR,0.85768,0.0099562,0.0023293,0,0
5,REACTOME SYNTHESIS OF PC,0.33812,0.0098079,-0.077044,0,0
5,REACTOME TRAFFICKING OF AMPA RECEPTORS,0.60272,0.0095328,-0.061088,0,0
5,MRNA METABOLIC PROCESS,0.58456,0.0090723,0.013075,0,0
5,G1 PHASE,0.7495,0.0086393,-0.036475,0,0
5,MAP KINASE ACTIVITY,0.36064,0.008389,0.11272,0,0
5,PHOSPHATASE BINDING,0.90599,0.0083247,-0.0094532,0,0
5,BIOCARTA FCER1 PATHWAY,0.88523,0.0080711,-0.0070747,0,0
5,PID ATF2 PATHWAY,0.77618,0.0080684,-0.025488,0,0
5,REACTOME GAB1 SIGNALOSOME,0.36526,0.0077986,0.041109,0,0
5,POSITIVE REGULATION OF PROTEIN SECRETION,0.38888,0.0071323,-0.092517,0,0
5,REACTOME SOS MEDIATED SIGNALLING,0.63354,0.0069325,0.023861,0,0
5,BIOCARTA TNFR1 PATHWAY,0.84397,0.0068549,-0.029475,0,0
5,ST PHOSPHOINOSITIDE 3 KINASE PATHWAY,0.85768,0.0067543,-0.0083546,0,0
5,PROTEIN TRANSPORTER ACTIVITY,0.46512,0.0066605,-0.065946,0,0
5,PID ERBB1 RECEPTOR PROXIMAL PATHWAY,0.92682,0.0063182,-0.0078846,0,0
5,REACTOME EXTENSION OF TELOMERES,0.74288,0.0056383,-0.024527,0,0
5,REGULATION OF CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.63978,0.0055961,-0.043109,0,0
5,BIOCARTA HIVNEF PATHWAY,0.63978,0.005545,-0.06959,0,0
5,REACTOME SEMAPHORIN INTERACTIONS,0.76281,0.0054655,0.017735,0,0
5,BIOCARTA PAR1 PATHWAY,0.47049,0.0050867,-0.058487,0,0
5,ENZYME BINDING,0.7495,0.0050343,-0.0056441,0,0
5,INOSITOL OR PHOSPHATIDYLINOSITOL KINASE ACTIVITY,0.79636,0.0049901,0.0071289,0,0
5,REACTOME COSTIMULATION BY THE CD28 FAMILY,0.89907,0.0048725,-0.0079088,0,0
5,REACTOME PLATELET HOMEOSTASIS,0.67776,0.0046975,0.025685,0,0
5,RESPONSE TO DNA DAMAGE STIMULUS,0.40349,0.0036848,0.020081,0,0
5,MEIOSIS I,0.51459,0.0033489,-0.044379,0,0
5,ACTIN FILAMENT BASED MOVEMENT,0.78962,0.0032767,0.025868,0,0
5,CYTOSKELETAL PROTEIN BINDING,0.59059,0.0029079,-0.027062,0,0
5,NEGATIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.91987,0.0026492,-0.0053916,0,0
5,NEGATIVE REGULATION OF TRANSCRIPTION,0.91293,0.0021956,-0.0092861,0,0
5,SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES,0.92682,0.0021595,-0.0067584,0,0
5,REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM,0.63354,0.0019901,0.017711,0,0
5,PID AR TF PATHWAY,0.51459,0.0017208,-0.035431,0,0
5,DNA BINDING,0.81668,0.0016699,-0.0079729,0,0
5,ACTIN FILAMENT BINDING,0.84397,0.00156,0.0023565,0,0
5,PROTEIN CATABOLIC PROCESS,0.69061,0.0014317,-0.024631,0,0
5,REACTOME IL 3 5 AND GM CSF SIGNALING,0.72969,0.0012349,0.016029,0,0
5,BIOCARTA ATM PATHWAY,0.82348,0.0010049,-0.026461,0,0
5,REGULATION OF MITOTIC CELL CYCLE,0.8303,0.00093951,-0.025832,0,0
5,PID TCR PATHWAY,0.77618,0.00049898,-0.021248,0,0
5,REACTOME FGFR4 LIGAND BINDING AND ACTIVATION,0.59664,0.0001402,0.022218,0,0
5,KEGG CHRONIC MYELOID LEUKEMIA,0.68418,-0.00026039,-0.027441,0,0
5,RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.35607,-0.00036642,-0.041853,0,0
5,REACTOME IL RECEPTOR SHC SIGNALING,0.92682,-0.00037701,0.010726,0,0
5,RESPONSE TO LIGHT STIMULUS,0.42855,-0.00049197,0.026554,0,0
5,KEGG ALDOSTERONE REGULATED SODIUM REABSORPTION,0.74288,-0.0005098,0.018047,0,0
5,REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,0.82348,-0.00051211,0.019772,0,0
5,TRANSCRIPTION FACTOR COMPLEX,0.55487,-0.00056915,0.0083928,0,0
5,REACTOME FANCONI ANEMIA PATHWAY,0.56075,-0.00073887,0.021176,0,0
5,REACTOME OPIOID SIGNALLING,0.78962,-0.000813,-0.018582,0,0
5,REACTOME SIGNALING BY HIPPO,0.89215,-0.00090519,-0.041033,0,0
5,BIOCARTA CERAMIDE PATHWAY,0.62732,-0.00093406,-0.038468,0,0
5,POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.8303,-0.0010587,-0.01699,0,0
5,TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.37932,-0.001268,0.03516,0,0
5,STRUCTURE SPECIFIC DNA BINDING,0.95466,-0.0013725,-0.0096439,0,0
5,PID NFAT TFPATHWAY,0.67137,-0.0016418,-0.046778,0,0
5,REACTOME FRS2 MEDIATED CASCADE,0.57857,-0.0018505,-0.025381,0,0
5,REACTOME ACYL CHAIN REMODELLING OF PG,0.57857,-0.0021901,-0.046008,0,0
5,VIRAL GENOME REPLICATION,0.58456,-0.0030428,-0.062739,0,0
5,BIOCARTA HCMV PATHWAY,1,-0.0031895,-0.010241,0,0
5,REACTOME FGFR LIGAND BINDING AND ACTIVATION,0.27611,-0.0032196,-0.070438,0,0
5,NEGATIVE REGULATION OF CELL MIGRATION,0.88523,-0.0034178,0.013131,0,0
5,PID LKB1 PATHWAY,0.84397,-0.0037482,-0.020301,0,0
5,REGULATION OF VIRAL REPRODUCTION,0.80989,-0.0038558,-0.031244,0,0
5,PID RETINOIC ACID PATHWAY,0.59664,-0.0040757,-0.043227,0,0
5,EMBRYO IMPLANTATION,0.80312,-0.0043532,-0.053187,0,0
5,REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING,0.9686,-0.0044788,-0.01594,0,0
5,REACTOME SIGNALING BY FGFR MUTANTS,0.61497,-0.0046728,0.022195,0,0
5,VACUOLAR MEMBRANE,0.98255,-0.0048792,-0.035851,0,0
5,PID E2F PATHWAY,0.96163,-0.0049532,-0.00066568,0,0
5,REACTOME G ALPHA1213 SIGNALLING EVENTS,0.73628,-0.0052958,0.020241,0,0
5,DNA RECOMBINATION,0.94073,-0.0053566,0.005334,0,0
5,REACTOME GRB2 EVENTS IN ERBB2 SIGNALING,0.96163,-0.0055767,-0.037647,0,0
5,KEGG SPLICEOSOME,0.60883,-0.0062018,0.020148,0,0
5,PID S1P S1P3 PATHWAY,0.99651,-0.0062541,-0.0051079,0,0
5,KEGG NUCLEOTIDE EXCISION REPAIR,0.69061,-0.0062589,-0.016057,0,0
5,PID FCER1PATHWAY,0.71006,-0.0065952,-0.019425,0,0
5,SEROTONIN RECEPTOR ACTIVITY,0.70355,-0.006981,-0.042735,0,0
5,PID PTP1BPATHWAY,0.43367,-0.007292,-0.062721,0,0
5,CELL FATE COMMITMENT,0.89907,-0.0073355,0.022587,0,0
5,KEGG OOCYTE MEIOSIS,0.76948,-0.0073574,-0.0077018,0,0
5,DNA METABOLIC PROCESS,0.36991,-0.007928,-0.022995,0,0
5,NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.31653,-0.0079403,-0.075278,0,0
5,PID AMB2 NEUTROPHILS PATHWAY,0.47049,-0.007983,0.027206,0,0
5,POSITIVE REGULATION OF RESPONSE TO STIMULUS,0.8303,-0.0080737,0.031337,0,0
5,CELL CYCLE PHASE,0.68418,-0.0080821,-0.0080546,0,0
5,NUCLEAR PART,0.47049,-0.0082635,-0.016402,0,0
5,ACTIN FILAMENT BASED PROCESS,0.41341,-0.0085445,-0.030971,0,0
5,RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY,0.76948,-0.0086651,-0.024052,0,0
5,MEIOTIC CELL CYCLE,0.89215,-0.0088071,0.007091,0,0
5,PID NETRIN PATHWAY,0.93377,-0.0092956,0.0009429,0,0
5,GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.76281,-0.0093921,-0.048618,0,0
5,VACUOLAR PART,0.95466,-0.009775,-0.026599,0,0
5,REGULATION OF CYTOKINE SECRETION,0.52025,-0.010039,-0.056551,0,0
5,NEGATIVE REGULATION OF METABOLIC PROCESS,0.84397,-0.010188,-0.011734,0,0
5,REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE,0.89907,-0.010382,0.084542,0,0
5,MEDIATOR COMPLEX,0.34256,-0.010553,-0.041238,0,0
5,PID IL3 PATHWAY,0.51459,-0.010705,-0.032226,0,0
5,KEGG LYSINE DEGRADATION,0.42347,-0.011035,-0.056642,0,0
5,CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.83713,-0.011096,-0.0084847,0,0
5,DNA DAMAGE CHECKPOINT,0.96163,-0.011147,0.0010847,0,0
5,GLUTAMATE RECEPTOR ACTIVITY,0.55487,-0.011178,0.098877,0,0
5,PROTEIN C TERMINUS BINDING,0.26847,-0.011354,-0.039395,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY,0.65234,-0.011467,0.08998,0,0
5,REGULATION OF CELL MIGRATION,0.48131,-0.011496,-0.11376,0,0
5,BIOCARTA HDAC PATHWAY,0.40843,-0.011674,-0.076512,0,0
5,REACTOME NRAGE SIGNALS DEATH THROUGH JNK,0.64605,-0.011751,-0.025657,0,0
5,REACTOME PLC BETA MEDIATED EVENTS,0.41341,-0.011868,-0.043872,0,0
5,REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,0.96163,-0.01204,0.011815,0,0
5,REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI,0.53167,-0.012412,-0.044913,0,0
5,CALCIUM ION TRANSPORT,0.62113,-0.012419,-0.051517,0,0
5,KEGG BETA ALANINE METABOLISM,0.91987,-0.012683,0.003763,0,0
5,CELL PROJECTION,0.17934,-0.012893,-0.058131,0,0
5,REACTOME ELONGATION ARREST AND RECOVERY,0.28785,-0.013061,-0.044244,0,0
5,REACTOME SHC MEDIATED CASCADE,0.15015,-0.013121,-0.079215,0,0
5,NEGATIVE REGULATION OF CELLULAR METABOLIC PROCESS,0.82348,-0.013544,-0.011628,0,0
5,NUCLEUS,0.090515,-0.013556,-0.033656,0,0
5,PID ERB GENOMIC PATHWAY,0.63354,-0.013612,-0.034922,0,0
5,CELL PROJECTION PART,0.88523,-0.013652,0.025175,0,0
5,REACTOME REGULATORY RNA PATHWAYS,0.83713,-0.013719,-0.0073991,0,0
5,REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS,0.81668,-0.013812,-0.048222,0,0
5,KEGG TERPENOID BACKBONE BIOSYNTHESIS,0.89907,-0.013875,-0.034086,0,0
5,REACTOME BOTULINUM NEUROTOXICITY,0.65234,-0.013943,-0.0066824,0,0
5,ESTABLISHMENT AND OR MAINTENANCE OF CELL POLARITY,0.46512,-0.013987,0.082385,0,0
5,SMALL CONJUGATING PROTEIN LIGASE ACTIVITY,0.79636,-0.014187,-0.015296,0,0
5,CARBOXY LYASE ACTIVITY,0.68418,-0.01434,-0.013957,0,0
5,SPECIFIC RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY,0.32077,-0.014471,-0.068434,0,0
5,ST T CELL SIGNAL TRANSDUCTION,0.91987,-0.01461,0.0090114,0,0
5,RESPONSE TO UV,0.86455,-0.014996,-0.0087411,0,0
5,UBIQUITIN CYCLE,0.57857,-0.015007,-0.029427,0,0
5,NUCLEAR MEMBRANE,0.87144,-0.015099,-0.012126,0,0
5,PID BCR 5PATHWAY,0.2839,-0.015166,-0.044322,0,0
5,REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX,0.53742,-0.015399,-0.035637,0,0
5,REACTOME MRNA PROCESSING,0.90599,-0.015464,0.003036,0,0
5,KEGG FC EPSILON RI SIGNALING PATHWAY,0.88523,-0.015494,0.0035268,0,0
5,REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE,0.81668,-0.015827,-0.0055344,0,0
5,NUCLEOTIDE KINASE ACTIVITY,0.96163,-0.015886,0.024837,0,0
5,DNA DEPENDENT DNA REPLICATION,0.40349,-0.016079,-0.042708,0,0
5,KEGG NEUROTROPHIN SIGNALING PATHWAY,0.71006,-0.016128,-0.0087424,0,0
5,NUCLEAR LUMEN,0.13355,-0.016204,-0.038031,0,0
5,GLYCOLIPID METABOLIC PROCESS,0.29586,-0.01673,-0.11689,0,0
5,CELLULAR PROTEIN CATABOLIC PROCESS,0.21256,-0.016934,-0.05418,0,0
5,CERAMIDE METABOLIC PROCESS,0.86455,-0.017264,-0.009666,0,0
5,KEGG SULFUR METABOLISM,0.62113,-0.017275,-0.056415,0,0
5,REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS,0.52025,-0.017403,0.061255,0,0
5,REACTOME IL 7 SIGNALING,0.61497,-0.01788,-0.059154,0,0
5,KEGG DNA REPLICATION,0.85768,-0.018114,0.017216,0,0
5,PID NCADHERINPATHWAY,0.56666,-0.018116,-0.053878,0,0
5,REACTOME ACTIVATION OF GENES BY ATF4,0.36991,-0.018282,-0.062037,0,0
5,REACTOME PHOSPHOLIPASE C MEDIATED CASCADE,0.91293,-0.018668,-0.0077939,0,0
5,BIOCARTA IL2RB PATHWAY,0.71006,-0.018679,-0.021807,0,0
5,CELL CYCLE GO 0007049,0.29992,-0.018683,-0.032642,0,0
5,PEROXISOMAL PART,0.73628,-0.018863,-0.018232,0,0
5,MICROBODY PART,0.73628,-0.018863,-0.018232,0,0
5,PID IL23PATHWAY,0.89907,-0.018904,-0.047327,0,0
5,KEGG COLORECTAL CANCER,0.27999,-0.018986,-0.053673,0,0
5,ACTIN CYTOSKELETON ORGANIZATION AND BIOGENESIS,0.31232,-0.019089,-0.034353,0,0
5,BIOCARTA BARRESTIN SRC PATHWAY,0.97557,-0.019278,0.025244,0,0
5,REACTOME RNA POL II TRANSCRIPTION,0.55487,-0.019412,0.01782,0,0
5,REACTOME SIGNALING BY ROBO RECEPTOR,0.60883,-0.019486,-0.027844,0,0
5,REACTOME FORMATION OF INCISION COMPLEX IN GG NER,0.72313,-0.019666,-0.027614,0,0
5,ANTIOXIDANT ACTIVITY,0.25729,-0.019743,-0.098054,0,0
5,REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS,0.2839,-0.01984,-0.054333,0,0
5,ACTIN CYTOSKELETON,0.2,-0.01994,-0.058058,0,0
5,REACTOME SEROTONIN RECEPTORS,0.51459,-0.020274,-0.049591,0,0
5,REACTOME MRNA SPLICING MINOR PATHWAY,0.54903,-0.020285,0.025433,0,0
5,KEGG VASOPRESSIN REGULATED WATER REABSORPTION,0.95466,-0.020355,0.0016656,0,0
5,PID VEGFR1 PATHWAY,0.79636,-0.020367,-0.027168,0,0
5,COVALENT CHROMATIN MODIFICATION,0.48131,-0.020419,-0.023339,0,0
5,REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER,0.72969,-0.0205,-0.014711,0,0
5,REACTOME PI METABOLISM,0.49227,-0.020505,-0.019125,0,0
5,REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS,0.36991,-0.020673,-0.049096,0,0
5,PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.81668,-0.02076,-0.018045,0,0
5,KEGG ACUTE MYELOID LEUKEMIA,0.34256,-0.021493,-0.038216,0,0
5,REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS,0.78962,-0.021536,0.043932,0,0
5,ORGANELLE PART,0.064293,-0.021635,-0.039444,0,0
5,NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.87144,-0.021704,0.0019746,0,0
5,RNA PROCESSING,0.43883,-0.021835,-0.031943,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE,0.74288,-0.021863,-0.0041554,0,0
5,REACTOME SHC RELATED EVENTS,0.43367,-0.022271,-0.037913,0,0
5,MEIOTIC RECOMBINATION,0.63354,-0.022326,-0.034235,0,0
5,REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE,0.18508,-0.022362,-0.056157,0,0
5,REACTOME SIGNALING BY FGFR,0.5726,-0.022546,-0.014297,0,0
5,INTRACELLULAR ORGANELLE PART,0.063042,-0.022593,-0.040068,0,0
5,PID SHP2 PATHWAY,0.53742,-0.022594,-0.042926,0,0
5,REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY,0.60883,-0.022626,-0.051565,0,0
5,RESPONSE TO ENDOGENOUS STIMULUS,0.16032,-0.022767,-0.032414,0,0
5,ENDONUCLEASE ACTIVITY,0.31653,-0.022861,-0.048585,0,0
5,REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT,0.71658,-0.023136,-0.021696,0,0
5,NON MEMBRANE BOUND ORGANELLE,0.22235,-0.023263,-0.031445,0,0
5,INTRACELLULAR NON MEMBRANE BOUND ORGANELLE,0.22235,-0.023263,-0.031445,0,0
5,REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS,0.53742,-0.023316,-0.13038,0,0
5,NUCLEAR ENVELOPE,0.62113,-0.02336,-0.012851,0,0
5,PROTEIN N TERMINUS BINDING,0.22905,-0.023389,-0.037253,0,0
5,POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.42855,-0.023571,-0.037754,0,0
5,KEGG NON SMALL CELL LUNG CANCER,0.33373,-0.023754,-0.039795,0,0
5,INTERMEDIATE FILAMENT,0.38408,-0.023831,-0.11306,0,0
5,INTERMEDIATE FILAMENT CYTOSKELETON,0.38408,-0.023831,-0.11306,0,0
5,ALDO KETO REDUCTASE ACTIVITY,0.67137,-0.023969,-0.1903,0,0
5,GLYCOSPHINGOLIPID METABOLIC PROCESS,0.88523,-0.023999,-0.010289,0,0
5,LEUKOCYTE CHEMOTAXIS,0.80312,-0.024159,0.067608,0,0
5,REACTOME MYOGENESIS,0.91293,-0.024225,-0.025678,0,0
5,REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND,0.97557,-0.024347,0.011717,0,0
5,REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION,0.72969,-0.024433,0.021875,0,0
5,REACTOME ACTIVATION OF RAC,0.99651,-0.024453,0.015472,0,0
5,HISTONE MODIFICATION,0.36526,-0.024499,-0.027363,0,0
5,REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS,0.30815,-0.024696,-0.060552,0,0
5,GLYCOPROTEIN METABOLIC PROCESS,0.33812,-0.024709,-0.076754,0,0
5,REACTOME CTNNB1 PHOSPHORYLATION CASCADE,0.62113,-0.024716,-0.024905,0,0
5,REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,0.18219,-0.024777,-0.060426,0,0
5,UBIQUITIN PROTEIN LIGASE ACTIVITY,0.48131,-0.024874,-0.030675,0,0
5,REACTOME VIRAL MESSENGER RNA SYNTHESIS,0.4598,-0.025067,-0.039918,0,0
5,DNA DIRECTED RNA POLYMERASEII HOLOENZYME,0.60272,-0.025239,-0.014559,0,0
5,REACTOME ENDOGENOUS STEROLS,0.57857,-0.025369,0.069303,0,0
5,PID DNAPK PATHWAY,0.29992,-0.025385,-0.056246,0,0
5,INDUCTION OF APOPTOSIS BY INTRACELLULAR SIGNALS,0.82348,-0.025427,-0.034219,0,0
5,REACTOME PI 3K CASCADE,0.50896,-0.026086,-0.024734,0,0
5,REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY,0.23245,-0.026097,-0.061431,0,0
5,REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR,0.64605,-0.026195,-0.011598,0,0
5,KEGG NON HOMOLOGOUS END JOINING,0.80312,-0.026283,-0.022177,0,0
5,REACTOME ERKS ARE INACTIVATED,0.90599,-0.026554,-0.017773,0,0
5,ACTIVATION OF MAPK ACTIVITY,0.50896,-0.02664,-0.027678,0,0
5,POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0695,-0.026724,-0.11727,0,0
5,SYNAPSE PART,0.71006,-0.026794,0.039278,0,0
5,NF KAPPAB BINDING,0.44402,-0.026815,-0.040272,0,0
5,TRANSCRIPTION ACTIVATOR ACTIVITY,0.43367,-0.026987,-0.015969,0,0
5,REACTOME SIGNALING BY ERBB2,0.59059,-0.027146,-0.010955,0,0
5,REGULATION OF DNA METABOLIC PROCESS,0.19095,-0.027284,-0.076,0,0
5,DNA MODIFICATION,0.75615,-0.027343,0.046258,0,0
5,BIOCARTA GATA3 PATHWAY,0.42855,-0.027648,-0.057617,0,0
5,MYOSIN COMPLEX,0.29992,-0.027694,-0.040609,0,0
5,ACETYLCHOLINE BINDING,0.76281,-0.027762,-0.024945,0,0
5,REACTOME POL SWITCHING,0.50337,-0.027812,-0.022069,0,0
5,REACTOME CELL CYCLE CHECKPOINTS,0.25001,-0.027986,-0.05333,0,0
5,GTPASE ACTIVITY,0.40349,-0.028079,-0.05313,0,0
5,ST G ALPHA S PATHWAY,0.4545,-0.028083,-0.042319,0,0
5,KEGG STEROID HORMONE BIOSYNTHESIS,0.40349,-0.0281,-0.079054,0,0
5,REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN,0.76281,-0.028131,0.016179,0,0
5,PID ERBB4 PATHWAY,0.23589,-0.028178,-0.053958,0,0
5,CIRCADIAN RHYTHM,0.50896,-0.028331,-0.032769,0,0
5,REACTOME ADHERENS JUNCTIONS INTERACTIONS,0.76948,-0.028351,-0.013942,0,0
5,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR BINDING,0.56075,-0.028478,-0.05648,0,0
5,PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.66501,-0.02872,-0.020678,0,0
5,NUCLEOSIDE TRIPHOSPHATASE ACTIVITY,0.10654,-0.028936,-0.046308,0,0
5,REGULATION OF TRANSCRIPTION,0.052669,-0.028941,-0.048741,0,0
5,REACTOME SHC1 EVENTS IN EGFR SIGNALING,0.67776,-0.029115,-0.043065,0,0
5,REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING,0.29992,-0.029302,-0.03578,0,0
5,PID TELOMERASEPATHWAY,0.16559,-0.029892,-0.063006,0,0
5,TRANSCRIPTION REPRESSOR ACTIVITY,0.077957,-0.030364,-0.056985,0,0
5,NUCLEAR MATRIX,0.78289,-0.030617,-0.01847,0,0
5,CELLULAR RESPONSE TO STIMULUS,0.71658,-0.030712,-0.027795,0,0
5,REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE,0.46512,-0.03072,-0.048425,0,0
5,PROTEIN POLYUBIQUITINATION,0.5726,-0.030748,-0.025326,0,0
5,REACTOME GABA RECEPTOR ACTIVATION,0.87833,-0.031249,-0.012343,0,0
5,REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT,0.31653,-0.031479,-0.051765,0,0
5,VITAMIN BINDING,0.92682,-0.031724,-0.0071316,0,0
5,CONDENSED NUCLEAR CHROMOSOME,0.59664,-0.031785,-0.018014,0,0
5,RHYTHMIC PROCESS,0.32938,-0.031869,-0.041801,0,0
5,REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.073629,-0.032451,-0.047209,0,0
5,RNA POLYMERASE II TRANSCRIPTION MEDIATOR ACTIVITY,0.80989,-0.032514,-0.003252,0,0
5,REACTOME INWARDLY RECTIFYING K CHANNELS,0.86455,-0.032563,0.013077,0,0
5,REACTOME MITOTIC G1 G1 S PHASES,0.48678,-0.032568,-0.032743,0,0
5,NOTCH SIGNALING PATHWAY,0.55487,-0.032699,-0.051132,0,0
5,REACTOME CELL CELL COMMUNICATION,0.20937,-0.032856,-0.057991,0,0
5,REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.14526,-0.032912,-0.044745,0,0
5,REACTOME SIGNALING BY FGFR IN DISEASE,0.72313,-0.033083,-0.0083014,0,0
5,ORGANELLE ORGANIZATION AND BIOGENESIS,0.088862,-0.033155,-0.036709,0,0
5,POSITIVE REGULATION OF CASPASE ACTIVITY,0.76948,-0.033416,-0.0083446,0,0
5,PROTEIN DOMAIN SPECIFIC BINDING,0.34256,-0.033661,-0.025594,0,0
5,BIOCARTA MCALPAIN PATHWAY,0.33373,-0.033828,-0.069647,0,0
5,REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.076492,-0.033881,-0.051492,0,0
5,KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION,0.23245,-0.033919,-0.053077,0,0
5,REGULATION OF RNA METABOLIC PROCESS,0.088862,-0.034151,-0.050077,0,0
5,SYSTEM DEVELOPMENT,0.14769,-0.034337,-0.049128,0,0
5,DNA INTEGRITY CHECKPOINT,0.98255,-0.034471,-0.0035859,0,0
5,PID CD8TCRPATHWAY,0.58456,-0.034544,-0.021302,0,0
5,REACTOME NCAM1 INTERACTIONS,0.83713,-0.034636,-0.046593,0,0
5,REACTOME LIGAND GATED ION CHANNEL TRANSPORT,0.17099,-0.034769,-0.15797,0,0
5,REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.034801,-0.057811,0,0
5,DOUBLE STRANDED RNA BINDING,0.44402,-0.034851,-0.040903,0,0
5,REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS,0.18508,-0.034899,-0.065946,0,0
5,PYROPHOSPHATASE ACTIVITY,0.029068,-0.034958,-0.058898,0,0
5,REGULATION OF TRANSCRIPTION FACTOR ACTIVITY,0.35607,-0.035132,-0.03635,0,0
5,BIOCARTA ATRBRCA PATHWAY,0.79636,-0.035235,-0.0019195,0,0
5,REACTOME NEGATIVE REGULATION OF FGFR SIGNALING,0.22568,-0.035277,-0.050586,0,0
5,NUCLEAR EXPORT,0.4978,-0.035283,-0.022305,0,0
5,REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.52594,-0.035747,-0.029494,0,0
5,BIOCARTA CARM ER PATHWAY,0.097379,-0.035752,-0.061398,0,0
5,REACTOME PI3K EVENTS IN ERBB2 SIGNALING,0.59664,-0.036022,-0.018048,0,0
5,BIOCARTA CK1 PATHWAY,0.86455,-0.036049,-0.018953,0,0
5,CLATHRIN COATED VESICLE,0.60883,-0.036121,-0.01774,0,0
5,NEGATIVE REGULATION OF GROWTH,0.46512,-0.0362,-0.058011,0,0
5,REGULATION OF GTPASE ACTIVITY,0.19095,-0.036387,-0.11758,0,0
5,BIOCARTA PITX2 PATHWAY,0.53742,-0.036826,-0.069582,0,0
5,BIOCARTA AGR PATHWAY,0.38408,-0.037007,-0.064443,0,0
5,HISTONE DEACETYLASE COMPLEX,0.76281,-0.037025,-0.0089539,0,0
5,PID FGF PATHWAY,0.19095,-0.037222,-0.064126,0,0
5,REACTOME SPRY REGULATION OF FGF SIGNALING,0.53167,-0.03741,-0.035455,0,0
5,ATPASE ACTIVITY,0.13583,-0.037412,-0.044086,0,0
5,CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.64605,-0.037479,-0.049305,0,0
5,NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.085627,-0.037507,-0.11968,0,0
5,KEGG GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS,0.052669,-0.037674,-0.11462,0,0
5,REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS,0.56666,-0.03774,-0.046155,0,0
5,NUCLEAR HORMONE RECEPTOR BINDING,0.188,-0.037778,-0.058509,0,0
5,REACTOME RNA POL III TRANSCRIPTION,0.26098,-0.037849,-0.05274,0,0
5,REACTOME ION TRANSPORT BY P TYPE ATPASES,0.78289,-0.037911,-0.0068881,0,0
5,REACTOME HIV LIFE CYCLE,0.37932,-0.03803,-0.034339,0,0
5,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES,0.034637,-0.038293,-0.054583,0,0
5,BIOCARTA NFAT PATHWAY,0.36064,-0.03834,-0.042865,0,0
5,INTEGRATOR COMPLEX,0.17099,-0.038385,-0.060672,0,0
5,PID CONE PATHWAY,0.22568,-0.038668,-0.097778,0,0
5,DNA HELICASE ACTIVITY,0.81668,-0.038687,-0.009227,0,0
5,RESPONSE TO ABIOTIC STIMULUS,0.26098,-0.038822,-0.027468,0,0
5,TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER,0.076492,-0.039356,-0.049157,0,0
5,INTRINSIC TO ENDOPLASMIC RETICULUM MEMBRANE,0.34702,-0.039389,-0.071983,0,0
5,INTEGRAL TO ENDOPLASMIC RETICULUM MEMBRANE,0.34702,-0.039389,-0.071983,0,0
5,SIG CD40PATHWAYMAP,0.56666,-0.039497,-0.034236,0,0
5,SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.44924,-0.039498,-0.072885,0,0
5,POSITIVE REGULATION OF RNA METABOLIC PROCESS,0.093897,-0.039617,-0.066397,0,0
5,PROTEIN UBIQUITINATION,0.50337,-0.039625,-0.037217,0,0
5,PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.27227,-0.039883,-0.074508,0,0
5,BIOCARTA GRANULOCYTES PATHWAY,0.52025,-0.039912,-0.099165,0,0
5,BIOCARTA MYOSIN PATHWAY,0.15264,-0.040058,-0.11098,0,0
5,MULTICELLULAR ORGANISMAL DEVELOPMENT,0.093897,-0.040125,-0.053733,0,0
5,REPRODUCTION,0.14048,-0.040217,-0.050281,0,0
5,REACTOME GLOBAL GENOMIC NER GG NER,0.29992,-0.040634,-0.041729,0,0
5,HELICASE ACTIVITY,0.35607,-0.040882,-0.040312,0,0
5,NEURON PROJECTION,0.24643,-0.041158,-0.10695,0,0
5,ACID AMINO ACID LIGASE ACTIVITY,0.12908,-0.041352,-0.069228,0,0
5,PID HIVNEFPATHWAY,0.53167,-0.04166,-0.051553,0,0
5,REGULATION OF PROTEIN SECRETION,0.14526,-0.041705,-0.11347,0,0
5,BIOCARTA IGF1MTOR PATHWAY,0.23589,-0.041711,-0.065025,0,0
5,PID SYNDECAN 2 PATHWAY,0.56666,-0.041712,-0.069675,0,0
5,PID BETACATENIN NUC PATHWAY,0.20937,-0.041742,-0.068229,0,0
5,TRANSCRIPTION COACTIVATOR ACTIVITY,0.48131,-0.041803,-0.013418,0,0
5,POSITIVE REGULATION OF NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID METABOLIC PROCESS,0.11235,-0.041879,-0.053424,0,0
5,BIOCARTA CXCR4 PATHWAY,0.68418,-0.042281,-0.021223,0,0
5,REACTOME PLATELET SENSITIZATION BY LDL,0.10654,-0.042375,-0.12164,0,0
5,NLS BEARING SUBSTRATE IMPORT INTO NUCLEUS,0.32506,-0.042522,-0.083879,0,0
5,POSITIVE REGULATION OF TRANSCRIPTION,0.13814,-0.042601,-0.052487,0,0
5,REACTOME G ALPHA I SIGNALLING EVENTS,0.13355,-0.042649,-0.063414,0,0
5,POSITIVE REGULATION OF TRANSCRIPTIONDNA DEPENDENT,0.080955,-0.042683,-0.069589,0,0
5,SMALL PROTEIN CONJUGATING ENZYME ACTIVITY,0.38888,-0.04271,-0.041537,0,0
5,REACTOME DOWNSTREAM SIGNAL TRANSDUCTION,0.59664,-0.043021,-0.017574,0,0
5,REACTOME PEPTIDE HORMONE BIOSYNTHESIS,0.89215,-0.043076,-0.062089,0,0
5,ST FAS SIGNALING PATHWAY,0.13355,-0.04334,-0.054038,0,0
5,KEGG B CELL RECEPTOR SIGNALING PATHWAY,0.26098,-0.043394,-0.052028,0,0
5,LEUKOCYTE DIFFERENTIATION,0.8303,-0.04347,-0.026895,0,0
5,PID TRKRPATHWAY,0.40843,-0.04362,-0.023695,0,0
5,PID CASPASE PATHWAY,0.16032,-0.04384,-0.093973,0,0
5,KEGG RNA DEGRADATION,0.35607,-0.043888,-0.036192,0,0
5,REACTOME DEVELOPMENTAL BIOLOGY,0.16032,-0.0439,-0.051637,0,0
5,BIOCARTA RAC1 PATHWAY,0.54321,-0.04406,-0.039843,0,0
5,PID PRLSIGNALINGEVENTSPATHWAY,0.96163,-0.044209,-0.010103,0,0
5,BIOCARTA LECTIN PATHWAY,0.43883,-0.04425,-0.080119,0,0
5,REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI,0.41341,-0.044297,-0.073983,0,0
5,TRANS GOLGI NETWORK,0.23245,-0.044343,-0.049006,0,0
5,REACTOME TRANSCRIPTION COUPLED NER TC NER,0.33812,-0.044425,-0.035847,0,0
5,REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS,0.43883,-0.044581,-0.13544,0,0
5,DI   TRI VALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.33812,-0.044672,-0.047464,0,0
5,PID CXCR4 PATHWAY,0.05161,-0.044893,-0.083983,0,0
5,REACTOME SIGNALING BY EGFR IN CANCER,0.17653,-0.044969,-0.042404,0,0
5,REACTOME SIGNAL TRANSDUCTION BY L1,0.99651,-0.045104,-0.001573,0,0
5,PEROXISOMAL MEMBRANE,0.38888,-0.045149,-0.054588,0,0
5,MICROBODY MEMBRANE,0.38888,-0.045149,-0.054588,0,0
5,MESODERM DEVELOPMENT,0.52594,-0.045447,-0.070141,0,0
5,KEGG BASAL CELL CARCINOMA,0.16294,-0.045575,-0.096687,0,0
5,REACTOME NEUROTRANSMITTER RELEASE CYCLE,0.61497,-0.0456,0.0062279,0,0
5,G PROTEIN COUPLED RECEPTOR ACTIVITY,0.10465,-0.045617,-0.065531,0,0
5,REACTOME SIGNAL ATTENUATION,0.67776,-0.045789,-0.00099245,0,0
5,ATPASE ACTIVITY COUPLED,0.14769,-0.045942,-0.044385,0,0
5,REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX,0.17374,-0.046191,-0.055074,0,0
5,HORMONE RECEPTOR BINDING,0.15264,-0.046236,-0.066903,0,0
5,PROTEIN STABILIZATION,0.19695,-0.046438,-0.10321,0,0
5,BIOCARTA FMLP PATHWAY,0.11841,-0.046495,-0.07328,0,0
5,REACTOME CELL CELL JUNCTION ORGANIZATION,0.38408,-0.046584,-0.029805,0,0
5,REACTOME DESTABILIZATION OF MRNA BY KSRP,0.29992,-0.046654,-0.057968,0,0
5,SIG BCR SIGNALING PATHWAY,0.66501,-0.046722,-0.032269,0,0
5,BIOCARTA DREAM PATHWAY,0.53742,-0.047013,-0.044382,0,0
5,MYELOID LEUKOCYTE DIFFERENTIATION,0.60883,-0.047207,-0.17011,0,0
5,ANATOMICAL STRUCTURE DEVELOPMENT,0.059411,-0.047414,-0.062969,0,0
5,BIOCARTA RANMS PATHWAY,0.55487,-0.04761,-0.051253,0,0
5,REACTOME BASE EXCISION REPAIR,0.26847,-0.047667,-0.044159,0,0
5,PID HDAC CLASSI PATHWAY,0.068167,-0.048063,-0.054111,0,0
5,ZINC ION BINDING,0.068167,-0.04817,-0.061223,0,0
5,REGULATION OF HYDROLASE ACTIVITY,0.26471,-0.04825,-0.04342,0,0
5,REACTOME O LINKED GLYCOSYLATION OF MUCINS,0.11434,-0.048362,-0.14165,0,0
5,REACTOME MRNA CAPPING,0.095625,-0.048771,-0.063102,0,0
5,BIOCARTA AKAP95 PATHWAY,0.62113,-0.049129,-0.036714,0,0
5,REACTOME DESTABILIZATION OF MRNA BY BRF1,0.15773,-0.049358,-0.094183,0,0
5,REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.50896,-0.049502,-0.090228,0,0
5,FOCAL ADHESION,0.3746,-0.049517,-0.092829,0,0
5,REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE,0.79636,-0.049671,-0.025592,0,0
5,PID P53REGULATIONPATHWAY,0.31232,-0.05006,-0.035673,0,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE AND NUCLEIC ACID TRANSPORT,0.064293,-0.050139,-0.066715,0,0
5,ST INTEGRIN SIGNALING PATHWAY,0.16559,-0.050296,-0.072209,0,0
5,CELL PROJECTION BIOGENESIS,0.088862,-0.050348,-0.093798,0,0
5,REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT,0.11039,-0.050408,-0.078816,0,0
5,REACTOME RNA POL III TRANSCRIPTION TERMINATION,0.24288,-0.050417,-0.076714,0,0
5,REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS,0.78289,-0.050485,0.00019517,0,0
5,BIOCARTA FAS PATHWAY,0.42855,-0.050518,-0.068591,0,0
5,SYNAPTIC TRANSMISSION,0.25001,-0.0506,-0.04387,0,0
5,REACTOME AXON GUIDANCE,0.29184,-0.050753,-0.052478,0,0
5,REGULATION OF CELL CYCLE,0.097379,-0.051011,-0.051478,0,0
5,MAINTENANCE OF LOCALIZATION,0.7495,-0.051094,-0.022686,0,0
5,TRICARBOXYLIC ACID CYCLE INTERMEDIATE METABOLIC PROCESS,0.3746,-0.051106,-0.063031,0,0
5,KEGG PROTEIN EXPORT,0.32938,-0.051268,-0.063982,0,0
5,NUCLEAR MEMBRANE PART,0.40349,-0.051279,-0.040275,0,0
5,REACTOME SIGNALLING BY NGF,0.057089,-0.051359,-0.051464,0,0
5,PHOSPHORIC MONOESTER HYDROLASE ACTIVITY,0.16559,-0.051434,-0.062197,0,0
5,SA PTEN PATHWAY,0.50337,-0.051784,-0.036939,0,0
5,MEMBRANE COAT,0.36991,-0.05185,-0.059567,0,0
5,COATED MEMBRANE,0.36991,-0.05185,-0.059567,0,0
5,CYTOKINE SECRETION,0.21905,-0.051949,-0.092247,0,0
5,ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES,0.26471,-0.052129,-0.080982,0,0
5,REACTOME MICRORNA MIRNA BIOGENESIS,0.22905,-0.052215,-0.043267,0,0
5,ACETYLTRANSFERASE ACTIVITY,0.19695,-0.05224,-0.083031,0,0
5,G1 PHASE OF MITOTIC CELL CYCLE,0.77618,-0.052428,-0.042008,0,0
5,BIOCARTA PTEN PATHWAY,0.32506,-0.052437,-0.049193,0,0
5,KEGG PATHOGENIC ESCHERICHIA COLI INFECTION,0.17934,-0.052745,-0.065071,0,0
5,REACTOME NUCLEOTIDE EXCISION REPAIR,0.28785,-0.052837,-0.03894,0,0
5,CELL MATRIX JUNCTION,0.21256,-0.052931,-0.12246,0,0
5,NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.23589,-0.05306,-0.061156,0,0
5,REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC,0.30815,-0.053252,-0.093745,0,0
5,BIOCARTA LONGEVITY PATHWAY,0.21579,-0.053328,-0.086108,0,0
5,KEGG P53 SIGNALING PATHWAY,0.26098,-0.053425,-0.068667,0,0
5,KEGG BIOSYNTHESIS OF UNSATURATED FATTY ACIDS,0.42855,-0.053515,-0.033113,0,0
5,REACTOME RNA POL II PRE TRANSCRIPTION EVENTS,0.29992,-0.053545,-0.030589,0,0
5,INTERPHASE OF MITOTIC CELL CYCLE,0.13355,-0.053562,-0.052983,0,0
5,EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.14048,-0.053723,-0.13978,0,0
5,REACTOME REGULATION OF IFNG SIGNALING,0.31653,-0.053881,-0.087465,0,0
5,REACTOME LATE PHASE OF HIV LIFE CYCLE,0.087232,-0.053978,-0.060005,0,0
5,PID AJDISS 2PATHWAY,0.91293,-0.054026,0.026187,0,0
5,REACTOME PERK REGULATED GENE EXPRESSION,0.21256,-0.054196,-0.079322,0,0
5,BIOCARTA TGFB PATHWAY,0.24288,-0.054381,-0.10524,0,0
5,RESPONSE TO BIOTIC STIMULUS,0.095625,-0.054393,-0.066095,0,0
5,REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.3746,-0.054489,-0.042653,0,0
5,BIOCARTA NDKDYNAMIN PATHWAY,0.21256,-0.05468,-0.10661,0,0
5,ENDONUCLEASE ACTIVITY GO 0016893,0.31653,-0.05512,-0.048607,0,0
5,REACTOME NEUROTRANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL,0.4545,-0.05515,-0.045012,0,0
5,KEGG PROSTATE CANCER,0.27999,-0.055248,-0.055193,0,0
5,PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY,0.26471,-0.055663,-0.079182,0,0
5,BIOCARTA STATHMIN PATHWAY,0.82348,-0.055773,0.022465,0,0
5,ENDORIBONUCLEASE ACTIVITY,0.33812,-0.0558,-0.052391,0,0
5,REACTOME SYNTHESIS OF DNA,0.17099,-0.055954,-0.065183,0,0
5,GABA RECEPTOR ACTIVITY,0.67137,-0.05596,-0.070151,0,0
5,NEURON DIFFERENTIATION,0.92682,-0.05615,-0.014227,0,0
5,REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX,0.099158,-0.056347,-0.14768,0,0
5,HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDESCATALYZING TRANSMEMBRANE MOVEMENT OF SUBSTANCES,0.27999,-0.056683,-0.076298,0,0
5,ENZYME INHIBITOR ACTIVITY,0.17099,-0.056988,-0.072632,0,0
5,NEUROPEPTIDE BINDING,0.26847,-0.057105,-0.10013,0,0
5,NEUROPEPTIDE RECEPTOR ACTIVITY,0.26847,-0.057105,-0.10013,0,0
5,KEGG TYPE II DIABETES MELLITUS,0.4545,-0.057116,-0.039127,0,0
5,REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK,0.041093,-0.057124,-0.067764,0,0
5,REACTOME NETRIN1 SIGNALING,0.62732,-0.057212,-0.033737,0,0
5,PID ERBB NETWORK PATHWAY,0.43883,-0.057353,-0.11432,0,0
5,REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES,0.085627,-0.057629,-0.0898,0,0
5,REACTOME RAF MAP KINASE CASCADE,0.94073,-0.057869,0.0032166,0,0
5,REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX ,0.11235,-0.057897,-0.052952,0,0
5,REACTOME SHC MEDIATED SIGNALLING,0.2839,-0.057899,-0.042574,0,0
5,PHOSPHOLIPASE C ACTIVATION,0.43883,-0.057985,-0.046463,0,0
5,KEGG GLIOMA,0.11636,-0.058035,-0.053685,0,0
5,VESICLE COAT,0.55487,-0.058105,-0.048529,0,0
5,PID INTEGRIN2 PATHWAY,0.12259,-0.058115,-0.14975,0,0
5,KEGG ADHERENS JUNCTION,0.19095,-0.058271,-0.070245,0,0
5,PID TGFBRPATHWAY,0.12473,-0.058289,-0.11161,0,0
5,CYSTEINE TYPE PEPTIDASE ACTIVITY,0.19695,-0.058507,-0.067087,0,0
5,PID GLYPICAN 1PATHWAY,0.42855,-0.058589,-0.074877,0,0
5,PID S1P S1P2 PATHWAY,0.31653,-0.05861,-0.046144,0,0
5,STEROID HORMONE RECEPTOR BINDING,0.25001,-0.058821,-0.091552,0,0
5,REACTOME PI3K EVENTS IN ERBB4 SIGNALING,0.49227,-0.058828,-0.01397,0,0
5,NUCLEOBASENUCLEOSIDENUCLEOTIDE KINASE ACTIVITY,0.44402,-0.05908,-0.033963,0,0
5,REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS ,0.44924,-0.059169,-0.094439,0,0
5,ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY,0.41842,-0.059238,-0.084412,0,0
5,KEGG LONG TERM POTENTIATION,0.14048,-0.05924,-0.067735,0,0
5,REACTOME DEADENYLATION DEPENDENT MRNA DECAY,0.060602,-0.059471,-0.076999,0,0
5,REACTOME PLATELET AGGREGATION PLUG FORMATION,0.1313,-0.059671,-0.083355,0,0
5,MUSCLE CELL DIFFERENTIATION,0.34702,-0.059804,-0.089908,0,0
5,KEGG TIGHT JUNCTION,0.099158,-0.060117,-0.072537,0,0
5,PID ALK1PATHWAY,0.11039,-0.060147,-0.10609,0,0
5,NADH DEHYDROGENASE COMPLEX,0.39858,-0.060258,-0.080116,0,0
5,MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I,0.39858,-0.060258,-0.080116,0,0
5,RESPIRATORY CHAIN COMPLEX I,0.39858,-0.060258,-0.080116,0,0
5,SH3 DOMAIN BINDING,0.48678,-0.060277,-0.044826,0,0
5,REGULATION OF T CELL PROLIFERATION,0.34702,-0.060319,-0.074634,0,0
5,PID LYSOPHOSPHOLIPID PATHWAY,0.29992,-0.060745,-0.06371,0,0
5,LOCOMOTORY BEHAVIOR,0.13355,-0.060747,-0.076342,0,0
5,ENDOSOME,0.092194,-0.060768,-0.092162,0,0
5,ADP BINDING,0.19393,-0.060928,-0.094717,0,0
5,REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND,0.63354,-0.061041,-0.027837,0,0
5,REACTOME GAP JUNCTION ASSEMBLY,0.40843,-0.061062,-0.052352,0,0
5,PID HNF3BPATHWAY,0.36064,-0.061363,-0.059889,0,0
5,SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES,0.15264,-0.061379,-0.090564,0,0
5,REACTOME REGULATION OF IFNA SIGNALING,0.44924,-0.061565,-0.055134,0,0
5,REACTOME G1 S TRANSITION,0.23589,-0.061641,-0.055614,0,0
5,REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC,0.17653,-0.061895,-0.10291,0,0
5,REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS,0.56075,-0.062014,-0.079587,0,0
5,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER,0.11039,-0.062037,-0.06972,0,0
5,PID KITPATHWAY,0.55487,-0.06205,-0.022654,0,0
5,BIOCARTA KERATINOCYTE PATHWAY,0.18508,-0.062123,-0.10222,0,0
5,LEADING EDGE,0.22905,-0.062129,-0.081397,0,0
5,PID NOTCH PATHWAY,0.18508,-0.062314,-0.073135,0,0
5,PID GMCSF PATHWAY,0.14048,-0.062448,-0.086465,0,0
5,BIOCARTA CDC42RAC PATHWAY,0.29992,-0.062706,-0.081428,0,0
5,RESPONSE TO NUTRIENT LEVELS,0.41842,-0.062886,-0.068101,0,0
5,NUCLEASE ACTIVITY,0.057089,-0.062913,-0.062036,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.15517,-0.063046,-0.081128,0,0
5,ST GA12 PATHWAY,0.12049,-0.063046,-0.095264,0,0
5,PID SMAD2 3PATHWAY,0.50337,-0.063478,-0.036234,0,0
5,PID RET PATHWAY,0.2839,-0.064094,-0.051493,0,0
5,BIOCARTA TNFR2 PATHWAY,0.097379,-0.064155,-0.14985,0,0
5,PROTEIN PROCESSING,0.14526,-0.064162,-0.057785,0,0
5,KEGG CHEMOKINE SIGNALING PATHWAY,0.033894,-0.064206,-0.076947,0,0
5,G1 S TRANSITION OF MITOTIC CELL CYCLE,0.40349,-0.064323,-0.035775,0,0
5,VOLTAGE GATED CATION CHANNEL ACTIVITY,0.30815,-0.064386,-0.073066,0,0
5,KEGG AXON GUIDANCE,0.25363,-0.064696,-0.070654,0,0
5,BIOCARTA D4GDI PATHWAY,0.20621,-0.064978,-0.14063,0,0
5,TRANSCRIPTION COREPRESSOR ACTIVITY,0.049546,-0.065168,-0.063645,0,0
5,GLUTAMATE SIGNALING PATHWAY,0.31232,-0.065476,-0.086489,0,0
5,PML BODY,0.35607,-0.065543,-0.077301,0,0
5,REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY,0.14048,-0.065874,-0.059336,0,0
5,REACTOME S PHASE,0.10845,-0.065998,-0.083137,0,0
5,REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA,0.3746,-0.066015,-0.069113,0,0
5,BIOCARTA ERK5 PATHWAY,0.15264,-0.066063,-0.074905,0,0
5,COFACTOR TRANSPORTER ACTIVITY,0.23937,-0.066079,-0.13337,0,0
5,TRANSMISSION OF NERVE IMPULSE,0.16828,-0.066168,-0.056484,0,0
5,ADAPTIVE IMMUNE RESPONSE GO 0002460,0.28785,-0.067111,-0.074861,0,0
5,PID IGF1 PATHWAY,0.088862,-0.067171,-0.06832,0,0
5,PROTEIN SERINE THREONINE KINASE ACTIVITY,0.188,-0.067212,-0.038448,0,0
5,KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY,0.04854,-0.067514,-0.11204,0,0
5,PID DELTANP63PATHWAY,0.46512,-0.067726,-0.074132,0,0
5,BIOCARTA CASPASE PATHWAY,0.5726,-0.067749,-0.081777,0,0
5,ISOPRENOID METABOLIC PROCESS,0.14285,-0.067829,-0.15753,0,0
5,BIOCARTA IL3 PATHWAY,0.21256,-0.068017,-0.11134,0,0
5,CELL CORTEX,0.11434,-0.068095,-0.073732,0,0
5,REACTOME POTASSIUM CHANNELS,0.35153,-0.068327,-0.026728,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE,0.29184,-0.06842,-0.047441,0,0
5,ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.20309,-0.068463,-0.06095,0,0
5,REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,0.1028,-0.068694,-0.1004,0,0
5,KEGG MELANOMA,0.082489,-0.068786,-0.073738,0,0
5,REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS,0.21256,-0.068989,-0.07882,0,0
5,HISTONE DEACETYLASE BINDING,0.057089,-0.069095,-0.11412,0,0
5,DIGESTION,0.41842,-0.06916,-0.07868,0,0
5,MAPKKK CASCADE GO 0000165,0.079444,-0.069468,-0.083177,0,0
5,REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.060602,-0.069682,-0.10417,0,0
5,REGULATION OF CELL GROWTH,0.075049,-0.069861,-0.12626,0,0
5,NEGATIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.082489,-0.070063,-0.10158,0,0
5,KEGG APOPTOSIS,0.16032,-0.070104,-0.090613,0,0
5,KEGG GNRH SIGNALING PATHWAY,0.05161,-0.070123,-0.078573,0,0
5,REACTOME M G1 TRANSITION,0.12908,-0.070128,-0.089484,0,0
5,REACTOME PIP3 ACTIVATES AKT SIGNALING,0.53742,-0.070135,-0.019151,0,0
5,ORGAN DEVELOPMENT,0.0020453,-0.070223,-0.10672,0,0
5,BIOCARTA NOS1 PATHWAY,0.35153,-0.070476,-0.066716,0,0
5,REACTOME HIV INFECTION,0.087232,-0.070752,-0.068004,0,0
5,ADAPTIVE IMMUNE RESPONSE,0.32077,-0.070932,-0.068185,0,0
5,DNA DIRECTED RNA POLYMERASE COMPLEX,0.10096,-0.071061,-0.083778,0,0
5,RNA POLYMERASE COMPLEX,0.10096,-0.071061,-0.083778,0,0
5,NUCLEAR DNA DIRECTED RNA POLYMERASE COMPLEX,0.10096,-0.071061,-0.083778,0,0
5,CELLULAR MORPHOGENESIS DURING DIFFERENTIATION,0.62732,-0.071369,-0.039674,0,0
5,TRANSCRIPTION FACTOR BINDING,0.055956,-0.071485,-0.043182,0,0
5,REACTOME ORC1 REMOVAL FROM CHROMATIN,0.064293,-0.07189,-0.10999,0,0
5,REACTOME SIGNALING BY GPCR,0.011904,-0.071939,-0.079066,0,0
5,REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING,0.031748,-0.07212,-0.11625,0,0
5,NUCLEAR PORE,0.29586,-0.072319,-0.056952,0,0
5,BIOCARTA GH PATHWAY,0.16294,-0.073006,-0.076251,0,0
5,INTERPHASE,0.11636,-0.073268,-0.053177,0,0
5,IMMUNE SYSTEM PROCESS,0.077957,-0.073468,-0.08443,0,0
5,REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.092194,-0.073541,-0.10486,0,0
5,BIOCARTA SPPA PATHWAY,0.3746,-0.073601,-0.051306,0,0
5,REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS,0.22235,-0.074311,-0.063745,0,0
5,PID AURORA B PATHWAY,0.24288,-0.074433,-0.074313,0,0
5,BIOCARTA DEATH PATHWAY,0.38408,-0.074652,-0.11937,0,0
5,REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX,0.27227,-0.074751,-0.050815,0,0
5,RESPONSE TO HYPOXIA,0.32938,-0.074774,-0.06493,0,0
5,REGULATION OF SYNAPSE STRUCTURE AND ACTIVITY,0.14048,-0.074814,-0.11304,0,0
5,CARBOXYLESTERASE ACTIVITY,0.075049,-0.074822,-0.10304,0,0
5,KEGG BUTANOATE METABOLISM,0.11636,-0.074992,-0.10239,0,0
5,G PROTEIN COUPLED RECEPTOR BINDING,0.29992,-0.075024,-0.075031,0,0
5,REACTOME G ALPHA Q SIGNALLING EVENTS,0.031059,-0.07504,-0.078317,0,0
5,REACTOME REGULATION OF BETA CELL DEVELOPMENT,0.50337,-0.075142,-0.031152,0,0
5,COATED VESICLE MEMBRANE,0.36991,-0.07537,-0.0674,0,0
5,REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER,0.14769,-0.075462,-0.082509,0,0
5,ST WNT BETA CATENIN PATHWAY,0.14526,-0.075825,-0.096132,0,0
5,REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES,0.62732,-0.075833,-0.020524,0,0
5,CORTICAL ACTIN CYTOSKELETON,0.69061,-0.075854,-0.035223,0,0
5,REACTOME GAP JUNCTION TRAFFICKING,0.27227,-0.075873,-0.064894,0,0
5,REACTOME SIGNALING BY ILS,0.061812,-0.076087,-0.094609,0,0
5,POLYSACCHARIDE BINDING,0.10654,-0.076163,-0.10486,0,0
5,ANTIPORTER ACTIVITY,0.19095,-0.076226,-0.10903,0,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS CHONDROITIN SULFATE,0.62113,-0.076332,-0.057414,0,0
5,BETA TUBULIN BINDING,0.35153,-0.076429,-0.088033,0,0
5,PID S1P META PATHWAY,0.22235,-0.076433,-0.087784,0,0
5,CYTOCHROME C OXIDASE ACTIVITY,0.060602,-0.076514,-0.14107,0,0
5,LIPID TRANSPORTER ACTIVITY,0.55487,-0.076675,-0.066643,0,0
5,MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.093897,-0.076862,-0.094898,0,0
5,KEGG STEROID BIOSYNTHESIS,0.48678,-0.076977,-0.086347,0,0
5,DI   TRI VALENT INORGANIC CATION TRANSPORT,0.31232,-0.077065,-0.072317,0,0
5,CELL SUBSTRATE ADHERENS JUNCTION,0.28785,-0.077073,-0.10291,0,0
5,REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS,0.33812,-0.077235,-0.05377,0,0
5,POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.099158,-0.077256,-0.07739,0,0
5,ENDOCYTIC VESICLE,0.20309,-0.07726,-0.10163,0,0
5,KEGG VEGF SIGNALING PATHWAY,0.15264,-0.077715,-0.051138,0,0
5,CELL CELL SIGNALING,0.073629,-0.077832,-0.069368,0,0
5,REACTOME ION CHANNEL TRANSPORT,0.14048,-0.077858,-0.06209,0,0
5,HEART DEVELOPMENT,0.16828,-0.077943,-0.064161,0,0
5,REACTOME SIGNALING BY NOTCH4,0.94769,-0.077977,0.019586,0,0
5,N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.079444,-0.07805,-0.13874,0,0
5,KEGG PARKINSONS DISEASE,0.025994,-0.078073,-0.12465,0,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR,0.34256,-0.078234,-0.074512,0,0
5,TRANSCRIPTION COFACTOR ACTIVITY,0.075049,-0.078422,-0.04007,0,0
5,AXON GUIDANCE,0.95466,-0.078747,0.020298,0,0
5,SODIUM ION TRANSPORT,0.59664,-0.079107,-0.053695,0,0
5,REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,0.31232,-0.079226,-0.14562,0,0
5,SPHINGOID METABOLIC PROCESS,0.16828,-0.079539,-0.1053,0,0
5,RIBONUCLEASE ACTIVITY,0.15517,-0.079564,-0.074367,0,0
5,BILE ACID METABOLIC PROCESS,0.4978,-0.079706,-0.091682,0,0
5,SERINE TYPE ENDOPEPTIDASE ACTIVITY,0.02268,-0.07992,-0.15099,0,0
5,PHOSPHOLIPID TRANSPORTER ACTIVITY,0.20621,-0.080053,-0.10097,0,0
5,SIG PIP3 SIGNALING IN CARDIAC MYOCTES,0.075049,-0.080456,-0.074958,0,0
5,SKELETAL MUSCLE DEVELOPMENT,0.12908,-0.080811,-0.10058,0,0
5,BIOCARTA BCR PATHWAY,0.26098,-0.080877,-0.05019,0,0
5,KEGG LONG TERM DEPRESSION,0.0047853,-0.080914,-0.1258,0,0
5,REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX,0.055956,-0.080957,-0.13252,0,0
5,SECRETORY PATHWAY,0.054842,-0.080987,-0.076358,0,0
5,PROTEIN TYROSINE PHOSPHATASE ACTIVITY,0.26847,-0.081037,-0.062757,0,0
5,REACTOME THE NLRP3 INFLAMMASOME,0.088862,-0.081188,-0.12599,0,0
5,DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX,0.15264,-0.081684,-0.12731,0,0
5,INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.060602,-0.081838,-0.14658,0,0
5,CELL JUNCTION,0.21256,-0.081855,-0.073985,0,0
5,B CELL DIFFERENTIATION,0.27611,-0.08217,-0.073452,0,0
5,BIOCARTA ARF PATHWAY,0.050569,-0.082444,-0.16939,0,0
5,PID EPOPATHWAY,0.50337,-0.082676,-0.046215,0,0
5,REACTOME GAP JUNCTION DEGRADATION,0.33812,-0.08286,-0.082227,0,0
5,REACTOME ERK MAPK TARGETS,0.62113,-0.082919,-0.015429,0,0
5,PID FOXM1PATHWAY,0.12908,-0.082977,-0.085979,0,0
5,PROTEIN DEACETYLASE ACTIVITY,0.10096,-0.083282,-0.097777,0,0
5,DNA DAMAGE RESPONSESIGNAL TRANSDUCTION RESULTING IN INDUCTION OF APOPTOSIS,0.95466,-0.083461,-0.027068,0,0
5,KEGG MATURITY ONSET DIABETES OF THE YOUNG,0.36991,-0.083472,-0.11322,0,0
5,REACTOME SHC1 EVENTS IN ERBB4 SIGNALING,0.060602,-0.083491,-0.10435,0,0
5,KEGG HEDGEHOG SIGNALING PATHWAY,0.12049,-0.083576,-0.082003,0,0
5,REGULATION OF ENDOCYTOSIS,0.20937,-0.083667,-0.10204,0,0
5,RNA HELICASE ACTIVITY,0.0695,-0.08368,-0.097244,0,0
5,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL,0.24643,-0.083766,-0.14876,0,0
5,CELL MIGRATION,0.16828,-0.083887,-0.072537,0,0
5,BIOCARTA BARR MAPK PATHWAY,0.25363,-0.084071,-0.070632,0,0
5,REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10,0.28785,-0.084231,-0.13903,0,0
5,RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.19095,-0.084577,-0.085921,0,0
5,PID HNF3APATHWAY,0.23245,-0.08468,-0.074623,0,0
5,GOLGI ASSOCIATED VESICLE,0.093897,-0.08494,-0.076577,0,0
5,KEGG GAP JUNCTION,0.020205,-0.08553,-0.087637,0,0
5,PDZ DOMAIN BINDING,0.22568,-0.085536,-0.062493,0,0
5,REGULATION OF TRANSPORT,0.080955,-0.085638,-0.072887,0,0
5,SA CASPASE CASCADE,0.50896,-0.085829,-0.048649,0,0
5,BIOCARTA EGF PATHWAY,0.18219,-0.086308,-0.085903,0,0
5,PID P38 MKK3 6PATHWAY,0.19393,-0.086312,-0.081984,0,0
5,REGULATION OF NEURON APOPTOSIS,0.33812,-0.086621,-0.060123,0,0
5,REACTOME RNA POL III CHAIN ELONGATION,0.1313,-0.086626,-0.10148,0,0
5,REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS,0.10096,-0.08664,-0.094581,0,0
5,PORE COMPLEX,0.16294,-0.087167,-0.070445,0,0
5,ST ADRENERGIC,0.10465,-0.087342,-0.085279,0,0
5,PID WNT CANONICAL PATHWAY,0.070855,-0.087512,-0.075914,0,0
5,EXTRACELLULAR SPACE,0.049546,-0.087587,-0.10665,0,0
5,APOPTOTIC PROGRAM,0.14048,-0.087843,-0.064744,0,0
5,POSITIVE REGULATION OF CELL CYCLE,0.12908,-0.087965,-0.1456,0,0
5,GENERATION OF NEURONS,0.55487,-0.088073,-0.035646,0,0
5,KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY,0.090515,-0.088185,-0.10655,0,0
5,SPHINGOLIPID METABOLIC PROCESS,0.11841,-0.08827,-0.083618,0,0
5,BIOCARTA PYK2 PATHWAY,0.18508,-0.088271,-0.052463,0,0
5,REACTOME APOPTOSIS,0.087232,-0.088273,-0.089586,0,0
5,BIOCARTA HSP27 PATHWAY,0.059411,-0.088282,-0.14188,0,0
5,RECEPTOR SIGNALING PROTEIN ACTIVITY,0.0039469,-0.088318,-0.11723,0,0
5,REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1,0.90599,-0.08855,-0.012045,0,0
5,PID CMYB PATHWAY,0.15264,-0.088763,-0.065897,0,0
5,DOUBLE STRANDED DNA BINDING,0.5726,-0.088901,-0.035748,0,0
5,ER NUCLEAR SIGNALING PATHWAY,0.27999,-0.089198,-0.061672,0,0
5,NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.097379,-0.089311,-0.11986,0,0
5,DEACETYLASE ACTIVITY,0.10654,-0.089329,-0.088736,0,0
5,NEUROPEPTIDE SIGNALING PATHWAY,0.63978,-0.089721,0.017838,0,0
5,NEUROLOGICAL SYSTEM PROCESS,0.017549,-0.089979,-0.08142,0,0
5,REACTOME TIE2 SIGNALING,0.46512,-0.090201,-0.038703,0,0
5,REACTOME G ALPHA S SIGNALLING EVENTS,0.24643,-0.090317,-0.045898,0,0
5,REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.090823,-0.082011,0,0
5,REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A,0.04854,-0.090906,-0.1128,0,0
5,BIOCARTA SODD PATHWAY,0.26471,-0.091157,-0.17649,0,0
5,POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.090515,-0.091171,-0.14781,0,0
5,PID IL4 2PATHWAY,0.17934,-0.091418,-0.088369,0,0
5,NEUROGENESIS,0.38408,-0.091515,-0.058314,0,0
5,MYOBLAST DIFFERENTIATION,0.23937,-0.091806,-0.14262,0,0
5,GLYCOSAMINOGLYCAN BINDING,0.12259,-0.091817,-0.10818,0,0
5,PID INSULIN GLUCOSE PATHWAY,0.13814,-0.091854,-0.083731,0,0
5,EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13583,-0.091994,-0.11154,0,0
5,PROTEIN EXPORT FROM NUCLEUS,0.12259,-0.092159,-0.077464,0,0
5,BIOCARTA IGF1 PATHWAY,0.11841,-0.092231,-0.082784,0,0
5,ANTIGEN BINDING,0.053746,-0.092245,-0.097349,0,0
5,NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.29586,-0.092587,-0.073711,0,0
5,NEURITE DEVELOPMENT,0.35607,-0.092848,-0.08432,0,0
5,VOLTAGE GATED CHANNEL ACTIVITY,0.21256,-0.092886,-0.082733,0,0
5,REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN,0.20621,-0.092984,-0.063115,0,0
5,POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS,0.04854,-0.093025,-0.10423,0,0
5,BIOCARTA GLEEVEC PATHWAY,0.14526,-0.093192,-0.083584,0,0
5,REACTOME APOPTOTIC EXECUTION PHASE,0.38408,-0.093226,-0.054729,0,0
5,REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS,0.14285,-0.093407,-0.12597,0,0
5,BIOCARTA EPONFKB PATHWAY,0.1313,-0.093824,-0.15144,0,0
5,REACTOME INSULIN RECEPTOR RECYCLING,0.55487,-0.0942,-0.057348,0,0
5,KEGG PRIMARY IMMUNODEFICIENCY,0.10096,-0.094283,-0.10999,0,0
5,SIG CHEMOTAXIS,0.036948,-0.094672,-0.093044,0,0
5,PID ER NONGENOMIC PATHWAY,0.16828,-0.094867,-0.088021,0,0
5,CYTOSOLIC PART,0.080955,-0.094902,-0.11446,0,0
5,BEHAVIOR,0.014486,-0.095133,-0.081349,0,0
5,CATION CHANNEL ACTIVITY,0.13355,-0.095197,-0.1006,0,0
5,SENSORY PERCEPTION,0.00063551,-0.09545,-0.10355,0,0
5,KEGG REGULATION OF AUTOPHAGY,0.020205,-0.095545,-0.10812,0,0
5,GTP BINDING,0.079444,-0.095649,-0.07735,0,0
5,B CELL ACTIVATION,0.13355,-0.09576,-0.10623,0,0
5,PID IL2 STAT5PATHWAY,0.057089,-0.095877,-0.14779,0,0
5,ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.084046,-0.096064,-0.14415,0,0
5,AXONOGENESIS,0.41842,-0.096067,-0.074552,0,0
5,REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA,0.066855,-0.096124,-0.14494,0,0
5,ANION CATION SYMPORTER ACTIVITY,0.17374,-0.096128,-0.11722,0,0
5,REACTOME PYRIMIDINE METABOLISM,0.093897,-0.096311,-0.11994,0,0
5,CATION TRANSPORT,0.072231,-0.096331,-0.10028,0,0
5,REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,0.18508,-0.096348,-0.055772,0,0
5,KEGG VASCULAR SMOOTH MUSCLE CONTRACTION,0.00026903,-0.096382,-0.13736,0,0
5,BIOCARTA IL22BP PATHWAY,0.2839,-0.096459,-0.13443,0,0
5,PID THROMBIN PAR1 PATHWAY,0.014138,-0.09679,-0.13839,0,0
5,REACTOME L1CAM INTERACTIONS,0.23589,-0.096898,-0.070101,0,0
5,REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE,0.070855,-0.097022,-0.14174,0,0
5,TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.17934,-0.097459,-0.071386,0,0
5,KEGG MTOR SIGNALING PATHWAY,0.073629,-0.097614,-0.057813,0,0
5,EXCITATORY EXTRACELLULAR LIGAND GATED ION CHANNEL ACTIVITY,0.17099,-0.097646,-0.14665,0,0
5,INTRACELLULAR RECEPTOR MEDIATED SIGNALING PATHWAY,0.14526,-0.097783,-0.043396,0,0
5,STRIATED MUSCLE DEVELOPMENT,0.080955,-0.098011,-0.10275,0,0
5,NEGATIVE REGULATION OF SIGNAL TRANSDUCTION,0.075049,-0.09854,-0.10219,0,0
5,BIOCARTA CARM1 PATHWAY,0.25363,-0.099059,-0.079356,0,0
5,BIOCARTA UCALPAIN PATHWAY,0.2839,-0.099254,-0.1051,0,0
5,ADHERENS JUNCTION,0.36064,-0.09933,-0.07349,0,0
5,REACTOME PROLACTIN RECEPTOR SIGNALING,0.055956,-0.099763,-0.11544,0,0
5,CELL CELL ADHESION,0.27611,-0.099823,-0.059417,0,0
5,REACTOME TRAF6 MEDIATED IRF7 ACTIVATION,0.52025,-0.099837,-0.076792,0,0
5,SMAD BINDING,0.082489,-0.099922,-0.10549,0,0
5,METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.13355,-0.099929,-0.091892,0,0
5,LIPOPROTEIN BINDING,0.17934,-0.101,-0.077507,0,0
5,BIOCARTA VDR PATHWAY,0.085627,-0.10106,-0.15318,0,0
5,KEGG ERBB SIGNALING PATHWAY,0.11434,-0.1012,-0.056006,0,0
5,ATP DEPENDENT HELICASE ACTIVITY,0.19095,-0.10205,-0.065661,0,0
5,PHOSPHOINOSITIDE BINDING,0.4545,-0.10241,-0.052896,0,0
5,POSITIVE REGULATION OF ANGIOGENESIS,0.050569,-0.10306,-0.21593,0,0
5,ANATOMICAL STRUCTURE MORPHOGENESIS,0.0006154,-0.10319,-0.12538,0,0
5,HORMONE ACTIVITY,0.52025,-0.10349,-0.070549,0,0
5,REACTOME NEURONAL SYSTEM,0.36991,-0.10406,-0.033562,0,0
5,REACTOME DARPP 32 EVENTS,0.27999,-0.10448,-0.076403,0,0
5,RESPONSE TO NUTRIENT,0.21579,-0.10476,-0.11596,0,0
5,METAL ION TRANSPORT,0.060602,-0.10499,-0.10502,0,0
5,APICAL PART OF CELL,0.16559,-0.10506,-0.12277,0,0
5,RESPONSE TO EXTRACELLULAR STIMULUS,0.12259,-0.1051,-0.097416,0,0
5,PID AVB3 OPN PATHWAY,0.19393,-0.10521,-0.14177,0,0
5,BIOCARTA ARENRF2 PATHWAY,0.41842,-0.10524,-0.071642,0,0
5,REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP,0.23937,-0.10537,-0.068957,0,0
5,INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.066855,-0.10565,-0.10368,0,0
5,BIOCARTA PROTEASOME PATHWAY,0.11841,-0.10578,-0.13609,0,0
5,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS LACTO AND NEOLACTO SERIES,0.11841,-0.10597,-0.12396,0,0
5,DEPHOSPHORYLATION,0.27227,-0.10598,-0.045349,0,0
5,STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.15517,-0.10599,-0.044799,0,0
5,KEGG MELANOGENESIS,0.070855,-0.10628,-0.072545,0,0
5,SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0041716,-0.10631,-0.13571,0,0
5,REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS,0.11636,-0.1064,-0.12608,0,0
5,TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.073629,-0.10647,-0.14381,0,0
5,PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.14048,-0.10651,-0.11528,0,0
5,REACTOME ENOS ACTIVATION AND REGULATION,0.080955,-0.10669,-0.1012,0,0
5,STRUCTURAL CONSTITUENT OF CYTOSKELETON,0.046579,-0.10683,-0.15589,0,0
5,TRANSPORT,2.9301e-06,-0.10684,-0.12606,0,0
5,BIOCARTA GSK3 PATHWAY,0.16559,-0.10685,-0.093591,0,0
5,ST ERK1 ERK2 MAPK PATHWAY,0.064293,-0.10702,-0.10707,0,0
5,PHOSPHORIC ESTER HYDROLASE ACTIVITY,0.0028141,-0.10729,-0.12461,0,0
5,NEURON DEVELOPMENT,0.25363,-0.10773,-0.08427,0,0
5,MONOVALENT INORGANIC CATION TRANSPORT,0.059411,-0.10783,-0.11095,0,0
5,PID TCRRASPATHWAY,0.23245,-0.108,-0.056897,0,0
5,RNA POLYMERASE ACTIVITY,0.10845,-0.10828,-0.095013,0,0
5,DEVELOPMENTAL MATURATION,0.24288,-0.10845,-0.10352,0,0
5,REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS,0.097379,-0.10892,-0.12753,0,0
5,BIOCARTA VIP PATHWAY,0.084046,-0.10926,-0.10569,0,0
5,KEGG VIBRIO CHOLERAE INFECTION,0.084046,-0.10945,-0.07821,0,0
5,PROTEIN AMINO ACID DEPHOSPHORYLATION,0.26098,-0.10948,-0.049957,0,0
5,REGULATION OF CELLULAR COMPONENT SIZE,0.085627,-0.10997,-0.1804,0,0
5,HEMOPOIESIS,0.04854,-0.10997,-0.097866,0,0
5,REGULATION OF PHOSPHORYLATION,0.075049,-0.11,-0.11841,0,0
5,BIOCARTA EPO PATHWAY,0.14526,-0.11013,-0.10289,0,0
5,REACTOME EICOSANOID LIGAND BINDING RECEPTORS,0.052669,-0.11048,-0.12553,0,0
5,REACTOME P2Y RECEPTORS,0.0021062,-0.11061,-0.1676,0,0
5,REACTOME TRAF6 MEDIATED NFKB ACTIVATION,0.057089,-0.11078,-0.1314,0,0
5,REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,0.17374,-0.11086,-0.14515,0,0
5,REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS,0.00098941,-0.11119,-0.22498,0,0
5,REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY,0.188,-0.11156,-0.10158,0,0
5,REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D,0.014486,-0.11186,-0.1316,0,0
5,NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.061812,-0.1124,-0.12155,0,0
5,ATP DEPENDENT RNA HELICASE ACTIVITY,0.040234,-0.11243,-0.12394,0,0
5,REACTOME TIGHT JUNCTION INTERACTIONS,0.32506,-0.11313,-0.0444,0,0
5,REGULATION OF HOMEOSTATIC PROCESS,0.19695,-0.11335,-0.15385,0,0
5,BIOCARTA COMP PATHWAY,0.17374,-0.11358,-0.13983,0,0
5,PID CIRCADIANPATHWAY,0.079444,-0.11369,-0.10888,0,0
5,BIOCARTA ERK PATHWAY,0.059411,-0.1137,-0.10437,0,0
5,MRNA BINDING,0.04854,-0.11374,-0.11367,0,0
5,REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS,0.26847,-0.11376,-0.098145,0,0
5,TRANSPORT VESICLE,0.052669,-0.11381,-0.12717,0,0
5,N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.070855,-0.11391,-0.098182,0,0
5,BIOCARTA PS1 PATHWAY,0.065563,-0.11429,-0.11483,0,0
5,BIOCARTA CACAM PATHWAY,0.19095,-0.11432,-0.09883,0,0
5,BIOCARTA TEL PATHWAY,0.10465,-0.11455,-0.1444,0,0
5,REGULATION OF CELL DIFFERENTIATION,0.093897,-0.11461,-0.099856,0,0
5,PEPTIDYL TYROSINE PHOSPHORYLATION,0.053746,-0.11467,-0.13367,0,0
5,INTERCELLULAR JUNCTION,0.14285,-0.11492,-0.10615,0,0
5,BIOCARTA AKAP13 PATHWAY,0.05161,-0.11553,-0.1518,0,0
5,REACTOME INTERACTION BETWEEN L1 AND ANKYRINS,0.34702,-0.11554,-0.056867,0,0
5,BIOCARTA EDG1 PATHWAY,0.097379,-0.1156,-0.08411,0,0
5,UDP GLYCOSYLTRANSFERASE ACTIVITY,0.090515,-0.11583,-0.15615,0,0
5,REGULATION OF PROTEIN STABILITY,0.001986,-0.11612,-0.14379,0,0
5,VESICLE MEDIATED TRANSPORT,4.2876e-06,-0.11639,-0.14666,0,0
5,G2 M TRANSITION OF MITOTIC CELL CYCLE,0.023205,-0.11703,-0.18738,0,0
5,KEGG WNT SIGNALING PATHWAY,0.00084609,-0.11704,-0.1178,0,0
5,PEPTIDYL TYROSINE MODIFICATION,0.066855,-0.11717,-0.12772,0,0
5,HEMATOPOIETIN INTERFERON CLASSD200 DOMAIN CYTOKINE RECEPTOR ACTIVITY,0.073629,-0.11741,-0.15015,0,0
5,REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.11841,-0.11854,-0.14989,0,0
5,REACTOME PLATELET CALCIUM HOMEOSTASIS,0.29992,-0.11856,-0.085227,0,0
5,AXON,0.14048,-0.11859,-0.16957,0,0
5,ION CHANNEL ACTIVITY,0.05161,-0.11939,-0.11236,0,0
5,MEMBRANE ORGANIZATION AND BIOGENESIS,0.0006154,-0.11949,-0.12851,0,0
5,REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE,0.0695,-0.11997,-0.1053,0,0
5,CYTOKINE BINDING,0.054842,-0.12011,-0.13113,0,0
5,REGULATION OF ACTIN POLYMERIZATION AND OR DEPOLYMERIZATION,0.26098,-0.12024,-0.11878,0,0
5,GATED CHANNEL ACTIVITY,0.16032,-0.12031,-0.072329,0,0
5,REGULATION OF CELLULAR PH,0.46512,-0.12059,-0.037949,0,0
5,PROTEIN TETRAMERIZATION,0.090515,-0.12089,-0.13832,0,0
5,BIOCARTA BIOPEPTIDES PATHWAY,0.061812,-0.12158,-0.13266,0,0
5,SYSTEM PROCESS,0.0010206,-0.12172,-0.11039,0,0
5,KEGG PANTOTHENATE AND COA BIOSYNTHESIS,0.014486,-0.12187,-0.19408,0,0
5,BIOCARTA AHSP PATHWAY,0.4978,-0.12227,-0.051921,0,0
5,BIOCARTA INSULIN PATHWAY,0.080955,-0.12231,-0.088121,0,0
5,MACROMOLECULAR COMPLEX DISASSEMBLY,0.022165,-0.12253,-0.13174,0,0
5,INTEGRIN COMPLEX,0.30815,-0.12253,-0.095641,0,0
5,MONOVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.1227,-0.11352,0,0
5,RNA DEPENDENT ATPASE ACTIVITY,0.05161,-0.1227,-0.10959,0,0
5,AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.084046,-0.12339,-0.16052,0,0
5,LOW DENSITY LIPOPROTEIN BINDING,0.19095,-0.12348,-0.10699,0,0
5,KEGG ASCORBATE AND ALDARATE METABOLISM,0.15264,-0.12359,-0.13006,0,0
5,REGULATION OF ACTIN FILAMENT LENGTH,0.11039,-0.12372,-0.18381,0,0
5,VOLTAGE GATED POTASSIUM CHANNEL COMPLEX,0.12049,-0.12392,-0.12199,0,0
5,CDC42 PROTEIN SIGNAL TRANSDUCTION,0.011904,-0.12451,-0.19872,0,0
5,NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY,0.28785,-0.12451,-0.086615,0,0
5,REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS ,0.016734,-0.12458,-0.17983,0,0
5,SECRETION BY CELL,0.0087944,-0.12473,-0.11566,0,0
5,3 5 EXONUCLEASE ACTIVITY,0.011326,-0.12491,-0.17094,0,0
5,ENDOPLASMIC RETICULUM LUMEN,0.070855,-0.12491,-0.24764,0,0
5,ACTIVATION OF PROTEIN KINASE ACTIVITY,0.24643,-0.12535,-0.061011,0,0
5,CALMODULIN BINDING,0.20309,-0.12563,-0.10119,0,0
5,REACTOME RESPIRATORY ELECTRON TRANSPORT,0.016339,-0.12572,-0.18771,0,0
5,PID IL2 PI3KPATHWAY,0.077957,-0.12633,-0.10016,0,0
5,REGULATION OF AXONOGENESIS,0.61497,-0.12655,-0.10772,0,0
5,PID TRAIL PATHWAY,0.12908,-0.12673,-0.12769,0,0
5,SUBSTRATE SPECIFIC CHANNEL ACTIVITY,0.049546,-0.12673,-0.11648,0,0
5,REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS,0.14526,-0.12687,-0.14951,0,0
5,COLLAGEN BINDING,0.25001,-0.12706,-0.15159,0,0
5,HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS,0.11235,-0.12723,-0.087557,0,0
5,REGULATION OF HEART CONTRACTION,0.014486,-0.12745,-0.15722,0,0
5,POSITIVE REGULATION OF CELL ADHESION,0.064293,-0.12749,-0.21709,0,0
5,SULFOTRANSFERASE ACTIVITY,0.079444,-0.12815,-0.087993,0,0
5,SYMPORTER ACTIVITY,0.0083534,-0.12874,-0.13837,0,0
5,NEGATIVE REGULATION OF CELLULAR PROTEIN METABOLIC PROCESS,0.057089,-0.12886,-0.13256,0,0
5,POTASSIUM ION TRANSPORT,0.050569,-0.12892,-0.13019,0,0
5,BIOCARTA AGPCR PATHWAY,0.32938,-0.12895,-0.048995,0,0
5,REACTOME METABOLISM OF POLYAMINES,0.17653,-0.12913,-0.11207,0,0
5,REGULATION OF PH,0.15015,-0.12941,-0.09305,0,0
5,BIOCARTA CCR5 PATHWAY,0.33812,-0.13,-0.082205,0,0
5,REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY,0.19695,-0.13006,-0.095885,0,0
5,REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS,0.67776,-0.13008,-0.05627,0,0
5,RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY,0.32506,-0.1303,-0.082905,0,0
5,SERINE TYPE PEPTIDASE ACTIVITY,0.0011549,-0.1309,-0.20366,0,0
5,ACTIN FILAMENT POLYMERIZATION,0.11636,-0.13105,-0.16954,0,0
5,BIOCARTA TPO PATHWAY,0.11235,-0.13109,-0.08551,0,0
5,PID HDAC CLASSIII PATHWAY,0.077957,-0.13142,-0.12934,0,0
5,REACTOME SIGNALING BY NODAL,0.093897,-0.13166,-0.079671,0,0
5,NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.085627,-0.1319,-0.14753,0,0
5,PROTEIN COMPLEX DISASSEMBLY,0.046579,-0.13204,-0.11801,0,0
5,SPECIFIC TRANSCRIPTIONAL REPRESSOR ACTIVITY,0.027188,-0.13222,-0.11204,0,0
5,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHATASE ACTIVITY,0.019739,-0.13242,-0.15223,0,0
5,VITAMIN TRANSPORT,0.025994,-0.13265,-0.15127,0,0
5,REACTOME SEMA4D IN SEMAPHORIN SIGNALING,0.15264,-0.1328,-0.11425,0,0
5,REACTOME RAP1 SIGNALLING,0.068167,-0.13282,-0.13174,0,0
5,KEGG CALCIUM SIGNALING PATHWAY,7.2754e-05,-0.13283,-0.1601,0,0
5,REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1,0.0073363,-0.13288,-0.14946,0,0
5,SYNAPSE ORGANIZATION AND BIOGENESIS,0.34702,-0.13299,-0.072879,0,0
5,BIOCARTA BARRESTIN PATHWAY,0.12049,-0.1331,-0.13161,0,0
5,BIOCARTA CLASSIC PATHWAY,0.27227,-0.13369,-0.15077,0,0
5,REACTOME PI3K CASCADE,6.5149e-05,-0.13393,-0.14121,0,0
5,EXTRINSIC TO MEMBRANE,0.059411,-0.13444,-0.18019,0,0
5,REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,0.13355,-0.13467,-0.12547,0,0
5,REACTOME PHOSPHORYLATION OF THE APC C,0.17934,-0.13557,-0.082079,0,0
5,OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORSNAD OR NADP AS ACCEPTOR,0.050569,-0.13565,-0.25351,0,0
5,POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.090515,-0.13663,-0.16875,0,0
5,REACTOME SIGNALING BY NOTCH3,0.15264,-0.13711,-0.095913,0,0
5,REGULATION OF CYTOKINE PRODUCTION,0.052669,-0.13721,-0.11878,0,0
5,REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION,0.19393,-0.13785,-0.091527,0,0
5,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GLOBO SERIES,0.070855,-0.13806,-0.15675,0,0
5,BIOCARTA NO2IL12 PATHWAY,0.016734,-0.13854,-0.14345,0,0
5,REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION,0.025414,-0.13874,-0.24149,0,0
5,VIRAL INFECTIOUS CYCLE,0.052669,-0.139,-0.10737,0,0
5,PROTEIN AMINO ACID LIPIDATION,0.00059588,-0.13904,-0.18266,0,0
5,REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING,0.023741,-0.14002,-0.13606,0,0
5,REACTOME METABOLISM OF NON CODING RNA,0.17653,-0.14046,-0.076561,0,0
5,REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS,0.40349,-0.14122,-0.098356,0,0
5,EARLY ENDOSOME,0.065563,-0.1426,-0.14853,0,0
5,BIOCARTA RELA PATHWAY,0.14048,-0.14344,-0.1773,0,0
5,POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.055956,-0.1438,-0.19293,0,0
5,CORNIFIED ENVELOPE,0.097379,-0.14387,-0.22433,0,0
5,REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21,0.05824,-0.14508,-0.13077,0,0
5,CHEMOKINE ACTIVITY,0.0030654,-0.14511,-0.18319,0,0
5,CHEMOKINE RECEPTOR BINDING,0.0030654,-0.14511,-0.18319,0,0
5,LIPID RAFT,0.077957,-0.14511,-0.17321,0,0
5,SMALL GTPASE REGULATOR ACTIVITY,0.004408,-0.14517,-0.14366,0,0
5,KEGG CARDIAC MUSCLE CONTRACTION,0.0071468,-0.14537,-0.12458,0,0
5,REACTOME SIGNALING BY NOTCH1,0.0059384,-0.1467,-0.13478,0,0
5,REACTOME OTHER SEMAPHORIN INTERACTIONS,0.12049,-0.1474,-0.13803,0,0
5,PID WNT NONCANONICAL PATHWAY,0.0036303,-0.14777,-0.16239,0,0
5,NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.059411,-0.1481,-0.15975,0,0
5,APICAL PLASMA MEMBRANE,0.12259,-0.14815,-0.13928,0,0
5,PROTEIN POLYMERIZATION,0.11039,-0.14863,-0.12168,0,0
5,REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION,0.23245,-0.1488,-0.072654,0,0
5,LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00031859,-0.14905,-0.18692,0,0
5,NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.025414,-0.14919,-0.14972,0,0
5,TIGHT JUNCTION,0.19695,-0.14958,-0.078919,0,0
5,KEGG ASTHMA,0.061812,-0.15146,-0.2246,0,0
5,BIOCARTA ERYTH PATHWAY,0.092194,-0.15203,-0.18308,0,0
5,PID RAC1 REG PATHWAY,0.038561,-0.15266,-0.12945,0,0
5,KEGG INSULIN SIGNALING PATHWAY,8.4205e-05,-0.1527,-0.12496,0,0
5,ACTIVATION OF JNK ACTIVITY,0.14285,-0.15276,-0.11473,0,0
5,PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION,0.17934,-0.15281,-0.13593,0,0
5,PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR,0.4545,-0.15403,-0.050626,0,0
5,APICOLATERAL PLASMA MEMBRANE,0.1028,-0.15422,-0.10199,0,0
5,APICAL JUNCTION COMPLEX,0.1028,-0.15422,-0.10199,0,0
5,OLIGOSACCHARYL TRANSFERASE COMPLEX,0.050569,-0.15471,-0.15949,0,0
5,NEUROPEPTIDE HORMONE ACTIVITY,0.69061,-0.15481,-0.023941,0,0
5,BIOCARTA CBL PATHWAY,0.188,-0.15556,-0.11045,0,0
5,REACTOME DCC MEDIATED ATTRACTIVE SIGNALING,0.13355,-0.15572,-0.11566,0,0
5,S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY,0.0014299,-0.15596,-0.1367,0,0
5,REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS,0.011047,-0.15631,-0.14421,0,0
5,CATABOLIC PROCESS,9.7801e-06,-0.15667,-0.15628,0,0
5,OXYGEN AND REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.087232,-0.15777,-0.13094,0,0
5,N METHYLTRANSFERASE ACTIVITY,0.0097392,-0.15806,-0.15602,0,0
5,POSITIVE REGULATION OF JNK ACTIVITY,0.10845,-0.15831,-0.10328,0,0
5,CELL MATURATION,0.30815,-0.15923,-0.088536,0,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE,0.063042,-0.15996,-0.14002,0,0
5,ENERGY RESERVE METABOLIC PROCESS,0.02268,-0.16199,-0.15769,0,0
5,ORGANELLAR SMALL RIBOSOMAL SUBUNIT,0.023741,-0.16368,-0.1576,0,0
5,MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT,0.023741,-0.16368,-0.1576,0,0
5,SMALL RIBOSOMAL SUBUNIT,0.023741,-0.16368,-0.1576,0,0
5,REGULATION OF I KAPPAB KINASE NF KAPPAB CASCADE,0.059411,-0.16385,-0.18236,0,0
5,REACTOME VOLTAGE GATED POTASSIUM CHANNELS,0.018836,-0.16685,-0.13168,0,0
5,LIPID HOMEOSTASIS,0.15773,-0.16699,-0.17635,0,0
5,CONTRACTILE FIBER,0.050569,-0.167,-0.13186,0,0
5,REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY,0.072231,-0.16725,-0.17365,0,0
5,HORMONE METABOLIC PROCESS,0.024846,-0.16781,-0.15056,0,0
5,PID NECTIN PATHWAY,0.37932,-0.16782,-0.062352,0,0
5,AMINE BINDING,0.027803,-0.16878,-0.16277,0,0
5,BIOCARTA PGC1A PATHWAY,0.015574,-0.16882,-0.16433,0,0
5,CELLULAR POLYSACCHARIDE METABOLIC PROCESS,0.03245,-0.16911,-0.13568,0,0
5,REACTOME BILE ACID AND BILE SALT METABOLISM,0.0083534,-0.16968,-0.19054,0,0
5,REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION,0.11434,-0.16988,-0.11057,0,0
5,ENDOTHELIAL CELL PROLIFERATION,0.11841,-0.17025,-0.22099,0,0
5,GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.065563,-0.17208,-0.13359,0,0
5,STRESS ACTIVATED PROTEIN KINASE SIGNALING PATHWAY,0.0040578,-0.17282,-0.15087,0,0
5,REGULATION OF NEUROGENESIS,0.16294,-0.17342,-0.22383,0,0
5,KEGG PRIMARY BILE ACID BIOSYNTHESIS,0.04854,-0.17389,-0.17731,0,0
5,REGULATION OF BLOOD PRESSURE,0.12689,-0.17589,-0.16924,0,0
5,REACTOME VITAMIN B5 PANTOTHENATE METABOLISM,0.0011199,-0.17606,-0.20935,0,0
5,REACTOME TRIGLYCERIDE BIOSYNTHESIS,0.00023468,-0.17652,-0.21054,0,0
5,EXTRACELLULAR STRUCTURE ORGANIZATION AND BIOGENESIS,0.0039469,-0.17673,-0.19393,0,0
5,RESPIRATORY GASEOUS EXCHANGE,0.061812,-0.17728,-0.14833,0,0
5,PID IL5 PATHWAY,0.053746,-0.17865,-0.14449,0,0
5,KEGG TYROSINE METABOLISM,0.00069957,-0.17881,-0.17549,0,0
5,MORPHOGENESIS OF AN EPITHELIUM,0.17934,-0.17925,-0.17524,0,0
5,KEGG ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY ARVC,0.024846,-0.17979,-0.15171,0,0
5,CELLULAR COMPONENT DISASSEMBLY,0.0017641,-0.18007,-0.15286,0,0
5,KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS,0.00063551,-0.18224,-0.17573,0,0
5,REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT,6.4994e-06,-0.1824,-0.17695,0,0
5,JNK CASCADE,0.0042883,-0.18309,-0.15683,0,0
5,ANION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.8583e-05,-0.1848,-0.18003,0,0
5,CELLULAR CATABOLIC PROCESS,6.2367e-06,-0.1849,-0.17123,0,0
5,REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,0.097379,-0.18584,-0.14046,0,0
5,PID ERA GENOMIC PATHWAY,0.00067758,-0.1863,-0.16897,0,0
5,POTASSIUM CHANNEL ACTIVITY,0.040234,-0.18659,-0.16071,0,0
5,SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0049174,-0.1882,-0.22452,0,0
5,AMINE METABOLIC PROCESS,1.4963e-07,-0.18873,-0.22814,0,0
5,REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE,0.0039469,-0.18907,-0.27669,0,0
5,APOPTOTIC NUCLEAR CHANGES,0.00027832,-0.19154,-0.18437,0,0
5,REGULATION OF MYELOID CELL DIFFERENTIATION,0.099158,-0.19244,-0.21185,0,0
5,POSITIVE REGULATION OF CELL DIFFERENTIATION,0.17374,-0.19347,-0.17955,0,0
5,REGULATION OF JNK CASCADE,0.0085714,-0.1943,-0.21075,0,0
5,KERATINOCYTE DIFFERENTIATION,0.064293,-0.19672,-0.20214,0,0
5,BIOCARTA EGFR SMRTE PATHWAY,0.070855,-0.19686,-0.17275,0,0
5,AMINE CATABOLIC PROCESS,0.00014418,-0.19755,-0.21087,0,0
5,BIOCARTA IL12 PATHWAY,0.0039469,-0.19775,-0.17449,0,0
5,KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS KERATAN SULFATE,0.00045924,-0.20291,-0.28194,0,0
5,DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.099158,-0.2052,-0.15117,0,0
5,SECRETORY GRANULE,0.11636,-0.20819,-0.15075,0,0
5,CARBOHYDRATE TRANSPORT,0.0067808,-0.20973,-0.16676,0,0
5,THIOLESTER HYDROLASE ACTIVITY,0.023205,-0.21067,-0.14374,0,0
5,CELL STRUCTURE DISASSEMBLY DURING APOPTOSIS,0.0041716,-0.211,-0.16777,0,0
5,REGULATION OF ACTION POTENTIAL,0.095625,-0.21208,-0.11289,0,0
5,REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN,0.0085714,-0.21259,-0.21142,0,0
5,KEGG PROXIMAL TUBULE BICARBONATE RECLAMATION,0.00034072,-0.2129,-0.23202,0,0
5,AMINO ACID AND DERIVATIVE METABOLIC PROCESS,4.1802e-07,-0.21343,-0.23457,0,0
5,CARBONATE DEHYDRATASE ACTIVITY,0.12473,-0.21721,-0.14024,0,0
5,PID IL8CXCR1 PATHWAY,0.0042883,-0.22039,-0.23789,0,0
5,REACTOME PYRUVATE METABOLISM,5.2139e-05,-0.22321,-0.33485,0,0
5,REACTOME IL 6 SIGNALING,0.2839,-0.224,-0.18098,0,0
5,STRIATED MUSCLE CONTRACTION GO 0006941,0.0023671,-0.22491,-0.23347,0,0
5,TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYLOTHER THAN METHYLGROUPS,0.0094949,-0.22513,-0.19314,0,0
5,CALCIUM INDEPENDENT CELL CELL ADHESION,0.084046,-0.22652,-0.16487,0,0
5,NUCLEOBASENUCLEOSIDE AND NUCLEOTIDE METABOLIC PROCESS,7.2754e-05,-0.22681,-0.21736,0,0
5,CARBON OXYGEN LYASE ACTIVITY,0.00031859,-0.23167,-0.24761,0,0
5,VOLTAGE GATED SODIUM CHANNEL ACTIVITY,0.20937,-0.23503,-0.097742,0,0
5,KEGG NITROGEN METABOLISM,0.010506,-0.23714,-0.18235,0,0
5,KEGG CIRCADIAN RHYTHM MAMMAL,0.059411,-0.23863,-0.19497,0,0
5,DNA CATABOLIC PROCESS,0.00050664,-0.24063,-0.18554,0,0
5,CELLULAR CARBOHYDRATE CATABOLIC PROCESS,6.4994e-06,-0.24187,-0.25278,0,0
5,CARBOHYDRATE CATABOLIC PROCESS,6.4994e-06,-0.24187,-0.25278,0,0
5,COFACTOR TRANSPORT,0.0031536,-0.2474,-0.25278,0,0
5,BIOPOLYMER BIOSYNTHETIC PROCESS,0.00029782,-0.2479,-0.27473,0,0
5,REACTOME PHASE II CONJUGATION,0.00019753,-0.25083,-0.26341,0,0
5,NUCLEOTIDE METABOLIC PROCESS,2.4346e-05,-0.25095,-0.24248,0,0
5,ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,3.4421e-05,-0.25277,-0.23775,0,0
5,REACTOME ZINC TRANSPORTERS,0.00018427,-0.25335,-0.2328,0,0
5,COPPER ION BINDING,0.00059588,-0.25376,-0.3025,0,0
5,RIBONUCLEOTIDE METABOLIC PROCESS,0.0047853,-0.2569,-0.21659,0,0
5,REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX,0.00029782,-0.25733,-0.26743,0,0
5,PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.050569,-0.25752,-0.20928,0,0
5,HOMOPHILIC CELL ADHESION,0.13355,-0.2609,-0.17352,0,0
5,HORMONE BINDING,0.31232,-0.26223,-0.12961,0,0
5,REGULATION OF MAPKKK CASCADE,0.0015189,-0.26634,-0.21752,0,0
5,KEGG GLYCINE SERINE AND THREONINE METABOLISM,5.2139e-05,-0.26795,-0.29894,0,0
5,KEGG STARCH AND SUCROSE METABOLISM,1.0604e-05,-0.27161,-0.26837,0,0
5,HYDRO LYASE ACTIVITY,0.00032948,-0.27283,-0.27521,0,0
5,REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS,0.009256,-0.28317,-0.26383,0,0
5,OXIDOREDUCTASE ACTIVITY GO 0016705,2.0833e-05,-0.29067,-0.32763,0,0
5,RIBOSOME,0.00030804,-0.29203,-0.28595,0,0
5,REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS,0.050569,-0.29492,-0.31511,0,0
5,REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE,0.0047853,-0.29527,-0.27523,0,0
5,KEGG PHENYLALANINE METABOLISM,0.00052342,-0.30466,-0.31724,0,0
5,KEGG GLYCOSPHINGOLIPID BIOSYNTHESIS GANGLIO SERIES,0.0062634,-0.3064,-0.28869,0,0
5,REACTOME INTERFERON ALPHA BETA SIGNALING,0.1028,-0.30649,-0.29577,0,0
5,BIOCARTA CDMAC PATHWAY,0.00038934,-0.307,-0.30823,0,0
5,REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS,0.0013054,-0.31546,-0.2977,0,0
5,GLUTATHIONE TRANSFERASE ACTIVITY,0.11434,-0.32001,-0.28071,0,0
5,INOSITOL OR PHOSPHATIDYLINOSITOL PHOSPHODIESTERASE ACTIVITY,0.00045924,-0.3402,-0.27107,0,0
5,POSITIVE REGULATION OF MAPKKK CASCADE,1.2962e-05,-0.34598,-0.43488,0,0
5,REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION,0.00095906,-0.34965,-0.38201,0,0
5,DNA FRAGMENTATION DURING APOPTOSIS,3.3132e-05,-0.36117,-0.31916,0,0
5,SULFURIC ESTER HYDROLASE ACTIVITY,0.0010859,-0.36169,-0.33038,0,0
5,KEGG PENTOSE PHOSPHATE PATHWAY,6.0504e-05,-0.36808,-0.32898,0,0
5,BIOCARTA ACE2 PATHWAY,0.0087944,-0.38608,-0.40359,0,0
5,ARYLSULFATASE ACTIVITY,0.00018427,-0.44003,-0.41933,0,0
5,INORGANIC ANION TRANSPORT,8.4205e-05,-0.4413,-0.34619,0,0
5,ENDOTHELIAL CELL MIGRATION,0.095625,-0.44342,-0.31534,0,0
5,REACTOME THE ACTIVATION OF ARYLSULFATASES,3.0576e-06,-0.46451,-0.49858,0,0
